data_2jt1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jt1 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.418 ' O ' HG13 ' A' ' 9' ' ' ILE . 8.1 tp . . . . . 0 N--CA 1.471 0.613 0 CA-C-O 120.902 0.382 . . . . 73.25 111.374 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.65 -42.04 94.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 120.756 0.312 . . . . 73.11 111.018 176.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.2 m -61.13 -41.12 96.14 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.004 0.43 . . . . 73.23 110.706 175.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.426 ' O ' HG13 ' A' ' 12' ' ' ILE . 62.0 tttp -57.27 -46.39 83.13 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.201 -0.454 . . . . 53.4 110.293 173.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.469 ' O ' HG21 ' A' ' 13' ' ' VAL . 70.3 mt -55.99 -48.83 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.205 -0.452 . . . . 64.31 111.494 176.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.5 mt -57.14 -45.24 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.012 0.434 . . . . 72.41 111.112 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.6 t -57.23 -45.94 83.42 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.171 -0.468 . . . . 71.11 111.064 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 8' ' ' LYS . 94.1 mt -59.37 -45.11 93.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.223 -0.444 . . . . 51.32 111.058 176.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.469 HG21 ' O ' ' A' ' 9' ' ' ILE . 96.2 t -57.98 -49.61 80.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.486 -0.324 . . . . 72.52 111.543 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -61.99 -52.66 63.11 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.938 0.399 . . . . 74.25 111.436 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.429 ' HG2' ' HE2' ' A' ' 19' ' ' MET . 28.7 tt0 -65.2 -32.58 74.33 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.101 -0.499 . . . . 51.32 111.936 -175.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.1 mmm180 -65.69 -62.72 1.35 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 122.17 -0.331 . . . . 73.44 111.737 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -56.56 -24.33 46.41 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.263 0.554 . . . . 64.24 110.901 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -64.52 -41.02 96.64 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.76 -0.655 . . . . 71.12 110.577 172.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.429 ' HE2' ' HG2' ' A' ' 15' ' ' GLU . 65.5 mtt -82.24 -28.15 32.07 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.347 -0.388 . . . . 74.01 111.792 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -77.65 -10.49 59.54 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.676 0.274 . . . . 72.31 111.252 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 64.1 -74.75 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.431 0.692 . . . . 75.22 112.835 174.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -106.44 -11.8 26.42 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.917 -0.659 . . . . 41.21 113.395 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -103.28 141.36 22.34 Favored Pre-proline 0 CA--C 1.538 0.511 0 O-C-N 122.541 -0.387 . . . . 73.2 112.022 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.507 ' HG2' ' HB3' ' A' ' 66' ' ' LEU . 53.5 Cg_endo -71.35 -176.56 1.98 Allowed 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.483 2.122 . . . . 65.31 113.216 175.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.402 HG23 ' HA ' ' A' ' 13' ' ' VAL . 13.4 t -88.75 152.13 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.248 -0.433 . . . . 74.43 111.755 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.559 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 10.8 mptt -98.86 132.44 44.21 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.399 -0.364 . . . . 75.43 111.188 -176.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.8 m -47.42 -47.16 26.86 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.012 0.375 . . . . 65.15 112.012 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -59.22 -55.77 30.7 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.505 -0.316 . . . . 74.51 111.653 175.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -51.53 -39.59 58.0 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.188 -0.46 . . . . 74.53 112.077 -174.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.5 mt -59.69 -41.42 85.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.067 0.46 . . . . 71.22 110.919 175.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.9 -39.41 83.61 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.226 -0.443 . . . . 74.42 111.282 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -60.75 -56.63 18.95 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.957 0.408 . . . . 75.22 111.31 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.26 -45.85 90.09 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.257 -0.428 . . . . 61.23 112.04 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.98 -23.61 58.3 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.214 0.45 . . . . 74.32 112.214 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.86 44.67 23.96 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.247 -0.501 . . . . 61.22 112.558 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.3 mt -126.88 178.67 5.81 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.135 0.493 . . . . 60.41 111.623 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.1 t -87.02 147.93 25.51 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.93 -0.577 . . . . 71.23 111.339 176.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.8 mm -55.65 -44.41 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 116.308 -0.405 . . . . 73.32 112.001 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.543 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 72.1 t80 -61.49 -53.93 49.93 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 111.566 0.21 . . . . 73.34 111.566 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -51.77 -49.1 63.3 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.508 0.67 . . . . 74.24 111.383 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.3 t -60.37 -51.6 71.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.717 -0.674 . . . . 74.11 112.204 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -60.76 -27.07 67.69 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 122.387 -0.196 . . . . 72.23 111.356 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 87.5 mt -62.46 -54.64 37.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.742 0.306 . . . . 74.03 110.375 175.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -57.82 -47.49 82.47 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.043 0.449 . . . . 74.14 111.08 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.2 mt -58.74 -43.83 90.32 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.034 -0.53 . . . . 51.42 111.983 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 49' ' ' HIS . 34.8 tt0 -67.06 -40.38 87.09 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.73 0.3 . . . . 74.35 111.553 -178.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -63.41 -50.23 70.65 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.938 0.399 . . . . 62.41 110.836 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.6 mt -58.46 -31.66 68.0 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.179 0.514 . . . . 72.24 110.927 174.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.531 ' HD2' ' HA ' ' A' ' 55' ' ' GLU . 28.3 t-80 -64.61 -54.58 29.8 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.246 -0.434 . . . . 73.4 111.768 176.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -66.42 -26.27 67.15 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.011 0.375 . . . . 63.22 112.011 -173.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.501 HG23 HG23 ' A' ' 53' ' ' VAL . 26.1 m -85.34 -1.5 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 112.21 0.448 . . . . 73.41 112.21 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.33 -14.81 47.26 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 115.053 0.781 . . . . 73.44 115.053 172.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.501 HG23 HG23 ' A' ' 51' ' ' VAL . 59.8 t -62.39 -51.02 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 117.833 0.816 . . . . 73.11 111.808 -176.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 94.2 mt -114.8 154.2 29.0 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.861 0.362 . . . . 64.41 111.618 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.531 ' HA ' ' HD2' ' A' ' 49' ' ' HIS . 9.0 tp10 -121.69 147.3 46.06 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.229 0.537 . . . . 75.52 110.998 176.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.416 ' HG2' ' OE1' ' A' ' 55' ' ' GLU . 23.2 pttm -81.7 95.39 7.22 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.593 -0.73 . . . . 71.41 111.855 -178.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.485 HG11 ' HG3' ' A' ' 24' ' ' PRO . 44.0 t . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 121.505 0.669 . . . . 75.51 110.118 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.507 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 83.7 mt . . . . . 0 CA--C 1.536 0.442 0 CA-C-O 120.907 0.384 . . . . 72.42 110.665 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -111.45 132.79 54.21 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.378 0.608 . . . . 73.22 112.182 -175.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -136.76 138.13 40.6 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.744 -0.662 . . . . 73.15 110.885 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.403 ' O ' HD13 ' A' ' 69' ' ' LEU . 2.4 pp -83.23 153.23 24.82 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.806 0.336 . . . . 74.54 111.697 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 70' ' ' LEU . 1.9 pt? . . . . . 0 N--CA 1.469 0.496 0 N-CA-C 112.005 0.372 . . . . 64.01 112.005 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.477 ' H ' HD13 ' A' ' 5' ' ' ILE . 2.8 mp . . . . . 0 N--CA 1.472 0.638 0 CA-C-O 120.804 0.335 . . . . 72.43 111.493 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.5 t -60.71 -53.02 54.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.806 0.336 . . . . 70.11 111.274 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.0 m -60.41 -36.16 77.49 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.022 0.439 . . . . 71.34 111.079 177.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.517 ' O ' HG13 ' A' ' 12' ' ' ILE . 62.4 tttp -60.05 -49.05 79.2 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.213 -0.449 . . . . 73.44 111.135 176.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.434 ' HA ' HD13 ' A' ' 12' ' ' ILE . 72.9 mt -59.6 -42.97 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.7 0.286 . . . . 70.44 111.502 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.1 mt -57.43 -43.61 82.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 121.328 0.585 . . . . 73.2 110.574 174.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.7 m -66.15 -30.73 71.27 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.881 -0.599 . . . . 73.24 111.604 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 8' ' ' LYS . 94.5 mt -67.07 -47.72 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.638 0.256 . . . . 73.21 111.279 177.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.465 HG12 HD21 ' A' ' 54' ' ' LEU . 56.1 t -60.12 -45.36 95.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.841 0.353 . . . . 74.23 110.45 175.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -54.77 -48.25 72.91 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.038 -0.528 . . . . 65.55 110.629 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.541 ' O ' ' HG2' ' A' ' 19' ' ' MET . 29.2 tt0 -57.24 -65.54 0.61 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.775 -0.648 . . . . 75.13 111.452 178.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -51.51 -51.86 51.69 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.844 0.354 . . . . 72.34 111.917 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -57.42 -35.27 69.86 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.117 -0.492 . . . . 73.53 111.56 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -81.39 -26.53 35.38 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.042 0.386 . . . . 74.53 112.042 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.541 ' HG2' ' O ' ' A' ' 15' ' ' GLU . 24.3 mmt -71.22 -58.94 3.06 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.839 0.352 . . . . 72.12 111.047 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -74.29 -29.52 61.69 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.602 -0.272 . . . . 75.24 111.235 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.1 t70 69.14 -72.57 0.1 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.539 0.57 . . . . 72.15 112.539 173.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.65 41.42 3.09 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.188 -0.53 . . . . 54.02 113.161 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.19 140.26 8.49 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 112.187 0.44 . . . . 73.54 112.187 -177.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.483 ' HG2' HD13 ' A' ' 66' ' ' LEU . 54.5 Cg_endo -71.66 151.9 58.59 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.516 2.144 . . . . 71.21 112.512 172.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.1 t -80.88 150.36 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 120.906 0.384 . . . . 75.03 111.447 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.457 ' O ' HG13 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -112.24 150.25 31.17 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.697 0.284 . . . . 74.34 110.819 -179.532 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.0 m -55.65 -31.85 62.68 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.02 0.438 . . . . 64.22 111.508 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -64.17 -59.21 4.71 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.182 -0.463 . . . . 72.02 112.175 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.414 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -67.49 -20.25 65.43 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.629 0.603 . . . . 74.21 112.629 -178.439 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 26' ' ' LYS . 77.3 mt -67.93 -51.22 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.048 0.451 . . . . 73.14 110.358 170.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.518 ' HA ' HG23 ' A' ' 41' ' ' VAL . . . -58.07 -39.42 78.47 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.124 -0.489 . . . . 75.41 111.189 175.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -51.81 -52.48 48.87 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.693 -0.685 . . . . 70.03 111.543 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.23 -24.94 60.55 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.956 0.408 . . . . 63.14 111.923 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.65 -24.33 36.38 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.062 0.393 . . . . 73.03 112.062 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.87 23.29 78.11 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.077 -0.582 . . . . 39.81 112.24 -174.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.7 mt -118.13 178.21 4.51 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.401 0.62 . . . . 53.44 111.783 -175.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.8 m -82.51 149.17 27.69 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.896 -0.593 . . . . 72.14 111.554 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.6 mm -52.89 -41.96 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 120.929 0.395 . . . . 43.12 111.966 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.455 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 47.4 t80 -60.65 -59.78 4.85 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.149 -0.478 . . . . 74.12 111.644 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -48.44 -58.04 5.22 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.92 0.391 . . . . 72.44 111.376 176.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.556 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 94.9 t -53.3 -45.95 56.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.01 -0.541 . . . . 72.04 111.535 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.484 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 7.7 tpt180 -60.86 -41.67 96.37 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.65 -0.25 . . . . 74.13 111.38 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 89.1 mt -55.51 -44.62 76.81 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.329 0.585 . . . . 70.5 110.738 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -66.25 -41.74 89.54 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.884 -0.598 . . . . 74.25 111.553 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 89.5 mt -59.43 -45.44 91.54 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.829 0.347 . . . . 71.45 111.103 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 42' ' ' ARG . 58.1 mm-40 -52.65 -52.74 54.35 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.293 0.568 . . . . 74.42 110.749 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -65.87 -33.53 76.05 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.842 -0.617 . . . . 62.23 111.848 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.402 ' HA ' HG21 ' A' ' 51' ' ' VAL . 76.8 mt -64.89 -27.79 69.1 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.846 0.355 . . . . 75.32 111.333 176.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -75.39 -37.6 60.42 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.131 0.491 . . . . 74.02 110.142 172.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -63.57 -43.64 96.4 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.773 -0.649 . . . . 65.14 112.388 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.499 HG23 HG22 ' A' ' 53' ' ' VAL . 25.5 m -80.07 -12.74 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.741 0.645 . . . . 73.43 112.741 -177.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.2 52.97 1.66 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.027 -0.606 . . . . 70.54 113.645 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.499 HG22 HG23 ' A' ' 51' ' ' VAL . 94.4 t -124.77 -56.88 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.021 0.438 . . . . 61.1 111.113 176.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 69' ' ' LEU . 70.1 mt -100.03 138.83 36.57 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.337 -0.392 . . . . 73.31 111.91 -177.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -109.46 160.5 16.16 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.263 -0.426 . . . . 74.55 110.295 174.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -100.07 136.25 40.26 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.19 0.519 . . . . 63.43 111.958 -176.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.9 t . . . . . 0 CA--C 1.538 0.49 0 CA-C-N 116.118 -0.492 . . . . 72.53 110.484 176.705 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.483 HD13 ' HG2' ' A' ' 24' ' ' PRO . 77.0 mt . . . . . 0 CA--C 1.539 0.55 0 CA-C-O 120.853 0.358 . . . . 73.41 111.041 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -109.23 137.09 47.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.424 0.63 . . . . 74.12 112.279 -175.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -154.22 116.88 4.39 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.0 -0.545 . . . . 61.33 110.187 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 54' ' ' LEU . 2.3 pp -66.05 174.44 2.52 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.027 0.751 . . . . 72.23 113.027 -172.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 78.2 mt . . . . . 0 CA--C 1.537 0.455 0 CA-C-N 115.938 -0.574 . . . . 74.01 111.35 179.55 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.558 HG12 HD12 ' A' ' 36' ' ' LEU . 10.8 tp . . . . . 0 CA--C 1.544 0.716 0 N-CA-C 112.191 0.441 . . . . 73.41 112.191 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.6 t -57.57 -37.25 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 120.911 0.386 . . . . 52.43 111.507 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.2 m -54.26 -47.87 71.81 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.0 0.429 . . . . 71.42 111.083 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.453 ' O ' HG13 ' A' ' 12' ' ' ILE . 87.5 tttt -66.28 -40.4 90.06 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.562 -0.29 . . . . 74.33 110.767 177.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.449 ' O ' HG22 ' A' ' 13' ' ' VAL . 67.4 mt -53.35 -47.33 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 120.81 0.338 . . . . 64.54 111.316 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.7 mt -59.12 -43.86 90.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.933 0.397 . . . . 75.04 110.926 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.8 t -61.16 -40.06 92.47 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.421 -0.354 . . . . 75.11 111.763 176.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.489 HD12 ' HB3' ' A' ' 33' ' ' ALA . 82.4 mt -61.69 -43.41 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.82 0.343 . . . . 72.54 110.736 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.526 ' HA ' HG23 ' A' ' 25' ' ' VAL . 91.5 t -59.04 -47.56 89.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.965 0.412 . . . . 71.42 111.018 176.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -60.54 -47.17 87.36 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.086 0.47 . . . . 74.13 111.264 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.01 -52.37 65.82 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.275 0.56 . . . . 73.03 111.039 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.576 ' HA ' ' HG2' ' A' ' 19' ' ' MET . 1.0 OUTLIER -62.1 -35.53 78.97 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.358 -0.383 . . . . 72.14 111.706 178.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -62.88 -25.18 68.18 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 122.315 -0.241 . . . . 74.31 111.261 173.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -84.47 -20.94 30.9 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.563 0.579 . . . . 74.14 112.563 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.576 ' HG2' ' HA ' ' A' ' 16' ' ' ARG . 20.4 ptm -89.25 -38.82 13.94 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.944 -0.473 . . . . 74.21 112.171 173.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -89.94 -41.47 11.75 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 111.88 0.326 . . . . 61.32 111.88 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 63.26 -74.58 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.807 0.669 . . . . 64.31 112.807 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.42 -28.57 73.65 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.094 -0.574 . . . . 63.32 113.495 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.36 147.0 33.84 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 120.765 0.317 . . . . 74.14 111.76 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.55 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 6.0 Cg_exo -72.86 172.19 15.87 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.447 2.098 . . . . 64.33 112.522 176.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.526 HG23 ' HA ' ' A' ' 13' ' ' VAL . 40.3 t -80.15 150.02 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.167 -0.47 . . . . 71.11 111.719 -175.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.598 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -100.05 145.94 27.34 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.347 -0.388 . . . . 53.41 110.624 -177.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.0 m -54.43 -34.7 61.9 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.567 0.58 . . . . 74.44 112.567 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -62.4 -42.65 99.59 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.447 0.536 . . . . 72.3 112.447 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -53.89 -42.95 69.23 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.152 0.427 . . . . 72.5 112.152 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.435 HD11 ' N ' ' A' ' 30' ' ' ILE . 2.9 mp -65.56 -50.1 73.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.979 0.419 . . . . 75.24 111.035 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.32 -58.57 7.89 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.01 0.433 . . . . 74.44 112.058 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.87 -42.4 93.61 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.804 0.668 . . . . 50.0 112.804 -178.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.489 ' HB3' HD12 ' A' ' 12' ' ' ILE . . . -75.25 -34.31 61.38 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.343 0.497 . . . . 75.41 112.343 -178.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.47 ' HB1' HD12 ' A' ' 5' ' ' ILE . . . -85.42 -21.19 28.89 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.133 0.42 . . . . 64.24 112.133 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.81 22.16 53.87 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.242 -0.504 . . . . 74.44 112.821 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.558 HD12 HG12 ' A' ' 5' ' ' ILE . 73.3 mt -101.42 173.83 6.26 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.959 0.409 . . . . 74.44 111.591 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.404 ' O ' HG21 ' A' ' 41' ' ' VAL . 47.4 t -98.01 148.29 23.65 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.354 -0.384 . . . . 75.52 111.051 177.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.3 mm -50.61 -49.32 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 112.836 0.68 . . . . 74.21 112.836 -175.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.526 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 47.6 t80 -51.37 -50.62 59.18 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.892 0.33 . . . . 71.23 111.892 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.448 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 27.6 tt0 -69.04 -40.3 78.67 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.844 0.354 . . . . 74.21 111.371 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.404 HG21 ' O ' ' A' ' 37' ' ' SER . 69.9 t -60.54 -51.71 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.418 -0.356 . . . . 74.12 111.875 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 8.7 ptm180 -57.41 -36.06 70.84 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.629 -0.259 . . . . 75.04 111.287 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 94.0 mt -60.16 -48.44 81.71 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.729 0.299 . . . . 74.43 110.932 177.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.448 ' CE2' ' HG2' ' A' ' 40' ' ' GLN . 25.5 m-85 -57.34 -48.05 80.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.04 0.447 . . . . 74.32 110.919 176.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.451 HD11 ' NE1' ' A' ' 67' ' ' TRP . 78.9 mt -60.97 -43.8 98.27 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.871 -0.604 . . . . 75.44 111.727 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 42' ' ' ARG . 46.9 mt-10 -57.98 -52.2 66.52 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.044 0.45 . . . . 62.11 111.089 175.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -59.25 -40.33 85.63 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.098 -0.501 . . . . 63.24 111.343 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.6 mt -59.9 -40.12 87.71 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.723 0.297 . . . . 71.12 111.468 176.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 65.3 t60 -67.12 -40.24 86.8 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.037 -0.415 . . . . 63.13 111.104 174.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -65.81 -43.42 88.67 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.068 -0.514 . . . . 63.44 112.156 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.491 HG23 HG22 ' A' ' 53' ' ' VAL . 34.0 m -78.27 -12.03 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 112.448 0.536 . . . . 65.33 112.448 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.93 52.51 1.5 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.085 -0.579 . . . . 53.33 113.713 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.491 HG22 HG23 ' A' ' 51' ' ' VAL . 91.3 t -124.17 -44.49 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 120.973 0.416 . . . . 54.2 111.323 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.7 mt -110.12 142.57 41.43 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.431 0.634 . . . . 72.31 112.517 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -91.44 119.63 31.58 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.373 -0.83 . . . . 61.21 109.038 172.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -85.18 94.86 8.98 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.163 0.506 . . . . 73.11 110.845 -173.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 51.4 t . . . . . 0 CA--C 1.54 0.587 0 CA-C-N 115.877 -0.602 . . . . 63.23 112.183 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 92.0 mt . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 110.198 -0.297 . . . . 72.22 110.198 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.451 ' NE1' HD11 ' A' ' 45' ' ' LEU . 59.9 m95 -115.99 123.38 47.87 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.547 0.689 . . . . 75.33 112.452 -171.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 -128.46 113.33 15.39 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.768 -0.651 . . . . 73.43 110.788 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 69' ' ' LEU . 3.7 pp -63.48 149.95 44.92 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.904 -0.498 . . . . 74.31 111.866 -178.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 87.8 mt . . . . . 0 CA--C 1.538 0.488 0 CA-C-N 116.225 -0.443 . . . . 73.34 111.522 -179.381 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.473 HG22 HD11 ' A' ' 36' ' ' LEU . 61.3 mt . . . . . 0 CA--C 1.536 0.428 0 CA-C-O 121.063 0.459 . . . . 73.24 110.145 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.9 t -58.49 -54.89 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.084 -0.507 . . . . 71.12 111.321 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.5 m -61.04 -33.82 73.9 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.981 0.42 . . . . 54.11 111.066 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.431 ' O ' HG13 ' A' ' 12' ' ' ILE . 61.9 tttp -59.28 -49.42 77.9 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.976 0.417 . . . . 72.53 110.692 176.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.504 ' O ' HG21 ' A' ' 13' ' ' VAL . 73.2 mt -56.91 -49.72 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.184 -0.462 . . . . 64.21 111.175 176.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.9 mt -53.74 -42.65 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 121.156 0.503 . . . . 75.15 111.457 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.0 m -62.77 -43.33 99.09 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.168 -0.469 . . . . 51.42 111.244 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 8' ' ' LYS . 74.8 mt -61.06 -43.31 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.043 0.449 . . . . 60.12 111.255 177.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.565 HG12 ' NE2' ' A' ' 17' ' ' GLN . 81.1 t -57.96 -52.15 61.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 116.064 -0.517 . . . . 71.24 111.391 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -63.71 -41.32 98.1 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.703 0.287 . . . . 72.33 111.524 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -51.58 -53.09 41.87 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.768 0.318 . . . . 75.31 111.158 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.536 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 3.1 mmp_? -57.05 -46.76 82.2 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 111.911 0.337 . . . . 73.34 111.911 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.565 ' NE2' HG12 ' A' ' 13' ' ' VAL . 66.0 mt-30 -64.69 -38.07 89.74 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.99 0.424 . . . . 64.33 112.14 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -77.76 -41.23 38.29 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.271 0.471 . . . . 72.51 112.271 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.676 ' HA ' ' HE2' ' A' ' 19' ' ' MET . 22.5 mmt -75.71 -45.46 36.59 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.177 0.436 . . . . 70.51 112.177 -177.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -82.28 -25.84 33.66 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.923 0.392 . . . . 61.31 110.538 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.8 t70 67.26 104.96 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.438 0.695 . . . . 74.11 112.01 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.7 -31.03 5.74 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 115.922 -0.581 . . . . 52.24 113.906 177.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.79 140.13 95.44 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 113.04 0.756 . . . . 74.2 113.04 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.19 146.4 17.81 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.899 2.399 . . . . 71.31 112.371 173.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.441 HG22 ' HB2' ' A' ' 16' ' ' ARG . 22.1 t -85.66 138.46 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.028 0.442 . . . . 72.11 112.061 -175.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.43 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -98.92 144.7 27.81 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.995 -0.548 . . . . 63.31 110.693 178.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 57.8 m -57.16 -32.73 66.72 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.843 0.354 . . . . 64.41 111.07 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -56.99 -57.54 12.1 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.243 -0.435 . . . . 74.23 112.147 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -54.59 -42.55 71.24 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.748 0.309 . . . . 64.4 111.712 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.7 mt -63.49 -43.71 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.404 -0.362 . . . . 71.21 111.337 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.1 -49.6 77.0 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.06 0.393 . . . . 74.43 112.06 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -65.48 -42.87 91.74 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.042 0.386 . . . . 51.52 112.042 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.89 -35.46 74.66 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.373 0.509 . . . . 72.03 112.373 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.64 -24.14 24.03 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.985 0.365 . . . . 62.33 111.985 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.29 37.4 24.6 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.365 -0.445 . . . . 65.15 112.96 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.473 HD11 HG22 ' A' ' 5' ' ' ILE . 84.1 mt -123.05 174.65 7.07 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.964 0.411 . . . . 71.35 111.743 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.445 ' O ' HG22 ' A' ' 41' ' ' VAL . 49.3 m -86.8 144.71 26.92 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.477 -0.329 . . . . 70.22 111.277 177.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.2 mm -47.15 -51.13 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 112.396 0.517 . . . . 75.31 112.396 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.48 ' CE2' HD12 ' A' ' 43' ' ' LEU . 82.8 t80 -54.44 -56.38 19.3 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.251 -0.431 . . . . 73.13 111.36 177.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -54.88 -49.0 72.26 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.073 -0.512 . . . . 75.31 111.69 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 37' ' ' SER . 89.4 t -54.68 -53.03 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.983 -0.553 . . . . 71.3 111.625 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -65.85 -26.85 67.84 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.949 -0.3 . . . . 73.34 111.61 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.48 HD12 ' CE2' ' A' ' 39' ' ' TYR . 80.7 mt -58.31 -48.77 79.46 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.948 0.404 . . . . 73.04 110.287 174.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -66.04 -34.12 77.37 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.234 -0.439 . . . . 71.35 111.192 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 88.5 mt -63.21 -46.08 88.66 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.66 0.267 . . . . 52.31 111.062 176.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 49' ' ' HIS . 1.1 mp0 -55.68 -48.09 75.66 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.717 0.294 . . . . 73.15 110.789 174.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 94.7 mt-30 -56.8 -50.7 71.55 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.813 0.34 . . . . 73.13 111.055 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.501 ' HA ' HG21 ' A' ' 51' ' ' VAL . 95.1 mt -58.52 -30.57 67.17 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.118 0.485 . . . . 71.23 111.439 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.467 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 7.3 t-80 -65.9 -45.95 80.09 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.901 0.382 . . . . 72.41 111.446 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -79.84 -23.73 41.8 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.222 0.823 . . . . 74.34 113.222 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.501 HG21 ' HA ' ' A' ' 48' ' ' LEU . 23.9 m -89.77 6.49 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 121.838 -0.539 . . . . 75.21 111.78 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.1 57.78 3.36 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 116.325 -0.398 . . . . 63.13 113.934 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.46 HG22 HG23 ' A' ' 51' ' ' VAL . 90.2 t -131.77 -51.94 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 122.431 -0.452 . . . . 63.24 111.816 177.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.9 mt -97.01 143.97 27.35 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.933 0.716 . . . . 70.23 112.933 -175.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -102.03 153.24 20.09 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.215 -0.902 . . . . 72.13 110.89 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.553 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 1.8 mppt? -97.21 119.85 36.48 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.767 0.318 . . . . 65.42 110.902 -176.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.2 t . . . . . 0 CA--C 1.537 0.481 0 CA-C-O 121.132 0.491 . . . . 72.1 112.186 -178.307 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.4 mt . . . . . 0 CA--C 1.538 0.514 0 CA-C-O 120.632 0.253 . . . . 75.14 110.643 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -106.16 132.8 51.79 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.611 0.967 . . . . 72.15 113.611 -169.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -139.21 -168.64 2.49 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.505 -0.771 . . . . 71.54 109.755 169.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 pp -114.21 169.16 9.23 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 122.026 -0.421 . . . . 71.0 111.225 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 89.2 mt . . . . . 0 CA--C 1.541 0.6 0 CA-C-O 121.059 0.456 . . . . 74.42 111.054 177.183 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.46 HD13 HD11 ' A' ' 36' ' ' LEU . 14.6 tt . . . . . 0 CA--C 1.54 0.578 0 CA-C-O 121.248 0.547 . . . . 74.31 110.877 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.5 t -69.07 -35.56 69.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.266 -0.425 . . . . 75.43 110.815 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.1 m -52.96 -43.47 66.39 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.101 0.477 . . . . 73.53 110.318 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.551 ' O ' HG13 ' A' ' 12' ' ' ILE . 40.5 ttmt -60.45 -48.51 81.45 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.993 -0.549 . . . . 75.3 110.776 175.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.4 mt -52.57 -47.17 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.892 0.377 . . . . 73.32 111.512 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.6 mt -61.8 -45.58 98.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.049 0.452 . . . . 42.11 111.202 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 84.7 p -67.96 -18.35 64.71 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.906 0.336 . . . . 63.22 111.906 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 8' ' ' LYS . 99.3 mt -75.01 -44.83 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.081 0.467 . . . . 72.22 110.417 172.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.8 t -59.96 -41.51 86.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.195 0.521 . . . . 63.42 110.34 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -65.36 -45.33 84.57 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.884 -0.598 . . . . 75.43 110.526 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -51.09 -52.2 45.94 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.14 -0.482 . . . . 65.42 111.734 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.9 mmt-85 -61.97 -37.68 85.68 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 111.952 0.353 . . . . 75.51 111.952 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -74.88 -12.97 60.49 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 122.148 -0.345 . . . . 64.51 111.86 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -82.6 -45.55 14.44 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.906 0.384 . . . . 70.32 110.459 171.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 93.6 mmm -70.11 -65.22 0.75 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.176 -0.466 . . . . 71.31 110.632 176.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -81.68 102.86 10.98 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.989 0.423 . . . . 74.04 110.004 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -51.11 95.57 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.115 0.783 . . . . 63.34 113.115 -172.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.91 33.05 84.57 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 115.721 -0.672 . . . . 74.5 113.657 175.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.96 145.97 30.69 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 120.879 0.371 . . . . 44.44 111.962 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.558 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 38.4 Cg_endo -65.28 131.56 28.73 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.513 2.142 . . . . 64.2 112.838 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.3 t -82.62 147.88 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.084 -0.507 . . . . 62.34 111.866 -176.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.431 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -100.61 146.72 26.79 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.297 -0.41 . . . . 64.02 111.035 -178.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.4 m -57.17 -32.53 66.52 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 111.909 0.337 . . . . 72.15 111.909 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 28' ' ' ARG . 3.9 mpt_? -60.75 -53.82 52.74 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.096 0.406 . . . . 74.34 112.096 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.415 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 9.5 m-20 -53.11 -47.61 68.49 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.969 0.414 . . . . 74.32 111.339 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.512 ' HA ' HG22 ' A' ' 12' ' ' ILE . 61.5 mt -59.49 -43.83 91.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.96 -0.564 . . . . 75.12 111.389 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.533 ' HA ' HG23 ' A' ' 41' ' ' VAL . . . -62.5 -54.34 41.47 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.167 0.432 . . . . 71.23 112.167 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.35 -43.87 96.46 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.95 0.352 . . . . 63.52 111.95 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.433 ' HB3' HD12 ' A' ' 12' ' ' ILE . . . -62.91 -37.81 88.46 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.79 0.329 . . . . 62.12 111.709 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.92 -18.58 36.9 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.99 0.424 . . . . 65.42 111.63 176.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.86 20.69 70.12 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.327 -0.397 . . . . 74.13 113.569 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.46 HD11 HD13 ' A' ' 5' ' ' ILE . 84.4 mt -111.61 176.39 5.04 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.14 0.495 . . . . 75.3 112.04 -175.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.6 m -83.29 147.45 27.96 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.026 -0.534 . . . . 75.53 111.711 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 39.6 mm -50.6 -51.29 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 112.796 0.665 . . . . 54.02 112.796 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -60.81 -49.6 76.82 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.742 0.306 . . . . 54.21 111.635 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -58.11 -50.41 73.59 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.176 0.513 . . . . 71.24 111.144 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.533 HG23 ' HA ' ' A' ' 31' ' ' ALA . 73.1 t -55.38 -46.56 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.139 -0.482 . . . . 74.0 111.131 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.507 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 16.5 ttt180 -53.11 -44.22 67.47 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.256 -0.429 . . . . 74.13 111.4 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.6 mt -54.69 -47.07 74.12 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.051 0.453 . . . . 71.24 110.781 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -62.41 -46.29 89.27 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.101 -0.499 . . . . 72.24 111.282 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 85.0 mt -61.42 -40.94 96.26 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.349 -0.387 . . . . 62.22 111.712 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 42' ' ' ARG . 55.5 mt-10 -59.31 -42.25 90.94 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.971 0.415 . . . . 72.43 111.107 177.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -71.88 -33.12 68.1 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.813 0.339 . . . . 65.45 111.159 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.73 -29.11 69.58 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.017 0.437 . . . . 72.13 111.207 174.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.435 ' HD2' ' HA ' ' A' ' 55' ' ' GLU . 54.4 t-80 -73.37 -28.96 62.32 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.083 0.468 . . . . 74.51 110.603 172.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -73.96 -52.25 13.42 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.927 -0.578 . . . . 74.21 111.584 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.488 HG23 HG21 ' A' ' 53' ' ' VAL . 34.1 m -73.5 -10.96 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 113.144 0.794 . . . . 75.21 113.144 -176.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.53 49.08 2.05 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.005 -0.617 . . . . 54.52 114.042 176.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.488 HG21 HG23 ' A' ' 51' ' ' VAL . 91.7 t -118.65 -52.5 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.968 0.413 . . . . 55.0 111.427 176.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 86.4 mt -114.91 148.57 38.48 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.018 0.437 . . . . 74.0 111.979 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.435 ' HA ' ' HD2' ' A' ' 49' ' ' HIS . 10.1 tp10 -111.97 133.7 53.99 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.216 -0.447 . . . . 73.23 111.092 174.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -85.65 97.89 10.37 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.987 -0.551 . . . . 74.45 110.734 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 46.7 t . . . . . 0 CA--C 1.537 0.458 0 CA-C-N 115.987 -0.551 . . . . 54.11 111.552 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.558 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 87.3 mt . . . . . 0 CA--C 1.54 0.596 0 CA-C-O 120.832 0.349 . . . . 63.53 111.329 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -124.38 133.54 53.39 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.307 0.575 . . . . 74.44 112.313 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -127.46 121.33 30.49 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.283 -0.417 . . . . 72.32 110.705 172.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.443 ' O ' HD13 ' A' ' 69' ' ' LEU . 2.9 pp -69.99 147.6 49.92 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.947 0.403 . . . . 72.11 111.659 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 CA--C 1.536 0.426 0 CA-C-N 116.437 -0.347 . . . . 73.42 111.662 -177.16 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.0 tp . . . . . 0 CA--C 1.543 0.71 0 N-CA-C 112.003 0.372 . . . . 71.14 112.003 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.8 t -61.78 -51.32 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 111.696 0.258 . . . . 73.14 111.696 -177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.1 m -56.63 -37.53 70.85 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.905 0.383 . . . . 63.42 111.423 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.501 ' O ' HG13 ' A' ' 12' ' ' ILE . 37.3 ttpt -65.28 -43.61 90.64 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.471 -0.331 . . . . 65.13 110.721 176.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.448 HG22 HG23 ' A' ' 30' ' ' ILE . 69.2 mt -59.41 -44.83 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.737 0.303 . . . . 72.42 111.503 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 69.0 mt -56.68 -45.65 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.27 0.557 . . . . 64.04 110.771 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.6 m -66.98 -29.32 69.13 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.933 -0.576 . . . . 73.23 111.905 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 8' ' ' LYS . 94.0 mt -63.94 -44.02 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.056 0.455 . . . . 72.45 110.91 174.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.415 ' HA ' HG23 ' A' ' 25' ' ' VAL . 59.3 t -57.31 -47.15 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.116 0.484 . . . . 73.31 110.729 175.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -61.27 -46.59 89.7 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.08 -0.509 . . . . 62.42 110.992 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -56.3 -46.75 79.67 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.1 -0.5 . . . . 70.54 111.421 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.418 ' HD3' ' SD ' ' A' ' 19' ' ' MET . 11.1 mmt180 -61.33 -36.67 80.79 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.5 -0.318 . . . . 72.53 111.729 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.432 ' NE2' ' HG ' ' A' ' 69' ' ' LEU . 73.6 mt-30 -75.79 -21.6 57.2 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.782 0.325 . . . . 70.13 111.814 176.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -70.53 -36.12 73.54 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.366 0.603 . . . . 74.05 110.04 170.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.418 ' SD ' ' HD3' ' A' ' 16' ' ' ARG . 74.3 mtp -67.69 -50.39 57.83 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.548 -0.751 . . . . 63.34 111.062 176.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -122.5 116.74 24.45 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.132 -0.486 . . . . 73.21 110.494 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -40.33 -53.28 2.6 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.213 0.82 . . . . 61.2 113.213 -173.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.94 53.98 0.7 Allowed Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.19 -0.529 . . . . 53.54 113.046 -176.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.83 110.27 61.7 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.361 0.504 . . . . 62.05 112.361 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.564 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 56.4 Cg_endo -69.88 122.29 8.94 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.093 1.862 . . . . 72.41 110.767 170.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.415 HG23 ' HA ' ' A' ' 13' ' ' VAL . 22.0 t -79.38 141.47 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 112.37 0.508 . . . . 71.34 112.37 -167.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.58 151.07 20.43 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.134 -0.484 . . . . 71.22 110.867 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.4 m -53.05 -37.33 61.5 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.201 -0.454 . . . . 62.4 111.526 175.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -64.22 -44.36 92.13 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.295 -0.411 . . . . 74.14 112.009 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.04 -41.34 98.0 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.994 0.426 . . . . 74.41 111.548 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.448 HG23 HG22 ' A' ' 9' ' ' ILE . 60.2 mt -65.78 -43.37 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 116.515 -0.311 . . . . 61.4 111.045 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.59 -37.51 81.6 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.202 0.525 . . . . 51.12 110.893 174.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.36 -48.33 81.77 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.662 -0.699 . . . . 73.01 111.697 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.16 -50.29 49.04 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.018 0.377 . . . . 62.4 112.018 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.0 -19.65 61.16 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.584 0.587 . . . . 74.11 112.584 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.17 40.0 51.36 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.159 -0.543 . . . . 63.42 112.673 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.4 175.26 6.53 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.805 0.336 . . . . 65.45 111.241 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.2 t -85.07 153.76 22.5 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.747 0.308 . . . . 70.12 111.192 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.59 -50.13 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 112.954 0.724 . . . . 65.2 112.954 -175.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -66.62 -44.72 81.29 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 122.197 -0.315 . . . . 74.42 111.763 -175.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -51.07 -55.44 17.56 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.203 0.525 . . . . 75.11 111.054 175.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.433 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 82.7 t -61.1 -39.86 83.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.064 -0.516 . . . . 71.3 110.942 176.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -53.52 -41.44 66.34 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.243 -0.435 . . . . 54.04 110.684 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.3 mt -62.92 -52.86 61.41 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.001 -0.545 . . . . 71.42 111.285 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -56.05 -36.85 68.5 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.011 0.434 . . . . 64.02 111.357 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.536 HD11 ' NE1' ' A' ' 67' ' ' TRP . 99.1 mt -69.78 -40.11 76.23 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.408 -0.36 . . . . 75.52 111.756 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -60.73 -37.94 83.45 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.025 0.44 . . . . 75.21 110.685 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -61.4 -54.02 49.06 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.385 -0.371 . . . . 73.42 110.712 174.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.5 mt -57.11 -31.53 65.39 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.15 0.5 . . . . 73.03 111.608 176.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -63.71 -50.82 67.65 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.921 -0.581 . . . . 74.23 111.803 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -76.79 -40.65 47.43 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.944 0.72 . . . . 73.32 112.944 -176.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.471 HG23 HG22 ' A' ' 53' ' ' VAL . 23.5 m -67.58 -16.14 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 112.253 0.464 . . . . 73.04 112.253 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.61 48.29 2.36 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.185 -0.531 . . . . 75.11 113.935 177.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.471 HG22 HG23 ' A' ' 51' ' ' VAL . 97.9 t -118.71 -40.94 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 121.075 0.464 . . . . 71.12 111.28 176.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.403 HD11 ' HB3' ' A' ' 67' ' ' TRP . 83.5 mt -112.85 136.45 52.46 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.401 0.619 . . . . 63.41 112.296 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -91.65 143.15 26.85 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.586 -0.734 . . . . 55.03 109.971 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -93.94 105.08 17.11 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.889 0.852 . . . . 75.13 111.662 -174.83 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 28.6 t . . . . . 0 CA--C 1.539 0.537 0 CA-C-O 121.358 0.599 . . . . 74.0 110.588 177.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 67.0 mt . . . . . 0 CA--C 1.537 0.45 0 CA-C-O 120.973 0.416 . . . . 74.03 110.191 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.536 ' NE1' HD11 ' A' ' 45' ' ' LEU . 67.1 m95 -93.88 116.43 28.89 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.335 0.588 . . . . 72.33 112.179 -172.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -114.69 111.49 21.37 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.843 -0.617 . . . . 73.14 110.534 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.432 ' HG ' ' NE2' ' A' ' 17' ' ' GLN . 3.5 pp -59.3 156.02 13.4 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 122.008 -0.433 . . . . 75.24 111.504 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.7 mt . . . . . 0 CA--C 1.539 0.526 0 CA-C-O 121.166 0.507 . . . . 73.3 111.231 179.27 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.628 ' H ' HD13 ' A' ' 5' ' ' ILE . 4.5 mp . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 121.098 0.475 . . . . 71.24 110.87 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.17 -47.11 91.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-N 116.116 -0.493 . . . . 74.31 111.145 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.1 m -52.22 -46.08 65.54 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.166 0.508 . . . . 74.13 111.354 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -55.36 -55.14 35.0 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.95 -0.568 . . . . 73.03 111.298 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.435 ' O ' HG21 ' A' ' 13' ' ' VAL . 62.8 mt -60.44 -46.04 95.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 112.038 0.384 . . . . 73.23 112.038 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.8 mt -58.51 -50.93 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 111.892 0.33 . . . . 75.44 111.892 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.6 p -55.92 -43.65 77.54 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.792 0.33 . . . . 40.42 111.771 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 82.5 mt -61.68 -55.91 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.927 0.394 . . . . 62.33 111.589 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 9' ' ' ILE . 80.1 t -55.07 -41.84 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.063 0.459 . . . . 72.42 111.523 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -65.5 -53.23 45.43 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.128 -0.487 . . . . 73.32 111.17 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -51.64 -49.5 62.16 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.104 0.478 . . . . 74.55 111.328 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -54.3 -51.12 65.65 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.733 -0.667 . . . . 74.24 111.943 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.483 ' NE2' ' HA ' ' A' ' 68' ' ' ARG . 78.3 mt-30 -66.32 -16.45 64.06 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.306 0.484 . . . . 74.4 112.306 -178.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -78.8 -29.63 45.01 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 122.045 -0.409 . . . . 53.13 110.791 170.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 23.2 mmt -91.5 -74.19 0.51 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.825 0.345 . . . . 71.34 111.54 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.27 77.79 8.91 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.91 0.862 . . . . 74.13 111.157 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -85.92 -28.06 24.57 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.116 -0.947 . . . . 74.43 111.06 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.36 -3.38 82.25 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 116.056 -0.52 . . . . 71.11 113.641 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -150.92 119.87 3.54 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 122.436 -0.45 . . . . 55.41 111.315 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.529 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 10.8 Cg_endo -52.59 152.87 15.4 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.99 2.46 . . . . 74.11 113.435 -178.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.6 t -79.99 150.36 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 112.141 0.423 . . . . 64.54 112.141 -172.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.498 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 9.9 mptt -96.69 151.42 19.64 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.868 0.366 . . . . 72.14 111.262 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.8 m -56.0 -36.58 68.08 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 116.286 -0.415 . . . . 73.44 111.957 177.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.2 mtm-85 -57.07 -58.33 8.66 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.975 0.417 . . . . 75.22 111.501 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.91 -44.19 70.34 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.651 -0.704 . . . . 73.14 112.27 -177.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.6 mt -63.68 -46.29 95.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.065 0.459 . . . . 71.42 111.115 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.549 ' HA ' HG22 ' A' ' 41' ' ' VAL . . . -62.74 -43.88 97.64 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.933 0.396 . . . . 64.55 111.578 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.35 -47.28 84.9 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.062 -0.517 . . . . 73.13 111.2 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.67 -29.56 68.88 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 111.895 0.332 . . . . 63.34 111.895 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.14 -15.44 36.11 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.103 0.409 . . . . 52.43 112.103 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.14 27.4 71.98 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.425 -0.417 . . . . 44.53 112.832 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.6 mt -117.87 175.29 5.73 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.126 0.488 . . . . 73.14 111.753 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.5 t -80.23 149.31 30.47 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.399 0.518 . . . . 72.25 112.399 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.7 mm -51.92 -40.52 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.962 -0.563 . . . . 73.2 111.001 174.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.445 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 85.8 t80 -64.83 -56.61 12.4 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.939 -0.573 . . . . 74.42 111.855 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -57.96 -51.06 71.2 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.178 0.513 . . . . 74.15 111.633 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.549 HG22 ' HA ' ' A' ' 31' ' ' ALA . 78.2 t -55.87 -47.94 79.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.146 -0.479 . . . . 74.54 111.602 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -57.35 -38.33 73.97 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.572 -0.286 . . . . 65.01 111.52 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 92.2 mt -58.38 -46.45 86.32 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.809 0.338 . . . . 54.42 111.079 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -65.99 -44.17 85.64 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.787 0.327 . . . . 72.33 111.517 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.74 -48.43 81.83 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.116 0.484 . . . . 75.54 111.634 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.25 -41.34 90.11 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.318 -0.401 . . . . 73.3 111.79 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -61.72 -41.55 97.77 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.217 -0.302 . . . . 73.2 111.386 176.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.9 mt -60.01 -33.39 71.93 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.763 0.316 . . . . 64.43 111.166 176.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -66.22 -49.76 66.17 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 122.166 -0.334 . . . . 72.44 110.959 172.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.63 -32.07 71.24 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 112.085 0.402 . . . . 75.23 112.085 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.424 HG21 HG22 ' A' ' 53' ' ' VAL . 30.9 m -90.96 2.66 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 112.717 0.636 . . . . 62.34 112.717 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.03 51.93 3.43 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.222 -0.513 . . . . 52.24 114.202 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.424 HG22 HG21 ' A' ' 51' ' ' VAL . 60.9 t -129.71 -58.51 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 122.394 -0.474 . . . . 75.04 110.91 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.5 mt -104.37 178.43 4.56 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.211 0.529 . . . . 74.02 111.872 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.533 ' HB3' ' HG3' ' A' ' 68' ' ' ARG . 11.7 tp10 -138.03 144.78 41.2 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 120.843 0.354 . . . . 72.5 111.254 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -89.81 129.18 36.23 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.128 0.788 . . . . 74.24 113.128 -174.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.464 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 45.4 t . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 108.679 -0.859 . . . . 64.14 108.679 165.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 96.4 mt . . . . . 0 N--CA 1.467 0.423 0 CA-C-O 121.108 0.48 . . . . 63.21 110.227 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 28.8 m95 -123.4 143.24 50.25 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.636 0.606 . . . . 75.21 112.636 -169.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.533 ' HG3' ' HB3' ' A' ' 55' ' ' GLU . 9.1 ptm180 -147.69 174.43 11.79 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.668 -0.696 . . . . 74.52 110.862 174.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.457 ' HG ' ' OE1' ' A' ' 17' ' ' GLN . 3.3 pp -125.22 177.57 6.05 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.872 0.368 . . . . 52.21 111.426 175.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.525 ' N ' HD23 ' A' ' 70' ' ' LEU . 1.3 pt? . . . . . 0 CA--C 1.541 0.608 0 CA-C-O 121.416 0.627 . . . . 71.13 110.751 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 5' ' ' ILE . 2.1 mp . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 112.154 0.427 . . . . 72.34 112.154 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.92 -35.07 72.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.189 0.518 . . . . 65.11 110.48 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.0 m -61.28 -38.14 85.7 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.042 -0.526 . . . . 74.04 110.603 173.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.433 ' O ' HG13 ' A' ' 12' ' ' ILE . 86.8 tttt -63.35 -42.53 98.92 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.308 -0.406 . . . . 64.34 110.613 174.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.5 mt -52.19 -45.13 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.027 0.441 . . . . 70.11 110.796 174.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.4 mt -58.45 -44.38 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 116.224 -0.444 . . . . 75.1 111.203 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.9 m -59.64 -42.2 92.24 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.393 -0.367 . . . . 72.33 111.266 176.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 8' ' ' LYS . 82.9 mt -59.59 -46.05 93.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.055 0.455 . . . . 75.24 111.054 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.549 ' HA ' HG23 ' A' ' 25' ' ' VAL . 63.7 t -60.5 -49.63 83.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.082 0.468 . . . . 62.15 111.096 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.501 ' NE2' HD22 ' A' ' 18' ' ' ASN . 24.7 tm0? -58.65 -41.59 86.42 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.239 0.542 . . . . 52.21 110.677 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -60.05 -51.04 71.33 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.779 -0.646 . . . . 73.21 112.156 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.455 ' HB2' HG22 ' A' ' 25' ' ' VAL . 27.4 mmt180 -59.09 -35.4 73.35 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.664 0.269 . . . . 75.44 111.202 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.489 ' NE2' HG12 ' A' ' 13' ' ' VAL . 44.1 mt-30 -67.02 -27.33 67.32 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.976 0.417 . . . . 74.03 111.642 175.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.519 ' N ' HD21 ' A' ' 18' ' ' ASN . 0.8 OUTLIER -76.17 -23.12 54.73 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.963 0.411 . . . . 71.44 110.898 174.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.7 mmt -75.19 -54.99 6.19 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.06 -0.518 . . . . 71.25 110.345 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -119.99 98.97 6.34 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.166 -0.47 . . . . 74.44 110.592 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -61.76 -15.89 44.88 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.844 0.683 . . . . 63.31 112.844 -174.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -117.29 31.88 5.64 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.34 -0.457 . . . . 51.53 113.297 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -140.36 136.97 17.2 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 112.45 0.537 . . . . 73.01 112.45 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.501 ' HG2' HD13 ' A' ' 66' ' ' LEU . 82.7 Cg_endo -83.29 159.61 15.1 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.63 2.22 . . . . 62.41 112.312 172.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.549 HG23 ' HA ' ' A' ' 13' ' ' VAL . 11.2 t -85.91 156.2 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.055 0.455 . . . . 71.53 111.986 -175.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.448 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -99.95 140.17 34.55 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.263 -0.426 . . . . 70.11 110.783 -175.14 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.2 m -55.61 -41.1 73.0 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.874 0.369 . . . . 73.33 111.791 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -61.43 -52.72 63.4 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.892 0.377 . . . . 72.41 111.353 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.09 -35.66 75.7 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.238 -0.437 . . . . 74.44 111.772 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.513 HG22 HD22 ' A' ' 45' ' ' LEU . 77.8 mt -66.95 -56.28 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.801 0.334 . . . . 73.53 111.464 176.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.431 ' HA ' HG23 ' A' ' 41' ' ' VAL . . . -56.45 -43.42 79.49 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.087 0.403 . . . . 71.14 112.087 -178.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.51 -53.03 58.4 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.041 -0.527 . . . . 73.21 110.958 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.11 -29.47 70.59 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 111.933 0.346 . . . . 60.2 111.933 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.75 -27.13 44.66 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.905 0.383 . . . . 65.43 111.914 177.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.99 45.99 9.85 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.089 -0.577 . . . . 41.1 112.965 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.2 mt -135.5 178.16 7.26 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.732 -0.275 . . . . 74.13 111.045 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.415 ' O ' HG21 ' A' ' 41' ' ' VAL . 66.5 m -82.18 142.9 31.8 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 122.395 -0.191 . . . . 74.31 111.306 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.449 ' O ' ' HG3' ' A' ' 42' ' ' ARG . 48.2 mm -51.72 -55.68 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 122.53 0.332 . . . . 61.14 111.752 -176.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -54.17 -48.19 71.19 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.036 0.446 . . . . 72.13 111.474 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -58.12 -45.94 86.45 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.865 -0.607 . . . . 73.44 111.795 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.431 HG23 ' HA ' ' A' ' 31' ' ' ALA . 99.1 t -66.71 -39.27 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.319 -0.4 . . . . 74.41 111.637 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 38' ' ' ILE . 79.4 mtp180 -53.4 -44.45 68.73 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.809 0.337 . . . . 72.13 110.856 176.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.444 ' O ' ' HG3' ' A' ' 47' ' ' GLN . 98.2 mt -59.61 -49.51 77.48 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.23 -0.441 . . . . 71.22 111.054 176.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 21.4 m-30 -58.85 -43.87 90.88 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.888 0.375 . . . . 64.43 111.717 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.513 HD22 HG22 ' A' ' 30' ' ' ILE . 96.7 mt -63.45 -45.54 90.4 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.373 -0.376 . . . . 74.34 111.588 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -61.33 -39.7 91.5 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 121.214 -0.194 . . . . 53.12 110.788 175.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 80.9 mt-30 -58.45 -44.16 89.1 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.965 0.412 . . . . 63.33 110.976 172.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.86 -31.22 71.46 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.345 -0.389 . . . . 75.52 111.946 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -73.98 -36.67 64.57 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.082 0.468 . . . . 75.45 110.918 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -64.26 -50.46 67.86 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.159 -0.473 . . . . 71.14 111.291 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.499 HG21 HG22 ' A' ' 53' ' ' VAL . 33.7 m -75.56 4.13 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 N-CA-C 112.641 0.608 . . . . 74.12 112.641 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.71 29.53 38.84 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 114.952 0.741 . . . . 74.32 114.952 171.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.499 HG22 HG21 ' A' ' 51' ' ' VAL . 82.2 t -96.46 -60.15 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 117.413 0.607 . . . . 75.52 111.269 174.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 69' ' ' LEU . 71.5 mt -99.26 145.48 27.24 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.226 0.536 . . . . 71.24 112.206 -176.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.512 ' HB2' HD23 ' A' ' 70' ' ' LEU . 9.3 tp10 -92.39 142.59 27.28 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.983 -0.553 . . . . 74.15 111.085 174.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -87.84 107.06 18.49 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.838 -0.619 . . . . 75.11 110.666 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 CA--C 1.542 0.664 0 CA-C-O 121.012 0.434 . . . . 65.15 112.002 -178.497 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.501 HD13 ' HG2' ' A' ' 24' ' ' PRO . 96.4 mt . . . . . 0 N--CA 1.47 0.525 0 CA-C-O 121.036 0.446 . . . . 64.02 111.319 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.444 ' CD1' HD13 ' A' ' 45' ' ' LEU . 67.1 m95 -108.04 117.54 34.39 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.809 0.67 . . . . 65.45 112.809 -170.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.457 ' HG3' ' OE1' ' A' ' 17' ' ' GLN . 55.8 ttt180 -120.63 178.7 4.58 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.402 -0.962 . . . . 73.34 108.402 171.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 54' ' ' LEU . 2.3 pp -101.52 160.97 13.98 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.526 1.057 . . . . 61.52 111.557 174.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.512 HD23 ' HB2' ' A' ' 55' ' ' GLU . 84.3 mt . . . . . 0 CA--C 1.535 0.388 0 CA-C-O 120.891 0.377 . . . . 72.15 110.337 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.7 mm . . . . . 0 N--CA 1.471 0.578 0 CA-C-O 121.05 0.452 . . . . 53.41 111.139 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.3 t -61.46 -48.11 90.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.341 -0.391 . . . . 73.0 110.923 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 99.5 m -58.13 -39.61 79.17 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.246 -0.434 . . . . 74.41 111.613 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.472 ' O ' HG13 ' A' ' 12' ' ' ILE . 60.1 tptt -57.57 -53.99 51.93 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.116 0.484 . . . . 71.51 110.485 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.51 HG22 HG23 ' A' ' 30' ' ' ILE . 67.8 mt -57.78 -48.65 83.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 115.784 -0.644 . . . . 74.55 111.931 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.7 mt -59.32 -44.31 92.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-O 120.966 0.412 . . . . 74.43 111.608 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.2 t -63.05 -32.49 73.87 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.336 -0.393 . . . . 70.24 111.556 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 8' ' ' LYS . 99.0 mt -71.35 -49.0 50.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.898 0.38 . . . . 72.34 111.336 176.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.403 HG21 ' O ' ' A' ' 9' ' ' ILE . 89.6 t -56.48 -44.09 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.135 0.493 . . . . 60.35 110.776 176.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -65.6 -39.96 92.13 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.945 -0.57 . . . . 74.2 110.898 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -55.57 -47.85 75.73 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.167 0.508 . . . . 52.4 110.87 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.55 ' HA ' ' HG2' ' A' ' 19' ' ' MET . 0.3 OUTLIER -64.46 -34.35 77.99 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.088 -0.506 . . . . 65.3 111.398 178.281 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -65.07 -40.03 94.1 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.038 0.447 . . . . 74.41 111.651 174.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -75.99 -21.94 56.38 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.281 0.474 . . . . 74.35 112.281 -177.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.55 ' HG2' ' HA ' ' A' ' 16' ' ' ARG . 24.8 ptm -83.77 -32.29 25.48 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.956 -0.465 . . . . 72.33 111.379 176.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -152.17 115.29 4.69 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.091 0.472 . . . . 71.0 110.805 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -69.4 -13.44 62.36 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.998 0.74 . . . . 74.13 112.998 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.03 15.15 12.34 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.052 -0.594 . . . . 72.24 113.487 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -107.71 113.58 61.25 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 112.174 0.435 . . . . 61.05 112.174 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.83 140.78 32.57 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.36 2.04 . . . . 71.32 112.067 172.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.4 t -79.12 154.64 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 120.923 0.392 . . . . 74.34 111.199 -176.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.559 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 2.3 mptp? -107.58 139.0 42.79 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.65 -0.25 . . . . 74.12 110.737 -177.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.2 m -53.49 -51.13 63.75 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.066 0.46 . . . . 65.54 111.8 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -64.85 -31.26 72.4 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.114 0.412 . . . . 65.22 112.114 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -63.54 -52.69 60.01 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.945 0.403 . . . . 63.3 111.046 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.51 HG23 HG22 ' A' ' 9' ' ' ILE . 64.2 mt -55.89 -43.13 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.045 0.45 . . . . 73.13 110.892 176.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.78 -35.68 73.21 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.102 -0.499 . . . . 73.42 111.876 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -74.1 -48.46 29.52 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.763 0.316 . . . . 71.35 110.992 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.11 -28.66 69.92 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.114 0.413 . . . . 70.22 112.114 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.22 -26.45 16.64 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.297 0.48 . . . . 55.23 112.297 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.21 31.47 38.25 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.267 -0.492 . . . . 73.1 112.713 -176.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.5 mt -115.35 169.26 9.28 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.845 0.355 . . . . 63.12 111.432 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.1 t -87.7 151.49 22.89 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.029 0.443 . . . . 62.32 111.772 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.1 mm -58.09 -48.85 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 112.985 0.735 . . . . 60.2 112.985 -172.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.541 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 41.8 p90 -56.68 -38.67 72.57 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 111.853 0.316 . . . . 74.53 111.853 -176.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -75.84 -47.18 26.64 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.079 0.466 . . . . 65.33 111.091 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.9 t -55.23 -48.28 76.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 116.17 -0.468 . . . . 72.33 111.614 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -65.61 -29.72 70.34 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 111.887 0.329 . . . . 71.24 111.887 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 65.6 mt -59.03 -49.28 78.49 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.167 -0.333 . . . . 73.2 110.577 176.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -61.28 -53.27 58.96 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.352 -0.385 . . . . 74.02 111.191 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.421 HD12 ' CD1' ' A' ' 67' ' ' TRP . 89.0 mt -55.37 -49.73 71.53 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.226 0.536 . . . . 74.31 112.393 -178.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.79 -41.73 95.6 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.937 -0.574 . . . . 62.34 112.095 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -68.83 -41.13 78.95 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.741 0.305 . . . . 75.25 110.942 176.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.0 mt -59.68 -31.63 69.74 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.746 0.307 . . . . 61.44 111.102 175.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.507 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 42.0 t-80 -66.43 -48.6 69.49 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.987 0.423 . . . . 75.3 111.031 173.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -59.96 -33.56 72.09 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 116.123 -0.489 . . . . 71.42 111.933 -176.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.492 HG21 HG22 ' A' ' 53' ' ' VAL . 33.9 m -89.44 1.53 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 112.841 0.682 . . . . 73.33 112.841 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.44 19.52 51.98 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 114.82 0.688 . . . . 53.21 114.82 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.492 HG22 HG21 ' A' ' 51' ' ' VAL . 81.6 t -88.53 -48.24 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 122.16 -0.612 . . . . 75.22 111.027 175.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 85.9 mt -114.79 152.39 32.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.285 -0.416 . . . . 62.45 111.503 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.46 ' HA ' ' HD2' ' A' ' 49' ' ' HIS . 10.5 tp10 -109.28 149.99 28.63 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.488 -0.323 . . . . 73.55 110.299 173.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.441 ' HD3' ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -98.86 137.78 36.94 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.165 0.507 . . . . 74.43 111.215 -178.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.488 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 88.7 t . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 120.995 0.426 . . . . 71.54 111.57 -177.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 70.5 mt . . . . . 0 CA--C 1.537 0.457 0 CA-C-O 120.934 0.397 . . . . 71.15 111.597 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.421 ' CD1' HD12 ' A' ' 45' ' ' LEU . 72.8 m95 -131.45 154.04 49.11 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.856 0.36 . . . . 74.35 111.351 -178.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.7 ttt85 -165.3 117.55 1.16 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.551 -0.295 . . . . 74.31 110.992 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 54' ' ' LEU . 4.2 pp -64.21 155.29 32.29 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.953 0.406 . . . . 71.45 111.661 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.435 ' H ' HD23 ' A' ' 70' ' ' LEU . 1.8 pt? . . . . . 0 N--CA 1.47 0.563 0 CA-C-O 121.035 0.445 . . . . 74.23 111.184 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.634 HG12 HD12 ' A' ' 36' ' ' LEU . 9.5 tp . . . . . 0 CA--C 1.542 0.647 0 N-CA-C 112.314 0.487 . . . . 73.35 112.314 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.7 t -58.46 -50.26 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.853 0.359 . . . . 73.34 111.509 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.9 m -60.88 -40.02 91.43 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.937 0.398 . . . . 74.41 111.041 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.603 ' HZ3' ' HB2' ' A' ' 8' ' ' LYS . 4.4 ttmp? -58.93 -48.77 80.3 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.34 -0.391 . . . . 74.23 111.095 177.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.9 mt -56.47 -48.11 80.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.421 -0.354 . . . . 75.3 111.586 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.5 mt -59.14 -43.27 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.079 0.466 . . . . 73.33 111.018 176.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.4 t -60.52 -40.02 89.92 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.948 -0.569 . . . . 71.21 111.628 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 8' ' ' LYS . 86.8 mt -61.08 -51.06 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.093 0.473 . . . . 55.21 111.185 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.6 t -57.97 -51.01 76.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.105 0.478 . . . . 61.01 111.008 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -54.07 -47.38 71.73 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.998 -0.546 . . . . 72.24 111.349 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -57.52 -53.49 57.56 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.145 -0.479 . . . . 54.53 111.785 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -62.69 -27.17 69.06 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.568 -0.287 . . . . 75.31 111.71 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -80.22 -26.79 38.94 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 122.16 -0.337 . . . . 75.01 111.705 175.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -64.59 -26.11 68.26 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.225 0.536 . . . . 62.12 109.856 170.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.0 mmm -78.43 -60.18 2.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.708 -0.678 . . . . 74.23 111.548 173.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -94.13 -55.86 3.05 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.771 0.656 . . . . 54.22 112.771 -176.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.3 t70 68.47 -69.08 0.16 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.455 0.702 . . . . 74.03 111.834 -176.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.44 -35.34 84.86 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.983 -0.627 . . . . 75.31 112.812 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.38 129.37 33.58 Favored Pre-proline 0 CA--C 1.541 0.63 0 O-C-N 122.618 -0.343 . . . . 74.44 111.069 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.04 164.14 33.1 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.421 2.08 . . . . 72.34 113.251 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.4 t -84.85 145.64 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.285 -0.416 . . . . 71.42 110.742 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -90.06 141.16 28.94 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.706 0.289 . . . . 54.51 110.788 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.1 m -52.01 -38.31 56.39 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.851 0.357 . . . . 60.35 111.873 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -63.35 -47.56 81.64 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 122.37 -0.206 . . . . 73.35 111.552 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.22 -52.5 51.95 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.002 0.429 . . . . 70.34 111.196 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.542 HG22 HD22 ' A' ' 45' ' ' LEU . 58.3 mt -58.44 -53.89 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 115.764 -0.653 . . . . 74.54 111.742 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.486 ' HA ' HG23 ' A' ' 41' ' ' VAL . . . -60.85 -45.43 94.55 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.096 0.406 . . . . 72.53 112.096 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.16 -40.4 96.05 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.088 -0.506 . . . . 74.34 111.595 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.451 ' HB3' HD11 ' A' ' 12' ' ' ILE . . . -71.97 -38.29 69.76 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.877 0.37 . . . . 39.03 111.324 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.82 -35.27 72.41 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.287 -0.415 . . . . 62.54 111.659 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.97 23.2 42.4 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.394 -0.432 . . . . 65.22 113.509 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.634 HD12 HG12 ' A' ' 5' ' ' ILE . 85.7 mt -113.24 171.67 7.41 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.964 0.412 . . . . 72.0 111.705 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.5 m -71.65 144.36 49.42 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.261 -0.427 . . . . 71.02 111.404 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.1 mm -50.85 -58.22 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.35 0.5 . . . . 63.31 112.35 -174.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.461 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 47.8 p90 -54.02 -40.69 67.26 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.158 0.429 . . . . 65.3 112.158 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -65.43 -47.3 76.7 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.169 0.509 . . . . 65.14 111.016 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 31' ' ' ALA . 60.9 t -58.7 -44.29 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.147 -0.479 . . . . 72.5 111.024 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -58.52 -33.69 70.14 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.616 -0.265 . . . . 64.05 111.686 178.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.537 ' O ' ' HG3' ' A' ' 47' ' ' GLN . 95.1 mt -60.07 -52.58 64.74 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 110.167 -0.309 . . . . 65.51 110.167 175.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -56.83 -46.0 81.96 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.115 0.484 . . . . 75.11 111.256 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.542 HD22 HG22 ' A' ' 30' ' ' ILE . 92.9 mt -59.92 -46.6 88.84 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.089 -0.505 . . . . 73.43 111.918 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -67.29 -37.18 83.0 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.509 0.195 . . . . 73.41 111.34 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.537 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 96.2 mt-30 -59.66 -45.19 92.8 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.064 0.459 . . . . 63.35 110.602 174.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.3 mt -61.42 -34.13 74.87 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.379 -0.373 . . . . 74.51 111.416 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.526 ' HD2' ' HA ' ' A' ' 55' ' ' GLU . 46.5 t-80 -70.56 -28.71 65.11 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.149 0.499 . . . . 73.2 111.015 174.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -79.65 -41.66 26.48 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.143 -0.481 . . . . 73.43 111.765 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.6 m -77.79 -24.71 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 111.914 0.339 . . . . 73.13 111.914 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.6 69.02 0.61 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.098 -0.572 . . . . 62.54 113.12 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.4 t -141.36 -60.92 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.111 0.481 . . . . 74.44 110.787 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.656 HD21 ' HB3' ' A' ' 69' ' ' LEU . 80.9 mt -103.98 145.75 29.7 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.148 -0.478 . . . . 74.23 111.962 -177.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.526 ' HA ' ' HD2' ' A' ' 49' ' ' HIS . 12.0 tp10 -108.53 141.11 40.91 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.029 0.442 . . . . 73.33 110.838 172.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? -89.96 94.87 9.97 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.144 0.497 . . . . 73.23 111.495 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 CA--C 1.542 0.66 0 CA-C-O 120.967 0.413 . . . . 75.03 110.835 177.003 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 66' ' ' LEU . 5.9 mp . . . . . 0 N--CA 1.466 0.364 0 N-CA-C 110.025 -0.361 . . . . 62.43 110.025 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.433 ' CD1' HD11 ' A' ' 45' ' ' LEU . 58.2 m95 -102.23 133.93 46.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.469 0.652 . . . . 73.2 111.906 -172.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -141.31 114.47 8.66 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.778 -0.646 . . . . 73.12 111.088 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.656 ' HB3' HD21 ' A' ' 54' ' ' LEU . 4.2 pp -67.76 151.58 46.99 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.426 0.631 . . . . 73.12 111.9 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.476 HD22 ' HB2' ' A' ' 55' ' ' GLU . 1.7 pt? . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 115.39 -0.823 . . . . 72.1 110.648 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.9 tp . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 112.054 0.39 . . . . 72.52 112.054 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.451 HG12 HD21 ' A' ' 48' ' ' LEU . 61.6 t -53.27 -49.53 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.402 -0.363 . . . . 72.45 111.955 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.0 m -55.45 -46.2 76.81 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.898 0.38 . . . . 74.33 111.408 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.493 ' O ' HG13 ' A' ' 12' ' ' ILE . 53.8 tptt -55.99 -50.61 70.37 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.366 -0.379 . . . . 64.45 111.49 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.3 mt -57.19 -42.33 79.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.312 -0.404 . . . . 65.53 111.562 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.2 mt -61.56 -46.06 97.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 121.003 0.43 . . . . 71.44 110.903 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.8 m -60.75 -32.67 71.96 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.348 -0.387 . . . . 71.12 111.506 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.516 HG22 ' HA ' ' A' ' 30' ' ' ILE . 96.4 mt -67.21 -41.32 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.788 0.328 . . . . 74.4 111.55 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.429 ' HA ' HG23 ' A' ' 25' ' ' VAL . 59.5 t -59.95 -41.23 85.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 121.207 0.527 . . . . 74.25 110.714 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -64.56 -48.15 76.09 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.058 0.456 . . . . 61.32 110.514 173.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -53.06 -56.3 17.21 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.624 -0.716 . . . . 74.04 112.25 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -67.48 -39.14 85.23 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.511 0.559 . . . . 61.35 112.511 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -74.21 -20.33 60.22 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.406 -0.518 . . . . 72.42 110.71 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -71.51 -24.53 61.98 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.497 0.665 . . . . 74.13 109.514 172.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.1 mmt -79.64 -47.89 14.65 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.871 -0.604 . . . . 75.12 111.504 169.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -98.56 84.69 3.21 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.052 0.453 . . . . 75.3 110.969 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -57.05 -37.34 71.66 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.397 0.518 . . . . 63.0 112.397 -177.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -108.11 20.14 31.33 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.244 -0.503 . . . . 74.11 113.868 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.412 ' HA ' ' HD2' ' A' ' 24' ' ' PRO . . . -158.39 108.33 1.68 Allowed Pre-proline 0 N--CA 1.468 0.459 0 CA-C-N 117.053 0.427 . . . . 62.22 111.785 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.505 ' HB3' ' HB2' ' A' ' 68' ' ' ARG . 1.5 Cg_endo -48.34 177.39 0.02 OUTLIER 'Trans proline' 0 CA--C 1.552 1.414 0 C-N-CA 122.954 2.436 . . . . 64.23 114.501 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.429 HG23 ' HA ' ' A' ' 13' ' ' VAL . 44.1 t -79.57 152.93 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 112.824 0.675 . . . . 72.04 112.824 -169.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.626 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 8.2 mptt -105.86 146.09 30.38 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.715 -0.675 . . . . 54.44 110.082 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.4 m -53.71 -44.34 69.77 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.652 0.612 . . . . 55.3 112.652 -176.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -59.47 -43.58 93.2 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 111.7 0.259 . . . . 72.13 111.7 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 2.8 m-20 -56.46 -39.62 73.47 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.039 0.447 . . . . 72.34 112.043 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.596 HG22 HD23 ' A' ' 45' ' ' LEU . 61.5 mt -68.94 -44.51 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.954 0.406 . . . . 71.24 111.289 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.474 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -61.82 -35.28 77.76 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.104 0.478 . . . . 53.3 111.162 175.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -65.58 -55.59 16.88 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.658 -0.701 . . . . 73.41 111.737 178.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.39 -37.99 87.9 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.762 0.653 . . . . 42.24 112.762 -176.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.48 -28.91 30.89 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 111.974 0.361 . . . . 73.05 111.974 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.64 39.05 22.6 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.066 -0.587 . . . . 53.44 112.586 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.5 mt -117.43 172.71 7.15 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 122.658 -0.319 . . . . 65.44 111.236 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.6 m -78.99 148.14 32.67 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.663 -0.244 . . . . 74.31 111.439 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.6 mm -52.66 -58.56 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 112.407 0.521 . . . . 75.22 112.407 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -57.05 -41.83 79.4 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.959 0.409 . . . . 74.12 111.567 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -56.42 -49.64 73.97 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.462 0.649 . . . . 61.33 111.068 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.474 HG21 ' HA ' ' A' ' 31' ' ' ALA . 64.2 t -65.11 -39.47 85.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.838 -0.619 . . . . 72.31 111.352 178.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.4 mmm-85 -50.94 -48.17 60.95 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.889 0.376 . . . . 71.31 111.315 175.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.5 mt -59.01 -51.59 69.39 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.183 -0.462 . . . . 75.22 111.091 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -60.2 -45.15 94.15 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.4 0.519 . . . . 75.14 112.4 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.596 HD23 HG22 ' A' ' 30' ' ' ILE . 91.0 mt -64.6 -52.77 55.79 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.175 0.512 . . . . 73.42 111.515 -177.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -66.34 -29.22 69.37 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.101 -0.5 . . . . 74.45 111.993 -177.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -74.56 -37.84 62.86 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 122.104 -0.373 . . . . 71.03 111.052 172.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.451 HD21 HG12 ' A' ' 6' ' ' VAL . 62.1 mt -64.37 -26.54 68.51 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.883 0.373 . . . . 71.02 110.843 173.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -72.86 -40.35 65.75 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.887 0.375 . . . . 74.1 110.69 171.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.19 -38.2 88.21 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 116.216 -0.447 . . . . 72.43 111.744 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.509 HG23 HG22 ' A' ' 53' ' ' VAL . 35.4 m -81.25 -12.09 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 112.218 0.451 . . . . 72.5 112.218 177.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.18 24.93 13.43 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 120.986 -0.626 . . . . 73.4 114.62 174.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.509 HG22 HG23 ' A' ' 51' ' ' VAL . 64.4 t -91.71 -56.59 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 117.493 0.647 . . . . 65.25 111.332 175.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 61.5 mt -105.13 125.88 51.46 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.079 -0.509 . . . . 73.23 111.498 -176.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -93.87 140.19 29.98 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.887 0.375 . . . . 74.5 111.703 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -88.62 94.01 9.75 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.97 0.414 . . . . 72.32 110.58 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.6 t . . . . . 0 CA--C 1.536 0.437 0 CA-C-N 116.666 -0.243 . . . . 74.45 110.461 175.532 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 91.4 mt . . . . . 0 CA--C 1.539 0.543 0 CA-C-O 121.043 0.449 . . . . 71.3 111.764 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -84.4 125.42 32.32 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.563 0.697 . . . . 73.2 112.614 -175.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.505 ' HB2' ' HB3' ' A' ' 24' ' ' PRO . 74.0 ttt180 -139.97 117.78 11.68 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.897 -0.592 . . . . 72.5 110.768 176.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -66.35 152.9 44.05 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.865 0.364 . . . . 75.34 111.12 178.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.6 mt . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 120.91 0.386 . . . . 74.01 111.826 -176.846 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.541 HD11 HD12 ' A' ' 36' ' ' LEU . 14.3 tt . . . . . 0 CA--C 1.54 0.56 0 CA-C-O 121.728 0.775 . . . . 72.21 109.917 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.549 HG12 HD13 ' A' ' 48' ' ' LEU . 92.8 t -56.83 -49.35 79.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.085 -0.962 . . . . 72.22 111.25 173.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.4 m -58.62 -33.3 69.88 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.133 0.492 . . . . 63.3 111.443 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.437 ' O ' HG13 ' A' ' 12' ' ' ILE . 58.8 tttp -62.58 -49.82 73.73 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.056 0.455 . . . . 61.31 110.297 174.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.487 ' HA ' HD13 ' A' ' 12' ' ' ILE . 72.1 mt -58.34 -43.53 86.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.98 -0.554 . . . . 52.42 111.332 178.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 73.6 mt -57.5 -42.08 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.911 0.386 . . . . 64.45 111.068 176.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.9 m -64.0 -34.16 77.37 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.252 -0.431 . . . . 64.12 111.28 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.487 HD13 ' HA ' ' A' ' 9' ' ' ILE . 83.6 mt -66.39 -46.01 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.918 0.39 . . . . 62.42 110.98 176.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.54 -45.58 96.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.054 0.454 . . . . 74.02 110.768 175.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -55.91 -49.6 73.01 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.009 -0.541 . . . . 64.11 111.165 175.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -54.63 -56.34 20.02 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.682 -0.69 . . . . 64.03 111.522 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 35.9 mmt-85 -57.53 -40.11 78.08 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.27 -0.423 . . . . 70.11 111.907 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.49 ' O ' ' N ' ' A' ' 21' ' ' ASP . 59.9 mt-30 -61.35 -47.36 86.25 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.245 -0.284 . . . . 72.52 110.989 175.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -57.93 -27.02 62.99 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.293 0.479 . . . . 70.24 112.293 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 47.9 mtt -55.78 -41.71 74.47 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.164 0.431 . . . . 71.44 112.164 174.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.491 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 30.7 t70 -128.63 8.58 5.86 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.021 0.439 . . . . 60.2 111.667 -176.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' A' ' 17' ' ' GLN . 31.9 t70 54.73 97.24 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.398 0.679 . . . . 71.23 112.418 -176.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.17 -13.6 66.64 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 114.465 0.546 . . . . 44.31 114.465 176.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.491 ' HB1' ' HB3' ' A' ' 20' ' ' ASP . . . -56.42 120.58 36.86 Favored Pre-proline 0 N--CA 1.473 0.691 0 N-CA-C 112.493 0.553 . . . . 52.12 112.493 -177.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.517 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 72.6 Cg_endo -75.1 152.91 40.88 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.62 2.213 . . . . 71.41 112.813 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.1 t -117.13 150.86 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 O-C-N 122.301 -0.249 . . . . 71.2 111.566 -175.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.448 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 9.6 mptt -87.91 158.14 18.77 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.894 0.378 . . . . 71.51 110.803 176.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.495 HG22 ' HB2' ' A' ' 42' ' ' ARG . 56.0 m -56.38 -47.29 79.22 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.903 0.382 . . . . 72.22 111.814 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.48 -37.78 87.28 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.759 0.314 . . . . 64.5 111.264 -177.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 3.5 m-20 -64.23 -44.75 90.88 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.81 0.338 . . . . 74.35 111.413 178.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.65 -47.41 91.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 116.193 -0.458 . . . . 73.3 111.014 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.495 ' HA ' HG23 ' A' ' 41' ' ' VAL . . . -57.81 -41.98 83.29 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.04 0.448 . . . . 52.44 111.331 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -62.95 -47.54 82.78 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.043 -0.526 . . . . 73.44 111.53 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.43 -26.64 66.51 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.914 0.388 . . . . 71.15 111.994 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.73 -22.04 22.39 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.052 0.39 . . . . 73.33 112.052 178.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.36 34.21 54.97 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.213 -0.518 . . . . 75.3 112.507 -174.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.541 HD12 HD11 ' A' ' 5' ' ' ILE . 95.7 mt -115.34 -178.85 3.48 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.118 0.485 . . . . 65.13 111.624 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.4 m -84.85 141.86 30.15 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.853 -0.612 . . . . 74.0 111.077 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.3 mm -55.61 -58.51 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.578 0.584 . . . . 74.34 112.578 -173.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.459 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 41.5 t80 -60.44 -40.44 91.11 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.818 0.342 . . . . 73.12 111.453 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.459 ' HG3' ' HE2' ' A' ' 44' ' ' TYR . 5.8 tp-100 -57.45 -52.5 65.12 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.231 0.539 . . . . 71.44 111.149 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.495 HG23 ' HA ' ' A' ' 31' ' ' ALA . 71.6 t -58.54 -45.15 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.005 -0.543 . . . . 73.33 111.345 176.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.495 ' HB2' HG22 ' A' ' 27' ' ' THR . 76.5 ttt180 -51.23 -39.32 56.36 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.116 -0.493 . . . . 71.32 111.524 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 93.4 mt -65.49 -44.72 86.2 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.365 -0.38 . . . . 64.14 111.547 177.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.459 ' HE2' ' HG3' ' A' ' 40' ' ' GLN . 69.3 m-85 -62.37 -40.35 96.15 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.246 0.546 . . . . 74.21 111.126 177.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.488 HD11 ' CD1' ' A' ' 67' ' ' TRP . 81.9 mt -65.39 -45.14 85.18 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.247 -0.433 . . . . 73.21 111.452 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -66.1 -38.86 89.3 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.578 0.584 . . . . 72.12 112.578 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 20.9 pt20 -66.67 -36.63 83.0 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 120.779 -0.369 . . . . 74.32 110.659 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.549 HD13 HG12 ' A' ' 6' ' ' VAL . 85.2 mt -68.12 -38.86 82.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.18 0.514 . . . . 75.01 110.842 173.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -68.28 -21.56 64.78 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.994 -0.548 . . . . 72.41 111.029 175.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -83.4 -50.9 7.87 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.22 -0.445 . . . . 72.23 111.603 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.2 m -70.72 -31.11 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 112.776 0.658 . . . . 73.22 112.776 -177.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 116.89 43.89 0.6 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 120.836 -0.697 . . . . 74.23 114.093 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.29 -38.06 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.081 0.467 . . . . 75.23 111.293 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.8 mt -111.28 136.98 49.6 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.938 0.399 . . . . 64.41 111.629 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -103.32 136.14 43.64 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.116 -0.493 . . . . 64.32 109.804 172.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -94.0 144.13 25.74 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.137 0.494 . . . . 64.54 110.99 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.581 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 16.2 t . . . . . 0 C--N 1.324 -0.533 0 N-CA-C 109.36 -0.608 . . . . 63.31 109.36 173.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.581 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 49.5 mt . . . . . 0 CA--C 1.538 0.504 0 CA-C-O 120.944 0.402 . . . . 63.22 111.042 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.488 ' CD1' HD11 ' A' ' 45' ' ' LEU . 49.8 m95 -106.3 127.68 53.43 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.887 0.375 . . . . 73.24 111.869 -176.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -140.58 121.67 14.71 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.215 0.531 . . . . 74.24 110.945 173.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 pp -69.23 161.23 29.63 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.949 0.404 . . . . 75.13 111.6 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.493 HD22 ' N ' ' A' ' 70' ' ' LEU . 1.5 pt? . . . . . 0 CA--C 1.539 0.551 0 CA-C-N 116.313 -0.403 . . . . 73.55 111.451 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.435 HG12 HD12 ' A' ' 36' ' ' LEU . 8.6 tp . . . . . 0 CA--C 1.539 0.538 0 N-CA-C 111.924 0.342 . . . . 65.1 111.924 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.7 t -58.81 -47.13 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.274 0.559 . . . . 70.31 110.932 178.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 m -61.49 -40.2 93.71 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.93 -0.577 . . . . 70.22 110.95 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.524 ' O ' HG13 ' A' ' 12' ' ' ILE . 88.5 tttt -61.14 -46.47 90.42 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.139 -0.482 . . . . 74.32 110.893 177.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.436 ' O ' HG21 ' A' ' 13' ' ' VAL . 78.2 mt -55.21 -49.28 73.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.88 0.372 . . . . 75.5 111.229 176.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 69.8 mt -59.09 -40.63 81.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.106 0.479 . . . . 74.43 111.02 176.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.3 t -63.38 -35.7 81.27 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.304 -0.407 . . . . 73.53 111.194 176.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 8' ' ' LYS . 86.0 mt -65.51 -44.14 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-O 121.245 0.545 . . . . 73.31 110.449 175.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.436 HG21 ' O ' ' A' ' 9' ' ' ILE . 95.5 t -56.92 -46.92 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 115.898 -0.592 . . . . 73.42 111.063 176.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -61.33 -49.15 78.16 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.208 -0.451 . . . . 72.4 110.96 176.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -54.47 -53.36 55.27 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.902 -0.59 . . . . 65.14 111.633 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.509 ' HG3' HG12 ' A' ' 25' ' ' VAL . 5.7 mmp_? -56.12 -42.22 76.51 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.239 -0.437 . . . . 75.11 112.128 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -70.25 -31.09 68.32 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.728 0.299 . . . . 71.3 111.692 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -60.68 -33.42 72.82 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.119 0.485 . . . . 71.01 110.825 173.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 95.7 mmm -61.59 -34.87 76.36 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.004 -0.544 . . . . 74.2 111.955 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -159.52 110.17 1.97 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.887 0.375 . . . . 63.55 110.68 177.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -59.85 -17.7 38.5 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.56 0.578 . . . . 73.14 112.56 -178.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.9 12.74 59.2 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 120.985 -0.626 . . . . 73.21 113.329 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . . . -122.98 139.8 32.17 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 117.06 0.43 . . . . 65.24 112.144 -177.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 23' ' ' ALA . 9.8 Cg_endo -87.95 174.3 4.7 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.041 2.494 . . . . 71.43 112.495 175.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.509 HG12 ' HG3' ' A' ' 16' ' ' ARG . 21.2 t -101.93 135.86 36.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.372 -0.376 . . . . 51.24 111.212 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.42 143.05 27.12 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.621 0.248 . . . . 74.45 111.025 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 67.9 m -55.97 -37.26 68.82 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.168 0.509 . . . . 74.34 110.79 173.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.1 mmm-85 -60.55 -55.8 28.98 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.016 -0.538 . . . . 65.34 111.196 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -51.62 -44.92 63.07 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.99 -0.55 . . . . 71.54 111.643 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.0 mt -61.83 -45.39 98.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.385 -0.37 . . . . 75.51 111.306 177.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.55 -31.92 71.01 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.896 0.379 . . . . 62.43 111.647 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -67.46 -51.08 55.71 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.231 -0.441 . . . . 74.0 111.362 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.48 -26.97 60.36 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.231 0.456 . . . . 74.12 112.231 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.67 -28.49 23.12 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.082 0.401 . . . . 63.14 112.082 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.02 32.58 60.49 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.043 -0.598 . . . . 42.45 113.317 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.435 HD12 HG12 ' A' ' 5' ' ' ILE . 88.7 mt -115.59 166.57 11.77 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.916 0.388 . . . . 74.33 111.042 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.402 ' O ' HG21 ' A' ' 41' ' ' VAL . 97.6 p -70.08 143.72 52.35 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.768 0.318 . . . . 75.33 111.277 178.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.5 mm -49.15 -50.08 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 112.366 0.506 . . . . 75.41 112.366 -177.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -62.67 -42.82 99.82 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.719 0.295 . . . . 73.33 111.405 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -63.97 -43.85 94.49 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.901 0.382 . . . . 74.5 111.077 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 37' ' ' SER . 81.9 t -57.84 -42.93 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.975 0.417 . . . . 74.34 110.539 175.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -55.84 -40.44 72.85 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.025 -0.534 . . . . 73.43 111.429 175.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.1 mt -59.34 -44.52 92.64 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.805 0.336 . . . . 71.41 111.17 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -65.37 -53.95 35.96 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.364 -0.38 . . . . 74.45 111.797 177.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.467 HD12 ' CD1' ' A' ' 67' ' ' TRP . 89.5 mt -56.84 -38.3 72.46 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.101 0.477 . . . . 63.25 111.705 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -61.64 -53.66 53.24 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.956 -0.566 . . . . 73.44 110.985 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -67.79 -39.03 84.08 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 111.804 0.298 . . . . 73.32 111.804 -178.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.9 mt -61.01 -35.26 76.4 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.214 0.531 . . . . 74.2 110.782 173.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -67.07 -46.23 74.93 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.254 -0.43 . . . . 73.12 111.517 174.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -66.09 -41.61 90.44 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.271 0.471 . . . . 73.34 112.271 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.489 HG21 HG22 ' A' ' 53' ' ' VAL . 34.4 m -71.15 -17.86 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 112.14 0.422 . . . . 61.31 112.14 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.65 29.19 5.1 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 120.836 -0.697 . . . . 74.32 114.274 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.489 HG22 HG21 ' A' ' 51' ' ' VAL . 97.3 t -94.87 -49.74 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 117.369 0.584 . . . . 75.31 110.895 174.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.8 mt -112.54 138.76 48.84 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.09 0.472 . . . . 75.31 111.866 -178.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.477 ' HB3' ' HG3' ' A' ' 68' ' ' ARG . 33.7 tt0 -91.76 146.3 23.87 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.382 -0.372 . . . . 64.13 110.171 175.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -87.68 138.62 31.31 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.17 0.433 . . . . 74.41 112.17 -174.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 62.1 t . . . . . 0 CA--C 1.541 0.614 0 CA-C-O 120.922 0.392 . . . . 72.43 110.486 172.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 94.3 mt . . . . . 0 CA--C 1.536 0.42 0 CA-C-O 120.976 0.417 . . . . 65.44 110.304 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.467 ' CD1' HD12 ' A' ' 45' ' ' LEU . 57.9 m95 -128.39 146.77 50.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.249 0.547 . . . . 74.1 111.844 -175.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.477 ' HG3' ' HB3' ' A' ' 55' ' ' GLU . 5.8 ptm180 -138.74 172.3 13.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.929 -0.578 . . . . 73.45 110.029 174.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pp -108.7 168.92 8.99 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.132 -0.355 . . . . 74.24 110.867 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.5 mt . . . . . 0 CA--C 1.54 0.591 0 CA-C-O 121.083 0.468 . . . . 73.15 111.707 -177.199 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.4 mm . . . . . 0 CA--C 1.537 0.448 0 CA-C-O 121.058 0.456 . . . . 71.42 110.386 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.1 t -57.73 -48.11 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.018 0.437 . . . . 54.54 110.91 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 78.0 m -61.33 -35.47 77.49 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.412 -0.358 . . . . 53.42 110.982 176.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.51 ' O ' HG13 ' A' ' 12' ' ' ILE . 86.9 tttt -60.28 -47.91 83.99 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.433 -0.349 . . . . 72.22 110.612 176.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 68.1 mt -57.32 -48.47 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.308 -0.405 . . . . 61.43 111.371 176.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.4 mt -57.21 -40.47 73.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.136 0.493 . . . . 64.03 110.993 176.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.6 m -61.34 -45.33 94.87 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.087 -0.506 . . . . 70.34 111.022 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.535 ' O ' ' HG2' ' A' ' 16' ' ' ARG . 83.1 mt -57.94 -56.03 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.17 -0.468 . . . . 72.12 111.563 179.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.52 HG11 HD23 ' A' ' 69' ' ' LEU . 49.0 t -56.82 -50.81 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.847 0.356 . . . . 63.13 111.602 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -57.11 -45.67 83.24 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.089 0.471 . . . . 65.33 111.219 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -60.02 -40.48 89.45 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.291 -0.413 . . . . 72.01 111.419 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 12' ' ' ILE . 23.4 mmm-85 -62.23 -39.48 92.95 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 122.178 -0.326 . . . . 65.01 110.503 175.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -65.69 -26.09 67.61 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.057 0.456 . . . . 50.23 111.556 175.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -78.05 -18.98 55.15 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.846 0.355 . . . . 65.42 111.008 173.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 94.8 mmm -81.05 -35.64 31.55 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.932 0.396 . . . . 74.32 111.103 174.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.559 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 18.6 t70 -142.98 138.75 30.29 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.457 -0.338 . . . . 65.3 110.913 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -61.79 -11.3 11.77 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.435 0.902 . . . . 73.52 113.435 -175.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.456 ' O ' ' HD3' ' A' ' 24' ' ' PRO . . . -150.08 51.59 0.53 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.973 -0.632 . . . . 72.42 112.954 177.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.559 ' HB1' ' HB3' ' A' ' 20' ' ' ASP . . . -83.8 109.49 18.87 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.567 0.58 . . . . 37.81 112.567 -177.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.544 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 88.9 Cg_endo -79.95 108.05 2.17 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.987 1.791 . . . . 63.42 111.083 171.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.408 HG23 ' HA ' ' A' ' 13' ' ' VAL . 14.6 t -79.02 144.3 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.414 0.626 . . . . 60.44 111.528 -172.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.598 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -95.36 138.82 32.52 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.106 -0.497 . . . . 73.01 111.479 -171.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.5 HG23 ' HD2' ' A' ' 42' ' ' ARG . 86.9 m -52.68 -38.81 61.15 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.049 0.452 . . . . 63.01 111.163 175.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -60.54 -58.52 8.14 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.054 -0.521 . . . . 71.03 111.016 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -51.17 -46.31 62.04 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.128 0.489 . . . . 64.4 111.312 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.5 mt -60.48 -44.48 96.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.117 -0.492 . . . . 75.22 111.505 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.59 -48.01 83.33 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.789 0.328 . . . . 72.13 111.615 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.67 -52.75 63.06 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.39 -0.368 . . . . 64.25 111.881 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.37 -37.7 87.8 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.366 0.506 . . . . 74.05 112.366 -178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.24 -35.85 58.79 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 111.841 0.312 . . . . 74.03 111.841 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.26 33.14 8.27 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.284 -0.484 . . . . 51.11 112.706 -176.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.8 mt -120.11 171.77 8.23 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.2 0.524 . . . . 74.33 111.708 -177.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.478 ' O ' HG22 ' A' ' 41' ' ' VAL . 39.7 m -81.84 147.28 29.43 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.985 -0.552 . . . . 62.03 111.08 178.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.481 ' O ' ' HD3' ' A' ' 42' ' ' ARG . 47.5 mm -51.17 -58.59 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 112.904 0.705 . . . . 75.32 112.904 -175.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -62.42 -32.1 72.89 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.994 0.426 . . . . 75.32 111.336 -178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -61.32 -45.26 95.17 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.378 0.609 . . . . 74.22 110.378 175.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 37' ' ' SER . 71.3 t -62.45 -36.8 76.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 115.842 -0.617 . . . . 74.15 111.658 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.5 ' HD2' HG23 ' A' ' 27' ' ' THR . 0.3 OUTLIER -47.29 -53.07 14.46 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 121.128 0.489 . . . . 73.42 111.179 173.348 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.403 ' O ' ' HG3' ' A' ' 47' ' ' GLN . 74.1 mt -60.06 -48.67 80.74 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.617 -0.72 . . . . 73.44 111.516 -177.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -57.42 -50.04 74.29 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.373 -0.376 . . . . 74.42 111.782 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 67.8 mt -62.96 -46.61 86.89 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.872 0.368 . . . . 60.33 111.862 -176.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -61.11 -41.77 97.3 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.544 -0.298 . . . . 74.24 111.732 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 87.3 mt-30 -65.48 -40.02 92.62 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.755 0.312 . . . . 74.45 111.325 176.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.0 -30.48 70.98 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.882 0.373 . . . . 74.31 111.127 175.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -65.09 -44.81 87.63 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.889 0.376 . . . . 75.31 110.946 173.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -62.21 -48.03 81.81 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.314 0.487 . . . . 75.21 112.314 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.506 HG21 HG22 ' A' ' 53' ' ' VAL . 33.2 m -74.29 2.8 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 112.802 0.668 . . . . 74.11 112.802 -177.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.72 34.99 10.61 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.747 -0.739 . . . . 51.03 114.255 174.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.506 HG22 HG21 ' A' ' 51' ' ' VAL . 63.7 t -107.65 -60.69 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 122.383 -0.481 . . . . 75.03 111.101 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 69' ' ' LEU . 79.3 mt -100.95 163.99 12.03 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.955 0.724 . . . . 74.04 112.955 -175.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -136.51 145.02 44.61 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.532 -0.758 . . . . 62.33 110.264 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -84.15 141.55 30.99 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.176 0.513 . . . . 74.13 112.292 -174.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.545 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 48.5 t . . . . . 0 C--O 1.241 0.635 0 CA-C-O 121.239 0.542 . . . . 61.02 109.831 172.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.545 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 87.7 mt . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 120.612 0.244 . . . . 74.34 110.507 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -129.83 122.67 29.18 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.035 0.445 . . . . 75.32 111.995 -175.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -104.16 -172.72 2.16 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.284 -0.416 . . . . 61.33 109.916 171.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 54' ' ' LEU . 3.0 pp -126.38 164.6 20.73 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.153 -0.342 . . . . 72.43 110.582 172.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.3 mt . . . . . 0 CA--C 1.536 0.404 0 CA-C-O 121.336 0.588 . . . . 74.43 110.779 178.852 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.4 ' N ' HD13 ' A' ' 5' ' ' ILE . 2.0 mp . . . . . 0 N--CA 1.474 0.764 0 CA-C-O 120.869 0.366 . . . . 74.34 111.034 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 51.4 t -60.09 -36.62 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 116.459 -0.337 . . . . 73.31 111.211 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 95.0 m -54.27 -41.21 68.58 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.445 -0.343 . . . . 73.31 111.436 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.536 ' O ' HG13 ' A' ' 12' ' ' ILE . 23.1 ttmm -60.89 -47.06 88.14 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.761 0.315 . . . . 70.44 110.59 177.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.417 ' O ' HG21 ' A' ' 13' ' ' VAL . 62.7 mt -57.26 -46.7 85.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 120.827 0.346 . . . . 64.42 111.039 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 72.1 mt -59.61 -42.96 89.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.912 0.386 . . . . 75.1 111.126 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.2 t -62.73 -39.1 93.01 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.894 0.378 . . . . 72.32 111.365 177.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.536 HG13 ' O ' ' A' ' 8' ' ' LYS . 94.1 mt -61.68 -51.03 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.806 0.336 . . . . 73.54 110.599 176.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.554 HG11 HG23 ' A' ' 25' ' ' VAL . 59.0 t -60.9 -45.13 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 116.392 -0.367 . . . . 74.53 111.479 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.458 ' HA ' HD23 ' A' ' 69' ' ' LEU . 57.7 tp60 -60.26 -46.21 90.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.867 0.365 . . . . 70.12 110.997 177.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -61.55 -39.18 90.16 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.956 0.408 . . . . 73.5 110.859 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.443 HH11 ' HD3' ' A' ' 16' ' ' ARG . 16.6 mmm-85 -65.27 -41.31 94.32 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.802 0.334 . . . . 72.14 111.216 175.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -64.73 -31.12 72.2 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.511 0.672 . . . . 74.13 110.591 173.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -75.8 -20.32 58.3 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.336 -0.847 . . . . 75.14 110.681 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 94.5 mmm -102.79 -69.64 0.78 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.018 -0.537 . . . . 71.41 111.383 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.483 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 49.3 m-20 -66.66 -66.5 0.55 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.051 0.389 . . . . 62.45 112.051 -178.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.1 t70 69.3 -60.87 0.45 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.423 0.689 . . . . 71.45 111.544 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.66 -28.13 72.53 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.276 -0.487 . . . . 74.5 112.73 176.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.483 ' HB1' ' HB3' ' A' ' 20' ' ' ASP . . . -103.25 134.01 20.01 Favored Pre-proline 0 CA--C 1.538 0.507 0 O-C-N 122.579 -0.366 . . . . 74.33 110.92 177.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.482 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 8.0 Cg_exo -71.88 167.0 27.84 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.533 2.155 . . . . 54.53 113.145 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.554 HG23 HG11 ' A' ' 13' ' ' VAL . 29.1 t -85.44 142.07 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 115.999 -0.546 . . . . 73.21 110.763 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.525 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -102.12 146.56 27.77 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.717 0.294 . . . . 70.3 110.628 -179.199 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.4 m -59.54 -29.72 68.11 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.26 0.552 . . . . 73.25 110.932 176.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -58.53 -61.62 2.46 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.617 -0.72 . . . . 74.21 111.761 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.496 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 3.2 m-20 -51.64 -42.95 62.44 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.185 -0.462 . . . . 75.54 111.792 -178.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.6 mt -64.54 -42.36 94.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 116.33 -0.396 . . . . 75.31 111.25 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.1 -47.85 81.08 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.976 0.417 . . . . 71.44 111.797 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -67.76 -42.29 82.0 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.156 0.428 . . . . 73.45 112.156 178.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.59 -49.51 53.4 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.33 0.492 . . . . 72.11 112.33 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.6 -28.18 51.47 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.243 0.46 . . . . 72.23 112.243 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.76 54.38 3.47 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.203 -0.522 . . . . 44.12 112.763 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.4 mt -132.83 159.0 41.08 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.02 0.438 . . . . 73.21 111.384 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.1 m -73.46 145.72 45.52 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.306 -0.246 . . . . 75.01 110.805 174.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.2 mm -50.23 -41.47 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 112.403 0.52 . . . . 72.52 112.403 -176.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.403 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 56.6 t80 -59.83 -55.39 34.8 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.9 0.381 . . . . 70.34 111.001 175.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -52.0 -45.72 64.63 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.024 -0.534 . . . . 64.13 111.392 177.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.56 -49.37 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.161 -0.472 . . . . 72.31 111.182 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 mtm105 -58.34 -36.89 74.12 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.662 -0.245 . . . . 75.04 111.587 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.501 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 88.7 mt -56.56 -52.39 64.97 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.183 0.516 . . . . 70.44 110.306 177.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -64.96 -43.59 92.15 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.197 -0.456 . . . . 74.21 112.052 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.7 mt -65.86 -50.0 66.13 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.9 0.381 . . . . 54.4 111.853 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -62.74 -34.12 76.54 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.532 -0.304 . . . . 63.01 111.631 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 11.7 mm-40 -68.12 -47.96 66.73 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.119 -0.363 . . . . 55.44 110.977 174.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.5 mt -58.17 -32.8 68.55 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.043 0.449 . . . . 71.21 110.977 175.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.422 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 5.2 t60 -68.19 -44.96 74.68 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.9 0.381 . . . . 73.33 111.143 173.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.5 -42.35 95.89 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.127 -0.488 . . . . 72.23 111.753 -177.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.498 HG23 HG22 ' A' ' 53' ' ' VAL . 25.3 m -74.44 -9.79 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 112.151 0.426 . . . . 74.43 112.151 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.49 10.91 37.19 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 115.033 0.773 . . . . 62.43 115.033 173.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.498 HG22 HG23 ' A' ' 51' ' ' VAL . 92.5 t -82.26 -52.87 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 117.626 0.713 . . . . 64.44 111.439 177.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 91.9 mt -106.09 160.99 14.88 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.323 0.583 . . . . 61.51 112.035 -177.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -129.39 139.3 51.73 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.847 -0.615 . . . . 71.54 110.088 174.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -88.91 103.25 15.84 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.062 0.458 . . . . 64.44 111.488 -176.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 44.8 t . . . . . 0 CA--C 1.54 0.569 0 CA-C-O 121.086 0.47 . . . . 72.25 110.56 175.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.53 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 85.4 mt . . . . . 0 CA--C 1.54 0.564 0 CA-C-O 120.672 0.272 . . . . 65.51 111.17 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -128.24 147.23 50.58 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.05 0.452 . . . . 75.13 112.142 -176.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -150.89 134.62 16.5 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.497 -0.32 . . . . 73.33 111.161 174.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.482 ' O ' HD13 ' A' ' 69' ' ' LEU . 2.4 pp -78.69 141.86 37.59 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.184 0.516 . . . . 65.31 111.745 177.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.437 ' H ' HD21 ' A' ' 70' ' ' LEU . 1.9 pt? . . . . . 0 N--CA 1.471 0.621 0 CA-C-N 116.284 -0.416 . . . . 71.45 111.674 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.1 mm . . . . . 0 CA--C 1.539 0.539 0 CA-C-O 120.947 0.403 . . . . 75.13 111.557 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.1 t -62.86 -52.78 55.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.844 0.354 . . . . 71.22 111.359 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.4 m -59.19 -35.37 73.47 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.499 -0.319 . . . . 61.52 111.405 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.403 ' O ' HG13 ' A' ' 12' ' ' ILE . 4.1 tppp? -57.36 -50.71 72.1 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 110.134 -0.321 . . . . 70.34 110.134 176.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.472 HG21 HG23 ' A' ' 30' ' ' ILE . 67.2 mt -57.95 -51.79 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 116.212 -0.449 . . . . 72.12 111.546 175.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 79.3 mt -55.55 -47.26 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 112.319 0.489 . . . . 74.42 112.319 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.1 p -60.46 -42.46 96.24 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.882 0.372 . . . . 72.55 111.277 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.448 HG22 ' HA ' ' A' ' 30' ' ' ILE . 93.8 mt -63.08 -46.97 94.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 116.208 -0.451 . . . . 72.23 111.304 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.588 HG11 HG23 ' A' ' 25' ' ' VAL . 80.9 t -54.03 -55.27 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.987 0.422 . . . . 74.13 111.189 176.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -57.93 -40.01 79.42 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.239 -0.437 . . . . 71.04 111.664 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -66.18 -42.97 88.15 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.915 0.388 . . . . 64.41 110.936 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.459 ' HB2' HG22 ' A' ' 25' ' ' VAL . 5.0 mmp_? -57.58 -39.95 77.91 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.866 0.365 . . . . 74.4 110.564 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.614 ' HA ' ' HB2' ' A' ' 23' ' ' ALA . 14.6 mm100 -61.97 -40.63 96.25 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.066 0.46 . . . . 71.33 110.935 174.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -60.88 -28.79 69.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.247 -0.433 . . . . 73.24 111.766 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.456 ' HA ' ' HE1' ' A' ' 19' ' ' MET . 28.1 mmt -60.54 -53.38 58.26 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.665 0.617 . . . . 74.02 112.665 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' A' ' 23' ' ' ALA . 13.4 t70 -117.9 142.35 47.43 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.77 0.319 . . . . 72.43 111.156 -176.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -63.01 94.08 0.07 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.307 0.575 . . . . 63.14 111.027 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.55 43.45 7.34 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 115.886 -0.597 . . . . 72.34 112.04 -174.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.614 ' HB2' ' HA ' ' A' ' 17' ' ' GLN . . . -67.53 147.15 98.79 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 113.208 0.818 . . . . 62.55 113.208 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.426 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 90.4 Cg_endo -100.71 131.04 0.15 Allowed 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 123.21 2.607 . . . . 71.53 111.463 159.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.588 HG23 HG11 ' A' ' 13' ' ' VAL . 48.8 t -79.31 138.38 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.165 0.507 . . . . 72.45 112.012 -176.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.411 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -89.8 134.11 34.36 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.227 -0.442 . . . . 73.1 110.437 177.1 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 56.2 m -55.75 -27.99 53.59 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.09 0.471 . . . . 71.23 111.615 177.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -65.22 -54.59 27.16 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.216 -0.447 . . . . 70.41 112.098 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.25 -50.42 38.84 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 122.856 0.463 . . . . 72.41 112.119 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.472 HG23 HG21 ' A' ' 9' ' ' ILE . 53.1 mt -58.17 -57.78 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.151 -0.477 . . . . 71.42 111.787 -177.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.11 -45.49 87.16 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.947 0.403 . . . . 61.22 111.524 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -61.6 -42.4 98.82 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.806 -0.634 . . . . 75.31 111.896 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.03 -41.41 28.93 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.519 0.563 . . . . 73.24 112.519 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.33 -19.87 60.31 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.513 0.56 . . . . 75.54 112.513 -176.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.32 17.0 56.46 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.042 -0.599 . . . . 73.32 112.817 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.4 mt -106.44 170.93 7.63 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.993 0.425 . . . . 74.2 111.306 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.5 t -94.68 161.98 13.97 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.323 -0.399 . . . . 63.12 111.157 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -57.15 -48.9 81.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 112.566 0.58 . . . . 63.12 112.566 -174.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.507 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 29.4 p90 -60.13 -44.07 95.18 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.998 0.427 . . . . 72.11 111.042 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -57.62 -52.3 65.97 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.62 0.724 . . . . 74.33 110.832 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 92.0 t -59.55 -46.27 93.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.542 -0.754 . . . . 64.54 111.414 178.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.5 mtm105 -58.5 -28.95 65.88 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.116 0.413 . . . . 72.52 112.116 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 87.6 mt -65.82 -52.34 51.39 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.983 0.42 . . . . 72.11 110.836 174.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -63.29 -41.02 98.94 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.438 -0.346 . . . . 74.43 111.569 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 88.2 mt -62.68 -37.93 88.39 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.0 0.428 . . . . 64.45 111.091 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -60.87 -42.66 98.32 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.304 -0.407 . . . . 74.02 110.741 176.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -62.49 -51.68 66.49 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.255 -0.43 . . . . 71.33 110.928 176.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.2 mt -57.92 -31.77 67.12 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.148 0.499 . . . . 74.41 111.407 176.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -70.88 -34.38 71.54 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.068 0.461 . . . . 73.34 110.836 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -73.46 -41.08 63.62 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.085 -0.507 . . . . 73.31 111.456 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.497 HG23 HG22 ' A' ' 53' ' ' VAL . 36.0 m -84.13 7.76 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 N-CA-C 112.886 0.699 . . . . 74.24 112.886 -177.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.51 44.7 10.51 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 120.942 -0.647 . . . . 71.24 114.46 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.497 HG22 HG23 ' A' ' 51' ' ' VAL . 91.2 t -114.31 -42.89 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.002 0.43 . . . . 54.22 111.331 175.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.4 mt -116.85 151.92 35.53 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.841 0.682 . . . . 64.12 112.841 -176.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.474 ' HB2' HD21 ' A' ' 70' ' ' LEU . 1.4 tm-20 -122.98 128.16 49.83 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.112 -0.949 . . . . 73.22 108.683 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.601 ' HB3' ' HZ3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -87.49 93.67 9.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.147 0.498 . . . . 62.25 111.311 -172.641 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 82.1 t . . . . . 0 CA--C 1.538 0.515 0 CA-C-N 115.91 -0.587 . . . . 75.25 111.963 -178.395 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 82.6 mt . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 120.927 0.394 . . . . 72.55 110.977 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -123.14 121.81 36.9 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.999 0.428 . . . . 74.44 111.687 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -118.67 127.45 53.58 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.345 -0.389 . . . . 70.12 110.755 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.426 ' O ' HD12 ' A' ' 69' ' ' LEU . 3.3 pp -79.16 150.35 31.74 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.077 0.465 . . . . 71.15 111.534 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.474 HD21 ' HB2' ' A' ' 55' ' ' GLU . 2.1 pt? . . . . . 0 CA--C 1.537 0.476 0 CA-C-N 116.175 -0.466 . . . . 71.54 110.887 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.8 tt . . . . . 0 CA--C 1.543 0.674 0 CA-C-O 121.123 0.487 . . . . 71.11 111.449 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.454 HG11 HD21 ' A' ' 48' ' ' LEU . 49.8 t -56.69 -29.92 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 112.599 0.592 . . . . 72.22 112.599 -176.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.2 m -51.91 -41.07 61.69 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.893 0.378 . . . . 75.12 111.527 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.484 ' HB2' ' HZ1' ' A' ' 8' ' ' LYS . 4.4 ttmp? -54.41 -52.09 62.82 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.07 0.462 . . . . 73.11 110.722 174.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.507 HG22 HG21 ' A' ' 30' ' ' ILE . 67.4 mt -59.1 -45.27 92.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.8 -0.637 . . . . 74.5 111.572 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.6 mt -58.41 -43.35 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.082 0.468 . . . . 74.2 111.053 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.2 t -64.0 -40.15 95.72 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.198 -0.455 . . . . 75.24 111.205 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 8' ' ' LYS . 84.9 mt -63.18 -44.53 99.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 120.705 0.288 . . . . 75.22 111.375 177.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.495 HG11 HG23 ' A' ' 25' ' ' VAL . 91.7 t -54.1 -53.62 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 121.409 0.623 . . . . 74.24 110.663 174.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -56.52 -44.65 80.97 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.439 -0.8 . . . . 62.35 111.442 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -58.34 -52.23 66.49 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.011 0.434 . . . . 70.35 111.258 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.451 ' HD2' ' HB3' ' A' ' 29' ' ' ASP . 1.9 mmp_? -49.93 -36.96 29.74 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.99 -0.55 . . . . 72.1 111.326 177.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.647 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 78.3 mt-30 -74.85 -42.53 57.79 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.227 -0.442 . . . . 70.43 112.019 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -56.86 -28.74 62.15 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.081 0.467 . . . . 71.34 111.424 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.4 mmt -72.58 -39.25 67.54 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.455 0.539 . . . . 65.13 112.455 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.528 ' HB2' ' HB1' ' A' ' 23' ' ' ALA . 4.1 m-20 -127.58 20.11 6.69 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.304 0.483 . . . . 73.43 112.304 -175.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.8 t70 59.22 -88.19 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.028 0.531 . . . . 72.12 112.429 176.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -85.94 56.38 4.83 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.682 -0.567 . . . . 54.24 111.682 177.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.647 ' HB3' ' HA ' ' A' ' 17' ' ' GLN . . . -96.0 118.17 65.9 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 113.327 0.862 . . . . 74.31 113.327 -171.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.426 ' HB3' HG12 ' A' ' 57' ' ' VAL . 91.3 Cg_endo -78.08 118.97 4.51 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.217 1.944 . . . . 71.53 110.72 168.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.495 HG23 HG11 ' A' ' 13' ' ' VAL . 61.7 t -78.34 132.53 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 121.075 0.464 . . . . 73.32 112.084 -171.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.475 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -89.6 132.67 34.99 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.856 -0.611 . . . . 65.33 110.297 -179.408 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.412 HG21 HD11 ' A' ' 45' ' ' LEU . 56.4 m -49.48 -38.53 30.32 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.566 0.58 . . . . 73.21 112.566 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -72.38 -29.1 63.45 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.612 0.597 . . . . 60.43 112.612 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.451 ' HB3' ' HD2' ' A' ' 16' ' ' ARG . 76.4 m-20 -54.04 -49.29 69.29 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.424 0.631 . . . . 73.33 111.06 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.507 HG21 HG22 ' A' ' 9' ' ' ILE . 59.0 mt -64.64 -37.08 79.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.653 -0.703 . . . . 74.42 111.388 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.27 -47.87 80.53 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.446 -0.343 . . . . 61.41 111.439 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -65.15 -48.74 72.46 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.8 0.333 . . . . 70.23 111.459 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.56 -52.6 63.79 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.452 0.538 . . . . 74.41 112.452 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.6 -19.9 44.45 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.418 0.525 . . . . 74.33 112.418 -177.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.79 47.22 20.86 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.828 -0.701 . . . . 53.11 112.594 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt -118.14 179.0 4.23 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.96 0.409 . . . . 74.33 111.404 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.8 t -86.57 143.72 27.55 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 111.734 0.272 . . . . 74.01 111.734 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.1 mm -55.18 -52.21 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 112.052 0.389 . . . . 74.54 112.052 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -60.41 -42.93 97.02 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.032 0.444 . . . . 74.52 110.99 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -57.32 -56.13 25.79 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.75 -0.659 . . . . 73.14 111.461 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 82.7 t -56.84 -41.42 75.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.193 -0.458 . . . . 72.33 111.204 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -54.87 -46.02 74.69 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.351 -0.386 . . . . 72.31 111.437 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.84 -45.1 95.28 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.255 -0.429 . . . . 62.24 112.061 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -68.68 -37.92 79.96 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.796 0.295 . . . . 74.42 111.796 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.5 HD13 ' NE1' ' A' ' 67' ' ' TRP . 93.7 mt -66.32 -37.33 85.14 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.072 0.463 . . . . 74.51 111.001 174.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.47 -55.99 27.61 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.974 -0.557 . . . . 73.11 111.094 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -60.65 -37.88 82.98 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.526 -0.306 . . . . 75.22 111.576 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.454 HD21 HG11 ' A' ' 6' ' ' VAL . 83.7 mt -61.01 -44.84 96.83 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.982 0.42 . . . . 73.44 111.11 176.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -68.01 -30.88 70.23 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.952 0.406 . . . . 74.24 111.177 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -78.58 -31.94 47.47 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.219 0.452 . . . . 75.24 112.219 -177.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.466 HG22 HG22 ' A' ' 53' ' ' VAL . 33.5 m -83.35 -25.6 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 121.966 -0.459 . . . . 62.53 111.468 176.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 118.54 8.81 9.76 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 120.973 -0.632 . . . . 61.53 114.334 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.466 HG22 HG22 ' A' ' 51' ' ' VAL . 91.5 t -77.88 -42.14 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 117.483 0.642 . . . . 74.12 111.572 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.7 mt -110.89 133.87 53.02 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.147 0.499 . . . . 71.3 112.038 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.487 ' HG2' ' NH2' ' A' ' 68' ' ' ARG . 8.1 tp10 -91.8 154.77 18.7 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.923 -0.581 . . . . 73.3 111.05 176.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -80.22 136.35 36.45 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.202 0.525 . . . . 64.11 112.015 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 44.3 t . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 121.054 0.454 . . . . 72.22 110.232 170.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.437 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 86.3 mt . . . . . 0 CA--C 1.536 0.423 0 N-CA-C 109.79 -0.448 . . . . 74.54 109.79 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.5 ' NE1' HD13 ' A' ' 45' ' ' LEU . 42.6 m95 -107.17 127.82 53.85 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.863 0.69 . . . . 74.52 112.863 -169.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.487 ' NH2' ' HG2' ' A' ' 55' ' ' GLU . 47.6 ttp180 -120.44 165.01 15.52 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.264 -0.643 . . . . 75.41 109.264 175.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.7 pp -123.41 151.64 42.4 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.331 -0.856 . . . . 53.13 111.988 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.437 ' N ' HD21 ' A' ' 70' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.469 0.523 0 CA-C-N 115.923 -0.581 . . . . 75.44 111.357 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.443 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.7 mp . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 112.242 0.46 . . . . 72.43 112.242 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.2 t -61.93 -54.83 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.121 0.486 . . . . 73.54 111.377 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 m -59.62 -31.42 69.49 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.019 -0.537 . . . . 75.35 111.46 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.514 ' O ' HG13 ' A' ' 12' ' ' ILE . 60.5 tptt -57.49 -57.0 14.59 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.2 -0.455 . . . . 73.22 110.679 176.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.467 ' HA ' HD13 ' A' ' 12' ' ' ILE . 67.1 mt -58.2 -43.56 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 116.141 -0.481 . . . . 75.24 111.63 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.0 mt -60.63 -42.74 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.12 0.486 . . . . 73.01 111.101 176.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.0 t -65.4 -33.34 75.73 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.215 -0.448 . . . . 61.51 111.271 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 8' ' ' LYS . 96.9 mt -63.44 -48.41 87.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.365 -0.38 . . . . 72.24 110.934 175.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.8 t -58.15 -47.35 87.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 120.735 0.302 . . . . 74.05 111.229 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -59.47 -45.43 91.67 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.15 0.5 . . . . 74.41 111.041 177.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -53.64 -46.9 70.69 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.963 -0.562 . . . . 73.14 111.52 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 12' ' ' ILE . 7.6 mmm180 -67.87 -37.43 81.79 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.216 -0.447 . . . . 72.32 111.473 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -62.9 -32.87 74.23 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.081 0.4 . . . . 73.25 112.081 176.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -92.21 -29.23 16.56 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.975 0.731 . . . . 75.22 112.975 -175.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.477 ' SD ' ' HD2' ' A' ' 16' ' ' ARG . 27.2 ptm -70.35 -26.67 63.85 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.119 -0.363 . . . . 74.34 111.598 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -127.13 179.25 5.52 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 116.475 -0.329 . . . . 71.54 110.337 -177.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -104.21 -12.58 16.59 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 122.156 -0.34 . . . . 73.33 111.91 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.3 44.09 0.23 Allowed Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.878 -0.677 . . . . 44.41 113.409 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.78 107.22 38.78 Favored Pre-proline 0 CA--C 1.537 0.444 0 O-C-N 122.562 -0.375 . . . . 62.54 111.62 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.524 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 46.6 Cg_endo -68.52 138.85 43.2 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.22 1.947 . . . . 44.41 111.696 176.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.9 t -79.96 120.61 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 120.899 0.38 . . . . 74.11 111.13 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.49 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -80.63 132.49 35.61 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.607 -0.269 . . . . 70.31 110.996 -176.821 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.3 m -51.97 -44.46 64.02 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.903 0.383 . . . . 71.23 111.665 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.513 ' NH1' HG13 ' A' ' 38' ' ' ILE . 36.1 mmt180 -61.21 -45.92 92.6 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.207 0.527 . . . . 75.4 110.682 176.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -58.52 -40.77 83.84 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.792 -0.64 . . . . 62.53 111.455 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 26' ' ' LYS . 66.0 mt -61.92 -39.69 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.793 0.33 . . . . 73.02 111.157 176.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.512 ' HA ' HG23 ' A' ' 41' ' ' VAL . . . -57.93 -48.74 79.02 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.268 -0.424 . . . . 72.42 111.892 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.13 -43.55 94.92 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 111.995 0.368 . . . . 72.01 111.995 176.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.12 -41.72 94.6 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.332 0.493 . . . . 75.31 112.332 -178.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.63 -23.91 27.33 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.218 0.451 . . . . 64.33 112.218 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.17 40.46 24.4 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.227 -0.511 . . . . 72.44 113.231 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.9 mt -128.63 161.06 30.53 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.613 -0.345 . . . . 72.25 111.37 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.424 ' O ' HG21 ' A' ' 41' ' ' VAL . 66.9 m -68.1 150.97 47.72 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.515 -0.311 . . . . 71.41 111.096 176.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.513 HG13 ' NH1' ' A' ' 28' ' ' ARG . 49.7 mm -52.21 -48.83 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 112.31 0.485 . . . . 62.32 112.31 -176.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.486 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 78.2 t80 -59.2 -49.05 79.35 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.529 -0.305 . . . . 75.31 111.242 178.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -54.98 -50.81 68.04 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.244 0.545 . . . . 72.3 110.899 176.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.512 HG23 ' HA ' ' A' ' 31' ' ' ALA . 88.8 t -56.18 -49.64 75.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.078 -0.51 . . . . 51.12 111.345 178.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.565 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 31.6 mtp180 -60.98 -34.3 74.56 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 111.752 0.278 . . . . 63.21 111.752 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 79.2 mt -55.78 -47.42 77.08 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.15 0.5 . . . . 74.24 110.407 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -65.51 -43.43 90.12 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.058 -0.519 . . . . 73.33 111.522 175.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.473 HD12 ' NE1' ' A' ' 67' ' ' TRP . 89.5 mt -64.15 -50.15 69.33 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 111.85 0.315 . . . . 72.24 111.85 -177.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' A' ' 42' ' ' ARG . 62.1 mm-40 -56.83 -45.82 82.1 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.32 -0.4 . . . . 54.01 111.061 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 88.3 mt-30 -62.92 -49.81 73.33 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.536 0.208 . . . . 60.41 110.973 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.412 ' HA ' HG21 ' A' ' 51' ' ' VAL . 94.5 mt -57.85 -28.95 64.58 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.019 0.437 . . . . 72.24 111.127 176.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.458 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 31.4 t-80 -67.07 -56.69 8.97 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.06 0.457 . . . . 73.25 111.077 174.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.13 -23.79 64.02 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.252 0.834 . . . . 74.22 113.252 -175.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.49 HG23 HG22 ' A' ' 53' ' ' VAL . 25.1 m -84.78 -4.58 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 121.887 -0.508 . . . . 73.24 111.947 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.3 17.9 38.17 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 114.617 0.607 . . . . 65.35 114.617 173.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.49 HG22 HG23 ' A' ' 51' ' ' VAL . 97.3 t -90.91 -50.01 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 117.294 0.547 . . . . 61.02 111.327 177.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.7 mt -106.69 131.03 54.29 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.178 0.513 . . . . 71.43 111.893 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -101.34 143.65 31.12 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.907 -0.588 . . . . 74.51 111.003 177.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.435 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -66.11 141.47 58.1 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.802 0.667 . . . . 71.41 112.802 -175.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 51.0 t . . . . . 0 N--CA 1.471 0.624 0 CA-C-N 116.285 -0.416 . . . . 73.51 110.959 171.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.524 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 66.8 mt . . . . . 0 CA--C 1.539 0.537 0 N-CA-C 109.969 -0.382 . . . . 65.42 109.969 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.473 ' NE1' HD12 ' A' ' 45' ' ' LEU . 75.7 m95 -121.16 147.86 45.02 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.328 0.585 . . . . 72.13 112.389 -174.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -148.78 133.68 18.04 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.934 -0.576 . . . . 71.14 110.397 173.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 pp -72.74 163.31 28.3 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.733 -0.604 . . . . 74.12 110.856 174.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.8 mt . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 112.191 0.441 . . . . 73.33 112.191 -175.566 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 70.2 mt . . . . . 0 N--CA 1.475 0.79 0 CA-C-O 120.875 0.369 . . . . 72.05 111.925 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.6 t -71.73 -46.04 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.093 0.473 . . . . 73.13 111.22 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.9 m -55.24 -39.52 69.83 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.8 -0.636 . . . . 73.44 112.227 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.516 ' O ' HG13 ' A' ' 12' ' ' ILE . 55.6 tptt -61.96 -50.86 70.42 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.739 0.304 . . . . 72.1 110.732 177.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 72.7 mt -55.79 -46.36 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.886 0.374 . . . . 73.43 111.486 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.2 mt -58.88 -45.22 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 121.192 0.52 . . . . 73.35 110.93 176.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.2 t -62.39 -35.17 78.36 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.003 -0.544 . . . . 71.42 111.821 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.545 HG22 ' HA ' ' A' ' 30' ' ' ILE . 96.8 mt -64.73 -49.7 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.871 0.367 . . . . 74.35 111.2 177.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 64.2 t -54.2 -49.17 64.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.062 0.458 . . . . 64.44 110.969 177.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -62.46 -44.09 97.25 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.012 -0.54 . . . . 70.11 111.487 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.408 ' HA ' ' ND2' ' A' ' 18' ' ' ASN . 10.1 tp10 -61.62 -37.46 84.06 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.153 0.501 . . . . 74.3 111.04 -178.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.469 ' HG3' HG12 ' A' ' 25' ' ' VAL . 8.3 mmm180 -64.29 -40.06 95.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 73.53 110.79 174.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.485 ' O ' ' HA ' ' A' ' 21' ' ' ASP . 74.1 mt-30 -72.69 -4.57 32.0 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.871 0.367 . . . . 72.24 111.58 175.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.408 ' ND2' ' HA ' ' A' ' 15' ' ' GLU . 81.2 m-20 -87.38 -42.56 12.76 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.029 0.442 . . . . 62.51 109.85 167.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 89.8 mmm -76.84 -66.91 0.76 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.938 -0.574 . . . . 74.23 111.319 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -71.5 -14.3 62.07 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.998 0.428 . . . . 75.02 111.087 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 17' ' ' GLN . 17.0 t70 74.54 -68.27 0.22 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.992 0.917 . . . . 72.12 112.673 177.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -136.1 36.81 1.97 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.553 -0.832 . . . . 65.54 113.885 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -102.85 152.72 38.52 Favored Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 122.51 -0.406 . . . . 71.52 111.499 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.53 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 49.9 Cg_endo -68.21 129.19 18.81 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.29 1.993 . . . . 75.43 111.999 174.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.469 HG12 ' HG3' ' A' ' 16' ' ' ARG . 38.5 t -79.44 135.83 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.155 0.502 . . . . 60.31 111.68 -174.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.531 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -88.28 135.72 33.32 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.139 -0.482 . . . . 72.05 111.29 -177.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.2 m -55.07 -31.27 61.03 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.907 0.384 . . . . 52.32 111.963 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -60.54 -54.15 48.89 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 111.798 0.295 . . . . 75.2 111.798 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.408 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 2.3 m-20 -57.82 -37.48 73.88 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.885 0.374 . . . . 73.12 111.619 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.545 ' HA ' HG22 ' A' ' 12' ' ' ILE . 59.0 mt -66.91 -49.23 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.428 -0.351 . . . . 73.31 111.293 178.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.06 -34.85 73.98 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.992 0.425 . . . . 61.21 111.455 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -66.08 -51.92 53.6 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.042 -0.526 . . . . 73.53 111.35 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.02 -35.84 72.17 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.506 0.558 . . . . 74.04 112.506 -177.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.18 -33.69 38.1 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.391 0.515 . . . . 75.53 112.391 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.37 -0.11 83.01 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.001 -0.618 . . . . 73.1 112.989 -177.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 71.6 mt -85.1 160.0 20.06 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 122.602 -0.352 . . . . 75.45 110.897 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.443 ' O ' HG21 ' A' ' 41' ' ' VAL . 47.6 t -79.74 157.44 27.13 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 120.788 0.328 . . . . 73.54 111.8 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.0 mm -51.95 -52.37 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 112.808 0.67 . . . . 72.35 112.808 -174.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.519 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 32.9 p90 -58.29 -44.43 88.49 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.985 0.421 . . . . 75.25 111.083 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -62.13 -47.09 86.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.241 0.543 . . . . 75.33 110.993 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 37' ' ' SER . 95.0 t -60.04 -51.47 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 115.972 -0.558 . . . . 73.01 111.877 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -62.94 -26.05 68.63 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 111.893 0.331 . . . . 71.21 111.893 -177.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 79.5 mt -65.99 -51.47 58.1 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.617 0.246 . . . . 63.04 111.011 175.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -65.56 -39.61 91.87 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.757 0.313 . . . . 74.41 111.695 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.495 HD12 ' CD1' ' A' ' 67' ' ' TRP . 96.5 mt -58.2 -41.69 84.53 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.344 0.592 . . . . 73.42 110.651 174.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -60.6 -43.97 96.79 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.629 -0.714 . . . . 75.32 111.054 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 74.9 mt-30 -60.38 -38.03 82.62 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.208 -0.451 . . . . 72.45 111.249 176.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 93.0 mt -63.83 -32.76 74.38 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.711 0.291 . . . . 75.01 111.309 175.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -70.56 -41.39 72.5 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 122.06 -0.4 . . . . 75.23 110.555 171.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -56.12 -42.68 77.23 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.785 -0.643 . . . . 73.13 111.848 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.497 HG21 HG23 ' A' ' 53' ' ' VAL . 35.0 m -82.13 -15.13 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 112.492 0.553 . . . . 63.13 112.492 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.92 8.06 32.43 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 114.658 0.623 . . . . 72.54 114.658 175.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.497 HG23 HG21 ' A' ' 51' ' ' VAL . 95.1 t -77.12 -52.61 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 117.409 0.605 . . . . 71.41 111.975 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.0 mt -106.41 149.94 26.52 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.72 0.637 . . . . 74.53 112.72 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 68' ' ' ARG . 12.6 pt-20 -111.1 146.08 37.44 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.992 -0.549 . . . . 74.54 110.068 172.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.424 ' HE3' ' HB2' ' A' ' 56' ' ' LYS . 46.1 mtmt -80.86 104.38 11.33 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.851 0.358 . . . . 54.11 111.475 -177.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 53.3 t . . . . . 0 C--O 1.241 0.644 0 CA-C-O 121.724 0.773 . . . . 72.23 110.948 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.554 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 72.8 mt . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 110.091 -0.337 . . . . 75.35 110.091 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.495 ' CD1' HD12 ' A' ' 45' ' ' LEU . 74.5 m95 -121.52 139.11 53.92 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.133 0.492 . . . . 74.25 112.005 -175.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.527 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 46.3 ttt180 -136.42 128.11 28.94 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.342 -0.39 . . . . 75.51 110.548 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 69' ' ' LEU . 4.6 pp -79.35 138.99 37.89 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.519 -0.738 . . . . 63.51 111.269 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.408 HD23 ' H ' ' A' ' 70' ' ' LEU . 2.1 pt? . . . . . 0 N--CA 1.469 0.486 0 CA-C-N 116.215 -0.448 . . . . 73.32 110.944 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.421 HG23 HD12 ' A' ' 36' ' ' LEU . 48.0 mm . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 112.819 0.674 . . . . 74.15 112.819 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.9 t -62.52 -57.77 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 120.949 0.404 . . . . 71.14 111.682 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.5 m -63.39 -34.44 77.74 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.981 0.42 . . . . 75.42 111.276 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.415 ' O ' HG13 ' A' ' 12' ' ' ILE . 57.0 tptt -56.19 -53.14 60.74 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.202 -0.453 . . . . 74.51 110.837 177.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.413 HG22 HG23 ' A' ' 30' ' ' ILE . 62.7 mt -59.1 -47.32 90.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.107 -0.497 . . . . 64.44 111.965 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 61.4 mt -60.42 -43.19 93.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 112.093 0.405 . . . . 54.21 112.093 -178.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 85.4 p -60.65 -36.87 79.73 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 120.781 0.324 . . . . 74.3 111.176 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.543 HG22 ' HA ' ' A' ' 30' ' ' ILE . 79.8 mt -64.29 -40.73 90.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.078 0.466 . . . . 71.14 111.504 176.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.58 -52.06 65.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 120.885 0.374 . . . . 53.31 110.914 177.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -59.35 -40.76 87.44 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.949 0.404 . . . . 74.31 110.864 176.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 12' ' ' ILE . 16.9 tp10 -47.75 -56.04 8.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.246 0.618 . . . . 65.41 111.841 177.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.501 ' HG3' HG12 ' A' ' 25' ' ' VAL . 1.2 mmp_? -63.09 -37.56 87.69 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.393 -0.367 . . . . 73.21 111.555 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -79.61 -13.99 59.12 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 111.955 0.354 . . . . 75.42 111.955 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -73.11 -35.95 66.66 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.028 0.442 . . . . 62.32 109.862 170.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.1 mmt -67.17 -58.79 4.21 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.814 -0.63 . . . . 63.15 110.885 172.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -124.61 104.12 8.52 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.435 -0.348 . . . . 71.24 110.836 176.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -61.38 -14.38 27.32 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.317 0.858 . . . . 64.21 113.317 -175.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -117.35 15.13 13.21 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 120.92 -0.657 . . . . 44.34 113.908 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.53 128.46 26.89 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 117.272 0.536 . . . . 61.22 112.082 -177.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.543 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 58.7 Cg_endo -71.42 135.45 26.61 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.364 2.043 . . . . 75.11 112.865 176.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.501 HG12 ' HG3' ' A' ' 16' ' ' ARG . 24.5 t -80.41 139.87 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 120.846 0.355 . . . . 62.44 111.449 -177.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.501 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 12.0 mptt -91.63 130.03 37.51 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.406 -0.361 . . . . 73.04 110.946 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.3 m -47.05 -34.5 5.84 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 120.919 0.39 . . . . 74.54 111.935 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -60.09 -49.26 78.33 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.386 -0.37 . . . . 74.33 111.795 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -56.22 -49.55 73.77 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.095 0.474 . . . . 74.54 110.788 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.543 ' HA ' HG22 ' A' ' 12' ' ' ILE . 64.3 mt -59.06 -48.36 86.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.907 -0.588 . . . . 64.52 111.555 178.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.488 ' HA ' HG23 ' A' ' 41' ' ' VAL . . . -57.73 -52.25 66.21 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.274 -0.421 . . . . 75.45 111.813 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -65.3 -41.97 93.54 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.285 -0.416 . . . . 74.44 111.711 -177.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.93 -39.69 87.41 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.214 0.45 . . . . 74.04 112.214 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.03 -20.79 40.95 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.001 0.371 . . . . 72.13 112.001 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.55 32.75 24.04 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.212 -0.518 . . . . 73.22 112.617 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.421 HD12 HG23 ' A' ' 5' ' ' ILE . 74.2 mt -122.21 161.71 22.72 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.873 0.368 . . . . 71.15 111.161 -177.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.0 m -82.78 152.13 25.83 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.703 0.287 . . . . 73.45 111.528 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.8 mm -50.56 -46.04 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 112.28 0.474 . . . . 70.22 112.28 -176.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -57.87 -52.07 66.99 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.809 0.338 . . . . 73.52 111.8 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -58.54 -46.49 86.73 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.209 0.528 . . . . 73.53 111.277 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.488 HG23 ' HA ' ' A' ' 31' ' ' ALA . 57.9 t -61.54 -42.23 93.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.802 -0.636 . . . . 73.42 111.52 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -55.03 -39.64 69.36 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.784 0.326 . . . . 72.21 111.615 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.56 -52.48 60.88 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.274 -0.421 . . . . 74.51 111.042 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -59.57 -50.21 74.76 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 111.932 0.345 . . . . 70.24 111.932 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.417 HD12 ' CD1' ' A' ' 67' ' ' TRP . 92.2 mt -57.51 -43.99 84.69 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.863 0.363 . . . . 71.1 111.69 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -59.1 -50.38 74.26 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.017 0.437 . . . . 74.15 110.796 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -54.87 -44.55 74.13 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.038 -0.528 . . . . 71.22 110.807 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.46 ' HA ' HG22 ' A' ' 51' ' ' VAL . 89.1 mt -59.46 -29.68 67.98 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.3 -0.409 . . . . 71.15 111.782 178.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -72.53 -46.46 54.44 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.955 -0.466 . . . . 75.02 110.89 174.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -70.39 -16.89 63.01 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.835 0.68 . . . . 64.32 112.835 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.518 HG21 HG22 ' A' ' 53' ' ' VAL . 30.1 m -98.96 4.64 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 O-C-N 122.106 -0.372 . . . . 70.41 111.749 176.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.44 31.42 27.7 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 114.7 0.64 . . . . 65.14 114.7 174.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.518 HG22 HG21 ' A' ' 51' ' ' VAL . 95.3 t -105.81 -54.59 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 117.213 0.506 . . . . 71.33 111.749 176.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.1 mt -99.18 162.91 12.79 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.889 0.7 . . . . 65.32 112.889 -176.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 68' ' ' ARG . 17.0 tp10 -124.95 149.56 47.52 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.381 -0.827 . . . . 71.03 110.709 -175.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -78.96 129.28 34.31 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.048 0.758 . . . . 70.41 113.048 -172.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.9 t . . . . . 0 CA--C 1.541 0.619 0 CA-C-O 120.757 0.313 . . . . 72.33 111.188 170.471 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.543 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 58.2 mt . . . . . 0 CA--C 1.538 0.484 0 CA-C-O 120.883 0.373 . . . . 74.44 110.159 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.417 ' CD1' HD12 ' A' ' 45' ' ' LEU . 57.7 m95 -126.37 135.86 51.97 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.191 0.811 . . . . 74.44 113.191 -171.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.508 ' HB2' ' HB3' ' A' ' 55' ' ' GLU . 63.0 mtp180 -113.24 176.21 5.12 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.521 -0.763 . . . . 62.3 109.333 169.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.421 ' O ' HD13 ' A' ' 69' ' ' LEU . 3.5 pp -127.1 149.66 49.84 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.715 -0.616 . . . . 63.54 112.343 175.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 N--CA 1.469 0.513 0 CA-C-N 116.204 -0.453 . . . . 74.45 110.866 173.979 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 120.852 0.358 . . . . 73.33 110.947 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.4 m -155.68 -22.71 0.11 Allowed 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 120.803 0.335 . . . . 71.55 111.507 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.535 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -46.74 -45.78 19.91 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.132 0.79 . . . . 52.34 113.132 179.423 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.2 t 47.15 -79.71 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.42 0.896 . . . . 72.41 113.42 176.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.48 ' N ' ' O ' ' A' ' 3' ' ' GLU . 8.1 tp -54.45 -35.83 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.902 0.382 . . . . 73.25 111.374 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 3' ' ' GLU . 59.5 t -63.65 -42.04 94.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 120.756 0.312 . . . . 73.11 111.018 176.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.2 m -61.13 -41.12 96.14 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.004 0.43 . . . . 73.23 110.706 175.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.426 ' O ' HG13 ' A' ' 12' ' ' ILE . 62.0 tttp -57.27 -46.39 83.13 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.201 -0.454 . . . . 53.4 110.293 173.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.469 ' O ' HG21 ' A' ' 13' ' ' VAL . 70.3 mt -55.99 -48.83 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.205 -0.452 . . . . 64.31 111.494 176.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.5 mt -57.14 -45.24 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.012 0.434 . . . . 72.41 111.112 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.6 t -57.23 -45.94 83.42 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.171 -0.468 . . . . 71.11 111.064 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 8' ' ' LYS . 94.1 mt -59.37 -45.11 93.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.223 -0.444 . . . . 51.32 111.058 176.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.469 HG21 ' O ' ' A' ' 9' ' ' ILE . 96.2 t -57.98 -49.61 80.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.486 -0.324 . . . . 72.52 111.543 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -61.99 -52.66 63.11 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.938 0.399 . . . . 74.25 111.436 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.429 ' HG2' ' HE2' ' A' ' 19' ' ' MET . 28.7 tt0 -65.2 -32.58 74.33 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.101 -0.499 . . . . 51.32 111.936 -175.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.1 mmm180 -65.69 -62.72 1.35 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 122.17 -0.331 . . . . 73.44 111.737 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -56.56 -24.33 46.41 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.263 0.554 . . . . 64.24 110.901 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -64.52 -41.02 96.64 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.76 -0.655 . . . . 71.12 110.577 172.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.429 ' HE2' ' HG2' ' A' ' 15' ' ' GLU . 65.5 mtt -82.24 -28.15 32.07 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.347 -0.388 . . . . 74.01 111.792 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -77.65 -10.49 59.54 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.676 0.274 . . . . 72.31 111.252 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 64.1 -74.75 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.431 0.692 . . . . 75.22 112.835 174.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -106.44 -11.8 26.42 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.917 -0.659 . . . . 41.21 113.395 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -103.28 141.36 22.34 Favored Pre-proline 0 CA--C 1.538 0.511 0 O-C-N 122.541 -0.387 . . . . 73.2 112.022 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.507 ' HG2' ' HB3' ' A' ' 66' ' ' LEU . 53.5 Cg_endo -71.35 -176.56 1.98 Allowed 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.483 2.122 . . . . 65.31 113.216 175.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.402 HG23 ' HA ' ' A' ' 13' ' ' VAL . 13.4 t -88.75 152.13 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.248 -0.433 . . . . 74.43 111.755 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.559 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 10.8 mptt -98.86 132.44 44.21 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.399 -0.364 . . . . 75.43 111.188 -176.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.8 m -47.42 -47.16 26.86 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.012 0.375 . . . . 65.15 112.012 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -59.22 -55.77 30.7 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.505 -0.316 . . . . 74.51 111.653 175.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -51.53 -39.59 58.0 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.188 -0.46 . . . . 74.53 112.077 -174.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.5 mt -59.69 -41.42 85.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.067 0.46 . . . . 71.22 110.919 175.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.9 -39.41 83.61 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.226 -0.443 . . . . 74.42 111.282 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -60.75 -56.63 18.95 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.957 0.408 . . . . 75.22 111.31 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.26 -45.85 90.09 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.257 -0.428 . . . . 61.23 112.04 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.98 -23.61 58.3 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.214 0.45 . . . . 74.32 112.214 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.86 44.67 23.96 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.247 -0.501 . . . . 61.22 112.558 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.3 mt -126.88 178.67 5.81 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.135 0.493 . . . . 60.41 111.623 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.1 t -87.02 147.93 25.51 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.93 -0.577 . . . . 71.23 111.339 176.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.8 mm -55.65 -44.41 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 116.308 -0.405 . . . . 73.32 112.001 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.543 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 72.1 t80 -61.49 -53.93 49.93 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 111.566 0.21 . . . . 73.34 111.566 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -51.77 -49.1 63.3 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.508 0.67 . . . . 74.24 111.383 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.3 t -60.37 -51.6 71.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.717 -0.674 . . . . 74.11 112.204 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -60.76 -27.07 67.69 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 122.387 -0.196 . . . . 72.23 111.356 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 87.5 mt -62.46 -54.64 37.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.742 0.306 . . . . 74.03 110.375 175.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -57.82 -47.49 82.47 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.043 0.449 . . . . 74.14 111.08 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.2 mt -58.74 -43.83 90.32 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.034 -0.53 . . . . 51.42 111.983 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 49' ' ' HIS . 34.8 tt0 -67.06 -40.38 87.09 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.73 0.3 . . . . 74.35 111.553 -178.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -63.41 -50.23 70.65 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.938 0.399 . . . . 62.41 110.836 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.6 mt -58.46 -31.66 68.0 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.179 0.514 . . . . 72.24 110.927 174.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.531 ' HD2' ' HA ' ' A' ' 55' ' ' GLU . 28.3 t-80 -64.61 -54.58 29.8 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.246 -0.434 . . . . 73.4 111.768 176.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -66.42 -26.27 67.15 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.011 0.375 . . . . 63.22 112.011 -173.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.501 HG23 HG23 ' A' ' 53' ' ' VAL . 26.1 m -85.34 -1.5 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 112.21 0.448 . . . . 73.41 112.21 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.33 -14.81 47.26 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 115.053 0.781 . . . . 73.44 115.053 172.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.501 HG23 HG23 ' A' ' 51' ' ' VAL . 59.8 t -62.39 -51.02 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 117.833 0.816 . . . . 73.11 111.808 -176.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 94.2 mt -114.8 154.2 29.0 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.861 0.362 . . . . 64.41 111.618 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.531 ' HA ' ' HD2' ' A' ' 49' ' ' HIS . 9.0 tp10 -121.69 147.3 46.06 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.229 0.537 . . . . 75.52 110.998 176.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.416 ' HG2' ' OE1' ' A' ' 55' ' ' GLU . 23.2 pttm -81.7 95.39 7.22 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.593 -0.73 . . . . 71.41 111.855 -178.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.485 HG11 ' HG3' ' A' ' 24' ' ' PRO . 44.0 t -85.64 83.97 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 121.505 0.669 . . . . 75.51 110.118 174.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.478 ' HB2' HG22 ' A' ' 63' ' ' VAL . 28.7 p-10 -154.63 152.48 30.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.059 -0.519 . . . . 74.03 111.746 -177.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.87 -33.09 74.84 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.182 -0.463 . . . . 70.42 111.318 175.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 151.61 -112.11 0.52 Allowed Glycine 0 CA--C 1.527 0.791 0 CA-C-N 116.33 -0.395 . . . . 65.51 112.899 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.445 ' N ' ' HD2' ' A' ' 61' ' ' LYS . 12.2 mptt -97.35 153.37 18.12 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.003 0.43 . . . . 43.32 110.998 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.38 4.9 85.64 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.284 -0.484 . . . . 51.13 113.407 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.478 HG22 ' HB2' ' A' ' 58' ' ' ASN . 27.2 m -119.21 145.65 38.87 Favored Pre-proline 0 CA--C 1.54 0.587 0 O-C-N 122.499 -0.412 . . . . 63.23 111.626 -179.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.94 -24.48 76.46 Favored 'Trans proline' 0 N--CA 1.482 0.837 0 C-N-CA 122.868 2.378 . . . . 43.1 113.26 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.63 124.71 1.48 Allowed Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.205 -0.522 . . . . 60.5 113.3 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.507 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 83.7 mt -111.78 136.25 51.3 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.907 0.384 . . . . 72.42 110.665 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -111.45 132.79 54.21 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.378 0.608 . . . . 73.22 112.182 -175.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -136.76 138.13 40.6 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.744 -0.662 . . . . 73.15 110.885 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.403 ' O ' HD13 ' A' ' 69' ' ' LEU . 2.4 pp -83.23 153.23 24.82 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.806 0.336 . . . . 74.54 111.697 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.588 ' HG ' ' HG2' ' A' ' 71' ' ' GLU . 1.9 pt? -143.4 -49.82 0.32 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.005 0.372 . . . . 64.01 112.005 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.588 ' HG2' ' HG ' ' A' ' 70' ' ' LEU . 28.0 mm-40 . . . . . 0 C--O 1.255 1.351 0 CA-C-O 118.48 -0.771 . . . . 73.23 111.867 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 120.912 0.387 . . . . 75.24 111.646 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.8 m -102.06 21.62 14.49 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.801 0.334 . . . . 75.14 111.759 -176.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -101.09 21.36 13.99 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.638 0.607 . . . . 73.3 112.638 -169.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.8 p -66.5 -6.24 14.15 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 112.698 0.629 . . . . 75.45 112.698 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.477 HD13 ' H ' ' A' ' 5' ' ' ILE . 2.8 mp -56.36 -37.1 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 120.804 0.335 . . . . 72.43 111.493 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.5 t -60.71 -53.02 54.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.806 0.336 . . . . 70.11 111.274 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.0 m -60.41 -36.16 77.49 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.022 0.439 . . . . 71.34 111.079 177.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.517 ' O ' HG13 ' A' ' 12' ' ' ILE . 62.4 tttp -60.05 -49.05 79.2 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.213 -0.449 . . . . 73.44 111.135 176.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.434 ' HA ' HD13 ' A' ' 12' ' ' ILE . 72.9 mt -59.6 -42.97 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.7 0.286 . . . . 70.44 111.502 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.1 mt -57.43 -43.61 82.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 121.328 0.585 . . . . 73.2 110.574 174.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.7 m -66.15 -30.73 71.27 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.881 -0.599 . . . . 73.24 111.604 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 8' ' ' LYS . 94.5 mt -67.07 -47.72 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.638 0.256 . . . . 73.21 111.279 177.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.465 HG12 HD21 ' A' ' 54' ' ' LEU . 56.1 t -60.12 -45.36 95.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.841 0.353 . . . . 74.23 110.45 175.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -54.77 -48.25 72.91 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.038 -0.528 . . . . 65.55 110.629 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.541 ' O ' ' HG2' ' A' ' 19' ' ' MET . 29.2 tt0 -57.24 -65.54 0.61 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.775 -0.648 . . . . 75.13 111.452 178.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -51.51 -51.86 51.69 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.844 0.354 . . . . 72.34 111.917 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -57.42 -35.27 69.86 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.117 -0.492 . . . . 73.53 111.56 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -81.39 -26.53 35.38 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.042 0.386 . . . . 74.53 112.042 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.541 ' HG2' ' O ' ' A' ' 15' ' ' GLU . 24.3 mmt -71.22 -58.94 3.06 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.839 0.352 . . . . 72.12 111.047 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -74.29 -29.52 61.69 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.602 -0.272 . . . . 75.24 111.235 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.1 t70 69.14 -72.57 0.1 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.539 0.57 . . . . 72.15 112.539 173.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.65 41.42 3.09 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.188 -0.53 . . . . 54.02 113.161 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.19 140.26 8.49 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 112.187 0.44 . . . . 73.54 112.187 -177.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.483 ' HG2' HD13 ' A' ' 66' ' ' LEU . 54.5 Cg_endo -71.66 151.9 58.59 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.516 2.144 . . . . 71.21 112.512 172.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.1 t -80.88 150.36 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 120.906 0.384 . . . . 75.03 111.447 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.457 ' O ' HG13 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -112.24 150.25 31.17 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.697 0.284 . . . . 74.34 110.819 -179.532 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.0 m -55.65 -31.85 62.68 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.02 0.438 . . . . 64.22 111.508 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -64.17 -59.21 4.71 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.182 -0.463 . . . . 72.02 112.175 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.414 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -67.49 -20.25 65.43 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.629 0.603 . . . . 74.21 112.629 -178.439 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 26' ' ' LYS . 77.3 mt -67.93 -51.22 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.048 0.451 . . . . 73.14 110.358 170.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.518 ' HA ' HG23 ' A' ' 41' ' ' VAL . . . -58.07 -39.42 78.47 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.124 -0.489 . . . . 75.41 111.189 175.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -51.81 -52.48 48.87 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.693 -0.685 . . . . 70.03 111.543 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.23 -24.94 60.55 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.956 0.408 . . . . 63.14 111.923 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.65 -24.33 36.38 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.062 0.393 . . . . 73.03 112.062 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.87 23.29 78.11 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.077 -0.582 . . . . 39.81 112.24 -174.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.7 mt -118.13 178.21 4.51 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.401 0.62 . . . . 53.44 111.783 -175.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.8 m -82.51 149.17 27.69 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.896 -0.593 . . . . 72.14 111.554 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.6 mm -52.89 -41.96 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 120.929 0.395 . . . . 43.12 111.966 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.455 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 47.4 t80 -60.65 -59.78 4.85 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.149 -0.478 . . . . 74.12 111.644 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -48.44 -58.04 5.22 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.92 0.391 . . . . 72.44 111.376 176.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.556 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 94.9 t -53.3 -45.95 56.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.01 -0.541 . . . . 72.04 111.535 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.484 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 7.7 tpt180 -60.86 -41.67 96.37 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.65 -0.25 . . . . 74.13 111.38 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 89.1 mt -55.51 -44.62 76.81 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.329 0.585 . . . . 70.5 110.738 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -66.25 -41.74 89.54 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.884 -0.598 . . . . 74.25 111.553 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 89.5 mt -59.43 -45.44 91.54 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.829 0.347 . . . . 71.45 111.103 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 42' ' ' ARG . 58.1 mm-40 -52.65 -52.74 54.35 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.293 0.568 . . . . 74.42 110.749 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -65.87 -33.53 76.05 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.842 -0.617 . . . . 62.23 111.848 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.402 ' HA ' HG21 ' A' ' 51' ' ' VAL . 76.8 mt -64.89 -27.79 69.1 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.846 0.355 . . . . 75.32 111.333 176.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -75.39 -37.6 60.42 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.131 0.491 . . . . 74.02 110.142 172.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -63.57 -43.64 96.4 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.773 -0.649 . . . . 65.14 112.388 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.499 HG23 HG22 ' A' ' 53' ' ' VAL . 25.5 m -80.07 -12.74 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.741 0.645 . . . . 73.43 112.741 -177.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.2 52.97 1.66 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.027 -0.606 . . . . 70.54 113.645 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.499 HG22 HG23 ' A' ' 51' ' ' VAL . 94.4 t -124.77 -56.88 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.021 0.438 . . . . 61.1 111.113 176.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 69' ' ' LEU . 70.1 mt -100.03 138.83 36.57 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.337 -0.392 . . . . 73.31 111.91 -177.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -109.46 160.5 16.16 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.263 -0.426 . . . . 74.55 110.295 174.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -100.07 136.25 40.26 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.19 0.519 . . . . 63.43 111.958 -176.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.9 t -121.08 127.44 75.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 116.118 -0.492 . . . . 72.53 110.484 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.401 ' HB2' HG22 ' A' ' 63' ' ' VAL . 31.5 p30 -173.0 -176.93 1.49 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.125 0.488 . . . . 64.45 112.212 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.494 ' HB2' HG13 ' A' ' 63' ' ' VAL . . . -91.95 -36.2 13.57 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.099 -0.5 . . . . 73.4 111.554 173.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.548 ' H ' HG22 ' A' ' 63' ' ' VAL . . . 136.91 -77.07 0.35 Allowed Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.377 -0.439 . . . . 75.21 113.517 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -95.62 128.14 42.24 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.236 0.458 . . . . 73.45 112.236 -175.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.67 43.21 99.31 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.274 -0.421 . . . . 62.02 113.767 175.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.548 HG22 ' H ' ' A' ' 60' ' ' GLY . 31.5 m -134.21 154.13 79.86 Favored Pre-proline 0 N--CA 1.47 0.532 0 O-C-N 122.492 -0.417 . . . . 71.3 111.421 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -78.59 119.32 4.43 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.299 1.999 . . . . 75.1 112.859 176.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.59 105.54 0.76 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.218 -0.515 . . . . 63.22 113.228 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.483 HD13 ' HG2' ' A' ' 24' ' ' PRO . 77.0 mt -85.48 153.77 22.24 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.853 0.358 . . . . 73.41 111.041 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -109.23 137.09 47.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.424 0.63 . . . . 74.12 112.279 -175.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -154.22 116.88 4.39 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.0 -0.545 . . . . 61.33 110.187 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 54' ' ' LEU . 2.3 pp -66.05 174.44 2.52 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.027 0.751 . . . . 72.23 113.027 -172.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 78.2 mt -59.92 90.67 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.938 -0.574 . . . . 74.01 111.35 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 C--O 1.251 1.146 0 CA-C-N 115.629 -0.714 . . . . 65.2 111.149 -178.728 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.436 ' C ' ' SD ' ' A' ' 1' ' ' MET . 3.1 ppp? . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 112.311 0.486 . . . . 72.13 112.311 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.7 m -80.68 87.09 5.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.184 0.516 . . . . 72.14 111.92 -175.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -106.49 149.03 27.5 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.964 -0.562 . . . . 55.13 110.319 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.2 t -51.86 -34.39 40.54 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 112.602 0.593 . . . . 72.24 112.602 -174.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.558 HG12 HD12 ' A' ' 36' ' ' LEU . 10.8 tp -69.91 -30.81 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 112.191 0.441 . . . . 73.41 112.191 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.6 t -57.57 -37.25 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 120.911 0.386 . . . . 52.43 111.507 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.2 m -54.26 -47.87 71.81 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.0 0.429 . . . . 71.42 111.083 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.453 ' O ' HG13 ' A' ' 12' ' ' ILE . 87.5 tttt -66.28 -40.4 90.06 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.562 -0.29 . . . . 74.33 110.767 177.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.449 ' O ' HG22 ' A' ' 13' ' ' VAL . 67.4 mt -53.35 -47.33 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 120.81 0.338 . . . . 64.54 111.316 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.7 mt -59.12 -43.86 90.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.933 0.397 . . . . 75.04 110.926 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.8 t -61.16 -40.06 92.47 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.421 -0.354 . . . . 75.11 111.763 176.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.489 HD12 ' HB3' ' A' ' 33' ' ' ALA . 82.4 mt -61.69 -43.41 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.82 0.343 . . . . 72.54 110.736 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.526 ' HA ' HG23 ' A' ' 25' ' ' VAL . 91.5 t -59.04 -47.56 89.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.965 0.412 . . . . 71.42 111.018 176.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -60.54 -47.17 87.36 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.086 0.47 . . . . 74.13 111.264 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.01 -52.37 65.82 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.275 0.56 . . . . 73.03 111.039 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.576 ' HA ' ' HG2' ' A' ' 19' ' ' MET . 1.0 OUTLIER -62.1 -35.53 78.97 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.358 -0.383 . . . . 72.14 111.706 178.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -62.88 -25.18 68.18 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 122.315 -0.241 . . . . 74.31 111.261 173.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -84.47 -20.94 30.9 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.563 0.579 . . . . 74.14 112.563 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.576 ' HG2' ' HA ' ' A' ' 16' ' ' ARG . 20.4 ptm -89.25 -38.82 13.94 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.944 -0.473 . . . . 74.21 112.171 173.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -89.94 -41.47 11.75 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 111.88 0.326 . . . . 61.32 111.88 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 63.26 -74.58 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.807 0.669 . . . . 64.31 112.807 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.42 -28.57 73.65 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.094 -0.574 . . . . 63.32 113.495 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.36 147.0 33.84 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 120.765 0.317 . . . . 74.14 111.76 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.55 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 6.0 Cg_exo -72.86 172.19 15.87 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.447 2.098 . . . . 64.33 112.522 176.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.526 HG23 ' HA ' ' A' ' 13' ' ' VAL . 40.3 t -80.15 150.02 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.167 -0.47 . . . . 71.11 111.719 -175.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.598 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -100.05 145.94 27.34 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.347 -0.388 . . . . 53.41 110.624 -177.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.0 m -54.43 -34.7 61.9 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.567 0.58 . . . . 74.44 112.567 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -62.4 -42.65 99.59 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.447 0.536 . . . . 72.3 112.447 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -53.89 -42.95 69.23 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.152 0.427 . . . . 72.5 112.152 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.435 HD11 ' N ' ' A' ' 30' ' ' ILE . 2.9 mp -65.56 -50.1 73.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.979 0.419 . . . . 75.24 111.035 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.32 -58.57 7.89 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.01 0.433 . . . . 74.44 112.058 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.87 -42.4 93.61 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.804 0.668 . . . . 50.0 112.804 -178.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.489 ' HB3' HD12 ' A' ' 12' ' ' ILE . . . -75.25 -34.31 61.38 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.343 0.497 . . . . 75.41 112.343 -178.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.47 ' HB1' HD12 ' A' ' 5' ' ' ILE . . . -85.42 -21.19 28.89 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.133 0.42 . . . . 64.24 112.133 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.81 22.16 53.87 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.242 -0.504 . . . . 74.44 112.821 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.558 HD12 HG12 ' A' ' 5' ' ' ILE . 73.3 mt -101.42 173.83 6.26 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.959 0.409 . . . . 74.44 111.591 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.404 ' O ' HG21 ' A' ' 41' ' ' VAL . 47.4 t -98.01 148.29 23.65 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.354 -0.384 . . . . 75.52 111.051 177.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.3 mm -50.61 -49.32 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 112.836 0.68 . . . . 74.21 112.836 -175.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.526 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 47.6 t80 -51.37 -50.62 59.18 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.892 0.33 . . . . 71.23 111.892 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.448 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 27.6 tt0 -69.04 -40.3 78.67 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.844 0.354 . . . . 74.21 111.371 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.404 HG21 ' O ' ' A' ' 37' ' ' SER . 69.9 t -60.54 -51.71 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.418 -0.356 . . . . 74.12 111.875 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 8.7 ptm180 -57.41 -36.06 70.84 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.629 -0.259 . . . . 75.04 111.287 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 94.0 mt -60.16 -48.44 81.71 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.729 0.299 . . . . 74.43 110.932 177.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.448 ' CE2' ' HG2' ' A' ' 40' ' ' GLN . 25.5 m-85 -57.34 -48.05 80.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.04 0.447 . . . . 74.32 110.919 176.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.451 HD11 ' NE1' ' A' ' 67' ' ' TRP . 78.9 mt -60.97 -43.8 98.27 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.871 -0.604 . . . . 75.44 111.727 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 42' ' ' ARG . 46.9 mt-10 -57.98 -52.2 66.52 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.044 0.45 . . . . 62.11 111.089 175.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -59.25 -40.33 85.63 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.098 -0.501 . . . . 63.24 111.343 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.6 mt -59.9 -40.12 87.71 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.723 0.297 . . . . 71.12 111.468 176.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 65.3 t60 -67.12 -40.24 86.8 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.037 -0.415 . . . . 63.13 111.104 174.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -65.81 -43.42 88.67 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.068 -0.514 . . . . 63.44 112.156 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.491 HG23 HG22 ' A' ' 53' ' ' VAL . 34.0 m -78.27 -12.03 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 112.448 0.536 . . . . 65.33 112.448 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.93 52.51 1.5 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.085 -0.579 . . . . 53.33 113.713 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.491 HG22 HG23 ' A' ' 51' ' ' VAL . 91.3 t -124.17 -44.49 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 120.973 0.416 . . . . 54.2 111.323 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.7 mt -110.12 142.57 41.43 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.431 0.634 . . . . 72.31 112.517 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -91.44 119.63 31.58 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.373 -0.83 . . . . 61.21 109.038 172.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -85.18 94.86 8.98 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.163 0.506 . . . . 73.11 110.845 -173.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 51.4 t -93.31 148.59 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.877 -0.602 . . . . 63.23 112.183 -176.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -134.56 100.12 4.55 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.358 -0.383 . . . . 70.54 110.568 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.16 96.8 0.85 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.15 0.5 . . . . 60.52 111.463 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.63 -92.17 1.51 Allowed Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.357 -0.449 . . . . 55.12 112.754 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.722 ' HZ2' ' HB2' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -175.33 -36.58 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.776 0.322 . . . . 75.12 111.421 179.403 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.44 -29.59 72.05 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.438 -0.411 . . . . 65.13 113.714 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.9 m -76.05 140.45 70.03 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-O 120.93 0.395 . . . . 74.43 111.69 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.05 -36.09 39.44 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.607 2.205 . . . . 73.03 113.219 -178.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 167.0 155.85 9.32 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 120.895 -0.669 . . . . 52.45 113.318 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 92.0 mt -133.45 139.01 46.46 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 122.915 0.486 . . . . 72.22 110.198 177.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.451 ' NE1' HD11 ' A' ' 45' ' ' LEU . 59.9 m95 -115.99 123.38 47.87 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.547 0.689 . . . . 75.33 112.452 -171.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 -128.46 113.33 15.39 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.768 -0.651 . . . . 73.43 110.788 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 69' ' ' LEU . 3.7 pp -63.48 149.95 44.92 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.904 -0.498 . . . . 74.31 111.866 -178.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 87.8 mt -84.25 160.18 20.82 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.225 -0.443 . . . . 73.34 111.522 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 C--O 1.252 1.23 0 CA-C-O 118.42 -0.8 . . . . 73.43 112.467 -179.105 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 mmt . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.591 0.234 . . . . 72.14 110.775 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.1 m -71.46 -45.86 61.48 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.135 0.42 . . . . 74.34 112.135 -178.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -79.77 157.71 27.03 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.942 0.401 . . . . 51.43 111.439 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.3 t -115.8 111.36 20.39 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.051 0.389 . . . . 71.32 112.051 -175.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.473 HG22 HD11 ' A' ' 36' ' ' LEU . 61.3 mt -65.94 -33.73 65.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 121.063 0.459 . . . . 73.24 110.145 173.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.9 t -58.49 -54.89 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.084 -0.507 . . . . 71.12 111.321 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.5 m -61.04 -33.82 73.9 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.981 0.42 . . . . 54.11 111.066 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.431 ' O ' HG13 ' A' ' 12' ' ' ILE . 61.9 tttp -59.28 -49.42 77.9 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.976 0.417 . . . . 72.53 110.692 176.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.504 ' O ' HG21 ' A' ' 13' ' ' VAL . 73.2 mt -56.91 -49.72 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.184 -0.462 . . . . 64.21 111.175 176.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.9 mt -53.74 -42.65 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 121.156 0.503 . . . . 75.15 111.457 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.0 m -62.77 -43.33 99.09 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.168 -0.469 . . . . 51.42 111.244 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 8' ' ' LYS . 74.8 mt -61.06 -43.31 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.043 0.449 . . . . 60.12 111.255 177.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.565 HG12 ' NE2' ' A' ' 17' ' ' GLN . 81.1 t -57.96 -52.15 61.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 116.064 -0.517 . . . . 71.24 111.391 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -63.71 -41.32 98.1 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.703 0.287 . . . . 72.33 111.524 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -51.58 -53.09 41.87 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.768 0.318 . . . . 75.31 111.158 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.536 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 3.1 mmp_? -57.05 -46.76 82.2 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 111.911 0.337 . . . . 73.34 111.911 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.565 ' NE2' HG12 ' A' ' 13' ' ' VAL . 66.0 mt-30 -64.69 -38.07 89.74 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.99 0.424 . . . . 64.33 112.14 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -77.76 -41.23 38.29 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.271 0.471 . . . . 72.51 112.271 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.676 ' HA ' ' HE2' ' A' ' 19' ' ' MET . 22.5 mmt -75.71 -45.46 36.59 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.177 0.436 . . . . 70.51 112.177 -177.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -82.28 -25.84 33.66 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.923 0.392 . . . . 61.31 110.538 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.8 t70 67.26 104.96 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.438 0.695 . . . . 74.11 112.01 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.7 -31.03 5.74 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 115.922 -0.581 . . . . 52.24 113.906 177.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.79 140.13 95.44 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 113.04 0.756 . . . . 74.2 113.04 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.19 146.4 17.81 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.899 2.399 . . . . 71.31 112.371 173.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.441 HG22 ' HB2' ' A' ' 16' ' ' ARG . 22.1 t -85.66 138.46 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.028 0.442 . . . . 72.11 112.061 -175.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.43 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -98.92 144.7 27.81 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.995 -0.548 . . . . 63.31 110.693 178.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 57.8 m -57.16 -32.73 66.72 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.843 0.354 . . . . 64.41 111.07 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -56.99 -57.54 12.1 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.243 -0.435 . . . . 74.23 112.147 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -54.59 -42.55 71.24 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.748 0.309 . . . . 64.4 111.712 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.7 mt -63.49 -43.71 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.404 -0.362 . . . . 71.21 111.337 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.1 -49.6 77.0 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.06 0.393 . . . . 74.43 112.06 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -65.48 -42.87 91.74 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.042 0.386 . . . . 51.52 112.042 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.89 -35.46 74.66 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.373 0.509 . . . . 72.03 112.373 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.64 -24.14 24.03 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.985 0.365 . . . . 62.33 111.985 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.29 37.4 24.6 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.365 -0.445 . . . . 65.15 112.96 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.473 HD11 HG22 ' A' ' 5' ' ' ILE . 84.1 mt -123.05 174.65 7.07 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.964 0.411 . . . . 71.35 111.743 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.445 ' O ' HG22 ' A' ' 41' ' ' VAL . 49.3 m -86.8 144.71 26.92 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.477 -0.329 . . . . 70.22 111.277 177.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.2 mm -47.15 -51.13 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 112.396 0.517 . . . . 75.31 112.396 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.48 ' CE2' HD12 ' A' ' 43' ' ' LEU . 82.8 t80 -54.44 -56.38 19.3 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.251 -0.431 . . . . 73.13 111.36 177.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -54.88 -49.0 72.26 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.073 -0.512 . . . . 75.31 111.69 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 37' ' ' SER . 89.4 t -54.68 -53.03 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.983 -0.553 . . . . 71.3 111.625 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -65.85 -26.85 67.84 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.949 -0.3 . . . . 73.34 111.61 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.48 HD12 ' CE2' ' A' ' 39' ' ' TYR . 80.7 mt -58.31 -48.77 79.46 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.948 0.404 . . . . 73.04 110.287 174.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -66.04 -34.12 77.37 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.234 -0.439 . . . . 71.35 111.192 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 88.5 mt -63.21 -46.08 88.66 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.66 0.267 . . . . 52.31 111.062 176.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 49' ' ' HIS . 1.1 mp0 -55.68 -48.09 75.66 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.717 0.294 . . . . 73.15 110.789 174.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 94.7 mt-30 -56.8 -50.7 71.55 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.813 0.34 . . . . 73.13 111.055 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.501 ' HA ' HG21 ' A' ' 51' ' ' VAL . 95.1 mt -58.52 -30.57 67.17 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.118 0.485 . . . . 71.23 111.439 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.467 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 7.3 t-80 -65.9 -45.95 80.09 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.901 0.382 . . . . 72.41 111.446 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -79.84 -23.73 41.8 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.222 0.823 . . . . 74.34 113.222 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.501 HG21 ' HA ' ' A' ' 48' ' ' LEU . 23.9 m -89.77 6.49 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 121.838 -0.539 . . . . 75.21 111.78 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.1 57.78 3.36 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 116.325 -0.398 . . . . 63.13 113.934 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.46 HG22 HG23 ' A' ' 51' ' ' VAL . 90.2 t -131.77 -51.94 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 122.431 -0.452 . . . . 63.24 111.816 177.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.9 mt -97.01 143.97 27.35 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.933 0.716 . . . . 70.23 112.933 -175.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -102.03 153.24 20.09 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.215 -0.902 . . . . 72.13 110.89 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.553 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 1.8 mppt? -97.21 119.85 36.48 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.767 0.318 . . . . 65.42 110.902 -176.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.2 t -108.83 106.96 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-O 121.132 0.491 . . . . 72.1 112.186 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -88.82 101.69 14.28 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.986 0.422 . . . . 64.15 110.511 175.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.47 -11.42 59.88 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.598 0.592 . . . . 71.32 112.598 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 165.8 178.48 38.77 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.714 -0.755 . . . . 62.44 113.256 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -77.1 96.0 4.36 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.777 0.322 . . . . 72.23 111.248 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 142.55 -23.06 2.35 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.865 -0.683 . . . . 39.06 113.145 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 32.9 m -80.53 137.73 51.52 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 116.912 0.356 . . . . 74.31 111.437 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.72 -47.33 4.03 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.284 1.989 . . . . 70.02 112.341 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 159.1 117.68 0.49 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.097 -0.573 . . . . 53.33 112.875 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.4 mt -88.46 159.88 17.78 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.632 0.253 . . . . 75.14 110.643 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -106.16 132.8 51.79 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.611 0.967 . . . . 72.15 113.611 -169.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -139.21 -168.64 2.49 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.505 -0.771 . . . . 71.54 109.755 169.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 pp -114.21 169.16 9.23 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 122.026 -0.421 . . . . 71.0 111.225 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.12 92.9 0.41 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.059 0.456 . . . . 74.42 111.054 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 . . . . . 0 C--O 1.252 1.232 0 CA-C-O 118.748 -0.644 . . . . 71.35 111.593 -176.713 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.429 ' H2 ' ' CD ' ' A' ' 3' ' ' GLU . 26.0 ttt . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.597 0.237 . . . . 74.43 111.501 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 t 67.24 31.38 6.65 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.851 0.686 . . . . 74.41 112.851 174.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.429 ' CD ' ' H2 ' ' A' ' 1' ' ' MET . 1.3 pm0 -93.55 12.56 24.79 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.596 0.591 . . . . 71.44 112.596 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.0 m -60.39 -40.12 89.74 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.826 -0.546 . . . . 63.45 110.909 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.46 HD13 HD11 ' A' ' 36' ' ' LEU . 14.6 tt -63.13 -31.56 53.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.248 0.547 . . . . 74.31 110.877 174.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.5 t -69.07 -35.56 69.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.266 -0.425 . . . . 75.43 110.815 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.1 m -52.96 -43.47 66.39 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.101 0.477 . . . . 73.53 110.318 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.551 ' O ' HG13 ' A' ' 12' ' ' ILE . 40.5 ttmt -60.45 -48.51 81.45 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.993 -0.549 . . . . 75.3 110.776 175.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.4 mt -52.57 -47.17 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.892 0.377 . . . . 73.32 111.512 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.6 mt -61.8 -45.58 98.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.049 0.452 . . . . 42.11 111.202 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 84.7 p -67.96 -18.35 64.71 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.906 0.336 . . . . 63.22 111.906 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 8' ' ' LYS . 99.3 mt -75.01 -44.83 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.081 0.467 . . . . 72.22 110.417 172.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.8 t -59.96 -41.51 86.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.195 0.521 . . . . 63.42 110.34 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -65.36 -45.33 84.57 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.884 -0.598 . . . . 75.43 110.526 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -51.09 -52.2 45.94 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.14 -0.482 . . . . 65.42 111.734 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.9 mmt-85 -61.97 -37.68 85.68 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 111.952 0.353 . . . . 75.51 111.952 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -74.88 -12.97 60.49 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 122.148 -0.345 . . . . 64.51 111.86 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -82.6 -45.55 14.44 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.906 0.384 . . . . 70.32 110.459 171.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 93.6 mmm -70.11 -65.22 0.75 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.176 -0.466 . . . . 71.31 110.632 176.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -81.68 102.86 10.98 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.989 0.423 . . . . 74.04 110.004 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -51.11 95.57 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.115 0.783 . . . . 63.34 113.115 -172.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.91 33.05 84.57 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 115.721 -0.672 . . . . 74.5 113.657 175.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.96 145.97 30.69 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 120.879 0.371 . . . . 44.44 111.962 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.558 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 38.4 Cg_endo -65.28 131.56 28.73 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.513 2.142 . . . . 64.2 112.838 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.3 t -82.62 147.88 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.084 -0.507 . . . . 62.34 111.866 -176.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.431 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -100.61 146.72 26.79 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.297 -0.41 . . . . 64.02 111.035 -178.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.4 m -57.17 -32.53 66.52 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 111.909 0.337 . . . . 72.15 111.909 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 28' ' ' ARG . 3.9 mpt_? -60.75 -53.82 52.74 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.096 0.406 . . . . 74.34 112.096 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.415 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 9.5 m-20 -53.11 -47.61 68.49 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.969 0.414 . . . . 74.32 111.339 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.512 ' HA ' HG22 ' A' ' 12' ' ' ILE . 61.5 mt -59.49 -43.83 91.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.96 -0.564 . . . . 75.12 111.389 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.533 ' HA ' HG23 ' A' ' 41' ' ' VAL . . . -62.5 -54.34 41.47 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.167 0.432 . . . . 71.23 112.167 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.35 -43.87 96.46 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.95 0.352 . . . . 63.52 111.95 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.433 ' HB3' HD12 ' A' ' 12' ' ' ILE . . . -62.91 -37.81 88.46 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.79 0.329 . . . . 62.12 111.709 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.92 -18.58 36.9 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.99 0.424 . . . . 65.42 111.63 176.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.86 20.69 70.12 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.327 -0.397 . . . . 74.13 113.569 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.46 HD11 HD13 ' A' ' 5' ' ' ILE . 84.4 mt -111.61 176.39 5.04 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.14 0.495 . . . . 75.3 112.04 -175.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.6 m -83.29 147.45 27.96 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.026 -0.534 . . . . 75.53 111.711 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 39.6 mm -50.6 -51.29 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 112.796 0.665 . . . . 54.02 112.796 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -60.81 -49.6 76.82 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.742 0.306 . . . . 54.21 111.635 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -58.11 -50.41 73.59 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.176 0.513 . . . . 71.24 111.144 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.533 HG23 ' HA ' ' A' ' 31' ' ' ALA . 73.1 t -55.38 -46.56 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.139 -0.482 . . . . 74.0 111.131 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.507 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 16.5 ttt180 -53.11 -44.22 67.47 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.256 -0.429 . . . . 74.13 111.4 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.6 mt -54.69 -47.07 74.12 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.051 0.453 . . . . 71.24 110.781 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -62.41 -46.29 89.27 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.101 -0.499 . . . . 72.24 111.282 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 85.0 mt -61.42 -40.94 96.26 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.349 -0.387 . . . . 62.22 111.712 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 42' ' ' ARG . 55.5 mt-10 -59.31 -42.25 90.94 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.971 0.415 . . . . 72.43 111.107 177.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -71.88 -33.12 68.1 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.813 0.339 . . . . 65.45 111.159 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.73 -29.11 69.58 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.017 0.437 . . . . 72.13 111.207 174.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.435 ' HD2' ' HA ' ' A' ' 55' ' ' GLU . 54.4 t-80 -73.37 -28.96 62.32 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.083 0.468 . . . . 74.51 110.603 172.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -73.96 -52.25 13.42 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.927 -0.578 . . . . 74.21 111.584 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.488 HG23 HG21 ' A' ' 53' ' ' VAL . 34.1 m -73.5 -10.96 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 113.144 0.794 . . . . 75.21 113.144 -176.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.53 49.08 2.05 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.005 -0.617 . . . . 54.52 114.042 176.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.488 HG21 HG23 ' A' ' 51' ' ' VAL . 91.7 t -118.65 -52.5 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.968 0.413 . . . . 55.0 111.427 176.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 86.4 mt -114.91 148.57 38.48 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.018 0.437 . . . . 74.0 111.979 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.435 ' HA ' ' HD2' ' A' ' 49' ' ' HIS . 10.1 tp10 -111.97 133.7 53.99 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.216 -0.447 . . . . 73.23 111.092 174.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -85.65 97.89 10.37 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.987 -0.551 . . . . 74.45 110.734 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 46.7 t -68.97 112.26 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 115.987 -0.551 . . . . 54.11 111.552 -178.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -136.13 116.67 13.81 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.026 -0.534 . . . . 74.12 110.717 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -106.13 22.78 15.11 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.662 0.615 . . . . 65.12 112.662 -177.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.3 175.37 27.2 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.904 -0.665 . . . . 38.95 113.104 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -75.36 120.74 21.24 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.952 0.406 . . . . 74.14 111.686 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.44 49.61 19.05 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.188 -0.53 . . . . 63.02 113.582 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.6 m -117.07 159.74 39.92 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 122.464 -0.433 . . . . 74.32 111.367 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -51.43 119.63 5.77 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.671 2.247 . . . . 70.44 113.391 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.2 105.63 2.02 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 121.196 -0.526 . . . . 44.14 113.224 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.558 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 87.3 mt -107.0 162.06 14.18 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.832 0.349 . . . . 63.53 111.329 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -124.38 133.54 53.39 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.307 0.575 . . . . 74.44 112.313 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -127.46 121.33 30.49 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.283 -0.417 . . . . 72.32 110.705 172.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.443 ' O ' HD13 ' A' ' 69' ' ' LEU . 2.9 pp -69.99 147.6 49.92 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.947 0.403 . . . . 72.11 111.659 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 72.5 mt -81.04 85.95 6.21 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.437 -0.347 . . . . 73.42 111.662 -177.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 C--O 1.255 1.371 0 CA-C-O 118.459 -0.782 . . . . 73.32 112.972 177.21 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 120.658 0.266 . . . . 62.04 111.552 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t 61.57 15.76 7.07 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.023 0.44 . . . . 65.43 111.545 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -81.52 93.94 6.77 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.136 0.493 . . . . 73.14 110.679 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 63.8 p -102.02 116.22 32.23 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.935 -0.575 . . . . 74.25 111.909 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.0 tp -59.35 -40.67 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 116.195 -0.457 . . . . 71.14 112.003 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.8 t -61.78 -51.32 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 111.696 0.258 . . . . 73.14 111.696 -177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.1 m -56.63 -37.53 70.85 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.905 0.383 . . . . 63.42 111.423 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.501 ' O ' HG13 ' A' ' 12' ' ' ILE . 37.3 ttpt -65.28 -43.61 90.64 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.471 -0.331 . . . . 65.13 110.721 176.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.448 HG22 HG23 ' A' ' 30' ' ' ILE . 69.2 mt -59.41 -44.83 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.737 0.303 . . . . 72.42 111.503 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 69.0 mt -56.68 -45.65 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.27 0.557 . . . . 64.04 110.771 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.6 m -66.98 -29.32 69.13 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.933 -0.576 . . . . 73.23 111.905 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 8' ' ' LYS . 94.0 mt -63.94 -44.02 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.056 0.455 . . . . 72.45 110.91 174.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.415 ' HA ' HG23 ' A' ' 25' ' ' VAL . 59.3 t -57.31 -47.15 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.116 0.484 . . . . 73.31 110.729 175.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -61.27 -46.59 89.7 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.08 -0.509 . . . . 62.42 110.992 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -56.3 -46.75 79.67 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.1 -0.5 . . . . 70.54 111.421 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.418 ' HD3' ' SD ' ' A' ' 19' ' ' MET . 11.1 mmt180 -61.33 -36.67 80.79 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.5 -0.318 . . . . 72.53 111.729 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.432 ' NE2' ' HG ' ' A' ' 69' ' ' LEU . 73.6 mt-30 -75.79 -21.6 57.2 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.782 0.325 . . . . 70.13 111.814 176.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -70.53 -36.12 73.54 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.366 0.603 . . . . 74.05 110.04 170.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.418 ' SD ' ' HD3' ' A' ' 16' ' ' ARG . 74.3 mtp -67.69 -50.39 57.83 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.548 -0.751 . . . . 63.34 111.062 176.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -122.5 116.74 24.45 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.132 -0.486 . . . . 73.21 110.494 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -40.33 -53.28 2.6 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.213 0.82 . . . . 61.2 113.213 -173.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.94 53.98 0.7 Allowed Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.19 -0.529 . . . . 53.54 113.046 -176.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.83 110.27 61.7 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.361 0.504 . . . . 62.05 112.361 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.564 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 56.4 Cg_endo -69.88 122.29 8.94 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.093 1.862 . . . . 72.41 110.767 170.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.415 HG23 ' HA ' ' A' ' 13' ' ' VAL . 22.0 t -79.38 141.47 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 112.37 0.508 . . . . 71.34 112.37 -167.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.58 151.07 20.43 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.134 -0.484 . . . . 71.22 110.867 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.4 m -53.05 -37.33 61.5 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.201 -0.454 . . . . 62.4 111.526 175.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -64.22 -44.36 92.13 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.295 -0.411 . . . . 74.14 112.009 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.04 -41.34 98.0 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.994 0.426 . . . . 74.41 111.548 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.448 HG23 HG22 ' A' ' 9' ' ' ILE . 60.2 mt -65.78 -43.37 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 116.515 -0.311 . . . . 61.4 111.045 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.59 -37.51 81.6 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.202 0.525 . . . . 51.12 110.893 174.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.36 -48.33 81.77 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.662 -0.699 . . . . 73.01 111.697 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.16 -50.29 49.04 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.018 0.377 . . . . 62.4 112.018 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.0 -19.65 61.16 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.584 0.587 . . . . 74.11 112.584 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.17 40.0 51.36 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.159 -0.543 . . . . 63.42 112.673 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.4 175.26 6.53 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.805 0.336 . . . . 65.45 111.241 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.2 t -85.07 153.76 22.5 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.747 0.308 . . . . 70.12 111.192 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.59 -50.13 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 112.954 0.724 . . . . 65.2 112.954 -175.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -66.62 -44.72 81.29 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 122.197 -0.315 . . . . 74.42 111.763 -175.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -51.07 -55.44 17.56 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.203 0.525 . . . . 75.11 111.054 175.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.433 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 82.7 t -61.1 -39.86 83.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.064 -0.516 . . . . 71.3 110.942 176.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -53.52 -41.44 66.34 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.243 -0.435 . . . . 54.04 110.684 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.3 mt -62.92 -52.86 61.41 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.001 -0.545 . . . . 71.42 111.285 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -56.05 -36.85 68.5 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.011 0.434 . . . . 64.02 111.357 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.536 HD11 ' NE1' ' A' ' 67' ' ' TRP . 99.1 mt -69.78 -40.11 76.23 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.408 -0.36 . . . . 75.52 111.756 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -60.73 -37.94 83.45 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.025 0.44 . . . . 75.21 110.685 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -61.4 -54.02 49.06 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.385 -0.371 . . . . 73.42 110.712 174.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.5 mt -57.11 -31.53 65.39 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.15 0.5 . . . . 73.03 111.608 176.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -63.71 -50.82 67.65 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.921 -0.581 . . . . 74.23 111.803 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -76.79 -40.65 47.43 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.944 0.72 . . . . 73.32 112.944 -176.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.471 HG23 HG22 ' A' ' 53' ' ' VAL . 23.5 m -67.58 -16.14 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 112.253 0.464 . . . . 73.04 112.253 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.61 48.29 2.36 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.185 -0.531 . . . . 75.11 113.935 177.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.471 HG22 HG23 ' A' ' 51' ' ' VAL . 97.9 t -118.71 -40.94 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 121.075 0.464 . . . . 71.12 111.28 176.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.403 HD11 ' HB3' ' A' ' 67' ' ' TRP . 83.5 mt -112.85 136.45 52.46 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.401 0.619 . . . . 63.41 112.296 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -91.65 143.15 26.85 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.586 -0.734 . . . . 55.03 109.971 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -93.94 105.08 17.11 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.889 0.852 . . . . 75.13 111.662 -174.83 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 28.6 t -82.75 75.7 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.358 0.599 . . . . 74.0 110.588 177.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 63.9 t30 177.5 -80.16 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.08 -0.964 . . . . 71.14 110.629 177.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -174.08 126.36 0.36 Allowed 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.619 0.6 . . . . 55.15 112.619 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.55 -106.2 0.47 Allowed Glycine 0 CA--C 1.533 1.211 0 N-CA-C 115.227 0.851 . . . . 65.01 115.227 170.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.426 ' HD3' ' N ' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -161.69 163.74 29.59 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.456 0.302 . . . . 54.44 111.463 -174.418 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.79 -55.62 3.02 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 121.403 -0.427 . . . . 74.01 113.729 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.5 m -55.97 150.85 27.22 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 112.243 0.461 . . . . 72.53 112.243 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.26 99.77 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.847 2.365 . . . . 72.33 112.918 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -125.83 151.13 17.67 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 121.079 -0.581 . . . . 65.11 112.934 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 67.0 mt -83.26 140.54 32.45 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.973 0.416 . . . . 74.03 110.191 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.536 ' NE1' HD11 ' A' ' 45' ' ' LEU . 67.1 m95 -93.88 116.43 28.89 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.335 0.588 . . . . 72.33 112.179 -172.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -114.69 111.49 21.37 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.843 -0.617 . . . . 73.14 110.534 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.432 ' HG ' ' NE2' ' A' ' 17' ' ' GLN . 3.5 pp -59.3 156.02 13.4 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 122.008 -0.433 . . . . 75.24 111.504 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.7 mt -67.92 101.84 1.17 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.166 0.507 . . . . 73.3 111.231 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--O 1.254 1.293 0 CA-C-O 118.43 -0.795 . . . . 73.14 111.792 178.285 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.621 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 120.929 0.395 . . . . 72.44 111.328 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.3 m -76.37 79.87 3.11 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.426 0.631 . . . . 73.23 111.699 -177.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -86.69 44.31 1.15 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.762 -0.654 . . . . 72.22 111.586 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 94.7 p 49.58 31.59 4.29 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.234 0.827 . . . . 74.41 113.234 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.628 ' H ' HD13 ' A' ' 5' ' ' ILE . 4.5 mp -58.64 -47.86 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 121.098 0.475 . . . . 71.24 110.87 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.17 -47.11 91.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-N 116.116 -0.493 . . . . 74.31 111.145 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.1 m -52.22 -46.08 65.54 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.166 0.508 . . . . 74.13 111.354 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -55.36 -55.14 35.0 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.95 -0.568 . . . . 73.03 111.298 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.435 ' O ' HG21 ' A' ' 13' ' ' VAL . 62.8 mt -60.44 -46.04 95.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 112.038 0.384 . . . . 73.23 112.038 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.8 mt -58.51 -50.93 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 111.892 0.33 . . . . 75.44 111.892 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.6 p -55.92 -43.65 77.54 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.792 0.33 . . . . 40.42 111.771 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 82.5 mt -61.68 -55.91 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.927 0.394 . . . . 62.33 111.589 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 9' ' ' ILE . 80.1 t -55.07 -41.84 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.063 0.459 . . . . 72.42 111.523 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -65.5 -53.23 45.43 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.128 -0.487 . . . . 73.32 111.17 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -51.64 -49.5 62.16 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.104 0.478 . . . . 74.55 111.328 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -54.3 -51.12 65.65 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.733 -0.667 . . . . 74.24 111.943 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.483 ' NE2' ' HA ' ' A' ' 68' ' ' ARG . 78.3 mt-30 -66.32 -16.45 64.06 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.306 0.484 . . . . 74.4 112.306 -178.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -78.8 -29.63 45.01 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 122.045 -0.409 . . . . 53.13 110.791 170.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 23.2 mmt -91.5 -74.19 0.51 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.825 0.345 . . . . 71.34 111.54 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.27 77.79 8.91 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.91 0.862 . . . . 74.13 111.157 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -85.92 -28.06 24.57 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.116 -0.947 . . . . 74.43 111.06 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.36 -3.38 82.25 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 116.056 -0.52 . . . . 71.11 113.641 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -150.92 119.87 3.54 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 122.436 -0.45 . . . . 55.41 111.315 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.529 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 10.8 Cg_endo -52.59 152.87 15.4 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.99 2.46 . . . . 74.11 113.435 -178.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.6 t -79.99 150.36 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 112.141 0.423 . . . . 64.54 112.141 -172.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.498 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 9.9 mptt -96.69 151.42 19.64 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.868 0.366 . . . . 72.14 111.262 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.8 m -56.0 -36.58 68.08 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 116.286 -0.415 . . . . 73.44 111.957 177.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.2 mtm-85 -57.07 -58.33 8.66 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.975 0.417 . . . . 75.22 111.501 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.91 -44.19 70.34 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.651 -0.704 . . . . 73.14 112.27 -177.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.6 mt -63.68 -46.29 95.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.065 0.459 . . . . 71.42 111.115 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.549 ' HA ' HG22 ' A' ' 41' ' ' VAL . . . -62.74 -43.88 97.64 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.933 0.396 . . . . 64.55 111.578 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.35 -47.28 84.9 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.062 -0.517 . . . . 73.13 111.2 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.67 -29.56 68.88 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 111.895 0.332 . . . . 63.34 111.895 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.14 -15.44 36.11 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.103 0.409 . . . . 52.43 112.103 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.14 27.4 71.98 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.425 -0.417 . . . . 44.53 112.832 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.6 mt -117.87 175.29 5.73 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.126 0.488 . . . . 73.14 111.753 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.5 t -80.23 149.31 30.47 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.399 0.518 . . . . 72.25 112.399 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.7 mm -51.92 -40.52 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.962 -0.563 . . . . 73.2 111.001 174.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.445 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 85.8 t80 -64.83 -56.61 12.4 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.939 -0.573 . . . . 74.42 111.855 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -57.96 -51.06 71.2 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.178 0.513 . . . . 74.15 111.633 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.549 HG22 ' HA ' ' A' ' 31' ' ' ALA . 78.2 t -55.87 -47.94 79.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.146 -0.479 . . . . 74.54 111.602 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -57.35 -38.33 73.97 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.572 -0.286 . . . . 65.01 111.52 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 92.2 mt -58.38 -46.45 86.32 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.809 0.338 . . . . 54.42 111.079 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -65.99 -44.17 85.64 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.787 0.327 . . . . 72.33 111.517 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.74 -48.43 81.83 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.116 0.484 . . . . 75.54 111.634 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.25 -41.34 90.11 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.318 -0.401 . . . . 73.3 111.79 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -61.72 -41.55 97.77 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.217 -0.302 . . . . 73.2 111.386 176.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.9 mt -60.01 -33.39 71.93 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.763 0.316 . . . . 64.43 111.166 176.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -66.22 -49.76 66.17 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 122.166 -0.334 . . . . 72.44 110.959 172.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.63 -32.07 71.24 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 112.085 0.402 . . . . 75.23 112.085 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.424 HG21 HG22 ' A' ' 53' ' ' VAL . 30.9 m -90.96 2.66 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 112.717 0.636 . . . . 62.34 112.717 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.03 51.93 3.43 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.222 -0.513 . . . . 52.24 114.202 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.424 HG22 HG21 ' A' ' 51' ' ' VAL . 60.9 t -129.71 -58.51 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 122.394 -0.474 . . . . 75.04 110.91 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.5 mt -104.37 178.43 4.56 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.211 0.529 . . . . 74.02 111.872 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.533 ' HB3' ' HG3' ' A' ' 68' ' ' ARG . 11.7 tp10 -138.03 144.78 41.2 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 120.843 0.354 . . . . 72.5 111.254 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -89.81 129.18 36.23 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.128 0.788 . . . . 74.24 113.128 -174.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.545 ' O ' ' HB2' ' A' ' 58' ' ' ASN . 45.4 t -120.36 116.31 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 108.679 -0.859 . . . . 64.14 108.679 165.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.545 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 4.4 m-20 77.05 131.28 0.05 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.234 0.614 . . . . 72.0 110.825 -169.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.22 -80.96 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.247 0.832 . . . . 72.33 113.247 -173.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 175.47 -18.64 0.05 OUTLIER Glycine 0 CA--C 1.531 1.034 0 C-N-CA 121.075 -0.583 . . . . 72.43 113.717 -176.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -74.52 100.08 3.78 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 122.146 -0.62 . . . . 75.14 111.388 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.37 -42.0 1.89 Allowed Glycine 0 CA--C 1.533 1.175 0 C-N-CA 121.235 -0.507 . . . . 72.15 113.612 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.0 m -60.46 136.91 92.23 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 122.636 0.374 . . . . 75.33 111.955 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.48 -31.46 51.19 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.775 2.317 . . . . 75.53 113.325 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.63 113.99 3.88 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.066 -0.588 . . . . 50.1 113.414 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 96.4 mt -109.39 137.1 47.76 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.108 0.48 . . . . 63.21 110.227 175.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 28.8 m95 -123.4 143.24 50.25 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.636 0.606 . . . . 75.21 112.636 -169.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.533 ' HG3' ' HB3' ' A' ' 55' ' ' GLU . 9.1 ptm180 -147.69 174.43 11.79 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.668 -0.696 . . . . 74.52 110.862 174.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.457 ' HG ' ' OE1' ' A' ' 17' ' ' GLN . 3.3 pp -125.22 177.57 6.05 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.872 0.368 . . . . 52.21 111.426 175.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.525 ' N ' HD23 ' A' ' 70' ' ' LEU . 1.3 pt? -142.2 79.16 1.65 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.416 0.627 . . . . 71.13 110.751 176.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 . . . . . 0 C--O 1.256 1.417 0 CA-C-O 118.782 -0.627 . . . . 71.21 111.104 -179.731 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.583 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.1 mpp? . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.963 0.411 . . . . 75.2 110.744 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.8 m -99.79 -68.31 0.81 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 111.894 0.331 . . . . 45.41 111.894 -175.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -88.99 138.58 31.28 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 116.371 -0.377 . . . . 74.3 110.748 -174.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.8 m -117.55 -36.01 3.82 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.148 0.795 . . . . 75.21 113.148 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 5' ' ' ILE . 2.1 mp -70.86 -58.17 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 112.154 0.427 . . . . 72.34 112.154 -173.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.92 -35.07 72.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.189 0.518 . . . . 65.11 110.48 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.0 m -61.28 -38.14 85.7 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.042 -0.526 . . . . 74.04 110.603 173.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.433 ' O ' HG13 ' A' ' 12' ' ' ILE . 86.8 tttt -63.35 -42.53 98.92 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.308 -0.406 . . . . 64.34 110.613 174.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.5 mt -52.19 -45.13 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.027 0.441 . . . . 70.11 110.796 174.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.4 mt -58.45 -44.38 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 116.224 -0.444 . . . . 75.1 111.203 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.9 m -59.64 -42.2 92.24 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.393 -0.367 . . . . 72.33 111.266 176.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 8' ' ' LYS . 82.9 mt -59.59 -46.05 93.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.055 0.455 . . . . 75.24 111.054 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.549 ' HA ' HG23 ' A' ' 25' ' ' VAL . 63.7 t -60.5 -49.63 83.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.082 0.468 . . . . 62.15 111.096 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.501 ' NE2' HD22 ' A' ' 18' ' ' ASN . 24.7 tm0? -58.65 -41.59 86.42 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.239 0.542 . . . . 52.21 110.677 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -60.05 -51.04 71.33 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.779 -0.646 . . . . 73.21 112.156 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.455 ' HB2' HG22 ' A' ' 25' ' ' VAL . 27.4 mmt180 -59.09 -35.4 73.35 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.664 0.269 . . . . 75.44 111.202 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.489 ' NE2' HG12 ' A' ' 13' ' ' VAL . 44.1 mt-30 -67.02 -27.33 67.32 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.976 0.417 . . . . 74.03 111.642 175.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.519 ' N ' HD21 ' A' ' 18' ' ' ASN . 0.8 OUTLIER -76.17 -23.12 54.73 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.963 0.411 . . . . 71.44 110.898 174.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.7 mmt -75.19 -54.99 6.19 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.06 -0.518 . . . . 71.25 110.345 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -119.99 98.97 6.34 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.166 -0.47 . . . . 74.44 110.592 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -61.76 -15.89 44.88 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.844 0.683 . . . . 63.31 112.844 -174.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -117.29 31.88 5.64 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.34 -0.457 . . . . 51.53 113.297 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -140.36 136.97 17.2 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 112.45 0.537 . . . . 73.01 112.45 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.501 ' HG2' HD13 ' A' ' 66' ' ' LEU . 82.7 Cg_endo -83.29 159.61 15.1 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.63 2.22 . . . . 62.41 112.312 172.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.549 HG23 ' HA ' ' A' ' 13' ' ' VAL . 11.2 t -85.91 156.2 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.055 0.455 . . . . 71.53 111.986 -175.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.448 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -99.95 140.17 34.55 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.263 -0.426 . . . . 70.11 110.783 -175.14 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.2 m -55.61 -41.1 73.0 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.874 0.369 . . . . 73.33 111.791 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -61.43 -52.72 63.4 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.892 0.377 . . . . 72.41 111.353 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.09 -35.66 75.7 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.238 -0.437 . . . . 74.44 111.772 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.513 HG22 HD22 ' A' ' 45' ' ' LEU . 77.8 mt -66.95 -56.28 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.801 0.334 . . . . 73.53 111.464 176.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.431 ' HA ' HG23 ' A' ' 41' ' ' VAL . . . -56.45 -43.42 79.49 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.087 0.403 . . . . 71.14 112.087 -178.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.51 -53.03 58.4 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.041 -0.527 . . . . 73.21 110.958 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.11 -29.47 70.59 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 111.933 0.346 . . . . 60.2 111.933 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.75 -27.13 44.66 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.905 0.383 . . . . 65.43 111.914 177.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.99 45.99 9.85 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.089 -0.577 . . . . 41.1 112.965 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.2 mt -135.5 178.16 7.26 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.732 -0.275 . . . . 74.13 111.045 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.415 ' O ' HG21 ' A' ' 41' ' ' VAL . 66.5 m -82.18 142.9 31.8 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 122.395 -0.191 . . . . 74.31 111.306 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.449 ' O ' ' HG3' ' A' ' 42' ' ' ARG . 48.2 mm -51.72 -55.68 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 122.53 0.332 . . . . 61.14 111.752 -176.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -54.17 -48.19 71.19 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.036 0.446 . . . . 72.13 111.474 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -58.12 -45.94 86.45 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.865 -0.607 . . . . 73.44 111.795 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.431 HG23 ' HA ' ' A' ' 31' ' ' ALA . 99.1 t -66.71 -39.27 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.319 -0.4 . . . . 74.41 111.637 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 38' ' ' ILE . 79.4 mtp180 -53.4 -44.45 68.73 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.809 0.337 . . . . 72.13 110.856 176.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.444 ' O ' ' HG3' ' A' ' 47' ' ' GLN . 98.2 mt -59.61 -49.51 77.48 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.23 -0.441 . . . . 71.22 111.054 176.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 21.4 m-30 -58.85 -43.87 90.88 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.888 0.375 . . . . 64.43 111.717 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.513 HD22 HG22 ' A' ' 30' ' ' ILE . 96.7 mt -63.45 -45.54 90.4 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.373 -0.376 . . . . 74.34 111.588 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -61.33 -39.7 91.5 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 121.214 -0.194 . . . . 53.12 110.788 175.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 80.9 mt-30 -58.45 -44.16 89.1 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.965 0.412 . . . . 63.33 110.976 172.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.86 -31.22 71.46 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.345 -0.389 . . . . 75.52 111.946 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -73.98 -36.67 64.57 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.082 0.468 . . . . 75.45 110.918 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -64.26 -50.46 67.86 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.159 -0.473 . . . . 71.14 111.291 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.499 HG21 HG22 ' A' ' 53' ' ' VAL . 33.7 m -75.56 4.13 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 N-CA-C 112.641 0.608 . . . . 74.12 112.641 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.71 29.53 38.84 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 114.952 0.741 . . . . 74.32 114.952 171.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.499 HG22 HG21 ' A' ' 51' ' ' VAL . 82.2 t -96.46 -60.15 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 117.413 0.607 . . . . 75.52 111.269 174.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 69' ' ' LEU . 71.5 mt -99.26 145.48 27.24 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.226 0.536 . . . . 71.24 112.206 -176.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.512 ' HB2' HD23 ' A' ' 70' ' ' LEU . 9.3 tp10 -92.39 142.59 27.28 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.983 -0.553 . . . . 74.15 111.085 174.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -87.84 107.06 18.49 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.838 -0.619 . . . . 75.11 110.666 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.6 t -108.99 104.9 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 121.012 0.434 . . . . 65.15 112.002 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -119.04 114.16 22.08 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.882 0.373 . . . . 74.34 110.709 176.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.99 -0.68 49.91 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.35 0.5 . . . . 75.23 112.35 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.98 -158.46 25.21 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 121.198 -0.525 . . . . 74.11 112.892 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -81.83 159.91 23.64 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.971 0.415 . . . . 74.45 111.31 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.11 -54.82 4.98 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.032 -0.604 . . . . 53.54 112.319 -177.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.0 m -79.44 133.7 59.5 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 122.737 -0.273 . . . . 62.51 110.742 174.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -74.86 -174.08 1.78 Allowed 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.416 2.078 . . . . 73.02 113.274 -177.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.08 99.02 1.51 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.131 -0.557 . . . . 63.34 112.456 177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.501 HD13 ' HG2' ' A' ' 24' ' ' PRO . 96.4 mt -73.81 141.86 46.19 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.036 0.446 . . . . 64.02 111.319 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.444 ' CD1' HD13 ' A' ' 45' ' ' LEU . 67.1 m95 -108.04 117.54 34.39 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.809 0.67 . . . . 65.45 112.809 -170.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.457 ' HG3' ' OE1' ' A' ' 17' ' ' GLN . 55.8 ttt180 -120.63 178.7 4.58 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.402 -0.962 . . . . 73.34 108.402 171.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 54' ' ' LEU . 2.3 pp -101.52 160.97 13.98 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.526 1.057 . . . . 61.52 111.557 174.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.512 HD23 ' HB2' ' A' ' 55' ' ' GLU . 84.3 mt -69.12 93.15 0.58 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.891 0.377 . . . . 72.15 110.337 176.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 C--O 1.253 1.243 0 CA-C-O 118.37 -0.824 . . . . 74.14 111.897 -174.341 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.746 0.308 . . . . 53.13 111.373 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.9 t -68.17 101.41 1.16 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.751 0.31 . . . . 71.52 111.116 178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -134.11 130.94 38.13 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.969 0.414 . . . . 73.55 111.276 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.9 m -63.07 -35.42 80.2 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.199 -0.455 . . . . 71.34 111.525 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.7 mm -59.47 -48.07 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.05 0.452 . . . . 53.41 111.139 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.3 t -61.46 -48.11 90.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.341 -0.391 . . . . 73.0 110.923 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 99.5 m -58.13 -39.61 79.17 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.246 -0.434 . . . . 74.41 111.613 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.472 ' O ' HG13 ' A' ' 12' ' ' ILE . 60.1 tptt -57.57 -53.99 51.93 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.116 0.484 . . . . 71.51 110.485 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.51 HG22 HG23 ' A' ' 30' ' ' ILE . 67.8 mt -57.78 -48.65 83.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 115.784 -0.644 . . . . 74.55 111.931 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.7 mt -59.32 -44.31 92.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-O 120.966 0.412 . . . . 74.43 111.608 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.2 t -63.05 -32.49 73.87 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.336 -0.393 . . . . 70.24 111.556 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 8' ' ' LYS . 99.0 mt -71.35 -49.0 50.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.898 0.38 . . . . 72.34 111.336 176.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.403 HG21 ' O ' ' A' ' 9' ' ' ILE . 89.6 t -56.48 -44.09 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.135 0.493 . . . . 60.35 110.776 176.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -65.6 -39.96 92.13 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.945 -0.57 . . . . 74.2 110.898 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -55.57 -47.85 75.73 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.167 0.508 . . . . 52.4 110.87 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.55 ' HA ' ' HG2' ' A' ' 19' ' ' MET . 0.3 OUTLIER -64.46 -34.35 77.99 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.088 -0.506 . . . . 65.3 111.398 178.281 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -65.07 -40.03 94.1 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.038 0.447 . . . . 74.41 111.651 174.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -75.99 -21.94 56.38 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.281 0.474 . . . . 74.35 112.281 -177.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.55 ' HG2' ' HA ' ' A' ' 16' ' ' ARG . 24.8 ptm -83.77 -32.29 25.48 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.956 -0.465 . . . . 72.33 111.379 176.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -152.17 115.29 4.69 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.091 0.472 . . . . 71.0 110.805 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -69.4 -13.44 62.36 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.998 0.74 . . . . 74.13 112.998 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.03 15.15 12.34 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.052 -0.594 . . . . 72.24 113.487 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -107.71 113.58 61.25 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 112.174 0.435 . . . . 61.05 112.174 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.83 140.78 32.57 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.36 2.04 . . . . 71.32 112.067 172.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.4 t -79.12 154.64 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 120.923 0.392 . . . . 74.34 111.199 -176.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.559 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 2.3 mptp? -107.58 139.0 42.79 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.65 -0.25 . . . . 74.12 110.737 -177.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.2 m -53.49 -51.13 63.75 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.066 0.46 . . . . 65.54 111.8 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -64.85 -31.26 72.4 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.114 0.412 . . . . 65.22 112.114 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -63.54 -52.69 60.01 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.945 0.403 . . . . 63.3 111.046 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.51 HG23 HG22 ' A' ' 9' ' ' ILE . 64.2 mt -55.89 -43.13 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.045 0.45 . . . . 73.13 110.892 176.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.78 -35.68 73.21 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.102 -0.499 . . . . 73.42 111.876 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -74.1 -48.46 29.52 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.763 0.316 . . . . 71.35 110.992 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.11 -28.66 69.92 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.114 0.413 . . . . 70.22 112.114 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.22 -26.45 16.64 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.297 0.48 . . . . 55.23 112.297 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.21 31.47 38.25 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.267 -0.492 . . . . 73.1 112.713 -176.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.5 mt -115.35 169.26 9.28 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.845 0.355 . . . . 63.12 111.432 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.1 t -87.7 151.49 22.89 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.029 0.443 . . . . 62.32 111.772 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.1 mm -58.09 -48.85 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 112.985 0.735 . . . . 60.2 112.985 -172.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.541 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 41.8 p90 -56.68 -38.67 72.57 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 111.853 0.316 . . . . 74.53 111.853 -176.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -75.84 -47.18 26.64 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.079 0.466 . . . . 65.33 111.091 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.9 t -55.23 -48.28 76.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 116.17 -0.468 . . . . 72.33 111.614 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -65.61 -29.72 70.34 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 111.887 0.329 . . . . 71.24 111.887 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 65.6 mt -59.03 -49.28 78.49 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.167 -0.333 . . . . 73.2 110.577 176.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -61.28 -53.27 58.96 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.352 -0.385 . . . . 74.02 111.191 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.421 HD12 ' CD1' ' A' ' 67' ' ' TRP . 89.0 mt -55.37 -49.73 71.53 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.226 0.536 . . . . 74.31 112.393 -178.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.79 -41.73 95.6 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.937 -0.574 . . . . 62.34 112.095 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -68.83 -41.13 78.95 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.741 0.305 . . . . 75.25 110.942 176.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.0 mt -59.68 -31.63 69.74 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.746 0.307 . . . . 61.44 111.102 175.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.507 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 42.0 t-80 -66.43 -48.6 69.49 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.987 0.423 . . . . 75.3 111.031 173.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -59.96 -33.56 72.09 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 116.123 -0.489 . . . . 71.42 111.933 -176.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.492 HG21 HG22 ' A' ' 53' ' ' VAL . 33.9 m -89.44 1.53 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 112.841 0.682 . . . . 73.33 112.841 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.44 19.52 51.98 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 114.82 0.688 . . . . 53.21 114.82 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.492 HG22 HG21 ' A' ' 51' ' ' VAL . 81.6 t -88.53 -48.24 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 122.16 -0.612 . . . . 75.22 111.027 175.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 85.9 mt -114.79 152.39 32.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.285 -0.416 . . . . 62.45 111.503 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.46 ' HA ' ' HD2' ' A' ' 49' ' ' HIS . 10.5 tp10 -109.28 149.99 28.63 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.488 -0.323 . . . . 73.55 110.299 173.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.441 ' HD3' ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -98.86 137.78 36.94 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.165 0.507 . . . . 74.43 111.215 -178.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.488 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 88.7 t -121.25 132.81 69.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 120.995 0.426 . . . . 71.54 111.57 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -153.15 101.04 2.52 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.308 -0.405 . . . . 54.13 110.113 177.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.69 -28.91 66.23 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.247 0.832 . . . . 71.41 113.247 -174.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.478 ' O ' HG21 ' A' ' 63' ' ' VAL . . . 179.93 165.12 33.31 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.755 -0.736 . . . . 73.23 113.438 -178.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -61.38 97.29 0.07 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.181 0.515 . . . . 64.4 111.015 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 144.1 -31.2 1.86 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-N 115.848 -0.614 . . . . 62.53 112.716 -177.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.478 HG21 ' O ' ' A' ' 60' ' ' GLY . 18.2 m -80.66 156.39 73.0 Favored Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 122.466 -0.432 . . . . 55.23 111.154 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 63' ' ' VAL . 50.4 Cg_endo -67.41 167.02 21.68 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.651 2.234 . . . . 73.12 113.722 -178.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.87 97.31 1.62 Allowed Glycine 0 CA--C 1.525 0.717 0 CA-C-N 115.979 -0.555 . . . . 52.21 112.605 176.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 70.5 mt -88.58 164.18 15.51 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.934 0.397 . . . . 71.15 111.597 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.421 ' CD1' HD12 ' A' ' 45' ' ' LEU . 72.8 m95 -131.45 154.04 49.11 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.856 0.36 . . . . 74.35 111.351 -178.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.7 ttt85 -165.3 117.55 1.16 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.551 -0.295 . . . . 74.31 110.992 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 54' ' ' LEU . 4.2 pp -64.21 155.29 32.29 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.953 0.406 . . . . 71.45 111.661 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.435 ' H ' HD23 ' A' ' 70' ' ' LEU . 1.8 pt? -123.06 13.64 9.76 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.035 0.445 . . . . 74.23 111.184 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.746 -0.645 . . . . 74.24 110.782 179.895 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.522 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 120.85 0.357 . . . . 75.32 111.563 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 84.3 p -161.33 167.12 26.43 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.336 -0.393 . . . . 54.24 110.913 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -68.53 101.09 1.2 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.201 0.524 . . . . 73.54 111.309 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.6 t -81.0 24.83 0.49 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.131 0.419 . . . . 75.45 112.131 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.634 HG12 HD12 ' A' ' 36' ' ' LEU . 9.5 tp -55.79 -36.19 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.314 0.487 . . . . 73.35 112.314 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.7 t -58.46 -50.26 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.853 0.359 . . . . 73.34 111.509 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.9 m -60.88 -40.02 91.43 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.937 0.398 . . . . 74.41 111.041 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.603 ' HB2' ' HZ3' ' A' ' 8' ' ' LYS . 4.4 ttmp? -58.93 -48.77 80.3 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.34 -0.391 . . . . 74.23 111.095 177.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.9 mt -56.47 -48.11 80.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.421 -0.354 . . . . 75.3 111.586 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.5 mt -59.14 -43.27 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.079 0.466 . . . . 73.33 111.018 176.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.4 t -60.52 -40.02 89.92 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.948 -0.569 . . . . 71.21 111.628 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 8' ' ' LYS . 86.8 mt -61.08 -51.06 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.093 0.473 . . . . 55.21 111.185 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.6 t -57.97 -51.01 76.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.105 0.478 . . . . 61.01 111.008 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -54.07 -47.38 71.73 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.998 -0.546 . . . . 72.24 111.349 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -57.52 -53.49 57.56 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.145 -0.479 . . . . 54.53 111.785 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -62.69 -27.17 69.06 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.568 -0.287 . . . . 75.31 111.71 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -80.22 -26.79 38.94 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 122.16 -0.337 . . . . 75.01 111.705 175.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -64.59 -26.11 68.26 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.225 0.536 . . . . 62.12 109.856 170.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.0 mmm -78.43 -60.18 2.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.708 -0.678 . . . . 74.23 111.548 173.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -94.13 -55.86 3.05 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.771 0.656 . . . . 54.22 112.771 -176.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.3 t70 68.47 -69.08 0.16 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.455 0.702 . . . . 74.03 111.834 -176.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.44 -35.34 84.86 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.983 -0.627 . . . . 75.31 112.812 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.38 129.37 33.58 Favored Pre-proline 0 CA--C 1.541 0.63 0 O-C-N 122.618 -0.343 . . . . 74.44 111.069 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.04 164.14 33.1 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.421 2.08 . . . . 72.34 113.251 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.4 t -84.85 145.64 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.285 -0.416 . . . . 71.42 110.742 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -90.06 141.16 28.94 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.706 0.289 . . . . 54.51 110.788 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.1 m -52.01 -38.31 56.39 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.851 0.357 . . . . 60.35 111.873 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -63.35 -47.56 81.64 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 122.37 -0.206 . . . . 73.35 111.552 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.22 -52.5 51.95 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.002 0.429 . . . . 70.34 111.196 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.542 HG22 HD22 ' A' ' 45' ' ' LEU . 58.3 mt -58.44 -53.89 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 115.764 -0.653 . . . . 74.54 111.742 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.486 ' HA ' HG23 ' A' ' 41' ' ' VAL . . . -60.85 -45.43 94.55 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.096 0.406 . . . . 72.53 112.096 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.16 -40.4 96.05 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.088 -0.506 . . . . 74.34 111.595 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.451 ' HB3' HD11 ' A' ' 12' ' ' ILE . . . -71.97 -38.29 69.76 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.877 0.37 . . . . 39.03 111.324 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.82 -35.27 72.41 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.287 -0.415 . . . . 62.54 111.659 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.97 23.2 42.4 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.394 -0.432 . . . . 65.22 113.509 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.634 HD12 HG12 ' A' ' 5' ' ' ILE . 85.7 mt -113.24 171.67 7.41 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.964 0.412 . . . . 72.0 111.705 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.5 m -71.65 144.36 49.42 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.261 -0.427 . . . . 71.02 111.404 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.1 mm -50.85 -58.22 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.35 0.5 . . . . 63.31 112.35 -174.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.461 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 47.8 p90 -54.02 -40.69 67.26 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.158 0.429 . . . . 65.3 112.158 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -65.43 -47.3 76.7 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.169 0.509 . . . . 65.14 111.016 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 31' ' ' ALA . 60.9 t -58.7 -44.29 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.147 -0.479 . . . . 72.5 111.024 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -58.52 -33.69 70.14 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.616 -0.265 . . . . 64.05 111.686 178.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.537 ' O ' ' HG3' ' A' ' 47' ' ' GLN . 95.1 mt -60.07 -52.58 64.74 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 110.167 -0.309 . . . . 65.51 110.167 175.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -56.83 -46.0 81.96 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.115 0.484 . . . . 75.11 111.256 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.542 HD22 HG22 ' A' ' 30' ' ' ILE . 92.9 mt -59.92 -46.6 88.84 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.089 -0.505 . . . . 73.43 111.918 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -67.29 -37.18 83.0 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.509 0.195 . . . . 73.41 111.34 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.537 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 96.2 mt-30 -59.66 -45.19 92.8 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.064 0.459 . . . . 63.35 110.602 174.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.3 mt -61.42 -34.13 74.87 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.379 -0.373 . . . . 74.51 111.416 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.526 ' HD2' ' HA ' ' A' ' 55' ' ' GLU . 46.5 t-80 -70.56 -28.71 65.11 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.149 0.499 . . . . 73.2 111.015 174.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -79.65 -41.66 26.48 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.143 -0.481 . . . . 73.43 111.765 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.6 m -77.79 -24.71 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 111.914 0.339 . . . . 73.13 111.914 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.6 69.02 0.61 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.098 -0.572 . . . . 62.54 113.12 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.4 t -141.36 -60.92 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.111 0.481 . . . . 74.44 110.787 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.656 HD21 ' HB3' ' A' ' 69' ' ' LEU . 80.9 mt -103.98 145.75 29.7 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.148 -0.478 . . . . 74.23 111.962 -177.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.526 ' HA ' ' HD2' ' A' ' 49' ' ' HIS . 12.0 tp10 -108.53 141.11 40.91 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.029 0.442 . . . . 73.33 110.838 172.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? -89.96 94.87 9.97 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.144 0.497 . . . . 73.23 111.495 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.566 ' O ' ' HB2' ' A' ' 58' ' ' ASN . 42.2 t -77.68 85.89 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 120.967 0.413 . . . . 75.03 110.835 177.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.566 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 66.1 t30 162.4 -177.86 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.221 1.008 . . . . 73.0 108.994 -178.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.431 ' HB3' HG21 ' A' ' 63' ' ' VAL . . . -67.83 -172.04 0.25 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 110.204 -0.295 . . . . 40.1 110.204 166.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -147.09 -158.47 7.84 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.159 -1.02 . . . . 52.41 114.009 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm 72.0 7.96 5.89 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.327 0.651 . . . . 61.3 112.377 176.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.57 -43.96 0.55 Allowed Glycine 0 CA--C 1.53 0.975 0 C-N-CA 120.55 -0.833 . . . . 71.21 113.933 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.431 HG21 ' HB3' ' A' ' 59' ' ' ALA . 33.7 m -54.3 151.58 13.28 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 122.331 0.252 . . . . 62.02 111.536 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -52.83 -69.34 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.089 2.526 . . . . 74.25 113.819 -172.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.414 ' HA2' ' CB ' ' A' ' 58' ' ' ASN . . . 84.94 151.58 14.74 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.699 -0.762 . . . . 75.42 114.164 177.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 66' ' ' LEU . 5.9 mp -110.06 133.55 53.09 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 110.025 -0.361 . . . . 62.43 110.025 174.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.433 ' CD1' HD11 ' A' ' 45' ' ' LEU . 58.2 m95 -102.23 133.93 46.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.469 0.652 . . . . 73.2 111.906 -172.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -141.31 114.47 8.66 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.778 -0.646 . . . . 73.12 111.088 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.656 ' HB3' HD21 ' A' ' 54' ' ' LEU . 4.2 pp -67.76 151.58 46.99 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.426 0.631 . . . . 73.12 111.9 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.476 HD22 ' HB2' ' A' ' 55' ' ' GLU . 1.7 pt? -139.56 159.66 41.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.39 -0.823 . . . . 72.1 110.648 -177.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.875 -0.583 . . . . 70.44 110.311 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtp . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 120.929 0.395 . . . . 53.24 111.594 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.0 m -81.18 -47.78 12.98 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.159 0.504 . . . . 73.42 109.829 172.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 59.92 20.92 9.91 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.147 0.795 . . . . 62.45 113.147 167.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.5 m 64.5 21.19 12.39 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.187 0.44 . . . . 73.42 112.187 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.9 tp -55.03 -27.08 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 112.054 0.39 . . . . 72.52 112.054 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.451 HG12 HD21 ' A' ' 48' ' ' LEU . 61.6 t -53.27 -49.53 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.402 -0.363 . . . . 72.45 111.955 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.0 m -55.45 -46.2 76.81 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.898 0.38 . . . . 74.33 111.408 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.493 ' O ' HG13 ' A' ' 12' ' ' ILE . 53.8 tptt -55.99 -50.61 70.37 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.366 -0.379 . . . . 64.45 111.49 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.3 mt -57.19 -42.33 79.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.312 -0.404 . . . . 65.53 111.562 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.2 mt -61.56 -46.06 97.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 121.003 0.43 . . . . 71.44 110.903 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.8 m -60.75 -32.67 71.96 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.348 -0.387 . . . . 71.12 111.506 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.516 HG22 ' HA ' ' A' ' 30' ' ' ILE . 96.4 mt -67.21 -41.32 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.788 0.328 . . . . 74.4 111.55 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.429 ' HA ' HG23 ' A' ' 25' ' ' VAL . 59.5 t -59.95 -41.23 85.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 121.207 0.527 . . . . 74.25 110.714 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -64.56 -48.15 76.09 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.058 0.456 . . . . 61.32 110.514 173.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -53.06 -56.3 17.21 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.624 -0.716 . . . . 74.04 112.25 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -67.48 -39.14 85.23 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.511 0.559 . . . . 61.35 112.511 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -74.21 -20.33 60.22 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.406 -0.518 . . . . 72.42 110.71 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -71.51 -24.53 61.98 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.497 0.665 . . . . 74.13 109.514 172.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.1 mmt -79.64 -47.89 14.65 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.871 -0.604 . . . . 75.12 111.504 169.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -98.56 84.69 3.21 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.052 0.453 . . . . 75.3 110.969 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -57.05 -37.34 71.66 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.397 0.518 . . . . 63.0 112.397 -177.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -108.11 20.14 31.33 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.244 -0.503 . . . . 74.11 113.868 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.412 ' HA ' ' HD2' ' A' ' 24' ' ' PRO . . . -158.39 108.33 1.68 Allowed Pre-proline 0 N--CA 1.468 0.459 0 CA-C-N 117.053 0.427 . . . . 62.22 111.785 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.505 ' HB3' ' HB2' ' A' ' 68' ' ' ARG . 1.5 Cg_endo -48.34 177.39 0.02 OUTLIER 'Trans proline' 0 CA--C 1.552 1.414 0 C-N-CA 122.954 2.436 . . . . 64.23 114.501 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.429 HG23 ' HA ' ' A' ' 13' ' ' VAL . 44.1 t -79.57 152.93 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 112.824 0.675 . . . . 72.04 112.824 -169.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.626 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 8.2 mptt -105.86 146.09 30.38 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.715 -0.675 . . . . 54.44 110.082 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.4 m -53.71 -44.34 69.77 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.652 0.612 . . . . 55.3 112.652 -176.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -59.47 -43.58 93.2 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 111.7 0.259 . . . . 72.13 111.7 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 2.8 m-20 -56.46 -39.62 73.47 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.039 0.447 . . . . 72.34 112.043 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.596 HG22 HD23 ' A' ' 45' ' ' LEU . 61.5 mt -68.94 -44.51 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.954 0.406 . . . . 71.24 111.289 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.474 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -61.82 -35.28 77.76 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.104 0.478 . . . . 53.3 111.162 175.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -65.58 -55.59 16.88 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.658 -0.701 . . . . 73.41 111.737 178.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.39 -37.99 87.9 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.762 0.653 . . . . 42.24 112.762 -176.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.48 -28.91 30.89 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 111.974 0.361 . . . . 73.05 111.974 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.64 39.05 22.6 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.066 -0.587 . . . . 53.44 112.586 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.5 mt -117.43 172.71 7.15 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 122.658 -0.319 . . . . 65.44 111.236 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.6 m -78.99 148.14 32.67 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.663 -0.244 . . . . 74.31 111.439 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.6 mm -52.66 -58.56 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 112.407 0.521 . . . . 75.22 112.407 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -57.05 -41.83 79.4 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.959 0.409 . . . . 74.12 111.567 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -56.42 -49.64 73.97 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.462 0.649 . . . . 61.33 111.068 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.474 HG21 ' HA ' ' A' ' 31' ' ' ALA . 64.2 t -65.11 -39.47 85.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.838 -0.619 . . . . 72.31 111.352 178.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.4 mmm-85 -50.94 -48.17 60.95 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.889 0.376 . . . . 71.31 111.315 175.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.5 mt -59.01 -51.59 69.39 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.183 -0.462 . . . . 75.22 111.091 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -60.2 -45.15 94.15 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.4 0.519 . . . . 75.14 112.4 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.596 HD23 HG22 ' A' ' 30' ' ' ILE . 91.0 mt -64.6 -52.77 55.79 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.175 0.512 . . . . 73.42 111.515 -177.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -66.34 -29.22 69.37 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.101 -0.5 . . . . 74.45 111.993 -177.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -74.56 -37.84 62.86 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 122.104 -0.373 . . . . 71.03 111.052 172.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.451 HD21 HG12 ' A' ' 6' ' ' VAL . 62.1 mt -64.37 -26.54 68.51 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.883 0.373 . . . . 71.02 110.843 173.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -72.86 -40.35 65.75 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.887 0.375 . . . . 74.1 110.69 171.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.19 -38.2 88.21 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 116.216 -0.447 . . . . 72.43 111.744 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.509 HG23 HG22 ' A' ' 53' ' ' VAL . 35.4 m -81.25 -12.09 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 112.218 0.451 . . . . 72.5 112.218 177.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.18 24.93 13.43 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 120.986 -0.626 . . . . 73.4 114.62 174.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.509 HG22 HG23 ' A' ' 51' ' ' VAL . 64.4 t -91.71 -56.59 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 117.493 0.647 . . . . 65.25 111.332 175.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 61.5 mt -105.13 125.88 51.46 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.079 -0.509 . . . . 73.23 111.498 -176.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -93.87 140.19 29.98 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.887 0.375 . . . . 74.5 111.703 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 59' ' ' ALA . 97.2 mttt -88.62 94.01 9.75 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.97 0.414 . . . . 72.32 110.58 175.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.62 132.53 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.666 -0.243 . . . . 74.45 110.461 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 63.6 t30 73.39 24.4 2.35 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.316 0.579 . . . . 74.34 111.144 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 56' ' ' LYS . . . -74.37 -17.63 60.79 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.204 0.446 . . . . 53.53 112.204 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.35 -94.21 0.01 OUTLIER Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.589 -0.339 . . . . 71.42 113.427 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -127.46 38.91 3.98 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.945 0.402 . . . . 73.24 111.009 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.11 42.5 1.28 Allowed Glycine 0 CA--C 1.53 1.03 0 N-CA-C 114.561 0.585 . . . . 73.01 114.561 173.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.7 m -111.67 146.87 35.59 Favored Pre-proline 0 N--CA 1.472 0.664 0 CA-C-N 117.491 0.646 . . . . 74.04 111.225 175.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.75 95.25 0.4 Allowed 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.391 2.061 . . . . 72.32 112.168 174.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -99.27 -134.94 8.69 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.19 -0.528 . . . . 75.41 113.341 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 91.4 mt -97.27 132.57 42.89 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.043 0.449 . . . . 71.3 111.764 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -84.4 125.42 32.32 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.563 0.697 . . . . 73.2 112.614 -175.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.505 ' HB2' ' HB3' ' A' ' 24' ' ' PRO . 74.0 ttt180 -139.97 117.78 11.68 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.897 -0.592 . . . . 72.5 110.768 176.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -66.35 152.9 44.05 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.865 0.364 . . . . 75.34 111.12 178.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.6 mt -80.69 124.76 29.29 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.91 0.386 . . . . 74.01 111.826 -176.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.396 -0.811 . . . . 74.4 111.324 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 120.514 0.197 . . . . 73.25 110.847 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.7 p -57.59 99.61 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.16 0.505 . . . . 74.34 111.485 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.76 -33.48 71.73 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.77 -0.65 . . . . 73.23 111.166 177.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.8 t -75.35 87.89 2.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.978 -0.556 . . . . 74.25 112.007 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.541 HD11 HD12 ' A' ' 36' ' ' LEU . 14.3 tt -59.63 -24.84 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.728 0.775 . . . . 72.21 109.917 171.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.549 HG12 HD13 ' A' ' 48' ' ' LEU . 92.8 t -56.83 -49.35 79.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.085 -0.962 . . . . 72.22 111.25 173.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.4 m -58.62 -33.3 69.88 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.133 0.492 . . . . 63.3 111.443 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.437 ' O ' HG13 ' A' ' 12' ' ' ILE . 58.8 tttp -62.58 -49.82 73.73 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.056 0.455 . . . . 61.31 110.297 174.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.487 ' HA ' HD13 ' A' ' 12' ' ' ILE . 72.1 mt -58.34 -43.53 86.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.98 -0.554 . . . . 52.42 111.332 178.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 73.6 mt -57.5 -42.08 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.911 0.386 . . . . 64.45 111.068 176.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.9 m -64.0 -34.16 77.37 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.252 -0.431 . . . . 64.12 111.28 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.487 HD13 ' HA ' ' A' ' 9' ' ' ILE . 83.6 mt -66.39 -46.01 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.918 0.39 . . . . 62.42 110.98 176.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.54 -45.58 96.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.054 0.454 . . . . 74.02 110.768 175.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -55.91 -49.6 73.01 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.009 -0.541 . . . . 64.11 111.165 175.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -54.63 -56.34 20.02 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.682 -0.69 . . . . 64.03 111.522 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 35.9 mmt-85 -57.53 -40.11 78.08 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.27 -0.423 . . . . 70.11 111.907 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.49 ' O ' ' N ' ' A' ' 21' ' ' ASP . 59.9 mt-30 -61.35 -47.36 86.25 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.245 -0.284 . . . . 72.52 110.989 175.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -57.93 -27.02 62.99 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.293 0.479 . . . . 70.24 112.293 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 47.9 mtt -55.78 -41.71 74.47 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.164 0.431 . . . . 71.44 112.164 174.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.491 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 30.7 t70 -128.63 8.58 5.86 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.021 0.439 . . . . 60.2 111.667 -176.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' A' ' 17' ' ' GLN . 31.9 t70 54.73 97.24 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.398 0.679 . . . . 71.23 112.418 -176.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.17 -13.6 66.64 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 114.465 0.546 . . . . 44.31 114.465 176.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.491 ' HB1' ' HB3' ' A' ' 20' ' ' ASP . . . -56.42 120.58 36.86 Favored Pre-proline 0 N--CA 1.473 0.691 0 N-CA-C 112.493 0.553 . . . . 52.12 112.493 -177.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.517 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 72.6 Cg_endo -75.1 152.91 40.88 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.62 2.213 . . . . 71.41 112.813 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.1 t -117.13 150.86 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 O-C-N 122.301 -0.249 . . . . 71.2 111.566 -175.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.448 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 9.6 mptt -87.91 158.14 18.77 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.894 0.378 . . . . 71.51 110.803 176.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.495 HG22 ' HB2' ' A' ' 42' ' ' ARG . 56.0 m -56.38 -47.29 79.22 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.903 0.382 . . . . 72.22 111.814 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.48 -37.78 87.28 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.759 0.314 . . . . 64.5 111.264 -177.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 3.5 m-20 -64.23 -44.75 90.88 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.81 0.338 . . . . 74.35 111.413 178.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.65 -47.41 91.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 116.193 -0.458 . . . . 73.3 111.014 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.495 ' HA ' HG23 ' A' ' 41' ' ' VAL . . . -57.81 -41.98 83.29 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.04 0.448 . . . . 52.44 111.331 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -62.95 -47.54 82.78 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.043 -0.526 . . . . 73.44 111.53 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.43 -26.64 66.51 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.914 0.388 . . . . 71.15 111.994 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.73 -22.04 22.39 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.052 0.39 . . . . 73.33 112.052 178.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.36 34.21 54.97 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.213 -0.518 . . . . 75.3 112.507 -174.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.541 HD12 HD11 ' A' ' 5' ' ' ILE . 95.7 mt -115.34 -178.85 3.48 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.118 0.485 . . . . 65.13 111.624 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.4 m -84.85 141.86 30.15 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.853 -0.612 . . . . 74.0 111.077 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.3 mm -55.61 -58.51 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.578 0.584 . . . . 74.34 112.578 -173.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.459 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 41.5 t80 -60.44 -40.44 91.11 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.818 0.342 . . . . 73.12 111.453 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.459 ' HG3' ' HE2' ' A' ' 44' ' ' TYR . 5.8 tp-100 -57.45 -52.5 65.12 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.231 0.539 . . . . 71.44 111.149 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.495 HG23 ' HA ' ' A' ' 31' ' ' ALA . 71.6 t -58.54 -45.15 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.005 -0.543 . . . . 73.33 111.345 176.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.495 ' HB2' HG22 ' A' ' 27' ' ' THR . 76.5 ttt180 -51.23 -39.32 56.36 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.116 -0.493 . . . . 71.32 111.524 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 93.4 mt -65.49 -44.72 86.2 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.365 -0.38 . . . . 64.14 111.547 177.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.459 ' HE2' ' HG3' ' A' ' 40' ' ' GLN . 69.3 m-85 -62.37 -40.35 96.15 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.246 0.546 . . . . 74.21 111.126 177.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.488 HD11 ' CD1' ' A' ' 67' ' ' TRP . 81.9 mt -65.39 -45.14 85.18 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.247 -0.433 . . . . 73.21 111.452 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -66.1 -38.86 89.3 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.578 0.584 . . . . 72.12 112.578 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 20.9 pt20 -66.67 -36.63 83.0 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 120.779 -0.369 . . . . 74.32 110.659 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.549 HD13 HG12 ' A' ' 6' ' ' VAL . 85.2 mt -68.12 -38.86 82.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.18 0.514 . . . . 75.01 110.842 173.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -68.28 -21.56 64.78 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.994 -0.548 . . . . 72.41 111.029 175.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -83.4 -50.9 7.87 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.22 -0.445 . . . . 72.23 111.603 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.2 m -70.72 -31.11 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 112.776 0.658 . . . . 73.22 112.776 -177.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 116.89 43.89 0.6 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 120.836 -0.697 . . . . 74.23 114.093 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.29 -38.06 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.081 0.467 . . . . 75.23 111.293 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.8 mt -111.28 136.98 49.6 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.938 0.399 . . . . 64.41 111.629 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -103.32 136.14 43.64 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.116 -0.493 . . . . 64.32 109.804 172.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -94.0 144.13 25.74 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.137 0.494 . . . . 64.54 110.99 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.581 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 16.2 t -103.77 142.9 16.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.36 -0.608 . . . . 63.31 109.36 173.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 71.2 m-20 76.44 163.34 0.24 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.149 0.58 . . . . 70.23 111.367 -174.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.27 -17.57 64.83 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.041 0.756 . . . . 65.11 113.041 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.07 -37.86 2.38 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 120.844 -0.693 . . . . 64.44 113.205 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -75.97 119.83 20.48 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 122.514 -0.404 . . . . 74.21 110.673 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.62 -60.71 3.29 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.163 -0.541 . . . . 74.52 113.041 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.4 m -75.86 152.44 84.75 Favored Pre-proline 0 CA--C 1.544 0.742 0 O-C-N 122.627 -0.337 . . . . 65.52 111.42 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -66.77 119.15 6.15 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.514 2.143 . . . . 62.31 113.207 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.21 108.46 2.52 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.021 -0.609 . . . . 74.5 112.659 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.581 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 49.5 mt -91.05 143.55 26.58 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.944 0.402 . . . . 63.22 111.042 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.488 ' CD1' HD11 ' A' ' 45' ' ' LEU . 49.8 m95 -106.3 127.68 53.43 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.887 0.375 . . . . 73.24 111.869 -176.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -140.58 121.67 14.71 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.215 0.531 . . . . 74.24 110.945 173.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 pp -69.23 161.23 29.63 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.949 0.404 . . . . 75.13 111.6 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.493 HD22 ' N ' ' A' ' 70' ' ' LEU . 1.5 pt? -138.9 34.48 2.17 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.313 -0.403 . . . . 73.55 111.451 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 . . . . . 0 C--O 1.254 1.329 0 CA-C-O 118.767 -0.635 . . . . 53.31 111.865 177.236 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtt . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 120.871 0.367 . . . . 71.31 111.872 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 91.2 p -92.91 -20.1 20.98 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.012 0.434 . . . . 63.43 110.729 174.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -63.69 137.06 57.93 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.884 -0.598 . . . . 72.21 112.077 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.8 m -75.05 65.0 1.42 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.06 0.457 . . . . 73.11 111.005 176.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.435 HG12 HD12 ' A' ' 36' ' ' LEU . 8.6 tp -60.7 -38.53 78.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.206 -0.452 . . . . 65.1 111.924 -177.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.7 t -58.81 -47.13 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.274 0.559 . . . . 70.31 110.932 178.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 m -61.49 -40.2 93.71 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.93 -0.577 . . . . 70.22 110.95 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.524 ' O ' HG13 ' A' ' 12' ' ' ILE . 88.5 tttt -61.14 -46.47 90.42 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.139 -0.482 . . . . 74.32 110.893 177.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.436 ' O ' HG21 ' A' ' 13' ' ' VAL . 78.2 mt -55.21 -49.28 73.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.88 0.372 . . . . 75.5 111.229 176.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 69.8 mt -59.09 -40.63 81.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.106 0.479 . . . . 74.43 111.02 176.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.3 t -63.38 -35.7 81.27 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.304 -0.407 . . . . 73.53 111.194 176.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 8' ' ' LYS . 86.0 mt -65.51 -44.14 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-O 121.245 0.545 . . . . 73.31 110.449 175.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.436 HG21 ' O ' ' A' ' 9' ' ' ILE . 95.5 t -56.92 -46.92 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 115.898 -0.592 . . . . 73.42 111.063 176.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -61.33 -49.15 78.16 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.208 -0.451 . . . . 72.4 110.96 176.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -54.47 -53.36 55.27 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.902 -0.59 . . . . 65.14 111.633 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.509 ' HG3' HG12 ' A' ' 25' ' ' VAL . 5.7 mmp_? -56.12 -42.22 76.51 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.239 -0.437 . . . . 75.11 112.128 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -70.25 -31.09 68.32 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.728 0.299 . . . . 71.3 111.692 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -60.68 -33.42 72.82 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.119 0.485 . . . . 71.01 110.825 173.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 95.7 mmm -61.59 -34.87 76.36 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.004 -0.544 . . . . 74.2 111.955 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -159.52 110.17 1.97 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.887 0.375 . . . . 63.55 110.68 177.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -59.85 -17.7 38.5 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.56 0.578 . . . . 73.14 112.56 -178.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.9 12.74 59.2 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 120.985 -0.626 . . . . 73.21 113.329 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . . . -122.98 139.8 32.17 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 117.06 0.43 . . . . 65.24 112.144 -177.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 23' ' ' ALA . 9.8 Cg_endo -87.95 174.3 4.7 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.041 2.494 . . . . 71.43 112.495 175.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.509 HG12 ' HG3' ' A' ' 16' ' ' ARG . 21.2 t -101.93 135.86 36.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.372 -0.376 . . . . 51.24 111.212 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.42 143.05 27.12 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.621 0.248 . . . . 74.45 111.025 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 67.9 m -55.97 -37.26 68.82 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.168 0.509 . . . . 74.34 110.79 173.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.1 mmm-85 -60.55 -55.8 28.98 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.016 -0.538 . . . . 65.34 111.196 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -51.62 -44.92 63.07 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.99 -0.55 . . . . 71.54 111.643 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.0 mt -61.83 -45.39 98.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.385 -0.37 . . . . 75.51 111.306 177.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.55 -31.92 71.01 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.896 0.379 . . . . 62.43 111.647 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -67.46 -51.08 55.71 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.231 -0.441 . . . . 74.0 111.362 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.48 -26.97 60.36 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.231 0.456 . . . . 74.12 112.231 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.67 -28.49 23.12 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.082 0.401 . . . . 63.14 112.082 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.02 32.58 60.49 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.043 -0.598 . . . . 42.45 113.317 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.435 HD12 HG12 ' A' ' 5' ' ' ILE . 88.7 mt -115.59 166.57 11.77 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.916 0.388 . . . . 74.33 111.042 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.402 ' O ' HG21 ' A' ' 41' ' ' VAL . 97.6 p -70.08 143.72 52.35 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.768 0.318 . . . . 75.33 111.277 178.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.5 mm -49.15 -50.08 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 112.366 0.506 . . . . 75.41 112.366 -177.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -62.67 -42.82 99.82 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.719 0.295 . . . . 73.33 111.405 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -63.97 -43.85 94.49 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.901 0.382 . . . . 74.5 111.077 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 37' ' ' SER . 81.9 t -57.84 -42.93 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.975 0.417 . . . . 74.34 110.539 175.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -55.84 -40.44 72.85 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.025 -0.534 . . . . 73.43 111.429 175.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.1 mt -59.34 -44.52 92.64 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.805 0.336 . . . . 71.41 111.17 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -65.37 -53.95 35.96 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.364 -0.38 . . . . 74.45 111.797 177.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.467 HD12 ' CD1' ' A' ' 67' ' ' TRP . 89.5 mt -56.84 -38.3 72.46 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.101 0.477 . . . . 63.25 111.705 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -61.64 -53.66 53.24 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.956 -0.566 . . . . 73.44 110.985 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -67.79 -39.03 84.08 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 111.804 0.298 . . . . 73.32 111.804 -178.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.9 mt -61.01 -35.26 76.4 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.214 0.531 . . . . 74.2 110.782 173.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -67.07 -46.23 74.93 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.254 -0.43 . . . . 73.12 111.517 174.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -66.09 -41.61 90.44 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.271 0.471 . . . . 73.34 112.271 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.489 HG21 HG22 ' A' ' 53' ' ' VAL . 34.4 m -71.15 -17.86 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 112.14 0.422 . . . . 61.31 112.14 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.65 29.19 5.1 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 120.836 -0.697 . . . . 74.32 114.274 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.489 HG22 HG21 ' A' ' 51' ' ' VAL . 97.3 t -94.87 -49.74 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 117.369 0.584 . . . . 75.31 110.895 174.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.8 mt -112.54 138.76 48.84 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.09 0.472 . . . . 75.31 111.866 -178.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.477 ' HB3' ' HG3' ' A' ' 68' ' ' ARG . 33.7 tt0 -91.76 146.3 23.87 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.382 -0.372 . . . . 64.13 110.171 175.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -87.68 138.62 31.31 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.17 0.433 . . . . 74.41 112.17 -174.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 62.1 t -132.49 108.75 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.922 0.392 . . . . 72.43 110.486 172.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.5 t30 60.74 93.79 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.211 0.529 . . . . 74.12 112.167 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.8 ' HA ' HG22 ' A' ' 63' ' ' VAL . . . -135.03 163.51 29.71 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.79 0.329 . . . . 75.43 111.82 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 137.37 -124.16 2.97 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 120.828 -0.701 . . . . 62.43 113.926 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -78.71 103.27 8.54 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.501 0.556 . . . . 74.41 112.501 -173.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 50.94 57.22 11.38 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 113.974 0.35 . . . . 72.44 113.974 176.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.8 HG22 ' HA ' ' A' ' 59' ' ' ALA . 32.6 m -100.93 158.81 31.11 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.625 -0.338 . . . . 74.52 111.618 -178.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.41 -17.11 39.34 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.157 1.905 . . . . 64.44 112.189 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.57 96.25 0.03 OUTLIER Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.849 -0.614 . . . . 61.44 113.64 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 94.3 mt -98.29 130.86 44.98 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.976 0.417 . . . . 65.44 110.304 174.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.467 ' CD1' HD12 ' A' ' 45' ' ' LEU . 57.9 m95 -128.39 146.77 50.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.249 0.547 . . . . 74.1 111.844 -175.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.477 ' HG3' ' HB3' ' A' ' 55' ' ' GLU . 5.8 ptm180 -138.74 172.3 13.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.929 -0.578 . . . . 73.45 110.029 174.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pp -108.7 168.92 8.99 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.132 -0.355 . . . . 74.24 110.867 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.5 mt -69.71 78.53 0.44 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.083 0.468 . . . . 73.15 111.707 -177.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 . . . . . 0 C--O 1.257 1.45 0 CA-C-O 118.843 -0.598 . . . . 75.44 111.076 -179.953 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.747 0.308 . . . . 65.51 110.563 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.1 p -72.55 106.56 4.66 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.261 0.553 . . . . 71.45 112.422 -174.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -104.84 108.43 19.91 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.986 -0.552 . . . . 74.43 111.235 175.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.3 t -176.56 111.56 0.09 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.012 0.435 . . . . 72.1 112.028 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.4 mm -76.15 -35.68 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 121.058 0.456 . . . . 71.42 110.386 176.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.1 t -57.73 -48.11 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.018 0.437 . . . . 54.54 110.91 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 78.0 m -61.33 -35.47 77.49 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.412 -0.358 . . . . 53.42 110.982 176.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.51 ' O ' HG13 ' A' ' 12' ' ' ILE . 86.9 tttt -60.28 -47.91 83.99 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.433 -0.349 . . . . 72.22 110.612 176.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 68.1 mt -57.32 -48.47 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.308 -0.405 . . . . 61.43 111.371 176.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.4 mt -57.21 -40.47 73.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.136 0.493 . . . . 64.03 110.993 176.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.6 m -61.34 -45.33 94.87 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.087 -0.506 . . . . 70.34 111.022 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.535 ' O ' ' HG2' ' A' ' 16' ' ' ARG . 83.1 mt -57.94 -56.03 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.17 -0.468 . . . . 72.12 111.563 179.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.52 HG11 HD23 ' A' ' 69' ' ' LEU . 49.0 t -56.82 -50.81 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.847 0.356 . . . . 63.13 111.602 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -57.11 -45.67 83.24 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.089 0.471 . . . . 65.33 111.219 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -60.02 -40.48 89.45 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.291 -0.413 . . . . 72.01 111.419 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 12' ' ' ILE . 23.4 mmm-85 -62.23 -39.48 92.95 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 122.178 -0.326 . . . . 65.01 110.503 175.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -65.69 -26.09 67.61 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.057 0.456 . . . . 50.23 111.556 175.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -78.05 -18.98 55.15 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.846 0.355 . . . . 65.42 111.008 173.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 94.8 mmm -81.05 -35.64 31.55 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.932 0.396 . . . . 74.32 111.103 174.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.559 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 18.6 t70 -142.98 138.75 30.29 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.457 -0.338 . . . . 65.3 110.913 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -61.79 -11.3 11.77 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.435 0.902 . . . . 73.52 113.435 -175.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.456 ' O ' ' HD3' ' A' ' 24' ' ' PRO . . . -150.08 51.59 0.53 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.973 -0.632 . . . . 72.42 112.954 177.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.559 ' HB1' ' HB3' ' A' ' 20' ' ' ASP . . . -83.8 109.49 18.87 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.567 0.58 . . . . 37.81 112.567 -177.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.544 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 88.9 Cg_endo -79.95 108.05 2.17 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.987 1.791 . . . . 63.42 111.083 171.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.408 HG23 ' HA ' ' A' ' 13' ' ' VAL . 14.6 t -79.02 144.3 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.414 0.626 . . . . 60.44 111.528 -172.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.598 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -95.36 138.82 32.52 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.106 -0.497 . . . . 73.01 111.479 -171.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.5 HG23 ' HD2' ' A' ' 42' ' ' ARG . 86.9 m -52.68 -38.81 61.15 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.049 0.452 . . . . 63.01 111.163 175.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -60.54 -58.52 8.14 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.054 -0.521 . . . . 71.03 111.016 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -51.17 -46.31 62.04 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.128 0.489 . . . . 64.4 111.312 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.5 mt -60.48 -44.48 96.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.117 -0.492 . . . . 75.22 111.505 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.59 -48.01 83.33 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.789 0.328 . . . . 72.13 111.615 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.67 -52.75 63.06 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.39 -0.368 . . . . 64.25 111.881 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.37 -37.7 87.8 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.366 0.506 . . . . 74.05 112.366 -178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.24 -35.85 58.79 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 111.841 0.312 . . . . 74.03 111.841 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.26 33.14 8.27 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.284 -0.484 . . . . 51.11 112.706 -176.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.8 mt -120.11 171.77 8.23 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.2 0.524 . . . . 74.33 111.708 -177.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.478 ' O ' HG22 ' A' ' 41' ' ' VAL . 39.7 m -81.84 147.28 29.43 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.985 -0.552 . . . . 62.03 111.08 178.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.481 ' O ' ' HD3' ' A' ' 42' ' ' ARG . 47.5 mm -51.17 -58.59 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 112.904 0.705 . . . . 75.32 112.904 -175.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -62.42 -32.1 72.89 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.994 0.426 . . . . 75.32 111.336 -178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -61.32 -45.26 95.17 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.378 0.609 . . . . 74.22 110.378 175.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 37' ' ' SER . 71.3 t -62.45 -36.8 76.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 115.842 -0.617 . . . . 74.15 111.658 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.5 ' HD2' HG23 ' A' ' 27' ' ' THR . 0.3 OUTLIER -47.29 -53.07 14.46 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 121.128 0.489 . . . . 73.42 111.179 173.348 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.403 ' O ' ' HG3' ' A' ' 47' ' ' GLN . 74.1 mt -60.06 -48.67 80.74 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.617 -0.72 . . . . 73.44 111.516 -177.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -57.42 -50.04 74.29 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.373 -0.376 . . . . 74.42 111.782 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 67.8 mt -62.96 -46.61 86.89 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.872 0.368 . . . . 60.33 111.862 -176.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -61.11 -41.77 97.3 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.544 -0.298 . . . . 74.24 111.732 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 87.3 mt-30 -65.48 -40.02 92.62 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.755 0.312 . . . . 74.45 111.325 176.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.0 -30.48 70.98 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.882 0.373 . . . . 74.31 111.127 175.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -65.09 -44.81 87.63 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.889 0.376 . . . . 75.31 110.946 173.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -62.21 -48.03 81.81 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.314 0.487 . . . . 75.21 112.314 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.506 HG21 HG22 ' A' ' 53' ' ' VAL . 33.2 m -74.29 2.8 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 112.802 0.668 . . . . 74.11 112.802 -177.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.72 34.99 10.61 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.747 -0.739 . . . . 51.03 114.255 174.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.506 HG22 HG21 ' A' ' 51' ' ' VAL . 63.7 t -107.65 -60.69 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 122.383 -0.481 . . . . 75.03 111.101 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 69' ' ' LEU . 79.3 mt -100.95 163.99 12.03 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.955 0.724 . . . . 74.04 112.955 -175.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -136.51 145.02 44.61 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.532 -0.758 . . . . 62.33 110.264 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -84.15 141.55 30.99 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.176 0.513 . . . . 74.13 112.292 -174.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.545 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 48.5 t -120.23 88.54 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.635 0 CA-C-O 121.239 0.542 . . . . 61.02 109.831 172.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -161.93 -167.38 1.65 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.642 -0.708 . . . . 74.23 111.365 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.92 -57.62 3.13 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.179 0.437 . . . . 71.32 112.179 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.96 -132.64 7.06 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.123 -0.56 . . . . 44.33 113.709 -176.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -124.24 146.78 48.52 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 122.389 -0.477 . . . . 74.34 110.867 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.14 -37.94 1.55 Allowed Glycine 0 CA--C 1.533 1.16 0 N-CA-C 114.393 0.517 . . . . 60.33 114.393 176.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.1 m -55.33 133.13 69.9 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 112.16 0.429 . . . . 74.53 112.16 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.87 146.98 61.17 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.609 2.206 . . . . 73.42 113.596 -176.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.64 -119.19 0.54 Allowed Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.971 -0.559 . . . . 51.23 112.02 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.545 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 87.7 mt -107.64 154.17 21.84 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.946 0.373 . . . . 74.34 110.507 176.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -129.83 122.67 29.18 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.035 0.445 . . . . 75.32 111.995 -175.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.408 HH21 ' CD ' ' A' ' 71' ' ' GLU . 75.5 mtp180 -104.16 -172.72 2.16 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.284 -0.416 . . . . 61.33 109.916 171.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 54' ' ' LEU . 3.0 pp -126.38 164.6 20.73 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.153 -0.342 . . . . 72.43 110.582 172.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.3 mt -67.32 92.25 0.28 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.336 0.588 . . . . 74.43 110.779 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.408 ' CD ' HH21 ' A' ' 68' ' ' ARG . 41.9 mt-10 . . . . . 0 C--O 1.252 1.2 0 CA-C-N 115.103 -0.953 . . . . 74.11 111.887 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 120.756 0.312 . . . . 75.03 111.641 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.3 t -138.37 130.86 29.07 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.763 0.316 . . . . 75.34 110.727 175.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -133.41 22.95 4.04 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.24 0.543 . . . . 53.54 111.179 -178.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.1 t -78.92 68.09 4.78 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.114 0.483 . . . . 62.15 111.674 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.4 ' N ' HD13 ' A' ' 5' ' ' ILE . 2.0 mp -91.12 -39.4 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 120.869 0.366 . . . . 74.34 111.034 177.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 51.4 t -60.09 -36.62 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 116.459 -0.337 . . . . 73.31 111.211 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 95.0 m -54.27 -41.21 68.58 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.445 -0.343 . . . . 73.31 111.436 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.536 ' O ' HG13 ' A' ' 12' ' ' ILE . 23.1 ttmm -60.89 -47.06 88.14 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.761 0.315 . . . . 70.44 110.59 177.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.417 ' O ' HG21 ' A' ' 13' ' ' VAL . 62.7 mt -57.26 -46.7 85.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 120.827 0.346 . . . . 64.42 111.039 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 72.1 mt -59.61 -42.96 89.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.912 0.386 . . . . 75.1 111.126 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.2 t -62.73 -39.1 93.01 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.894 0.378 . . . . 72.32 111.365 177.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.536 HG13 ' O ' ' A' ' 8' ' ' LYS . 94.1 mt -61.68 -51.03 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.806 0.336 . . . . 73.54 110.599 176.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.554 HG11 HG23 ' A' ' 25' ' ' VAL . 59.0 t -60.9 -45.13 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 116.392 -0.367 . . . . 74.53 111.479 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.458 ' HA ' HD23 ' A' ' 69' ' ' LEU . 57.7 tp60 -60.26 -46.21 90.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.867 0.365 . . . . 70.12 110.997 177.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -61.55 -39.18 90.16 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.956 0.408 . . . . 73.5 110.859 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.443 HH11 ' HD3' ' A' ' 16' ' ' ARG . 16.6 mmm-85 -65.27 -41.31 94.32 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.802 0.334 . . . . 72.14 111.216 175.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -64.73 -31.12 72.2 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.511 0.672 . . . . 74.13 110.591 173.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -75.8 -20.32 58.3 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.336 -0.847 . . . . 75.14 110.681 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 94.5 mmm -102.79 -69.64 0.78 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.018 -0.537 . . . . 71.41 111.383 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.483 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 49.3 m-20 -66.66 -66.5 0.55 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.051 0.389 . . . . 62.45 112.051 -178.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.1 t70 69.3 -60.87 0.45 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.423 0.689 . . . . 71.45 111.544 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.66 -28.13 72.53 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.276 -0.487 . . . . 74.5 112.73 176.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.483 ' HB1' ' HB3' ' A' ' 20' ' ' ASP . . . -103.25 134.01 20.01 Favored Pre-proline 0 CA--C 1.538 0.507 0 O-C-N 122.579 -0.366 . . . . 74.33 110.92 177.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.482 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 8.0 Cg_exo -71.88 167.0 27.84 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.533 2.155 . . . . 54.53 113.145 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.554 HG23 HG11 ' A' ' 13' ' ' VAL . 29.1 t -85.44 142.07 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 115.999 -0.546 . . . . 73.21 110.763 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.525 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -102.12 146.56 27.77 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.717 0.294 . . . . 70.3 110.628 -179.199 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.4 m -59.54 -29.72 68.11 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.26 0.552 . . . . 73.25 110.932 176.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -58.53 -61.62 2.46 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.617 -0.72 . . . . 74.21 111.761 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.496 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 3.2 m-20 -51.64 -42.95 62.44 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.185 -0.462 . . . . 75.54 111.792 -178.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.6 mt -64.54 -42.36 94.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 116.33 -0.396 . . . . 75.31 111.25 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.1 -47.85 81.08 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.976 0.417 . . . . 71.44 111.797 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -67.76 -42.29 82.0 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.156 0.428 . . . . 73.45 112.156 178.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.59 -49.51 53.4 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.33 0.492 . . . . 72.11 112.33 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.6 -28.18 51.47 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.243 0.46 . . . . 72.23 112.243 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.76 54.38 3.47 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.203 -0.522 . . . . 44.12 112.763 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.4 mt -132.83 159.0 41.08 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.02 0.438 . . . . 73.21 111.384 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.1 m -73.46 145.72 45.52 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.306 -0.246 . . . . 75.01 110.805 174.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.2 mm -50.23 -41.47 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 112.403 0.52 . . . . 72.52 112.403 -176.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.403 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 56.6 t80 -59.83 -55.39 34.8 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.9 0.381 . . . . 70.34 111.001 175.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -52.0 -45.72 64.63 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.024 -0.534 . . . . 64.13 111.392 177.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.56 -49.37 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.161 -0.472 . . . . 72.31 111.182 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 mtm105 -58.34 -36.89 74.12 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.662 -0.245 . . . . 75.04 111.587 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.501 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 88.7 mt -56.56 -52.39 64.97 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.183 0.516 . . . . 70.44 110.306 177.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -64.96 -43.59 92.15 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.197 -0.456 . . . . 74.21 112.052 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.7 mt -65.86 -50.0 66.13 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.9 0.381 . . . . 54.4 111.853 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -62.74 -34.12 76.54 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.532 -0.304 . . . . 63.01 111.631 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 11.7 mm-40 -68.12 -47.96 66.73 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.119 -0.363 . . . . 55.44 110.977 174.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.5 mt -58.17 -32.8 68.55 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.043 0.449 . . . . 71.21 110.977 175.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.422 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 5.2 t60 -68.19 -44.96 74.68 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.9 0.381 . . . . 73.33 111.143 173.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.5 -42.35 95.89 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.127 -0.488 . . . . 72.23 111.753 -177.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.498 HG23 HG22 ' A' ' 53' ' ' VAL . 25.3 m -74.44 -9.79 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 112.151 0.426 . . . . 74.43 112.151 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.49 10.91 37.19 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 115.033 0.773 . . . . 62.43 115.033 173.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.498 HG22 HG23 ' A' ' 51' ' ' VAL . 92.5 t -82.26 -52.87 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 117.626 0.713 . . . . 64.44 111.439 177.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 91.9 mt -106.09 160.99 14.88 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.323 0.583 . . . . 61.51 112.035 -177.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -129.39 139.3 51.73 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.847 -0.615 . . . . 71.54 110.088 174.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -88.91 103.25 15.84 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.062 0.458 . . . . 64.44 111.488 -176.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 44.8 t -79.15 93.13 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.086 0.47 . . . . 72.25 110.56 175.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.425 ' ND2' HG23 ' A' ' 63' ' ' VAL . 28.1 t-20 -143.2 122.83 13.28 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.935 0.398 . . . . 73.43 111.364 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.23 -21.99 62.05 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.625 0.602 . . . . 74.43 112.625 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 145.64 -164.88 28.06 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.088 -0.577 . . . . 37.59 113.489 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -59.07 116.82 4.09 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 122.769 0.428 . . . . 71.25 111.692 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 126.86 -59.74 0.67 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.401 -0.428 . . . . 72.2 112.872 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.425 HG23 ' ND2' ' A' ' 58' ' ' ASN . 31.7 m -70.11 153.8 95.05 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 112.058 0.392 . . . . 74.21 112.058 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.76 155.75 68.72 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.484 2.122 . . . . 70.34 113.399 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.91 104.44 2.56 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.089 -0.577 . . . . 52.34 112.644 176.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.53 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 85.4 mt -94.48 156.16 16.59 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.806 0.303 . . . . 65.51 111.17 178.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -128.24 147.23 50.58 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.05 0.452 . . . . 75.13 112.142 -176.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -150.89 134.62 16.5 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.497 -0.32 . . . . 73.33 111.161 174.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.482 ' O ' HD13 ' A' ' 69' ' ' LEU . 2.4 pp -78.69 141.86 37.59 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.184 0.516 . . . . 65.31 111.745 177.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.437 ' H ' HD21 ' A' ' 70' ' ' LEU . 1.9 pt? -124.86 -26.65 3.72 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.284 -0.416 . . . . 71.45 111.674 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 . . . . . 0 C--O 1.252 1.219 0 CA-C-O 118.815 -0.612 . . . . 61.44 111.294 179.549 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.8 mtp . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 120.743 0.306 . . . . 44.11 111.558 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.9 t 57.59 72.7 0.5 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.991 0.737 . . . . 73.53 112.991 175.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -104.98 100.5 10.1 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.089 0.471 . . . . 64.03 110.328 174.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.3 m -91.78 102.51 15.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.039 -0.528 . . . . 61.33 111.221 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.1 mm -61.65 -49.91 82.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.947 0.403 . . . . 75.13 111.557 -177.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.1 t -62.86 -52.78 55.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.844 0.354 . . . . 71.22 111.359 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.4 m -59.19 -35.37 73.47 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.499 -0.319 . . . . 61.52 111.405 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.403 ' O ' HG13 ' A' ' 12' ' ' ILE . 4.1 tppp? -57.36 -50.71 72.1 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 110.134 -0.321 . . . . 70.34 110.134 176.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.472 HG21 HG23 ' A' ' 30' ' ' ILE . 67.2 mt -57.95 -51.79 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 116.212 -0.449 . . . . 72.12 111.546 175.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 79.3 mt -55.55 -47.26 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 112.319 0.489 . . . . 74.42 112.319 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.1 p -60.46 -42.46 96.24 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.882 0.372 . . . . 72.55 111.277 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.448 HG22 ' HA ' ' A' ' 30' ' ' ILE . 93.8 mt -63.08 -46.97 94.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 116.208 -0.451 . . . . 72.23 111.304 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.588 HG11 HG23 ' A' ' 25' ' ' VAL . 80.9 t -54.03 -55.27 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.987 0.422 . . . . 74.13 111.189 176.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -57.93 -40.01 79.42 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.239 -0.437 . . . . 71.04 111.664 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -66.18 -42.97 88.15 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.915 0.388 . . . . 64.41 110.936 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.459 ' HB2' HG22 ' A' ' 25' ' ' VAL . 5.0 mmp_? -57.58 -39.95 77.91 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.866 0.365 . . . . 74.4 110.564 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.614 ' HA ' ' HB2' ' A' ' 23' ' ' ALA . 14.6 mm100 -61.97 -40.63 96.25 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.066 0.46 . . . . 71.33 110.935 174.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -60.88 -28.79 69.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.247 -0.433 . . . . 73.24 111.766 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.456 ' HA ' ' HE1' ' A' ' 19' ' ' MET . 28.1 mmt -60.54 -53.38 58.26 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.665 0.617 . . . . 74.02 112.665 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' A' ' 23' ' ' ALA . 13.4 t70 -117.9 142.35 47.43 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.77 0.319 . . . . 72.43 111.156 -176.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -63.01 94.08 0.07 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.307 0.575 . . . . 63.14 111.027 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.55 43.45 7.34 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 115.886 -0.597 . . . . 72.34 112.04 -174.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.614 ' HB2' ' HA ' ' A' ' 17' ' ' GLN . . . -67.53 147.15 98.79 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 113.208 0.818 . . . . 62.55 113.208 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.426 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 90.4 Cg_endo -100.71 131.04 0.15 Allowed 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 123.21 2.607 . . . . 71.53 111.463 159.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.588 HG23 HG11 ' A' ' 13' ' ' VAL . 48.8 t -79.31 138.38 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.165 0.507 . . . . 72.45 112.012 -176.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.411 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -89.8 134.11 34.36 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.227 -0.442 . . . . 73.1 110.437 177.1 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 56.2 m -55.75 -27.99 53.59 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.09 0.471 . . . . 71.23 111.615 177.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -65.22 -54.59 27.16 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.216 -0.447 . . . . 70.41 112.098 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.25 -50.42 38.84 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 122.856 0.463 . . . . 72.41 112.119 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.472 HG23 HG21 ' A' ' 9' ' ' ILE . 53.1 mt -58.17 -57.78 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.151 -0.477 . . . . 71.42 111.787 -177.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.11 -45.49 87.16 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.947 0.403 . . . . 61.22 111.524 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -61.6 -42.4 98.82 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.806 -0.634 . . . . 75.31 111.896 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.03 -41.41 28.93 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.519 0.563 . . . . 73.24 112.519 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.33 -19.87 60.31 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.513 0.56 . . . . 75.54 112.513 -176.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.32 17.0 56.46 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.042 -0.599 . . . . 73.32 112.817 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.4 mt -106.44 170.93 7.63 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.993 0.425 . . . . 74.2 111.306 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.5 t -94.68 161.98 13.97 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.323 -0.399 . . . . 63.12 111.157 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -57.15 -48.9 81.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 112.566 0.58 . . . . 63.12 112.566 -174.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.507 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 29.4 p90 -60.13 -44.07 95.18 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.998 0.427 . . . . 72.11 111.042 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -57.62 -52.3 65.97 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.62 0.724 . . . . 74.33 110.832 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 92.0 t -59.55 -46.27 93.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.542 -0.754 . . . . 64.54 111.414 178.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.5 mtm105 -58.5 -28.95 65.88 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.116 0.413 . . . . 72.52 112.116 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 87.6 mt -65.82 -52.34 51.39 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.983 0.42 . . . . 72.11 110.836 174.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -63.29 -41.02 98.94 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.438 -0.346 . . . . 74.43 111.569 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 88.2 mt -62.68 -37.93 88.39 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.0 0.428 . . . . 64.45 111.091 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -60.87 -42.66 98.32 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.304 -0.407 . . . . 74.02 110.741 176.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -62.49 -51.68 66.49 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.255 -0.43 . . . . 71.33 110.928 176.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.2 mt -57.92 -31.77 67.12 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.148 0.499 . . . . 74.41 111.407 176.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -70.88 -34.38 71.54 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.068 0.461 . . . . 73.34 110.836 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -73.46 -41.08 63.62 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.085 -0.507 . . . . 73.31 111.456 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.497 HG23 HG22 ' A' ' 53' ' ' VAL . 36.0 m -84.13 7.76 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 N-CA-C 112.886 0.699 . . . . 74.24 112.886 -177.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.51 44.7 10.51 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 120.942 -0.647 . . . . 71.24 114.46 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.497 HG22 HG23 ' A' ' 51' ' ' VAL . 91.2 t -114.31 -42.89 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.002 0.43 . . . . 54.22 111.331 175.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.4 mt -116.85 151.92 35.53 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.841 0.682 . . . . 64.12 112.841 -176.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.474 ' HB2' HD21 ' A' ' 70' ' ' LEU . 1.4 tm-20 -122.98 128.16 49.83 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.112 -0.949 . . . . 73.22 108.683 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.601 ' HB3' ' HZ3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -87.49 93.67 9.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.147 0.498 . . . . 62.25 111.311 -172.641 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 82.1 t -75.08 121.0 25.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 115.91 -0.587 . . . . 75.25 111.963 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.429 ' OD1' ' NZ ' ' A' ' 56' ' ' LYS . 5.3 p-10 -141.98 125.2 16.42 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.939 0.399 . . . . 45.44 110.869 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.461 ' N ' HG22 ' A' ' 63' ' ' VAL . . . -76.37 66.17 2.38 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.318 0.488 . . . . 74.43 112.318 -178.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.59 -147.58 19.51 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 114.146 0.418 . . . . 71.32 114.146 177.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -89.06 136.94 32.74 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.742 0.645 . . . . 74.1 112.742 -177.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.23 44.36 93.9 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 115.954 -0.567 . . . . 44.04 114.267 174.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.461 HG22 ' N ' ' A' ' 59' ' ' ALA . 26.4 m -127.29 154.22 77.04 Favored Pre-proline 0 CA--C 1.542 0.655 0 O-C-N 122.575 -0.368 . . . . 74.24 111.731 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.61 130.43 33.48 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.938 2.426 . . . . 64.05 113.497 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.04 107.72 2.57 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 116.186 -0.461 . . . . 63.23 113.295 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 82.6 mt -99.34 157.78 16.17 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.927 0.394 . . . . 72.55 110.977 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -123.14 121.81 36.9 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.999 0.428 . . . . 74.44 111.687 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -118.67 127.45 53.58 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.345 -0.389 . . . . 70.12 110.755 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.426 ' O ' HD12 ' A' ' 69' ' ' LEU . 3.3 pp -79.16 150.35 31.74 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.077 0.465 . . . . 71.15 111.534 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.474 HD21 ' HB2' ' A' ' 55' ' ' GLU . 2.1 pt? -143.34 131.61 22.04 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.175 -0.466 . . . . 71.54 110.887 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.276 0 CA-C-O 118.192 -0.908 . . . . 63.44 112.058 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.592 ' SD ' HG21 ' A' ' 6' ' ' VAL . 24.5 ptt? . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.875 0.369 . . . . 72.44 111.703 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.0 m -104.49 -40.07 6.19 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.237 -0.438 . . . . 74.31 110.039 169.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -99.81 165.09 11.74 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.254 -0.43 . . . . 61.22 110.84 173.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.3 m -73.07 90.45 1.53 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.051 0.453 . . . . 55.31 111.541 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.8 tt -102.28 -22.67 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 121.123 0.487 . . . . 71.11 111.449 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.592 HG21 ' SD ' ' A' ' 1' ' ' MET . 49.8 t -56.69 -29.92 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 112.599 0.592 . . . . 72.22 112.599 -176.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.2 m -51.91 -41.07 61.69 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.893 0.378 . . . . 75.12 111.527 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.484 ' HB2' ' HZ1' ' A' ' 8' ' ' LYS . 4.4 ttmp? -54.41 -52.09 62.82 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.07 0.462 . . . . 73.11 110.722 174.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.507 HG22 HG21 ' A' ' 30' ' ' ILE . 67.4 mt -59.1 -45.27 92.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.8 -0.637 . . . . 74.5 111.572 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.6 mt -58.41 -43.35 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.082 0.468 . . . . 74.2 111.053 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.2 t -64.0 -40.15 95.72 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.198 -0.455 . . . . 75.24 111.205 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 8' ' ' LYS . 84.9 mt -63.18 -44.53 99.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 120.705 0.288 . . . . 75.22 111.375 177.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.495 HG11 HG23 ' A' ' 25' ' ' VAL . 91.7 t -54.1 -53.62 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 121.409 0.623 . . . . 74.24 110.663 174.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -56.52 -44.65 80.97 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.439 -0.8 . . . . 62.35 111.442 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -58.34 -52.23 66.49 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.011 0.434 . . . . 70.35 111.258 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.451 ' HD2' ' HB3' ' A' ' 29' ' ' ASP . 1.9 mmp_? -49.93 -36.96 29.74 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.99 -0.55 . . . . 72.1 111.326 177.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.647 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 78.3 mt-30 -74.85 -42.53 57.79 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.227 -0.442 . . . . 70.43 112.019 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -56.86 -28.74 62.15 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.081 0.467 . . . . 71.34 111.424 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.4 mmt -72.58 -39.25 67.54 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.455 0.539 . . . . 65.13 112.455 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.528 ' HB2' ' HB1' ' A' ' 23' ' ' ALA . 4.1 m-20 -127.58 20.11 6.69 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.304 0.483 . . . . 73.43 112.304 -175.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.8 t70 59.22 -88.19 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.028 0.531 . . . . 72.12 112.429 176.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -85.94 56.38 4.83 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.682 -0.567 . . . . 54.24 111.682 177.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.647 ' HB3' ' HA ' ' A' ' 17' ' ' GLN . . . -96.0 118.17 65.9 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 113.327 0.862 . . . . 74.31 113.327 -171.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.426 ' HB3' HG12 ' A' ' 57' ' ' VAL . 91.3 Cg_endo -78.08 118.97 4.51 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.217 1.944 . . . . 71.53 110.72 168.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.495 HG23 HG11 ' A' ' 13' ' ' VAL . 61.7 t -78.34 132.53 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 121.075 0.464 . . . . 73.32 112.084 -171.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.475 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -89.6 132.67 34.99 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.856 -0.611 . . . . 65.33 110.297 -179.408 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.412 HG21 HD11 ' A' ' 45' ' ' LEU . 56.4 m -49.48 -38.53 30.32 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.566 0.58 . . . . 73.21 112.566 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -72.38 -29.1 63.45 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.612 0.597 . . . . 60.43 112.612 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.451 ' HB3' ' HD2' ' A' ' 16' ' ' ARG . 76.4 m-20 -54.04 -49.29 69.29 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.424 0.631 . . . . 73.33 111.06 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.507 HG21 HG22 ' A' ' 9' ' ' ILE . 59.0 mt -64.64 -37.08 79.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.653 -0.703 . . . . 74.42 111.388 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.27 -47.87 80.53 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.446 -0.343 . . . . 61.41 111.439 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -65.15 -48.74 72.46 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.8 0.333 . . . . 70.23 111.459 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.56 -52.6 63.79 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.452 0.538 . . . . 74.41 112.452 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.6 -19.9 44.45 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.418 0.525 . . . . 74.33 112.418 -177.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.79 47.22 20.86 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.828 -0.701 . . . . 53.11 112.594 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt -118.14 179.0 4.23 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.96 0.409 . . . . 74.33 111.404 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.8 t -86.57 143.72 27.55 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 111.734 0.272 . . . . 74.01 111.734 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.1 mm -55.18 -52.21 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 112.052 0.389 . . . . 74.54 112.052 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -60.41 -42.93 97.02 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.032 0.444 . . . . 74.52 110.99 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -57.32 -56.13 25.79 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.75 -0.659 . . . . 73.14 111.461 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 82.7 t -56.84 -41.42 75.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.193 -0.458 . . . . 72.33 111.204 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -54.87 -46.02 74.69 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.351 -0.386 . . . . 72.31 111.437 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.84 -45.1 95.28 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.255 -0.429 . . . . 62.24 112.061 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -68.68 -37.92 79.96 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.796 0.295 . . . . 74.42 111.796 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.5 HD13 ' NE1' ' A' ' 67' ' ' TRP . 93.7 mt -66.32 -37.33 85.14 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.072 0.463 . . . . 74.51 111.001 174.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.47 -55.99 27.61 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.974 -0.557 . . . . 73.11 111.094 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -60.65 -37.88 82.98 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.526 -0.306 . . . . 75.22 111.576 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.454 HD21 HG11 ' A' ' 6' ' ' VAL . 83.7 mt -61.01 -44.84 96.83 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.982 0.42 . . . . 73.44 111.11 176.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -68.01 -30.88 70.23 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.952 0.406 . . . . 74.24 111.177 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -78.58 -31.94 47.47 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.219 0.452 . . . . 75.24 112.219 -177.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.466 HG22 HG22 ' A' ' 53' ' ' VAL . 33.5 m -83.35 -25.6 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 121.966 -0.459 . . . . 62.53 111.468 176.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 118.54 8.81 9.76 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 120.973 -0.632 . . . . 61.53 114.334 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.466 HG22 HG22 ' A' ' 51' ' ' VAL . 91.5 t -77.88 -42.14 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 117.483 0.642 . . . . 74.12 111.572 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.7 mt -110.89 133.87 53.02 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.147 0.499 . . . . 71.3 112.038 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.487 ' HG2' ' NH2' ' A' ' 68' ' ' ARG . 8.1 tp10 -91.8 154.77 18.7 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.923 -0.581 . . . . 73.3 111.05 176.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -80.22 136.35 36.45 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.202 0.525 . . . . 64.11 112.015 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 44.3 t -131.96 92.72 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.054 0.454 . . . . 72.22 110.232 170.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.528 ' HB3' ' HA2' ' A' ' 65' ' ' GLY . 27.3 p-10 -158.41 149.38 20.62 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.023 0.439 . . . . 62.31 112.151 -177.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.92 10.76 10.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.928 0.394 . . . . 61.24 111.961 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.99 -62.01 4.6 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.39 -0.433 . . . . 38.55 113.784 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -71.52 125.76 27.9 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.255 0.465 . . . . 71.24 112.255 -176.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.87 -67.05 1.72 Allowed Glycine 0 CA--C 1.529 0.919 0 N-CA-C 114.587 0.595 . . . . 60.14 114.587 173.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.4 m -52.22 130.83 42.04 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 112.987 0.736 . . . . 71.32 112.987 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.6 -40.64 17.22 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.603 2.202 . . . . 73.21 112.624 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.528 ' HA2' ' HB3' ' A' ' 58' ' ' ASN . . . 141.13 133.16 2.89 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.026 -0.607 . . . . 71.55 113.313 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.437 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 86.3 mt -101.63 150.9 22.63 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 109.79 -0.448 . . . . 74.54 109.79 173.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.5 ' NE1' HD13 ' A' ' 45' ' ' LEU . 42.6 m95 -107.17 127.82 53.85 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.863 0.69 . . . . 74.52 112.863 -169.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.487 ' NH2' ' HG2' ' A' ' 55' ' ' GLU . 47.6 ttp180 -120.44 165.01 15.52 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.264 -0.643 . . . . 75.41 109.264 175.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.7 pp -123.41 151.64 42.4 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.331 -0.856 . . . . 53.13 111.988 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.437 ' N ' HD21 ' A' ' 70' ' ' LEU . 1.0 OUTLIER -123.18 23.33 9.2 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.923 -0.581 . . . . 75.44 111.357 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 . . . . . 0 C--O 1.253 1.24 0 CA-C-O 119.097 -0.477 . . . . 61.41 110.938 179.687 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 120.736 0.303 . . . . 74.44 111.482 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.6 t -153.6 91.86 1.52 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.877 0.37 . . . . 51.04 111.189 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -176.25 -171.89 0.45 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.198 -0.455 . . . . 74.14 111.099 -177.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.1 p 53.2 37.67 25.66 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.393 0.677 . . . . 72.12 112.401 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.443 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.7 mp -53.86 -47.87 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 112.242 0.46 . . . . 72.43 112.242 -175.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.2 t -61.93 -54.83 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.121 0.486 . . . . 73.54 111.377 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 m -59.62 -31.42 69.49 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.019 -0.537 . . . . 75.35 111.46 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.514 ' O ' HG13 ' A' ' 12' ' ' ILE . 60.5 tptt -57.49 -57.0 14.59 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.2 -0.455 . . . . 73.22 110.679 176.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.467 ' HA ' HD13 ' A' ' 12' ' ' ILE . 67.1 mt -58.2 -43.56 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 116.141 -0.481 . . . . 75.24 111.63 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.0 mt -60.63 -42.74 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.12 0.486 . . . . 73.01 111.101 176.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.0 t -65.4 -33.34 75.73 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.215 -0.448 . . . . 61.51 111.271 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 8' ' ' LYS . 96.9 mt -63.44 -48.41 87.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.365 -0.38 . . . . 72.24 110.934 175.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.8 t -58.15 -47.35 87.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 120.735 0.302 . . . . 74.05 111.229 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -59.47 -45.43 91.67 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.15 0.5 . . . . 74.41 111.041 177.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -53.64 -46.9 70.69 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.963 -0.562 . . . . 73.14 111.52 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 12' ' ' ILE . 7.6 mmm180 -67.87 -37.43 81.79 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.216 -0.447 . . . . 72.32 111.473 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -62.9 -32.87 74.23 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.081 0.4 . . . . 73.25 112.081 176.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -92.21 -29.23 16.56 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.975 0.731 . . . . 75.22 112.975 -175.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.477 ' SD ' ' HD2' ' A' ' 16' ' ' ARG . 27.2 ptm -70.35 -26.67 63.85 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.119 -0.363 . . . . 74.34 111.598 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -127.13 179.25 5.52 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 116.475 -0.329 . . . . 71.54 110.337 -177.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -104.21 -12.58 16.59 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 122.156 -0.34 . . . . 73.33 111.91 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.3 44.09 0.23 Allowed Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.878 -0.677 . . . . 44.41 113.409 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.78 107.22 38.78 Favored Pre-proline 0 CA--C 1.537 0.444 0 O-C-N 122.562 -0.375 . . . . 62.54 111.62 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.524 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 46.6 Cg_endo -68.52 138.85 43.2 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.22 1.947 . . . . 44.41 111.696 176.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.9 t -79.96 120.61 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 120.899 0.38 . . . . 74.11 111.13 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.49 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -80.63 132.49 35.61 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.607 -0.269 . . . . 70.31 110.996 -176.821 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.3 m -51.97 -44.46 64.02 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.903 0.383 . . . . 71.23 111.665 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.513 ' NH1' HG13 ' A' ' 38' ' ' ILE . 36.1 mmt180 -61.21 -45.92 92.6 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.207 0.527 . . . . 75.4 110.682 176.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -58.52 -40.77 83.84 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.792 -0.64 . . . . 62.53 111.455 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 26' ' ' LYS . 66.0 mt -61.92 -39.69 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.793 0.33 . . . . 73.02 111.157 176.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.512 ' HA ' HG23 ' A' ' 41' ' ' VAL . . . -57.93 -48.74 79.02 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.268 -0.424 . . . . 72.42 111.892 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.13 -43.55 94.92 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 111.995 0.368 . . . . 72.01 111.995 176.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.12 -41.72 94.6 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.332 0.493 . . . . 75.31 112.332 -178.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.63 -23.91 27.33 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.218 0.451 . . . . 64.33 112.218 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.17 40.46 24.4 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.227 -0.511 . . . . 72.44 113.231 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.9 mt -128.63 161.06 30.53 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.613 -0.345 . . . . 72.25 111.37 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.424 ' O ' HG21 ' A' ' 41' ' ' VAL . 66.9 m -68.1 150.97 47.72 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.515 -0.311 . . . . 71.41 111.096 176.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.513 HG13 ' NH1' ' A' ' 28' ' ' ARG . 49.7 mm -52.21 -48.83 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 112.31 0.485 . . . . 62.32 112.31 -176.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.486 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 78.2 t80 -59.2 -49.05 79.35 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.529 -0.305 . . . . 75.31 111.242 178.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -54.98 -50.81 68.04 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.244 0.545 . . . . 72.3 110.899 176.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.512 HG23 ' HA ' ' A' ' 31' ' ' ALA . 88.8 t -56.18 -49.64 75.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.078 -0.51 . . . . 51.12 111.345 178.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.565 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 31.6 mtp180 -60.98 -34.3 74.56 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 111.752 0.278 . . . . 63.21 111.752 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 79.2 mt -55.78 -47.42 77.08 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.15 0.5 . . . . 74.24 110.407 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -65.51 -43.43 90.12 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.058 -0.519 . . . . 73.33 111.522 175.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.473 HD12 ' NE1' ' A' ' 67' ' ' TRP . 89.5 mt -64.15 -50.15 69.33 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 111.85 0.315 . . . . 72.24 111.85 -177.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' A' ' 42' ' ' ARG . 62.1 mm-40 -56.83 -45.82 82.1 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.32 -0.4 . . . . 54.01 111.061 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 88.3 mt-30 -62.92 -49.81 73.33 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.536 0.208 . . . . 60.41 110.973 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.412 ' HA ' HG21 ' A' ' 51' ' ' VAL . 94.5 mt -57.85 -28.95 64.58 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.019 0.437 . . . . 72.24 111.127 176.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.458 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 31.4 t-80 -67.07 -56.69 8.97 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.06 0.457 . . . . 73.25 111.077 174.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.13 -23.79 64.02 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.252 0.834 . . . . 74.22 113.252 -175.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.49 HG23 HG22 ' A' ' 53' ' ' VAL . 25.1 m -84.78 -4.58 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 121.887 -0.508 . . . . 73.24 111.947 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.3 17.9 38.17 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 114.617 0.607 . . . . 65.35 114.617 173.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.49 HG22 HG23 ' A' ' 51' ' ' VAL . 97.3 t -90.91 -50.01 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 117.294 0.547 . . . . 61.02 111.327 177.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.7 mt -106.69 131.03 54.29 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.178 0.513 . . . . 71.43 111.893 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -101.34 143.65 31.12 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.907 -0.588 . . . . 74.51 111.003 177.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.435 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -66.11 141.47 58.1 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.802 0.667 . . . . 71.41 112.802 -175.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 51.0 t -134.41 102.15 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 116.285 -0.416 . . . . 73.51 110.959 171.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.1 t30 49.37 87.09 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.901 0.48 . . . . 61.23 112.108 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.497 ' HB1' ' HA2' ' A' ' 65' ' ' GLY . . . -156.71 175.77 13.61 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.989 0.737 . . . . 72.21 112.989 -175.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 143.05 -106.95 0.45 Allowed Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.508 -0.769 . . . . 74.33 111.93 -177.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.9 mtmm -128.34 136.53 51.07 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.969 0.414 . . . . 75.22 111.003 174.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.1 8.48 87.4 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.159 -0.543 . . . . 52.05 112.301 -175.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.71 122.15 11.07 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 122.973 0.509 . . . . 74.21 111.391 -176.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.77 111.88 1.65 Allowed 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.732 2.288 . . . . 73.51 112.397 175.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.497 ' HA2' ' HB1' ' A' ' 59' ' ' ALA . . . -56.38 123.66 32.23 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.32 -0.467 . . . . 73.2 114.175 -177.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.524 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 66.8 mt -102.08 143.86 31.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.969 -0.382 . . . . 65.42 109.969 174.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.473 ' NE1' HD12 ' A' ' 45' ' ' LEU . 75.7 m95 -121.16 147.86 45.02 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.328 0.585 . . . . 72.13 112.389 -174.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -148.78 133.68 18.04 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.934 -0.576 . . . . 71.14 110.397 173.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 pp -72.74 163.31 28.3 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.733 -0.604 . . . . 74.12 110.856 174.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.8 mt -68.18 86.14 0.26 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.191 0.441 . . . . 73.33 112.191 -175.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 C--O 1.254 1.296 0 CA-C-O 118.416 -0.802 . . . . 52.11 112.891 179.411 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 mmt . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.89 0.376 . . . . 74.33 110.624 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.1 m -91.63 148.99 21.87 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.74 0.305 . . . . 74.54 111.259 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -61.72 -21.8 64.82 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.189 0.519 . . . . 73.32 110.903 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.4 m -56.79 -27.87 60.47 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.717 -0.674 . . . . 70.22 112.564 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 70.2 mt -52.34 -56.2 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 120.875 0.369 . . . . 72.05 111.925 -178.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.6 t -71.73 -46.04 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.093 0.473 . . . . 73.13 111.22 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.9 m -55.24 -39.52 69.83 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.8 -0.636 . . . . 73.44 112.227 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.516 ' O ' HG13 ' A' ' 12' ' ' ILE . 55.6 tptt -61.96 -50.86 70.42 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.739 0.304 . . . . 72.1 110.732 177.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 72.7 mt -55.79 -46.36 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.886 0.374 . . . . 73.43 111.486 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.2 mt -58.88 -45.22 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 121.192 0.52 . . . . 73.35 110.93 176.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.2 t -62.39 -35.17 78.36 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.003 -0.544 . . . . 71.42 111.821 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.545 HG22 ' HA ' ' A' ' 30' ' ' ILE . 96.8 mt -64.73 -49.7 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.871 0.367 . . . . 74.35 111.2 177.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 64.2 t -54.2 -49.17 64.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.062 0.458 . . . . 64.44 110.969 177.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -62.46 -44.09 97.25 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.012 -0.54 . . . . 70.11 111.487 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.408 ' HA ' ' ND2' ' A' ' 18' ' ' ASN . 10.1 tp10 -61.62 -37.46 84.06 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.153 0.501 . . . . 74.3 111.04 -178.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.469 ' HG3' HG12 ' A' ' 25' ' ' VAL . 8.3 mmm180 -64.29 -40.06 95.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 73.53 110.79 174.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.485 ' O ' ' HA ' ' A' ' 21' ' ' ASP . 74.1 mt-30 -72.69 -4.57 32.0 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.871 0.367 . . . . 72.24 111.58 175.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.408 ' ND2' ' HA ' ' A' ' 15' ' ' GLU . 81.2 m-20 -87.38 -42.56 12.76 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.029 0.442 . . . . 62.51 109.85 167.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 89.8 mmm -76.84 -66.91 0.76 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.938 -0.574 . . . . 74.23 111.319 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -71.5 -14.3 62.07 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.998 0.428 . . . . 75.02 111.087 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 17' ' ' GLN . 17.0 t70 74.54 -68.27 0.22 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.992 0.917 . . . . 72.12 112.673 177.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -136.1 36.81 1.97 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.553 -0.832 . . . . 65.54 113.885 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -102.85 152.72 38.52 Favored Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 122.51 -0.406 . . . . 71.52 111.499 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.53 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 49.9 Cg_endo -68.21 129.19 18.81 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.29 1.993 . . . . 75.43 111.999 174.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.469 HG12 ' HG3' ' A' ' 16' ' ' ARG . 38.5 t -79.44 135.83 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.155 0.502 . . . . 60.31 111.68 -174.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.531 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -88.28 135.72 33.32 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.139 -0.482 . . . . 72.05 111.29 -177.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.2 m -55.07 -31.27 61.03 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.907 0.384 . . . . 52.32 111.963 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -60.54 -54.15 48.89 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 111.798 0.295 . . . . 75.2 111.798 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.408 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 2.3 m-20 -57.82 -37.48 73.88 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.885 0.374 . . . . 73.12 111.619 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.545 ' HA ' HG22 ' A' ' 12' ' ' ILE . 59.0 mt -66.91 -49.23 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.428 -0.351 . . . . 73.31 111.293 178.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.06 -34.85 73.98 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.992 0.425 . . . . 61.21 111.455 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -66.08 -51.92 53.6 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.042 -0.526 . . . . 73.53 111.35 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.02 -35.84 72.17 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.506 0.558 . . . . 74.04 112.506 -177.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.18 -33.69 38.1 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.391 0.515 . . . . 75.53 112.391 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.37 -0.11 83.01 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.001 -0.618 . . . . 73.1 112.989 -177.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 71.6 mt -85.1 160.0 20.06 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 122.602 -0.352 . . . . 75.45 110.897 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.443 ' O ' HG21 ' A' ' 41' ' ' VAL . 47.6 t -79.74 157.44 27.13 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 120.788 0.328 . . . . 73.54 111.8 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.0 mm -51.95 -52.37 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 112.808 0.67 . . . . 72.35 112.808 -174.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.519 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 32.9 p90 -58.29 -44.43 88.49 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.985 0.421 . . . . 75.25 111.083 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -62.13 -47.09 86.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.241 0.543 . . . . 75.33 110.993 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 37' ' ' SER . 95.0 t -60.04 -51.47 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 115.972 -0.558 . . . . 73.01 111.877 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -62.94 -26.05 68.63 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 111.893 0.331 . . . . 71.21 111.893 -177.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 79.5 mt -65.99 -51.47 58.1 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.617 0.246 . . . . 63.04 111.011 175.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -65.56 -39.61 91.87 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.757 0.313 . . . . 74.41 111.695 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.495 HD12 ' CD1' ' A' ' 67' ' ' TRP . 96.5 mt -58.2 -41.69 84.53 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.344 0.592 . . . . 73.42 110.651 174.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -60.6 -43.97 96.79 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.629 -0.714 . . . . 75.32 111.054 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 74.9 mt-30 -60.38 -38.03 82.62 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.208 -0.451 . . . . 72.45 111.249 176.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 93.0 mt -63.83 -32.76 74.38 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.711 0.291 . . . . 75.01 111.309 175.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -70.56 -41.39 72.5 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 122.06 -0.4 . . . . 75.23 110.555 171.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -56.12 -42.68 77.23 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.785 -0.643 . . . . 73.13 111.848 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.497 HG21 HG23 ' A' ' 53' ' ' VAL . 35.0 m -82.13 -15.13 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 112.492 0.553 . . . . 63.13 112.492 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.92 8.06 32.43 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 114.658 0.623 . . . . 72.54 114.658 175.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.497 HG23 HG21 ' A' ' 51' ' ' VAL . 95.1 t -77.12 -52.61 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 117.409 0.605 . . . . 71.41 111.975 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.0 mt -106.41 149.94 26.52 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.72 0.637 . . . . 74.53 112.72 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 68' ' ' ARG . 12.6 pt-20 -111.1 146.08 37.44 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.992 -0.549 . . . . 74.54 110.068 172.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.424 ' HE3' ' HB2' ' A' ' 56' ' ' LYS . 46.1 mtmt -80.86 104.38 11.33 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.851 0.358 . . . . 54.11 111.475 -177.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 53.3 t -88.0 90.5 3.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-O 121.724 0.773 . . . . 72.23 110.948 176.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.713 HD22 ' HA2' ' A' ' 65' ' ' GLY . 15.5 m120 -138.93 89.4 2.36 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.974 -1.012 . . . . 43.11 109.681 174.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.42 -58.55 3.19 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.759 0.651 . . . . 73.5 112.759 -173.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -100.3 -168.58 29.12 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.1 -0.571 . . . . 63.12 113.89 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -98.12 135.32 39.95 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 122.52 -0.4 . . . . 61.11 111.343 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.16 27.35 33.89 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 121.152 -0.547 . . . . 63.53 112.808 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 32.6 m -106.56 153.21 40.73 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 120.78 0.324 . . . . 74.13 111.857 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -76.67 162.15 33.11 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.558 2.172 . . . . 74.31 112.85 176.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.713 ' HA2' HD22 ' A' ' 58' ' ' ASN . . . -74.72 103.46 1.54 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.0 -0.619 . . . . 72.4 113.22 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.554 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 72.8 mt -99.96 139.12 36.09 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.966 0.383 . . . . 75.35 110.091 175.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.495 ' CD1' HD12 ' A' ' 45' ' ' LEU . 74.5 m95 -121.52 139.11 53.92 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.133 0.492 . . . . 74.25 112.005 -175.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.527 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 46.3 ttt180 -136.42 128.11 28.94 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.342 -0.39 . . . . 75.51 110.548 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 69' ' ' LEU . 4.6 pp -79.35 138.99 37.89 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.519 -0.738 . . . . 63.51 111.269 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.408 HD23 ' H ' ' A' ' 70' ' ' LEU . 2.1 pt? -124.6 11.47 8.54 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.215 -0.448 . . . . 73.32 110.944 179.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 . . . . . 0 C--O 1.254 1.332 0 CA-C-O 118.546 -0.74 . . . . 62.41 110.945 -178.741 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.8 mtp . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.809 0.338 . . . . 63.11 111.333 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.9 m 56.56 18.95 3.87 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.208 0.818 . . . . 53.22 113.208 176.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 58.72 26.98 15.31 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-O 121.498 0.666 . . . . 54.12 111.31 178.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.7 p -50.22 -57.64 7.36 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.257 0.836 . . . . 64.41 113.257 -174.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.421 HG23 HD12 ' A' ' 36' ' ' LEU . 48.0 mm -49.58 -41.3 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 112.819 0.674 . . . . 74.15 112.819 -175.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.9 t -62.52 -57.77 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 120.949 0.404 . . . . 71.14 111.682 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.5 m -63.39 -34.44 77.74 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.981 0.42 . . . . 75.42 111.276 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.415 ' O ' HG13 ' A' ' 12' ' ' ILE . 57.0 tptt -56.19 -53.14 60.74 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.202 -0.453 . . . . 74.51 110.837 177.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.413 HG22 HG23 ' A' ' 30' ' ' ILE . 62.7 mt -59.1 -47.32 90.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.107 -0.497 . . . . 64.44 111.965 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 61.4 mt -60.42 -43.19 93.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 112.093 0.405 . . . . 54.21 112.093 -178.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 85.4 p -60.65 -36.87 79.73 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 120.781 0.324 . . . . 74.3 111.176 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.543 HG22 ' HA ' ' A' ' 30' ' ' ILE . 79.8 mt -64.29 -40.73 90.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.078 0.466 . . . . 71.14 111.504 176.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.58 -52.06 65.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 120.885 0.374 . . . . 53.31 110.914 177.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -59.35 -40.76 87.44 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.949 0.404 . . . . 74.31 110.864 176.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 12' ' ' ILE . 16.9 tp10 -47.75 -56.04 8.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.246 0.618 . . . . 65.41 111.841 177.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.501 ' HG3' HG12 ' A' ' 25' ' ' VAL . 1.2 mmp_? -63.09 -37.56 87.69 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.393 -0.367 . . . . 73.21 111.555 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -79.61 -13.99 59.12 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 111.955 0.354 . . . . 75.42 111.955 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -73.11 -35.95 66.66 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.028 0.442 . . . . 62.32 109.862 170.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.1 mmt -67.17 -58.79 4.21 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.814 -0.63 . . . . 63.15 110.885 172.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -124.61 104.12 8.52 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.435 -0.348 . . . . 71.24 110.836 176.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -61.38 -14.38 27.32 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.317 0.858 . . . . 64.21 113.317 -175.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -117.35 15.13 13.21 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 120.92 -0.657 . . . . 44.34 113.908 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.53 128.46 26.89 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 117.272 0.536 . . . . 61.22 112.082 -177.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.543 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 58.7 Cg_endo -71.42 135.45 26.61 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.364 2.043 . . . . 75.11 112.865 176.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.501 HG12 ' HG3' ' A' ' 16' ' ' ARG . 24.5 t -80.41 139.87 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 120.846 0.355 . . . . 62.44 111.449 -177.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.501 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 12.0 mptt -91.63 130.03 37.51 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.406 -0.361 . . . . 73.04 110.946 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.3 m -47.05 -34.5 5.84 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 120.919 0.39 . . . . 74.54 111.935 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -60.09 -49.26 78.33 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.386 -0.37 . . . . 74.33 111.795 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -56.22 -49.55 73.77 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.095 0.474 . . . . 74.54 110.788 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.543 ' HA ' HG22 ' A' ' 12' ' ' ILE . 64.3 mt -59.06 -48.36 86.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.907 -0.588 . . . . 64.52 111.555 178.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.488 ' HA ' HG23 ' A' ' 41' ' ' VAL . . . -57.73 -52.25 66.21 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.274 -0.421 . . . . 75.45 111.813 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -65.3 -41.97 93.54 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.285 -0.416 . . . . 74.44 111.711 -177.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.93 -39.69 87.41 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.214 0.45 . . . . 74.04 112.214 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.03 -20.79 40.95 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.001 0.371 . . . . 72.13 112.001 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.55 32.75 24.04 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.212 -0.518 . . . . 73.22 112.617 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.421 HD12 HG23 ' A' ' 5' ' ' ILE . 74.2 mt -122.21 161.71 22.72 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.873 0.368 . . . . 71.15 111.161 -177.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.0 m -82.78 152.13 25.83 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.703 0.287 . . . . 73.45 111.528 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.8 mm -50.56 -46.04 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 112.28 0.474 . . . . 70.22 112.28 -176.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -57.87 -52.07 66.99 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.809 0.338 . . . . 73.52 111.8 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -58.54 -46.49 86.73 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.209 0.528 . . . . 73.53 111.277 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.488 HG23 ' HA ' ' A' ' 31' ' ' ALA . 57.9 t -61.54 -42.23 93.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.802 -0.636 . . . . 73.42 111.52 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -55.03 -39.64 69.36 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.784 0.326 . . . . 72.21 111.615 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.56 -52.48 60.88 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.274 -0.421 . . . . 74.51 111.042 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -59.57 -50.21 74.76 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 111.932 0.345 . . . . 70.24 111.932 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.417 HD12 ' CD1' ' A' ' 67' ' ' TRP . 92.2 mt -57.51 -43.99 84.69 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.863 0.363 . . . . 71.1 111.69 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -59.1 -50.38 74.26 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.017 0.437 . . . . 74.15 110.796 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -54.87 -44.55 74.13 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.038 -0.528 . . . . 71.22 110.807 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.46 ' HA ' HG22 ' A' ' 51' ' ' VAL . 89.1 mt -59.46 -29.68 67.98 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.3 -0.409 . . . . 71.15 111.782 178.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -72.53 -46.46 54.44 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.955 -0.466 . . . . 75.02 110.89 174.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -70.39 -16.89 63.01 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.835 0.68 . . . . 64.32 112.835 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.518 HG21 HG22 ' A' ' 53' ' ' VAL . 30.1 m -98.96 4.64 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 O-C-N 122.106 -0.372 . . . . 70.41 111.749 176.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.44 31.42 27.7 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 114.7 0.64 . . . . 65.14 114.7 174.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.518 HG22 HG21 ' A' ' 51' ' ' VAL . 95.3 t -105.81 -54.59 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 117.213 0.506 . . . . 71.33 111.749 176.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.1 mt -99.18 162.91 12.79 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.889 0.7 . . . . 65.32 112.889 -176.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 68' ' ' ARG . 17.0 tp10 -124.95 149.56 47.52 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.381 -0.827 . . . . 71.03 110.709 -175.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -78.96 129.28 34.31 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.048 0.758 . . . . 70.41 113.048 -172.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.9 t -140.09 115.83 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.757 0.313 . . . . 72.33 111.188 170.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.8 t30 56.5 88.78 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.559 0.577 . . . . 74.12 112.559 175.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.48 ' HA ' HG22 ' A' ' 63' ' ' VAL . . . -136.53 152.77 50.87 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.063 -0.517 . . . . 62.05 111.646 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.28 -103.16 0.47 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.18 -0.533 . . . . 72.12 113.381 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.707 ' H ' ' HD2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -104.8 126.73 52.17 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.935 0.397 . . . . 72.41 111.742 -174.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.47 49.04 62.2 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.199 -0.455 . . . . 61.31 113.597 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.48 HG22 ' HA ' ' A' ' 59' ' ' ALA . 35.5 m -116.96 140.14 26.62 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 112.042 0.386 . . . . 72.54 112.042 -175.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -83.63 -3.45 10.64 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.947 2.431 . . . . 60.22 112.908 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.92 102.96 0.08 OUTLIER Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.181 -0.533 . . . . 54.24 113.024 -177.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.543 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 58.2 mt -107.64 133.11 52.55 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.883 0.373 . . . . 74.44 110.159 177.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.417 ' CD1' HD12 ' A' ' 45' ' ' LEU . 57.7 m95 -126.37 135.86 51.97 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.191 0.811 . . . . 74.44 113.191 -171.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.508 ' HB2' ' HB3' ' A' ' 55' ' ' GLU . 63.0 mtp180 -113.24 176.21 5.12 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.521 -0.763 . . . . 62.3 109.333 169.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.421 ' O ' HD13 ' A' ' 69' ' ' LEU . 3.5 pp -127.1 149.66 49.84 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.715 -0.616 . . . . 63.54 112.343 175.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.57 -5.97 9.22 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.204 -0.453 . . . . 74.45 110.866 173.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.251 1.137 0 N-CA-C 112.975 0.731 . . . . 73.43 112.975 176.275 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.418 ' O ' HG13 ' A' ' 9' ' ' ILE . 8.1 tp . . . . . 0 N--CA 1.471 0.613 0 CA-C-O 120.902 0.382 . . . . 73.25 111.374 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.65 -42.04 94.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 120.756 0.312 . . . . 73.11 111.018 176.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.2 m -61.13 -41.12 96.14 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.004 0.43 . . . . 73.23 110.706 175.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.421 ' O ' HG13 ' A' ' 12' ' ' ILE . 62.0 tttp -57.27 -46.39 83.13 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.201 -0.454 . . . . 53.4 110.293 173.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.483 ' O ' HG23 ' A' ' 13' ' ' VAL . 70.3 mt -55.99 -48.83 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.205 -0.452 . . . . 64.31 111.494 176.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.5 mt -57.14 -45.24 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.012 0.434 . . . . 72.41 111.112 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.6 t -57.23 -45.94 83.42 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.171 -0.468 . . . . 71.11 111.064 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 8' ' ' LYS . 94.1 mt -59.37 -45.11 93.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.223 -0.444 . . . . 41.1 111.058 176.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 9' ' ' ILE . 96.2 t -57.98 -49.61 80.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.486 -0.324 . . . . 72.52 111.543 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -61.99 -52.66 63.11 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.938 0.399 . . . . 74.25 111.436 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -65.2 -32.58 74.33 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.101 -0.499 . . . . 51.32 111.936 -175.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.1 mmm180 -65.69 -62.72 1.35 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 122.17 -0.331 . . . . 73.44 111.737 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -56.56 -24.33 46.41 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.263 0.554 . . . . 64.24 110.901 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -64.52 -41.02 96.64 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.76 -0.655 . . . . 71.12 110.577 172.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 65.5 mtt -82.24 -28.15 32.07 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.347 -0.388 . . . . 74.01 111.792 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -77.65 -10.49 59.54 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.676 0.274 . . . . 72.31 111.252 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 64.1 -74.75 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.431 0.692 . . . . 75.22 112.835 174.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -106.44 -11.8 26.42 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.917 -0.659 . . . . 41.21 113.395 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -103.28 141.36 22.34 Favored Pre-proline 0 CA--C 1.538 0.511 0 O-C-N 122.541 -0.387 . . . . 63.43 112.022 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.528 ' HG2' ' HB3' ' A' ' 66' ' ' LEU . 53.5 Cg_endo -71.35 -176.56 1.98 Allowed 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.483 2.122 . . . . 65.31 113.216 175.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.406 HG21 ' HA ' ' A' ' 13' ' ' VAL . 13.4 t -88.75 152.13 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.248 -0.433 . . . . 74.43 111.755 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.568 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 10.8 mptt -98.86 132.44 44.21 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.399 -0.364 . . . . 75.43 111.188 -176.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.8 m -47.42 -47.16 26.86 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.012 0.375 . . . . 65.15 112.012 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -59.22 -55.77 30.7 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.505 -0.316 . . . . 74.51 111.653 175.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -51.53 -39.59 58.0 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.188 -0.46 . . . . 74.53 112.077 -174.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.5 mt -59.69 -41.42 85.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.067 0.46 . . . . 63.52 110.919 175.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.9 -39.41 83.61 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.226 -0.443 . . . . 74.42 111.282 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -60.75 -56.63 18.95 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.957 0.408 . . . . 75.22 111.31 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.26 -45.85 90.09 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.257 -0.428 . . . . 61.23 112.04 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.98 -23.61 58.3 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.214 0.45 . . . . 74.32 112.214 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.86 44.67 23.96 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.247 -0.501 . . . . 61.22 112.558 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.3 mt -126.88 178.67 5.81 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.135 0.493 . . . . 60.41 111.623 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.406 ' O ' HG23 ' A' ' 41' ' ' VAL . 31.1 t -87.02 147.93 25.51 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.93 -0.577 . . . . 64.13 111.339 176.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.8 mm -55.65 -44.41 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 116.308 -0.405 . . . . 64.13 112.001 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.556 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 72.1 t80 -61.49 -53.93 49.93 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 111.566 0.21 . . . . 73.12 111.566 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -51.77 -49.1 63.3 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.508 0.67 . . . . 74.24 111.383 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 37' ' ' SER . 94.3 t -60.37 -51.6 71.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.717 -0.674 . . . . 74.11 112.204 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -60.76 -27.07 67.69 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 122.387 -0.196 . . . . 72.23 111.356 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 87.5 mt -62.46 -54.64 37.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.742 0.306 . . . . 55.24 110.375 175.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -57.82 -47.49 82.47 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.043 0.449 . . . . 74.14 111.08 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.2 mt -58.74 -43.83 90.32 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.034 -0.53 . . . . 44.44 111.983 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 49' ' ' HIS . 34.8 tt0 -67.06 -40.38 87.09 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.73 0.3 . . . . 74.35 111.553 -178.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -63.41 -50.23 70.65 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.938 0.399 . . . . 62.41 110.836 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.6 mt -58.46 -31.66 68.0 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.179 0.514 . . . . 72.24 110.927 174.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.537 ' HD2' ' HA ' ' A' ' 55' ' ' GLU . 28.3 t-80 -64.61 -54.58 29.8 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.246 -0.434 . . . . 72.53 111.768 176.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -66.42 -26.27 67.15 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.011 0.375 . . . . 63.22 112.011 -173.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.536 HG23 HG23 ' A' ' 53' ' ' VAL . 26.1 m -85.34 -1.5 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 112.21 0.448 . . . . 54.41 112.21 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.33 -14.81 47.26 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 115.053 0.781 . . . . 73.44 115.053 172.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.536 HG23 HG23 ' A' ' 51' ' ' VAL . 59.8 t -62.39 -51.02 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 117.833 0.816 . . . . 73.11 111.808 -176.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 94.2 mt -114.8 154.2 29.0 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.861 0.362 . . . . 64.41 111.618 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.537 ' HA ' ' HD2' ' A' ' 49' ' ' HIS . 9.0 tp10 -121.69 147.3 46.06 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.229 0.537 . . . . 43.22 110.998 176.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.427 ' HG2' ' OE1' ' A' ' 55' ' ' GLU . 23.2 pttm -81.7 95.39 7.22 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.593 -0.73 . . . . 71.41 111.855 -178.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.514 HG11 ' HG3' ' A' ' 24' ' ' PRO . 44.0 t . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 121.505 0.669 . . . . 75.51 110.118 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.528 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 83.7 mt . . . . . 0 CA--C 1.536 0.442 0 CA-C-O 120.907 0.384 . . . . 51.3 110.665 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -111.45 132.79 54.21 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.378 0.608 . . . . 64.25 112.182 -175.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -136.76 138.13 40.6 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.744 -0.662 . . . . 73.15 110.885 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.418 ' O ' HD12 ' A' ' 69' ' ' LEU . 2.4 pp -83.23 153.23 24.82 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.806 0.336 . . . . 74.54 111.697 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.501 ' N ' HD23 ' A' ' 70' ' ' LEU . 1.9 pt? . . . . . 0 N--CA 1.469 0.496 0 N-CA-C 112.005 0.372 . . . . 50.32 112.005 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 5' ' ' ILE . 2.8 mp . . . . . 0 N--CA 1.472 0.638 0 CA-C-O 120.804 0.335 . . . . 72.43 111.493 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.5 t -60.71 -53.02 54.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.806 0.336 . . . . 70.11 111.274 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.0 m -60.41 -36.16 77.49 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.022 0.439 . . . . 71.34 111.079 177.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.517 ' O ' HG13 ' A' ' 12' ' ' ILE . 62.4 tttp -60.05 -49.05 79.2 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.213 -0.449 . . . . 73.44 111.135 176.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.445 ' HA ' HD12 ' A' ' 12' ' ' ILE . 72.9 mt -59.6 -42.97 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.7 0.286 . . . . 70.44 111.502 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.1 mt -57.43 -43.61 82.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 121.328 0.585 . . . . 73.2 110.574 174.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.7 m -66.15 -30.73 71.27 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.881 -0.599 . . . . 73.24 111.604 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 8' ' ' LYS . 94.5 mt -67.07 -47.72 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.638 0.256 . . . . 73.21 111.279 177.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.491 HG11 HD22 ' A' ' 54' ' ' LEU . 56.1 t -60.12 -45.36 95.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.841 0.353 . . . . 74.23 110.45 175.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -54.77 -48.25 72.91 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.038 -0.528 . . . . 65.55 110.629 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.552 ' O ' ' HG2' ' A' ' 19' ' ' MET . 29.2 tt0 -57.24 -65.54 0.61 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.775 -0.648 . . . . 75.13 111.452 178.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -51.51 -51.86 51.69 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.844 0.354 . . . . 72.34 111.917 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -57.42 -35.27 69.86 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.117 -0.492 . . . . 73.14 111.56 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -81.39 -26.53 35.38 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.042 0.386 . . . . 74.02 112.042 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.552 ' HG2' ' O ' ' A' ' 15' ' ' GLU . 24.3 mmt -71.22 -58.94 3.06 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.839 0.352 . . . . 72.12 111.047 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -74.29 -29.52 61.69 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.602 -0.272 . . . . 75.24 111.235 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.1 t70 69.14 -72.57 0.1 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.539 0.57 . . . . 72.15 112.539 173.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.65 41.42 3.09 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.188 -0.53 . . . . 54.02 113.161 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.19 140.26 8.49 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 112.187 0.44 . . . . 73.54 112.187 -177.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.545 ' HG2' HD13 ' A' ' 66' ' ' LEU . 54.5 Cg_endo -71.66 151.9 58.59 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.516 2.144 . . . . 71.21 112.512 172.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.1 t -80.88 150.36 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 120.906 0.384 . . . . 65.04 111.447 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.457 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -112.24 150.25 31.17 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.697 0.284 . . . . 74.34 110.819 -179.532 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.0 m -55.65 -31.85 62.68 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.02 0.438 . . . . 64.22 111.508 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -64.17 -59.21 4.71 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.182 -0.463 . . . . 72.02 112.175 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.417 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -67.49 -20.25 65.43 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.629 0.603 . . . . 74.21 112.629 -178.439 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 26' ' ' LYS . 77.3 mt -67.93 -51.22 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.048 0.451 . . . . 73.14 110.358 170.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.512 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -58.07 -39.42 78.47 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.124 -0.489 . . . . 75.41 111.189 175.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -51.81 -52.48 48.87 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.693 -0.685 . . . . 70.03 111.543 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.23 -24.94 60.55 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.956 0.408 . . . . 63.14 111.923 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.65 -24.33 36.38 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.062 0.393 . . . . 73.03 112.062 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.87 23.29 78.11 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.077 -0.582 . . . . 34.41 112.24 -174.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.7 mt -118.13 178.21 4.51 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.401 0.62 . . . . 53.44 111.783 -175.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.8 m -82.51 149.17 27.69 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.896 -0.593 . . . . 72.14 111.554 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.6 mm -52.89 -41.96 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 120.929 0.395 . . . . 43.12 111.966 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.467 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 47.4 t80 -60.65 -59.78 4.85 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.149 -0.478 . . . . 74.12 111.644 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -48.44 -58.04 5.22 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.92 0.391 . . . . 72.44 111.376 176.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.569 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 94.9 t -53.3 -45.95 56.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.01 -0.541 . . . . 72.04 111.535 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.496 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 7.7 tpt180 -60.86 -41.67 96.37 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.65 -0.25 . . . . 74.13 111.38 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 89.1 mt -55.51 -44.62 76.81 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.329 0.585 . . . . 70.5 110.738 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -66.25 -41.74 89.54 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.884 -0.598 . . . . 74.23 111.553 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 89.5 mt -59.43 -45.44 91.54 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.829 0.347 . . . . 54.21 111.103 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 42' ' ' ARG . 58.1 mm-40 -52.65 -52.74 54.35 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.293 0.568 . . . . 74.42 110.749 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -65.87 -33.53 76.05 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.842 -0.617 . . . . 62.23 111.848 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.401 ' HA ' HG22 ' A' ' 51' ' ' VAL . 76.8 mt -64.89 -27.79 69.1 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.846 0.355 . . . . 75.32 111.333 176.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -75.39 -37.6 60.42 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.131 0.491 . . . . 71.11 110.142 172.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -63.57 -43.64 96.4 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.773 -0.649 . . . . 65.14 112.388 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.539 HG23 HG23 ' A' ' 53' ' ' VAL . 25.5 m -80.07 -12.74 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.741 0.645 . . . . 73.43 112.741 -177.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.2 52.97 1.66 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.027 -0.606 . . . . 70.54 113.645 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.539 HG23 HG23 ' A' ' 51' ' ' VAL . 94.4 t -124.77 -56.88 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.021 0.438 . . . . 61.1 111.113 176.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 69' ' ' LEU . 70.1 mt -100.03 138.83 36.57 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.337 -0.392 . . . . 73.31 111.91 -177.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -109.46 160.5 16.16 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.263 -0.426 . . . . 74.55 110.295 174.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -100.07 136.25 40.26 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.19 0.519 . . . . 63.43 111.958 -176.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.9 t . . . . . 0 CA--C 1.538 0.49 0 CA-C-N 116.118 -0.492 . . . . 70.12 110.484 176.705 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.545 HD13 ' HG2' ' A' ' 24' ' ' PRO . 77.0 mt . . . . . 0 CA--C 1.539 0.55 0 CA-C-O 120.853 0.358 . . . . 73.41 111.041 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -109.23 137.09 47.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.424 0.63 . . . . 72.15 112.279 -175.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -154.22 116.88 4.39 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.0 -0.545 . . . . 61.33 110.187 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 54' ' ' LEU . 2.3 pp -66.05 174.44 2.52 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.027 0.751 . . . . 72.23 113.027 -172.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 78.2 mt . . . . . 0 CA--C 1.537 0.455 0 CA-C-N 115.938 -0.574 . . . . 74.01 111.35 179.55 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.589 HG12 HD11 ' A' ' 36' ' ' LEU . 10.8 tp . . . . . 0 CA--C 1.544 0.716 0 N-CA-C 112.191 0.441 . . . . 71.41 112.191 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.6 t -57.57 -37.25 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 120.911 0.386 . . . . 52.43 111.507 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.2 m -54.26 -47.87 71.81 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.0 0.429 . . . . 71.42 111.083 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.453 ' O ' HG13 ' A' ' 12' ' ' ILE . 87.5 tttt -66.28 -40.4 90.06 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.562 -0.29 . . . . 74.33 110.767 177.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.458 ' O ' HG23 ' A' ' 13' ' ' VAL . 67.4 mt -53.35 -47.33 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 120.81 0.338 . . . . 64.54 111.316 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.7 mt -59.12 -43.86 90.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.933 0.397 . . . . 75.04 110.926 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.8 t -61.16 -40.06 92.47 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.421 -0.354 . . . . 75.11 111.763 176.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.462 HD13 ' HB3' ' A' ' 33' ' ' ALA . 82.4 mt -61.69 -43.41 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.82 0.343 . . . . 72.54 110.736 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.527 ' HA ' HG21 ' A' ' 25' ' ' VAL . 91.5 t -59.04 -47.56 89.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.965 0.412 . . . . 71.42 111.018 176.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -60.54 -47.17 87.36 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.086 0.47 . . . . 74.13 111.264 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.01 -52.37 65.82 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.275 0.56 . . . . 73.03 111.039 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.612 ' HA ' ' HG2' ' A' ' 19' ' ' MET . 1.0 OUTLIER -62.1 -35.53 78.97 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.358 -0.383 . . . . 72.14 111.706 178.752 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -62.88 -25.18 68.18 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 122.315 -0.241 . . . . 74.31 111.261 173.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -84.47 -20.94 30.9 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.563 0.579 . . . . 74.14 112.563 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.612 ' HG2' ' HA ' ' A' ' 16' ' ' ARG . 20.4 ptm -89.25 -38.82 13.94 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.944 -0.473 . . . . 74.21 112.171 173.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -89.94 -41.47 11.75 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 111.88 0.326 . . . . 61.32 111.88 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 63.26 -74.58 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.807 0.669 . . . . 64.31 112.807 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.42 -28.57 73.65 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.094 -0.574 . . . . 63.32 113.495 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.36 147.0 33.84 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 120.765 0.317 . . . . 74.14 111.76 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.573 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 6.0 Cg_exo -72.86 172.19 15.87 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.447 2.098 . . . . 64.33 112.522 176.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.527 HG21 ' HA ' ' A' ' 13' ' ' VAL . 40.3 t -80.15 150.02 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.167 -0.47 . . . . 71.11 111.719 -175.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.611 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -100.05 145.94 27.34 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.347 -0.388 . . . . 53.41 110.624 -177.391 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.0 m -54.43 -34.7 61.9 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.567 0.58 . . . . 54.04 112.567 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -62.4 -42.65 99.59 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.447 0.536 . . . . 72.3 112.447 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -53.89 -42.95 69.23 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.152 0.427 . . . . 72.5 112.152 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 30' ' ' ILE . 2.9 mp -65.56 -50.1 73.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.979 0.419 . . . . 75.24 111.035 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.32 -58.57 7.89 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.01 0.433 . . . . 74.44 112.058 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.87 -42.4 93.61 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.804 0.668 . . . . 45.14 112.804 -178.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.462 ' HB3' HD13 ' A' ' 12' ' ' ILE . . . -75.25 -34.31 61.38 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.343 0.497 . . . . 71.3 112.343 -178.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.432 ' HB1' HD11 ' A' ' 5' ' ' ILE . . . -85.42 -21.19 28.89 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.133 0.42 . . . . 64.24 112.133 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.81 22.16 53.87 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.242 -0.504 . . . . 74.44 112.821 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.589 HD11 HG12 ' A' ' 5' ' ' ILE . 73.3 mt -101.42 173.83 6.26 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.959 0.409 . . . . 74.32 111.591 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.417 ' O ' HG23 ' A' ' 41' ' ' VAL . 47.4 t -98.01 148.29 23.65 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.354 -0.384 . . . . 75.13 111.051 177.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.3 mm -50.61 -49.32 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 112.836 0.68 . . . . 74.21 112.836 -175.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.534 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 47.6 t80 -51.37 -50.62 59.18 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.892 0.33 . . . . 71.23 111.892 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.46 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 35.1 tt0 -69.04 -40.3 78.67 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.844 0.354 . . . . 74.21 111.371 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 37' ' ' SER . 69.9 t -60.54 -51.71 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.418 -0.356 . . . . 74.12 111.875 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 8.7 ptm180 -57.41 -36.06 70.84 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.629 -0.259 . . . . 75.04 111.287 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 94.0 mt -60.16 -48.44 81.71 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.729 0.299 . . . . 74.43 110.932 177.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.46 ' CE2' ' HG2' ' A' ' 40' ' ' GLN . 25.5 m-85 -57.34 -48.05 80.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.04 0.447 . . . . 73.54 110.919 176.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.455 HD13 ' NE1' ' A' ' 67' ' ' TRP . 78.9 mt -60.97 -43.8 98.27 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.871 -0.604 . . . . 74.43 111.727 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 42' ' ' ARG . 46.9 mt-10 -57.98 -52.2 66.52 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.044 0.45 . . . . 62.11 111.089 175.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 83.9 mm-40 -59.25 -40.33 85.63 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.098 -0.501 . . . . 63.24 111.343 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.6 mt -59.9 -40.12 87.71 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.723 0.297 . . . . 71.12 111.468 176.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 65.3 t60 -67.12 -40.24 86.8 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.037 -0.415 . . . . 63.13 111.104 174.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -65.81 -43.42 88.67 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.068 -0.514 . . . . 54.54 112.156 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.517 HG23 HG23 ' A' ' 53' ' ' VAL . 34.0 m -78.27 -12.03 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 112.448 0.536 . . . . 65.33 112.448 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.93 52.51 1.5 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.085 -0.579 . . . . 53.33 113.713 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.517 HG23 HG23 ' A' ' 51' ' ' VAL . 91.3 t -124.17 -44.49 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 120.973 0.416 . . . . 54.2 111.323 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.7 mt -110.12 142.57 41.43 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.431 0.634 . . . . 72.31 112.517 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -91.44 119.63 31.58 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.373 -0.83 . . . . 61.21 109.038 172.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -85.18 94.86 8.98 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.163 0.506 . . . . 73.11 110.845 -173.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.451 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 51.4 t . . . . . 0 CA--C 1.54 0.587 0 CA-C-N 115.877 -0.602 . . . . 63.23 112.183 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 92.0 mt . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 110.198 -0.297 . . . . 72.22 110.198 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.455 ' NE1' HD13 ' A' ' 45' ' ' LEU . 59.9 m95 -115.99 123.38 47.87 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.547 0.689 . . . . 75.33 112.452 -171.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 -128.46 113.33 15.39 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.768 -0.651 . . . . 73.43 110.788 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.455 ' O ' HD12 ' A' ' 69' ' ' LEU . 3.7 pp -63.48 149.95 44.92 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.904 -0.498 . . . . 74.31 111.866 -178.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 87.8 mt . . . . . 0 CA--C 1.538 0.488 0 CA-C-N 116.225 -0.443 . . . . 73.34 111.522 -179.381 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.483 HG21 HD11 ' A' ' 36' ' ' LEU . 61.3 mt . . . . . 0 CA--C 1.536 0.428 0 CA-C-O 121.063 0.459 . . . . 73.24 110.145 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.9 t -58.49 -54.89 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.084 -0.507 . . . . 71.12 111.321 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.5 m -61.04 -33.82 73.9 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.981 0.42 . . . . 54.11 111.066 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.427 ' O ' HG13 ' A' ' 12' ' ' ILE . 61.9 tttp -59.28 -49.42 77.9 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.976 0.417 . . . . 72.53 110.692 176.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.513 ' O ' HG23 ' A' ' 13' ' ' VAL . 73.2 mt -56.91 -49.72 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.184 -0.462 . . . . 64.21 111.175 176.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.9 mt -53.74 -42.65 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 121.156 0.503 . . . . 75.15 111.457 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.0 m -62.77 -43.33 99.09 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.168 -0.469 . . . . 35.11 111.244 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 8' ' ' LYS . 74.8 mt -61.06 -43.31 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.043 0.449 . . . . 60.12 111.255 177.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 9' ' ' ILE . 81.1 t -57.96 -52.15 61.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 116.064 -0.517 . . . . 71.24 111.391 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -63.71 -41.32 98.1 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.703 0.287 . . . . 72.25 111.524 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -51.58 -53.09 41.87 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.768 0.318 . . . . 75.31 111.158 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.529 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 3.1 mmp_? -57.05 -46.76 82.2 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 111.911 0.337 . . . . 73.34 111.911 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.732 HE22 ' HG ' ' A' ' 69' ' ' LEU . 21.9 mt-30 -64.69 -38.07 89.74 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.99 0.424 . . . . 64.33 112.14 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -77.76 -41.23 38.29 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.271 0.471 . . . . 72.51 112.271 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.5 mmt -75.71 -45.46 36.59 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.177 0.436 . . . . 70.51 112.177 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -82.28 -25.84 33.66 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.923 0.392 . . . . 61.31 110.538 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.8 t70 67.26 104.96 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.438 0.695 . . . . 74.11 112.01 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.7 -31.03 5.74 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 115.922 -0.581 . . . . 52.24 113.906 177.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.79 140.13 95.44 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 113.04 0.756 . . . . 74.2 113.04 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.19 146.4 17.81 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.899 2.399 . . . . 71.31 112.371 173.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.474 HG22 ' HB2' ' A' ' 16' ' ' ARG . 22.1 t -85.66 138.46 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.028 0.442 . . . . 72.11 112.061 -175.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.445 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -98.92 144.7 27.81 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.995 -0.548 . . . . 45.31 110.693 178.702 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 57.8 m -57.16 -32.73 66.72 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.843 0.354 . . . . 64.41 111.07 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -56.99 -57.54 12.1 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.243 -0.435 . . . . 74.13 112.147 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -54.59 -42.55 71.24 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.748 0.309 . . . . 64.4 111.712 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.401 ' HA ' HG21 ' A' ' 12' ' ' ILE . 58.7 mt -63.49 -43.71 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.404 -0.362 . . . . 71.21 111.337 177.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.1 -49.6 77.0 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.06 0.393 . . . . 74.43 112.06 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -65.48 -42.87 91.74 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.042 0.386 . . . . 51.52 112.042 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.89 -35.46 74.66 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.373 0.509 . . . . 72.03 112.373 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.64 -24.14 24.03 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.985 0.365 . . . . 62.33 111.985 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.29 37.4 24.6 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.365 -0.445 . . . . 65.15 112.96 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.483 HD11 HG21 ' A' ' 5' ' ' ILE . 84.1 mt -123.05 174.65 7.07 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.964 0.411 . . . . 71.35 111.743 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 41' ' ' VAL . 49.3 m -86.8 144.71 26.92 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.477 -0.329 . . . . 70.22 111.277 177.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.2 mm -47.15 -51.13 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 112.396 0.517 . . . . 75.31 112.396 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.497 ' CE2' HD11 ' A' ' 43' ' ' LEU . 82.8 t80 -54.44 -56.38 19.3 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.251 -0.431 . . . . 73.13 111.36 177.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -54.88 -49.0 72.26 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.073 -0.512 . . . . 75.31 111.69 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 37' ' ' SER . 89.4 t -54.68 -53.03 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.983 -0.553 . . . . 71.3 111.625 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -65.85 -26.85 67.84 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.949 -0.3 . . . . 73.34 111.61 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.497 HD11 ' CE2' ' A' ' 39' ' ' TYR . 80.7 mt -58.31 -48.77 79.46 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.948 0.404 . . . . 54.41 110.287 174.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -66.04 -34.12 77.37 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.234 -0.439 . . . . 64.11 111.192 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 88.5 mt -63.21 -46.08 88.66 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.66 0.267 . . . . 52.31 111.062 176.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 49' ' ' HIS . 1.1 mp0 -55.68 -48.09 75.66 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.717 0.294 . . . . 65.1 110.789 174.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 94.7 mt-30 -56.8 -50.7 71.55 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.813 0.34 . . . . 73.13 111.055 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.522 ' HA ' HG22 ' A' ' 51' ' ' VAL . 95.1 mt -58.52 -30.57 67.17 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.118 0.485 . . . . 71.23 111.439 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.475 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 7.3 t-80 -65.9 -45.95 80.09 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.901 0.382 . . . . 72.41 111.446 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -79.84 -23.73 41.8 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.222 0.823 . . . . 74.34 113.222 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 48' ' ' LEU . 23.9 m -89.77 6.49 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 121.838 -0.539 . . . . 75.21 111.78 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.1 57.78 3.36 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 116.325 -0.398 . . . . 63.13 113.934 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.469 HG23 HG23 ' A' ' 51' ' ' VAL . 90.2 t -131.77 -51.94 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 122.431 -0.452 . . . . 52.25 111.816 177.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.9 mt -97.01 143.97 27.35 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.933 0.716 . . . . 70.23 112.933 -175.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -102.03 153.24 20.09 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.215 -0.902 . . . . 72.13 110.89 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.547 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 1.8 mppt? -97.21 119.85 36.48 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.767 0.318 . . . . 65.42 110.902 -176.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 49.2 t . . . . . 0 CA--C 1.537 0.481 0 CA-C-O 121.132 0.491 . . . . 72.1 112.186 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 94.4 mt . . . . . 0 CA--C 1.538 0.514 0 CA-C-O 120.632 0.253 . . . . 75.14 110.643 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -106.16 132.8 51.79 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.611 0.967 . . . . 72.15 113.611 -169.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 68' ' ' ARG . 12.4 mtp180 -139.21 -168.64 2.49 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.505 -0.771 . . . . 71.54 109.755 169.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.732 ' HG ' HE22 ' A' ' 17' ' ' GLN . 2.5 pp -114.21 169.16 9.23 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 122.026 -0.421 . . . . 71.0 111.225 177.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 89.2 mt . . . . . 0 CA--C 1.541 0.6 0 CA-C-O 121.059 0.456 . . . . 74.42 111.054 177.183 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 36' ' ' LEU . 14.6 tt . . . . . 0 CA--C 1.54 0.578 0 CA-C-O 121.248 0.547 . . . . 71.12 110.877 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.5 t -69.07 -35.56 69.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.266 -0.425 . . . . 75.43 110.815 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.1 m -52.96 -43.47 66.39 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.101 0.477 . . . . 73.53 110.318 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.557 ' O ' HG13 ' A' ' 12' ' ' ILE . 40.5 ttmt -60.45 -48.51 81.45 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.993 -0.549 . . . . 75.3 110.776 175.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.4 mt -52.57 -47.17 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.892 0.377 . . . . 73.32 111.512 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.6 mt -61.8 -45.58 98.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.049 0.452 . . . . 42.11 111.202 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 84.7 p -67.96 -18.35 64.71 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.906 0.336 . . . . 61.44 111.906 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 8' ' ' LYS . 99.3 mt -75.01 -44.83 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.081 0.467 . . . . 70.22 110.417 172.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.8 t -59.96 -41.51 86.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.195 0.521 . . . . 63.22 110.34 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -65.36 -45.33 84.57 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.884 -0.598 . . . . 75.43 110.526 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -51.09 -52.2 45.94 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.14 -0.482 . . . . 50.22 111.734 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.9 mmt-85 -61.97 -37.68 85.68 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 111.952 0.353 . . . . 75.51 111.952 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -74.88 -12.97 60.49 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 122.148 -0.345 . . . . 64.51 111.86 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -82.6 -45.55 14.44 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.906 0.384 . . . . 70.32 110.459 171.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 93.6 mmm -70.11 -65.22 0.75 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.176 -0.466 . . . . 71.31 110.632 176.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -81.68 102.86 10.98 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.989 0.423 . . . . 74.04 110.004 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -51.11 95.57 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.115 0.783 . . . . 62.34 113.115 -172.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.91 33.05 84.57 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 115.721 -0.672 . . . . 74.5 113.657 175.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.96 145.97 30.69 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 120.879 0.371 . . . . 44.44 111.962 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.586 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 38.4 Cg_endo -65.28 131.56 28.73 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.513 2.142 . . . . 64.2 112.838 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.3 t -82.62 147.88 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.084 -0.507 . . . . 53.23 111.866 -176.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -100.61 146.72 26.79 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.297 -0.41 . . . . 64.02 111.035 -178.869 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.4 m -57.17 -32.53 66.52 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 111.909 0.337 . . . . 72.15 111.909 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 28' ' ' ARG . 3.9 mpt_? -60.75 -53.82 52.74 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.096 0.406 . . . . 71.15 112.096 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.421 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 9.5 m-20 -53.11 -47.61 68.49 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.969 0.414 . . . . 74.32 111.339 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.532 ' HA ' HG21 ' A' ' 12' ' ' ILE . 61.5 mt -59.49 -43.83 91.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.96 -0.564 . . . . 75.12 111.389 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.557 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -62.5 -54.34 41.47 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.167 0.432 . . . . 71.23 112.167 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.35 -43.87 96.46 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.95 0.352 . . . . 63.52 111.95 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.422 ' HB3' HD13 ' A' ' 12' ' ' ILE . . . -62.91 -37.81 88.46 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.79 0.329 . . . . 62.12 111.709 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.92 -18.58 36.9 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.99 0.424 . . . . 65.42 111.63 176.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.86 20.69 70.12 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.327 -0.397 . . . . 74.13 113.569 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.505 HD11 HD11 ' A' ' 5' ' ' ILE . 84.4 mt -111.61 176.39 5.04 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.14 0.495 . . . . 75.3 112.04 -175.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.6 m -83.29 147.45 27.96 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.026 -0.534 . . . . 75.53 111.711 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 39.6 mm -50.6 -51.29 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 112.796 0.665 . . . . 44.21 112.796 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.404 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 77.8 t80 -60.81 -49.6 76.82 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.742 0.306 . . . . 54.21 111.635 -178.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -58.11 -50.41 73.59 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.176 0.513 . . . . 71.24 111.144 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.557 HG21 ' HA ' ' A' ' 31' ' ' ALA . 73.1 t -55.38 -46.56 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.139 -0.482 . . . . 74.0 111.131 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.508 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 16.5 ttt180 -53.11 -44.22 67.47 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.256 -0.429 . . . . 74.13 111.4 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 97.6 mt -54.69 -47.07 74.12 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.051 0.453 . . . . 71.24 110.781 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -62.41 -46.29 89.27 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.101 -0.499 . . . . 72.24 111.282 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 85.0 mt -61.42 -40.94 96.26 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.349 -0.387 . . . . 62.22 111.712 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' A' ' 42' ' ' ARG . 55.5 mt-10 -59.31 -42.25 90.94 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.971 0.415 . . . . 72.43 111.107 177.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -71.88 -33.12 68.1 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.813 0.339 . . . . 65.45 111.159 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.73 -29.11 69.58 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.017 0.437 . . . . 72.13 111.207 174.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.44 ' HD2' ' HA ' ' A' ' 55' ' ' GLU . 54.4 t-80 -73.37 -28.96 62.32 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.083 0.468 . . . . 74.51 110.603 172.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -73.96 -52.25 13.42 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.927 -0.578 . . . . 74.21 111.584 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.518 HG23 HG23 ' A' ' 53' ' ' VAL . 34.1 m -73.5 -10.96 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 113.144 0.794 . . . . 75.21 113.144 -176.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.53 49.08 2.05 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.005 -0.617 . . . . 54.52 114.042 176.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.518 HG23 HG23 ' A' ' 51' ' ' VAL . 91.7 t -118.65 -52.5 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.968 0.413 . . . . 55.0 111.427 176.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 86.4 mt -114.91 148.57 38.48 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.018 0.437 . . . . 74.0 111.979 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.44 ' HA ' ' HD2' ' A' ' 49' ' ' HIS . 10.1 tp10 -111.97 133.7 53.99 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.216 -0.447 . . . . 73.23 111.092 174.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -85.65 97.89 10.37 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.987 -0.551 . . . . 73.54 110.734 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 46.7 t . . . . . 0 CA--C 1.537 0.458 0 CA-C-N 115.987 -0.551 . . . . 34.13 111.552 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.586 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 87.3 mt . . . . . 0 CA--C 1.54 0.596 0 CA-C-O 120.832 0.349 . . . . 63.53 111.329 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -124.38 133.54 53.39 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.307 0.575 . . . . 74.44 112.313 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -127.46 121.33 30.49 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.283 -0.417 . . . . 72.32 110.705 172.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.461 ' O ' HD12 ' A' ' 69' ' ' LEU . 2.9 pp -69.99 147.6 49.92 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.947 0.403 . . . . 72.11 111.659 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 CA--C 1.536 0.426 0 CA-C-N 116.437 -0.347 . . . . 73.42 111.662 -177.16 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.0 tp . . . . . 0 CA--C 1.543 0.71 0 N-CA-C 112.003 0.372 . . . . 71.14 112.003 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.8 t -61.78 -51.32 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 111.696 0.258 . . . . 73.14 111.696 -177.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.1 m -56.63 -37.53 70.85 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.905 0.383 . . . . 63.42 111.423 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.504 ' O ' HG13 ' A' ' 12' ' ' ILE . 37.3 ttpt -65.28 -43.61 90.64 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.471 -0.331 . . . . 65.13 110.721 176.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.489 HG23 HG21 ' A' ' 30' ' ' ILE . 69.2 mt -59.41 -44.83 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.737 0.303 . . . . 72.42 111.503 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 69.0 mt -56.68 -45.65 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.27 0.557 . . . . 64.04 110.771 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.6 m -66.98 -29.32 69.13 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.933 -0.576 . . . . 73.23 111.905 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 8' ' ' LYS . 94.0 mt -63.94 -44.02 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.056 0.455 . . . . 61.01 110.91 174.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.425 ' HA ' HG21 ' A' ' 25' ' ' VAL . 59.3 t -57.31 -47.15 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.116 0.484 . . . . 73.31 110.729 175.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -61.27 -46.59 89.7 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.08 -0.509 . . . . 62.42 110.992 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -56.3 -46.75 79.67 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.1 -0.5 . . . . 70.54 111.421 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.42 ' HD3' ' SD ' ' A' ' 19' ' ' MET . 11.1 mmt180 -61.33 -36.67 80.79 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.5 -0.318 . . . . 72.53 111.729 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.428 ' NE2' ' HG ' ' A' ' 69' ' ' LEU . 73.6 mt-30 -75.79 -21.6 57.2 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.782 0.325 . . . . 70.13 111.814 176.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -70.53 -36.12 73.54 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.366 0.603 . . . . 74.05 110.04 170.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.42 ' SD ' ' HD3' ' A' ' 16' ' ' ARG . 74.3 mtp -67.69 -50.39 57.83 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.548 -0.751 . . . . 61.12 111.062 176.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -122.5 116.74 24.45 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.132 -0.486 . . . . 73.21 110.494 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -40.33 -53.28 2.6 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.213 0.82 . . . . 61.2 113.213 -173.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.94 53.98 0.7 Allowed Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.19 -0.529 . . . . 53.54 113.046 -176.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.414 ' HA ' ' HD2' ' A' ' 24' ' ' PRO . . . -101.83 110.27 61.7 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.361 0.504 . . . . 62.05 112.361 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.587 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 56.4 Cg_endo -69.88 122.29 8.94 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.093 1.862 . . . . 72.41 110.767 170.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.425 HG21 ' HA ' ' A' ' 13' ' ' VAL . 22.0 t -79.38 141.47 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 112.37 0.508 . . . . 71.34 112.37 -167.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -97.58 151.07 20.43 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.134 -0.484 . . . . 71.22 110.867 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.4 m -53.05 -37.33 61.5 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.201 -0.454 . . . . 62.4 111.526 175.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -64.22 -44.36 92.13 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.295 -0.411 . . . . 74.14 112.009 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.04 -41.34 98.0 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.994 0.426 . . . . 74.41 111.548 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.489 HG21 HG23 ' A' ' 9' ' ' ILE . 60.2 mt -65.78 -43.37 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 116.515 -0.311 . . . . 61.4 111.045 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.59 -37.51 81.6 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.202 0.525 . . . . 32.32 110.893 174.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.36 -48.33 81.77 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.662 -0.699 . . . . 73.01 111.697 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.16 -50.29 49.04 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.018 0.377 . . . . 62.4 112.018 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.0 -19.65 61.16 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.584 0.587 . . . . 74.11 112.584 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.17 40.0 51.36 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.159 -0.543 . . . . 63.42 112.673 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.4 175.26 6.53 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.805 0.336 . . . . 65.45 111.241 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.2 t -85.07 153.76 22.5 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.747 0.308 . . . . 70.12 111.192 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.59 -50.13 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 112.954 0.724 . . . . 65.2 112.954 -175.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -66.62 -44.72 81.29 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 122.197 -0.315 . . . . 63.51 111.763 -175.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -51.07 -55.44 17.56 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.203 0.525 . . . . 75.11 111.054 175.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.445 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 82.7 t -61.1 -39.86 83.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.064 -0.516 . . . . 71.3 110.942 176.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -53.52 -41.44 66.34 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.243 -0.435 . . . . 54.04 110.684 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.3 mt -62.92 -52.86 61.41 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.001 -0.545 . . . . 71.42 111.285 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -56.05 -36.85 68.5 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.011 0.434 . . . . 64.02 111.357 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.552 HD13 ' NE1' ' A' ' 67' ' ' TRP . 99.1 mt -69.78 -40.11 76.23 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.408 -0.36 . . . . 75.22 111.756 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -60.73 -37.94 83.45 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.025 0.44 . . . . 75.21 110.685 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -61.4 -54.02 49.06 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.385 -0.371 . . . . 52.52 110.712 174.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.5 mt -57.11 -31.53 65.39 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.15 0.5 . . . . 73.03 111.608 176.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -63.71 -50.82 67.65 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.921 -0.581 . . . . 71.13 111.803 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -76.79 -40.65 47.43 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.944 0.72 . . . . 73.32 112.944 -176.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.505 HG23 HG23 ' A' ' 53' ' ' VAL . 23.5 m -67.58 -16.14 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 112.253 0.464 . . . . 73.04 112.253 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.61 48.29 2.36 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.185 -0.531 . . . . 75.11 113.935 177.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.505 HG23 HG23 ' A' ' 51' ' ' VAL . 97.9 t -118.71 -40.94 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 121.075 0.464 . . . . 71.12 111.28 176.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.418 HD13 ' HB3' ' A' ' 67' ' ' TRP . 83.5 mt -112.85 136.45 52.46 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.401 0.619 . . . . 63.41 112.296 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -91.65 143.15 26.85 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.586 -0.734 . . . . 55.03 109.971 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -93.94 105.08 17.11 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.889 0.852 . . . . 75.13 111.662 -174.83 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 28.6 t . . . . . 0 CA--C 1.539 0.537 0 CA-C-O 121.358 0.599 . . . . 74.0 110.588 177.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.587 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 67.0 mt . . . . . 0 CA--C 1.537 0.45 0 CA-C-O 120.973 0.416 . . . . 74.03 110.191 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.552 ' NE1' HD13 ' A' ' 45' ' ' LEU . 67.1 m95 -93.88 116.43 28.89 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.335 0.588 . . . . 63.13 112.179 -172.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -114.69 111.49 21.37 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.843 -0.617 . . . . 72.31 110.534 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.428 ' HG ' ' NE2' ' A' ' 17' ' ' GLN . 3.5 pp -59.3 156.02 13.4 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 122.008 -0.433 . . . . 75.24 111.504 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.7 mt . . . . . 0 CA--C 1.539 0.526 0 CA-C-O 121.166 0.507 . . . . 73.3 111.231 179.27 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 121.098 0.475 . . . . 71.24 110.87 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.17 -47.11 91.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-N 116.116 -0.493 . . . . 74.31 111.145 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.1 m -52.22 -46.08 65.54 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.166 0.508 . . . . 72.33 111.354 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -55.36 -55.14 35.0 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.95 -0.568 . . . . 73.03 111.298 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.464 ' O ' HG23 ' A' ' 13' ' ' VAL . 62.8 mt -60.44 -46.04 95.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 112.038 0.384 . . . . 73.23 112.038 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.8 mt -58.51 -50.93 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 111.892 0.33 . . . . 74.43 111.892 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.6 p -55.92 -43.65 77.54 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.792 0.33 . . . . 40.42 111.771 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 82.5 mt -61.68 -55.91 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.927 0.394 . . . . 43.33 111.589 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 9' ' ' ILE . 80.1 t -55.07 -41.84 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.063 0.459 . . . . 72.42 111.523 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -65.5 -53.23 45.43 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.128 -0.487 . . . . 73.32 111.17 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -51.64 -49.5 62.16 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.104 0.478 . . . . 74.55 111.328 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -54.3 -51.12 65.65 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.733 -0.667 . . . . 74.24 111.943 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.487 ' NE2' ' HA ' ' A' ' 68' ' ' ARG . 78.3 mt-30 -66.32 -16.45 64.06 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.306 0.484 . . . . 74.4 112.306 -178.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -78.8 -29.63 45.01 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 122.045 -0.409 . . . . 53.13 110.791 170.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 23.2 mmt -91.5 -74.19 0.51 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.825 0.345 . . . . 71.34 111.54 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.27 77.79 8.91 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.91 0.862 . . . . 74.13 111.157 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -85.92 -28.06 24.57 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.116 -0.947 . . . . 74.43 111.06 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.36 -3.38 82.25 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 116.056 -0.52 . . . . 71.11 113.641 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -150.92 119.87 3.54 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 122.436 -0.45 . . . . 54.13 111.315 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.551 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 10.8 Cg_endo -52.59 152.87 15.4 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.99 2.46 . . . . 74.11 113.435 -178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.6 t -79.99 150.36 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 112.141 0.423 . . . . 64.12 112.141 -172.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.511 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 9.9 mptt -96.69 151.42 19.64 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.868 0.366 . . . . 72.14 111.262 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.8 m -56.0 -36.58 68.08 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 116.286 -0.415 . . . . 73.44 111.957 177.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.2 mtm-85 -57.07 -58.33 8.66 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.975 0.417 . . . . 75.22 111.501 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.91 -44.19 70.34 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.651 -0.704 . . . . 73.14 112.27 -177.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.6 mt -63.68 -46.29 95.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.065 0.459 . . . . 64.44 111.115 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.548 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -62.74 -43.88 97.64 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.933 0.396 . . . . 64.55 111.578 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.35 -47.28 84.9 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.062 -0.517 . . . . 61.03 111.2 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.67 -29.56 68.88 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 111.895 0.332 . . . . 63.34 111.895 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.14 -15.44 36.11 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.103 0.409 . . . . 52.43 112.103 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.14 27.4 71.98 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.425 -0.417 . . . . 44.53 112.832 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.6 mt -117.87 175.29 5.73 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.126 0.488 . . . . 73.14 111.753 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.5 t -80.23 149.31 30.47 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.399 0.518 . . . . 72.25 112.399 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.7 mm -51.92 -40.52 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.962 -0.563 . . . . 73.2 111.001 174.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.454 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 85.8 t80 -64.83 -56.61 12.4 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.939 -0.573 . . . . 74.42 111.855 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -57.96 -51.06 71.2 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.178 0.513 . . . . 71.35 111.633 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.548 HG21 ' HA ' ' A' ' 31' ' ' ALA . 78.2 t -55.87 -47.94 79.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.146 -0.479 . . . . 74.54 111.602 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -57.35 -38.33 73.97 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.572 -0.286 . . . . 65.01 111.52 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 92.2 mt -58.38 -46.45 86.32 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.809 0.338 . . . . 54.42 111.079 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -65.99 -44.17 85.64 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.787 0.327 . . . . 71.32 111.517 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.74 -48.43 81.83 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.116 0.484 . . . . 75.54 111.634 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.25 -41.34 90.11 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.318 -0.401 . . . . 73.3 111.79 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -61.72 -41.55 97.77 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.217 -0.302 . . . . 73.2 111.386 176.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.9 mt -60.01 -33.39 71.93 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.763 0.316 . . . . 64.43 111.166 176.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -66.22 -49.76 66.17 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 122.166 -0.334 . . . . 72.44 110.959 172.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.63 -32.07 71.24 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 112.085 0.402 . . . . 75.23 112.085 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.453 HG23 HG23 ' A' ' 53' ' ' VAL . 30.9 m -90.96 2.66 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 112.717 0.636 . . . . 62.34 112.717 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.03 51.93 3.43 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.222 -0.513 . . . . 52.24 114.202 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.453 HG23 HG23 ' A' ' 51' ' ' VAL . 60.9 t -129.71 -58.51 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 122.394 -0.474 . . . . 75.04 110.91 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.5 mt -104.37 178.43 4.56 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.211 0.529 . . . . 74.02 111.872 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.548 ' HB3' ' HG3' ' A' ' 68' ' ' ARG . 11.7 tp10 -138.03 144.78 41.2 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 120.843 0.354 . . . . 72.5 111.254 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -89.81 129.18 36.23 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.128 0.788 . . . . 74.24 113.128 -174.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.482 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 45.4 t . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 108.679 -0.859 . . . . 64.14 108.679 165.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 96.4 mt . . . . . 0 N--CA 1.467 0.423 0 CA-C-O 121.108 0.48 . . . . 63.21 110.227 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 28.8 m95 -123.4 143.24 50.25 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.636 0.606 . . . . 75.21 112.636 -169.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.548 ' HG3' ' HB3' ' A' ' 55' ' ' GLU . 9.1 ptm180 -147.69 174.43 11.79 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.668 -0.696 . . . . 72.41 110.862 174.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.459 ' HG ' ' OE1' ' A' ' 17' ' ' GLN . 3.3 pp -125.22 177.57 6.05 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.872 0.368 . . . . 52.21 111.426 175.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.526 ' N ' HD23 ' A' ' 70' ' ' LEU . 1.3 pt? . . . . . 0 CA--C 1.541 0.608 0 CA-C-O 121.416 0.627 . . . . 71.13 110.751 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.465 ' N ' HD12 ' A' ' 5' ' ' ILE . 2.1 mp . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 112.154 0.427 . . . . 72.34 112.154 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.92 -35.07 72.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.189 0.518 . . . . 65.11 110.48 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.0 m -61.28 -38.14 85.7 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.042 -0.526 . . . . 74.04 110.603 173.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.43 ' O ' HG13 ' A' ' 12' ' ' ILE . 86.8 tttt -63.35 -42.53 98.92 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.308 -0.406 . . . . 64.24 110.613 174.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.433 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.5 mt -52.19 -45.13 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.027 0.441 . . . . 70.11 110.796 174.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.4 mt -58.45 -44.38 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 116.224 -0.444 . . . . 75.1 111.203 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.9 m -59.64 -42.2 92.24 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.393 -0.367 . . . . 72.33 111.266 176.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 8' ' ' LYS . 82.9 mt -59.59 -46.05 93.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.055 0.455 . . . . 75.24 111.054 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.558 ' HA ' HG21 ' A' ' 25' ' ' VAL . 63.7 t -60.5 -49.63 83.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.082 0.468 . . . . 62.15 111.096 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.65 -41.59 86.42 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.239 0.542 . . . . 52.21 110.677 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -60.05 -51.04 71.33 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.779 -0.646 . . . . 73.21 112.156 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.482 ' HB2' HG22 ' A' ' 25' ' ' VAL . 27.4 mmt180 -59.09 -35.4 73.35 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.664 0.269 . . . . 75.44 111.202 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.507 ' NE2' HG12 ' A' ' 13' ' ' VAL . 44.1 mt-30 -67.02 -27.33 67.32 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.976 0.417 . . . . 74.03 111.642 175.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -76.17 -23.12 54.73 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.963 0.411 . . . . 71.44 110.898 174.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.7 mmt -75.19 -54.99 6.19 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.06 -0.518 . . . . 71.25 110.345 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -119.99 98.97 6.34 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.166 -0.47 . . . . 74.05 110.592 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -61.76 -15.89 44.88 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.844 0.683 . . . . 63.31 112.844 -174.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -117.29 31.88 5.64 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.34 -0.457 . . . . 51.53 113.297 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -140.36 136.97 17.2 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 112.45 0.537 . . . . 73.01 112.45 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.556 ' HG2' HD13 ' A' ' 66' ' ' LEU . 82.7 Cg_endo -83.29 159.61 15.1 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.63 2.22 . . . . 62.41 112.312 172.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.558 HG21 ' HA ' ' A' ' 13' ' ' VAL . 11.2 t -85.91 156.2 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.055 0.455 . . . . 71.53 111.986 -175.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.46 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -99.95 140.17 34.55 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.263 -0.426 . . . . 70.11 110.783 -175.14 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.2 m -55.61 -41.1 73.0 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.874 0.369 . . . . 73.33 111.791 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -61.43 -52.72 63.4 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.892 0.377 . . . . 72.41 111.353 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.09 -35.66 75.7 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.238 -0.437 . . . . 74.44 111.772 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.529 HG21 HD21 ' A' ' 45' ' ' LEU . 77.8 mt -66.95 -56.28 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.801 0.334 . . . . 51.53 111.464 176.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.412 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -56.45 -43.42 79.49 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.087 0.403 . . . . 71.14 112.087 -178.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.51 -53.03 58.4 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.041 -0.527 . . . . 51.54 110.958 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.11 -29.47 70.59 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 111.933 0.346 . . . . 60.2 111.933 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.75 -27.13 44.66 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.905 0.383 . . . . 62.01 111.914 177.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.99 45.99 9.85 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.089 -0.577 . . . . 41.1 112.965 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.2 mt -135.5 178.16 7.26 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.732 -0.275 . . . . 74.13 111.045 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.422 ' O ' HG23 ' A' ' 41' ' ' VAL . 66.5 m -82.18 142.9 31.8 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 122.395 -0.191 . . . . 74.31 111.306 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.443 ' O ' ' HG3' ' A' ' 42' ' ' ARG . 48.2 mm -51.72 -55.68 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 122.53 0.332 . . . . 61.14 111.752 -176.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -54.17 -48.19 71.19 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.036 0.446 . . . . 72.13 111.474 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -58.12 -45.94 86.45 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.865 -0.607 . . . . 73.44 111.795 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 37' ' ' SER . 99.1 t -66.71 -39.27 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.319 -0.4 . . . . 74.41 111.637 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 38' ' ' ILE . 79.4 mtp180 -53.4 -44.45 68.73 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.809 0.337 . . . . 72.13 110.856 176.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.44 ' O ' ' HG3' ' A' ' 47' ' ' GLN . 98.2 mt -59.61 -49.51 77.48 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.23 -0.441 . . . . 71.22 111.054 176.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 21.4 m-30 -58.85 -43.87 90.88 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.888 0.375 . . . . 53.3 111.717 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.529 HD21 HG21 ' A' ' 30' ' ' ILE . 96.7 mt -63.45 -45.54 90.4 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.373 -0.376 . . . . 74.34 111.588 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -61.33 -39.7 91.5 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 121.214 -0.194 . . . . 53.12 110.788 175.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 80.9 mt-30 -58.45 -44.16 89.1 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.965 0.412 . . . . 63.33 110.976 172.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.86 -31.22 71.46 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.345 -0.389 . . . . 75.52 111.946 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -73.98 -36.67 64.57 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.082 0.468 . . . . 75.45 110.918 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -64.26 -50.46 67.86 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.159 -0.473 . . . . 71.14 111.291 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.549 HG23 HG23 ' A' ' 53' ' ' VAL . 33.7 m -75.56 4.13 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 N-CA-C 112.641 0.608 . . . . 73.43 112.641 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.71 29.53 38.84 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 114.952 0.741 . . . . 74.32 114.952 171.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.549 HG23 HG23 ' A' ' 51' ' ' VAL . 82.2 t -96.46 -60.15 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 117.413 0.607 . . . . 75.52 111.269 174.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.462 HD22 HG11 ' A' ' 13' ' ' VAL . 71.5 mt -99.26 145.48 27.24 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.226 0.536 . . . . 71.24 112.206 -176.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.525 ' HB2' HD23 ' A' ' 70' ' ' LEU . 9.3 tp10 -92.39 142.59 27.28 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.983 -0.553 . . . . 74.15 111.085 174.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -87.84 107.06 18.49 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.838 -0.619 . . . . 71.33 110.666 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 CA--C 1.542 0.664 0 CA-C-O 121.012 0.434 . . . . 65.15 112.002 -178.497 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.556 HD13 ' HG2' ' A' ' 24' ' ' PRO . 96.4 mt . . . . . 0 N--CA 1.47 0.525 0 CA-C-O 121.036 0.446 . . . . 64.02 111.319 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.452 ' CD1' HD13 ' A' ' 45' ' ' LEU . 67.1 m95 -108.04 117.54 34.39 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.809 0.67 . . . . 64.25 112.809 -170.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.475 ' HG3' ' OE1' ' A' ' 17' ' ' GLN . 55.8 ttt180 -120.63 178.7 4.58 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.402 -0.962 . . . . 73.34 108.402 171.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 54' ' ' LEU . 2.3 pp -101.52 160.97 13.98 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.526 1.057 . . . . 61.52 111.557 174.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.525 HD23 ' HB2' ' A' ' 55' ' ' GLU . 84.3 mt . . . . . 0 CA--C 1.535 0.388 0 CA-C-O 120.891 0.377 . . . . 72.15 110.337 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.7 mm . . . . . 0 N--CA 1.471 0.578 0 CA-C-O 121.05 0.452 . . . . 53.41 111.139 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.3 t -61.46 -48.11 90.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.341 -0.391 . . . . 73.0 110.923 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 99.5 m -58.13 -39.61 79.17 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.246 -0.434 . . . . 74.41 111.613 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.467 ' O ' HG13 ' A' ' 12' ' ' ILE . 60.1 tptt -57.57 -53.99 51.93 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.116 0.484 . . . . 71.51 110.485 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.527 HG23 HG21 ' A' ' 30' ' ' ILE . 67.8 mt -57.78 -48.65 83.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 115.784 -0.644 . . . . 74.55 111.931 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.7 mt -59.32 -44.31 92.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-O 120.966 0.412 . . . . 74.43 111.608 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.2 t -63.05 -32.49 73.87 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.336 -0.393 . . . . 70.24 111.556 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 8' ' ' LYS . 99.0 mt -71.35 -49.0 50.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.898 0.38 . . . . 72.34 111.336 176.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 9' ' ' ILE . 89.6 t -56.48 -44.09 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.135 0.493 . . . . 60.35 110.776 176.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -65.6 -39.96 92.13 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.945 -0.57 . . . . 74.2 110.898 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -55.57 -47.85 75.73 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.167 0.508 . . . . 52.4 110.87 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.572 ' HA ' ' HG2' ' A' ' 19' ' ' MET . 0.3 OUTLIER -64.46 -34.35 77.99 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.088 -0.506 . . . . 65.3 111.398 178.281 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.417 ' NE2' ' HG3' ' A' ' 68' ' ' ARG . 12.3 mm-40 -65.07 -40.03 94.1 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.038 0.447 . . . . 71.34 111.651 174.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -75.99 -21.94 56.38 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.281 0.474 . . . . 74.35 112.281 -177.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.572 ' HG2' ' HA ' ' A' ' 16' ' ' ARG . 24.8 ptm -83.77 -32.29 25.48 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.956 -0.465 . . . . 65.32 111.379 176.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -152.17 115.29 4.69 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.091 0.472 . . . . 71.0 110.805 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -69.4 -13.44 62.36 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.998 0.74 . . . . 74.13 112.998 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.03 15.15 12.34 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.052 -0.594 . . . . 72.24 113.487 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -107.71 113.58 61.25 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 112.174 0.435 . . . . 61.05 112.174 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.83 140.78 32.57 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.36 2.04 . . . . 71.32 112.067 172.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.411 HG13 ' HG3' ' A' ' 16' ' ' ARG . 5.4 t -79.12 154.64 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 120.923 0.392 . . . . 74.34 111.199 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.567 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 2.3 mptp? -107.58 139.0 42.79 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.65 -0.25 . . . . 74.12 110.737 -177.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.2 m -53.49 -51.13 63.75 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.066 0.46 . . . . 65.54 111.8 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -64.85 -31.26 72.4 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.114 0.412 . . . . 65.22 112.114 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -63.54 -52.69 60.01 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.945 0.403 . . . . 63.3 111.046 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.527 HG21 HG23 ' A' ' 9' ' ' ILE . 64.2 mt -55.89 -43.13 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.045 0.45 . . . . 73.13 110.892 176.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.78 -35.68 73.21 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.102 -0.499 . . . . 73.42 111.876 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -74.1 -48.46 29.52 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.763 0.316 . . . . 71.35 110.992 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.11 -28.66 69.92 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.114 0.413 . . . . 70.22 112.114 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.22 -26.45 16.64 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.297 0.48 . . . . 53.44 112.297 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.21 31.47 38.25 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.267 -0.492 . . . . 73.1 112.713 -176.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.5 mt -115.35 169.26 9.28 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.845 0.355 . . . . 63.12 111.432 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.412 ' O ' HG23 ' A' ' 41' ' ' VAL . 46.1 t -87.7 151.49 22.89 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.029 0.443 . . . . 62.32 111.772 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.1 mm -58.09 -48.85 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 112.985 0.735 . . . . 60.2 112.985 -172.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.552 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 41.8 p90 -56.68 -38.67 72.57 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 111.853 0.316 . . . . 74.53 111.853 -176.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -75.84 -47.18 26.64 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.079 0.466 . . . . 65.33 111.091 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 37' ' ' SER . 90.9 t -55.23 -48.28 76.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 116.17 -0.468 . . . . 72.33 111.614 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -65.61 -29.72 70.34 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 111.887 0.329 . . . . 71.24 111.887 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 65.6 mt -59.03 -49.28 78.49 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.167 -0.333 . . . . 61.33 110.577 176.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -61.28 -53.27 58.96 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.352 -0.385 . . . . 74.02 111.191 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.426 HD13 ' CD1' ' A' ' 67' ' ' TRP . 89.0 mt -55.37 -49.73 71.53 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.226 0.536 . . . . 74.31 112.393 -178.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.79 -41.73 95.6 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.937 -0.574 . . . . 62.34 112.095 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -68.83 -41.13 78.95 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.741 0.305 . . . . 75.25 110.942 176.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.0 mt -59.68 -31.63 69.74 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.746 0.307 . . . . 61.44 111.102 175.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.512 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 42.0 t-80 -66.43 -48.6 69.49 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.987 0.423 . . . . 73.13 111.031 173.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -59.96 -33.56 72.09 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 116.123 -0.489 . . . . 71.42 111.933 -176.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.523 HG23 HG23 ' A' ' 53' ' ' VAL . 33.9 m -89.44 1.53 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 112.841 0.682 . . . . 73.33 112.841 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.44 19.52 51.98 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 114.82 0.688 . . . . 53.21 114.82 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.523 HG23 HG23 ' A' ' 51' ' ' VAL . 81.6 t -88.53 -48.24 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 122.16 -0.612 . . . . 75.22 111.027 175.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 85.9 mt -114.79 152.39 32.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.285 -0.416 . . . . 61.2 111.503 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.459 ' HA ' ' HD2' ' A' ' 49' ' ' HIS . 10.5 tp10 -109.28 149.99 28.63 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.488 -0.323 . . . . 73.55 110.299 173.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -98.86 137.78 36.94 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.165 0.507 . . . . 74.43 111.215 -178.735 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.513 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 88.7 t . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 120.995 0.426 . . . . 71.54 111.57 -177.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.513 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 70.5 mt . . . . . 0 CA--C 1.537 0.457 0 CA-C-O 120.934 0.397 . . . . 71.15 111.597 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.426 ' CD1' HD13 ' A' ' 45' ' ' LEU . 72.8 m95 -131.45 154.04 49.11 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.856 0.36 . . . . 74.35 111.351 -178.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.417 ' HG3' ' NE2' ' A' ' 17' ' ' GLN . 50.7 ttt85 -165.3 117.55 1.16 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.551 -0.295 . . . . 74.31 110.992 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 54' ' ' LEU . 4.2 pp -64.21 155.29 32.29 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.953 0.406 . . . . 71.45 111.661 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.518 ' H ' HD23 ' A' ' 70' ' ' LEU . 1.8 pt? . . . . . 0 N--CA 1.47 0.563 0 CA-C-O 121.035 0.445 . . . . 74.23 111.184 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.64 HG12 HD11 ' A' ' 36' ' ' LEU . 9.5 tp . . . . . 0 CA--C 1.542 0.647 0 N-CA-C 112.314 0.487 . . . . 73.35 112.314 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.7 t -58.46 -50.26 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.853 0.359 . . . . 63.43 111.509 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.9 m -60.88 -40.02 91.43 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.937 0.398 . . . . 74.41 111.041 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.484 ' O ' HG13 ' A' ' 12' ' ' ILE . 4.4 ttmp? -58.93 -48.77 80.3 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.34 -0.391 . . . . 74.23 111.095 177.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.9 mt -56.47 -48.11 80.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.421 -0.354 . . . . 75.3 111.586 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.5 mt -59.14 -43.27 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.079 0.466 . . . . 73.33 111.018 176.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.4 t -60.52 -40.02 89.92 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.948 -0.569 . . . . 71.21 111.628 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 8' ' ' LYS . 86.8 mt -61.08 -51.06 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.093 0.473 . . . . 53.25 111.185 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.6 t -57.97 -51.01 76.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.105 0.478 . . . . 54.21 111.008 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -54.07 -47.38 71.73 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.998 -0.546 . . . . 72.24 111.349 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -57.52 -53.49 57.56 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.145 -0.479 . . . . 54.53 111.785 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -62.69 -27.17 69.06 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.568 -0.287 . . . . 75.31 111.71 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -80.22 -26.79 38.94 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 122.16 -0.337 . . . . 75.01 111.705 175.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -64.59 -26.11 68.26 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.225 0.536 . . . . 62.12 109.856 170.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.0 mmm -78.43 -60.18 2.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.708 -0.678 . . . . 74.23 111.548 173.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 23' ' ' ALA . 24.6 m-20 -94.13 -55.86 3.05 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.771 0.656 . . . . 54.22 112.771 -176.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.3 t70 68.47 -69.08 0.16 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.455 0.702 . . . . 74.03 111.834 -176.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.44 -35.34 84.86 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.983 -0.627 . . . . 75.31 112.812 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 20' ' ' ASP . . . -96.38 129.37 33.58 Favored Pre-proline 0 CA--C 1.541 0.63 0 O-C-N 122.618 -0.343 . . . . 74.44 111.069 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.04 164.14 33.1 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.421 2.08 . . . . 72.23 113.251 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.4 t -84.85 145.64 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.285 -0.416 . . . . 71.42 110.742 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.449 ' H ' ' HD2' ' A' ' 26' ' ' LYS . 6.5 mptt -90.06 141.16 28.94 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.706 0.289 . . . . 54.51 110.788 -176.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.1 m -52.01 -38.31 56.39 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.851 0.357 . . . . 60.35 111.873 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 28' ' ' ARG . 5.2 mpt_? -63.35 -47.56 81.64 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 122.37 -0.206 . . . . 73.35 111.552 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.22 -52.5 51.95 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.002 0.429 . . . . 70.34 111.196 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.56 HG21 HD21 ' A' ' 45' ' ' LEU . 58.3 mt -58.44 -53.89 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 115.764 -0.653 . . . . 74.13 111.742 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.468 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -60.85 -45.43 94.55 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.096 0.406 . . . . 72.12 112.096 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.16 -40.4 96.05 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.088 -0.506 . . . . 70.2 111.595 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.402 ' HB3' HD13 ' A' ' 12' ' ' ILE . . . -71.97 -38.29 69.76 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.877 0.37 . . . . 33.4 111.324 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.82 -35.27 72.41 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.287 -0.415 . . . . 62.54 111.659 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.97 23.2 42.4 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.394 -0.432 . . . . 65.22 113.509 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.64 HD11 HG12 ' A' ' 5' ' ' ILE . 85.7 mt -113.24 171.67 7.41 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.964 0.412 . . . . 72.0 111.705 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.5 m -71.65 144.36 49.42 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.261 -0.427 . . . . 71.02 111.404 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.1 mm -50.85 -58.22 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.35 0.5 . . . . 63.31 112.35 -174.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.471 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 47.8 p90 -54.02 -40.69 67.26 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.158 0.429 . . . . 62.2 112.158 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -65.43 -47.3 76.7 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.169 0.509 . . . . 65.14 111.016 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' A' ' 31' ' ' ALA . 60.9 t -58.7 -44.29 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.147 -0.479 . . . . 72.5 111.024 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -58.52 -33.69 70.14 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.616 -0.265 . . . . 64.05 111.686 178.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.533 ' O ' ' HG3' ' A' ' 47' ' ' GLN . 95.1 mt -60.07 -52.58 64.74 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 110.167 -0.309 . . . . 65.23 110.167 175.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -56.83 -46.0 81.96 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.115 0.484 . . . . 75.11 111.256 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.56 HD21 HG21 ' A' ' 30' ' ' ILE . 92.9 mt -59.92 -46.6 88.84 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.089 -0.505 . . . . 73.43 111.918 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -67.29 -37.18 83.0 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.509 0.195 . . . . 73.41 111.34 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 96.2 mt-30 -59.66 -45.19 92.8 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.064 0.459 . . . . 63.35 110.602 174.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 94.3 mt -61.42 -34.13 74.87 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.379 -0.373 . . . . 74.51 111.416 176.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -70.56 -28.71 65.11 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.149 0.499 . . . . 73.2 111.015 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -79.65 -41.66 26.48 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.143 -0.481 . . . . 73.43 111.765 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.6 m -77.79 -24.71 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 111.914 0.339 . . . . 63.12 111.914 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.6 69.02 0.61 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.098 -0.572 . . . . 62.54 113.12 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 99.4 t -141.36 -60.92 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.111 0.481 . . . . 73.13 110.787 177.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.665 HD23 ' HB3' ' A' ' 69' ' ' LEU . 80.9 mt -103.98 145.75 29.7 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.148 -0.478 . . . . 74.23 111.962 -177.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.549 ' HB2' HD22 ' A' ' 70' ' ' LEU . 12.0 tp10 -108.53 141.11 40.91 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.029 0.442 . . . . 73.33 110.838 172.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? -89.96 94.87 9.97 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.144 0.497 . . . . 73.23 111.495 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 CA--C 1.542 0.66 0 CA-C-O 120.967 0.413 . . . . 75.03 110.835 177.003 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 66' ' ' LEU . 5.9 mp . . . . . 0 N--CA 1.466 0.364 0 N-CA-C 110.025 -0.361 . . . . 61.54 110.025 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.443 ' CD1' HD13 ' A' ' 45' ' ' LEU . 58.2 m95 -102.23 133.93 46.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.469 0.652 . . . . 73.2 111.906 -172.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -141.31 114.47 8.66 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.778 -0.646 . . . . 73.12 111.088 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.665 ' HB3' HD23 ' A' ' 54' ' ' LEU . 4.2 pp -67.76 151.58 46.99 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.426 0.631 . . . . 71.43 111.9 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.549 HD22 ' HB2' ' A' ' 55' ' ' GLU . 1.7 pt? . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 115.39 -0.823 . . . . 72.1 110.648 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.9 tp . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 112.054 0.39 . . . . 72.52 112.054 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.467 HG13 HD21 ' A' ' 48' ' ' LEU . 61.6 t -53.27 -49.53 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.402 -0.363 . . . . 72.45 111.955 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.0 m -55.45 -46.2 76.81 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.898 0.38 . . . . 74.33 111.408 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.499 ' O ' HG13 ' A' ' 12' ' ' ILE . 53.8 tptt -55.99 -50.61 70.37 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.366 -0.379 . . . . 64.45 111.49 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.3 mt -57.19 -42.33 79.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.312 -0.404 . . . . 64.22 111.562 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.2 mt -61.56 -46.06 97.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 121.003 0.43 . . . . 71.44 110.903 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.8 m -60.75 -32.67 71.96 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.348 -0.387 . . . . 55.41 111.506 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.536 HG21 ' HA ' ' A' ' 30' ' ' ILE . 96.4 mt -67.21 -41.32 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.788 0.328 . . . . 74.4 111.55 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.437 ' HA ' HG21 ' A' ' 25' ' ' VAL . 59.5 t -59.95 -41.23 85.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 121.207 0.527 . . . . 62.22 110.714 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -64.56 -48.15 76.09 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.058 0.456 . . . . 61.32 110.514 173.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -53.06 -56.3 17.21 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.624 -0.716 . . . . 74.04 112.25 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -67.48 -39.14 85.23 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.511 0.559 . . . . 61.35 112.511 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -74.21 -20.33 60.22 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.406 -0.518 . . . . 72.42 110.71 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -71.51 -24.53 61.98 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.497 0.665 . . . . 74.13 109.514 172.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.1 mmt -79.64 -47.89 14.65 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.871 -0.604 . . . . 75.12 111.504 169.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -98.56 84.69 3.21 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.052 0.453 . . . . 75.3 110.969 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -57.05 -37.34 71.66 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.397 0.518 . . . . 63.0 112.397 -177.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -108.11 20.14 31.33 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.244 -0.503 . . . . 74.11 113.868 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.436 ' HA ' ' HD2' ' A' ' 24' ' ' PRO . . . -158.39 108.33 1.68 Allowed Pre-proline 0 N--CA 1.468 0.459 0 CA-C-N 117.053 0.427 . . . . 62.22 111.785 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.53 ' HB3' ' HB2' ' A' ' 68' ' ' ARG . 1.5 Cg_endo -48.34 177.39 0.02 OUTLIER 'Trans proline' 0 CA--C 1.552 1.414 0 C-N-CA 122.954 2.436 . . . . 54.44 114.501 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.437 HG21 ' HA ' ' A' ' 13' ' ' VAL . 44.1 t -79.57 152.93 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 112.824 0.675 . . . . 72.04 112.824 -169.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.639 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 8.2 mptt -105.86 146.09 30.38 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.715 -0.675 . . . . 54.44 110.082 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.4 m -53.71 -44.34 69.77 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.652 0.612 . . . . 55.3 112.652 -176.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -59.47 -43.58 93.2 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 111.7 0.259 . . . . 72.13 111.7 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.465 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 2.8 m-20 -56.46 -39.62 73.47 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.039 0.447 . . . . 72.34 112.043 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.615 HG21 HD21 ' A' ' 45' ' ' LEU . 61.5 mt -68.94 -44.51 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.954 0.406 . . . . 71.24 111.289 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.473 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -61.82 -35.28 77.76 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.104 0.478 . . . . 53.3 111.162 175.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -65.58 -55.59 16.88 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.658 -0.701 . . . . 73.41 111.737 178.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.39 -37.99 87.9 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.762 0.653 . . . . 42.24 112.762 -176.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.48 -28.91 30.89 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 111.974 0.361 . . . . 73.05 111.974 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.64 39.05 22.6 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.066 -0.587 . . . . 53.44 112.586 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.5 mt -117.43 172.71 7.15 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 122.658 -0.319 . . . . 65.44 111.236 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.401 ' O ' HG23 ' A' ' 41' ' ' VAL . 50.6 m -78.99 148.14 32.67 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.663 -0.244 . . . . 74.31 111.439 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.6 mm -52.66 -58.56 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 112.407 0.521 . . . . 75.22 112.407 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -57.05 -41.83 79.4 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.959 0.409 . . . . 74.12 111.567 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -56.42 -49.64 73.97 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.462 0.649 . . . . 61.33 111.068 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.473 HG21 ' HA ' ' A' ' 31' ' ' ALA . 64.2 t -65.11 -39.47 85.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.838 -0.619 . . . . 72.31 111.352 178.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.4 mmm-85 -50.94 -48.17 60.95 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.889 0.376 . . . . 71.31 111.315 175.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.5 mt -59.01 -51.59 69.39 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.183 -0.462 . . . . 75.22 111.091 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -60.2 -45.15 94.15 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.4 0.519 . . . . 75.14 112.4 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.615 HD21 HG21 ' A' ' 30' ' ' ILE . 91.0 mt -64.6 -52.77 55.79 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.175 0.512 . . . . 73.42 111.515 -177.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.405 ' HG2' ' HH2' ' A' ' 67' ' ' TRP . 34.4 mt-10 -66.34 -29.22 69.37 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.101 -0.5 . . . . 74.45 111.993 -177.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -74.56 -37.84 62.86 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 122.104 -0.373 . . . . 71.03 111.052 172.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.467 HD21 HG13 ' A' ' 6' ' ' VAL . 62.1 mt -64.37 -26.54 68.51 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.883 0.373 . . . . 71.02 110.843 173.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -72.86 -40.35 65.75 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.887 0.375 . . . . 74.1 110.69 171.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.19 -38.2 88.21 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 116.216 -0.447 . . . . 72.43 111.744 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.6 HG23 HG23 ' A' ' 53' ' ' VAL . 35.4 m -81.25 -12.09 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 112.218 0.451 . . . . 72.5 112.218 177.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.18 24.93 13.43 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 120.986 -0.626 . . . . 73.4 114.62 174.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.6 HG23 HG23 ' A' ' 51' ' ' VAL . 64.4 t -91.71 -56.59 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 117.493 0.647 . . . . 65.25 111.332 175.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 61.5 mt -105.13 125.88 51.46 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.079 -0.509 . . . . 73.23 111.498 -176.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -93.87 140.19 29.98 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.887 0.375 . . . . 74.5 111.703 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -88.62 94.01 9.75 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.97 0.414 . . . . 72.32 110.58 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.6 t . . . . . 0 CA--C 1.536 0.437 0 CA-C-N 116.666 -0.243 . . . . 74.45 110.461 175.532 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 91.4 mt . . . . . 0 CA--C 1.539 0.543 0 CA-C-O 121.043 0.449 . . . . 70.41 111.764 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.405 ' HH2' ' HG2' ' A' ' 46' ' ' GLU . 85.3 m95 -84.4 125.42 32.32 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.563 0.697 . . . . 73.2 112.614 -175.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.53 ' HB2' ' HB3' ' A' ' 24' ' ' PRO . 74.0 ttt180 -139.97 117.78 11.68 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.897 -0.592 . . . . 72.5 110.768 176.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 69' ' ' LEU . 2.6 pt? -66.35 152.9 44.05 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.865 0.364 . . . . 75.34 111.12 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.6 mt . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 120.91 0.386 . . . . 74.01 111.826 -176.846 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.598 HD11 HD11 ' A' ' 36' ' ' LEU . 14.3 tt . . . . . 0 CA--C 1.54 0.56 0 CA-C-O 121.728 0.775 . . . . 72.21 109.917 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.556 HG13 HD11 ' A' ' 48' ' ' LEU . 92.8 t -56.83 -49.35 79.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.085 -0.962 . . . . 71.32 111.25 173.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.4 m -58.62 -33.3 69.88 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.133 0.492 . . . . 63.3 111.443 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.441 ' O ' HG13 ' A' ' 12' ' ' ILE . 58.8 tttp -62.58 -49.82 73.73 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.056 0.455 . . . . 61.31 110.297 174.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.497 ' HA ' HD12 ' A' ' 12' ' ' ILE . 72.1 mt -58.34 -43.53 86.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.98 -0.554 . . . . 52.42 111.332 178.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 73.6 mt -57.5 -42.08 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.911 0.386 . . . . 64.45 111.068 176.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.9 m -64.0 -34.16 77.37 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.252 -0.431 . . . . 64.12 111.28 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 9' ' ' ILE . 83.6 mt -66.39 -46.01 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.918 0.39 . . . . 61.31 110.98 176.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.54 -45.58 96.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.054 0.454 . . . . 74.02 110.768 175.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -55.91 -49.6 73.01 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.009 -0.541 . . . . 64.11 111.165 175.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -54.63 -56.34 20.02 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.682 -0.69 . . . . 64.03 111.522 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 35.9 mmt-85 -57.53 -40.11 78.08 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.27 -0.423 . . . . 70.11 111.907 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.49 ' O ' ' N ' ' A' ' 21' ' ' ASP . 16.6 mt-30 -61.35 -47.36 86.25 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.245 -0.284 . . . . 72.52 110.989 175.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -57.93 -27.02 62.99 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.293 0.479 . . . . 70.24 112.293 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 47.9 mtt -55.78 -41.71 74.47 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.164 0.431 . . . . 71.44 112.164 174.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 23' ' ' ALA . 30.7 t70 -128.63 8.58 5.86 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.021 0.439 . . . . 60.2 111.667 -176.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' A' ' 17' ' ' GLN . 31.9 t70 54.73 97.24 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.398 0.679 . . . . 71.23 112.418 -176.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.17 -13.6 66.64 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 114.465 0.546 . . . . 44.31 114.465 176.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . . . -56.42 120.58 36.86 Favored Pre-proline 0 N--CA 1.473 0.691 0 N-CA-C 112.493 0.553 . . . . 52.12 112.493 -177.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.546 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 72.6 Cg_endo -75.1 152.91 40.88 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.62 2.213 . . . . 71.41 112.813 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.1 t -117.13 150.86 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 O-C-N 122.301 -0.249 . . . . 71.2 111.566 -175.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.455 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 9.6 mptt -87.91 158.14 18.77 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.894 0.378 . . . . 71.51 110.803 176.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.509 HG21 ' HB2' ' A' ' 42' ' ' ARG . 56.0 m -56.38 -47.29 79.22 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.903 0.382 . . . . 72.22 111.814 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.48 -37.78 87.28 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.759 0.314 . . . . 64.5 111.264 -177.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 3.5 m-20 -64.23 -44.75 90.88 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.81 0.338 . . . . 74.35 111.413 178.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.65 -47.41 91.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 116.193 -0.458 . . . . 73.3 111.014 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.497 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -57.81 -41.98 83.29 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.04 0.448 . . . . 23.41 111.331 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -62.95 -47.54 82.78 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.043 -0.526 . . . . 73.44 111.53 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.43 -26.64 66.51 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.914 0.388 . . . . 71.15 111.994 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.73 -22.04 22.39 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.052 0.39 . . . . 73.33 112.052 178.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.36 34.21 54.97 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.213 -0.518 . . . . 75.3 112.507 -174.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.598 HD11 HD11 ' A' ' 5' ' ' ILE . 95.7 mt -115.34 -178.85 3.48 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.118 0.485 . . . . 65.13 111.624 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.4 m -84.85 141.86 30.15 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.853 -0.612 . . . . 74.0 111.077 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.3 mm -55.61 -58.51 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.578 0.584 . . . . 74.34 112.578 -173.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.469 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 41.5 t80 -60.44 -40.44 91.11 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.818 0.342 . . . . 62.1 111.453 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.473 ' HG3' ' HE2' ' A' ' 44' ' ' TYR . 5.8 tp-100 -57.45 -52.5 65.12 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.231 0.539 . . . . 71.44 111.149 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.497 HG21 ' HA ' ' A' ' 31' ' ' ALA . 71.6 t -58.54 -45.15 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.005 -0.543 . . . . 73.33 111.345 176.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.509 ' HB2' HG21 ' A' ' 27' ' ' THR . 76.5 ttt180 -51.23 -39.32 56.36 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.116 -0.493 . . . . 61.41 111.524 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 93.4 mt -65.49 -44.72 86.2 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.365 -0.38 . . . . 64.14 111.547 177.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.473 ' HE2' ' HG3' ' A' ' 40' ' ' GLN . 69.3 m-85 -62.37 -40.35 96.15 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.246 0.546 . . . . 74.21 111.126 177.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.498 HD13 ' CD1' ' A' ' 67' ' ' TRP . 81.9 mt -65.39 -45.14 85.18 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.247 -0.433 . . . . 73.21 111.452 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -66.1 -38.86 89.3 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.578 0.584 . . . . 72.12 112.578 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 20.9 pt20 -66.67 -36.63 83.0 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 120.779 -0.369 . . . . 74.32 110.659 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.556 HD11 HG13 ' A' ' 6' ' ' VAL . 85.2 mt -68.12 -38.86 82.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.18 0.514 . . . . 75.01 110.842 173.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.401 ' CE1' ' HD3' ' A' ' 56' ' ' LYS . 12.9 t-80 -68.28 -21.56 64.78 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.994 -0.548 . . . . 72.41 111.029 175.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -83.4 -50.9 7.87 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.22 -0.445 . . . . 72.23 111.603 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.2 m -70.72 -31.11 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 112.776 0.658 . . . . 51.21 112.776 -177.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 116.89 43.89 0.6 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 120.836 -0.697 . . . . 74.23 114.093 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.29 -38.06 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.081 0.467 . . . . 75.23 111.293 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.8 mt -111.28 136.98 49.6 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.938 0.399 . . . . 50.32 111.629 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -103.32 136.14 43.64 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.116 -0.493 . . . . 54.01 109.804 172.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.401 ' HD3' ' CE1' ' A' ' 49' ' ' HIS . 19.0 pttm -94.0 144.13 25.74 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.137 0.494 . . . . 64.54 110.99 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 16.2 t . . . . . 0 C--N 1.324 -0.533 0 N-CA-C 109.36 -0.608 . . . . 60.44 109.36 173.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.599 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 49.5 mt . . . . . 0 CA--C 1.538 0.504 0 CA-C-O 120.944 0.402 . . . . 55.31 111.042 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.498 ' CD1' HD13 ' A' ' 45' ' ' LEU . 49.8 m95 -106.3 127.68 53.43 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.887 0.375 . . . . 73.24 111.869 -176.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -140.58 121.67 14.71 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.215 0.531 . . . . 74.24 110.945 173.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 pp -69.23 161.23 29.63 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.949 0.404 . . . . 75.13 111.6 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.5 ' N ' HD23 ' A' ' 70' ' ' LEU . 1.5 pt? . . . . . 0 CA--C 1.539 0.551 0 CA-C-N 116.313 -0.403 . . . . 51.32 111.451 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.456 HG12 HD11 ' A' ' 36' ' ' LEU . 8.6 tp . . . . . 0 CA--C 1.539 0.538 0 N-CA-C 111.924 0.342 . . . . 65.1 111.924 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.7 t -58.81 -47.13 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.274 0.559 . . . . 70.31 110.932 178.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 m -61.49 -40.2 93.71 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.93 -0.577 . . . . 70.22 110.95 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.527 ' O ' HG13 ' A' ' 12' ' ' ILE . 88.5 tttt -61.14 -46.47 90.42 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.139 -0.482 . . . . 74.32 110.893 177.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 13' ' ' VAL . 78.2 mt -55.21 -49.28 73.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.88 0.372 . . . . 75.5 111.229 176.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 69.8 mt -59.09 -40.63 81.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.106 0.479 . . . . 74.43 111.02 176.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.3 t -63.38 -35.7 81.27 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.304 -0.407 . . . . 73.53 111.194 176.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 8' ' ' LYS . 86.0 mt -65.51 -44.14 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-O 121.245 0.545 . . . . 73.31 110.449 175.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 9' ' ' ILE . 95.5 t -56.92 -46.92 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 115.898 -0.592 . . . . 73.42 111.063 176.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -61.33 -49.15 78.16 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.208 -0.451 . . . . 72.4 110.96 176.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -54.47 -53.36 55.27 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.902 -0.59 . . . . 65.14 111.633 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.52 ' HG3' HG13 ' A' ' 25' ' ' VAL . 5.7 mmp_? -56.12 -42.22 76.51 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.239 -0.437 . . . . 71.4 112.128 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -70.25 -31.09 68.32 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.728 0.299 . . . . 71.3 111.692 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -60.68 -33.42 72.82 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.119 0.485 . . . . 71.01 110.825 173.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 95.7 mmm -61.59 -34.87 76.36 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.004 -0.544 . . . . 74.2 111.955 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -159.52 110.17 1.97 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.887 0.375 . . . . 63.55 110.68 177.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -59.85 -17.7 38.5 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.56 0.578 . . . . 73.14 112.56 -178.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.9 12.74 59.2 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 120.985 -0.626 . . . . 73.21 113.329 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . . . -122.98 139.8 32.17 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 117.06 0.43 . . . . 64.41 112.144 -177.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.418 ' HG2' HD13 ' A' ' 66' ' ' LEU . 9.8 Cg_endo -87.95 174.3 4.7 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.041 2.494 . . . . 71.43 112.495 175.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.52 HG13 ' HG3' ' A' ' 16' ' ' ARG . 21.2 t -101.93 135.86 36.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.372 -0.376 . . . . 51.24 111.212 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.42 143.05 27.12 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.621 0.248 . . . . 64.12 111.025 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 67.9 m -55.97 -37.26 68.82 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.168 0.509 . . . . 54.04 110.79 173.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.1 mmm-85 -60.55 -55.8 28.98 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.016 -0.538 . . . . 65.34 111.196 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -51.62 -44.92 63.07 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.99 -0.55 . . . . 71.54 111.643 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.0 mt -61.83 -45.39 98.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.385 -0.37 . . . . 73.21 111.306 177.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.55 -31.92 71.01 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.896 0.379 . . . . 62.43 111.647 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -67.46 -51.08 55.71 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.231 -0.441 . . . . 74.0 111.362 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.48 -26.97 60.36 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.231 0.456 . . . . 74.12 112.231 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.67 -28.49 23.12 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.082 0.401 . . . . 63.14 112.082 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.02 32.58 60.49 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.043 -0.598 . . . . 42.45 113.317 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.456 HD11 HG12 ' A' ' 5' ' ' ILE . 88.7 mt -115.59 166.57 11.77 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.916 0.388 . . . . 74.33 111.042 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.404 ' O ' HG23 ' A' ' 41' ' ' VAL . 97.6 p -70.08 143.72 52.35 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.768 0.318 . . . . 72.31 111.277 178.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.5 mm -49.15 -50.08 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 112.366 0.506 . . . . 75.41 112.366 -177.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -62.67 -42.82 99.82 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.719 0.295 . . . . 73.33 111.405 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -63.97 -43.85 94.49 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.901 0.382 . . . . 74.5 111.077 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 37' ' ' SER . 81.9 t -57.84 -42.93 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.975 0.417 . . . . 63.33 110.539 175.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -55.84 -40.44 72.85 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.025 -0.534 . . . . 73.43 111.429 175.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.1 mt -59.34 -44.52 92.64 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.805 0.336 . . . . 71.41 111.17 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -65.37 -53.95 35.96 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.364 -0.38 . . . . 62.52 111.797 177.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.478 HD13 ' CD1' ' A' ' 67' ' ' TRP . 89.5 mt -56.84 -38.3 72.46 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.101 0.477 . . . . 63.25 111.705 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -61.64 -53.66 53.24 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.956 -0.566 . . . . 73.44 110.985 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -67.79 -39.03 84.08 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 111.804 0.298 . . . . 73.32 111.804 -178.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.9 mt -61.01 -35.26 76.4 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.214 0.531 . . . . 74.2 110.782 173.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -67.07 -46.23 74.93 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.254 -0.43 . . . . 71.44 111.517 174.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -66.09 -41.61 90.44 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.271 0.471 . . . . 73.34 112.271 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.504 HG23 HG23 ' A' ' 53' ' ' VAL . 34.4 m -71.15 -17.86 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 112.14 0.422 . . . . 55.41 112.14 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.65 29.19 5.1 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 120.836 -0.697 . . . . 74.32 114.274 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.504 HG23 HG23 ' A' ' 51' ' ' VAL . 97.3 t -94.87 -49.74 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 117.369 0.584 . . . . 75.31 110.895 174.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.8 mt -112.54 138.76 48.84 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.09 0.472 . . . . 75.31 111.866 -178.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.511 ' HB3' ' HG3' ' A' ' 68' ' ' ARG . 33.7 tt0 -91.76 146.3 23.87 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.382 -0.372 . . . . 64.13 110.171 175.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -87.68 138.62 31.31 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.17 0.433 . . . . 74.41 112.17 -174.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 62.1 t . . . . . 0 CA--C 1.541 0.614 0 CA-C-O 120.922 0.392 . . . . 72.43 110.486 172.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 94.3 mt . . . . . 0 CA--C 1.536 0.42 0 CA-C-O 120.976 0.417 . . . . 65.44 110.304 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.478 ' CD1' HD13 ' A' ' 45' ' ' LEU . 57.9 m95 -128.39 146.77 50.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.249 0.547 . . . . 74.1 111.844 -175.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.511 ' HG3' ' HB3' ' A' ' 55' ' ' GLU . 5.8 ptm180 -138.74 172.3 13.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.929 -0.578 . . . . 73.3 110.029 174.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pp -108.7 168.92 8.99 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.132 -0.355 . . . . 74.24 110.867 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.5 mt . . . . . 0 CA--C 1.54 0.591 0 CA-C-O 121.083 0.468 . . . . 63.41 111.707 -177.199 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.4 mm . . . . . 0 CA--C 1.537 0.448 0 CA-C-O 121.058 0.456 . . . . 71.42 110.386 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.1 t -57.73 -48.11 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.018 0.437 . . . . 54.54 110.91 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 78.0 m -61.33 -35.47 77.49 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.412 -0.358 . . . . 53.42 110.982 176.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.51 ' O ' HG13 ' A' ' 12' ' ' ILE . 86.9 tttt -60.28 -47.91 83.99 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.433 -0.349 . . . . 72.22 110.612 176.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 68.1 mt -57.32 -48.47 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.308 -0.405 . . . . 61.43 111.371 176.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.4 mt -57.21 -40.47 73.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.136 0.493 . . . . 64.03 110.993 176.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.6 m -61.34 -45.33 94.87 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.087 -0.506 . . . . 70.34 111.022 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.544 ' O ' ' HG2' ' A' ' 16' ' ' ARG . 83.1 mt -57.94 -56.03 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.17 -0.468 . . . . 72.12 111.563 179.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.548 HG12 HD23 ' A' ' 69' ' ' LEU . 49.0 t -56.82 -50.81 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.847 0.356 . . . . 63.13 111.602 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -57.11 -45.67 83.24 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.089 0.471 . . . . 61.21 111.219 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -60.02 -40.48 89.45 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.291 -0.413 . . . . 72.01 111.419 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 12' ' ' ILE . 23.4 mmm-85 -62.23 -39.48 92.95 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 122.178 -0.326 . . . . 65.01 110.503 175.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -65.69 -26.09 67.61 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.057 0.456 . . . . 50.23 111.556 175.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -78.05 -18.98 55.15 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.846 0.355 . . . . 65.42 111.008 173.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 94.8 mmm -81.05 -35.64 31.55 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.932 0.396 . . . . 74.32 111.103 174.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.582 ' HB3' ' HB2' ' A' ' 23' ' ' ALA . 18.6 t70 -142.98 138.75 30.29 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.457 -0.338 . . . . 65.3 110.913 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -61.79 -11.3 11.77 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.435 0.902 . . . . 73.52 113.435 -175.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.472 ' O ' ' HD3' ' A' ' 24' ' ' PRO . . . -150.08 51.59 0.53 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.973 -0.632 . . . . 72.42 112.954 177.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.582 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . . . -83.8 109.49 18.87 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.567 0.58 . . . . 23.24 112.567 -177.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.569 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 88.9 Cg_endo -79.95 108.05 2.17 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.987 1.791 . . . . 63.42 111.083 171.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 13' ' ' VAL . 14.6 t -79.02 144.3 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.414 0.626 . . . . 60.44 111.528 -172.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.612 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -95.36 138.82 32.52 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.106 -0.497 . . . . 73.01 111.479 -171.889 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.53 HG21 ' HD2' ' A' ' 42' ' ' ARG . 86.9 m -52.68 -38.81 61.15 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.049 0.452 . . . . 63.01 111.163 175.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -60.54 -58.52 8.14 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.054 -0.521 . . . . 71.03 111.016 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -51.17 -46.31 62.04 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.128 0.489 . . . . 64.4 111.312 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.5 mt -60.48 -44.48 96.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.117 -0.492 . . . . 74.31 111.505 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.59 -48.01 83.33 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.789 0.328 . . . . 61.32 111.615 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.67 -52.75 63.06 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.39 -0.368 . . . . 64.25 111.881 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.37 -37.7 87.8 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.366 0.506 . . . . 74.05 112.366 -178.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.24 -35.85 58.79 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 111.841 0.312 . . . . 52.32 111.841 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.26 33.14 8.27 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.284 -0.484 . . . . 51.11 112.706 -176.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.8 mt -120.11 171.77 8.23 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.2 0.524 . . . . 74.33 111.708 -177.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.494 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.7 m -81.84 147.28 29.43 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.985 -0.552 . . . . 62.03 111.08 178.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.497 ' O ' ' HD3' ' A' ' 42' ' ' ARG . 47.5 mm -51.17 -58.59 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 112.904 0.705 . . . . 75.32 112.904 -175.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -62.42 -32.1 72.89 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.994 0.426 . . . . 75.32 111.336 -178.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -61.32 -45.26 95.17 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.378 0.609 . . . . 74.22 110.378 175.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 37' ' ' SER . 71.3 t -62.45 -36.8 76.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 115.842 -0.617 . . . . 73.32 111.658 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.53 ' HD2' HG21 ' A' ' 27' ' ' THR . 0.3 OUTLIER -47.29 -53.07 14.46 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 121.128 0.489 . . . . 73.42 111.179 173.348 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.401 ' O ' ' HG3' ' A' ' 47' ' ' GLN . 74.1 mt -60.06 -48.67 80.74 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.617 -0.72 . . . . 73.44 111.516 -177.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -57.42 -50.04 74.29 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.373 -0.376 . . . . 74.42 111.782 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 67.8 mt -62.96 -46.61 86.89 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.872 0.368 . . . . 60.33 111.862 -176.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -61.11 -41.77 97.3 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.544 -0.298 . . . . 74.24 111.732 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 87.3 mt-30 -65.48 -40.02 92.62 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.755 0.312 . . . . 74.45 111.325 176.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.0 -30.48 70.98 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.882 0.373 . . . . 74.31 111.127 175.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -65.09 -44.81 87.63 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.889 0.376 . . . . 73.52 110.946 173.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -62.21 -48.03 81.81 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.314 0.487 . . . . 75.21 112.314 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.546 HG23 HG23 ' A' ' 53' ' ' VAL . 33.2 m -74.29 2.8 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 112.802 0.668 . . . . 74.11 112.802 -177.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.72 34.99 10.61 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.747 -0.739 . . . . 51.03 114.255 174.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.546 HG23 HG23 ' A' ' 51' ' ' VAL . 63.7 t -107.65 -60.69 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 122.383 -0.481 . . . . 64.11 111.101 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 69' ' ' LEU . 79.3 mt -100.95 163.99 12.03 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.955 0.724 . . . . 70.04 112.955 -175.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -136.51 145.02 44.61 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.532 -0.758 . . . . 62.33 110.264 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -84.15 141.55 30.99 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.176 0.513 . . . . 74.13 112.292 -174.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 48.5 t . . . . . 0 C--O 1.241 0.635 0 CA-C-O 121.239 0.542 . . . . 61.02 109.831 172.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.569 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 87.7 mt . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 120.612 0.244 . . . . 74.34 110.507 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -129.83 122.67 29.18 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.035 0.445 . . . . 75.32 111.995 -175.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -104.16 -172.72 2.16 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.284 -0.416 . . . . 61.33 109.916 171.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 54' ' ' LEU . 3.0 pp -126.38 164.6 20.73 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.153 -0.342 . . . . 72.43 110.582 172.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.3 mt . . . . . 0 CA--C 1.536 0.404 0 CA-C-O 121.336 0.588 . . . . 74.43 110.779 178.852 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 5' ' ' ILE . 2.0 mp . . . . . 0 N--CA 1.474 0.764 0 CA-C-O 120.869 0.366 . . . . 74.34 111.034 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 51.4 t -60.09 -36.62 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 116.459 -0.337 . . . . 73.31 111.211 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 95.0 m -54.27 -41.21 68.58 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.445 -0.343 . . . . 72.14 111.436 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.537 ' O ' HG13 ' A' ' 12' ' ' ILE . 23.1 ttmm -60.89 -47.06 88.14 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.761 0.315 . . . . 70.44 110.59 177.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 13' ' ' VAL . 62.7 mt -57.26 -46.7 85.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 120.827 0.346 . . . . 64.42 111.039 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 72.1 mt -59.61 -42.96 89.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.912 0.386 . . . . 73.41 111.126 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.2 t -62.73 -39.1 93.01 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.894 0.378 . . . . 72.32 111.365 177.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 8' ' ' LYS . 94.1 mt -61.68 -51.03 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.806 0.336 . . . . 73.54 110.599 176.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.572 HG13 HG21 ' A' ' 25' ' ' VAL . 59.0 t -60.9 -45.13 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 116.392 -0.367 . . . . 74.53 111.479 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.477 ' HA ' HD21 ' A' ' 69' ' ' LEU . 57.7 tp60 -60.26 -46.21 90.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.867 0.365 . . . . 70.12 110.997 177.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -61.55 -39.18 90.16 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.956 0.408 . . . . 73.5 110.859 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 12' ' ' ILE . 16.6 mmm-85 -65.27 -41.31 94.32 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.802 0.334 . . . . 72.14 111.216 175.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -64.73 -31.12 72.2 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.511 0.672 . . . . 74.13 110.591 173.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -75.8 -20.32 58.3 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.336 -0.847 . . . . 73.31 110.681 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 94.5 mmm -102.79 -69.64 0.78 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.018 -0.537 . . . . 70.44 111.383 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.507 ' HB3' ' HB3' ' A' ' 23' ' ' ALA . 49.3 m-20 -66.66 -66.5 0.55 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.051 0.389 . . . . 62.45 112.051 -178.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.1 t70 69.3 -60.87 0.45 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.423 0.689 . . . . 71.45 111.544 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.66 -28.13 72.53 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.276 -0.487 . . . . 74.5 112.73 176.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 20' ' ' ASP . . . -103.25 134.01 20.01 Favored Pre-proline 0 CA--C 1.538 0.507 0 O-C-N 122.579 -0.366 . . . . 74.33 110.92 177.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.515 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 8.0 Cg_exo -71.88 167.0 27.84 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.533 2.155 . . . . 54.53 113.145 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.572 HG21 HG13 ' A' ' 13' ' ' VAL . 29.1 t -85.44 142.07 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 115.999 -0.546 . . . . 73.21 110.763 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.538 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -102.12 146.56 27.77 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.717 0.294 . . . . 70.3 110.628 -179.199 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.4 m -59.54 -29.72 68.11 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.26 0.552 . . . . 73.25 110.932 176.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -58.53 -61.62 2.46 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.617 -0.72 . . . . 74.21 111.761 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.502 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 3.2 m-20 -51.64 -42.95 62.44 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.185 -0.462 . . . . 75.54 111.792 -178.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.6 mt -64.54 -42.36 94.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 116.33 -0.396 . . . . 74.01 111.25 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.1 -47.85 81.08 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.976 0.417 . . . . 71.44 111.797 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -67.76 -42.29 82.0 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.156 0.428 . . . . 73.45 112.156 178.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.59 -49.51 53.4 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.33 0.492 . . . . 72.11 112.33 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.6 -28.18 51.47 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.243 0.46 . . . . 72.23 112.243 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.76 54.38 3.47 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.203 -0.522 . . . . 44.12 112.763 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.4 mt -132.83 159.0 41.08 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.02 0.438 . . . . 73.21 111.384 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.1 m -73.46 145.72 45.52 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.306 -0.246 . . . . 75.01 110.805 174.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.2 mm -50.23 -41.47 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 112.403 0.52 . . . . 72.52 112.403 -176.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.417 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 56.6 t80 -59.83 -55.39 34.8 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.9 0.381 . . . . 70.34 111.001 175.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -52.0 -45.72 64.63 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.024 -0.534 . . . . 64.13 111.392 177.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.56 -49.37 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.161 -0.472 . . . . 72.31 111.182 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 mtm105 -58.34 -36.89 74.12 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.662 -0.245 . . . . 75.04 111.587 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.517 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 88.7 mt -56.56 -52.39 64.97 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.183 0.516 . . . . 70.44 110.306 177.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -64.96 -43.59 92.15 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.197 -0.456 . . . . 74.21 112.052 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.7 mt -65.86 -50.0 66.13 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.9 0.381 . . . . 54.4 111.853 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -62.74 -34.12 76.54 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.532 -0.304 . . . . 63.01 111.631 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 11.7 mm-40 -68.12 -47.96 66.73 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.119 -0.363 . . . . 55.44 110.977 174.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.5 mt -58.17 -32.8 68.55 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.043 0.449 . . . . 71.21 110.977 175.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.432 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 5.2 t60 -68.19 -44.96 74.68 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.9 0.381 . . . . 71.4 111.143 173.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.5 -42.35 95.89 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.127 -0.488 . . . . 62.55 111.753 -177.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.516 HG23 HG23 ' A' ' 53' ' ' VAL . 25.3 m -74.44 -9.79 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 112.151 0.426 . . . . 74.43 112.151 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.49 10.91 37.19 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 115.033 0.773 . . . . 62.43 115.033 173.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.516 HG23 HG23 ' A' ' 51' ' ' VAL . 92.5 t -82.26 -52.87 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 117.626 0.713 . . . . 64.44 111.439 177.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 91.9 mt -106.09 160.99 14.88 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.323 0.583 . . . . 54.12 112.035 -177.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -129.39 139.3 51.73 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.847 -0.615 . . . . 71.54 110.088 174.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -88.91 103.25 15.84 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.062 0.458 . . . . 61.34 111.488 -176.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.553 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 44.8 t . . . . . 0 CA--C 1.54 0.569 0 CA-C-O 121.086 0.47 . . . . 72.25 110.56 175.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.553 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 85.4 mt . . . . . 0 CA--C 1.54 0.564 0 CA-C-O 120.672 0.272 . . . . 65.51 111.17 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -128.24 147.23 50.58 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.05 0.452 . . . . 75.13 112.142 -176.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -150.89 134.62 16.5 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.497 -0.32 . . . . 73.33 111.161 174.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.52 ' O ' HD12 ' A' ' 69' ' ' LEU . 2.4 pp -78.69 141.86 37.59 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.184 0.516 . . . . 65.31 111.745 177.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.497 ' H ' HD23 ' A' ' 70' ' ' LEU . 1.9 pt? . . . . . 0 N--CA 1.471 0.621 0 CA-C-N 116.284 -0.416 . . . . 71.45 111.674 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.1 mm . . . . . 0 CA--C 1.539 0.539 0 CA-C-O 120.947 0.403 . . . . 72.45 111.557 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.1 t -62.86 -52.78 55.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.844 0.354 . . . . 71.22 111.359 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.4 m -59.19 -35.37 73.47 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.499 -0.319 . . . . 52.24 111.405 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -57.36 -50.71 72.1 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 110.134 -0.321 . . . . 70.34 110.134 176.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.48 HG23 HG21 ' A' ' 30' ' ' ILE . 67.2 mt -57.95 -51.79 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 116.212 -0.449 . . . . 72.12 111.546 175.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 79.3 mt -55.55 -47.26 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 112.319 0.489 . . . . 73.01 112.319 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.1 p -60.46 -42.46 96.24 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.882 0.372 . . . . 72.55 111.277 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.434 HG21 ' HA ' ' A' ' 30' ' ' ILE . 93.8 mt -63.08 -46.97 94.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 116.208 -0.451 . . . . 53.55 111.304 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.614 HG13 HG21 ' A' ' 25' ' ' VAL . 80.9 t -54.03 -55.27 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.987 0.422 . . . . 61.1 111.189 176.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -57.93 -40.01 79.42 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.239 -0.437 . . . . 71.04 111.664 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -66.18 -42.97 88.15 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.915 0.388 . . . . 64.15 110.936 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.496 ' HB2' HG22 ' A' ' 25' ' ' VAL . 5.0 mmp_? -57.58 -39.95 77.91 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.866 0.365 . . . . 74.4 110.564 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.679 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 14.6 mm100 -61.97 -40.63 96.25 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.066 0.46 . . . . 71.33 110.935 174.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -60.88 -28.79 69.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.247 -0.433 . . . . 73.24 111.766 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 28.1 mmt -60.54 -53.38 58.26 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.665 0.617 . . . . 74.02 112.665 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.695 ' HB3' ' HB2' ' A' ' 23' ' ' ALA . 13.4 t70 -117.9 142.35 47.43 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.77 0.319 . . . . 72.43 111.156 -176.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -63.01 94.08 0.07 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.307 0.575 . . . . 63.14 111.027 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.55 43.45 7.34 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 115.886 -0.597 . . . . 72.34 112.04 -174.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.695 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . . . -67.53 147.15 98.79 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 113.208 0.818 . . . . 62.55 113.208 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.441 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 90.4 Cg_endo -100.71 131.04 0.15 Allowed 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 123.21 2.607 . . . . 71.53 111.463 159.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.614 HG21 HG13 ' A' ' 13' ' ' VAL . 48.8 t -79.31 138.38 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.165 0.507 . . . . 72.45 112.012 -176.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.422 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -89.8 134.11 34.36 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.227 -0.442 . . . . 71.43 110.437 177.1 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 56.2 m -55.75 -27.99 53.59 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.09 0.471 . . . . 71.23 111.615 177.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -65.22 -54.59 27.16 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.216 -0.447 . . . . 70.41 112.098 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.25 -50.42 38.84 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 122.856 0.463 . . . . 72.41 112.119 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.48 HG21 HG23 ' A' ' 9' ' ' ILE . 53.1 mt -58.17 -57.78 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.151 -0.477 . . . . 71.42 111.787 -177.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.11 -45.49 87.16 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.947 0.403 . . . . 61.22 111.524 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -61.6 -42.4 98.82 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.806 -0.634 . . . . 75.31 111.896 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.03 -41.41 28.93 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.519 0.563 . . . . 73.24 112.519 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.33 -19.87 60.31 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.513 0.56 . . . . 75.54 112.513 -176.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.32 17.0 56.46 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.042 -0.599 . . . . 73.32 112.817 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.4 mt -106.44 170.93 7.63 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.993 0.425 . . . . 74.2 111.306 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.5 t -94.68 161.98 13.97 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.323 -0.399 . . . . 63.12 111.157 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -57.15 -48.9 81.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 112.566 0.58 . . . . 63.12 112.566 -174.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.518 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 29.4 p90 -60.13 -44.07 95.18 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.998 0.427 . . . . 71.42 111.042 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -57.62 -52.3 65.97 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.62 0.724 . . . . 74.33 110.832 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.459 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 92.0 t -59.55 -46.27 93.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.542 -0.754 . . . . 64.54 111.414 178.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.5 mtm105 -58.5 -28.95 65.88 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.116 0.413 . . . . 72.52 112.116 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 87.6 mt -65.82 -52.34 51.39 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.983 0.42 . . . . 72.11 110.836 174.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -63.29 -41.02 98.94 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.438 -0.346 . . . . 74.43 111.569 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 88.2 mt -62.68 -37.93 88.39 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.0 0.428 . . . . 64.45 111.091 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -60.87 -42.66 98.32 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.304 -0.407 . . . . 74.02 110.741 176.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -62.49 -51.68 66.49 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.255 -0.43 . . . . 71.33 110.928 176.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.2 mt -57.92 -31.77 67.12 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.148 0.499 . . . . 74.41 111.407 176.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -70.88 -34.38 71.54 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.068 0.461 . . . . 64.24 110.836 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -73.46 -41.08 63.62 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.085 -0.507 . . . . 73.31 111.456 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.549 HG23 HG23 ' A' ' 53' ' ' VAL . 36.0 m -84.13 7.76 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 N-CA-C 112.886 0.699 . . . . 74.24 112.886 -177.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.51 44.7 10.51 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 120.942 -0.647 . . . . 71.24 114.46 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.549 HG23 HG23 ' A' ' 51' ' ' VAL . 91.2 t -114.31 -42.89 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.002 0.43 . . . . 54.22 111.331 175.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.4 mt -116.85 151.92 35.53 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.841 0.682 . . . . 52.42 112.841 -176.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.502 ' HB2' HD22 ' A' ' 70' ' ' LEU . 1.4 tm-20 -122.98 128.16 49.83 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.112 -0.949 . . . . 73.22 108.683 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.504 ' NZ ' ' HB3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -87.49 93.67 9.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.147 0.498 . . . . 62.25 111.311 -172.641 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 82.1 t . . . . . 0 CA--C 1.538 0.515 0 CA-C-N 115.91 -0.587 . . . . 73.24 111.963 -178.395 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 82.6 mt . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 120.927 0.394 . . . . 72.55 110.977 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -123.14 121.81 36.9 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.999 0.428 . . . . 74.44 111.687 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -118.67 127.45 53.58 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.345 -0.389 . . . . 70.12 110.755 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 69' ' ' LEU . 3.3 pp -79.16 150.35 31.74 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.077 0.465 . . . . 71.15 111.534 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 55' ' ' GLU . 2.1 pt? . . . . . 0 CA--C 1.537 0.476 0 CA-C-N 116.175 -0.466 . . . . 51.42 110.887 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.8 tt . . . . . 0 CA--C 1.543 0.674 0 CA-C-O 121.123 0.487 . . . . 71.11 111.449 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.472 HG11 HD21 ' A' ' 48' ' ' LEU . 49.8 t -56.69 -29.92 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 112.599 0.592 . . . . 72.22 112.599 -176.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.2 m -51.91 -41.07 61.69 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.893 0.378 . . . . 75.12 111.527 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.481 ' O ' HG13 ' A' ' 12' ' ' ILE . 4.4 ttmp? -54.41 -52.09 62.82 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.07 0.462 . . . . 73.11 110.722 174.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.535 HG23 HG21 ' A' ' 30' ' ' ILE . 67.4 mt -59.1 -45.27 92.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.8 -0.637 . . . . 54.55 111.572 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.6 mt -58.41 -43.35 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.082 0.468 . . . . 52.25 111.053 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.2 t -64.0 -40.15 95.72 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.198 -0.455 . . . . 70.31 111.205 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 8' ' ' LYS . 84.9 mt -63.18 -44.53 99.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 120.705 0.288 . . . . 75.22 111.375 177.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.536 HG13 HG21 ' A' ' 25' ' ' VAL . 91.7 t -54.1 -53.62 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 121.409 0.623 . . . . 74.24 110.663 174.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -56.52 -44.65 80.97 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.439 -0.8 . . . . 54.53 111.442 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 19' ' ' MET . 6.7 tp10 -58.34 -52.23 66.49 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.011 0.434 . . . . 70.35 111.258 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.48 ' HD2' ' HB3' ' A' ' 29' ' ' ASP . 1.9 mmp_? -49.93 -36.96 29.74 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.99 -0.55 . . . . 72.1 111.326 177.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.745 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 78.3 mt-30 -74.85 -42.53 57.79 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.227 -0.442 . . . . 70.43 112.019 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -56.86 -28.74 62.15 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.081 0.467 . . . . 71.34 111.424 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.41 ' HG2' ' O ' ' A' ' 15' ' ' GLU . 26.4 mmt -72.58 -39.25 67.54 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.455 0.539 . . . . 65.13 112.455 -178.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.677 ' HB2' ' HB2' ' A' ' 23' ' ' ALA . 4.1 m-20 -127.58 20.11 6.69 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.304 0.483 . . . . 73.43 112.304 -175.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.8 t70 59.22 -88.19 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.028 0.531 . . . . 72.12 112.429 176.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -85.94 56.38 4.83 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.682 -0.567 . . . . 54.24 111.682 177.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.745 ' HB3' ' HA ' ' A' ' 17' ' ' GLN . . . -96.0 118.17 65.9 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 113.327 0.862 . . . . 74.31 113.327 -171.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.459 ' HB3' HG11 ' A' ' 57' ' ' VAL . 91.3 Cg_endo -78.08 118.97 4.51 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.217 1.944 . . . . 71.53 110.72 168.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.536 HG21 HG13 ' A' ' 13' ' ' VAL . 61.7 t -78.34 132.53 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 121.075 0.464 . . . . 73.32 112.084 -171.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.491 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -89.6 132.67 34.99 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.856 -0.611 . . . . 65.33 110.297 -179.408 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.435 HG23 HD12 ' A' ' 45' ' ' LEU . 56.4 m -49.48 -38.53 30.32 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.566 0.58 . . . . 73.21 112.566 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -72.38 -29.1 63.45 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.612 0.597 . . . . 60.43 112.612 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.48 ' HB3' ' HD2' ' A' ' 16' ' ' ARG . 76.4 m-20 -54.04 -49.29 69.29 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.424 0.631 . . . . 73.33 111.06 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.535 HG21 HG23 ' A' ' 9' ' ' ILE . 59.0 mt -64.64 -37.08 79.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.653 -0.703 . . . . 74.42 111.388 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.27 -47.87 80.53 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.446 -0.343 . . . . 61.41 111.439 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -65.15 -48.74 72.46 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.8 0.333 . . . . 70.23 111.459 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.56 -52.6 63.79 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.452 0.538 . . . . 44.22 112.452 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.6 -19.9 44.45 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.418 0.525 . . . . 74.33 112.418 -177.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.79 47.22 20.86 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.828 -0.701 . . . . 53.11 112.594 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt -118.14 179.0 4.23 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.96 0.409 . . . . 74.33 111.404 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.8 t -86.57 143.72 27.55 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 111.734 0.272 . . . . 74.01 111.734 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.1 mm -55.18 -52.21 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 112.052 0.389 . . . . 74.54 112.052 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.407 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 60.6 t80 -60.41 -42.93 97.02 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.032 0.444 . . . . 74.52 110.99 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -57.32 -56.13 25.79 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.75 -0.659 . . . . 70.32 111.461 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 82.7 t -56.84 -41.42 75.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.193 -0.458 . . . . 72.33 111.204 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -54.87 -46.02 74.69 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.351 -0.386 . . . . 72.31 111.437 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 84.4 mt -61.84 -45.1 95.28 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.255 -0.429 . . . . 62.24 112.061 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.409 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 63.5 m-85 -68.68 -37.92 79.96 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.796 0.295 . . . . 64.42 111.796 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.52 HD13 ' NE1' ' A' ' 67' ' ' TRP . 93.7 mt -66.32 -37.33 85.14 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.072 0.463 . . . . 74.51 111.001 174.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.47 -55.99 27.61 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.974 -0.557 . . . . 73.11 111.094 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 13.8 pt20 -60.65 -37.88 82.98 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.526 -0.306 . . . . 75.22 111.576 -177.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.472 HD21 HG11 ' A' ' 6' ' ' VAL . 83.7 mt -61.01 -44.84 96.83 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.982 0.42 . . . . 73.44 111.11 176.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -68.01 -30.88 70.23 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.952 0.406 . . . . 74.24 111.177 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -78.58 -31.94 47.47 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.219 0.452 . . . . 75.24 112.219 -177.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.506 HG23 HG23 ' A' ' 53' ' ' VAL . 33.5 m -83.35 -25.6 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 121.966 -0.459 . . . . 62.53 111.468 176.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 118.54 8.81 9.76 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 120.973 -0.632 . . . . 61.53 114.334 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.506 HG23 HG23 ' A' ' 51' ' ' VAL . 91.5 t -77.88 -42.14 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 117.483 0.642 . . . . 74.12 111.572 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.7 mt -110.89 133.87 53.02 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.147 0.499 . . . . 71.3 112.038 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.506 ' HG2' ' NH2' ' A' ' 68' ' ' ARG . 8.1 tp10 -91.8 154.77 18.7 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.923 -0.581 . . . . 73.3 111.05 176.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -80.22 136.35 36.45 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.202 0.525 . . . . 64.11 112.015 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.459 HG11 ' HB3' ' A' ' 24' ' ' PRO . 44.3 t . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 121.054 0.454 . . . . 72.22 110.232 170.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 86.3 mt . . . . . 0 CA--C 1.536 0.423 0 N-CA-C 109.79 -0.448 . . . . 65.44 109.79 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.52 ' NE1' HD13 ' A' ' 45' ' ' LEU . 42.6 m95 -107.17 127.82 53.85 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.863 0.69 . . . . 74.52 112.863 -169.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.506 ' NH2' ' HG2' ' A' ' 55' ' ' GLU . 47.6 ttp180 -120.44 165.01 15.52 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.264 -0.643 . . . . 75.41 109.264 175.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.7 pp -123.41 151.64 42.4 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.331 -0.856 . . . . 53.13 111.988 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.441 ' N ' HD23 ' A' ' 70' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.469 0.523 0 CA-C-N 115.923 -0.581 . . . . 72.53 111.357 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.446 ' N ' HD12 ' A' ' 5' ' ' ILE . 2.7 mp . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 112.242 0.46 . . . . 72.43 112.242 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.2 t -61.93 -54.83 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.121 0.486 . . . . 73.54 111.377 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 m -59.62 -31.42 69.49 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.019 -0.537 . . . . 72.41 111.46 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.514 ' O ' HG13 ' A' ' 12' ' ' ILE . 60.5 tptt -57.49 -57.0 14.59 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.2 -0.455 . . . . 73.22 110.679 176.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.486 ' HA ' HD12 ' A' ' 12' ' ' ILE . 67.1 mt -58.2 -43.56 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 116.141 -0.481 . . . . 75.24 111.63 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.0 mt -60.63 -42.74 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.12 0.486 . . . . 73.01 111.101 176.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.0 t -65.4 -33.34 75.73 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.215 -0.448 . . . . 61.51 111.271 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 8' ' ' LYS . 96.9 mt -63.44 -48.41 87.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.365 -0.38 . . . . 72.24 110.934 175.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.8 t -58.15 -47.35 87.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 120.735 0.302 . . . . 71.54 111.229 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -59.47 -45.43 91.67 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.15 0.5 . . . . 74.41 111.041 177.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -53.64 -46.9 70.69 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.963 -0.562 . . . . 73.14 111.52 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 12' ' ' ILE . 7.6 mmm180 -67.87 -37.43 81.79 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.216 -0.447 . . . . 64.52 111.473 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -62.9 -32.87 74.23 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.081 0.4 . . . . 73.25 112.081 176.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -92.21 -29.23 16.56 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.975 0.731 . . . . 75.22 112.975 -175.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.488 ' SD ' ' HD2' ' A' ' 16' ' ' ARG . 27.2 ptm -70.35 -26.67 63.85 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.119 -0.363 . . . . 74.34 111.598 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -127.13 179.25 5.52 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 116.475 -0.329 . . . . 63.23 110.337 -177.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -104.21 -12.58 16.59 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 122.156 -0.34 . . . . 73.33 111.91 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.3 44.09 0.23 Allowed Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.878 -0.677 . . . . 44.41 113.409 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.78 107.22 38.78 Favored Pre-proline 0 CA--C 1.537 0.444 0 O-C-N 122.562 -0.375 . . . . 62.54 111.62 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.55 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 46.6 Cg_endo -68.52 138.85 43.2 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.22 1.947 . . . . 44.41 111.696 176.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.421 HG22 ' HB2' ' A' ' 16' ' ' ARG . 7.9 t -79.96 120.61 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 120.899 0.38 . . . . 74.11 111.13 -175.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.501 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -80.63 132.49 35.61 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.607 -0.269 . . . . 70.31 110.996 -176.821 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.3 m -51.97 -44.46 64.02 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.903 0.383 . . . . 71.23 111.665 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.503 ' NH1' HG13 ' A' ' 38' ' ' ILE . 36.1 mmt180 -61.21 -45.92 92.6 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.207 0.527 . . . . 75.4 110.682 176.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -58.52 -40.77 83.84 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.792 -0.64 . . . . 62.53 111.455 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 26' ' ' LYS . 66.0 mt -61.92 -39.69 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.793 0.33 . . . . 73.02 111.157 176.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.521 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -57.93 -48.74 79.02 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.268 -0.424 . . . . 72.42 111.892 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.13 -43.55 94.92 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 111.995 0.368 . . . . 72.01 111.995 176.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.12 -41.72 94.6 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.332 0.493 . . . . 75.31 112.332 -178.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.63 -23.91 27.33 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.218 0.451 . . . . 64.33 112.218 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.17 40.46 24.4 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.227 -0.511 . . . . 72.44 113.231 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.9 mt -128.63 161.06 30.53 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.613 -0.345 . . . . 72.25 111.37 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 41' ' ' VAL . 66.9 m -68.1 150.97 47.72 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.515 -0.311 . . . . 71.41 111.096 176.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.503 HG13 ' NH1' ' A' ' 28' ' ' ARG . 49.7 mm -52.21 -48.83 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 112.31 0.485 . . . . 62.32 112.31 -176.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.497 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 78.2 t80 -59.2 -49.05 79.35 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.529 -0.305 . . . . 75.31 111.242 178.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -54.98 -50.81 68.04 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.244 0.545 . . . . 72.3 110.899 176.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.521 HG21 ' HA ' ' A' ' 31' ' ' ALA . 88.8 t -56.18 -49.64 75.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.078 -0.51 . . . . 51.12 111.345 178.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.573 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 31.6 mtp180 -60.98 -34.3 74.56 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 111.752 0.278 . . . . 63.21 111.752 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 79.2 mt -55.78 -47.42 77.08 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.15 0.5 . . . . 74.24 110.407 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.409 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 87.0 m-85 -65.51 -43.43 90.12 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.058 -0.519 . . . . 73.33 111.522 175.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.486 HD13 ' NE1' ' A' ' 67' ' ' TRP . 89.5 mt -64.15 -50.15 69.33 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 111.85 0.315 . . . . 72.24 111.85 -177.099 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 42' ' ' ARG . 62.1 mm-40 -56.83 -45.82 82.1 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.32 -0.4 . . . . 54.01 111.061 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 88.3 mt-30 -62.92 -49.81 73.33 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.536 0.208 . . . . 60.41 110.973 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.427 ' HA ' HG22 ' A' ' 51' ' ' VAL . 94.5 mt -57.85 -28.95 64.58 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.019 0.437 . . . . 70.12 111.127 176.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.465 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 31.4 t-80 -67.07 -56.69 8.97 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.06 0.457 . . . . 73.25 111.077 174.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.13 -23.79 64.02 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.252 0.834 . . . . 74.22 113.252 -175.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.525 HG23 HG23 ' A' ' 53' ' ' VAL . 25.1 m -84.78 -4.58 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 121.887 -0.508 . . . . 73.24 111.947 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.3 17.9 38.17 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 114.617 0.607 . . . . 65.35 114.617 173.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.525 HG23 HG23 ' A' ' 51' ' ' VAL . 97.3 t -90.91 -50.01 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 117.294 0.547 . . . . 52.3 111.327 177.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.7 mt -106.69 131.03 54.29 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.178 0.513 . . . . 71.43 111.893 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -101.34 143.65 31.12 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.907 -0.588 . . . . 74.51 111.003 177.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.447 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -66.11 141.47 58.1 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.802 0.667 . . . . 70.13 112.802 -175.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 51.0 t . . . . . 0 N--CA 1.471 0.624 0 CA-C-N 116.285 -0.416 . . . . 73.51 110.959 171.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 66.8 mt . . . . . 0 CA--C 1.539 0.537 0 N-CA-C 109.969 -0.382 . . . . 65.42 109.969 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.486 ' NE1' HD13 ' A' ' 45' ' ' LEU . 75.7 m95 -121.16 147.86 45.02 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.328 0.585 . . . . 72.13 112.389 -174.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -148.78 133.68 18.04 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.934 -0.576 . . . . 71.14 110.397 173.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 pp -72.74 163.31 28.3 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.733 -0.604 . . . . 74.12 110.856 174.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.8 mt . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 112.191 0.441 . . . . 73.33 112.191 -175.566 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 70.2 mt . . . . . 0 N--CA 1.475 0.79 0 CA-C-O 120.875 0.369 . . . . 72.05 111.925 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.6 t -71.73 -46.04 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.093 0.473 . . . . 73.13 111.22 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.9 m -55.24 -39.52 69.83 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.8 -0.636 . . . . 54.23 112.227 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.517 ' O ' HG13 ' A' ' 12' ' ' ILE . 55.6 tptt -61.96 -50.86 70.42 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.739 0.304 . . . . 72.1 110.732 177.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 72.7 mt -55.79 -46.36 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.886 0.374 . . . . 73.43 111.486 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.2 mt -58.88 -45.22 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 121.192 0.52 . . . . 73.32 110.93 176.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.2 t -62.39 -35.17 78.36 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.003 -0.544 . . . . 71.42 111.821 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.565 HG21 ' HA ' ' A' ' 30' ' ' ILE . 96.8 mt -64.73 -49.7 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.871 0.367 . . . . 74.35 111.2 177.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 64.2 t -54.2 -49.17 64.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.062 0.458 . . . . 64.15 110.969 177.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -62.46 -44.09 97.25 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.012 -0.54 . . . . 70.11 111.487 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.416 ' HA ' ' ND2' ' A' ' 18' ' ' ASN . 10.1 tp10 -61.62 -37.46 84.06 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.153 0.501 . . . . 74.3 111.04 -178.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.481 ' HG3' HG13 ' A' ' 25' ' ' VAL . 8.3 mmm180 -64.29 -40.06 95.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 73.53 110.79 174.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' A' ' 21' ' ' ASP . 74.1 mt-30 -72.69 -4.57 32.0 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.871 0.367 . . . . 72.24 111.58 175.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.416 ' ND2' ' HA ' ' A' ' 15' ' ' GLU . 81.2 m-20 -87.38 -42.56 12.76 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.029 0.442 . . . . 62.51 109.85 167.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 89.8 mmm -76.84 -66.91 0.76 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.938 -0.574 . . . . 74.23 111.319 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -71.5 -14.3 62.07 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.998 0.428 . . . . 75.02 111.087 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 17' ' ' GLN . 17.0 t70 74.54 -68.27 0.22 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.992 0.917 . . . . 72.12 112.673 177.121 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -136.1 36.81 1.97 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.553 -0.832 . . . . 65.54 113.885 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -102.85 152.72 38.52 Favored Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 122.51 -0.406 . . . . 71.52 111.499 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.554 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 49.9 Cg_endo -68.21 129.19 18.81 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.29 1.993 . . . . 75.43 111.999 174.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.481 HG13 ' HG3' ' A' ' 16' ' ' ARG . 38.5 t -79.44 135.83 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.155 0.502 . . . . 60.31 111.68 -174.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.542 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -88.28 135.72 33.32 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.139 -0.482 . . . . 72.05 111.29 -177.938 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.2 m -55.07 -31.27 61.03 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.907 0.384 . . . . 52.32 111.963 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -60.54 -54.15 48.89 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 111.798 0.295 . . . . 75.2 111.798 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.42 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 2.3 m-20 -57.82 -37.48 73.88 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.885 0.374 . . . . 73.12 111.619 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.565 ' HA ' HG21 ' A' ' 12' ' ' ILE . 59.0 mt -66.91 -49.23 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.428 -0.351 . . . . 73.31 111.293 178.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.06 -34.85 73.98 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.992 0.425 . . . . 61.21 111.455 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -66.08 -51.92 53.6 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.042 -0.526 . . . . 73.53 111.35 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.02 -35.84 72.17 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.506 0.558 . . . . 74.04 112.506 -177.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.18 -33.69 38.1 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.391 0.515 . . . . 54.43 112.391 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.37 -0.11 83.01 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.001 -0.618 . . . . 73.1 112.989 -177.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 71.6 mt -85.1 160.0 20.06 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 122.602 -0.352 . . . . 75.45 110.897 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 41' ' ' VAL . 47.6 t -79.74 157.44 27.13 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 120.788 0.328 . . . . 73.54 111.8 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.0 mm -51.95 -52.37 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 112.808 0.67 . . . . 72.35 112.808 -174.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.532 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 32.9 p90 -58.29 -44.43 88.49 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.985 0.421 . . . . 71.03 111.083 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -62.13 -47.09 86.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.241 0.543 . . . . 64.03 110.993 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 37' ' ' SER . 95.0 t -60.04 -51.47 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 115.972 -0.558 . . . . 73.01 111.877 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -62.94 -26.05 68.63 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 111.893 0.331 . . . . 71.21 111.893 -177.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 79.5 mt -65.99 -51.47 58.1 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.617 0.246 . . . . 63.04 111.011 175.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -65.56 -39.61 91.87 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.757 0.313 . . . . 72.32 111.695 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.504 HD13 ' CD1' ' A' ' 67' ' ' TRP . 96.5 mt -58.2 -41.69 84.53 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.344 0.592 . . . . 73.42 110.651 174.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -60.6 -43.97 96.79 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.629 -0.714 . . . . 75.32 111.054 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 74.9 mt-30 -60.38 -38.03 82.62 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.208 -0.451 . . . . 71.33 111.249 176.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 93.0 mt -63.83 -32.76 74.38 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.711 0.291 . . . . 64.1 111.309 175.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -70.56 -41.39 72.5 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 122.06 -0.4 . . . . 75.23 110.555 171.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -56.12 -42.68 77.23 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.785 -0.643 . . . . 73.13 111.848 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.559 HG23 HG23 ' A' ' 53' ' ' VAL . 35.0 m -82.13 -15.13 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 112.492 0.553 . . . . 63.13 112.492 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.92 8.06 32.43 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 114.658 0.623 . . . . 72.54 114.658 175.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.559 HG23 HG23 ' A' ' 51' ' ' VAL . 95.1 t -77.12 -52.61 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 117.409 0.605 . . . . 64.35 111.975 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.0 mt -106.41 149.94 26.52 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.72 0.637 . . . . 74.53 112.72 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 68' ' ' ARG . 12.6 pt-20 -111.1 146.08 37.44 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.992 -0.549 . . . . 74.54 110.068 172.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.429 ' HE3' ' HB2' ' A' ' 56' ' ' LYS . 46.1 mtmt -80.86 104.38 11.33 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.851 0.358 . . . . 52.05 111.475 -177.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.582 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 53.3 t . . . . . 0 C--O 1.241 0.644 0 CA-C-O 121.724 0.773 . . . . 70.42 110.948 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.582 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 72.8 mt . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 110.091 -0.337 . . . . 61.32 110.091 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.504 ' CD1' HD13 ' A' ' 45' ' ' LEU . 74.5 m95 -121.52 139.11 53.92 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.133 0.492 . . . . 74.25 112.005 -175.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.536 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 46.3 ttt180 -136.42 128.11 28.94 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.342 -0.39 . . . . 75.51 110.548 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 69' ' ' LEU . 4.6 pp -79.35 138.99 37.89 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.519 -0.738 . . . . 63.51 111.269 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.478 ' H ' HD23 ' A' ' 70' ' ' LEU . 2.1 pt? . . . . . 0 N--CA 1.469 0.486 0 CA-C-N 116.215 -0.448 . . . . 73.32 110.944 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.42 HG23 HD11 ' A' ' 36' ' ' LEU . 48.0 mm . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 112.819 0.674 . . . . 74.15 112.819 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.9 t -62.52 -57.77 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 120.949 0.404 . . . . 71.14 111.682 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.5 m -63.39 -34.44 77.74 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.981 0.42 . . . . 75.42 111.276 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.408 ' O ' HG13 ' A' ' 12' ' ' ILE . 57.0 tptt -56.19 -53.14 60.74 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.202 -0.453 . . . . 74.51 110.837 177.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.416 HG23 HG21 ' A' ' 30' ' ' ILE . 62.7 mt -59.1 -47.32 90.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.107 -0.497 . . . . 61.53 111.965 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 61.4 mt -60.42 -43.19 93.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 112.093 0.405 . . . . 54.21 112.093 -178.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 85.4 p -60.65 -36.87 79.73 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 120.781 0.324 . . . . 60.23 111.176 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.593 HG21 ' HA ' ' A' ' 30' ' ' ILE . 79.8 mt -64.29 -40.73 90.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.078 0.466 . . . . 71.14 111.504 176.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.58 -52.06 65.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 120.885 0.374 . . . . 53.31 110.914 177.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -59.35 -40.76 87.44 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.949 0.404 . . . . 74.31 110.864 176.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 12' ' ' ILE . 16.9 tp10 -47.75 -56.04 8.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.246 0.618 . . . . 65.41 111.841 177.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.504 ' HG3' HG13 ' A' ' 25' ' ' VAL . 1.2 mmp_? -63.09 -37.56 87.69 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.393 -0.367 . . . . 73.21 111.555 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -79.61 -13.99 59.12 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 111.955 0.354 . . . . 75.42 111.955 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -73.11 -35.95 66.66 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.028 0.442 . . . . 62.32 109.862 170.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.1 mmt -67.17 -58.79 4.21 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.814 -0.63 . . . . 63.15 110.885 172.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -124.61 104.12 8.52 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.435 -0.348 . . . . 71.24 110.836 176.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -61.38 -14.38 27.32 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.317 0.858 . . . . 64.21 113.317 -175.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -117.35 15.13 13.21 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 120.92 -0.657 . . . . 44.34 113.908 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.53 128.46 26.89 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 117.272 0.536 . . . . 42.41 112.082 -177.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.575 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 58.7 Cg_endo -71.42 135.45 26.61 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.364 2.043 . . . . 75.11 112.865 176.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.504 HG13 ' HG3' ' A' ' 16' ' ' ARG . 24.5 t -80.41 139.87 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 120.846 0.355 . . . . 62.44 111.449 -177.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.514 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 12.0 mptt -91.63 130.03 37.51 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.406 -0.361 . . . . 73.04 110.946 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.3 m -47.05 -34.5 5.84 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 120.919 0.39 . . . . 74.54 111.935 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -60.09 -49.26 78.33 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.386 -0.37 . . . . 72.14 111.795 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -56.22 -49.55 73.77 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.095 0.474 . . . . 74.54 110.788 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.593 ' HA ' HG21 ' A' ' 12' ' ' ILE . 64.3 mt -59.06 -48.36 86.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.907 -0.588 . . . . 64.52 111.555 178.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.483 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -57.73 -52.25 66.21 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.274 -0.421 . . . . 75.45 111.813 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -65.3 -41.97 93.54 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.285 -0.416 . . . . 74.44 111.711 -177.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.93 -39.69 87.41 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.214 0.45 . . . . 73.34 112.214 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.03 -20.79 40.95 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.001 0.371 . . . . 72.13 112.001 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.55 32.75 24.04 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.212 -0.518 . . . . 73.22 112.617 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.42 HD11 HG23 ' A' ' 5' ' ' ILE . 74.2 mt -122.21 161.71 22.72 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.873 0.368 . . . . 64.01 111.161 -177.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 41' ' ' VAL . 69.0 m -82.78 152.13 25.83 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.703 0.287 . . . . 73.45 111.528 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.8 mm -50.56 -46.04 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 112.28 0.474 . . . . 70.22 112.28 -176.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -57.87 -52.07 66.99 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.809 0.338 . . . . 64.42 111.8 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -58.54 -46.49 86.73 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.209 0.528 . . . . 72.21 111.277 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.483 HG21 ' HA ' ' A' ' 31' ' ' ALA . 57.9 t -61.54 -42.23 93.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.802 -0.636 . . . . 73.42 111.52 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -55.03 -39.64 69.36 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.784 0.326 . . . . 72.21 111.615 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.56 -52.48 60.88 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.274 -0.421 . . . . 74.51 111.042 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -59.57 -50.21 74.76 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 111.932 0.345 . . . . 70.24 111.932 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.424 HD13 ' CD1' ' A' ' 67' ' ' TRP . 92.2 mt -57.51 -43.99 84.69 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.863 0.363 . . . . 71.1 111.69 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -59.1 -50.38 74.26 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.017 0.437 . . . . 74.15 110.796 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -54.87 -44.55 74.13 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.038 -0.528 . . . . 71.22 110.807 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.471 ' HA ' HG22 ' A' ' 51' ' ' VAL . 89.1 mt -59.46 -29.68 67.98 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.3 -0.409 . . . . 70.41 111.782 178.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -72.53 -46.46 54.44 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.955 -0.466 . . . . 75.02 110.89 174.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -70.39 -16.89 63.01 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.835 0.68 . . . . 61.14 112.835 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.592 HG23 HG23 ' A' ' 53' ' ' VAL . 30.1 m -98.96 4.64 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 O-C-N 122.106 -0.372 . . . . 70.41 111.749 176.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.44 31.42 27.7 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 114.7 0.64 . . . . 65.14 114.7 174.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.592 HG23 HG23 ' A' ' 51' ' ' VAL . 95.3 t -105.81 -54.59 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 117.213 0.506 . . . . 71.33 111.749 176.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.1 mt -99.18 162.91 12.79 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.889 0.7 . . . . 51.02 112.889 -176.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 68' ' ' ARG . 17.0 tp10 -124.95 149.56 47.52 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.381 -0.827 . . . . 53.53 110.709 -175.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -78.96 129.28 34.31 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.048 0.758 . . . . 70.41 113.048 -172.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.9 t . . . . . 0 CA--C 1.541 0.619 0 CA-C-O 120.757 0.313 . . . . 72.33 111.188 170.471 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 58.2 mt . . . . . 0 CA--C 1.538 0.484 0 CA-C-O 120.883 0.373 . . . . 71.43 110.159 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.424 ' CD1' HD13 ' A' ' 45' ' ' LEU . 57.7 m95 -126.37 135.86 51.97 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.191 0.811 . . . . 70.34 113.191 -171.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.533 ' HB2' ' HB3' ' A' ' 55' ' ' GLU . 63.0 mtp180 -113.24 176.21 5.12 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.521 -0.763 . . . . 62.3 109.333 169.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.444 ' O ' HD12 ' A' ' 69' ' ' LEU . 3.5 pp -127.1 149.66 49.84 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.715 -0.616 . . . . 63.54 112.343 175.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.438 ' H ' HD23 ' A' ' 70' ' ' LEU . 1.4 pt? . . . . . 0 N--CA 1.469 0.513 0 CA-C-N 116.204 -0.453 . . . . 74.45 110.866 173.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 120.852 0.358 . . . . 70.2 110.947 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.4 m -155.68 -22.71 0.11 Allowed 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 120.803 0.335 . . . . 61.33 111.507 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.539 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -46.74 -45.78 19.91 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.132 0.79 . . . . 52.34 113.132 179.423 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.2 t 47.15 -79.71 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.42 0.896 . . . . 72.41 113.42 176.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.48 ' N ' ' O ' ' A' ' 3' ' ' GLU . 8.1 tp -54.45 -35.83 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.902 0.382 . . . . 73.25 111.374 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' A' ' 3' ' ' GLU . 59.5 t -63.65 -42.04 94.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 120.756 0.312 . . . . 73.11 111.018 176.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.2 m -61.13 -41.12 96.14 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.004 0.43 . . . . 73.23 110.706 175.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.421 ' O ' HG13 ' A' ' 12' ' ' ILE . 62.0 tttp -57.27 -46.39 83.13 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.201 -0.454 . . . . 53.4 110.293 173.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.483 ' O ' HG23 ' A' ' 13' ' ' VAL . 70.3 mt -55.99 -48.83 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.205 -0.452 . . . . 64.31 111.494 176.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.5 mt -57.14 -45.24 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.012 0.434 . . . . 72.41 111.112 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.6 t -57.23 -45.94 83.42 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.171 -0.468 . . . . 71.11 111.064 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 8' ' ' LYS . 94.1 mt -59.37 -45.11 93.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.223 -0.444 . . . . 41.1 111.058 176.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 9' ' ' ILE . 96.2 t -57.98 -49.61 80.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.486 -0.324 . . . . 72.52 111.543 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -61.99 -52.66 63.11 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.938 0.399 . . . . 74.25 111.436 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -65.2 -32.58 74.33 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.101 -0.499 . . . . 51.32 111.936 -175.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.1 mmm180 -65.69 -62.72 1.35 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 122.17 -0.331 . . . . 73.44 111.737 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -56.56 -24.33 46.41 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.263 0.554 . . . . 64.24 110.901 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -64.52 -41.02 96.64 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.76 -0.655 . . . . 71.12 110.577 172.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 65.5 mtt -82.24 -28.15 32.07 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.347 -0.388 . . . . 74.01 111.792 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -77.65 -10.49 59.54 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.676 0.274 . . . . 72.31 111.252 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 64.1 -74.75 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.431 0.692 . . . . 75.22 112.835 174.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -106.44 -11.8 26.42 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.917 -0.659 . . . . 41.21 113.395 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -103.28 141.36 22.34 Favored Pre-proline 0 CA--C 1.538 0.511 0 O-C-N 122.541 -0.387 . . . . 63.43 112.022 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.528 ' HG2' ' HB3' ' A' ' 66' ' ' LEU . 53.5 Cg_endo -71.35 -176.56 1.98 Allowed 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.483 2.122 . . . . 65.31 113.216 175.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.406 HG21 ' HA ' ' A' ' 13' ' ' VAL . 13.4 t -88.75 152.13 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.248 -0.433 . . . . 74.43 111.755 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.568 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 10.8 mptt -98.86 132.44 44.21 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.399 -0.364 . . . . 75.43 111.188 -176.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.8 m -47.42 -47.16 26.86 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.012 0.375 . . . . 65.15 112.012 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -59.22 -55.77 30.7 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.505 -0.316 . . . . 74.51 111.653 175.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -51.53 -39.59 58.0 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.188 -0.46 . . . . 74.53 112.077 -174.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.5 mt -59.69 -41.42 85.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.067 0.46 . . . . 63.52 110.919 175.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.9 -39.41 83.61 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.226 -0.443 . . . . 74.42 111.282 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -60.75 -56.63 18.95 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.957 0.408 . . . . 75.22 111.31 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.26 -45.85 90.09 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.257 -0.428 . . . . 61.23 112.04 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.98 -23.61 58.3 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.214 0.45 . . . . 74.32 112.214 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.86 44.67 23.96 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.247 -0.501 . . . . 61.22 112.558 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.3 mt -126.88 178.67 5.81 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.135 0.493 . . . . 60.41 111.623 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.406 ' O ' HG23 ' A' ' 41' ' ' VAL . 31.1 t -87.02 147.93 25.51 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.93 -0.577 . . . . 64.13 111.339 176.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.8 mm -55.65 -44.41 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 116.308 -0.405 . . . . 64.13 112.001 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.556 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 72.1 t80 -61.49 -53.93 49.93 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 111.566 0.21 . . . . 73.12 111.566 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -51.77 -49.1 63.3 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.508 0.67 . . . . 74.24 111.383 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 37' ' ' SER . 94.3 t -60.37 -51.6 71.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.717 -0.674 . . . . 74.11 112.204 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -60.76 -27.07 67.69 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 122.387 -0.196 . . . . 72.23 111.356 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 87.5 mt -62.46 -54.64 37.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.742 0.306 . . . . 55.24 110.375 175.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -57.82 -47.49 82.47 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.043 0.449 . . . . 74.14 111.08 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.2 mt -58.74 -43.83 90.32 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.034 -0.53 . . . . 44.44 111.983 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 49' ' ' HIS . 34.8 tt0 -67.06 -40.38 87.09 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.73 0.3 . . . . 74.35 111.553 -178.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -63.41 -50.23 70.65 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.938 0.399 . . . . 62.41 110.836 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.6 mt -58.46 -31.66 68.0 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.179 0.514 . . . . 72.24 110.927 174.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.537 ' HD2' ' HA ' ' A' ' 55' ' ' GLU . 28.3 t-80 -64.61 -54.58 29.8 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.246 -0.434 . . . . 72.53 111.768 176.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -66.42 -26.27 67.15 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.011 0.375 . . . . 63.22 112.011 -173.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.536 HG23 HG23 ' A' ' 53' ' ' VAL . 26.1 m -85.34 -1.5 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 112.21 0.448 . . . . 54.41 112.21 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.33 -14.81 47.26 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 115.053 0.781 . . . . 73.44 115.053 172.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.536 HG23 HG23 ' A' ' 51' ' ' VAL . 59.8 t -62.39 -51.02 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 117.833 0.816 . . . . 73.11 111.808 -176.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 94.2 mt -114.8 154.2 29.0 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.861 0.362 . . . . 64.41 111.618 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.537 ' HA ' ' HD2' ' A' ' 49' ' ' HIS . 9.0 tp10 -121.69 147.3 46.06 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.229 0.537 . . . . 43.22 110.998 176.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.427 ' HG2' ' OE1' ' A' ' 55' ' ' GLU . 23.2 pttm -81.7 95.39 7.22 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.593 -0.73 . . . . 71.41 111.855 -178.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.514 HG11 ' HG3' ' A' ' 24' ' ' PRO . 44.0 t -85.64 83.97 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 121.505 0.669 . . . . 75.51 110.118 174.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.49 ' HB2' HG21 ' A' ' 63' ' ' VAL . 28.7 p-10 -154.63 152.48 30.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.059 -0.519 . . . . 74.03 111.746 -177.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.87 -33.09 74.84 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.182 -0.463 . . . . 70.42 111.318 175.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 151.61 -112.11 0.52 Allowed Glycine 0 CA--C 1.527 0.791 0 CA-C-N 116.33 -0.395 . . . . 65.51 112.899 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.457 ' N ' ' HD2' ' A' ' 61' ' ' LYS . 12.2 mptt -97.35 153.37 18.12 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.003 0.43 . . . . 43.32 110.998 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.38 4.9 85.64 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.284 -0.484 . . . . 51.13 113.407 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.49 HG21 ' HB2' ' A' ' 58' ' ' ASN . 27.2 m -119.21 145.65 38.87 Favored Pre-proline 0 CA--C 1.54 0.587 0 O-C-N 122.499 -0.412 . . . . 63.23 111.626 -179.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.94 -24.48 76.46 Favored 'Trans proline' 0 N--CA 1.482 0.837 0 C-N-CA 122.868 2.378 . . . . 32.04 113.26 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.63 124.71 1.48 Allowed Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.205 -0.522 . . . . 60.5 113.3 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.528 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 83.7 mt -111.78 136.25 51.3 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.907 0.384 . . . . 51.3 110.665 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -111.45 132.79 54.21 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.378 0.608 . . . . 64.25 112.182 -175.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -136.76 138.13 40.6 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.744 -0.662 . . . . 73.15 110.885 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.418 ' O ' HD12 ' A' ' 69' ' ' LEU . 2.4 pp -83.23 153.23 24.82 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.806 0.336 . . . . 74.54 111.697 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.582 ' HG ' ' HG2' ' A' ' 71' ' ' GLU . 1.9 pt? -143.4 -49.82 0.32 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.005 0.372 . . . . 50.32 112.005 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.582 ' HG2' ' HG ' ' A' ' 70' ' ' LEU . 28.0 mm-40 . . . . . 0 C--O 1.255 1.351 0 CA-C-O 118.48 -0.771 . . . . 73.23 111.867 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 120.912 0.387 . . . . 75.24 111.646 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.8 m -102.06 21.62 14.49 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.801 0.334 . . . . 75.14 111.759 -176.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -101.09 21.36 13.99 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.638 0.607 . . . . 73.3 112.638 -169.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.8 p -66.5 -6.24 14.15 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 112.698 0.629 . . . . 75.45 112.698 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.534 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.8 mp -56.36 -37.1 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 120.804 0.335 . . . . 72.43 111.493 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.5 t -60.71 -53.02 54.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.806 0.336 . . . . 70.11 111.274 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.0 m -60.41 -36.16 77.49 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.022 0.439 . . . . 71.34 111.079 177.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.517 ' O ' HG13 ' A' ' 12' ' ' ILE . 62.4 tttp -60.05 -49.05 79.2 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.213 -0.449 . . . . 73.44 111.135 176.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.445 ' HA ' HD12 ' A' ' 12' ' ' ILE . 72.9 mt -59.6 -42.97 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.7 0.286 . . . . 70.44 111.502 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.1 mt -57.43 -43.61 82.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 121.328 0.585 . . . . 73.2 110.574 174.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.7 m -66.15 -30.73 71.27 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.881 -0.599 . . . . 73.24 111.604 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 8' ' ' LYS . 94.5 mt -67.07 -47.72 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.638 0.256 . . . . 73.21 111.279 177.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.491 HG11 HD22 ' A' ' 54' ' ' LEU . 56.1 t -60.12 -45.36 95.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.841 0.353 . . . . 74.23 110.45 175.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -54.77 -48.25 72.91 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.038 -0.528 . . . . 65.55 110.629 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.552 ' O ' ' HG2' ' A' ' 19' ' ' MET . 29.2 tt0 -57.24 -65.54 0.61 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.775 -0.648 . . . . 75.13 111.452 178.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -51.51 -51.86 51.69 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.844 0.354 . . . . 72.34 111.917 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -57.42 -35.27 69.86 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.117 -0.492 . . . . 73.14 111.56 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -81.39 -26.53 35.38 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.042 0.386 . . . . 74.02 112.042 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.552 ' HG2' ' O ' ' A' ' 15' ' ' GLU . 24.3 mmt -71.22 -58.94 3.06 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.839 0.352 . . . . 72.12 111.047 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -74.29 -29.52 61.69 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.602 -0.272 . . . . 75.24 111.235 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.1 t70 69.14 -72.57 0.1 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.539 0.57 . . . . 72.15 112.539 173.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.65 41.42 3.09 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.188 -0.53 . . . . 54.02 113.161 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.19 140.26 8.49 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 112.187 0.44 . . . . 73.54 112.187 -177.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.545 ' HG2' HD13 ' A' ' 66' ' ' LEU . 54.5 Cg_endo -71.66 151.9 58.59 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.516 2.144 . . . . 71.21 112.512 172.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.1 t -80.88 150.36 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 120.906 0.384 . . . . 65.04 111.447 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.457 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -112.24 150.25 31.17 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.697 0.284 . . . . 74.34 110.819 -179.532 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.0 m -55.65 -31.85 62.68 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.02 0.438 . . . . 64.22 111.508 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -64.17 -59.21 4.71 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.182 -0.463 . . . . 72.02 112.175 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.417 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -67.49 -20.25 65.43 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.629 0.603 . . . . 74.21 112.629 -178.439 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 26' ' ' LYS . 77.3 mt -67.93 -51.22 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.048 0.451 . . . . 73.14 110.358 170.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.512 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -58.07 -39.42 78.47 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.124 -0.489 . . . . 75.41 111.189 175.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -51.81 -52.48 48.87 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.693 -0.685 . . . . 70.03 111.543 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.23 -24.94 60.55 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.956 0.408 . . . . 63.14 111.923 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.65 -24.33 36.38 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.062 0.393 . . . . 73.03 112.062 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.87 23.29 78.11 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.077 -0.582 . . . . 34.41 112.24 -174.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.7 mt -118.13 178.21 4.51 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.401 0.62 . . . . 53.44 111.783 -175.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.8 m -82.51 149.17 27.69 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.896 -0.593 . . . . 72.14 111.554 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.6 mm -52.89 -41.96 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 120.929 0.395 . . . . 43.12 111.966 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.467 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 47.4 t80 -60.65 -59.78 4.85 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.149 -0.478 . . . . 74.12 111.644 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -48.44 -58.04 5.22 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.92 0.391 . . . . 72.44 111.376 176.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.569 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 94.9 t -53.3 -45.95 56.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.01 -0.541 . . . . 72.04 111.535 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.496 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 7.7 tpt180 -60.86 -41.67 96.37 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.65 -0.25 . . . . 74.13 111.38 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 89.1 mt -55.51 -44.62 76.81 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.329 0.585 . . . . 70.5 110.738 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -66.25 -41.74 89.54 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.884 -0.598 . . . . 74.23 111.553 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 89.5 mt -59.43 -45.44 91.54 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.829 0.347 . . . . 54.21 111.103 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 42' ' ' ARG . 58.1 mm-40 -52.65 -52.74 54.35 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.293 0.568 . . . . 74.42 110.749 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -65.87 -33.53 76.05 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.842 -0.617 . . . . 62.23 111.848 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.401 ' HA ' HG22 ' A' ' 51' ' ' VAL . 76.8 mt -64.89 -27.79 69.1 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.846 0.355 . . . . 75.32 111.333 176.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -75.39 -37.6 60.42 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.131 0.491 . . . . 71.11 110.142 172.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -63.57 -43.64 96.4 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.773 -0.649 . . . . 65.14 112.388 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.539 HG23 HG23 ' A' ' 53' ' ' VAL . 25.5 m -80.07 -12.74 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.741 0.645 . . . . 73.43 112.741 -177.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.2 52.97 1.66 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.027 -0.606 . . . . 70.54 113.645 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.539 HG23 HG23 ' A' ' 51' ' ' VAL . 94.4 t -124.77 -56.88 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.021 0.438 . . . . 61.1 111.113 176.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 69' ' ' LEU . 70.1 mt -100.03 138.83 36.57 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.337 -0.392 . . . . 73.31 111.91 -177.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -109.46 160.5 16.16 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.263 -0.426 . . . . 74.55 110.295 174.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -100.07 136.25 40.26 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.19 0.519 . . . . 63.43 111.958 -176.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.9 t -121.08 127.44 75.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 116.118 -0.492 . . . . 70.12 110.484 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.417 ' HB2' HG21 ' A' ' 63' ' ' VAL . 31.5 p30 -173.0 -176.93 1.49 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.125 0.488 . . . . 64.45 112.212 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.573 ' HB3' HG11 ' A' ' 63' ' ' VAL . . . -91.95 -36.2 13.57 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.099 -0.5 . . . . 73.4 111.554 173.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.576 ' H ' HG21 ' A' ' 63' ' ' VAL . . . 136.91 -77.07 0.35 Allowed Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.377 -0.439 . . . . 75.21 113.517 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -95.62 128.14 42.24 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.236 0.458 . . . . 73.45 112.236 -175.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.67 43.21 99.31 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.274 -0.421 . . . . 62.02 113.767 175.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.576 HG21 ' H ' ' A' ' 60' ' ' GLY . 31.5 m -134.21 154.13 79.86 Favored Pre-proline 0 N--CA 1.47 0.532 0 O-C-N 122.492 -0.417 . . . . 71.3 111.421 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -78.59 119.32 4.43 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.299 1.999 . . . . 75.1 112.859 176.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.59 105.54 0.76 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.218 -0.515 . . . . 63.22 113.228 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.545 HD13 ' HG2' ' A' ' 24' ' ' PRO . 77.0 mt -85.48 153.77 22.24 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.853 0.358 . . . . 73.41 111.041 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -109.23 137.09 47.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.424 0.63 . . . . 72.15 112.279 -175.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -154.22 116.88 4.39 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.0 -0.545 . . . . 61.33 110.187 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 54' ' ' LEU . 2.3 pp -66.05 174.44 2.52 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.027 0.751 . . . . 72.23 113.027 -172.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 78.2 mt -59.92 90.67 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.938 -0.574 . . . . 74.01 111.35 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 C--O 1.251 1.146 0 CA-C-N 115.629 -0.714 . . . . 65.2 111.149 -178.728 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.436 ' C ' ' SD ' ' A' ' 1' ' ' MET . 3.1 ppp? . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 112.311 0.486 . . . . 72.13 112.311 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.7 m -80.68 87.09 5.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.184 0.516 . . . . 72.14 111.92 -175.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -106.49 149.03 27.5 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.964 -0.562 . . . . 55.13 110.319 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.2 t -51.86 -34.39 40.54 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 112.602 0.593 . . . . 72.24 112.602 -174.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.589 HG12 HD11 ' A' ' 36' ' ' LEU . 10.8 tp -69.91 -30.81 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 112.191 0.441 . . . . 71.41 112.191 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.6 t -57.57 -37.25 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 120.911 0.386 . . . . 52.43 111.507 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.2 m -54.26 -47.87 71.81 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.0 0.429 . . . . 71.42 111.083 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.453 ' O ' HG13 ' A' ' 12' ' ' ILE . 87.5 tttt -66.28 -40.4 90.06 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.562 -0.29 . . . . 74.33 110.767 177.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.458 ' O ' HG23 ' A' ' 13' ' ' VAL . 67.4 mt -53.35 -47.33 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 120.81 0.338 . . . . 64.54 111.316 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.7 mt -59.12 -43.86 90.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.933 0.397 . . . . 75.04 110.926 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.8 t -61.16 -40.06 92.47 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.421 -0.354 . . . . 75.11 111.763 176.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.462 HD13 ' HB3' ' A' ' 33' ' ' ALA . 82.4 mt -61.69 -43.41 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.82 0.343 . . . . 72.54 110.736 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.527 ' HA ' HG21 ' A' ' 25' ' ' VAL . 91.5 t -59.04 -47.56 89.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.965 0.412 . . . . 71.42 111.018 176.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -60.54 -47.17 87.36 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.086 0.47 . . . . 74.13 111.264 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.01 -52.37 65.82 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.275 0.56 . . . . 73.03 111.039 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.612 ' HA ' ' HG2' ' A' ' 19' ' ' MET . 1.0 OUTLIER -62.1 -35.53 78.97 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.358 -0.383 . . . . 72.14 111.706 178.752 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -62.88 -25.18 68.18 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 122.315 -0.241 . . . . 74.31 111.261 173.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -84.47 -20.94 30.9 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.563 0.579 . . . . 74.14 112.563 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.612 ' HG2' ' HA ' ' A' ' 16' ' ' ARG . 20.4 ptm -89.25 -38.82 13.94 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.944 -0.473 . . . . 74.21 112.171 173.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -89.94 -41.47 11.75 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 111.88 0.326 . . . . 61.32 111.88 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 63.26 -74.58 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.807 0.669 . . . . 64.31 112.807 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.42 -28.57 73.65 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.094 -0.574 . . . . 63.32 113.495 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.36 147.0 33.84 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 120.765 0.317 . . . . 74.14 111.76 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.573 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 6.0 Cg_exo -72.86 172.19 15.87 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.447 2.098 . . . . 64.33 112.522 176.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.527 HG21 ' HA ' ' A' ' 13' ' ' VAL . 40.3 t -80.15 150.02 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.167 -0.47 . . . . 71.11 111.719 -175.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.611 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -100.05 145.94 27.34 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.347 -0.388 . . . . 53.41 110.624 -177.391 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.0 m -54.43 -34.7 61.9 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.567 0.58 . . . . 54.04 112.567 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -62.4 -42.65 99.59 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.447 0.536 . . . . 72.3 112.447 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -53.89 -42.95 69.23 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.152 0.427 . . . . 72.5 112.152 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 30' ' ' ILE . 2.9 mp -65.56 -50.1 73.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.979 0.419 . . . . 75.24 111.035 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.32 -58.57 7.89 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.01 0.433 . . . . 74.44 112.058 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.87 -42.4 93.61 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.804 0.668 . . . . 45.14 112.804 -178.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.462 ' HB3' HD13 ' A' ' 12' ' ' ILE . . . -75.25 -34.31 61.38 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.343 0.497 . . . . 71.3 112.343 -178.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.432 ' HB1' HD11 ' A' ' 5' ' ' ILE . . . -85.42 -21.19 28.89 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.133 0.42 . . . . 64.24 112.133 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.81 22.16 53.87 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.242 -0.504 . . . . 74.44 112.821 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.589 HD11 HG12 ' A' ' 5' ' ' ILE . 73.3 mt -101.42 173.83 6.26 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.959 0.409 . . . . 74.32 111.591 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.417 ' O ' HG23 ' A' ' 41' ' ' VAL . 47.4 t -98.01 148.29 23.65 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.354 -0.384 . . . . 75.13 111.051 177.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.3 mm -50.61 -49.32 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 112.836 0.68 . . . . 74.21 112.836 -175.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.534 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 47.6 t80 -51.37 -50.62 59.18 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.892 0.33 . . . . 71.23 111.892 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.46 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 35.1 tt0 -69.04 -40.3 78.67 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.844 0.354 . . . . 74.21 111.371 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 37' ' ' SER . 69.9 t -60.54 -51.71 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.418 -0.356 . . . . 74.12 111.875 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 8.7 ptm180 -57.41 -36.06 70.84 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.629 -0.259 . . . . 75.04 111.287 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 94.0 mt -60.16 -48.44 81.71 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.729 0.299 . . . . 74.43 110.932 177.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.46 ' CE2' ' HG2' ' A' ' 40' ' ' GLN . 25.5 m-85 -57.34 -48.05 80.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.04 0.447 . . . . 73.54 110.919 176.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.455 HD13 ' NE1' ' A' ' 67' ' ' TRP . 78.9 mt -60.97 -43.8 98.27 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.871 -0.604 . . . . 74.43 111.727 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 42' ' ' ARG . 46.9 mt-10 -57.98 -52.2 66.52 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.044 0.45 . . . . 62.11 111.089 175.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 83.9 mm-40 -59.25 -40.33 85.63 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.098 -0.501 . . . . 63.24 111.343 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.6 mt -59.9 -40.12 87.71 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.723 0.297 . . . . 71.12 111.468 176.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 65.3 t60 -67.12 -40.24 86.8 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.037 -0.415 . . . . 63.13 111.104 174.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -65.81 -43.42 88.67 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.068 -0.514 . . . . 54.54 112.156 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.517 HG23 HG23 ' A' ' 53' ' ' VAL . 34.0 m -78.27 -12.03 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 112.448 0.536 . . . . 65.33 112.448 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.93 52.51 1.5 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.085 -0.579 . . . . 53.33 113.713 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.517 HG23 HG23 ' A' ' 51' ' ' VAL . 91.3 t -124.17 -44.49 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 120.973 0.416 . . . . 54.2 111.323 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.7 mt -110.12 142.57 41.43 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.431 0.634 . . . . 72.31 112.517 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -91.44 119.63 31.58 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.373 -0.83 . . . . 61.21 109.038 172.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -85.18 94.86 8.98 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.163 0.506 . . . . 73.11 110.845 -173.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.451 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 51.4 t -93.31 148.59 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.877 -0.602 . . . . 63.23 112.183 -176.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -134.56 100.12 4.55 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.358 -0.383 . . . . 70.54 110.568 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.16 96.8 0.85 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.15 0.5 . . . . 60.52 111.463 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.63 -92.17 1.51 Allowed Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.357 -0.449 . . . . 55.12 112.754 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -175.33 -36.58 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.776 0.322 . . . . 75.12 111.421 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.44 -29.59 72.05 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.438 -0.411 . . . . 65.13 113.714 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.9 m -76.05 140.45 70.03 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-O 120.93 0.395 . . . . 73.42 111.69 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.05 -36.09 39.44 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.607 2.205 . . . . 73.03 113.219 -178.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 167.0 155.85 9.32 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 120.895 -0.669 . . . . 52.45 113.318 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 92.0 mt -133.45 139.01 46.46 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 122.915 0.486 . . . . 72.22 110.198 177.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.455 ' NE1' HD13 ' A' ' 45' ' ' LEU . 59.9 m95 -115.99 123.38 47.87 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.547 0.689 . . . . 75.33 112.452 -171.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 -128.46 113.33 15.39 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.768 -0.651 . . . . 73.43 110.788 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.455 ' O ' HD12 ' A' ' 69' ' ' LEU . 3.7 pp -63.48 149.95 44.92 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.904 -0.498 . . . . 74.31 111.866 -178.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 87.8 mt -84.25 160.18 20.82 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.225 -0.443 . . . . 73.34 111.522 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 C--O 1.252 1.23 0 CA-C-O 118.42 -0.8 . . . . 70.44 112.467 -179.105 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 mmt . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.591 0.234 . . . . 72.14 110.775 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.1 m -71.46 -45.86 61.48 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.135 0.42 . . . . 74.34 112.135 -178.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -79.77 157.71 27.03 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.942 0.401 . . . . 51.43 111.439 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.3 t -115.8 111.36 20.39 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.051 0.389 . . . . 71.32 112.051 -175.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.483 HG21 HD11 ' A' ' 36' ' ' LEU . 61.3 mt -65.94 -33.73 65.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 121.063 0.459 . . . . 73.24 110.145 173.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.9 t -58.49 -54.89 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.084 -0.507 . . . . 71.12 111.321 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.5 m -61.04 -33.82 73.9 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.981 0.42 . . . . 54.11 111.066 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.427 ' O ' HG13 ' A' ' 12' ' ' ILE . 61.9 tttp -59.28 -49.42 77.9 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.976 0.417 . . . . 72.53 110.692 176.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.513 ' O ' HG23 ' A' ' 13' ' ' VAL . 73.2 mt -56.91 -49.72 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.184 -0.462 . . . . 64.21 111.175 176.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.9 mt -53.74 -42.65 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 121.156 0.503 . . . . 75.15 111.457 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.0 m -62.77 -43.33 99.09 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.168 -0.469 . . . . 35.11 111.244 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 8' ' ' LYS . 74.8 mt -61.06 -43.31 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.043 0.449 . . . . 60.12 111.255 177.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 9' ' ' ILE . 81.1 t -57.96 -52.15 61.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 116.064 -0.517 . . . . 71.24 111.391 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -63.71 -41.32 98.1 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.703 0.287 . . . . 72.25 111.524 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -51.58 -53.09 41.87 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.768 0.318 . . . . 75.31 111.158 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.529 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 3.1 mmp_? -57.05 -46.76 82.2 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 111.911 0.337 . . . . 73.34 111.911 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.732 HE22 ' HG ' ' A' ' 69' ' ' LEU . 21.9 mt-30 -64.69 -38.07 89.74 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.99 0.424 . . . . 64.33 112.14 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -77.76 -41.23 38.29 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.271 0.471 . . . . 72.51 112.271 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.5 mmt -75.71 -45.46 36.59 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.177 0.436 . . . . 70.51 112.177 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -82.28 -25.84 33.66 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.923 0.392 . . . . 61.31 110.538 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.8 t70 67.26 104.96 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.438 0.695 . . . . 74.11 112.01 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.7 -31.03 5.74 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 115.922 -0.581 . . . . 52.24 113.906 177.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.79 140.13 95.44 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 113.04 0.756 . . . . 74.2 113.04 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.19 146.4 17.81 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.899 2.399 . . . . 71.31 112.371 173.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.474 HG22 ' HB2' ' A' ' 16' ' ' ARG . 22.1 t -85.66 138.46 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.028 0.442 . . . . 72.11 112.061 -175.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.445 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -98.92 144.7 27.81 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.995 -0.548 . . . . 45.31 110.693 178.702 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 57.8 m -57.16 -32.73 66.72 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.843 0.354 . . . . 64.41 111.07 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -56.99 -57.54 12.1 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.243 -0.435 . . . . 74.13 112.147 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -54.59 -42.55 71.24 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.748 0.309 . . . . 64.4 111.712 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.401 ' HA ' HG21 ' A' ' 12' ' ' ILE . 58.7 mt -63.49 -43.71 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.404 -0.362 . . . . 71.21 111.337 177.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.1 -49.6 77.0 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.06 0.393 . . . . 74.43 112.06 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -65.48 -42.87 91.74 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.042 0.386 . . . . 51.52 112.042 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.89 -35.46 74.66 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.373 0.509 . . . . 72.03 112.373 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.64 -24.14 24.03 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.985 0.365 . . . . 62.33 111.985 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.29 37.4 24.6 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.365 -0.445 . . . . 65.15 112.96 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.483 HD11 HG21 ' A' ' 5' ' ' ILE . 84.1 mt -123.05 174.65 7.07 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.964 0.411 . . . . 71.35 111.743 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 41' ' ' VAL . 49.3 m -86.8 144.71 26.92 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.477 -0.329 . . . . 70.22 111.277 177.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.2 mm -47.15 -51.13 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 112.396 0.517 . . . . 75.31 112.396 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.497 ' CE2' HD11 ' A' ' 43' ' ' LEU . 82.8 t80 -54.44 -56.38 19.3 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.251 -0.431 . . . . 73.13 111.36 177.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -54.88 -49.0 72.26 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.073 -0.512 . . . . 75.31 111.69 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 37' ' ' SER . 89.4 t -54.68 -53.03 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.983 -0.553 . . . . 71.3 111.625 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -65.85 -26.85 67.84 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.949 -0.3 . . . . 73.34 111.61 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.497 HD11 ' CE2' ' A' ' 39' ' ' TYR . 80.7 mt -58.31 -48.77 79.46 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.948 0.404 . . . . 54.41 110.287 174.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -66.04 -34.12 77.37 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.234 -0.439 . . . . 64.11 111.192 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 88.5 mt -63.21 -46.08 88.66 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.66 0.267 . . . . 52.31 111.062 176.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 49' ' ' HIS . 1.1 mp0 -55.68 -48.09 75.66 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.717 0.294 . . . . 65.1 110.789 174.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 94.7 mt-30 -56.8 -50.7 71.55 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.813 0.34 . . . . 73.13 111.055 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.522 ' HA ' HG22 ' A' ' 51' ' ' VAL . 95.1 mt -58.52 -30.57 67.17 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.118 0.485 . . . . 71.23 111.439 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.475 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 7.3 t-80 -65.9 -45.95 80.09 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.901 0.382 . . . . 72.41 111.446 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -79.84 -23.73 41.8 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.222 0.823 . . . . 74.34 113.222 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 48' ' ' LEU . 23.9 m -89.77 6.49 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 121.838 -0.539 . . . . 75.21 111.78 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.1 57.78 3.36 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 116.325 -0.398 . . . . 63.13 113.934 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.469 HG23 HG23 ' A' ' 51' ' ' VAL . 90.2 t -131.77 -51.94 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 122.431 -0.452 . . . . 52.25 111.816 177.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.9 mt -97.01 143.97 27.35 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.933 0.716 . . . . 70.23 112.933 -175.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -102.03 153.24 20.09 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.215 -0.902 . . . . 72.13 110.89 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.547 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 1.8 mppt? -97.21 119.85 36.48 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.767 0.318 . . . . 65.42 110.902 -176.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 49.2 t -108.83 106.96 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-O 121.132 0.491 . . . . 72.1 112.186 -178.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -88.82 101.69 14.28 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.986 0.422 . . . . 64.15 110.511 175.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.435 ' H ' HG21 ' A' ' 63' ' ' VAL . . . -76.47 -11.42 59.88 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.598 0.592 . . . . 71.32 112.598 -177.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.406 ' O ' HG22 ' A' ' 63' ' ' VAL . . . 165.8 178.48 38.77 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.714 -0.755 . . . . 62.44 113.256 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -77.1 96.0 4.36 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.777 0.322 . . . . 72.23 111.248 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 142.55 -23.06 2.35 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.865 -0.683 . . . . 31.23 113.145 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.435 HG21 ' H ' ' A' ' 59' ' ' ALA . 32.9 m -80.53 137.73 51.52 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 116.912 0.356 . . . . 73.14 111.437 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.72 -47.33 4.03 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.284 1.989 . . . . 70.02 112.341 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 159.1 117.68 0.49 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.097 -0.573 . . . . 53.33 112.875 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 94.4 mt -88.46 159.88 17.78 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.632 0.253 . . . . 75.14 110.643 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -106.16 132.8 51.79 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.611 0.967 . . . . 72.15 113.611 -169.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 68' ' ' ARG . 12.4 mtp180 -139.21 -168.64 2.49 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.505 -0.771 . . . . 71.54 109.755 169.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.732 ' HG ' HE22 ' A' ' 17' ' ' GLN . 2.5 pp -114.21 169.16 9.23 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 122.026 -0.421 . . . . 71.0 111.225 177.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.12 92.9 0.41 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.059 0.456 . . . . 74.42 111.054 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 . . . . . 0 C--O 1.252 1.232 0 CA-C-O 118.748 -0.644 . . . . 71.35 111.593 -176.713 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.597 0.237 . . . . 74.23 111.501 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 t 67.24 31.38 6.65 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.851 0.686 . . . . 74.41 112.851 174.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -93.55 12.56 24.79 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.596 0.591 . . . . 71.23 112.596 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.0 m -60.39 -40.12 89.74 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.826 -0.546 . . . . 63.45 110.909 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 36' ' ' LEU . 14.6 tt -63.13 -31.56 53.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.248 0.547 . . . . 71.12 110.877 174.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.5 t -69.07 -35.56 69.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.266 -0.425 . . . . 75.43 110.815 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.1 m -52.96 -43.47 66.39 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.101 0.477 . . . . 73.53 110.318 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.557 ' O ' HG13 ' A' ' 12' ' ' ILE . 40.5 ttmt -60.45 -48.51 81.45 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.993 -0.549 . . . . 75.3 110.776 175.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.4 mt -52.57 -47.17 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.892 0.377 . . . . 73.32 111.512 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.6 mt -61.8 -45.58 98.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.049 0.452 . . . . 42.11 111.202 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 84.7 p -67.96 -18.35 64.71 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.906 0.336 . . . . 61.44 111.906 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 8' ' ' LYS . 99.3 mt -75.01 -44.83 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.081 0.467 . . . . 70.22 110.417 172.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.8 t -59.96 -41.51 86.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.195 0.521 . . . . 63.22 110.34 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -65.36 -45.33 84.57 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.884 -0.598 . . . . 75.43 110.526 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -51.09 -52.2 45.94 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.14 -0.482 . . . . 50.22 111.734 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.9 mmt-85 -61.97 -37.68 85.68 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 111.952 0.353 . . . . 75.51 111.952 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -74.88 -12.97 60.49 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 122.148 -0.345 . . . . 64.51 111.86 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -82.6 -45.55 14.44 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.906 0.384 . . . . 70.32 110.459 171.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 93.6 mmm -70.11 -65.22 0.75 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.176 -0.466 . . . . 71.31 110.632 176.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -81.68 102.86 10.98 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.989 0.423 . . . . 74.04 110.004 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -51.11 95.57 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.115 0.783 . . . . 62.34 113.115 -172.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.91 33.05 84.57 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 115.721 -0.672 . . . . 74.5 113.657 175.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.96 145.97 30.69 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 120.879 0.371 . . . . 44.44 111.962 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.586 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 38.4 Cg_endo -65.28 131.56 28.73 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.513 2.142 . . . . 64.2 112.838 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.3 t -82.62 147.88 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.084 -0.507 . . . . 53.23 111.866 -176.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -100.61 146.72 26.79 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.297 -0.41 . . . . 64.02 111.035 -178.869 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.4 m -57.17 -32.53 66.52 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 111.909 0.337 . . . . 72.15 111.909 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 28' ' ' ARG . 3.9 mpt_? -60.75 -53.82 52.74 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.096 0.406 . . . . 71.15 112.096 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.421 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 9.5 m-20 -53.11 -47.61 68.49 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.969 0.414 . . . . 74.32 111.339 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.532 ' HA ' HG21 ' A' ' 12' ' ' ILE . 61.5 mt -59.49 -43.83 91.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.96 -0.564 . . . . 75.12 111.389 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.557 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -62.5 -54.34 41.47 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.167 0.432 . . . . 71.23 112.167 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.35 -43.87 96.46 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.95 0.352 . . . . 63.52 111.95 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.422 ' HB3' HD13 ' A' ' 12' ' ' ILE . . . -62.91 -37.81 88.46 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.79 0.329 . . . . 62.12 111.709 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.92 -18.58 36.9 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.99 0.424 . . . . 65.42 111.63 176.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.86 20.69 70.12 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.327 -0.397 . . . . 74.13 113.569 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.505 HD11 HD11 ' A' ' 5' ' ' ILE . 84.4 mt -111.61 176.39 5.04 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.14 0.495 . . . . 75.3 112.04 -175.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.6 m -83.29 147.45 27.96 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.026 -0.534 . . . . 75.53 111.711 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 39.6 mm -50.6 -51.29 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 112.796 0.665 . . . . 44.21 112.796 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.404 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 77.8 t80 -60.81 -49.6 76.82 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.742 0.306 . . . . 54.21 111.635 -178.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -58.11 -50.41 73.59 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.176 0.513 . . . . 71.24 111.144 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.557 HG21 ' HA ' ' A' ' 31' ' ' ALA . 73.1 t -55.38 -46.56 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.139 -0.482 . . . . 74.0 111.131 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.508 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 16.5 ttt180 -53.11 -44.22 67.47 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.256 -0.429 . . . . 74.13 111.4 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 97.6 mt -54.69 -47.07 74.12 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.051 0.453 . . . . 71.24 110.781 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -62.41 -46.29 89.27 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.101 -0.499 . . . . 72.24 111.282 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 85.0 mt -61.42 -40.94 96.26 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.349 -0.387 . . . . 62.22 111.712 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' A' ' 42' ' ' ARG . 55.5 mt-10 -59.31 -42.25 90.94 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.971 0.415 . . . . 72.43 111.107 177.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -71.88 -33.12 68.1 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.813 0.339 . . . . 65.45 111.159 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.73 -29.11 69.58 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.017 0.437 . . . . 72.13 111.207 174.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.44 ' HD2' ' HA ' ' A' ' 55' ' ' GLU . 54.4 t-80 -73.37 -28.96 62.32 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.083 0.468 . . . . 74.51 110.603 172.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -73.96 -52.25 13.42 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.927 -0.578 . . . . 74.21 111.584 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.518 HG23 HG23 ' A' ' 53' ' ' VAL . 34.1 m -73.5 -10.96 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 113.144 0.794 . . . . 75.21 113.144 -176.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.53 49.08 2.05 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.005 -0.617 . . . . 54.52 114.042 176.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.518 HG23 HG23 ' A' ' 51' ' ' VAL . 91.7 t -118.65 -52.5 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.968 0.413 . . . . 55.0 111.427 176.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 86.4 mt -114.91 148.57 38.48 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.018 0.437 . . . . 74.0 111.979 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.44 ' HA ' ' HD2' ' A' ' 49' ' ' HIS . 10.1 tp10 -111.97 133.7 53.99 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.216 -0.447 . . . . 73.23 111.092 174.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -85.65 97.89 10.37 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.987 -0.551 . . . . 73.54 110.734 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 46.7 t -68.97 112.26 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 115.987 -0.551 . . . . 34.13 111.552 -178.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -136.13 116.67 13.81 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.026 -0.534 . . . . 74.12 110.717 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.407 ' H ' HG21 ' A' ' 63' ' ' VAL . . . -106.13 22.78 15.11 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.662 0.615 . . . . 65.12 112.662 -177.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.3 175.37 27.2 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.904 -0.665 . . . . 31.45 113.104 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -75.36 120.74 21.24 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.952 0.406 . . . . 74.14 111.686 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.44 49.61 19.05 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.188 -0.53 . . . . 63.02 113.582 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.407 HG21 ' H ' ' A' ' 59' ' ' ALA . 33.6 m -117.07 159.74 39.92 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 122.464 -0.433 . . . . 74.32 111.367 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -51.43 119.63 5.77 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.671 2.247 . . . . 70.44 113.391 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.2 105.63 2.02 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 121.196 -0.526 . . . . 44.14 113.224 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.586 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 87.3 mt -107.0 162.06 14.18 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.832 0.349 . . . . 63.53 111.329 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -124.38 133.54 53.39 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.307 0.575 . . . . 74.44 112.313 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -127.46 121.33 30.49 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.283 -0.417 . . . . 72.32 110.705 172.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.461 ' O ' HD12 ' A' ' 69' ' ' LEU . 2.9 pp -69.99 147.6 49.92 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.947 0.403 . . . . 72.11 111.659 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 72.5 mt -81.04 85.95 6.21 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.437 -0.347 . . . . 73.42 111.662 -177.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 C--O 1.255 1.371 0 CA-C-O 118.459 -0.782 . . . . 73.32 112.972 177.21 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 120.658 0.266 . . . . 62.04 111.552 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t 61.57 15.76 7.07 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.023 0.44 . . . . 53.34 111.545 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -81.52 93.94 6.77 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.136 0.493 . . . . 73.14 110.679 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 63.8 p -102.02 116.22 32.23 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.935 -0.575 . . . . 74.25 111.909 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.0 tp -59.35 -40.67 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 116.195 -0.457 . . . . 71.14 112.003 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.8 t -61.78 -51.32 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 111.696 0.258 . . . . 73.14 111.696 -177.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.1 m -56.63 -37.53 70.85 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.905 0.383 . . . . 63.42 111.423 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.504 ' O ' HG13 ' A' ' 12' ' ' ILE . 37.3 ttpt -65.28 -43.61 90.64 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.471 -0.331 . . . . 65.13 110.721 176.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.489 HG23 HG21 ' A' ' 30' ' ' ILE . 69.2 mt -59.41 -44.83 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.737 0.303 . . . . 72.42 111.503 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 69.0 mt -56.68 -45.65 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.27 0.557 . . . . 64.04 110.771 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.6 m -66.98 -29.32 69.13 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.933 -0.576 . . . . 73.23 111.905 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 8' ' ' LYS . 94.0 mt -63.94 -44.02 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.056 0.455 . . . . 61.01 110.91 174.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.425 ' HA ' HG21 ' A' ' 25' ' ' VAL . 59.3 t -57.31 -47.15 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.116 0.484 . . . . 73.31 110.729 175.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -61.27 -46.59 89.7 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.08 -0.509 . . . . 62.42 110.992 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -56.3 -46.75 79.67 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.1 -0.5 . . . . 70.54 111.421 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.42 ' HD3' ' SD ' ' A' ' 19' ' ' MET . 11.1 mmt180 -61.33 -36.67 80.79 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.5 -0.318 . . . . 72.53 111.729 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.428 ' NE2' ' HG ' ' A' ' 69' ' ' LEU . 73.6 mt-30 -75.79 -21.6 57.2 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.782 0.325 . . . . 70.13 111.814 176.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -70.53 -36.12 73.54 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.366 0.603 . . . . 74.05 110.04 170.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.42 ' SD ' ' HD3' ' A' ' 16' ' ' ARG . 74.3 mtp -67.69 -50.39 57.83 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.548 -0.751 . . . . 61.12 111.062 176.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -122.5 116.74 24.45 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.132 -0.486 . . . . 73.21 110.494 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -40.33 -53.28 2.6 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.213 0.82 . . . . 61.2 113.213 -173.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.94 53.98 0.7 Allowed Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.19 -0.529 . . . . 53.54 113.046 -176.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.414 ' HA ' ' HD2' ' A' ' 24' ' ' PRO . . . -101.83 110.27 61.7 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.361 0.504 . . . . 62.05 112.361 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.587 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 56.4 Cg_endo -69.88 122.29 8.94 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.093 1.862 . . . . 72.41 110.767 170.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.425 HG21 ' HA ' ' A' ' 13' ' ' VAL . 22.0 t -79.38 141.47 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 112.37 0.508 . . . . 71.34 112.37 -167.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -97.58 151.07 20.43 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.134 -0.484 . . . . 71.22 110.867 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.4 m -53.05 -37.33 61.5 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.201 -0.454 . . . . 62.4 111.526 175.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -64.22 -44.36 92.13 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.295 -0.411 . . . . 74.14 112.009 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.04 -41.34 98.0 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.994 0.426 . . . . 74.41 111.548 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.489 HG21 HG23 ' A' ' 9' ' ' ILE . 60.2 mt -65.78 -43.37 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 116.515 -0.311 . . . . 61.4 111.045 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.59 -37.51 81.6 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.202 0.525 . . . . 32.32 110.893 174.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.36 -48.33 81.77 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.662 -0.699 . . . . 73.01 111.697 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.16 -50.29 49.04 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.018 0.377 . . . . 62.4 112.018 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.0 -19.65 61.16 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.584 0.587 . . . . 74.11 112.584 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.17 40.0 51.36 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.159 -0.543 . . . . 63.42 112.673 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.4 175.26 6.53 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.805 0.336 . . . . 65.45 111.241 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.2 t -85.07 153.76 22.5 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.747 0.308 . . . . 70.12 111.192 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.59 -50.13 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 112.954 0.724 . . . . 65.2 112.954 -175.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -66.62 -44.72 81.29 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 122.197 -0.315 . . . . 63.51 111.763 -175.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -51.07 -55.44 17.56 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.203 0.525 . . . . 75.11 111.054 175.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.445 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 82.7 t -61.1 -39.86 83.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.064 -0.516 . . . . 71.3 110.942 176.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -53.52 -41.44 66.34 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.243 -0.435 . . . . 54.04 110.684 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.3 mt -62.92 -52.86 61.41 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.001 -0.545 . . . . 71.42 111.285 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -56.05 -36.85 68.5 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.011 0.434 . . . . 64.02 111.357 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.552 HD13 ' NE1' ' A' ' 67' ' ' TRP . 99.1 mt -69.78 -40.11 76.23 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.408 -0.36 . . . . 75.22 111.756 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -60.73 -37.94 83.45 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.025 0.44 . . . . 75.21 110.685 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -61.4 -54.02 49.06 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.385 -0.371 . . . . 52.52 110.712 174.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.5 mt -57.11 -31.53 65.39 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.15 0.5 . . . . 73.03 111.608 176.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -63.71 -50.82 67.65 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.921 -0.581 . . . . 71.13 111.803 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -76.79 -40.65 47.43 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.944 0.72 . . . . 73.32 112.944 -176.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.505 HG23 HG23 ' A' ' 53' ' ' VAL . 23.5 m -67.58 -16.14 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 112.253 0.464 . . . . 73.04 112.253 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.61 48.29 2.36 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.185 -0.531 . . . . 75.11 113.935 177.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.505 HG23 HG23 ' A' ' 51' ' ' VAL . 97.9 t -118.71 -40.94 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 121.075 0.464 . . . . 71.12 111.28 176.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.418 HD13 ' HB3' ' A' ' 67' ' ' TRP . 83.5 mt -112.85 136.45 52.46 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.401 0.619 . . . . 63.41 112.296 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -91.65 143.15 26.85 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.586 -0.734 . . . . 55.03 109.971 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -93.94 105.08 17.11 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.889 0.852 . . . . 75.13 111.662 -174.83 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 28.6 t -82.75 75.7 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.358 0.599 . . . . 74.0 110.588 177.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 63.9 t30 177.5 -80.16 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.08 -0.964 . . . . 71.14 110.629 177.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -174.08 126.36 0.36 Allowed 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.619 0.6 . . . . 55.15 112.619 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.55 -106.2 0.47 Allowed Glycine 0 CA--C 1.533 1.211 0 N-CA-C 115.227 0.851 . . . . 65.01 115.227 170.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.439 ' HD3' ' N ' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -161.69 163.74 29.59 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.456 0.302 . . . . 54.44 111.463 -174.418 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.79 -55.62 3.02 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 121.403 -0.427 . . . . 74.01 113.729 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.5 m -55.97 150.85 27.22 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 112.243 0.461 . . . . 72.53 112.243 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.26 99.77 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.847 2.365 . . . . 72.33 112.918 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -125.83 151.13 17.67 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 121.079 -0.581 . . . . 65.11 112.934 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.587 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 67.0 mt -83.26 140.54 32.45 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.973 0.416 . . . . 74.03 110.191 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.552 ' NE1' HD13 ' A' ' 45' ' ' LEU . 67.1 m95 -93.88 116.43 28.89 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.335 0.588 . . . . 63.13 112.179 -172.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -114.69 111.49 21.37 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.843 -0.617 . . . . 72.31 110.534 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.428 ' HG ' ' NE2' ' A' ' 17' ' ' GLN . 3.5 pp -59.3 156.02 13.4 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 122.008 -0.433 . . . . 75.24 111.504 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.7 mt -67.92 101.84 1.17 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.166 0.507 . . . . 73.3 111.231 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--O 1.254 1.293 0 CA-C-O 118.43 -0.795 . . . . 73.14 111.792 178.285 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.621 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 120.929 0.395 . . . . 72.44 111.328 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.3 m -76.37 79.87 3.11 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.426 0.631 . . . . 44.31 111.699 -177.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -86.69 44.31 1.15 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.762 -0.654 . . . . 72.22 111.586 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 94.7 p 49.58 31.59 4.29 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.234 0.827 . . . . 74.41 113.234 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.685 ' H ' HD12 ' A' ' 5' ' ' ILE . 4.5 mp -58.64 -47.86 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 121.098 0.475 . . . . 71.24 110.87 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.17 -47.11 91.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-N 116.116 -0.493 . . . . 74.31 111.145 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.1 m -52.22 -46.08 65.54 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.166 0.508 . . . . 72.33 111.354 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -55.36 -55.14 35.0 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.95 -0.568 . . . . 73.03 111.298 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.464 ' O ' HG23 ' A' ' 13' ' ' VAL . 62.8 mt -60.44 -46.04 95.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 112.038 0.384 . . . . 73.23 112.038 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.8 mt -58.51 -50.93 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 111.892 0.33 . . . . 74.43 111.892 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.6 p -55.92 -43.65 77.54 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.792 0.33 . . . . 40.42 111.771 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 82.5 mt -61.68 -55.91 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.927 0.394 . . . . 43.33 111.589 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 9' ' ' ILE . 80.1 t -55.07 -41.84 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.063 0.459 . . . . 72.42 111.523 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -65.5 -53.23 45.43 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.128 -0.487 . . . . 73.32 111.17 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -51.64 -49.5 62.16 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.104 0.478 . . . . 74.55 111.328 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -54.3 -51.12 65.65 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.733 -0.667 . . . . 74.24 111.943 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.487 ' NE2' ' HA ' ' A' ' 68' ' ' ARG . 78.3 mt-30 -66.32 -16.45 64.06 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.306 0.484 . . . . 74.4 112.306 -178.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -78.8 -29.63 45.01 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 122.045 -0.409 . . . . 53.13 110.791 170.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 23.2 mmt -91.5 -74.19 0.51 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.825 0.345 . . . . 71.34 111.54 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.27 77.79 8.91 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.91 0.862 . . . . 74.13 111.157 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -85.92 -28.06 24.57 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.116 -0.947 . . . . 74.43 111.06 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.36 -3.38 82.25 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 116.056 -0.52 . . . . 71.11 113.641 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -150.92 119.87 3.54 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 122.436 -0.45 . . . . 54.13 111.315 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.551 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 10.8 Cg_endo -52.59 152.87 15.4 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.99 2.46 . . . . 74.11 113.435 -178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.6 t -79.99 150.36 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 112.141 0.423 . . . . 64.12 112.141 -172.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.511 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 9.9 mptt -96.69 151.42 19.64 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.868 0.366 . . . . 72.14 111.262 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.8 m -56.0 -36.58 68.08 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 116.286 -0.415 . . . . 73.44 111.957 177.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.2 mtm-85 -57.07 -58.33 8.66 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.975 0.417 . . . . 75.22 111.501 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.91 -44.19 70.34 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.651 -0.704 . . . . 73.14 112.27 -177.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.6 mt -63.68 -46.29 95.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.065 0.459 . . . . 64.44 111.115 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.548 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -62.74 -43.88 97.64 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.933 0.396 . . . . 64.55 111.578 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.35 -47.28 84.9 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.062 -0.517 . . . . 61.03 111.2 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.67 -29.56 68.88 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 111.895 0.332 . . . . 63.34 111.895 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.14 -15.44 36.11 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.103 0.409 . . . . 52.43 112.103 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.14 27.4 71.98 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.425 -0.417 . . . . 44.53 112.832 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.6 mt -117.87 175.29 5.73 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.126 0.488 . . . . 73.14 111.753 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.5 t -80.23 149.31 30.47 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.399 0.518 . . . . 72.25 112.399 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.7 mm -51.92 -40.52 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.962 -0.563 . . . . 73.2 111.001 174.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.454 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 85.8 t80 -64.83 -56.61 12.4 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.939 -0.573 . . . . 74.42 111.855 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -57.96 -51.06 71.2 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.178 0.513 . . . . 71.35 111.633 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.548 HG21 ' HA ' ' A' ' 31' ' ' ALA . 78.2 t -55.87 -47.94 79.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.146 -0.479 . . . . 74.54 111.602 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -57.35 -38.33 73.97 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.572 -0.286 . . . . 65.01 111.52 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 92.2 mt -58.38 -46.45 86.32 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.809 0.338 . . . . 54.42 111.079 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -65.99 -44.17 85.64 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.787 0.327 . . . . 71.32 111.517 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.74 -48.43 81.83 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.116 0.484 . . . . 75.54 111.634 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.25 -41.34 90.11 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.318 -0.401 . . . . 73.3 111.79 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -61.72 -41.55 97.77 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.217 -0.302 . . . . 73.2 111.386 176.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.9 mt -60.01 -33.39 71.93 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.763 0.316 . . . . 64.43 111.166 176.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -66.22 -49.76 66.17 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 122.166 -0.334 . . . . 72.44 110.959 172.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.63 -32.07 71.24 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 112.085 0.402 . . . . 75.23 112.085 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.453 HG23 HG23 ' A' ' 53' ' ' VAL . 30.9 m -90.96 2.66 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 112.717 0.636 . . . . 62.34 112.717 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.03 51.93 3.43 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.222 -0.513 . . . . 52.24 114.202 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.453 HG23 HG23 ' A' ' 51' ' ' VAL . 60.9 t -129.71 -58.51 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 122.394 -0.474 . . . . 75.04 110.91 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.5 mt -104.37 178.43 4.56 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.211 0.529 . . . . 74.02 111.872 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.548 ' HB3' ' HG3' ' A' ' 68' ' ' ARG . 11.7 tp10 -138.03 144.78 41.2 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 120.843 0.354 . . . . 72.5 111.254 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -89.81 129.18 36.23 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.128 0.788 . . . . 74.24 113.128 -174.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.545 ' O ' ' HB2' ' A' ' 58' ' ' ASN . 45.4 t -120.36 116.31 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 108.679 -0.859 . . . . 64.14 108.679 165.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.545 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 4.4 m-20 77.05 131.28 0.05 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.234 0.614 . . . . 72.0 110.825 -169.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.22 -80.96 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.247 0.832 . . . . 72.33 113.247 -173.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 175.47 -18.64 0.05 OUTLIER Glycine 0 CA--C 1.531 1.034 0 C-N-CA 121.075 -0.583 . . . . 72.43 113.717 -176.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -74.52 100.08 3.78 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 122.146 -0.62 . . . . 75.1 111.388 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.37 -42.0 1.89 Allowed Glycine 0 CA--C 1.533 1.175 0 C-N-CA 121.235 -0.507 . . . . 72.15 113.612 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.425 ' HB ' HD22 ' A' ' 58' ' ' ASN . 29.0 m -60.46 136.91 92.23 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 122.636 0.374 . . . . 75.33 111.955 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.48 -31.46 51.19 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.775 2.317 . . . . 75.53 113.325 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.63 113.99 3.88 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.066 -0.588 . . . . 50.1 113.414 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 96.4 mt -109.39 137.1 47.76 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.108 0.48 . . . . 63.21 110.227 175.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 28.8 m95 -123.4 143.24 50.25 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.636 0.606 . . . . 75.21 112.636 -169.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.548 ' HG3' ' HB3' ' A' ' 55' ' ' GLU . 9.1 ptm180 -147.69 174.43 11.79 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.668 -0.696 . . . . 72.41 110.862 174.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.459 ' HG ' ' OE1' ' A' ' 17' ' ' GLN . 3.3 pp -125.22 177.57 6.05 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.872 0.368 . . . . 52.21 111.426 175.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.526 ' N ' HD23 ' A' ' 70' ' ' LEU . 1.3 pt? -142.2 79.16 1.65 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.416 0.627 . . . . 71.13 110.751 176.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 . . . . . 0 C--O 1.256 1.417 0 CA-C-O 118.782 -0.627 . . . . 42.53 111.104 -179.731 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.422 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.1 mpp? . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.963 0.411 . . . . 75.2 110.744 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.8 m -99.79 -68.31 0.81 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 111.894 0.331 . . . . 45.41 111.894 -175.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -88.99 138.58 31.28 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 116.371 -0.377 . . . . 74.3 110.748 -174.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.8 m -117.55 -36.01 3.82 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.148 0.795 . . . . 75.21 113.148 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.465 ' N ' HD12 ' A' ' 5' ' ' ILE . 2.1 mp -70.86 -58.17 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 112.154 0.427 . . . . 72.34 112.154 -173.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.92 -35.07 72.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.189 0.518 . . . . 65.11 110.48 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.0 m -61.28 -38.14 85.7 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.042 -0.526 . . . . 74.04 110.603 173.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.43 ' O ' HG13 ' A' ' 12' ' ' ILE . 86.8 tttt -63.35 -42.53 98.92 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.308 -0.406 . . . . 64.24 110.613 174.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.433 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.5 mt -52.19 -45.13 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.027 0.441 . . . . 70.11 110.796 174.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.4 mt -58.45 -44.38 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 116.224 -0.444 . . . . 75.1 111.203 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.9 m -59.64 -42.2 92.24 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.393 -0.367 . . . . 72.33 111.266 176.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 8' ' ' LYS . 82.9 mt -59.59 -46.05 93.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.055 0.455 . . . . 75.24 111.054 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.558 ' HA ' HG21 ' A' ' 25' ' ' VAL . 63.7 t -60.5 -49.63 83.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.082 0.468 . . . . 62.15 111.096 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.65 -41.59 86.42 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.239 0.542 . . . . 52.21 110.677 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -60.05 -51.04 71.33 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.779 -0.646 . . . . 73.21 112.156 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.482 ' HB2' HG22 ' A' ' 25' ' ' VAL . 27.4 mmt180 -59.09 -35.4 73.35 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.664 0.269 . . . . 75.44 111.202 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.507 ' NE2' HG12 ' A' ' 13' ' ' VAL . 44.1 mt-30 -67.02 -27.33 67.32 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.976 0.417 . . . . 74.03 111.642 175.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -76.17 -23.12 54.73 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.963 0.411 . . . . 71.44 110.898 174.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.7 mmt -75.19 -54.99 6.19 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.06 -0.518 . . . . 71.25 110.345 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -119.99 98.97 6.34 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.166 -0.47 . . . . 74.05 110.592 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -61.76 -15.89 44.88 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.844 0.683 . . . . 63.31 112.844 -174.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -117.29 31.88 5.64 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.34 -0.457 . . . . 51.53 113.297 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -140.36 136.97 17.2 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 112.45 0.537 . . . . 73.01 112.45 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.556 ' HG2' HD13 ' A' ' 66' ' ' LEU . 82.7 Cg_endo -83.29 159.61 15.1 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.63 2.22 . . . . 62.41 112.312 172.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.558 HG21 ' HA ' ' A' ' 13' ' ' VAL . 11.2 t -85.91 156.2 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.055 0.455 . . . . 71.53 111.986 -175.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.46 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -99.95 140.17 34.55 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.263 -0.426 . . . . 70.11 110.783 -175.14 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.2 m -55.61 -41.1 73.0 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.874 0.369 . . . . 73.33 111.791 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -61.43 -52.72 63.4 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.892 0.377 . . . . 72.41 111.353 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.09 -35.66 75.7 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.238 -0.437 . . . . 74.44 111.772 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.529 HG21 HD21 ' A' ' 45' ' ' LEU . 77.8 mt -66.95 -56.28 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.801 0.334 . . . . 51.53 111.464 176.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.412 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -56.45 -43.42 79.49 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.087 0.403 . . . . 71.14 112.087 -178.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.51 -53.03 58.4 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.041 -0.527 . . . . 51.54 110.958 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.11 -29.47 70.59 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 111.933 0.346 . . . . 60.2 111.933 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.75 -27.13 44.66 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.905 0.383 . . . . 62.01 111.914 177.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.99 45.99 9.85 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.089 -0.577 . . . . 41.1 112.965 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.2 mt -135.5 178.16 7.26 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.732 -0.275 . . . . 74.13 111.045 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.422 ' O ' HG23 ' A' ' 41' ' ' VAL . 66.5 m -82.18 142.9 31.8 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 122.395 -0.191 . . . . 74.31 111.306 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.443 ' O ' ' HG3' ' A' ' 42' ' ' ARG . 48.2 mm -51.72 -55.68 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 122.53 0.332 . . . . 61.14 111.752 -176.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -54.17 -48.19 71.19 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.036 0.446 . . . . 72.13 111.474 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -58.12 -45.94 86.45 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.865 -0.607 . . . . 73.44 111.795 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 37' ' ' SER . 99.1 t -66.71 -39.27 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.319 -0.4 . . . . 74.41 111.637 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 38' ' ' ILE . 79.4 mtp180 -53.4 -44.45 68.73 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.809 0.337 . . . . 72.13 110.856 176.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.44 ' O ' ' HG3' ' A' ' 47' ' ' GLN . 98.2 mt -59.61 -49.51 77.48 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.23 -0.441 . . . . 71.22 111.054 176.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 21.4 m-30 -58.85 -43.87 90.88 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.888 0.375 . . . . 53.3 111.717 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.529 HD21 HG21 ' A' ' 30' ' ' ILE . 96.7 mt -63.45 -45.54 90.4 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.373 -0.376 . . . . 74.34 111.588 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -61.33 -39.7 91.5 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 121.214 -0.194 . . . . 53.12 110.788 175.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 80.9 mt-30 -58.45 -44.16 89.1 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.965 0.412 . . . . 63.33 110.976 172.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.86 -31.22 71.46 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.345 -0.389 . . . . 75.52 111.946 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -73.98 -36.67 64.57 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.082 0.468 . . . . 75.45 110.918 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -64.26 -50.46 67.86 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.159 -0.473 . . . . 71.14 111.291 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.549 HG23 HG23 ' A' ' 53' ' ' VAL . 33.7 m -75.56 4.13 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 N-CA-C 112.641 0.608 . . . . 73.43 112.641 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.71 29.53 38.84 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 114.952 0.741 . . . . 74.32 114.952 171.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.549 HG23 HG23 ' A' ' 51' ' ' VAL . 82.2 t -96.46 -60.15 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 117.413 0.607 . . . . 75.52 111.269 174.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.462 HD22 HG11 ' A' ' 13' ' ' VAL . 71.5 mt -99.26 145.48 27.24 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.226 0.536 . . . . 71.24 112.206 -176.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.525 ' HB2' HD23 ' A' ' 70' ' ' LEU . 9.3 tp10 -92.39 142.59 27.28 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.983 -0.553 . . . . 74.15 111.085 174.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -87.84 107.06 18.49 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.838 -0.619 . . . . 71.33 110.666 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.6 t -108.99 104.9 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 121.012 0.434 . . . . 65.15 112.002 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -119.04 114.16 22.08 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.882 0.373 . . . . 74.34 110.709 176.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.99 -0.68 49.91 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.35 0.5 . . . . 75.23 112.35 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.98 -158.46 25.21 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 121.198 -0.525 . . . . 74.11 112.892 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -81.83 159.91 23.64 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.971 0.415 . . . . 74.45 111.31 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.11 -54.82 4.98 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.032 -0.604 . . . . 53.54 112.319 -177.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.0 m -79.44 133.7 59.5 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 122.737 -0.273 . . . . 62.51 110.742 174.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -74.86 -174.08 1.78 Allowed 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.416 2.078 . . . . 73.02 113.274 -177.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.08 99.02 1.51 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.131 -0.557 . . . . 63.34 112.456 177.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.556 HD13 ' HG2' ' A' ' 24' ' ' PRO . 96.4 mt -73.81 141.86 46.19 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.036 0.446 . . . . 64.02 111.319 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.452 ' CD1' HD13 ' A' ' 45' ' ' LEU . 67.1 m95 -108.04 117.54 34.39 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.809 0.67 . . . . 64.25 112.809 -170.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.475 ' HG3' ' OE1' ' A' ' 17' ' ' GLN . 55.8 ttt180 -120.63 178.7 4.58 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.402 -0.962 . . . . 73.34 108.402 171.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 54' ' ' LEU . 2.3 pp -101.52 160.97 13.98 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.526 1.057 . . . . 61.52 111.557 174.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.525 HD23 ' HB2' ' A' ' 55' ' ' GLU . 84.3 mt -69.12 93.15 0.58 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.891 0.377 . . . . 72.15 110.337 176.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 C--O 1.253 1.243 0 CA-C-O 118.37 -0.824 . . . . 73.44 111.897 -174.341 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.746 0.308 . . . . 53.13 111.373 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.9 t -68.17 101.41 1.16 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.751 0.31 . . . . 71.52 111.116 178.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -134.11 130.94 38.13 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.969 0.414 . . . . 73.55 111.276 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.9 m -63.07 -35.42 80.2 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.199 -0.455 . . . . 61.24 111.525 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.7 mm -59.47 -48.07 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.05 0.452 . . . . 53.41 111.139 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.3 t -61.46 -48.11 90.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.341 -0.391 . . . . 73.0 110.923 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 99.5 m -58.13 -39.61 79.17 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.246 -0.434 . . . . 74.41 111.613 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.467 ' O ' HG13 ' A' ' 12' ' ' ILE . 60.1 tptt -57.57 -53.99 51.93 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.116 0.484 . . . . 71.51 110.485 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.527 HG23 HG21 ' A' ' 30' ' ' ILE . 67.8 mt -57.78 -48.65 83.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 115.784 -0.644 . . . . 74.55 111.931 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.7 mt -59.32 -44.31 92.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-O 120.966 0.412 . . . . 74.43 111.608 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.2 t -63.05 -32.49 73.87 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.336 -0.393 . . . . 70.24 111.556 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 8' ' ' LYS . 99.0 mt -71.35 -49.0 50.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.898 0.38 . . . . 72.34 111.336 176.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 9' ' ' ILE . 89.6 t -56.48 -44.09 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.135 0.493 . . . . 60.35 110.776 176.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -65.6 -39.96 92.13 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.945 -0.57 . . . . 74.2 110.898 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -55.57 -47.85 75.73 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.167 0.508 . . . . 52.4 110.87 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.572 ' HA ' ' HG2' ' A' ' 19' ' ' MET . 0.3 OUTLIER -64.46 -34.35 77.99 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.088 -0.506 . . . . 65.3 111.398 178.281 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.417 ' NE2' ' HG3' ' A' ' 68' ' ' ARG . 12.3 mm-40 -65.07 -40.03 94.1 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.038 0.447 . . . . 71.34 111.651 174.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -75.99 -21.94 56.38 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.281 0.474 . . . . 74.35 112.281 -177.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.572 ' HG2' ' HA ' ' A' ' 16' ' ' ARG . 24.8 ptm -83.77 -32.29 25.48 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.956 -0.465 . . . . 65.32 111.379 176.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -152.17 115.29 4.69 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.091 0.472 . . . . 71.0 110.805 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -69.4 -13.44 62.36 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.998 0.74 . . . . 74.13 112.998 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.03 15.15 12.34 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.052 -0.594 . . . . 72.24 113.487 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -107.71 113.58 61.25 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 112.174 0.435 . . . . 61.05 112.174 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.83 140.78 32.57 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.36 2.04 . . . . 71.32 112.067 172.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.411 HG13 ' HG3' ' A' ' 16' ' ' ARG . 5.4 t -79.12 154.64 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 120.923 0.392 . . . . 74.34 111.199 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.567 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 2.3 mptp? -107.58 139.0 42.79 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.65 -0.25 . . . . 74.12 110.737 -177.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.2 m -53.49 -51.13 63.75 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.066 0.46 . . . . 65.54 111.8 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -64.85 -31.26 72.4 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.114 0.412 . . . . 65.22 112.114 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -63.54 -52.69 60.01 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.945 0.403 . . . . 63.3 111.046 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.527 HG21 HG23 ' A' ' 9' ' ' ILE . 64.2 mt -55.89 -43.13 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.045 0.45 . . . . 73.13 110.892 176.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.78 -35.68 73.21 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.102 -0.499 . . . . 73.42 111.876 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -74.1 -48.46 29.52 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.763 0.316 . . . . 71.35 110.992 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.11 -28.66 69.92 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.114 0.413 . . . . 70.22 112.114 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.22 -26.45 16.64 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.297 0.48 . . . . 53.44 112.297 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.21 31.47 38.25 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.267 -0.492 . . . . 73.1 112.713 -176.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.5 mt -115.35 169.26 9.28 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.845 0.355 . . . . 63.12 111.432 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.412 ' O ' HG23 ' A' ' 41' ' ' VAL . 46.1 t -87.7 151.49 22.89 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.029 0.443 . . . . 62.32 111.772 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.1 mm -58.09 -48.85 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 112.985 0.735 . . . . 60.2 112.985 -172.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.552 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 41.8 p90 -56.68 -38.67 72.57 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 111.853 0.316 . . . . 74.53 111.853 -176.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -75.84 -47.18 26.64 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.079 0.466 . . . . 65.33 111.091 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 37' ' ' SER . 90.9 t -55.23 -48.28 76.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 116.17 -0.468 . . . . 72.33 111.614 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -65.61 -29.72 70.34 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 111.887 0.329 . . . . 71.24 111.887 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 65.6 mt -59.03 -49.28 78.49 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.167 -0.333 . . . . 61.33 110.577 176.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -61.28 -53.27 58.96 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.352 -0.385 . . . . 74.02 111.191 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.426 HD13 ' CD1' ' A' ' 67' ' ' TRP . 89.0 mt -55.37 -49.73 71.53 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.226 0.536 . . . . 74.31 112.393 -178.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.79 -41.73 95.6 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.937 -0.574 . . . . 62.34 112.095 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -68.83 -41.13 78.95 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.741 0.305 . . . . 75.25 110.942 176.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.0 mt -59.68 -31.63 69.74 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.746 0.307 . . . . 61.44 111.102 175.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.512 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 42.0 t-80 -66.43 -48.6 69.49 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.987 0.423 . . . . 73.13 111.031 173.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -59.96 -33.56 72.09 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 116.123 -0.489 . . . . 71.42 111.933 -176.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.523 HG23 HG23 ' A' ' 53' ' ' VAL . 33.9 m -89.44 1.53 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 112.841 0.682 . . . . 73.33 112.841 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.44 19.52 51.98 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 114.82 0.688 . . . . 53.21 114.82 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.523 HG23 HG23 ' A' ' 51' ' ' VAL . 81.6 t -88.53 -48.24 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 122.16 -0.612 . . . . 75.22 111.027 175.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 85.9 mt -114.79 152.39 32.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.285 -0.416 . . . . 61.2 111.503 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.459 ' HA ' ' HD2' ' A' ' 49' ' ' HIS . 10.5 tp10 -109.28 149.99 28.63 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.488 -0.323 . . . . 73.55 110.299 173.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.445 ' HE2' ' HB2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -98.86 137.78 36.94 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.165 0.507 . . . . 74.43 111.215 -178.735 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.513 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 88.7 t -121.25 132.81 69.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 120.995 0.426 . . . . 71.54 111.57 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -153.15 101.04 2.52 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.308 -0.405 . . . . 51.24 110.113 177.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.69 -28.91 66.23 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.247 0.832 . . . . 43.31 113.247 -174.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.488 ' O ' HG22 ' A' ' 63' ' ' VAL . . . 179.93 165.12 33.31 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.755 -0.736 . . . . 73.23 113.438 -178.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -61.38 97.29 0.07 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.181 0.515 . . . . 64.4 111.015 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 144.1 -31.2 1.86 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-N 115.848 -0.614 . . . . 62.53 112.716 -177.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 60' ' ' GLY . 18.2 m -80.66 156.39 73.0 Favored Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 122.466 -0.432 . . . . 55.23 111.154 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 63' ' ' VAL . 50.4 Cg_endo -67.41 167.02 21.68 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.651 2.234 . . . . 73.12 113.722 -178.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.87 97.31 1.62 Allowed Glycine 0 CA--C 1.525 0.717 0 CA-C-N 115.979 -0.555 . . . . 52.21 112.605 176.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.513 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 70.5 mt -88.58 164.18 15.51 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.934 0.397 . . . . 71.15 111.597 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.426 ' CD1' HD13 ' A' ' 45' ' ' LEU . 72.8 m95 -131.45 154.04 49.11 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.856 0.36 . . . . 74.35 111.351 -178.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.417 ' HG3' ' NE2' ' A' ' 17' ' ' GLN . 50.7 ttt85 -165.3 117.55 1.16 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.551 -0.295 . . . . 74.31 110.992 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 54' ' ' LEU . 4.2 pp -64.21 155.29 32.29 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.953 0.406 . . . . 71.45 111.661 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.518 ' H ' HD23 ' A' ' 70' ' ' LEU . 1.8 pt? -123.06 13.64 9.76 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.035 0.445 . . . . 74.23 111.184 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.746 -0.645 . . . . 74.24 110.782 179.895 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.427 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 120.85 0.357 . . . . 75.32 111.563 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 84.3 p -161.33 167.12 26.43 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.336 -0.393 . . . . 53.23 110.913 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -68.53 101.09 1.2 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.201 0.524 . . . . 73.54 111.309 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.6 t -81.0 24.83 0.49 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.131 0.419 . . . . 75.45 112.131 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.64 HG12 HD11 ' A' ' 36' ' ' LEU . 9.5 tp -55.79 -36.19 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.314 0.487 . . . . 73.35 112.314 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.7 t -58.46 -50.26 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.853 0.359 . . . . 63.43 111.509 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.9 m -60.88 -40.02 91.43 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.937 0.398 . . . . 74.41 111.041 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.484 ' O ' HG13 ' A' ' 12' ' ' ILE . 4.4 ttmp? -58.93 -48.77 80.3 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.34 -0.391 . . . . 74.23 111.095 177.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.9 mt -56.47 -48.11 80.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.421 -0.354 . . . . 75.3 111.586 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.5 mt -59.14 -43.27 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.079 0.466 . . . . 73.33 111.018 176.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.4 t -60.52 -40.02 89.92 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.948 -0.569 . . . . 71.21 111.628 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 8' ' ' LYS . 86.8 mt -61.08 -51.06 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.093 0.473 . . . . 53.25 111.185 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.6 t -57.97 -51.01 76.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.105 0.478 . . . . 54.21 111.008 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -54.07 -47.38 71.73 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.998 -0.546 . . . . 72.24 111.349 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -57.52 -53.49 57.56 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.145 -0.479 . . . . 54.53 111.785 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -62.69 -27.17 69.06 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.568 -0.287 . . . . 75.31 111.71 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -80.22 -26.79 38.94 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 122.16 -0.337 . . . . 75.01 111.705 175.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -64.59 -26.11 68.26 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.225 0.536 . . . . 62.12 109.856 170.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.0 mmm -78.43 -60.18 2.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.708 -0.678 . . . . 74.23 111.548 173.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 23' ' ' ALA . 24.6 m-20 -94.13 -55.86 3.05 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.771 0.656 . . . . 54.22 112.771 -176.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.3 t70 68.47 -69.08 0.16 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.455 0.702 . . . . 74.03 111.834 -176.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.44 -35.34 84.86 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.983 -0.627 . . . . 75.31 112.812 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 20' ' ' ASP . . . -96.38 129.37 33.58 Favored Pre-proline 0 CA--C 1.541 0.63 0 O-C-N 122.618 -0.343 . . . . 74.44 111.069 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.04 164.14 33.1 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.421 2.08 . . . . 72.23 113.251 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.4 t -84.85 145.64 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.285 -0.416 . . . . 71.42 110.742 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.449 ' H ' ' HD2' ' A' ' 26' ' ' LYS . 6.5 mptt -90.06 141.16 28.94 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.706 0.289 . . . . 54.51 110.788 -176.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.1 m -52.01 -38.31 56.39 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.851 0.357 . . . . 60.35 111.873 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 28' ' ' ARG . 5.2 mpt_? -63.35 -47.56 81.64 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 122.37 -0.206 . . . . 73.35 111.552 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.22 -52.5 51.95 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.002 0.429 . . . . 70.34 111.196 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.56 HG21 HD21 ' A' ' 45' ' ' LEU . 58.3 mt -58.44 -53.89 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 115.764 -0.653 . . . . 74.13 111.742 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.468 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -60.85 -45.43 94.55 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.096 0.406 . . . . 72.12 112.096 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.16 -40.4 96.05 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.088 -0.506 . . . . 70.2 111.595 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.402 ' HB3' HD13 ' A' ' 12' ' ' ILE . . . -71.97 -38.29 69.76 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.877 0.37 . . . . 33.4 111.324 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.82 -35.27 72.41 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.287 -0.415 . . . . 62.54 111.659 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.97 23.2 42.4 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.394 -0.432 . . . . 65.22 113.509 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.64 HD11 HG12 ' A' ' 5' ' ' ILE . 85.7 mt -113.24 171.67 7.41 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.964 0.412 . . . . 72.0 111.705 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.5 m -71.65 144.36 49.42 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.261 -0.427 . . . . 71.02 111.404 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.1 mm -50.85 -58.22 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.35 0.5 . . . . 63.31 112.35 -174.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.471 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 47.8 p90 -54.02 -40.69 67.26 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.158 0.429 . . . . 62.2 112.158 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -65.43 -47.3 76.7 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.169 0.509 . . . . 65.14 111.016 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' A' ' 31' ' ' ALA . 60.9 t -58.7 -44.29 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.147 -0.479 . . . . 72.5 111.024 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -58.52 -33.69 70.14 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.616 -0.265 . . . . 64.05 111.686 178.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.533 ' O ' ' HG3' ' A' ' 47' ' ' GLN . 95.1 mt -60.07 -52.58 64.74 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 110.167 -0.309 . . . . 65.23 110.167 175.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -56.83 -46.0 81.96 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.115 0.484 . . . . 75.11 111.256 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.56 HD21 HG21 ' A' ' 30' ' ' ILE . 92.9 mt -59.92 -46.6 88.84 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.089 -0.505 . . . . 73.43 111.918 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -67.29 -37.18 83.0 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.509 0.195 . . . . 73.41 111.34 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 96.2 mt-30 -59.66 -45.19 92.8 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.064 0.459 . . . . 63.35 110.602 174.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 94.3 mt -61.42 -34.13 74.87 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.379 -0.373 . . . . 74.51 111.416 176.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -70.56 -28.71 65.11 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.149 0.499 . . . . 73.2 111.015 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -79.65 -41.66 26.48 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.143 -0.481 . . . . 73.43 111.765 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.6 m -77.79 -24.71 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 111.914 0.339 . . . . 63.12 111.914 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.6 69.02 0.61 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.098 -0.572 . . . . 62.54 113.12 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 99.4 t -141.36 -60.92 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.111 0.481 . . . . 73.13 110.787 177.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.665 HD23 ' HB3' ' A' ' 69' ' ' LEU . 80.9 mt -103.98 145.75 29.7 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.148 -0.478 . . . . 74.23 111.962 -177.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.549 ' HB2' HD22 ' A' ' 70' ' ' LEU . 12.0 tp10 -108.53 141.11 40.91 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.029 0.442 . . . . 73.33 110.838 172.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? -89.96 94.87 9.97 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.144 0.497 . . . . 73.23 111.495 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.577 ' O ' ' HB2' ' A' ' 58' ' ' ASN . 42.2 t -77.68 85.89 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 120.967 0.413 . . . . 75.03 110.835 177.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.577 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 66.1 t30 162.4 -177.86 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.221 1.008 . . . . 73.0 108.994 -178.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.43 ' HB3' HG21 ' A' ' 63' ' ' VAL . . . -67.83 -172.04 0.25 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 110.204 -0.295 . . . . 22.42 110.204 166.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -147.09 -158.47 7.84 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.159 -1.02 . . . . 52.41 114.009 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm 72.0 7.96 5.89 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.327 0.651 . . . . 61.3 112.377 176.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.57 -43.96 0.55 Allowed Glycine 0 CA--C 1.53 0.975 0 C-N-CA 120.55 -0.833 . . . . 71.21 113.933 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.43 HG21 ' HB3' ' A' ' 59' ' ' ALA . 33.7 m -54.3 151.58 13.28 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 122.331 0.252 . . . . 44.25 111.536 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -52.83 -69.34 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.089 2.526 . . . . 74.25 113.819 -172.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.431 ' HA2' ' CB ' ' A' ' 58' ' ' ASN . . . 84.94 151.58 14.74 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.699 -0.762 . . . . 75.42 114.164 177.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 66' ' ' LEU . 5.9 mp -110.06 133.55 53.09 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 110.025 -0.361 . . . . 61.54 110.025 174.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.443 ' CD1' HD13 ' A' ' 45' ' ' LEU . 58.2 m95 -102.23 133.93 46.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.469 0.652 . . . . 73.2 111.906 -172.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -141.31 114.47 8.66 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.778 -0.646 . . . . 73.12 111.088 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.665 ' HB3' HD23 ' A' ' 54' ' ' LEU . 4.2 pp -67.76 151.58 46.99 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.426 0.631 . . . . 71.43 111.9 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.549 HD22 ' HB2' ' A' ' 55' ' ' GLU . 1.7 pt? -139.56 159.66 41.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.39 -0.823 . . . . 72.1 110.648 -177.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.875 -0.583 . . . . 70.44 110.311 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtp . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 120.929 0.395 . . . . 53.24 111.594 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.0 m -81.18 -47.78 12.98 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.159 0.504 . . . . 73.42 109.829 172.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 59.92 20.92 9.91 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.147 0.795 . . . . 62.45 113.147 167.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.5 m 64.5 21.19 12.39 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.187 0.44 . . . . 73.42 112.187 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.9 tp -55.03 -27.08 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 112.054 0.39 . . . . 72.52 112.054 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.467 HG13 HD21 ' A' ' 48' ' ' LEU . 61.6 t -53.27 -49.53 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.402 -0.363 . . . . 72.45 111.955 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.0 m -55.45 -46.2 76.81 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.898 0.38 . . . . 74.33 111.408 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.499 ' O ' HG13 ' A' ' 12' ' ' ILE . 53.8 tptt -55.99 -50.61 70.37 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.366 -0.379 . . . . 64.45 111.49 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.3 mt -57.19 -42.33 79.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.312 -0.404 . . . . 64.22 111.562 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.2 mt -61.56 -46.06 97.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 121.003 0.43 . . . . 71.44 110.903 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.8 m -60.75 -32.67 71.96 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.348 -0.387 . . . . 55.41 111.506 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.536 HG21 ' HA ' ' A' ' 30' ' ' ILE . 96.4 mt -67.21 -41.32 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.788 0.328 . . . . 74.4 111.55 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.437 ' HA ' HG21 ' A' ' 25' ' ' VAL . 59.5 t -59.95 -41.23 85.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 121.207 0.527 . . . . 62.22 110.714 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -64.56 -48.15 76.09 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.058 0.456 . . . . 61.32 110.514 173.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -53.06 -56.3 17.21 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.624 -0.716 . . . . 74.04 112.25 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -67.48 -39.14 85.23 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.511 0.559 . . . . 61.35 112.511 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -74.21 -20.33 60.22 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.406 -0.518 . . . . 72.42 110.71 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -71.51 -24.53 61.98 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.497 0.665 . . . . 74.13 109.514 172.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.1 mmt -79.64 -47.89 14.65 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.871 -0.604 . . . . 75.12 111.504 169.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -98.56 84.69 3.21 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.052 0.453 . . . . 75.3 110.969 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -57.05 -37.34 71.66 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.397 0.518 . . . . 63.0 112.397 -177.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -108.11 20.14 31.33 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.244 -0.503 . . . . 74.11 113.868 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.436 ' HA ' ' HD2' ' A' ' 24' ' ' PRO . . . -158.39 108.33 1.68 Allowed Pre-proline 0 N--CA 1.468 0.459 0 CA-C-N 117.053 0.427 . . . . 62.22 111.785 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.53 ' HB3' ' HB2' ' A' ' 68' ' ' ARG . 1.5 Cg_endo -48.34 177.39 0.02 OUTLIER 'Trans proline' 0 CA--C 1.552 1.414 0 C-N-CA 122.954 2.436 . . . . 54.44 114.501 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.437 HG21 ' HA ' ' A' ' 13' ' ' VAL . 44.1 t -79.57 152.93 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 112.824 0.675 . . . . 72.04 112.824 -169.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.639 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 8.2 mptt -105.86 146.09 30.38 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.715 -0.675 . . . . 54.44 110.082 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.4 m -53.71 -44.34 69.77 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.652 0.612 . . . . 55.3 112.652 -176.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -59.47 -43.58 93.2 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 111.7 0.259 . . . . 72.13 111.7 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.465 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 2.8 m-20 -56.46 -39.62 73.47 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.039 0.447 . . . . 72.34 112.043 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.615 HG21 HD21 ' A' ' 45' ' ' LEU . 61.5 mt -68.94 -44.51 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.954 0.406 . . . . 71.24 111.289 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.473 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -61.82 -35.28 77.76 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.104 0.478 . . . . 53.3 111.162 175.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -65.58 -55.59 16.88 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.658 -0.701 . . . . 73.41 111.737 178.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.39 -37.99 87.9 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.762 0.653 . . . . 42.24 112.762 -176.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.48 -28.91 30.89 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 111.974 0.361 . . . . 73.05 111.974 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.64 39.05 22.6 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.066 -0.587 . . . . 53.44 112.586 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.5 mt -117.43 172.71 7.15 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 122.658 -0.319 . . . . 65.44 111.236 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.401 ' O ' HG23 ' A' ' 41' ' ' VAL . 50.6 m -78.99 148.14 32.67 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.663 -0.244 . . . . 74.31 111.439 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.6 mm -52.66 -58.56 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 112.407 0.521 . . . . 75.22 112.407 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -57.05 -41.83 79.4 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.959 0.409 . . . . 74.12 111.567 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -56.42 -49.64 73.97 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.462 0.649 . . . . 61.33 111.068 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.473 HG21 ' HA ' ' A' ' 31' ' ' ALA . 64.2 t -65.11 -39.47 85.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.838 -0.619 . . . . 72.31 111.352 178.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.4 mmm-85 -50.94 -48.17 60.95 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.889 0.376 . . . . 71.31 111.315 175.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.5 mt -59.01 -51.59 69.39 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.183 -0.462 . . . . 75.22 111.091 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -60.2 -45.15 94.15 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.4 0.519 . . . . 75.14 112.4 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.615 HD21 HG21 ' A' ' 30' ' ' ILE . 91.0 mt -64.6 -52.77 55.79 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.175 0.512 . . . . 73.42 111.515 -177.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.405 ' HG2' ' HH2' ' A' ' 67' ' ' TRP . 34.4 mt-10 -66.34 -29.22 69.37 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.101 -0.5 . . . . 74.45 111.993 -177.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -74.56 -37.84 62.86 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 122.104 -0.373 . . . . 71.03 111.052 172.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.467 HD21 HG13 ' A' ' 6' ' ' VAL . 62.1 mt -64.37 -26.54 68.51 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.883 0.373 . . . . 71.02 110.843 173.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -72.86 -40.35 65.75 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.887 0.375 . . . . 74.1 110.69 171.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.19 -38.2 88.21 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 116.216 -0.447 . . . . 72.43 111.744 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.6 HG23 HG23 ' A' ' 53' ' ' VAL . 35.4 m -81.25 -12.09 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 112.218 0.451 . . . . 72.5 112.218 177.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.18 24.93 13.43 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 120.986 -0.626 . . . . 73.4 114.62 174.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.6 HG23 HG23 ' A' ' 51' ' ' VAL . 64.4 t -91.71 -56.59 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 117.493 0.647 . . . . 65.25 111.332 175.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 61.5 mt -105.13 125.88 51.46 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.079 -0.509 . . . . 73.23 111.498 -176.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -93.87 140.19 29.98 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.887 0.375 . . . . 74.5 111.703 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . 97.2 mttt -88.62 94.01 9.75 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.97 0.414 . . . . 72.32 110.58 175.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.403 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 59.6 t -71.62 132.53 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.666 -0.243 . . . . 74.45 110.461 175.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.403 ' HB3' ' O ' ' A' ' 57' ' ' VAL . 63.6 t30 73.39 24.4 2.35 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.316 0.579 . . . . 73.13 111.144 -177.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' A' ' 56' ' ' LYS . . . -74.37 -17.63 60.79 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.204 0.446 . . . . 53.53 112.204 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.35 -94.21 0.01 OUTLIER Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.589 -0.339 . . . . 71.42 113.427 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -127.46 38.91 3.98 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.945 0.402 . . . . 71.04 111.009 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.11 42.5 1.28 Allowed Glycine 0 CA--C 1.53 1.03 0 N-CA-C 114.561 0.585 . . . . 73.01 114.561 173.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.7 m -111.67 146.87 35.59 Favored Pre-proline 0 N--CA 1.472 0.664 0 CA-C-N 117.491 0.646 . . . . 74.04 111.225 175.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.75 95.25 0.4 Allowed 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.391 2.061 . . . . 72.32 112.168 174.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -99.27 -134.94 8.69 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.19 -0.528 . . . . 75.41 113.341 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 91.4 mt -97.27 132.57 42.89 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.043 0.449 . . . . 70.41 111.764 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.405 ' HH2' ' HG2' ' A' ' 46' ' ' GLU . 85.3 m95 -84.4 125.42 32.32 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.563 0.697 . . . . 73.2 112.614 -175.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.53 ' HB2' ' HB3' ' A' ' 24' ' ' PRO . 74.0 ttt180 -139.97 117.78 11.68 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.897 -0.592 . . . . 72.5 110.768 176.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 69' ' ' LEU . 2.6 pt? -66.35 152.9 44.05 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.865 0.364 . . . . 75.34 111.12 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.6 mt -80.69 124.76 29.29 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.91 0.386 . . . . 74.01 111.826 -176.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.396 -0.811 . . . . 72.14 111.324 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 120.514 0.197 . . . . 73.25 110.847 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.7 p -57.59 99.61 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.16 0.505 . . . . 74.34 111.485 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.76 -33.48 71.73 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.77 -0.65 . . . . 51.21 111.166 177.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.8 t -75.35 87.89 2.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.978 -0.556 . . . . 74.21 112.007 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.598 HD11 HD11 ' A' ' 36' ' ' LEU . 14.3 tt -59.63 -24.84 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.728 0.775 . . . . 72.21 109.917 171.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.556 HG13 HD11 ' A' ' 48' ' ' LEU . 92.8 t -56.83 -49.35 79.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.085 -0.962 . . . . 71.32 111.25 173.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.4 m -58.62 -33.3 69.88 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.133 0.492 . . . . 63.3 111.443 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.441 ' O ' HG13 ' A' ' 12' ' ' ILE . 58.8 tttp -62.58 -49.82 73.73 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.056 0.455 . . . . 61.31 110.297 174.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.497 ' HA ' HD12 ' A' ' 12' ' ' ILE . 72.1 mt -58.34 -43.53 86.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.98 -0.554 . . . . 52.42 111.332 178.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 73.6 mt -57.5 -42.08 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.911 0.386 . . . . 64.45 111.068 176.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.9 m -64.0 -34.16 77.37 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.252 -0.431 . . . . 64.12 111.28 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 9' ' ' ILE . 83.6 mt -66.39 -46.01 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.918 0.39 . . . . 61.31 110.98 176.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.54 -45.58 96.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.054 0.454 . . . . 74.02 110.768 175.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -55.91 -49.6 73.01 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.009 -0.541 . . . . 64.11 111.165 175.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -54.63 -56.34 20.02 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.682 -0.69 . . . . 64.03 111.522 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 35.9 mmt-85 -57.53 -40.11 78.08 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.27 -0.423 . . . . 70.11 111.907 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.49 ' O ' ' N ' ' A' ' 21' ' ' ASP . 16.6 mt-30 -61.35 -47.36 86.25 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.245 -0.284 . . . . 72.52 110.989 175.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -57.93 -27.02 62.99 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.293 0.479 . . . . 70.24 112.293 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 47.9 mtt -55.78 -41.71 74.47 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.164 0.431 . . . . 71.44 112.164 174.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 23' ' ' ALA . 30.7 t70 -128.63 8.58 5.86 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.021 0.439 . . . . 60.2 111.667 -176.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' A' ' 17' ' ' GLN . 31.9 t70 54.73 97.24 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.398 0.679 . . . . 71.23 112.418 -176.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.17 -13.6 66.64 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 114.465 0.546 . . . . 44.31 114.465 176.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . . . -56.42 120.58 36.86 Favored Pre-proline 0 N--CA 1.473 0.691 0 N-CA-C 112.493 0.553 . . . . 52.12 112.493 -177.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.546 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 72.6 Cg_endo -75.1 152.91 40.88 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.62 2.213 . . . . 71.41 112.813 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.1 t -117.13 150.86 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 O-C-N 122.301 -0.249 . . . . 71.2 111.566 -175.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.455 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 9.6 mptt -87.91 158.14 18.77 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.894 0.378 . . . . 71.51 110.803 176.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.509 HG21 ' HB2' ' A' ' 42' ' ' ARG . 56.0 m -56.38 -47.29 79.22 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.903 0.382 . . . . 72.22 111.814 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.48 -37.78 87.28 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.759 0.314 . . . . 64.5 111.264 -177.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 3.5 m-20 -64.23 -44.75 90.88 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.81 0.338 . . . . 74.35 111.413 178.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.65 -47.41 91.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 116.193 -0.458 . . . . 73.3 111.014 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.497 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -57.81 -41.98 83.29 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.04 0.448 . . . . 23.41 111.331 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -62.95 -47.54 82.78 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.043 -0.526 . . . . 73.44 111.53 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.43 -26.64 66.51 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.914 0.388 . . . . 71.15 111.994 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.73 -22.04 22.39 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.052 0.39 . . . . 73.33 112.052 178.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.36 34.21 54.97 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.213 -0.518 . . . . 75.3 112.507 -174.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.598 HD11 HD11 ' A' ' 5' ' ' ILE . 95.7 mt -115.34 -178.85 3.48 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.118 0.485 . . . . 65.13 111.624 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.4 m -84.85 141.86 30.15 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.853 -0.612 . . . . 74.0 111.077 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.3 mm -55.61 -58.51 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.578 0.584 . . . . 74.34 112.578 -173.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.469 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 41.5 t80 -60.44 -40.44 91.11 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.818 0.342 . . . . 62.1 111.453 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.473 ' HG3' ' HE2' ' A' ' 44' ' ' TYR . 5.8 tp-100 -57.45 -52.5 65.12 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.231 0.539 . . . . 71.44 111.149 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.497 HG21 ' HA ' ' A' ' 31' ' ' ALA . 71.6 t -58.54 -45.15 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.005 -0.543 . . . . 73.33 111.345 176.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.509 ' HB2' HG21 ' A' ' 27' ' ' THR . 76.5 ttt180 -51.23 -39.32 56.36 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.116 -0.493 . . . . 61.41 111.524 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 93.4 mt -65.49 -44.72 86.2 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.365 -0.38 . . . . 64.14 111.547 177.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.473 ' HE2' ' HG3' ' A' ' 40' ' ' GLN . 69.3 m-85 -62.37 -40.35 96.15 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.246 0.546 . . . . 74.21 111.126 177.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.498 HD13 ' CD1' ' A' ' 67' ' ' TRP . 81.9 mt -65.39 -45.14 85.18 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.247 -0.433 . . . . 73.21 111.452 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -66.1 -38.86 89.3 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.578 0.584 . . . . 72.12 112.578 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 20.9 pt20 -66.67 -36.63 83.0 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 120.779 -0.369 . . . . 74.32 110.659 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.556 HD11 HG13 ' A' ' 6' ' ' VAL . 85.2 mt -68.12 -38.86 82.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.18 0.514 . . . . 75.01 110.842 173.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.401 ' CE1' ' HD3' ' A' ' 56' ' ' LYS . 12.9 t-80 -68.28 -21.56 64.78 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.994 -0.548 . . . . 72.41 111.029 175.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -83.4 -50.9 7.87 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.22 -0.445 . . . . 72.23 111.603 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.2 m -70.72 -31.11 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 112.776 0.658 . . . . 51.21 112.776 -177.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 116.89 43.89 0.6 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 120.836 -0.697 . . . . 74.23 114.093 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.29 -38.06 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.081 0.467 . . . . 75.23 111.293 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.8 mt -111.28 136.98 49.6 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.938 0.399 . . . . 50.32 111.629 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -103.32 136.14 43.64 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.116 -0.493 . . . . 54.01 109.804 172.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.401 ' HD3' ' CE1' ' A' ' 49' ' ' HIS . 19.0 pttm -94.0 144.13 25.74 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.137 0.494 . . . . 64.54 110.99 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 16.2 t -103.77 142.9 16.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.36 -0.608 . . . . 60.44 109.36 173.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 71.2 m-20 76.44 163.34 0.24 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.149 0.58 . . . . 62.14 111.367 -174.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.27 -17.57 64.83 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.041 0.756 . . . . 65.11 113.041 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.07 -37.86 2.38 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 120.844 -0.693 . . . . 64.44 113.205 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -75.97 119.83 20.48 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 122.514 -0.404 . . . . 72.11 110.673 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.62 -60.71 3.29 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.163 -0.541 . . . . 74.52 113.041 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.418 ' CG2' ' HB3' ' A' ' 58' ' ' ASN . 33.4 m -75.86 152.44 84.75 Favored Pre-proline 0 CA--C 1.544 0.742 0 O-C-N 122.627 -0.337 . . . . 65.52 111.42 178.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -66.77 119.15 6.15 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.514 2.143 . . . . 62.31 113.207 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.21 108.46 2.52 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.021 -0.609 . . . . 74.5 112.659 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.599 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 49.5 mt -91.05 143.55 26.58 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.944 0.402 . . . . 55.31 111.042 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.498 ' CD1' HD13 ' A' ' 45' ' ' LEU . 49.8 m95 -106.3 127.68 53.43 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.887 0.375 . . . . 73.24 111.869 -176.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -140.58 121.67 14.71 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.215 0.531 . . . . 74.24 110.945 173.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 pp -69.23 161.23 29.63 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.949 0.404 . . . . 75.13 111.6 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.5 ' N ' HD23 ' A' ' 70' ' ' LEU . 1.5 pt? -138.9 34.48 2.17 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.313 -0.403 . . . . 51.32 111.451 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 . . . . . 0 C--O 1.254 1.329 0 CA-C-O 118.767 -0.635 . . . . 53.31 111.865 177.236 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtt . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 120.871 0.367 . . . . 71.31 111.872 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 91.2 p -92.91 -20.1 20.98 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.012 0.434 . . . . 63.43 110.729 174.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -63.69 137.06 57.93 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.884 -0.598 . . . . 72.21 112.077 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.8 m -75.05 65.0 1.42 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.06 0.457 . . . . 73.11 111.005 176.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.456 HG12 HD11 ' A' ' 36' ' ' LEU . 8.6 tp -60.7 -38.53 78.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.206 -0.452 . . . . 65.1 111.924 -177.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.7 t -58.81 -47.13 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.274 0.559 . . . . 70.31 110.932 178.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 m -61.49 -40.2 93.71 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.93 -0.577 . . . . 70.22 110.95 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.527 ' O ' HG13 ' A' ' 12' ' ' ILE . 88.5 tttt -61.14 -46.47 90.42 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.139 -0.482 . . . . 74.32 110.893 177.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 13' ' ' VAL . 78.2 mt -55.21 -49.28 73.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.88 0.372 . . . . 75.5 111.229 176.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 69.8 mt -59.09 -40.63 81.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.106 0.479 . . . . 74.43 111.02 176.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.3 t -63.38 -35.7 81.27 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.304 -0.407 . . . . 73.53 111.194 176.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 8' ' ' LYS . 86.0 mt -65.51 -44.14 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-O 121.245 0.545 . . . . 73.31 110.449 175.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 9' ' ' ILE . 95.5 t -56.92 -46.92 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 115.898 -0.592 . . . . 73.42 111.063 176.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -61.33 -49.15 78.16 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.208 -0.451 . . . . 72.4 110.96 176.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -54.47 -53.36 55.27 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.902 -0.59 . . . . 65.14 111.633 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.52 ' HG3' HG13 ' A' ' 25' ' ' VAL . 5.7 mmp_? -56.12 -42.22 76.51 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.239 -0.437 . . . . 71.4 112.128 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -70.25 -31.09 68.32 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.728 0.299 . . . . 71.3 111.692 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -60.68 -33.42 72.82 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.119 0.485 . . . . 71.01 110.825 173.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 95.7 mmm -61.59 -34.87 76.36 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.004 -0.544 . . . . 74.2 111.955 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -159.52 110.17 1.97 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.887 0.375 . . . . 63.55 110.68 177.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -59.85 -17.7 38.5 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.56 0.578 . . . . 73.14 112.56 -178.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.9 12.74 59.2 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 120.985 -0.626 . . . . 73.21 113.329 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . . . -122.98 139.8 32.17 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 117.06 0.43 . . . . 64.41 112.144 -177.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.418 ' HG2' HD13 ' A' ' 66' ' ' LEU . 9.8 Cg_endo -87.95 174.3 4.7 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.041 2.494 . . . . 71.43 112.495 175.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.52 HG13 ' HG3' ' A' ' 16' ' ' ARG . 21.2 t -101.93 135.86 36.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.372 -0.376 . . . . 51.24 111.212 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.42 143.05 27.12 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.621 0.248 . . . . 64.12 111.025 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 67.9 m -55.97 -37.26 68.82 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.168 0.509 . . . . 54.04 110.79 173.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.1 mmm-85 -60.55 -55.8 28.98 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.016 -0.538 . . . . 65.34 111.196 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -51.62 -44.92 63.07 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.99 -0.55 . . . . 71.54 111.643 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.0 mt -61.83 -45.39 98.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.385 -0.37 . . . . 73.21 111.306 177.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.55 -31.92 71.01 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.896 0.379 . . . . 62.43 111.647 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -67.46 -51.08 55.71 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.231 -0.441 . . . . 74.0 111.362 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.48 -26.97 60.36 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.231 0.456 . . . . 74.12 112.231 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.67 -28.49 23.12 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.082 0.401 . . . . 63.14 112.082 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.02 32.58 60.49 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.043 -0.598 . . . . 42.45 113.317 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.456 HD11 HG12 ' A' ' 5' ' ' ILE . 88.7 mt -115.59 166.57 11.77 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.916 0.388 . . . . 74.33 111.042 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.404 ' O ' HG23 ' A' ' 41' ' ' VAL . 97.6 p -70.08 143.72 52.35 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.768 0.318 . . . . 72.31 111.277 178.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.5 mm -49.15 -50.08 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 112.366 0.506 . . . . 75.41 112.366 -177.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -62.67 -42.82 99.82 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.719 0.295 . . . . 73.33 111.405 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -63.97 -43.85 94.49 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.901 0.382 . . . . 74.5 111.077 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 37' ' ' SER . 81.9 t -57.84 -42.93 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.975 0.417 . . . . 63.33 110.539 175.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -55.84 -40.44 72.85 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.025 -0.534 . . . . 73.43 111.429 175.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.1 mt -59.34 -44.52 92.64 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.805 0.336 . . . . 71.41 111.17 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -65.37 -53.95 35.96 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.364 -0.38 . . . . 62.52 111.797 177.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.478 HD13 ' CD1' ' A' ' 67' ' ' TRP . 89.5 mt -56.84 -38.3 72.46 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.101 0.477 . . . . 63.25 111.705 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -61.64 -53.66 53.24 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.956 -0.566 . . . . 73.44 110.985 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -67.79 -39.03 84.08 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 111.804 0.298 . . . . 73.32 111.804 -178.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.9 mt -61.01 -35.26 76.4 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.214 0.531 . . . . 74.2 110.782 173.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -67.07 -46.23 74.93 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.254 -0.43 . . . . 71.44 111.517 174.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -66.09 -41.61 90.44 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.271 0.471 . . . . 73.34 112.271 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.504 HG23 HG23 ' A' ' 53' ' ' VAL . 34.4 m -71.15 -17.86 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 112.14 0.422 . . . . 55.41 112.14 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.65 29.19 5.1 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 120.836 -0.697 . . . . 74.32 114.274 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.504 HG23 HG23 ' A' ' 51' ' ' VAL . 97.3 t -94.87 -49.74 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 117.369 0.584 . . . . 75.31 110.895 174.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.8 mt -112.54 138.76 48.84 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.09 0.472 . . . . 75.31 111.866 -178.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.511 ' HB3' ' HG3' ' A' ' 68' ' ' ARG . 33.7 tt0 -91.76 146.3 23.87 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.382 -0.372 . . . . 64.13 110.171 175.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -87.68 138.62 31.31 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.17 0.433 . . . . 74.41 112.17 -174.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 62.1 t -132.49 108.75 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.922 0.392 . . . . 72.43 110.486 172.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.5 t30 60.74 93.79 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.211 0.529 . . . . 74.12 112.167 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.823 ' HA ' HG21 ' A' ' 63' ' ' VAL . . . -135.03 163.51 29.71 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.79 0.329 . . . . 75.43 111.82 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 137.37 -124.16 2.97 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 120.828 -0.701 . . . . 62.43 113.926 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -78.71 103.27 8.54 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.501 0.556 . . . . 74.41 112.501 -173.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 50.94 57.22 11.38 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 113.974 0.35 . . . . 72.44 113.974 176.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.823 HG21 ' HA ' ' A' ' 59' ' ' ALA . 32.6 m -100.93 158.81 31.11 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.625 -0.338 . . . . 74.52 111.618 -178.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.41 -17.11 39.34 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.157 1.905 . . . . 64.44 112.189 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.57 96.25 0.03 OUTLIER Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.849 -0.614 . . . . 61.44 113.64 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 94.3 mt -98.29 130.86 44.98 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.976 0.417 . . . . 65.44 110.304 174.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.478 ' CD1' HD13 ' A' ' 45' ' ' LEU . 57.9 m95 -128.39 146.77 50.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.249 0.547 . . . . 74.1 111.844 -175.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.511 ' HG3' ' HB3' ' A' ' 55' ' ' GLU . 5.8 ptm180 -138.74 172.3 13.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.929 -0.578 . . . . 73.3 110.029 174.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pp -108.7 168.92 8.99 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.132 -0.355 . . . . 74.24 110.867 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.5 mt -69.71 78.53 0.44 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.083 0.468 . . . . 63.41 111.707 -177.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 . . . . . 0 C--O 1.257 1.45 0 CA-C-O 118.843 -0.598 . . . . 75.44 111.076 -179.953 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.747 0.308 . . . . 65.51 110.563 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.1 p -72.55 106.56 4.66 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.261 0.553 . . . . 50.2 112.422 -174.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -104.84 108.43 19.91 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.986 -0.552 . . . . 74.21 111.235 175.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.3 t -176.56 111.56 0.09 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.012 0.435 . . . . 72.03 112.028 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.4 mm -76.15 -35.68 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 121.058 0.456 . . . . 71.42 110.386 176.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.1 t -57.73 -48.11 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.018 0.437 . . . . 54.54 110.91 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 78.0 m -61.33 -35.47 77.49 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.412 -0.358 . . . . 53.42 110.982 176.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.51 ' O ' HG13 ' A' ' 12' ' ' ILE . 86.9 tttt -60.28 -47.91 83.99 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.433 -0.349 . . . . 72.22 110.612 176.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 68.1 mt -57.32 -48.47 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.308 -0.405 . . . . 61.43 111.371 176.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.4 mt -57.21 -40.47 73.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.136 0.493 . . . . 64.03 110.993 176.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.6 m -61.34 -45.33 94.87 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.087 -0.506 . . . . 70.34 111.022 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.544 ' O ' ' HG2' ' A' ' 16' ' ' ARG . 83.1 mt -57.94 -56.03 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.17 -0.468 . . . . 72.12 111.563 179.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.548 HG12 HD23 ' A' ' 69' ' ' LEU . 49.0 t -56.82 -50.81 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.847 0.356 . . . . 63.13 111.602 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -57.11 -45.67 83.24 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.089 0.471 . . . . 61.21 111.219 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -60.02 -40.48 89.45 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.291 -0.413 . . . . 72.01 111.419 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 12' ' ' ILE . 23.4 mmm-85 -62.23 -39.48 92.95 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 122.178 -0.326 . . . . 65.01 110.503 175.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -65.69 -26.09 67.61 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.057 0.456 . . . . 50.23 111.556 175.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -78.05 -18.98 55.15 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.846 0.355 . . . . 65.42 111.008 173.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 94.8 mmm -81.05 -35.64 31.55 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.932 0.396 . . . . 74.32 111.103 174.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.582 ' HB3' ' HB2' ' A' ' 23' ' ' ALA . 18.6 t70 -142.98 138.75 30.29 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.457 -0.338 . . . . 65.3 110.913 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -61.79 -11.3 11.77 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.435 0.902 . . . . 73.52 113.435 -175.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.472 ' O ' ' HD3' ' A' ' 24' ' ' PRO . . . -150.08 51.59 0.53 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.973 -0.632 . . . . 72.42 112.954 177.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.582 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . . . -83.8 109.49 18.87 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.567 0.58 . . . . 23.24 112.567 -177.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.569 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 88.9 Cg_endo -79.95 108.05 2.17 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.987 1.791 . . . . 63.42 111.083 171.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 13' ' ' VAL . 14.6 t -79.02 144.3 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.414 0.626 . . . . 60.44 111.528 -172.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.612 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -95.36 138.82 32.52 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.106 -0.497 . . . . 73.01 111.479 -171.889 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.53 HG21 ' HD2' ' A' ' 42' ' ' ARG . 86.9 m -52.68 -38.81 61.15 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.049 0.452 . . . . 63.01 111.163 175.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -60.54 -58.52 8.14 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.054 -0.521 . . . . 71.03 111.016 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -51.17 -46.31 62.04 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.128 0.489 . . . . 64.4 111.312 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.5 mt -60.48 -44.48 96.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.117 -0.492 . . . . 74.31 111.505 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.59 -48.01 83.33 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.789 0.328 . . . . 61.32 111.615 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.67 -52.75 63.06 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.39 -0.368 . . . . 64.25 111.881 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.37 -37.7 87.8 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.366 0.506 . . . . 74.05 112.366 -178.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.24 -35.85 58.79 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 111.841 0.312 . . . . 52.32 111.841 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.26 33.14 8.27 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.284 -0.484 . . . . 51.11 112.706 -176.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.8 mt -120.11 171.77 8.23 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.2 0.524 . . . . 74.33 111.708 -177.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.494 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.7 m -81.84 147.28 29.43 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.985 -0.552 . . . . 62.03 111.08 178.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.497 ' O ' ' HD3' ' A' ' 42' ' ' ARG . 47.5 mm -51.17 -58.59 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 112.904 0.705 . . . . 75.32 112.904 -175.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -62.42 -32.1 72.89 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.994 0.426 . . . . 75.32 111.336 -178.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -61.32 -45.26 95.17 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.378 0.609 . . . . 74.22 110.378 175.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 37' ' ' SER . 71.3 t -62.45 -36.8 76.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 115.842 -0.617 . . . . 73.32 111.658 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.53 ' HD2' HG21 ' A' ' 27' ' ' THR . 0.3 OUTLIER -47.29 -53.07 14.46 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 121.128 0.489 . . . . 73.42 111.179 173.348 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.401 ' O ' ' HG3' ' A' ' 47' ' ' GLN . 74.1 mt -60.06 -48.67 80.74 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.617 -0.72 . . . . 73.44 111.516 -177.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -57.42 -50.04 74.29 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.373 -0.376 . . . . 74.42 111.782 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 67.8 mt -62.96 -46.61 86.89 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.872 0.368 . . . . 60.33 111.862 -176.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -61.11 -41.77 97.3 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.544 -0.298 . . . . 74.24 111.732 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 87.3 mt-30 -65.48 -40.02 92.62 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.755 0.312 . . . . 74.45 111.325 176.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.0 -30.48 70.98 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.882 0.373 . . . . 74.31 111.127 175.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -65.09 -44.81 87.63 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.889 0.376 . . . . 73.52 110.946 173.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -62.21 -48.03 81.81 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.314 0.487 . . . . 75.21 112.314 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.546 HG23 HG23 ' A' ' 53' ' ' VAL . 33.2 m -74.29 2.8 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 112.802 0.668 . . . . 74.11 112.802 -177.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.72 34.99 10.61 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.747 -0.739 . . . . 51.03 114.255 174.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.546 HG23 HG23 ' A' ' 51' ' ' VAL . 63.7 t -107.65 -60.69 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 122.383 -0.481 . . . . 64.11 111.101 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 69' ' ' LEU . 79.3 mt -100.95 163.99 12.03 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.955 0.724 . . . . 70.04 112.955 -175.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -136.51 145.02 44.61 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.532 -0.758 . . . . 62.33 110.264 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -84.15 141.55 30.99 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.176 0.513 . . . . 74.13 112.292 -174.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 48.5 t -120.23 88.54 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.635 0 CA-C-O 121.239 0.542 . . . . 61.02 109.831 172.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -161.93 -167.38 1.65 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.642 -0.708 . . . . 74.23 111.365 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.92 -57.62 3.13 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.179 0.437 . . . . 71.32 112.179 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.96 -132.64 7.06 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.123 -0.56 . . . . 44.33 113.709 -176.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -124.24 146.78 48.52 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 122.389 -0.477 . . . . 74.34 110.867 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.14 -37.94 1.55 Allowed Glycine 0 CA--C 1.533 1.16 0 N-CA-C 114.393 0.517 . . . . 60.33 114.393 176.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.1 m -55.33 133.13 69.9 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 112.16 0.429 . . . . 74.53 112.16 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.87 146.98 61.17 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.609 2.206 . . . . 73.42 113.596 -176.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.64 -119.19 0.54 Allowed Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.971 -0.559 . . . . 51.23 112.02 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.569 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 87.7 mt -107.64 154.17 21.84 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.946 0.373 . . . . 74.34 110.507 176.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -129.83 122.67 29.18 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.035 0.445 . . . . 75.32 111.995 -175.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.425 HH21 ' CD ' ' A' ' 71' ' ' GLU . 75.5 mtp180 -104.16 -172.72 2.16 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.284 -0.416 . . . . 61.33 109.916 171.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 54' ' ' LEU . 3.0 pp -126.38 164.6 20.73 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.153 -0.342 . . . . 72.43 110.582 172.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.3 mt -67.32 92.25 0.28 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.336 0.588 . . . . 74.43 110.779 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.425 ' CD ' HH21 ' A' ' 68' ' ' ARG . 41.9 mt-10 . . . . . 0 C--O 1.252 1.2 0 CA-C-N 115.103 -0.953 . . . . 74.11 111.887 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 120.756 0.312 . . . . 75.03 111.641 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.3 t -138.37 130.86 29.07 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.763 0.316 . . . . 75.34 110.727 175.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -133.41 22.95 4.04 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.24 0.543 . . . . 53.54 111.179 -178.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.1 t -78.92 68.09 4.78 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.114 0.483 . . . . 62.15 111.674 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 5' ' ' ILE . 2.0 mp -91.12 -39.4 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 120.869 0.366 . . . . 74.34 111.034 177.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 51.4 t -60.09 -36.62 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 116.459 -0.337 . . . . 73.31 111.211 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 95.0 m -54.27 -41.21 68.58 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.445 -0.343 . . . . 72.14 111.436 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.537 ' O ' HG13 ' A' ' 12' ' ' ILE . 23.1 ttmm -60.89 -47.06 88.14 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.761 0.315 . . . . 70.44 110.59 177.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 13' ' ' VAL . 62.7 mt -57.26 -46.7 85.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 120.827 0.346 . . . . 64.42 111.039 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 72.1 mt -59.61 -42.96 89.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.912 0.386 . . . . 73.41 111.126 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.2 t -62.73 -39.1 93.01 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.894 0.378 . . . . 72.32 111.365 177.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 8' ' ' LYS . 94.1 mt -61.68 -51.03 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.806 0.336 . . . . 73.54 110.599 176.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.572 HG13 HG21 ' A' ' 25' ' ' VAL . 59.0 t -60.9 -45.13 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 116.392 -0.367 . . . . 74.53 111.479 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.477 ' HA ' HD21 ' A' ' 69' ' ' LEU . 57.7 tp60 -60.26 -46.21 90.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.867 0.365 . . . . 70.12 110.997 177.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -61.55 -39.18 90.16 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.956 0.408 . . . . 73.5 110.859 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 12' ' ' ILE . 16.6 mmm-85 -65.27 -41.31 94.32 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.802 0.334 . . . . 72.14 111.216 175.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -64.73 -31.12 72.2 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.511 0.672 . . . . 74.13 110.591 173.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -75.8 -20.32 58.3 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.336 -0.847 . . . . 73.31 110.681 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 94.5 mmm -102.79 -69.64 0.78 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.018 -0.537 . . . . 70.44 111.383 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.507 ' HB3' ' HB3' ' A' ' 23' ' ' ALA . 49.3 m-20 -66.66 -66.5 0.55 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.051 0.389 . . . . 62.45 112.051 -178.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.1 t70 69.3 -60.87 0.45 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.423 0.689 . . . . 71.45 111.544 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.66 -28.13 72.53 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.276 -0.487 . . . . 74.5 112.73 176.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 20' ' ' ASP . . . -103.25 134.01 20.01 Favored Pre-proline 0 CA--C 1.538 0.507 0 O-C-N 122.579 -0.366 . . . . 74.33 110.92 177.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.515 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 8.0 Cg_exo -71.88 167.0 27.84 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.533 2.155 . . . . 54.53 113.145 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.572 HG21 HG13 ' A' ' 13' ' ' VAL . 29.1 t -85.44 142.07 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 115.999 -0.546 . . . . 73.21 110.763 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.538 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -102.12 146.56 27.77 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.717 0.294 . . . . 70.3 110.628 -179.199 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.4 m -59.54 -29.72 68.11 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.26 0.552 . . . . 73.25 110.932 176.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -58.53 -61.62 2.46 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.617 -0.72 . . . . 74.21 111.761 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.502 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 3.2 m-20 -51.64 -42.95 62.44 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.185 -0.462 . . . . 75.54 111.792 -178.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.6 mt -64.54 -42.36 94.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 116.33 -0.396 . . . . 74.01 111.25 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.1 -47.85 81.08 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.976 0.417 . . . . 71.44 111.797 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -67.76 -42.29 82.0 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.156 0.428 . . . . 73.45 112.156 178.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.59 -49.51 53.4 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.33 0.492 . . . . 72.11 112.33 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.6 -28.18 51.47 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.243 0.46 . . . . 72.23 112.243 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.76 54.38 3.47 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.203 -0.522 . . . . 44.12 112.763 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.4 mt -132.83 159.0 41.08 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.02 0.438 . . . . 73.21 111.384 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.1 m -73.46 145.72 45.52 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.306 -0.246 . . . . 75.01 110.805 174.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.2 mm -50.23 -41.47 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 112.403 0.52 . . . . 72.52 112.403 -176.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.417 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 56.6 t80 -59.83 -55.39 34.8 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.9 0.381 . . . . 70.34 111.001 175.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -52.0 -45.72 64.63 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.024 -0.534 . . . . 64.13 111.392 177.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.56 -49.37 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.161 -0.472 . . . . 72.31 111.182 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 mtm105 -58.34 -36.89 74.12 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.662 -0.245 . . . . 75.04 111.587 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.517 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 88.7 mt -56.56 -52.39 64.97 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.183 0.516 . . . . 70.44 110.306 177.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -64.96 -43.59 92.15 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.197 -0.456 . . . . 74.21 112.052 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.7 mt -65.86 -50.0 66.13 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.9 0.381 . . . . 54.4 111.853 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -62.74 -34.12 76.54 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.532 -0.304 . . . . 63.01 111.631 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 11.7 mm-40 -68.12 -47.96 66.73 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.119 -0.363 . . . . 55.44 110.977 174.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.5 mt -58.17 -32.8 68.55 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.043 0.449 . . . . 71.21 110.977 175.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.432 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 5.2 t60 -68.19 -44.96 74.68 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.9 0.381 . . . . 71.4 111.143 173.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.5 -42.35 95.89 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.127 -0.488 . . . . 62.55 111.753 -177.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.516 HG23 HG23 ' A' ' 53' ' ' VAL . 25.3 m -74.44 -9.79 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 112.151 0.426 . . . . 74.43 112.151 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.49 10.91 37.19 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 115.033 0.773 . . . . 62.43 115.033 173.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.516 HG23 HG23 ' A' ' 51' ' ' VAL . 92.5 t -82.26 -52.87 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 117.626 0.713 . . . . 64.44 111.439 177.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 91.9 mt -106.09 160.99 14.88 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.323 0.583 . . . . 54.12 112.035 -177.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -129.39 139.3 51.73 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.847 -0.615 . . . . 71.54 110.088 174.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -88.91 103.25 15.84 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.062 0.458 . . . . 61.34 111.488 -176.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.553 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 44.8 t -79.15 93.13 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.086 0.47 . . . . 72.25 110.56 175.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.432 ' ND2' HG23 ' A' ' 63' ' ' VAL . 28.1 t-20 -143.2 122.83 13.28 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.935 0.398 . . . . 73.43 111.364 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.23 -21.99 62.05 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.625 0.602 . . . . 74.43 112.625 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 145.64 -164.88 28.06 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.088 -0.577 . . . . 34.21 113.489 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -59.07 116.82 4.09 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 122.769 0.428 . . . . 71.25 111.692 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 126.86 -59.74 0.67 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.401 -0.428 . . . . 72.2 112.872 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.432 HG23 ' ND2' ' A' ' 58' ' ' ASN . 31.7 m -70.11 153.8 95.05 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 112.058 0.392 . . . . 74.21 112.058 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.76 155.75 68.72 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.484 2.122 . . . . 63.3 113.399 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.91 104.44 2.56 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.089 -0.577 . . . . 52.34 112.644 176.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.553 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 85.4 mt -94.48 156.16 16.59 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.806 0.303 . . . . 65.51 111.17 178.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -128.24 147.23 50.58 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.05 0.452 . . . . 75.13 112.142 -176.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -150.89 134.62 16.5 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.497 -0.32 . . . . 73.33 111.161 174.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.52 ' O ' HD12 ' A' ' 69' ' ' LEU . 2.4 pp -78.69 141.86 37.59 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.184 0.516 . . . . 65.31 111.745 177.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.497 ' H ' HD23 ' A' ' 70' ' ' LEU . 1.9 pt? -124.86 -26.65 3.72 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.284 -0.416 . . . . 71.45 111.674 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 . . . . . 0 C--O 1.252 1.219 0 CA-C-O 118.815 -0.612 . . . . 61.44 111.294 179.549 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.8 mtp . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 120.743 0.306 . . . . 44.11 111.558 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.9 t 57.59 72.7 0.5 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.991 0.737 . . . . 73.53 112.991 175.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -104.98 100.5 10.1 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.089 0.471 . . . . 64.03 110.328 174.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.3 m -91.78 102.51 15.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.039 -0.528 . . . . 50.25 111.221 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.1 mm -61.65 -49.91 82.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.947 0.403 . . . . 72.45 111.557 -177.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.1 t -62.86 -52.78 55.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.844 0.354 . . . . 71.22 111.359 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.4 m -59.19 -35.37 73.47 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.499 -0.319 . . . . 52.24 111.405 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -57.36 -50.71 72.1 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 110.134 -0.321 . . . . 70.34 110.134 176.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.48 HG23 HG21 ' A' ' 30' ' ' ILE . 67.2 mt -57.95 -51.79 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 116.212 -0.449 . . . . 72.12 111.546 175.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 79.3 mt -55.55 -47.26 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 112.319 0.489 . . . . 73.01 112.319 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.1 p -60.46 -42.46 96.24 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.882 0.372 . . . . 72.55 111.277 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.434 HG21 ' HA ' ' A' ' 30' ' ' ILE . 93.8 mt -63.08 -46.97 94.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 116.208 -0.451 . . . . 53.55 111.304 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.614 HG13 HG21 ' A' ' 25' ' ' VAL . 80.9 t -54.03 -55.27 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.987 0.422 . . . . 61.1 111.189 176.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -57.93 -40.01 79.42 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.239 -0.437 . . . . 71.04 111.664 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -66.18 -42.97 88.15 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.915 0.388 . . . . 64.15 110.936 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.496 ' HB2' HG22 ' A' ' 25' ' ' VAL . 5.0 mmp_? -57.58 -39.95 77.91 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.866 0.365 . . . . 74.4 110.564 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.679 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 14.6 mm100 -61.97 -40.63 96.25 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.066 0.46 . . . . 71.33 110.935 174.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -60.88 -28.79 69.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.247 -0.433 . . . . 73.24 111.766 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 28.1 mmt -60.54 -53.38 58.26 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.665 0.617 . . . . 74.02 112.665 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.695 ' HB3' ' HB2' ' A' ' 23' ' ' ALA . 13.4 t70 -117.9 142.35 47.43 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.77 0.319 . . . . 72.43 111.156 -176.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -63.01 94.08 0.07 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.307 0.575 . . . . 63.14 111.027 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.55 43.45 7.34 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 115.886 -0.597 . . . . 72.34 112.04 -174.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.695 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . . . -67.53 147.15 98.79 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 113.208 0.818 . . . . 62.55 113.208 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.441 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 90.4 Cg_endo -100.71 131.04 0.15 Allowed 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 123.21 2.607 . . . . 71.53 111.463 159.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.614 HG21 HG13 ' A' ' 13' ' ' VAL . 48.8 t -79.31 138.38 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.165 0.507 . . . . 72.45 112.012 -176.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.422 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -89.8 134.11 34.36 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.227 -0.442 . . . . 71.43 110.437 177.1 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 56.2 m -55.75 -27.99 53.59 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.09 0.471 . . . . 71.23 111.615 177.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -65.22 -54.59 27.16 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.216 -0.447 . . . . 70.41 112.098 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.25 -50.42 38.84 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 122.856 0.463 . . . . 72.41 112.119 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.48 HG21 HG23 ' A' ' 9' ' ' ILE . 53.1 mt -58.17 -57.78 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.151 -0.477 . . . . 71.42 111.787 -177.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.11 -45.49 87.16 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.947 0.403 . . . . 61.22 111.524 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -61.6 -42.4 98.82 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.806 -0.634 . . . . 75.31 111.896 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.03 -41.41 28.93 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.519 0.563 . . . . 73.24 112.519 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.33 -19.87 60.31 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.513 0.56 . . . . 75.54 112.513 -176.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.32 17.0 56.46 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.042 -0.599 . . . . 73.32 112.817 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.4 mt -106.44 170.93 7.63 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.993 0.425 . . . . 74.2 111.306 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.5 t -94.68 161.98 13.97 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.323 -0.399 . . . . 63.12 111.157 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -57.15 -48.9 81.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 112.566 0.58 . . . . 63.12 112.566 -174.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.518 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 29.4 p90 -60.13 -44.07 95.18 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.998 0.427 . . . . 71.42 111.042 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -57.62 -52.3 65.97 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.62 0.724 . . . . 74.33 110.832 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.459 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 92.0 t -59.55 -46.27 93.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.542 -0.754 . . . . 64.54 111.414 178.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.5 mtm105 -58.5 -28.95 65.88 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.116 0.413 . . . . 72.52 112.116 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 87.6 mt -65.82 -52.34 51.39 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.983 0.42 . . . . 72.11 110.836 174.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -63.29 -41.02 98.94 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.438 -0.346 . . . . 74.43 111.569 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 88.2 mt -62.68 -37.93 88.39 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.0 0.428 . . . . 64.45 111.091 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -60.87 -42.66 98.32 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.304 -0.407 . . . . 74.02 110.741 176.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -62.49 -51.68 66.49 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.255 -0.43 . . . . 71.33 110.928 176.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.2 mt -57.92 -31.77 67.12 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.148 0.499 . . . . 74.41 111.407 176.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -70.88 -34.38 71.54 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.068 0.461 . . . . 64.24 110.836 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -73.46 -41.08 63.62 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.085 -0.507 . . . . 73.31 111.456 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.549 HG23 HG23 ' A' ' 53' ' ' VAL . 36.0 m -84.13 7.76 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 N-CA-C 112.886 0.699 . . . . 74.24 112.886 -177.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.51 44.7 10.51 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 120.942 -0.647 . . . . 71.24 114.46 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.549 HG23 HG23 ' A' ' 51' ' ' VAL . 91.2 t -114.31 -42.89 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.002 0.43 . . . . 54.22 111.331 175.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.4 mt -116.85 151.92 35.53 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.841 0.682 . . . . 52.42 112.841 -176.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.502 ' HB2' HD22 ' A' ' 70' ' ' LEU . 1.4 tm-20 -122.98 128.16 49.83 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.112 -0.949 . . . . 73.22 108.683 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.617 ' HB3' ' HZ3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -87.49 93.67 9.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.147 0.498 . . . . 62.25 111.311 -172.641 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 82.1 t -75.08 121.0 25.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 115.91 -0.587 . . . . 73.24 111.963 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -141.98 125.2 16.42 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.939 0.399 . . . . 45.44 110.869 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.465 ' N ' HG21 ' A' ' 63' ' ' VAL . . . -76.37 66.17 2.38 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.318 0.488 . . . . 74.43 112.318 -178.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.59 -147.58 19.51 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 114.146 0.418 . . . . 71.32 114.146 177.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -89.06 136.94 32.74 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.742 0.645 . . . . 74.1 112.742 -177.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.23 44.36 93.9 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 115.954 -0.567 . . . . 44.04 114.267 174.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.465 HG21 ' N ' ' A' ' 59' ' ' ALA . 26.4 m -127.29 154.22 77.04 Favored Pre-proline 0 CA--C 1.542 0.655 0 O-C-N 122.575 -0.368 . . . . 74.24 111.731 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.61 130.43 33.48 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.938 2.426 . . . . 64.05 113.497 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.04 107.72 2.57 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 116.186 -0.461 . . . . 63.23 113.295 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 82.6 mt -99.34 157.78 16.17 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.927 0.394 . . . . 72.55 110.977 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -123.14 121.81 36.9 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.999 0.428 . . . . 74.44 111.687 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -118.67 127.45 53.58 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.345 -0.389 . . . . 70.12 110.755 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 69' ' ' LEU . 3.3 pp -79.16 150.35 31.74 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.077 0.465 . . . . 71.15 111.534 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 55' ' ' GLU . 2.1 pt? -143.34 131.61 22.04 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.175 -0.466 . . . . 51.42 110.887 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.276 0 CA-C-O 118.192 -0.908 . . . . 63.44 112.058 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.603 ' SD ' HG23 ' A' ' 6' ' ' VAL . 24.5 ptt? . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.875 0.369 . . . . 72.44 111.703 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.0 m -104.49 -40.07 6.19 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.237 -0.438 . . . . 74.31 110.039 169.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -99.81 165.09 11.74 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.254 -0.43 . . . . 61.22 110.84 173.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.3 m -73.07 90.45 1.53 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.051 0.453 . . . . 55.31 111.541 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.8 tt -102.28 -22.67 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 121.123 0.487 . . . . 71.11 111.449 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.603 HG23 ' SD ' ' A' ' 1' ' ' MET . 49.8 t -56.69 -29.92 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 112.599 0.592 . . . . 72.22 112.599 -176.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.2 m -51.91 -41.07 61.69 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.893 0.378 . . . . 75.12 111.527 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.481 ' O ' HG13 ' A' ' 12' ' ' ILE . 4.4 ttmp? -54.41 -52.09 62.82 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.07 0.462 . . . . 73.11 110.722 174.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.535 HG23 HG21 ' A' ' 30' ' ' ILE . 67.4 mt -59.1 -45.27 92.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.8 -0.637 . . . . 54.55 111.572 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.6 mt -58.41 -43.35 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.082 0.468 . . . . 52.25 111.053 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.2 t -64.0 -40.15 95.72 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.198 -0.455 . . . . 70.31 111.205 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 8' ' ' LYS . 84.9 mt -63.18 -44.53 99.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 120.705 0.288 . . . . 75.22 111.375 177.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.536 HG13 HG21 ' A' ' 25' ' ' VAL . 91.7 t -54.1 -53.62 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 121.409 0.623 . . . . 74.24 110.663 174.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -56.52 -44.65 80.97 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.439 -0.8 . . . . 54.53 111.442 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 19' ' ' MET . 6.7 tp10 -58.34 -52.23 66.49 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.011 0.434 . . . . 70.35 111.258 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.48 ' HD2' ' HB3' ' A' ' 29' ' ' ASP . 1.9 mmp_? -49.93 -36.96 29.74 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.99 -0.55 . . . . 72.1 111.326 177.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.745 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 78.3 mt-30 -74.85 -42.53 57.79 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.227 -0.442 . . . . 70.43 112.019 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -56.86 -28.74 62.15 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.081 0.467 . . . . 71.34 111.424 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.41 ' HG2' ' O ' ' A' ' 15' ' ' GLU . 26.4 mmt -72.58 -39.25 67.54 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.455 0.539 . . . . 65.13 112.455 -178.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.677 ' HB2' ' HB2' ' A' ' 23' ' ' ALA . 4.1 m-20 -127.58 20.11 6.69 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.304 0.483 . . . . 73.43 112.304 -175.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.8 t70 59.22 -88.19 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.028 0.531 . . . . 72.12 112.429 176.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -85.94 56.38 4.83 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.682 -0.567 . . . . 54.24 111.682 177.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.745 ' HB3' ' HA ' ' A' ' 17' ' ' GLN . . . -96.0 118.17 65.9 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 113.327 0.862 . . . . 74.31 113.327 -171.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.459 ' HB3' HG11 ' A' ' 57' ' ' VAL . 91.3 Cg_endo -78.08 118.97 4.51 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.217 1.944 . . . . 71.53 110.72 168.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.536 HG21 HG13 ' A' ' 13' ' ' VAL . 61.7 t -78.34 132.53 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 121.075 0.464 . . . . 73.32 112.084 -171.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.491 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -89.6 132.67 34.99 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.856 -0.611 . . . . 65.33 110.297 -179.408 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.435 HG23 HD12 ' A' ' 45' ' ' LEU . 56.4 m -49.48 -38.53 30.32 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.566 0.58 . . . . 73.21 112.566 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -72.38 -29.1 63.45 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.612 0.597 . . . . 60.43 112.612 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.48 ' HB3' ' HD2' ' A' ' 16' ' ' ARG . 76.4 m-20 -54.04 -49.29 69.29 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.424 0.631 . . . . 73.33 111.06 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.535 HG21 HG23 ' A' ' 9' ' ' ILE . 59.0 mt -64.64 -37.08 79.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.653 -0.703 . . . . 74.42 111.388 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.27 -47.87 80.53 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.446 -0.343 . . . . 61.41 111.439 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -65.15 -48.74 72.46 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.8 0.333 . . . . 70.23 111.459 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.56 -52.6 63.79 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.452 0.538 . . . . 44.22 112.452 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.6 -19.9 44.45 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.418 0.525 . . . . 74.33 112.418 -177.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.79 47.22 20.86 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.828 -0.701 . . . . 53.11 112.594 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt -118.14 179.0 4.23 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.96 0.409 . . . . 74.33 111.404 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.8 t -86.57 143.72 27.55 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 111.734 0.272 . . . . 74.01 111.734 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.1 mm -55.18 -52.21 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 112.052 0.389 . . . . 74.54 112.052 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.407 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 60.6 t80 -60.41 -42.93 97.02 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.032 0.444 . . . . 74.52 110.99 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -57.32 -56.13 25.79 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.75 -0.659 . . . . 70.32 111.461 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 82.7 t -56.84 -41.42 75.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.193 -0.458 . . . . 72.33 111.204 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -54.87 -46.02 74.69 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.351 -0.386 . . . . 72.31 111.437 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 84.4 mt -61.84 -45.1 95.28 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.255 -0.429 . . . . 62.24 112.061 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.409 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 63.5 m-85 -68.68 -37.92 79.96 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.796 0.295 . . . . 64.42 111.796 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.52 HD13 ' NE1' ' A' ' 67' ' ' TRP . 93.7 mt -66.32 -37.33 85.14 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.072 0.463 . . . . 74.51 111.001 174.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.47 -55.99 27.61 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.974 -0.557 . . . . 73.11 111.094 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 13.8 pt20 -60.65 -37.88 82.98 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.526 -0.306 . . . . 75.22 111.576 -177.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.472 HD21 HG11 ' A' ' 6' ' ' VAL . 83.7 mt -61.01 -44.84 96.83 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.982 0.42 . . . . 73.44 111.11 176.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -68.01 -30.88 70.23 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.952 0.406 . . . . 74.24 111.177 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -78.58 -31.94 47.47 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.219 0.452 . . . . 75.24 112.219 -177.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.506 HG23 HG23 ' A' ' 53' ' ' VAL . 33.5 m -83.35 -25.6 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 121.966 -0.459 . . . . 62.53 111.468 176.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 118.54 8.81 9.76 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 120.973 -0.632 . . . . 61.53 114.334 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.506 HG23 HG23 ' A' ' 51' ' ' VAL . 91.5 t -77.88 -42.14 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 117.483 0.642 . . . . 74.12 111.572 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.7 mt -110.89 133.87 53.02 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.147 0.499 . . . . 71.3 112.038 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.506 ' HG2' ' NH2' ' A' ' 68' ' ' ARG . 8.1 tp10 -91.8 154.77 18.7 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.923 -0.581 . . . . 73.3 111.05 176.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -80.22 136.35 36.45 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.202 0.525 . . . . 64.11 112.015 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.459 HG11 ' HB3' ' A' ' 24' ' ' PRO . 44.3 t -131.96 92.72 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.054 0.454 . . . . 72.22 110.232 170.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.556 ' HB3' ' HA2' ' A' ' 65' ' ' GLY . 27.3 p-10 -158.41 149.38 20.62 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.023 0.439 . . . . 62.31 112.151 -177.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.92 10.76 10.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.928 0.394 . . . . 61.24 111.961 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.99 -62.01 4.6 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.39 -0.433 . . . . 34.21 113.784 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -71.52 125.76 27.9 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.255 0.465 . . . . 71.24 112.255 -176.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.87 -67.05 1.72 Allowed Glycine 0 CA--C 1.529 0.919 0 N-CA-C 114.587 0.595 . . . . 60.14 114.587 173.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.4 m -52.22 130.83 42.04 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 112.987 0.736 . . . . 71.32 112.987 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.6 -40.64 17.22 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.603 2.202 . . . . 73.21 112.624 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.556 ' HA2' ' HB3' ' A' ' 58' ' ' ASN . . . 141.13 133.16 2.89 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.026 -0.607 . . . . 71.55 113.313 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 86.3 mt -101.63 150.9 22.63 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 109.79 -0.448 . . . . 65.44 109.79 173.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.52 ' NE1' HD13 ' A' ' 45' ' ' LEU . 42.6 m95 -107.17 127.82 53.85 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.863 0.69 . . . . 74.52 112.863 -169.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.506 ' NH2' ' HG2' ' A' ' 55' ' ' GLU . 47.6 ttp180 -120.44 165.01 15.52 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.264 -0.643 . . . . 75.41 109.264 175.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.7 pp -123.41 151.64 42.4 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.331 -0.856 . . . . 53.13 111.988 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.441 ' N ' HD23 ' A' ' 70' ' ' LEU . 1.0 OUTLIER -123.18 23.33 9.2 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.923 -0.581 . . . . 72.53 111.357 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 . . . . . 0 C--O 1.253 1.24 0 CA-C-O 119.097 -0.477 . . . . 61.41 110.938 179.687 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 120.736 0.303 . . . . 74.44 111.482 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.6 t -153.6 91.86 1.52 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.877 0.37 . . . . 51.04 111.189 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -176.25 -171.89 0.45 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.198 -0.455 . . . . 74.14 111.099 -177.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.1 p 53.2 37.67 25.66 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.393 0.677 . . . . 72.12 112.401 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.498 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.7 mp -53.86 -47.87 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 112.242 0.46 . . . . 72.43 112.242 -175.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.2 t -61.93 -54.83 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.121 0.486 . . . . 73.54 111.377 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 m -59.62 -31.42 69.49 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.019 -0.537 . . . . 72.41 111.46 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.514 ' O ' HG13 ' A' ' 12' ' ' ILE . 60.5 tptt -57.49 -57.0 14.59 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.2 -0.455 . . . . 73.22 110.679 176.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.486 ' HA ' HD12 ' A' ' 12' ' ' ILE . 67.1 mt -58.2 -43.56 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 116.141 -0.481 . . . . 75.24 111.63 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.0 mt -60.63 -42.74 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.12 0.486 . . . . 73.01 111.101 176.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.0 t -65.4 -33.34 75.73 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.215 -0.448 . . . . 61.51 111.271 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 8' ' ' LYS . 96.9 mt -63.44 -48.41 87.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.365 -0.38 . . . . 72.24 110.934 175.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.8 t -58.15 -47.35 87.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 120.735 0.302 . . . . 71.54 111.229 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -59.47 -45.43 91.67 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.15 0.5 . . . . 74.41 111.041 177.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -53.64 -46.9 70.69 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.963 -0.562 . . . . 73.14 111.52 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 12' ' ' ILE . 7.6 mmm180 -67.87 -37.43 81.79 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.216 -0.447 . . . . 64.52 111.473 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -62.9 -32.87 74.23 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.081 0.4 . . . . 73.25 112.081 176.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -92.21 -29.23 16.56 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.975 0.731 . . . . 75.22 112.975 -175.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.488 ' SD ' ' HD2' ' A' ' 16' ' ' ARG . 27.2 ptm -70.35 -26.67 63.85 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.119 -0.363 . . . . 74.34 111.598 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -127.13 179.25 5.52 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 116.475 -0.329 . . . . 63.23 110.337 -177.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -104.21 -12.58 16.59 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 122.156 -0.34 . . . . 73.33 111.91 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.3 44.09 0.23 Allowed Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.878 -0.677 . . . . 44.41 113.409 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.78 107.22 38.78 Favored Pre-proline 0 CA--C 1.537 0.444 0 O-C-N 122.562 -0.375 . . . . 62.54 111.62 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.55 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 46.6 Cg_endo -68.52 138.85 43.2 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.22 1.947 . . . . 44.41 111.696 176.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.421 HG22 ' HB2' ' A' ' 16' ' ' ARG . 7.9 t -79.96 120.61 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 120.899 0.38 . . . . 74.11 111.13 -175.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.501 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -80.63 132.49 35.61 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.607 -0.269 . . . . 70.31 110.996 -176.821 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.3 m -51.97 -44.46 64.02 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.903 0.383 . . . . 71.23 111.665 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.503 ' NH1' HG13 ' A' ' 38' ' ' ILE . 36.1 mmt180 -61.21 -45.92 92.6 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.207 0.527 . . . . 75.4 110.682 176.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -58.52 -40.77 83.84 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.792 -0.64 . . . . 62.53 111.455 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 26' ' ' LYS . 66.0 mt -61.92 -39.69 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.793 0.33 . . . . 73.02 111.157 176.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.521 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -57.93 -48.74 79.02 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.268 -0.424 . . . . 72.42 111.892 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.13 -43.55 94.92 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 111.995 0.368 . . . . 72.01 111.995 176.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.12 -41.72 94.6 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.332 0.493 . . . . 75.31 112.332 -178.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.63 -23.91 27.33 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.218 0.451 . . . . 64.33 112.218 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.17 40.46 24.4 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.227 -0.511 . . . . 72.44 113.231 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.9 mt -128.63 161.06 30.53 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.613 -0.345 . . . . 72.25 111.37 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 41' ' ' VAL . 66.9 m -68.1 150.97 47.72 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.515 -0.311 . . . . 71.41 111.096 176.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.503 HG13 ' NH1' ' A' ' 28' ' ' ARG . 49.7 mm -52.21 -48.83 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 112.31 0.485 . . . . 62.32 112.31 -176.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.497 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 78.2 t80 -59.2 -49.05 79.35 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.529 -0.305 . . . . 75.31 111.242 178.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -54.98 -50.81 68.04 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.244 0.545 . . . . 72.3 110.899 176.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.521 HG21 ' HA ' ' A' ' 31' ' ' ALA . 88.8 t -56.18 -49.64 75.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.078 -0.51 . . . . 51.12 111.345 178.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.573 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 31.6 mtp180 -60.98 -34.3 74.56 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 111.752 0.278 . . . . 63.21 111.752 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 79.2 mt -55.78 -47.42 77.08 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.15 0.5 . . . . 74.24 110.407 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.409 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 87.0 m-85 -65.51 -43.43 90.12 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.058 -0.519 . . . . 73.33 111.522 175.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.486 HD13 ' NE1' ' A' ' 67' ' ' TRP . 89.5 mt -64.15 -50.15 69.33 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 111.85 0.315 . . . . 72.24 111.85 -177.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 42' ' ' ARG . 62.1 mm-40 -56.83 -45.82 82.1 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.32 -0.4 . . . . 54.01 111.061 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 88.3 mt-30 -62.92 -49.81 73.33 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.536 0.208 . . . . 60.41 110.973 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.427 ' HA ' HG22 ' A' ' 51' ' ' VAL . 94.5 mt -57.85 -28.95 64.58 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.019 0.437 . . . . 70.12 111.127 176.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.465 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 31.4 t-80 -67.07 -56.69 8.97 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.06 0.457 . . . . 73.25 111.077 174.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.13 -23.79 64.02 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.252 0.834 . . . . 74.22 113.252 -175.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.525 HG23 HG23 ' A' ' 53' ' ' VAL . 25.1 m -84.78 -4.58 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 121.887 -0.508 . . . . 73.24 111.947 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.3 17.9 38.17 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 114.617 0.607 . . . . 65.35 114.617 173.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.525 HG23 HG23 ' A' ' 51' ' ' VAL . 97.3 t -90.91 -50.01 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 117.294 0.547 . . . . 52.3 111.327 177.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.7 mt -106.69 131.03 54.29 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.178 0.513 . . . . 71.43 111.893 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -101.34 143.65 31.12 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.907 -0.588 . . . . 74.51 111.003 177.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.447 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -66.11 141.47 58.1 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.802 0.667 . . . . 70.13 112.802 -175.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 51.0 t -134.41 102.15 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 116.285 -0.416 . . . . 73.51 110.959 171.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.1 t30 49.37 87.09 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.901 0.48 . . . . 61.23 112.108 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.566 ' HB2' ' HA2' ' A' ' 65' ' ' GLY . . . -156.71 175.77 13.61 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.989 0.737 . . . . 62.12 112.989 -175.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 143.05 -106.95 0.45 Allowed Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.508 -0.769 . . . . 74.33 111.93 -177.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.9 mtmm -128.34 136.53 51.07 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.969 0.414 . . . . 75.22 111.003 174.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.1 8.48 87.4 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.159 -0.543 . . . . 52.05 112.301 -175.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.71 122.15 11.07 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 122.973 0.509 . . . . 74.21 111.391 -176.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.77 111.88 1.65 Allowed 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.732 2.288 . . . . 73.51 112.397 175.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.566 ' HA2' ' HB2' ' A' ' 59' ' ' ALA . . . -56.38 123.66 32.23 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.32 -0.467 . . . . 73.2 114.175 -177.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 66.8 mt -102.08 143.86 31.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.969 -0.382 . . . . 65.42 109.969 174.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.486 ' NE1' HD13 ' A' ' 45' ' ' LEU . 75.7 m95 -121.16 147.86 45.02 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.328 0.585 . . . . 72.13 112.389 -174.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -148.78 133.68 18.04 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.934 -0.576 . . . . 71.14 110.397 173.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 pp -72.74 163.31 28.3 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.733 -0.604 . . . . 74.12 110.856 174.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.8 mt -68.18 86.14 0.26 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.191 0.441 . . . . 73.33 112.191 -175.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 C--O 1.254 1.296 0 CA-C-O 118.416 -0.802 . . . . 52.11 112.891 179.411 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 mmt . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.89 0.376 . . . . 74.33 110.624 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.1 m -91.63 148.99 21.87 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.74 0.305 . . . . 52.11 111.259 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -61.72 -21.8 64.82 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.189 0.519 . . . . 73.32 110.903 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.4 m -56.79 -27.87 60.47 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.717 -0.674 . . . . 51.2 112.564 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 70.2 mt -52.34 -56.2 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 120.875 0.369 . . . . 72.05 111.925 -178.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.6 t -71.73 -46.04 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.093 0.473 . . . . 73.13 111.22 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.9 m -55.24 -39.52 69.83 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.8 -0.636 . . . . 54.23 112.227 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.517 ' O ' HG13 ' A' ' 12' ' ' ILE . 55.6 tptt -61.96 -50.86 70.42 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.739 0.304 . . . . 72.1 110.732 177.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 72.7 mt -55.79 -46.36 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.886 0.374 . . . . 73.43 111.486 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.2 mt -58.88 -45.22 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 121.192 0.52 . . . . 73.32 110.93 176.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.2 t -62.39 -35.17 78.36 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.003 -0.544 . . . . 71.42 111.821 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.565 HG21 ' HA ' ' A' ' 30' ' ' ILE . 96.8 mt -64.73 -49.7 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.871 0.367 . . . . 74.35 111.2 177.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 64.2 t -54.2 -49.17 64.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.062 0.458 . . . . 64.15 110.969 177.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -62.46 -44.09 97.25 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.012 -0.54 . . . . 70.11 111.487 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.416 ' HA ' ' ND2' ' A' ' 18' ' ' ASN . 10.1 tp10 -61.62 -37.46 84.06 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.153 0.501 . . . . 74.3 111.04 -178.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.481 ' HG3' HG13 ' A' ' 25' ' ' VAL . 8.3 mmm180 -64.29 -40.06 95.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 73.53 110.79 174.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' A' ' 21' ' ' ASP . 74.1 mt-30 -72.69 -4.57 32.0 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.871 0.367 . . . . 72.24 111.58 175.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.416 ' ND2' ' HA ' ' A' ' 15' ' ' GLU . 81.2 m-20 -87.38 -42.56 12.76 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.029 0.442 . . . . 62.51 109.85 167.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 89.8 mmm -76.84 -66.91 0.76 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.938 -0.574 . . . . 74.23 111.319 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -71.5 -14.3 62.07 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.998 0.428 . . . . 75.02 111.087 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 17' ' ' GLN . 17.0 t70 74.54 -68.27 0.22 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.992 0.917 . . . . 72.12 112.673 177.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -136.1 36.81 1.97 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.553 -0.832 . . . . 65.54 113.885 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -102.85 152.72 38.52 Favored Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 122.51 -0.406 . . . . 71.52 111.499 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.554 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 49.9 Cg_endo -68.21 129.19 18.81 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.29 1.993 . . . . 75.43 111.999 174.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.481 HG13 ' HG3' ' A' ' 16' ' ' ARG . 38.5 t -79.44 135.83 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.155 0.502 . . . . 60.31 111.68 -174.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.542 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -88.28 135.72 33.32 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.139 -0.482 . . . . 72.05 111.29 -177.938 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.2 m -55.07 -31.27 61.03 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.907 0.384 . . . . 52.32 111.963 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -60.54 -54.15 48.89 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 111.798 0.295 . . . . 75.2 111.798 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.42 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 2.3 m-20 -57.82 -37.48 73.88 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.885 0.374 . . . . 73.12 111.619 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.565 ' HA ' HG21 ' A' ' 12' ' ' ILE . 59.0 mt -66.91 -49.23 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.428 -0.351 . . . . 73.31 111.293 178.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.06 -34.85 73.98 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.992 0.425 . . . . 61.21 111.455 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -66.08 -51.92 53.6 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.042 -0.526 . . . . 73.53 111.35 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.02 -35.84 72.17 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.506 0.558 . . . . 74.04 112.506 -177.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.18 -33.69 38.1 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.391 0.515 . . . . 54.43 112.391 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.37 -0.11 83.01 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.001 -0.618 . . . . 73.1 112.989 -177.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 71.6 mt -85.1 160.0 20.06 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 122.602 -0.352 . . . . 75.45 110.897 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 41' ' ' VAL . 47.6 t -79.74 157.44 27.13 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 120.788 0.328 . . . . 73.54 111.8 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.0 mm -51.95 -52.37 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 112.808 0.67 . . . . 72.35 112.808 -174.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.532 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 32.9 p90 -58.29 -44.43 88.49 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.985 0.421 . . . . 71.03 111.083 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -62.13 -47.09 86.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.241 0.543 . . . . 64.03 110.993 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 37' ' ' SER . 95.0 t -60.04 -51.47 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 115.972 -0.558 . . . . 73.01 111.877 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -62.94 -26.05 68.63 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 111.893 0.331 . . . . 71.21 111.893 -177.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 79.5 mt -65.99 -51.47 58.1 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.617 0.246 . . . . 63.04 111.011 175.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -65.56 -39.61 91.87 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.757 0.313 . . . . 72.32 111.695 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.504 HD13 ' CD1' ' A' ' 67' ' ' TRP . 96.5 mt -58.2 -41.69 84.53 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.344 0.592 . . . . 73.42 110.651 174.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -60.6 -43.97 96.79 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.629 -0.714 . . . . 75.32 111.054 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 74.9 mt-30 -60.38 -38.03 82.62 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.208 -0.451 . . . . 71.33 111.249 176.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 93.0 mt -63.83 -32.76 74.38 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.711 0.291 . . . . 64.1 111.309 175.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -70.56 -41.39 72.5 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 122.06 -0.4 . . . . 75.23 110.555 171.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -56.12 -42.68 77.23 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.785 -0.643 . . . . 73.13 111.848 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.559 HG23 HG23 ' A' ' 53' ' ' VAL . 35.0 m -82.13 -15.13 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 112.492 0.553 . . . . 63.13 112.492 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.92 8.06 32.43 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 114.658 0.623 . . . . 72.54 114.658 175.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.559 HG23 HG23 ' A' ' 51' ' ' VAL . 95.1 t -77.12 -52.61 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 117.409 0.605 . . . . 64.35 111.975 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.0 mt -106.41 149.94 26.52 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.72 0.637 . . . . 74.53 112.72 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 68' ' ' ARG . 12.6 pt-20 -111.1 146.08 37.44 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.992 -0.549 . . . . 74.54 110.068 172.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.429 ' HE3' ' HB2' ' A' ' 56' ' ' LYS . 46.1 mtmt -80.86 104.38 11.33 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.851 0.358 . . . . 52.05 111.475 -177.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.582 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 53.3 t -88.0 90.5 3.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-O 121.724 0.773 . . . . 70.42 110.948 176.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -138.93 89.4 2.36 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.974 -1.012 . . . . 41.4 109.681 174.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.42 -58.55 3.19 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.759 0.651 . . . . 73.5 112.759 -173.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -100.3 -168.58 29.12 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.1 -0.571 . . . . 63.12 113.89 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -98.12 135.32 39.95 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 122.52 -0.4 . . . . 61.11 111.343 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.16 27.35 33.89 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 121.152 -0.547 . . . . 63.53 112.808 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 32.6 m -106.56 153.21 40.73 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 120.78 0.324 . . . . 74.13 111.857 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -76.67 162.15 33.11 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.558 2.172 . . . . 74.31 112.85 176.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.72 103.46 1.54 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.0 -0.619 . . . . 72.4 113.22 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.582 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 72.8 mt -99.96 139.12 36.09 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.966 0.383 . . . . 61.32 110.091 175.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.504 ' CD1' HD13 ' A' ' 45' ' ' LEU . 74.5 m95 -121.52 139.11 53.92 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.133 0.492 . . . . 74.25 112.005 -175.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.536 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 46.3 ttt180 -136.42 128.11 28.94 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.342 -0.39 . . . . 75.51 110.548 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 69' ' ' LEU . 4.6 pp -79.35 138.99 37.89 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.519 -0.738 . . . . 63.51 111.269 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.478 ' H ' HD23 ' A' ' 70' ' ' LEU . 2.1 pt? -124.6 11.47 8.54 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.215 -0.448 . . . . 73.32 110.944 179.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 . . . . . 0 C--O 1.254 1.332 0 CA-C-O 118.546 -0.74 . . . . 62.41 110.945 -178.741 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.8 mtp . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.809 0.338 . . . . 52.44 111.333 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.9 m 56.56 18.95 3.87 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.208 0.818 . . . . 53.22 113.208 176.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 58.72 26.98 15.31 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-O 121.498 0.666 . . . . 54.12 111.31 178.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.7 p -50.22 -57.64 7.36 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.257 0.836 . . . . 64.41 113.257 -174.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.42 HG23 HD11 ' A' ' 36' ' ' LEU . 48.0 mm -49.58 -41.3 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 112.819 0.674 . . . . 74.15 112.819 -175.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.9 t -62.52 -57.77 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 120.949 0.404 . . . . 71.14 111.682 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.5 m -63.39 -34.44 77.74 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.981 0.42 . . . . 75.42 111.276 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.408 ' O ' HG13 ' A' ' 12' ' ' ILE . 57.0 tptt -56.19 -53.14 60.74 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.202 -0.453 . . . . 74.51 110.837 177.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.416 HG23 HG21 ' A' ' 30' ' ' ILE . 62.7 mt -59.1 -47.32 90.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.107 -0.497 . . . . 61.53 111.965 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 61.4 mt -60.42 -43.19 93.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 112.093 0.405 . . . . 54.21 112.093 -178.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 85.4 p -60.65 -36.87 79.73 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 120.781 0.324 . . . . 60.23 111.176 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.593 HG21 ' HA ' ' A' ' 30' ' ' ILE . 79.8 mt -64.29 -40.73 90.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.078 0.466 . . . . 71.14 111.504 176.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.58 -52.06 65.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 120.885 0.374 . . . . 53.31 110.914 177.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -59.35 -40.76 87.44 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.949 0.404 . . . . 74.31 110.864 176.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 12' ' ' ILE . 16.9 tp10 -47.75 -56.04 8.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.246 0.618 . . . . 65.41 111.841 177.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.504 ' HG3' HG13 ' A' ' 25' ' ' VAL . 1.2 mmp_? -63.09 -37.56 87.69 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.393 -0.367 . . . . 73.21 111.555 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -79.61 -13.99 59.12 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 111.955 0.354 . . . . 75.42 111.955 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -73.11 -35.95 66.66 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.028 0.442 . . . . 62.32 109.862 170.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.1 mmt -67.17 -58.79 4.21 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.814 -0.63 . . . . 63.15 110.885 172.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -124.61 104.12 8.52 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.435 -0.348 . . . . 71.24 110.836 176.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -61.38 -14.38 27.32 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.317 0.858 . . . . 64.21 113.317 -175.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -117.35 15.13 13.21 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 120.92 -0.657 . . . . 44.34 113.908 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.53 128.46 26.89 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 117.272 0.536 . . . . 42.41 112.082 -177.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.575 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 58.7 Cg_endo -71.42 135.45 26.61 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.364 2.043 . . . . 75.11 112.865 176.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.504 HG13 ' HG3' ' A' ' 16' ' ' ARG . 24.5 t -80.41 139.87 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 120.846 0.355 . . . . 62.44 111.449 -177.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.514 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 12.0 mptt -91.63 130.03 37.51 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.406 -0.361 . . . . 73.04 110.946 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.3 m -47.05 -34.5 5.84 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 120.919 0.39 . . . . 74.54 111.935 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -60.09 -49.26 78.33 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.386 -0.37 . . . . 72.14 111.795 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -56.22 -49.55 73.77 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.095 0.474 . . . . 74.54 110.788 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.593 ' HA ' HG21 ' A' ' 12' ' ' ILE . 64.3 mt -59.06 -48.36 86.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.907 -0.588 . . . . 64.52 111.555 178.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.483 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -57.73 -52.25 66.21 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.274 -0.421 . . . . 75.45 111.813 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -65.3 -41.97 93.54 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.285 -0.416 . . . . 74.44 111.711 -177.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.93 -39.69 87.41 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.214 0.45 . . . . 73.34 112.214 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.03 -20.79 40.95 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.001 0.371 . . . . 72.13 112.001 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.55 32.75 24.04 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.212 -0.518 . . . . 73.22 112.617 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.42 HD11 HG23 ' A' ' 5' ' ' ILE . 74.2 mt -122.21 161.71 22.72 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.873 0.368 . . . . 64.01 111.161 -177.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 41' ' ' VAL . 69.0 m -82.78 152.13 25.83 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.703 0.287 . . . . 73.45 111.528 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.8 mm -50.56 -46.04 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 112.28 0.474 . . . . 70.22 112.28 -176.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -57.87 -52.07 66.99 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.809 0.338 . . . . 64.42 111.8 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -58.54 -46.49 86.73 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.209 0.528 . . . . 72.21 111.277 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.483 HG21 ' HA ' ' A' ' 31' ' ' ALA . 57.9 t -61.54 -42.23 93.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.802 -0.636 . . . . 73.42 111.52 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -55.03 -39.64 69.36 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.784 0.326 . . . . 72.21 111.615 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.56 -52.48 60.88 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.274 -0.421 . . . . 74.51 111.042 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -59.57 -50.21 74.76 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 111.932 0.345 . . . . 70.24 111.932 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.424 HD13 ' CD1' ' A' ' 67' ' ' TRP . 92.2 mt -57.51 -43.99 84.69 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.863 0.363 . . . . 71.1 111.69 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -59.1 -50.38 74.26 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.017 0.437 . . . . 74.15 110.796 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -54.87 -44.55 74.13 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.038 -0.528 . . . . 71.22 110.807 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.471 ' HA ' HG22 ' A' ' 51' ' ' VAL . 89.1 mt -59.46 -29.68 67.98 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.3 -0.409 . . . . 70.41 111.782 178.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -72.53 -46.46 54.44 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.955 -0.466 . . . . 75.02 110.89 174.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -70.39 -16.89 63.01 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.835 0.68 . . . . 61.14 112.835 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.592 HG23 HG23 ' A' ' 53' ' ' VAL . 30.1 m -98.96 4.64 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 O-C-N 122.106 -0.372 . . . . 70.41 111.749 176.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.44 31.42 27.7 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 114.7 0.64 . . . . 65.14 114.7 174.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.592 HG23 HG23 ' A' ' 51' ' ' VAL . 95.3 t -105.81 -54.59 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 117.213 0.506 . . . . 71.33 111.749 176.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.1 mt -99.18 162.91 12.79 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.889 0.7 . . . . 51.02 112.889 -176.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 68' ' ' ARG . 17.0 tp10 -124.95 149.56 47.52 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.381 -0.827 . . . . 53.53 110.709 -175.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -78.96 129.28 34.31 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.048 0.758 . . . . 70.41 113.048 -172.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.9 t -140.09 115.83 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.757 0.313 . . . . 72.33 111.188 170.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 56.5 88.78 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.559 0.577 . . . . 54.44 112.559 175.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.501 ' HA ' HG21 ' A' ' 63' ' ' VAL . . . -136.53 152.77 50.87 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.063 -0.517 . . . . 62.05 111.646 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.28 -103.16 0.47 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.18 -0.533 . . . . 72.12 113.381 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.784 ' H ' ' HD2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -104.8 126.73 52.17 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.935 0.397 . . . . 72.41 111.742 -174.813 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.47 49.04 62.2 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.199 -0.455 . . . . 61.31 113.597 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.501 HG21 ' HA ' ' A' ' 59' ' ' ALA . 35.5 m -116.96 140.14 26.62 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 112.042 0.386 . . . . 72.54 112.042 -175.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -83.63 -3.45 10.64 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.947 2.431 . . . . 60.22 112.908 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.92 102.96 0.08 OUTLIER Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.181 -0.533 . . . . 54.24 113.024 -177.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 58.2 mt -107.64 133.11 52.55 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.883 0.373 . . . . 71.43 110.159 177.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.424 ' CD1' HD13 ' A' ' 45' ' ' LEU . 57.7 m95 -126.37 135.86 51.97 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.191 0.811 . . . . 70.34 113.191 -171.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.533 ' HB2' ' HB3' ' A' ' 55' ' ' GLU . 63.0 mtp180 -113.24 176.21 5.12 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.521 -0.763 . . . . 62.3 109.333 169.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.444 ' O ' HD12 ' A' ' 69' ' ' LEU . 3.5 pp -127.1 149.66 49.84 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.715 -0.616 . . . . 63.54 112.343 175.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.438 ' H ' HD23 ' A' ' 70' ' ' LEU . 1.4 pt? -121.57 -5.97 9.22 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.204 -0.453 . . . . 74.45 110.866 173.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.251 1.137 0 N-CA-C 112.975 0.731 . . . . 73.43 112.975 176.275 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.418 ' O ' HG13 ' A' ' 9' ' ' ILE . 8.1 tp . . . . . 0 N--CA 1.471 0.613 0 CA-C-O 120.902 0.382 . . . . 73.25 111.374 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.65 -42.04 94.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 120.756 0.312 . . . . 73.109999999999999 111.018 176.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.2 m -61.13 -41.12 96.14 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.004 0.43 . . . . 73.230000000000004 110.706 175.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.421 ' O ' HG13 ' A' ' 12' ' ' ILE . 62.0 tttp -57.27 -46.39 83.13 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.201 -0.454 . . . . 53.399999999999999 110.293 173.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.483 ' O ' HG23 ' A' ' 13' ' ' VAL . 70.3 mt -55.99 -48.83 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.205 -0.452 . . . . 64.310000000000002 111.494 176.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.5 mt -57.14 -45.24 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.012 0.434 . . . . 72.409999999999997 111.112 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.6 t -57.23 -45.94 83.42 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.171 -0.468 . . . . 71.109999999999999 111.064 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 8' ' ' LYS . 94.1 mt -59.37 -45.11 93.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.223 -0.444 . . . . 41.100000000000001 111.058 176.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 9' ' ' ILE . 96.2 t -57.98 -49.61 80.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.486 -0.324 . . . . 72.519999999999996 111.543 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -61.99 -52.66 63.11 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.938 0.399 . . . . 74.25 111.436 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -65.2 -32.58 74.33 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.101 -0.499 . . . . 51.32 111.936 -175.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.1 mmm180 -65.69 -62.72 1.35 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 122.17 -0.331 . . . . 73.439999999999998 111.737 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -56.56 -24.33 46.41 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.263 0.554 . . . . 64.239999999999995 110.901 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -64.52 -41.02 96.64 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.76 -0.655 . . . . 71.120000000000005 110.577 172.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 65.5 mtt -82.24 -28.15 32.07 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.347 -0.388 . . . . 74.010000000000005 111.792 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -77.65 -10.49 59.54 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.676 0.274 . . . . 72.310000000000002 111.252 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 64.1 -74.75 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.431 0.692 . . . . 75.219999999999999 112.835 174.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -106.44 -11.8 26.42 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.917 -0.659 . . . . 41.210000000000001 113.395 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -103.28 141.36 22.34 Favored Pre-proline 0 CA--C 1.538 0.511 0 O-C-N 122.541 -0.387 . . . . 63.43 112.022 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.528 ' HG2' ' HB3' ' A' ' 66' ' ' LEU . 53.5 Cg_endo -71.35 -176.56 1.98 Allowed 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.483 2.122 . . . . 65.310000000000002 113.216 175.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.406 HG21 ' HA ' ' A' ' 13' ' ' VAL . 13.4 t -88.75 152.13 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.248 -0.433 . . . . 74.430000000000007 111.755 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.568 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 10.8 mptt -98.86 132.44 44.21 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.399 -0.364 . . . . 75.430000000000007 111.188 -176.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.8 m -47.42 -47.16 26.86 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.012 0.375 . . . . 65.150000000000006 112.012 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -59.22 -55.77 30.7 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.505 -0.316 . . . . 74.510000000000005 111.653 175.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -51.53 -39.59 58.0 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.188 -0.46 . . . . 74.530000000000001 112.077 -174.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.5 mt -59.69 -41.42 85.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.067 0.46 . . . . 63.520000000000003 110.919 175.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.9 -39.41 83.61 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.226 -0.443 . . . . 74.420000000000002 111.282 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -60.75 -56.63 18.95 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.957 0.408 . . . . 75.219999999999999 111.31 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.26 -45.85 90.09 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.257 -0.428 . . . . 61.229999999999997 112.04 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.98 -23.61 58.3 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.214 0.45 . . . . 74.319999999999993 112.214 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.86 44.67 23.96 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.247 -0.501 . . . . 61.219999999999999 112.558 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.3 mt -126.88 178.67 5.81 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.135 0.493 . . . . 60.409999999999997 111.623 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.406 ' O ' HG23 ' A' ' 41' ' ' VAL . 31.1 t -87.02 147.93 25.51 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.93 -0.577 . . . . 64.129999999999995 111.339 176.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.8 mm -55.65 -44.41 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 116.308 -0.405 . . . . 64.129999999999995 112.001 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.556 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 72.1 t80 -61.49 -53.93 49.93 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 111.566 0.21 . . . . 73.120000000000005 111.566 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -51.77 -49.1 63.3 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.508 0.67 . . . . 74.239999999999995 111.383 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 37' ' ' SER . 94.3 t -60.37 -51.6 71.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.717 -0.674 . . . . 74.109999999999999 112.204 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -60.76 -27.07 67.69 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 122.387 -0.196 . . . . 72.230000000000004 111.356 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 87.5 mt -62.46 -54.64 37.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.742 0.306 . . . . 55.240000000000002 110.375 175.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -57.82 -47.49 82.47 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.043 0.449 . . . . 74.140000000000001 111.08 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.2 mt -58.74 -43.83 90.32 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.034 -0.53 . . . . 44.439999999999998 111.983 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 49' ' ' HIS . 34.8 tt0 -67.06 -40.38 87.09 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.73 0.3 . . . . 74.349999999999994 111.553 -178.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -63.41 -50.23 70.65 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.938 0.399 . . . . 62.409999999999997 110.836 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.6 mt -58.46 -31.66 68.0 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.179 0.514 . . . . 72.239999999999995 110.927 174.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.537 ' HD2' ' HA ' ' A' ' 55' ' ' GLU . 28.3 t-80 -64.61 -54.58 29.8 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.246 -0.434 . . . . 72.530000000000001 111.768 176.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -66.42 -26.27 67.15 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.011 0.375 . . . . 63.219999999999999 112.011 -173.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.536 HG23 HG23 ' A' ' 53' ' ' VAL . 26.1 m -85.34 -1.5 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 112.21 0.448 . . . . 54.409999999999997 112.21 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.33 -14.81 47.26 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 115.053 0.781 . . . . 73.439999999999998 115.053 172.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.536 HG23 HG23 ' A' ' 51' ' ' VAL . 59.8 t -62.39 -51.02 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 117.833 0.816 . . . . 73.109999999999999 111.808 -176.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 94.2 mt -114.8 154.2 29.0 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.861 0.362 . . . . 64.409999999999997 111.618 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.537 ' HA ' ' HD2' ' A' ' 49' ' ' HIS . 9.0 tp10 -121.69 147.3 46.06 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.229 0.537 . . . . 43.219999999999999 110.998 176.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.427 ' HG2' ' OE1' ' A' ' 55' ' ' GLU . 23.2 pttm -81.7 95.39 7.22 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.593 -0.73 . . . . 71.409999999999997 111.855 -178.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.514 HG11 ' HG3' ' A' ' 24' ' ' PRO . 44.0 t . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 121.505 0.669 . . . . 75.510000000000005 110.118 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.528 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 83.7 mt . . . . . 0 CA--C 1.536 0.442 0 CA-C-O 120.907 0.384 . . . . 51.299999999999997 110.665 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -111.45 132.79 54.21 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.378 0.608 . . . . 64.25 112.182 -175.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -136.76 138.13 40.6 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.744 -0.662 . . . . 73.150000000000006 110.885 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.418 ' O ' HD12 ' A' ' 69' ' ' LEU . 2.4 pp -83.23 153.23 24.82 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.806 0.336 . . . . 74.540000000000006 111.697 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.501 HD23 ' N ' ' A' ' 70' ' ' LEU . 1.9 pt? . . . . . 0 N--CA 1.469 0.496 0 N-CA-C 112.005 0.372 . . . . 50.32 112.005 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 5' ' ' ILE . 2.8 mp . . . . . 0 N--CA 1.472 0.638 0 CA-C-O 120.804 0.335 . . . . 72.430000000000007 111.493 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.5 t -60.71 -53.02 54.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.806 0.336 . . . . 70.109999999999999 111.274 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.0 m -60.41 -36.16 77.49 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.022 0.439 . . . . 71.340000000000003 111.079 177.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.517 ' O ' HG13 ' A' ' 12' ' ' ILE . 62.4 tttp -60.05 -49.05 79.2 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.213 -0.449 . . . . 73.439999999999998 111.135 176.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.445 ' HA ' HD12 ' A' ' 12' ' ' ILE . 72.9 mt -59.6 -42.97 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.7 0.286 . . . . 70.439999999999998 111.502 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.1 mt -57.43 -43.61 82.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 121.328 0.585 . . . . 73.200000000000003 110.574 174.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.7 m -66.15 -30.73 71.27 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.881 -0.599 . . . . 73.239999999999995 111.604 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 8' ' ' LYS . 94.5 mt -67.07 -47.72 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.638 0.256 . . . . 73.209999999999994 111.279 177.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.491 HG11 HD22 ' A' ' 54' ' ' LEU . 56.1 t -60.12 -45.36 95.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.841 0.353 . . . . 74.230000000000004 110.45 175.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -54.77 -48.25 72.91 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.038 -0.528 . . . . 65.549999999999997 110.629 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.552 ' O ' ' HG2' ' A' ' 19' ' ' MET . 29.2 tt0 -57.24 -65.54 0.61 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.775 -0.648 . . . . 75.129999999999995 111.452 178.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -51.51 -51.86 51.69 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.844 0.354 . . . . 72.340000000000003 111.917 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -57.42 -35.27 69.86 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.117 -0.492 . . . . 73.140000000000001 111.56 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -81.39 -26.53 35.38 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.042 0.386 . . . . 74.019999999999996 112.042 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.552 ' HG2' ' O ' ' A' ' 15' ' ' GLU . 24.3 mmt -71.22 -58.94 3.06 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.839 0.352 . . . . 72.120000000000005 111.047 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -74.29 -29.52 61.69 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.602 -0.272 . . . . 75.239999999999995 111.235 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.1 t70 69.14 -72.57 0.1 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.539 0.57 . . . . 72.150000000000006 112.539 173.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.65 41.42 3.09 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.188 -0.53 . . . . 54.020000000000003 113.161 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.19 140.26 8.49 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 112.187 0.44 . . . . 73.540000000000006 112.187 -177.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.545 ' HG2' HD13 ' A' ' 66' ' ' LEU . 54.5 Cg_endo -71.66 151.9 58.59 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.516 2.144 . . . . 71.209999999999994 112.512 172.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.1 t -80.88 150.36 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 120.906 0.384 . . . . 65.040000000000006 111.447 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.457 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -112.24 150.25 31.17 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.697 0.284 . . . . 74.340000000000003 110.819 -179.532 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.0 m -55.65 -31.85 62.68 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.02 0.438 . . . . 64.219999999999999 111.508 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -64.17 -59.21 4.71 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.182 -0.463 . . . . 72.019999999999996 112.175 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.417 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -67.49 -20.25 65.43 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.629 0.603 . . . . 74.209999999999994 112.629 -178.439 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 26' ' ' LYS . 77.3 mt -67.93 -51.22 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.048 0.451 . . . . 73.140000000000001 110.358 170.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.512 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -58.07 -39.42 78.47 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.124 -0.489 . . . . 75.409999999999997 111.189 175.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -51.81 -52.48 48.87 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.693 -0.685 . . . . 70.030000000000001 111.543 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.23 -24.94 60.55 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.956 0.408 . . . . 63.140000000000001 111.923 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.65 -24.33 36.38 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.062 0.393 . . . . 73.030000000000001 112.062 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.87 23.29 78.11 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.077 -0.582 . . . . 34.409999999999997 112.24 -174.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.7 mt -118.13 178.21 4.51 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.401 0.62 . . . . 53.439999999999998 111.783 -175.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.8 m -82.51 149.17 27.69 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.896 -0.593 . . . . 72.140000000000001 111.554 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.6 mm -52.89 -41.96 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 120.929 0.395 . . . . 43.119999999999997 111.966 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.467 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 47.4 t80 -60.65 -59.78 4.85 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.149 -0.478 . . . . 74.120000000000005 111.644 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -48.44 -58.04 5.22 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.92 0.391 . . . . 72.439999999999998 111.376 176.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.569 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 94.9 t -53.3 -45.95 56.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.01 -0.541 . . . . 72.040000000000006 111.535 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.496 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 7.7 tpt180 -60.86 -41.67 96.37 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.65 -0.25 . . . . 74.129999999999995 111.38 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 89.1 mt -55.51 -44.62 76.81 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.329 0.585 . . . . 70.5 110.738 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -66.25 -41.74 89.54 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.884 -0.598 . . . . 74.230000000000004 111.553 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 89.5 mt -59.43 -45.44 91.54 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.829 0.347 . . . . 54.210000000000001 111.103 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 42' ' ' ARG . 58.1 mm-40 -52.65 -52.74 54.35 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.293 0.568 . . . . 74.420000000000002 110.749 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -65.87 -33.53 76.05 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.842 -0.617 . . . . 62.229999999999997 111.848 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.401 ' HA ' HG22 ' A' ' 51' ' ' VAL . 76.8 mt -64.89 -27.79 69.1 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.846 0.355 . . . . 75.319999999999993 111.333 176.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -75.39 -37.6 60.42 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.131 0.491 . . . . 71.109999999999999 110.142 172.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -63.57 -43.64 96.4 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.773 -0.649 . . . . 65.140000000000001 112.388 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.539 HG23 HG23 ' A' ' 53' ' ' VAL . 25.5 m -80.07 -12.74 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.741 0.645 . . . . 73.430000000000007 112.741 -177.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.2 52.97 1.66 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.027 -0.606 . . . . 70.540000000000006 113.645 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.539 HG23 HG23 ' A' ' 51' ' ' VAL . 94.4 t -124.77 -56.88 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.021 0.438 . . . . 61.100000000000001 111.113 176.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 69' ' ' LEU . 70.1 mt -100.03 138.83 36.57 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.337 -0.392 . . . . 73.310000000000002 111.91 -177.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -109.46 160.5 16.16 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.263 -0.426 . . . . 74.549999999999997 110.295 174.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -100.07 136.25 40.26 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.19 0.519 . . . . 63.43 111.958 -176.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.9 t . . . . . 0 CA--C 1.538 0.49 0 CA-C-N 116.118 -0.492 . . . . 70.120000000000005 110.484 176.705 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.545 HD13 ' HG2' ' A' ' 24' ' ' PRO . 77.0 mt . . . . . 0 CA--C 1.539 0.55 0 CA-C-O 120.853 0.358 . . . . 73.409999999999997 111.041 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -109.23 137.09 47.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.424 0.63 . . . . 72.150000000000006 112.279 -175.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -154.22 116.88 4.39 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.0 -0.545 . . . . 61.329999999999998 110.187 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 54' ' ' LEU . 2.3 pp -66.05 174.44 2.52 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.027 0.751 . . . . 72.230000000000004 113.027 -172.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 78.2 mt . . . . . 0 CA--C 1.537 0.455 0 CA-C-N 115.938 -0.574 . . . . 74.010000000000005 111.35 179.55 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.589 HG12 HD11 ' A' ' 36' ' ' LEU . 10.8 tp . . . . . 0 CA--C 1.544 0.716 0 N-CA-C 112.191 0.441 . . . . 71.409999999999997 112.191 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.6 t -57.57 -37.25 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 120.911 0.386 . . . . 52.43 111.507 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.2 m -54.26 -47.87 71.81 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.0 0.429 . . . . 71.420000000000002 111.083 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.453 ' O ' HG13 ' A' ' 12' ' ' ILE . 87.5 tttt -66.28 -40.4 90.06 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.562 -0.29 . . . . 74.329999999999998 110.767 177.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.458 ' O ' HG23 ' A' ' 13' ' ' VAL . 67.4 mt -53.35 -47.33 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 120.81 0.338 . . . . 64.540000000000006 111.316 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.7 mt -59.12 -43.86 90.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.933 0.397 . . . . 75.040000000000006 110.926 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.8 t -61.16 -40.06 92.47 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.421 -0.354 . . . . 75.109999999999999 111.763 176.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.462 HD13 ' HB3' ' A' ' 33' ' ' ALA . 82.4 mt -61.69 -43.41 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.82 0.343 . . . . 72.540000000000006 110.736 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.527 ' HA ' HG21 ' A' ' 25' ' ' VAL . 91.5 t -59.04 -47.56 89.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.965 0.412 . . . . 71.420000000000002 111.018 176.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -60.54 -47.17 87.36 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.086 0.47 . . . . 74.129999999999995 111.264 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.01 -52.37 65.82 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.275 0.56 . . . . 73.030000000000001 111.039 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.612 ' HA ' ' HG2' ' A' ' 19' ' ' MET . 1.0 OUTLIER -62.1 -35.53 78.97 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.358 -0.383 . . . . 72.140000000000001 111.706 178.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -62.88 -25.18 68.18 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 122.315 -0.241 . . . . 74.310000000000002 111.261 173.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -84.47 -20.94 30.9 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.563 0.579 . . . . 74.140000000000001 112.563 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.612 ' HG2' ' HA ' ' A' ' 16' ' ' ARG . 20.4 ptm -89.25 -38.82 13.94 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.944 -0.473 . . . . 74.209999999999994 112.171 173.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -89.94 -41.47 11.75 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 111.88 0.326 . . . . 61.32 111.88 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 63.26 -74.58 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.807 0.669 . . . . 64.310000000000002 112.807 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.42 -28.57 73.65 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.094 -0.574 . . . . 63.32 113.495 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.36 147.0 33.84 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 120.765 0.317 . . . . 74.140000000000001 111.76 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.573 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 6.0 Cg_exo -72.86 172.19 15.87 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.447 2.098 . . . . 64.329999999999998 112.522 176.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.527 HG21 ' HA ' ' A' ' 13' ' ' VAL . 40.3 t -80.15 150.02 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.167 -0.47 . . . . 71.109999999999999 111.719 -175.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.611 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -100.05 145.94 27.34 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.347 -0.388 . . . . 53.409999999999997 110.624 -177.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.0 m -54.43 -34.7 61.9 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.567 0.58 . . . . 54.039999999999999 112.567 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -62.4 -42.65 99.59 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.447 0.536 . . . . 72.299999999999997 112.447 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -53.89 -42.95 69.23 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.152 0.427 . . . . 72.5 112.152 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.457 ' N ' HD12 ' A' ' 30' ' ' ILE . 2.9 mp -65.56 -50.1 73.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.979 0.419 . . . . 75.239999999999995 111.035 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.32 -58.57 7.89 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.01 0.433 . . . . 74.439999999999998 112.058 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.87 -42.4 93.61 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.804 0.668 . . . . 45.140000000000001 112.804 -178.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.462 ' HB3' HD13 ' A' ' 12' ' ' ILE . . . -75.25 -34.31 61.38 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.343 0.497 . . . . 71.299999999999997 112.343 -178.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.432 ' HB1' HD11 ' A' ' 5' ' ' ILE . . . -85.42 -21.19 28.89 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.133 0.42 . . . . 64.239999999999995 112.133 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.81 22.16 53.87 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.242 -0.504 . . . . 74.439999999999998 112.821 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.589 HD11 HG12 ' A' ' 5' ' ' ILE . 73.3 mt -101.42 173.83 6.26 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.959 0.409 . . . . 74.319999999999993 111.591 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.417 ' O ' HG23 ' A' ' 41' ' ' VAL . 47.4 t -98.01 148.29 23.65 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.354 -0.384 . . . . 75.129999999999995 111.051 177.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.3 mm -50.61 -49.32 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 112.836 0.68 . . . . 74.209999999999994 112.836 -175.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.534 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 47.6 t80 -51.37 -50.62 59.18 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.892 0.33 . . . . 71.230000000000004 111.892 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.46 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 27.6 tt0 -69.04 -40.3 78.67 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.844 0.354 . . . . 74.209999999999994 111.371 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 37' ' ' SER . 69.9 t -60.54 -51.71 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.418 -0.356 . . . . 74.120000000000005 111.875 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 8.7 ptm180 -57.41 -36.06 70.84 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.629 -0.259 . . . . 75.040000000000006 111.287 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 94.0 mt -60.16 -48.44 81.71 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.729 0.299 . . . . 74.430000000000007 110.932 177.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.46 ' CE2' ' HG2' ' A' ' 40' ' ' GLN . 25.5 m-85 -57.34 -48.05 80.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.04 0.447 . . . . 73.540000000000006 110.919 176.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.455 HD13 ' NE1' ' A' ' 67' ' ' TRP . 78.9 mt -60.97 -43.8 98.27 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.871 -0.604 . . . . 74.430000000000007 111.727 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 42' ' ' ARG . 46.9 mt-10 -57.98 -52.2 66.52 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.044 0.45 . . . . 62.109999999999999 111.089 175.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 83.9 mm-40 -59.25 -40.33 85.63 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.098 -0.501 . . . . 63.240000000000002 111.343 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.6 mt -59.9 -40.12 87.71 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.723 0.297 . . . . 71.120000000000005 111.468 176.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 65.3 t60 -67.12 -40.24 86.8 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.037 -0.415 . . . . 63.130000000000003 111.104 174.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -65.81 -43.42 88.67 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.068 -0.514 . . . . 54.539999999999999 112.156 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.517 HG23 HG23 ' A' ' 53' ' ' VAL . 34.0 m -78.27 -12.03 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 112.448 0.536 . . . . 65.329999999999998 112.448 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.93 52.51 1.5 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.085 -0.579 . . . . 53.329999999999998 113.713 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.517 HG23 HG23 ' A' ' 51' ' ' VAL . 91.3 t -124.17 -44.49 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 120.973 0.416 . . . . 54.200000000000003 111.323 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.7 mt -110.12 142.57 41.43 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.431 0.634 . . . . 72.310000000000002 112.517 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -91.44 119.63 31.58 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.373 -0.83 . . . . 61.210000000000001 109.038 172.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -85.18 94.86 8.98 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.163 0.506 . . . . 73.109999999999999 110.845 -173.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.451 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 51.4 t . . . . . 0 CA--C 1.54 0.587 0 CA-C-N 115.877 -0.602 . . . . 63.229999999999997 112.183 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 92.0 mt . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 110.198 -0.297 . . . . 72.219999999999999 110.198 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.455 ' NE1' HD13 ' A' ' 45' ' ' LEU . 59.9 m95 -115.99 123.38 47.87 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.547 0.689 . . . . 75.329999999999998 112.452 -171.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 -128.46 113.33 15.39 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.768 -0.651 . . . . 73.430000000000007 110.788 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.455 ' O ' HD12 ' A' ' 69' ' ' LEU . 3.7 pp -63.48 149.95 44.92 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.904 -0.498 . . . . 74.310000000000002 111.866 -178.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 87.8 mt . . . . . 0 CA--C 1.538 0.488 0 CA-C-N 116.225 -0.443 . . . . 73.340000000000003 111.522 -179.381 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.483 HG21 HD11 ' A' ' 36' ' ' LEU . 61.3 mt . . . . . 0 CA--C 1.536 0.428 0 CA-C-O 121.063 0.459 . . . . 73.239999999999995 110.145 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.9 t -58.49 -54.89 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.084 -0.507 . . . . 71.120000000000005 111.321 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.5 m -61.04 -33.82 73.9 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.981 0.42 . . . . 54.109999999999999 111.066 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.427 ' O ' HG13 ' A' ' 12' ' ' ILE . 61.9 tttp -59.28 -49.42 77.9 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.976 0.417 . . . . 72.530000000000001 110.692 176.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.513 ' O ' HG23 ' A' ' 13' ' ' VAL . 73.2 mt -56.91 -49.72 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.184 -0.462 . . . . 64.209999999999994 111.175 176.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.9 mt -53.74 -42.65 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 121.156 0.503 . . . . 75.150000000000006 111.457 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.0 m -62.77 -43.33 99.09 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.168 -0.469 . . . . 35.109999999999999 111.244 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 8' ' ' LYS . 74.8 mt -61.06 -43.31 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.043 0.449 . . . . 60.119999999999997 111.255 177.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.575 HG12 ' NE2' ' A' ' 17' ' ' GLN . 81.1 t -57.96 -52.15 61.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 116.064 -0.517 . . . . 71.239999999999995 111.391 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -63.71 -41.32 98.1 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.703 0.287 . . . . 72.25 111.524 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -51.58 -53.09 41.87 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.768 0.318 . . . . 75.310000000000002 111.158 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.529 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 3.1 mmp_? -57.05 -46.76 82.2 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 111.911 0.337 . . . . 73.340000000000003 111.911 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.575 ' NE2' HG12 ' A' ' 13' ' ' VAL . 66.0 mt-30 -64.69 -38.07 89.74 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.99 0.424 . . . . 64.329999999999998 112.14 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -77.76 -41.23 38.29 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.271 0.471 . . . . 72.510000000000005 112.271 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.5 mmt -75.71 -45.46 36.59 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.177 0.436 . . . . 70.510000000000005 112.177 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -82.28 -25.84 33.66 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.923 0.392 . . . . 61.310000000000002 110.538 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.8 t70 67.26 104.96 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.438 0.695 . . . . 74.109999999999999 112.01 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.7 -31.03 5.74 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 115.922 -0.581 . . . . 52.240000000000002 113.906 177.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.79 140.13 95.44 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 113.04 0.756 . . . . 74.200000000000003 113.04 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.19 146.4 17.81 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.899 2.399 . . . . 71.310000000000002 112.371 173.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.474 HG22 ' HB2' ' A' ' 16' ' ' ARG . 22.1 t -85.66 138.46 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.028 0.442 . . . . 72.109999999999999 112.061 -175.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.445 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -98.92 144.7 27.81 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.995 -0.548 . . . . 45.310000000000002 110.693 178.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 57.8 m -57.16 -32.73 66.72 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.843 0.354 . . . . 64.409999999999997 111.07 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -56.99 -57.54 12.1 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.243 -0.435 . . . . 74.129999999999995 112.147 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -54.59 -42.55 71.24 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.748 0.309 . . . . 64.400000000000006 111.712 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.401 ' HA ' HG21 ' A' ' 12' ' ' ILE . 58.7 mt -63.49 -43.71 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.404 -0.362 . . . . 71.209999999999994 111.337 177.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.1 -49.6 77.0 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.06 0.393 . . . . 74.430000000000007 112.06 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -65.48 -42.87 91.74 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.042 0.386 . . . . 51.520000000000003 112.042 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.89 -35.46 74.66 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.373 0.509 . . . . 72.030000000000001 112.373 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.64 -24.14 24.03 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.985 0.365 . . . . 62.329999999999998 111.985 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.29 37.4 24.6 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.365 -0.445 . . . . 65.150000000000006 112.96 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.483 HD11 HG21 ' A' ' 5' ' ' ILE . 84.1 mt -123.05 174.65 7.07 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.964 0.411 . . . . 71.349999999999994 111.743 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 41' ' ' VAL . 49.3 m -86.8 144.71 26.92 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.477 -0.329 . . . . 70.219999999999999 111.277 177.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.2 mm -47.15 -51.13 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 112.396 0.517 . . . . 75.310000000000002 112.396 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.497 ' CE2' HD11 ' A' ' 43' ' ' LEU . 82.8 t80 -54.44 -56.38 19.3 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.251 -0.431 . . . . 73.129999999999995 111.36 177.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -54.88 -49.0 72.26 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.073 -0.512 . . . . 75.310000000000002 111.69 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 37' ' ' SER . 89.4 t -54.68 -53.03 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.983 -0.553 . . . . 71.299999999999997 111.625 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -65.85 -26.85 67.84 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.949 -0.3 . . . . 73.340000000000003 111.61 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.497 HD11 ' CE2' ' A' ' 39' ' ' TYR . 80.7 mt -58.31 -48.77 79.46 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.948 0.404 . . . . 54.409999999999997 110.287 174.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -66.04 -34.12 77.37 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.234 -0.439 . . . . 64.109999999999999 111.192 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 88.5 mt -63.21 -46.08 88.66 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.66 0.267 . . . . 52.310000000000002 111.062 176.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 49' ' ' HIS . 1.1 mp0 -55.68 -48.09 75.66 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.717 0.294 . . . . 65.099999999999994 110.789 174.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 94.7 mt-30 -56.8 -50.7 71.55 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.813 0.34 . . . . 73.129999999999995 111.055 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.522 ' HA ' HG22 ' A' ' 51' ' ' VAL . 95.1 mt -58.52 -30.57 67.17 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.118 0.485 . . . . 71.230000000000004 111.439 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.475 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 7.3 t-80 -65.9 -45.95 80.09 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.901 0.382 . . . . 72.409999999999997 111.446 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -79.84 -23.73 41.8 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.222 0.823 . . . . 74.340000000000003 113.222 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 48' ' ' LEU . 23.9 m -89.77 6.49 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 121.838 -0.539 . . . . 75.209999999999994 111.78 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.1 57.78 3.36 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 116.325 -0.398 . . . . 63.130000000000003 113.934 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.469 HG23 HG23 ' A' ' 51' ' ' VAL . 90.2 t -131.77 -51.94 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 122.431 -0.452 . . . . 52.25 111.816 177.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.9 mt -97.01 143.97 27.35 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.933 0.716 . . . . 70.230000000000004 112.933 -175.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -102.03 153.24 20.09 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.215 -0.902 . . . . 72.129999999999995 110.89 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.547 ' HD3' ' N ' ' A' ' 56' ' ' LYS . 1.8 mppt? -97.21 119.85 36.48 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.767 0.318 . . . . 65.420000000000002 110.902 -176.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 49.2 t . . . . . 0 CA--C 1.537 0.481 0 CA-C-O 121.132 0.491 . . . . 72.099999999999994 112.186 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 94.4 mt . . . . . 0 CA--C 1.538 0.514 0 CA-C-O 120.632 0.253 . . . . 75.140000000000001 110.643 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -106.16 132.8 51.79 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.611 0.967 . . . . 72.150000000000006 113.611 -169.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 68' ' ' ARG . 12.4 mtp180 -139.21 -168.64 2.49 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.505 -0.771 . . . . 71.540000000000006 109.755 169.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 pp -114.21 169.16 9.23 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 122.026 -0.421 . . . . 71.0 111.225 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 89.2 mt . . . . . 0 CA--C 1.541 0.6 0 CA-C-O 121.059 0.456 . . . . 74.420000000000002 111.054 177.183 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 36' ' ' LEU . 14.6 tt . . . . . 0 CA--C 1.54 0.578 0 CA-C-O 121.248 0.547 . . . . 71.120000000000005 110.877 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.5 t -69.07 -35.56 69.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.266 -0.425 . . . . 75.430000000000007 110.815 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.1 m -52.96 -43.47 66.39 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.101 0.477 . . . . 73.530000000000001 110.318 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.557 ' O ' HG13 ' A' ' 12' ' ' ILE . 40.5 ttmt -60.45 -48.51 81.45 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.993 -0.549 . . . . 75.299999999999997 110.776 175.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.4 mt -52.57 -47.17 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.892 0.377 . . . . 73.319999999999993 111.512 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.6 mt -61.8 -45.58 98.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.049 0.452 . . . . 42.109999999999999 111.202 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 84.7 p -67.96 -18.35 64.71 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.906 0.336 . . . . 61.439999999999998 111.906 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 8' ' ' LYS . 99.3 mt -75.01 -44.83 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.081 0.467 . . . . 70.219999999999999 110.417 172.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.8 t -59.96 -41.51 86.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.195 0.521 . . . . 63.219999999999999 110.34 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -65.36 -45.33 84.57 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.884 -0.598 . . . . 75.430000000000007 110.526 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -51.09 -52.2 45.94 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.14 -0.482 . . . . 50.219999999999999 111.734 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.9 mmt-85 -61.97 -37.68 85.68 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 111.952 0.353 . . . . 75.510000000000005 111.952 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -74.88 -12.97 60.49 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 122.148 -0.345 . . . . 64.510000000000005 111.86 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -82.6 -45.55 14.44 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.906 0.384 . . . . 70.319999999999993 110.459 171.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 93.6 mmm -70.11 -65.22 0.75 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.176 -0.466 . . . . 71.310000000000002 110.632 176.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -81.68 102.86 10.98 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.989 0.423 . . . . 74.040000000000006 110.004 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -51.11 95.57 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.115 0.783 . . . . 62.340000000000003 113.115 -172.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.91 33.05 84.57 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 115.721 -0.672 . . . . 74.5 113.657 175.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.96 145.97 30.69 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 120.879 0.371 . . . . 44.439999999999998 111.962 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.586 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 38.4 Cg_endo -65.28 131.56 28.73 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.513 2.142 . . . . 64.200000000000003 112.838 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.3 t -82.62 147.88 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.084 -0.507 . . . . 53.229999999999997 111.866 -176.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.448 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -100.61 146.72 26.79 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.297 -0.41 . . . . 64.019999999999996 111.035 -178.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.4 m -57.17 -32.53 66.52 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 111.909 0.337 . . . . 72.150000000000006 111.909 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 28' ' ' ARG . 3.9 mpt_? -60.75 -53.82 52.74 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.096 0.406 . . . . 71.150000000000006 112.096 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.421 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 9.5 m-20 -53.11 -47.61 68.49 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.969 0.414 . . . . 74.319999999999993 111.339 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.532 ' HA ' HG21 ' A' ' 12' ' ' ILE . 61.5 mt -59.49 -43.83 91.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.96 -0.564 . . . . 75.120000000000005 111.389 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.557 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -62.5 -54.34 41.47 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.167 0.432 . . . . 71.230000000000004 112.167 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.35 -43.87 96.46 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.95 0.352 . . . . 63.520000000000003 111.95 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.422 ' HB3' HD13 ' A' ' 12' ' ' ILE . . . -62.91 -37.81 88.46 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.79 0.329 . . . . 62.119999999999997 111.709 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.92 -18.58 36.9 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.99 0.424 . . . . 65.420000000000002 111.63 176.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.86 20.69 70.12 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.327 -0.397 . . . . 74.129999999999995 113.569 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.505 HD11 HD11 ' A' ' 5' ' ' ILE . 84.4 mt -111.61 176.39 5.04 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.14 0.495 . . . . 75.299999999999997 112.04 -175.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.6 m -83.29 147.45 27.96 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.026 -0.534 . . . . 75.530000000000001 111.711 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 39.6 mm -50.6 -51.29 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 112.796 0.665 . . . . 44.210000000000001 112.796 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.404 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 77.8 t80 -60.81 -49.6 76.82 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.742 0.306 . . . . 54.210000000000001 111.635 -178.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -58.11 -50.41 73.59 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.176 0.513 . . . . 71.239999999999995 111.144 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.557 HG21 ' HA ' ' A' ' 31' ' ' ALA . 73.1 t -55.38 -46.56 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.139 -0.482 . . . . 74.0 111.131 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.508 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 16.5 ttt180 -53.11 -44.22 67.47 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.256 -0.429 . . . . 74.129999999999995 111.4 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 97.6 mt -54.69 -47.07 74.12 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.051 0.453 . . . . 71.239999999999995 110.781 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -62.41 -46.29 89.27 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.101 -0.499 . . . . 72.239999999999995 111.282 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 85.0 mt -61.42 -40.94 96.26 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.349 -0.387 . . . . 62.219999999999999 111.712 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' A' ' 42' ' ' ARG . 55.5 mt-10 -59.31 -42.25 90.94 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.971 0.415 . . . . 72.430000000000007 111.107 177.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -71.88 -33.12 68.1 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.813 0.339 . . . . 65.450000000000003 111.159 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.73 -29.11 69.58 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.017 0.437 . . . . 72.129999999999995 111.207 174.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.44 ' HD2' ' HA ' ' A' ' 55' ' ' GLU . 54.4 t-80 -73.37 -28.96 62.32 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.083 0.468 . . . . 74.510000000000005 110.603 172.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -73.96 -52.25 13.42 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.927 -0.578 . . . . 74.209999999999994 111.584 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.518 HG23 HG23 ' A' ' 53' ' ' VAL . 34.1 m -73.5 -10.96 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 113.144 0.794 . . . . 75.209999999999994 113.144 -176.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.53 49.08 2.05 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.005 -0.617 . . . . 54.520000000000003 114.042 176.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.518 HG23 HG23 ' A' ' 51' ' ' VAL . 91.7 t -118.65 -52.5 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.968 0.413 . . . . 55.0 111.427 176.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 86.4 mt -114.91 148.57 38.48 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.018 0.437 . . . . 74.0 111.979 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.44 ' HA ' ' HD2' ' A' ' 49' ' ' HIS . 10.1 tp10 -111.97 133.7 53.99 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.216 -0.447 . . . . 73.230000000000004 111.092 174.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -85.65 97.89 10.37 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.987 -0.551 . . . . 73.540000000000006 110.734 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 46.7 t . . . . . 0 CA--C 1.537 0.458 0 CA-C-N 115.987 -0.551 . . . . 34.130000000000003 111.552 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.586 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 87.3 mt . . . . . 0 CA--C 1.54 0.596 0 CA-C-O 120.832 0.349 . . . . 63.530000000000001 111.329 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -124.38 133.54 53.39 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.307 0.575 . . . . 74.439999999999998 112.313 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -127.46 121.33 30.49 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.283 -0.417 . . . . 72.319999999999993 110.705 172.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.461 ' O ' HD12 ' A' ' 69' ' ' LEU . 2.9 pp -69.99 147.6 49.92 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.947 0.403 . . . . 72.109999999999999 111.659 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 CA--C 1.536 0.426 0 CA-C-N 116.437 -0.347 . . . . 73.420000000000002 111.662 -177.16 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.0 tp . . . . . 0 CA--C 1.543 0.71 0 N-CA-C 112.003 0.372 . . . . 71.140000000000001 112.003 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.8 t -61.78 -51.32 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 111.696 0.258 . . . . 73.140000000000001 111.696 -177.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.1 m -56.63 -37.53 70.85 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.905 0.383 . . . . 63.420000000000002 111.423 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.504 ' O ' HG13 ' A' ' 12' ' ' ILE . 37.3 ttpt -65.28 -43.61 90.64 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.471 -0.331 . . . . 65.129999999999995 110.721 176.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.489 HG23 HG21 ' A' ' 30' ' ' ILE . 69.2 mt -59.41 -44.83 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.737 0.303 . . . . 72.420000000000002 111.503 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 69.0 mt -56.68 -45.65 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.27 0.557 . . . . 64.040000000000006 110.771 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.6 m -66.98 -29.32 69.13 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.933 -0.576 . . . . 73.230000000000004 111.905 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 8' ' ' LYS . 94.0 mt -63.94 -44.02 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.056 0.455 . . . . 61.009999999999998 110.91 174.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.425 ' HA ' HG21 ' A' ' 25' ' ' VAL . 59.3 t -57.31 -47.15 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.116 0.484 . . . . 73.310000000000002 110.729 175.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -61.27 -46.59 89.7 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.08 -0.509 . . . . 62.420000000000002 110.992 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -56.3 -46.75 79.67 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.1 -0.5 . . . . 70.540000000000006 111.421 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.42 ' HD3' ' SD ' ' A' ' 19' ' ' MET . 11.1 mmt180 -61.33 -36.67 80.79 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.5 -0.318 . . . . 72.530000000000001 111.729 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.428 ' NE2' ' HG ' ' A' ' 69' ' ' LEU . 73.6 mt-30 -75.79 -21.6 57.2 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.782 0.325 . . . . 70.129999999999995 111.814 176.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -70.53 -36.12 73.54 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.366 0.603 . . . . 74.049999999999997 110.04 170.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.42 ' SD ' ' HD3' ' A' ' 16' ' ' ARG . 74.3 mtp -67.69 -50.39 57.83 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.548 -0.751 . . . . 61.119999999999997 111.062 176.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -122.5 116.74 24.45 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.132 -0.486 . . . . 73.209999999999994 110.494 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -40.33 -53.28 2.6 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.213 0.82 . . . . 61.200000000000003 113.213 -173.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.94 53.98 0.7 Allowed Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.19 -0.529 . . . . 53.539999999999999 113.046 -176.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.414 ' HA ' ' HD2' ' A' ' 24' ' ' PRO . . . -101.83 110.27 61.7 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.361 0.504 . . . . 62.049999999999997 112.361 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.587 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 56.4 Cg_endo -69.88 122.29 8.94 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.093 1.862 . . . . 72.409999999999997 110.767 170.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.425 HG21 ' HA ' ' A' ' 13' ' ' VAL . 22.0 t -79.38 141.47 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 112.37 0.508 . . . . 71.340000000000003 112.37 -167.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -97.58 151.07 20.43 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.134 -0.484 . . . . 71.219999999999999 110.867 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.4 m -53.05 -37.33 61.5 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.201 -0.454 . . . . 62.399999999999999 111.526 175.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -64.22 -44.36 92.13 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.295 -0.411 . . . . 74.140000000000001 112.009 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.04 -41.34 98.0 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.994 0.426 . . . . 74.409999999999997 111.548 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.489 HG21 HG23 ' A' ' 9' ' ' ILE . 60.2 mt -65.78 -43.37 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 116.515 -0.311 . . . . 61.399999999999999 111.045 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.59 -37.51 81.6 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.202 0.525 . . . . 32.32 110.893 174.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.36 -48.33 81.77 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.662 -0.699 . . . . 73.010000000000005 111.697 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.16 -50.29 49.04 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.018 0.377 . . . . 62.399999999999999 112.018 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.0 -19.65 61.16 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.584 0.587 . . . . 74.109999999999999 112.584 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.17 40.0 51.36 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.159 -0.543 . . . . 63.420000000000002 112.673 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.4 175.26 6.53 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.805 0.336 . . . . 65.450000000000003 111.241 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.2 t -85.07 153.76 22.5 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.747 0.308 . . . . 70.120000000000005 111.192 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.59 -50.13 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 112.954 0.724 . . . . 65.200000000000003 112.954 -175.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -66.62 -44.72 81.29 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 122.197 -0.315 . . . . 63.509999999999998 111.763 -175.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -51.07 -55.44 17.56 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.203 0.525 . . . . 75.109999999999999 111.054 175.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.445 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 82.7 t -61.1 -39.86 83.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.064 -0.516 . . . . 71.299999999999997 110.942 176.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -53.52 -41.44 66.34 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.243 -0.435 . . . . 54.039999999999999 110.684 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.3 mt -62.92 -52.86 61.41 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.001 -0.545 . . . . 71.420000000000002 111.285 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -56.05 -36.85 68.5 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.011 0.434 . . . . 64.019999999999996 111.357 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.552 HD13 ' NE1' ' A' ' 67' ' ' TRP . 99.1 mt -69.78 -40.11 76.23 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.408 -0.36 . . . . 75.219999999999999 111.756 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -60.73 -37.94 83.45 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.025 0.44 . . . . 75.209999999999994 110.685 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -61.4 -54.02 49.06 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.385 -0.371 . . . . 52.520000000000003 110.712 174.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.5 mt -57.11 -31.53 65.39 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.15 0.5 . . . . 73.030000000000001 111.608 176.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -63.71 -50.82 67.65 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.921 -0.581 . . . . 71.129999999999995 111.803 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -76.79 -40.65 47.43 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.944 0.72 . . . . 73.319999999999993 112.944 -176.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.505 HG23 HG23 ' A' ' 53' ' ' VAL . 23.5 m -67.58 -16.14 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 112.253 0.464 . . . . 73.040000000000006 112.253 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.61 48.29 2.36 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.185 -0.531 . . . . 75.109999999999999 113.935 177.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.505 HG23 HG23 ' A' ' 51' ' ' VAL . 97.9 t -118.71 -40.94 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 121.075 0.464 . . . . 71.120000000000005 111.28 176.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.418 HD13 ' HB3' ' A' ' 67' ' ' TRP . 83.5 mt -112.85 136.45 52.46 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.401 0.619 . . . . 63.409999999999997 112.296 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -91.65 143.15 26.85 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.586 -0.734 . . . . 55.030000000000001 109.971 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -93.94 105.08 17.11 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.889 0.852 . . . . 75.129999999999995 111.662 -174.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 28.6 t . . . . . 0 CA--C 1.539 0.537 0 CA-C-O 121.358 0.599 . . . . 74.0 110.588 177.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.587 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 67.0 mt . . . . . 0 CA--C 1.537 0.45 0 CA-C-O 120.973 0.416 . . . . 74.030000000000001 110.191 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.552 ' NE1' HD13 ' A' ' 45' ' ' LEU . 67.1 m95 -93.88 116.43 28.89 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.335 0.588 . . . . 63.130000000000003 112.179 -172.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -114.69 111.49 21.37 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.843 -0.617 . . . . 72.310000000000002 110.534 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.428 ' HG ' ' NE2' ' A' ' 17' ' ' GLN . 3.5 pp -59.3 156.02 13.4 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 122.008 -0.433 . . . . 75.239999999999995 111.504 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.7 mt . . . . . 0 CA--C 1.539 0.526 0 CA-C-O 121.166 0.507 . . . . 73.299999999999997 111.231 179.27 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 121.098 0.475 . . . . 71.239999999999995 110.87 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.17 -47.11 91.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-N 116.116 -0.493 . . . . 74.310000000000002 111.145 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.1 m -52.22 -46.08 65.54 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.166 0.508 . . . . 72.329999999999998 111.354 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -55.36 -55.14 35.0 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.95 -0.568 . . . . 73.030000000000001 111.298 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.464 ' O ' HG23 ' A' ' 13' ' ' VAL . 62.8 mt -60.44 -46.04 95.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 112.038 0.384 . . . . 73.230000000000004 112.038 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.8 mt -58.51 -50.93 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 111.892 0.33 . . . . 74.430000000000007 111.892 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.6 p -55.92 -43.65 77.54 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.792 0.33 . . . . 40.420000000000002 111.771 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 82.5 mt -61.68 -55.91 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.927 0.394 . . . . 43.329999999999998 111.589 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 9' ' ' ILE . 80.1 t -55.07 -41.84 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.063 0.459 . . . . 72.420000000000002 111.523 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -65.5 -53.23 45.43 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.128 -0.487 . . . . 73.319999999999993 111.17 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -51.64 -49.5 62.16 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.104 0.478 . . . . 74.549999999999997 111.328 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -54.3 -51.12 65.65 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.733 -0.667 . . . . 74.239999999999995 111.943 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.487 ' NE2' ' HA ' ' A' ' 68' ' ' ARG . 78.3 mt-30 -66.32 -16.45 64.06 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.306 0.484 . . . . 74.400000000000006 112.306 -178.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -78.8 -29.63 45.01 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 122.045 -0.409 . . . . 53.130000000000003 110.791 170.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 23.2 mmt -91.5 -74.19 0.51 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.825 0.345 . . . . 71.340000000000003 111.54 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.27 77.79 8.91 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.91 0.862 . . . . 74.129999999999995 111.157 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -85.92 -28.06 24.57 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.116 -0.947 . . . . 74.430000000000007 111.06 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.36 -3.38 82.25 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 116.056 -0.52 . . . . 71.109999999999999 113.641 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -150.92 119.87 3.54 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 122.436 -0.45 . . . . 54.130000000000003 111.315 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.551 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 10.8 Cg_endo -52.59 152.87 15.4 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.99 2.46 . . . . 74.109999999999999 113.435 -178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.6 t -79.99 150.36 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 112.141 0.423 . . . . 64.120000000000005 112.141 -172.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.511 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 9.9 mptt -96.69 151.42 19.64 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.868 0.366 . . . . 72.140000000000001 111.262 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.8 m -56.0 -36.58 68.08 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 116.286 -0.415 . . . . 73.439999999999998 111.957 177.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.2 mtm-85 -57.07 -58.33 8.66 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.975 0.417 . . . . 75.219999999999999 111.501 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.91 -44.19 70.34 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.651 -0.704 . . . . 73.140000000000001 112.27 -177.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.6 mt -63.68 -46.29 95.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.065 0.459 . . . . 64.439999999999998 111.115 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.548 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -62.74 -43.88 97.64 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.933 0.396 . . . . 64.549999999999997 111.578 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.35 -47.28 84.9 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.062 -0.517 . . . . 61.030000000000001 111.2 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.67 -29.56 68.88 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 111.895 0.332 . . . . 63.340000000000003 111.895 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.14 -15.44 36.11 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.103 0.409 . . . . 52.43 112.103 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.14 27.4 71.98 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.425 -0.417 . . . . 44.530000000000001 112.832 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.6 mt -117.87 175.29 5.73 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.126 0.488 . . . . 73.140000000000001 111.753 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.5 t -80.23 149.31 30.47 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.399 0.518 . . . . 72.25 112.399 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.7 mm -51.92 -40.52 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.962 -0.563 . . . . 73.200000000000003 111.001 174.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.454 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 85.8 t80 -64.83 -56.61 12.4 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.939 -0.573 . . . . 74.420000000000002 111.855 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -57.96 -51.06 71.2 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.178 0.513 . . . . 71.349999999999994 111.633 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.548 HG21 ' HA ' ' A' ' 31' ' ' ALA . 78.2 t -55.87 -47.94 79.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.146 -0.479 . . . . 74.540000000000006 111.602 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -57.35 -38.33 73.97 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.572 -0.286 . . . . 65.010000000000005 111.52 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 92.2 mt -58.38 -46.45 86.32 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.809 0.338 . . . . 54.420000000000002 111.079 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -65.99 -44.17 85.64 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.787 0.327 . . . . 71.319999999999993 111.517 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.74 -48.43 81.83 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.116 0.484 . . . . 75.540000000000006 111.634 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.25 -41.34 90.11 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.318 -0.401 . . . . 73.299999999999997 111.79 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -61.72 -41.55 97.77 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.217 -0.302 . . . . 73.200000000000003 111.386 176.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.9 mt -60.01 -33.39 71.93 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.763 0.316 . . . . 64.430000000000007 111.166 176.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -66.22 -49.76 66.17 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 122.166 -0.334 . . . . 72.439999999999998 110.959 172.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.63 -32.07 71.24 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 112.085 0.402 . . . . 75.230000000000004 112.085 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.453 HG23 HG23 ' A' ' 53' ' ' VAL . 30.9 m -90.96 2.66 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 112.717 0.636 . . . . 62.340000000000003 112.717 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.03 51.93 3.43 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.222 -0.513 . . . . 52.240000000000002 114.202 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.453 HG23 HG23 ' A' ' 51' ' ' VAL . 60.9 t -129.71 -58.51 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 122.394 -0.474 . . . . 75.040000000000006 110.91 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.5 mt -104.37 178.43 4.56 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.211 0.529 . . . . 74.019999999999996 111.872 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.548 ' HB3' ' HG3' ' A' ' 68' ' ' ARG . 11.7 tp10 -138.03 144.78 41.2 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 120.843 0.354 . . . . 72.5 111.254 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -89.81 129.18 36.23 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.128 0.788 . . . . 74.239999999999995 113.128 -174.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.482 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 45.4 t . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 108.679 -0.859 . . . . 64.140000000000001 108.679 165.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 96.4 mt . . . . . 0 N--CA 1.467 0.423 0 CA-C-O 121.108 0.48 . . . . 63.210000000000001 110.227 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 28.8 m95 -123.4 143.24 50.25 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.636 0.606 . . . . 75.209999999999994 112.636 -169.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.548 ' HG3' ' HB3' ' A' ' 55' ' ' GLU . 9.1 ptm180 -147.69 174.43 11.79 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.668 -0.696 . . . . 72.409999999999997 110.862 174.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.459 ' HG ' ' OE1' ' A' ' 17' ' ' GLN . 3.3 pp -125.22 177.57 6.05 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.872 0.368 . . . . 52.210000000000001 111.426 175.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.526 ' N ' HD23 ' A' ' 70' ' ' LEU . 1.3 pt? . . . . . 0 CA--C 1.541 0.608 0 CA-C-O 121.416 0.627 . . . . 71.129999999999995 110.751 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.465 ' N ' HD12 ' A' ' 5' ' ' ILE . 2.1 mp . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 112.154 0.427 . . . . 72.340000000000003 112.154 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.92 -35.07 72.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.189 0.518 . . . . 65.109999999999999 110.48 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.0 m -61.28 -38.14 85.7 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.042 -0.526 . . . . 74.040000000000006 110.603 173.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.43 ' O ' HG13 ' A' ' 12' ' ' ILE . 86.8 tttt -63.35 -42.53 98.92 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.308 -0.406 . . . . 64.239999999999995 110.613 174.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.433 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.5 mt -52.19 -45.13 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.027 0.441 . . . . 70.109999999999999 110.796 174.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.4 mt -58.45 -44.38 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 116.224 -0.444 . . . . 75.099999999999994 111.203 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.9 m -59.64 -42.2 92.24 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.393 -0.367 . . . . 72.329999999999998 111.266 176.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 8' ' ' LYS . 82.9 mt -59.59 -46.05 93.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.055 0.455 . . . . 75.239999999999995 111.054 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.558 ' HA ' HG21 ' A' ' 25' ' ' VAL . 63.7 t -60.5 -49.63 83.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.082 0.468 . . . . 62.149999999999999 111.096 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.521 ' NE2' HD21 ' A' ' 18' ' ' ASN . 24.7 tm0? -58.65 -41.59 86.42 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.239 0.542 . . . . 52.210000000000001 110.677 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -60.05 -51.04 71.33 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.779 -0.646 . . . . 73.209999999999994 112.156 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.482 ' HB2' HG22 ' A' ' 25' ' ' VAL . 27.4 mmt180 -59.09 -35.4 73.35 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.664 0.269 . . . . 75.439999999999998 111.202 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.507 ' NE2' HG12 ' A' ' 13' ' ' VAL . 44.1 mt-30 -67.02 -27.33 67.32 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.976 0.417 . . . . 74.030000000000001 111.642 175.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.532 HD22 ' N ' ' A' ' 18' ' ' ASN . 0.8 OUTLIER -76.17 -23.12 54.73 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.963 0.411 . . . . 71.439999999999998 110.898 174.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.7 mmt -75.19 -54.99 6.19 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.06 -0.518 . . . . 71.25 110.345 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -119.99 98.97 6.34 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.166 -0.47 . . . . 74.049999999999997 110.592 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -61.76 -15.89 44.88 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.844 0.683 . . . . 63.310000000000002 112.844 -174.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -117.29 31.88 5.64 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.34 -0.457 . . . . 51.530000000000001 113.297 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -140.36 136.97 17.2 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 112.45 0.537 . . . . 73.010000000000005 112.45 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.556 ' HG2' HD13 ' A' ' 66' ' ' LEU . 82.7 Cg_endo -83.29 159.61 15.1 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.63 2.22 . . . . 62.409999999999997 112.312 172.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.558 HG21 ' HA ' ' A' ' 13' ' ' VAL . 11.2 t -85.91 156.2 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.055 0.455 . . . . 71.530000000000001 111.986 -175.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.46 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -99.95 140.17 34.55 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.263 -0.426 . . . . 70.109999999999999 110.783 -175.14 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.2 m -55.61 -41.1 73.0 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.874 0.369 . . . . 73.329999999999998 111.791 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -61.43 -52.72 63.4 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.892 0.377 . . . . 72.409999999999997 111.353 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.09 -35.66 75.7 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.238 -0.437 . . . . 74.439999999999998 111.772 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.529 HG21 HD21 ' A' ' 45' ' ' LEU . 77.8 mt -66.95 -56.28 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.801 0.334 . . . . 51.530000000000001 111.464 176.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.412 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -56.45 -43.42 79.49 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.087 0.403 . . . . 71.140000000000001 112.087 -178.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.51 -53.03 58.4 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.041 -0.527 . . . . 51.539999999999999 110.958 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.11 -29.47 70.59 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 111.933 0.346 . . . . 60.200000000000003 111.933 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.75 -27.13 44.66 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.905 0.383 . . . . 62.009999999999998 111.914 177.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.99 45.99 9.85 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.089 -0.577 . . . . 41.100000000000001 112.965 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.2 mt -135.5 178.16 7.26 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.732 -0.275 . . . . 74.129999999999995 111.045 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.422 ' O ' HG23 ' A' ' 41' ' ' VAL . 66.5 m -82.18 142.9 31.8 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 122.395 -0.191 . . . . 74.310000000000002 111.306 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.443 ' O ' ' HG3' ' A' ' 42' ' ' ARG . 48.2 mm -51.72 -55.68 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 122.53 0.332 . . . . 61.140000000000001 111.752 -176.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -54.17 -48.19 71.19 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.036 0.446 . . . . 72.129999999999995 111.474 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -58.12 -45.94 86.45 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.865 -0.607 . . . . 73.439999999999998 111.795 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 37' ' ' SER . 99.1 t -66.71 -39.27 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.319 -0.4 . . . . 74.409999999999997 111.637 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 38' ' ' ILE . 79.4 mtp180 -53.4 -44.45 68.73 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.809 0.337 . . . . 72.129999999999995 110.856 176.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.44 ' O ' ' HG3' ' A' ' 47' ' ' GLN . 98.2 mt -59.61 -49.51 77.48 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.23 -0.441 . . . . 71.219999999999999 111.054 176.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 21.4 m-30 -58.85 -43.87 90.88 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.888 0.375 . . . . 53.299999999999997 111.717 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.529 HD21 HG21 ' A' ' 30' ' ' ILE . 96.7 mt -63.45 -45.54 90.4 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.373 -0.376 . . . . 74.340000000000003 111.588 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -61.33 -39.7 91.5 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 121.214 -0.194 . . . . 53.119999999999997 110.788 175.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 80.9 mt-30 -58.45 -44.16 89.1 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.965 0.412 . . . . 63.329999999999998 110.976 172.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.86 -31.22 71.46 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.345 -0.389 . . . . 75.519999999999996 111.946 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -73.98 -36.67 64.57 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.082 0.468 . . . . 75.450000000000003 110.918 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -64.26 -50.46 67.86 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.159 -0.473 . . . . 71.140000000000001 111.291 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.549 HG23 HG23 ' A' ' 53' ' ' VAL . 33.7 m -75.56 4.13 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 N-CA-C 112.641 0.608 . . . . 73.430000000000007 112.641 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.71 29.53 38.84 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 114.952 0.741 . . . . 74.319999999999993 114.952 171.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.549 HG23 HG23 ' A' ' 51' ' ' VAL . 82.2 t -96.46 -60.15 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 117.413 0.607 . . . . 75.519999999999996 111.269 174.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.462 HD22 HG11 ' A' ' 13' ' ' VAL . 71.5 mt -99.26 145.48 27.24 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.226 0.536 . . . . 71.239999999999995 112.206 -176.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.525 ' HB2' HD23 ' A' ' 70' ' ' LEU . 9.3 tp10 -92.39 142.59 27.28 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.983 -0.553 . . . . 74.150000000000006 111.085 174.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -87.84 107.06 18.49 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.838 -0.619 . . . . 71.329999999999998 110.666 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 CA--C 1.542 0.664 0 CA-C-O 121.012 0.434 . . . . 65.150000000000006 112.002 -178.497 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.556 HD13 ' HG2' ' A' ' 24' ' ' PRO . 96.4 mt . . . . . 0 N--CA 1.47 0.525 0 CA-C-O 121.036 0.446 . . . . 64.019999999999996 111.319 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.452 ' CD1' HD13 ' A' ' 45' ' ' LEU . 67.1 m95 -108.04 117.54 34.39 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.809 0.67 . . . . 64.25 112.809 -170.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.475 ' HG3' ' OE1' ' A' ' 17' ' ' GLN . 55.8 ttt180 -120.63 178.7 4.58 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.402 -0.962 . . . . 73.340000000000003 108.402 171.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 54' ' ' LEU . 2.3 pp -101.52 160.97 13.98 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.526 1.057 . . . . 61.520000000000003 111.557 174.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.525 HD23 ' HB2' ' A' ' 55' ' ' GLU . 84.3 mt . . . . . 0 CA--C 1.535 0.388 0 CA-C-O 120.891 0.377 . . . . 72.150000000000006 110.337 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.7 mm . . . . . 0 N--CA 1.471 0.578 0 CA-C-O 121.05 0.452 . . . . 53.409999999999997 111.139 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.3 t -61.46 -48.11 90.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.341 -0.391 . . . . 73.0 110.923 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 99.5 m -58.13 -39.61 79.17 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.246 -0.434 . . . . 74.409999999999997 111.613 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.467 ' O ' HG13 ' A' ' 12' ' ' ILE . 60.1 tptt -57.57 -53.99 51.93 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.116 0.484 . . . . 71.510000000000005 110.485 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.527 HG23 HG21 ' A' ' 30' ' ' ILE . 67.8 mt -57.78 -48.65 83.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 115.784 -0.644 . . . . 74.549999999999997 111.931 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.7 mt -59.32 -44.31 92.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-O 120.966 0.412 . . . . 74.430000000000007 111.608 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.2 t -63.05 -32.49 73.87 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.336 -0.393 . . . . 70.239999999999995 111.556 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 8' ' ' LYS . 99.0 mt -71.35 -49.0 50.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.898 0.38 . . . . 72.340000000000003 111.336 176.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 9' ' ' ILE . 89.6 t -56.48 -44.09 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.135 0.493 . . . . 60.350000000000001 110.776 176.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -65.6 -39.96 92.13 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.945 -0.57 . . . . 74.200000000000003 110.898 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -55.57 -47.85 75.73 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.167 0.508 . . . . 52.399999999999999 110.87 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.572 ' HA ' ' HG2' ' A' ' 19' ' ' MET . 0.3 OUTLIER -64.46 -34.35 77.99 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.088 -0.506 . . . . 65.299999999999997 111.398 178.281 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.417 ' NE2' ' HG3' ' A' ' 68' ' ' ARG . 12.3 mm-40 -65.07 -40.03 94.1 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.038 0.447 . . . . 71.340000000000003 111.651 174.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -75.99 -21.94 56.38 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.281 0.474 . . . . 74.349999999999994 112.281 -177.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.572 ' HG2' ' HA ' ' A' ' 16' ' ' ARG . 24.8 ptm -83.77 -32.29 25.48 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.956 -0.465 . . . . 65.319999999999993 111.379 176.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -152.17 115.29 4.69 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.091 0.472 . . . . 71.0 110.805 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -69.4 -13.44 62.36 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.998 0.74 . . . . 74.129999999999995 112.998 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.03 15.15 12.34 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.052 -0.594 . . . . 72.239999999999995 113.487 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -107.71 113.58 61.25 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 112.174 0.435 . . . . 61.049999999999997 112.174 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.83 140.78 32.57 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.36 2.04 . . . . 71.319999999999993 112.067 172.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.411 HG13 ' HG3' ' A' ' 16' ' ' ARG . 5.4 t -79.12 154.64 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 120.923 0.392 . . . . 74.340000000000003 111.199 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.567 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 2.3 mptp? -107.58 139.0 42.79 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.65 -0.25 . . . . 74.120000000000005 110.737 -177.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.2 m -53.49 -51.13 63.75 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.066 0.46 . . . . 65.540000000000006 111.8 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -64.85 -31.26 72.4 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.114 0.412 . . . . 65.219999999999999 112.114 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -63.54 -52.69 60.01 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.945 0.403 . . . . 63.299999999999997 111.046 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.527 HG21 HG23 ' A' ' 9' ' ' ILE . 64.2 mt -55.89 -43.13 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.045 0.45 . . . . 73.129999999999995 110.892 176.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.78 -35.68 73.21 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.102 -0.499 . . . . 73.420000000000002 111.876 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -74.1 -48.46 29.52 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.763 0.316 . . . . 71.349999999999994 110.992 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.11 -28.66 69.92 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.114 0.413 . . . . 70.219999999999999 112.114 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.22 -26.45 16.64 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.297 0.48 . . . . 53.439999999999998 112.297 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.21 31.47 38.25 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.267 -0.492 . . . . 73.099999999999994 112.713 -176.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.5 mt -115.35 169.26 9.28 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.845 0.355 . . . . 63.119999999999997 111.432 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.412 ' O ' HG23 ' A' ' 41' ' ' VAL . 46.1 t -87.7 151.49 22.89 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.029 0.443 . . . . 62.32 111.772 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.1 mm -58.09 -48.85 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 112.985 0.735 . . . . 60.200000000000003 112.985 -172.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.552 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 41.8 p90 -56.68 -38.67 72.57 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 111.853 0.316 . . . . 74.530000000000001 111.853 -176.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -75.84 -47.18 26.64 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.079 0.466 . . . . 65.329999999999998 111.091 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 37' ' ' SER . 90.9 t -55.23 -48.28 76.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 116.17 -0.468 . . . . 72.329999999999998 111.614 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -65.61 -29.72 70.34 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 111.887 0.329 . . . . 71.239999999999995 111.887 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 65.6 mt -59.03 -49.28 78.49 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.167 -0.333 . . . . 61.329999999999998 110.577 176.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -61.28 -53.27 58.96 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.352 -0.385 . . . . 74.019999999999996 111.191 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.426 HD13 ' CD1' ' A' ' 67' ' ' TRP . 89.0 mt -55.37 -49.73 71.53 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.226 0.536 . . . . 74.310000000000002 112.393 -178.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.79 -41.73 95.6 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.937 -0.574 . . . . 62.340000000000003 112.095 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -68.83 -41.13 78.95 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.741 0.305 . . . . 75.25 110.942 176.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.0 mt -59.68 -31.63 69.74 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.746 0.307 . . . . 61.439999999999998 111.102 175.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.512 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 42.0 t-80 -66.43 -48.6 69.49 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.987 0.423 . . . . 73.129999999999995 111.031 173.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -59.96 -33.56 72.09 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 116.123 -0.489 . . . . 71.420000000000002 111.933 -176.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.523 HG23 HG23 ' A' ' 53' ' ' VAL . 33.9 m -89.44 1.53 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 112.841 0.682 . . . . 73.329999999999998 112.841 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.44 19.52 51.98 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 114.82 0.688 . . . . 53.210000000000001 114.82 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.523 HG23 HG23 ' A' ' 51' ' ' VAL . 81.6 t -88.53 -48.24 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 122.16 -0.612 . . . . 75.219999999999999 111.027 175.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 85.9 mt -114.79 152.39 32.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.285 -0.416 . . . . 61.200000000000003 111.503 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.459 ' HA ' ' HD2' ' A' ' 49' ' ' HIS . 10.5 tp10 -109.28 149.99 28.63 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.488 -0.323 . . . . 73.549999999999997 110.299 173.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -98.86 137.78 36.94 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.165 0.507 . . . . 74.430000000000007 111.215 -178.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.513 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 88.7 t . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 120.995 0.426 . . . . 71.540000000000006 111.57 -177.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.513 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 70.5 mt . . . . . 0 CA--C 1.537 0.457 0 CA-C-O 120.934 0.397 . . . . 71.150000000000006 111.597 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.426 ' CD1' HD13 ' A' ' 45' ' ' LEU . 72.8 m95 -131.45 154.04 49.11 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.856 0.36 . . . . 74.349999999999994 111.351 -178.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.417 ' HG3' ' NE2' ' A' ' 17' ' ' GLN . 50.7 ttt85 -165.3 117.55 1.16 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.551 -0.295 . . . . 74.310000000000002 110.992 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 54' ' ' LEU . 4.2 pp -64.21 155.29 32.29 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.953 0.406 . . . . 71.450000000000003 111.661 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.518 ' H ' HD23 ' A' ' 70' ' ' LEU . 1.8 pt? . . . . . 0 N--CA 1.47 0.563 0 CA-C-O 121.035 0.445 . . . . 74.230000000000004 111.184 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.64 HG12 HD11 ' A' ' 36' ' ' LEU . 9.5 tp . . . . . 0 CA--C 1.542 0.647 0 N-CA-C 112.314 0.487 . . . . 73.349999999999994 112.314 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.7 t -58.46 -50.26 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.853 0.359 . . . . 63.43 111.509 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.9 m -60.88 -40.02 91.43 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.937 0.398 . . . . 74.409999999999997 111.041 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.484 ' O ' HG13 ' A' ' 12' ' ' ILE . 4.4 ttmp? -58.93 -48.77 80.3 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.34 -0.391 . . . . 74.230000000000004 111.095 177.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.9 mt -56.47 -48.11 80.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.421 -0.354 . . . . 75.299999999999997 111.586 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.5 mt -59.14 -43.27 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.079 0.466 . . . . 73.329999999999998 111.018 176.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.4 t -60.52 -40.02 89.92 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.948 -0.569 . . . . 71.209999999999994 111.628 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 8' ' ' LYS . 86.8 mt -61.08 -51.06 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.093 0.473 . . . . 53.25 111.185 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.6 t -57.97 -51.01 76.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.105 0.478 . . . . 54.210000000000001 111.008 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -54.07 -47.38 71.73 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.998 -0.546 . . . . 72.239999999999995 111.349 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -57.52 -53.49 57.56 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.145 -0.479 . . . . 54.530000000000001 111.785 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -62.69 -27.17 69.06 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.568 -0.287 . . . . 75.310000000000002 111.71 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -80.22 -26.79 38.94 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 122.16 -0.337 . . . . 75.010000000000005 111.705 175.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -64.59 -26.11 68.26 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.225 0.536 . . . . 62.119999999999997 109.856 170.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.0 mmm -78.43 -60.18 2.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.708 -0.678 . . . . 74.230000000000004 111.548 173.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 23' ' ' ALA . 24.6 m-20 -94.13 -55.86 3.05 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.771 0.656 . . . . 54.219999999999999 112.771 -176.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.3 t70 68.47 -69.08 0.16 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.455 0.702 . . . . 74.030000000000001 111.834 -176.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.44 -35.34 84.86 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.983 -0.627 . . . . 75.310000000000002 112.812 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 20' ' ' ASP . . . -96.38 129.37 33.58 Favored Pre-proline 0 CA--C 1.541 0.63 0 O-C-N 122.618 -0.343 . . . . 74.439999999999998 111.069 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.04 164.14 33.1 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.421 2.08 . . . . 72.230000000000004 113.251 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.4 t -84.85 145.64 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.285 -0.416 . . . . 71.420000000000002 110.742 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.449 ' HD2' ' H ' ' A' ' 26' ' ' LYS . 6.5 mptt -90.06 141.16 28.94 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.706 0.289 . . . . 54.509999999999998 110.788 -176.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.1 m -52.01 -38.31 56.39 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.851 0.357 . . . . 60.350000000000001 111.873 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 28' ' ' ARG . 5.2 mpt_? -63.35 -47.56 81.64 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 122.37 -0.206 . . . . 73.349999999999994 111.552 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.22 -52.5 51.95 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.002 0.429 . . . . 70.340000000000003 111.196 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.56 HG21 HD21 ' A' ' 45' ' ' LEU . 58.3 mt -58.44 -53.89 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 115.764 -0.653 . . . . 74.129999999999995 111.742 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.468 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -60.85 -45.43 94.55 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.096 0.406 . . . . 72.120000000000005 112.096 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.16 -40.4 96.05 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.088 -0.506 . . . . 70.200000000000003 111.595 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.402 ' HB3' HD13 ' A' ' 12' ' ' ILE . . . -71.97 -38.29 69.76 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.877 0.37 . . . . 33.399999999999999 111.324 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.82 -35.27 72.41 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.287 -0.415 . . . . 62.539999999999999 111.659 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.97 23.2 42.4 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.394 -0.432 . . . . 65.219999999999999 113.509 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.64 HD11 HG12 ' A' ' 5' ' ' ILE . 85.7 mt -113.24 171.67 7.41 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.964 0.412 . . . . 72.0 111.705 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.5 m -71.65 144.36 49.42 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.261 -0.427 . . . . 71.019999999999996 111.404 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.1 mm -50.85 -58.22 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.35 0.5 . . . . 63.310000000000002 112.35 -174.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.471 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 47.8 p90 -54.02 -40.69 67.26 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.158 0.429 . . . . 62.200000000000003 112.158 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -65.43 -47.3 76.7 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.169 0.509 . . . . 65.140000000000001 111.016 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' A' ' 31' ' ' ALA . 60.9 t -58.7 -44.29 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.147 -0.479 . . . . 72.5 111.024 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -58.52 -33.69 70.14 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.616 -0.265 . . . . 64.049999999999997 111.686 178.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.533 ' O ' ' HG3' ' A' ' 47' ' ' GLN . 95.1 mt -60.07 -52.58 64.74 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 110.167 -0.309 . . . . 65.230000000000004 110.167 175.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -56.83 -46.0 81.96 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.115 0.484 . . . . 75.109999999999999 111.256 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.56 HD21 HG21 ' A' ' 30' ' ' ILE . 92.9 mt -59.92 -46.6 88.84 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.089 -0.505 . . . . 73.430000000000007 111.918 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -67.29 -37.18 83.0 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.509 0.195 . . . . 73.409999999999997 111.34 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 96.2 mt-30 -59.66 -45.19 92.8 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.064 0.459 . . . . 63.350000000000001 110.602 174.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 94.3 mt -61.42 -34.13 74.87 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.379 -0.373 . . . . 74.510000000000005 111.416 176.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.532 ' HD2' ' HA ' ' A' ' 55' ' ' GLU . 46.5 t-80 -70.56 -28.71 65.11 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.149 0.499 . . . . 73.200000000000003 111.015 174.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -79.65 -41.66 26.48 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.143 -0.481 . . . . 73.430000000000007 111.765 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.6 m -77.79 -24.71 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 111.914 0.339 . . . . 63.119999999999997 111.914 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.6 69.02 0.61 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.098 -0.572 . . . . 62.539999999999999 113.12 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 99.4 t -141.36 -60.92 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.111 0.481 . . . . 73.129999999999995 110.787 177.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.665 HD23 ' HB3' ' A' ' 69' ' ' LEU . 80.9 mt -103.98 145.75 29.7 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.148 -0.478 . . . . 74.230000000000004 111.962 -177.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.549 ' HB2' HD22 ' A' ' 70' ' ' LEU . 12.0 tp10 -108.53 141.11 40.91 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.029 0.442 . . . . 73.329999999999998 110.838 172.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? -89.96 94.87 9.97 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.144 0.497 . . . . 73.230000000000004 111.495 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 CA--C 1.542 0.66 0 CA-C-O 120.967 0.413 . . . . 75.030000000000001 110.835 177.003 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 66' ' ' LEU . 5.9 mp . . . . . 0 N--CA 1.466 0.364 0 N-CA-C 110.025 -0.361 . . . . 61.539999999999999 110.025 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.443 ' CD1' HD13 ' A' ' 45' ' ' LEU . 58.2 m95 -102.23 133.93 46.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.469 0.652 . . . . 73.200000000000003 111.906 -172.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -141.31 114.47 8.66 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.778 -0.646 . . . . 73.120000000000005 111.088 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.665 ' HB3' HD23 ' A' ' 54' ' ' LEU . 4.2 pp -67.76 151.58 46.99 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.426 0.631 . . . . 71.430000000000007 111.9 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.549 HD22 ' HB2' ' A' ' 55' ' ' GLU . 1.7 pt? . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 115.39 -0.823 . . . . 72.099999999999994 110.648 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.9 tp . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 112.054 0.39 . . . . 72.519999999999996 112.054 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.467 HG13 HD21 ' A' ' 48' ' ' LEU . 61.6 t -53.27 -49.53 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.402 -0.363 . . . . 72.450000000000003 111.955 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.0 m -55.45 -46.2 76.81 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.898 0.38 . . . . 74.329999999999998 111.408 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.499 ' O ' HG13 ' A' ' 12' ' ' ILE . 53.8 tptt -55.99 -50.61 70.37 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.366 -0.379 . . . . 64.450000000000003 111.49 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.3 mt -57.19 -42.33 79.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.312 -0.404 . . . . 64.219999999999999 111.562 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.2 mt -61.56 -46.06 97.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 121.003 0.43 . . . . 71.439999999999998 110.903 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.8 m -60.75 -32.67 71.96 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.348 -0.387 . . . . 55.409999999999997 111.506 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.536 HG21 ' HA ' ' A' ' 30' ' ' ILE . 96.4 mt -67.21 -41.32 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.788 0.328 . . . . 74.400000000000006 111.55 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.437 ' HA ' HG21 ' A' ' 25' ' ' VAL . 59.5 t -59.95 -41.23 85.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 121.207 0.527 . . . . 62.219999999999999 110.714 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -64.56 -48.15 76.09 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.058 0.456 . . . . 61.32 110.514 173.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -53.06 -56.3 17.21 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.624 -0.716 . . . . 74.040000000000006 112.25 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -67.48 -39.14 85.23 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.511 0.559 . . . . 61.350000000000001 112.511 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -74.21 -20.33 60.22 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.406 -0.518 . . . . 72.420000000000002 110.71 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -71.51 -24.53 61.98 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.497 0.665 . . . . 74.129999999999995 109.514 172.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.1 mmt -79.64 -47.89 14.65 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.871 -0.604 . . . . 75.120000000000005 111.504 169.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -98.56 84.69 3.21 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.052 0.453 . . . . 75.299999999999997 110.969 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -57.05 -37.34 71.66 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.397 0.518 . . . . 63.0 112.397 -177.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -108.11 20.14 31.33 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.244 -0.503 . . . . 74.109999999999999 113.868 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.436 ' HA ' ' HD2' ' A' ' 24' ' ' PRO . . . -158.39 108.33 1.68 Allowed Pre-proline 0 N--CA 1.468 0.459 0 CA-C-N 117.053 0.427 . . . . 62.219999999999999 111.785 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.53 ' HB3' ' HB2' ' A' ' 68' ' ' ARG . 1.5 Cg_endo -48.34 177.39 0.02 OUTLIER 'Trans proline' 0 CA--C 1.552 1.414 0 C-N-CA 122.954 2.436 . . . . 54.439999999999998 114.501 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.437 HG21 ' HA ' ' A' ' 13' ' ' VAL . 44.1 t -79.57 152.93 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 112.824 0.675 . . . . 72.040000000000006 112.824 -169.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.639 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 8.2 mptt -105.86 146.09 30.38 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.715 -0.675 . . . . 54.439999999999998 110.082 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.4 m -53.71 -44.34 69.77 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.652 0.612 . . . . 55.299999999999997 112.652 -176.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -59.47 -43.58 93.2 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 111.7 0.259 . . . . 72.129999999999995 111.7 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.465 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 2.8 m-20 -56.46 -39.62 73.47 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.039 0.447 . . . . 72.340000000000003 112.043 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.615 HG21 HD21 ' A' ' 45' ' ' LEU . 61.5 mt -68.94 -44.51 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.954 0.406 . . . . 71.239999999999995 111.289 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.473 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -61.82 -35.28 77.76 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.104 0.478 . . . . 53.299999999999997 111.162 175.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -65.58 -55.59 16.88 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.658 -0.701 . . . . 73.409999999999997 111.737 178.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.39 -37.99 87.9 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.762 0.653 . . . . 42.240000000000002 112.762 -176.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.48 -28.91 30.89 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 111.974 0.361 . . . . 73.049999999999997 111.974 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.64 39.05 22.6 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.066 -0.587 . . . . 53.439999999999998 112.586 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.5 mt -117.43 172.71 7.15 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 122.658 -0.319 . . . . 65.439999999999998 111.236 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.401 ' O ' HG23 ' A' ' 41' ' ' VAL . 50.6 m -78.99 148.14 32.67 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.663 -0.244 . . . . 74.310000000000002 111.439 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.6 mm -52.66 -58.56 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 112.407 0.521 . . . . 75.219999999999999 112.407 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -57.05 -41.83 79.4 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.959 0.409 . . . . 74.120000000000005 111.567 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -56.42 -49.64 73.97 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.462 0.649 . . . . 61.329999999999998 111.068 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.473 HG21 ' HA ' ' A' ' 31' ' ' ALA . 64.2 t -65.11 -39.47 85.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.838 -0.619 . . . . 72.310000000000002 111.352 178.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.4 mmm-85 -50.94 -48.17 60.95 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.889 0.376 . . . . 71.310000000000002 111.315 175.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.5 mt -59.01 -51.59 69.39 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.183 -0.462 . . . . 75.219999999999999 111.091 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -60.2 -45.15 94.15 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.4 0.519 . . . . 75.140000000000001 112.4 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.615 HD21 HG21 ' A' ' 30' ' ' ILE . 91.0 mt -64.6 -52.77 55.79 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.175 0.512 . . . . 73.420000000000002 111.515 -177.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.405 ' HG2' ' HH2' ' A' ' 67' ' ' TRP . 34.4 mt-10 -66.34 -29.22 69.37 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.101 -0.5 . . . . 74.450000000000003 111.993 -177.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -74.56 -37.84 62.86 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 122.104 -0.373 . . . . 71.030000000000001 111.052 172.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.467 HD21 HG13 ' A' ' 6' ' ' VAL . 62.1 mt -64.37 -26.54 68.51 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.883 0.373 . . . . 71.019999999999996 110.843 173.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -72.86 -40.35 65.75 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.887 0.375 . . . . 74.099999999999994 110.69 171.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.19 -38.2 88.21 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 116.216 -0.447 . . . . 72.430000000000007 111.744 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.6 HG23 HG23 ' A' ' 53' ' ' VAL . 35.4 m -81.25 -12.09 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 112.218 0.451 . . . . 72.5 112.218 177.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.18 24.93 13.43 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 120.986 -0.626 . . . . 73.400000000000006 114.62 174.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.6 HG23 HG23 ' A' ' 51' ' ' VAL . 64.4 t -91.71 -56.59 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 117.493 0.647 . . . . 65.25 111.332 175.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 61.5 mt -105.13 125.88 51.46 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.079 -0.509 . . . . 73.230000000000004 111.498 -176.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -93.87 140.19 29.98 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.887 0.375 . . . . 74.5 111.703 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -88.62 94.01 9.75 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.97 0.414 . . . . 72.319999999999993 110.58 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.6 t . . . . . 0 CA--C 1.536 0.437 0 CA-C-N 116.666 -0.243 . . . . 74.450000000000003 110.461 175.532 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 91.4 mt . . . . . 0 CA--C 1.539 0.543 0 CA-C-O 121.043 0.449 . . . . 70.409999999999997 111.764 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.405 ' HH2' ' HG2' ' A' ' 46' ' ' GLU . 85.3 m95 -84.4 125.42 32.32 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.563 0.697 . . . . 73.200000000000003 112.614 -175.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.53 ' HB2' ' HB3' ' A' ' 24' ' ' PRO . 74.0 ttt180 -139.97 117.78 11.68 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.897 -0.592 . . . . 72.5 110.768 176.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 69' ' ' LEU . 2.6 pt? -66.35 152.9 44.05 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.865 0.364 . . . . 75.340000000000003 111.12 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.6 mt . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 120.91 0.386 . . . . 74.010000000000005 111.826 -176.846 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.598 HD11 HD11 ' A' ' 36' ' ' LEU . 14.3 tt . . . . . 0 CA--C 1.54 0.56 0 CA-C-O 121.728 0.775 . . . . 72.209999999999994 109.917 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.556 HG13 HD11 ' A' ' 48' ' ' LEU . 92.8 t -56.83 -49.35 79.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.085 -0.962 . . . . 71.319999999999993 111.25 173.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.4 m -58.62 -33.3 69.88 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.133 0.492 . . . . 63.299999999999997 111.443 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.441 ' O ' HG13 ' A' ' 12' ' ' ILE . 58.8 tttp -62.58 -49.82 73.73 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.056 0.455 . . . . 61.310000000000002 110.297 174.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.497 ' HA ' HD12 ' A' ' 12' ' ' ILE . 72.1 mt -58.34 -43.53 86.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.98 -0.554 . . . . 52.420000000000002 111.332 178.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 73.6 mt -57.5 -42.08 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.911 0.386 . . . . 64.450000000000003 111.068 176.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.9 m -64.0 -34.16 77.37 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.252 -0.431 . . . . 64.120000000000005 111.28 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 9' ' ' ILE . 83.6 mt -66.39 -46.01 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.918 0.39 . . . . 61.310000000000002 110.98 176.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.54 -45.58 96.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.054 0.454 . . . . 74.019999999999996 110.768 175.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -55.91 -49.6 73.01 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.009 -0.541 . . . . 64.109999999999999 111.165 175.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -54.63 -56.34 20.02 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.682 -0.69 . . . . 64.030000000000001 111.522 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 35.9 mmt-85 -57.53 -40.11 78.08 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.27 -0.423 . . . . 70.109999999999999 111.907 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.49 ' O ' ' N ' ' A' ' 21' ' ' ASP . 59.9 mt-30 -61.35 -47.36 86.25 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.245 -0.284 . . . . 72.519999999999996 110.989 175.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -57.93 -27.02 62.99 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.293 0.479 . . . . 70.239999999999995 112.293 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 47.9 mtt -55.78 -41.71 74.47 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.164 0.431 . . . . 71.439999999999998 112.164 174.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 23' ' ' ALA . 30.7 t70 -128.63 8.58 5.86 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.021 0.439 . . . . 60.200000000000003 111.667 -176.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' A' ' 17' ' ' GLN . 31.9 t70 54.73 97.24 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.398 0.679 . . . . 71.230000000000004 112.418 -176.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.17 -13.6 66.64 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 114.465 0.546 . . . . 44.310000000000002 114.465 176.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . . . -56.42 120.58 36.86 Favored Pre-proline 0 N--CA 1.473 0.691 0 N-CA-C 112.493 0.553 . . . . 52.119999999999997 112.493 -177.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.546 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 72.6 Cg_endo -75.1 152.91 40.88 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.62 2.213 . . . . 71.409999999999997 112.813 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.1 t -117.13 150.86 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 O-C-N 122.301 -0.249 . . . . 71.200000000000003 111.566 -175.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.455 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 9.6 mptt -87.91 158.14 18.77 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.894 0.378 . . . . 71.510000000000005 110.803 176.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.509 HG21 ' HB2' ' A' ' 42' ' ' ARG . 56.0 m -56.38 -47.29 79.22 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.903 0.382 . . . . 72.219999999999999 111.814 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.48 -37.78 87.28 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.759 0.314 . . . . 64.5 111.264 -177.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 3.5 m-20 -64.23 -44.75 90.88 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.81 0.338 . . . . 74.349999999999994 111.413 178.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.65 -47.41 91.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 116.193 -0.458 . . . . 73.299999999999997 111.014 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.497 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -57.81 -41.98 83.29 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.04 0.448 . . . . 23.41 111.331 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -62.95 -47.54 82.78 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.043 -0.526 . . . . 73.439999999999998 111.53 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.43 -26.64 66.51 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.914 0.388 . . . . 71.150000000000006 111.994 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.73 -22.04 22.39 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.052 0.39 . . . . 73.329999999999998 112.052 178.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.36 34.21 54.97 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.213 -0.518 . . . . 75.299999999999997 112.507 -174.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.598 HD11 HD11 ' A' ' 5' ' ' ILE . 95.7 mt -115.34 -178.85 3.48 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.118 0.485 . . . . 65.129999999999995 111.624 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.4 m -84.85 141.86 30.15 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.853 -0.612 . . . . 74.0 111.077 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.3 mm -55.61 -58.51 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.578 0.584 . . . . 74.340000000000003 112.578 -173.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.469 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 41.5 t80 -60.44 -40.44 91.11 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.818 0.342 . . . . 62.100000000000001 111.453 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.473 ' HG3' ' HE2' ' A' ' 44' ' ' TYR . 5.8 tp-100 -57.45 -52.5 65.12 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.231 0.539 . . . . 71.439999999999998 111.149 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.497 HG21 ' HA ' ' A' ' 31' ' ' ALA . 71.6 t -58.54 -45.15 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.005 -0.543 . . . . 73.329999999999998 111.345 176.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.509 ' HB2' HG21 ' A' ' 27' ' ' THR . 76.5 ttt180 -51.23 -39.32 56.36 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.116 -0.493 . . . . 61.409999999999997 111.524 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 93.4 mt -65.49 -44.72 86.2 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.365 -0.38 . . . . 64.140000000000001 111.547 177.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.473 ' HE2' ' HG3' ' A' ' 40' ' ' GLN . 69.3 m-85 -62.37 -40.35 96.15 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.246 0.546 . . . . 74.209999999999994 111.126 177.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.498 HD13 ' CD1' ' A' ' 67' ' ' TRP . 81.9 mt -65.39 -45.14 85.18 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.247 -0.433 . . . . 73.209999999999994 111.452 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -66.1 -38.86 89.3 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.578 0.584 . . . . 72.120000000000005 112.578 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 20.9 pt20 -66.67 -36.63 83.0 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 120.779 -0.369 . . . . 74.319999999999993 110.659 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.556 HD11 HG13 ' A' ' 6' ' ' VAL . 85.2 mt -68.12 -38.86 82.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.18 0.514 . . . . 75.010000000000005 110.842 173.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.401 ' CE1' ' HD3' ' A' ' 56' ' ' LYS . 12.9 t-80 -68.28 -21.56 64.78 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.994 -0.548 . . . . 72.409999999999997 111.029 175.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -83.4 -50.9 7.87 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.22 -0.445 . . . . 72.230000000000004 111.603 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.2 m -70.72 -31.11 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 112.776 0.658 . . . . 51.210000000000001 112.776 -177.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 116.89 43.89 0.6 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 120.836 -0.697 . . . . 74.230000000000004 114.093 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.29 -38.06 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.081 0.467 . . . . 75.230000000000004 111.293 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.8 mt -111.28 136.98 49.6 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.938 0.399 . . . . 50.32 111.629 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -103.32 136.14 43.64 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.116 -0.493 . . . . 54.009999999999998 109.804 172.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.401 ' HD3' ' CE1' ' A' ' 49' ' ' HIS . 19.0 pttm -94.0 144.13 25.74 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.137 0.494 . . . . 64.540000000000006 110.99 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 16.2 t . . . . . 0 C--N 1.324 -0.533 0 N-CA-C 109.36 -0.608 . . . . 60.439999999999998 109.36 173.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.599 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 49.5 mt . . . . . 0 CA--C 1.538 0.504 0 CA-C-O 120.944 0.402 . . . . 55.310000000000002 111.042 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.498 ' CD1' HD13 ' A' ' 45' ' ' LEU . 49.8 m95 -106.3 127.68 53.43 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.887 0.375 . . . . 73.239999999999995 111.869 -176.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -140.58 121.67 14.71 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.215 0.531 . . . . 74.239999999999995 110.945 173.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 pp -69.23 161.23 29.63 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.949 0.404 . . . . 75.129999999999995 111.6 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.5 HD23 ' N ' ' A' ' 70' ' ' LEU . 1.5 pt? . . . . . 0 CA--C 1.539 0.551 0 CA-C-N 116.313 -0.403 . . . . 51.32 111.451 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.456 HG12 HD11 ' A' ' 36' ' ' LEU . 8.6 tp . . . . . 0 CA--C 1.539 0.538 0 N-CA-C 111.924 0.342 . . . . 65.099999999999994 111.924 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.7 t -58.81 -47.13 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.274 0.559 . . . . 70.310000000000002 110.932 178.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 m -61.49 -40.2 93.71 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.93 -0.577 . . . . 70.219999999999999 110.95 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.527 ' O ' HG13 ' A' ' 12' ' ' ILE . 88.5 tttt -61.14 -46.47 90.42 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.139 -0.482 . . . . 74.319999999999993 110.893 177.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 13' ' ' VAL . 78.2 mt -55.21 -49.28 73.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.88 0.372 . . . . 75.5 111.229 176.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 69.8 mt -59.09 -40.63 81.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.106 0.479 . . . . 74.430000000000007 111.02 176.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.3 t -63.38 -35.7 81.27 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.304 -0.407 . . . . 73.530000000000001 111.194 176.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 8' ' ' LYS . 86.0 mt -65.51 -44.14 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-O 121.245 0.545 . . . . 73.310000000000002 110.449 175.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 9' ' ' ILE . 95.5 t -56.92 -46.92 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 115.898 -0.592 . . . . 73.420000000000002 111.063 176.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -61.33 -49.15 78.16 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.208 -0.451 . . . . 72.400000000000006 110.96 176.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -54.47 -53.36 55.27 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.902 -0.59 . . . . 65.140000000000001 111.633 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.52 ' HG3' HG13 ' A' ' 25' ' ' VAL . 5.7 mmp_? -56.12 -42.22 76.51 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.239 -0.437 . . . . 71.400000000000006 112.128 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.41 ' NE2' ' HA ' ' A' ' 68' ' ' ARG . 77.8 mt-30 -70.25 -31.09 68.32 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.728 0.299 . . . . 71.299999999999997 111.692 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -60.68 -33.42 72.82 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.119 0.485 . . . . 71.010000000000005 110.825 173.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 95.7 mmm -61.59 -34.87 76.36 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.004 -0.544 . . . . 74.200000000000003 111.955 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -159.52 110.17 1.97 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.887 0.375 . . . . 63.549999999999997 110.68 177.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -59.85 -17.7 38.5 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.56 0.578 . . . . 73.140000000000001 112.56 -178.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.9 12.74 59.2 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 120.985 -0.626 . . . . 73.209999999999994 113.329 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . . . -122.98 139.8 32.17 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 117.06 0.43 . . . . 64.409999999999997 112.144 -177.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.418 ' HG2' HD13 ' A' ' 66' ' ' LEU . 9.8 Cg_endo -87.95 174.3 4.7 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.041 2.494 . . . . 71.430000000000007 112.495 175.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.52 HG13 ' HG3' ' A' ' 16' ' ' ARG . 21.2 t -101.93 135.86 36.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.372 -0.376 . . . . 51.240000000000002 111.212 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.42 143.05 27.12 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.621 0.248 . . . . 64.120000000000005 111.025 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 67.9 m -55.97 -37.26 68.82 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.168 0.509 . . . . 54.039999999999999 110.79 173.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.1 mmm-85 -60.55 -55.8 28.98 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.016 -0.538 . . . . 65.340000000000003 111.196 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -51.62 -44.92 63.07 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.99 -0.55 . . . . 71.540000000000006 111.643 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.0 mt -61.83 -45.39 98.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.385 -0.37 . . . . 73.209999999999994 111.306 177.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.55 -31.92 71.01 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.896 0.379 . . . . 62.43 111.647 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -67.46 -51.08 55.71 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.231 -0.441 . . . . 74.0 111.362 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.48 -26.97 60.36 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.231 0.456 . . . . 74.120000000000005 112.231 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.67 -28.49 23.12 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.082 0.401 . . . . 63.140000000000001 112.082 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.02 32.58 60.49 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.043 -0.598 . . . . 42.450000000000003 113.317 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.456 HD11 HG12 ' A' ' 5' ' ' ILE . 88.7 mt -115.59 166.57 11.77 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.916 0.388 . . . . 74.329999999999998 111.042 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.404 ' O ' HG23 ' A' ' 41' ' ' VAL . 97.6 p -70.08 143.72 52.35 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.768 0.318 . . . . 72.310000000000002 111.277 178.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.5 mm -49.15 -50.08 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 112.366 0.506 . . . . 75.409999999999997 112.366 -177.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -62.67 -42.82 99.82 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.719 0.295 . . . . 73.329999999999998 111.405 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -63.97 -43.85 94.49 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.901 0.382 . . . . 74.5 111.077 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 37' ' ' SER . 81.9 t -57.84 -42.93 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.975 0.417 . . . . 63.329999999999998 110.539 175.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -55.84 -40.44 72.85 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.025 -0.534 . . . . 73.430000000000007 111.429 175.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.1 mt -59.34 -44.52 92.64 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.805 0.336 . . . . 71.409999999999997 111.17 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -65.37 -53.95 35.96 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.364 -0.38 . . . . 62.520000000000003 111.797 177.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.478 HD13 ' CD1' ' A' ' 67' ' ' TRP . 89.5 mt -56.84 -38.3 72.46 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.101 0.477 . . . . 63.25 111.705 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -61.64 -53.66 53.24 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.956 -0.566 . . . . 73.439999999999998 110.985 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -67.79 -39.03 84.08 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 111.804 0.298 . . . . 73.319999999999993 111.804 -178.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.9 mt -61.01 -35.26 76.4 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.214 0.531 . . . . 74.200000000000003 110.782 173.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -67.07 -46.23 74.93 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.254 -0.43 . . . . 71.439999999999998 111.517 174.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -66.09 -41.61 90.44 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.271 0.471 . . . . 73.340000000000003 112.271 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.504 HG23 HG23 ' A' ' 53' ' ' VAL . 34.4 m -71.15 -17.86 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 112.14 0.422 . . . . 55.409999999999997 112.14 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.65 29.19 5.1 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 120.836 -0.697 . . . . 74.319999999999993 114.274 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.504 HG23 HG23 ' A' ' 51' ' ' VAL . 97.3 t -94.87 -49.74 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 117.369 0.584 . . . . 75.310000000000002 110.895 174.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.8 mt -112.54 138.76 48.84 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.09 0.472 . . . . 75.310000000000002 111.866 -178.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.511 ' HB3' ' HG3' ' A' ' 68' ' ' ARG . 33.7 tt0 -91.76 146.3 23.87 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.382 -0.372 . . . . 64.129999999999995 110.171 175.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -87.68 138.62 31.31 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.17 0.433 . . . . 74.409999999999997 112.17 -174.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 62.1 t . . . . . 0 CA--C 1.541 0.614 0 CA-C-O 120.922 0.392 . . . . 72.430000000000007 110.486 172.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 94.3 mt . . . . . 0 CA--C 1.536 0.42 0 CA-C-O 120.976 0.417 . . . . 65.439999999999998 110.304 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.478 ' CD1' HD13 ' A' ' 45' ' ' LEU . 57.9 m95 -128.39 146.77 50.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.249 0.547 . . . . 74.099999999999994 111.844 -175.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.511 ' HG3' ' HB3' ' A' ' 55' ' ' GLU . 5.8 ptm180 -138.74 172.3 13.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.929 -0.578 . . . . 73.299999999999997 110.029 174.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pp -108.7 168.92 8.99 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.132 -0.355 . . . . 74.239999999999995 110.867 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.5 mt . . . . . 0 CA--C 1.54 0.591 0 CA-C-O 121.083 0.468 . . . . 63.409999999999997 111.707 -177.199 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.4 mm . . . . . 0 CA--C 1.537 0.448 0 CA-C-O 121.058 0.456 . . . . 71.420000000000002 110.386 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.1 t -57.73 -48.11 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.018 0.437 . . . . 54.539999999999999 110.91 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 78.0 m -61.33 -35.47 77.49 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.412 -0.358 . . . . 53.420000000000002 110.982 176.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.51 ' O ' HG13 ' A' ' 12' ' ' ILE . 86.9 tttt -60.28 -47.91 83.99 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.433 -0.349 . . . . 72.219999999999999 110.612 176.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 68.1 mt -57.32 -48.47 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.308 -0.405 . . . . 61.43 111.371 176.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.4 mt -57.21 -40.47 73.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.136 0.493 . . . . 64.030000000000001 110.993 176.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.6 m -61.34 -45.33 94.87 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.087 -0.506 . . . . 70.340000000000003 111.022 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.544 ' O ' ' HG2' ' A' ' 16' ' ' ARG . 83.1 mt -57.94 -56.03 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.17 -0.468 . . . . 72.120000000000005 111.563 179.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.548 HG12 HD23 ' A' ' 69' ' ' LEU . 49.0 t -56.82 -50.81 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.847 0.356 . . . . 63.130000000000003 111.602 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -57.11 -45.67 83.24 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.089 0.471 . . . . 61.210000000000001 111.219 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -60.02 -40.48 89.45 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.291 -0.413 . . . . 72.010000000000005 111.419 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 12' ' ' ILE . 23.4 mmm-85 -62.23 -39.48 92.95 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 122.178 -0.326 . . . . 65.010000000000005 110.503 175.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -65.69 -26.09 67.61 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.057 0.456 . . . . 50.229999999999997 111.556 175.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -78.05 -18.98 55.15 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.846 0.355 . . . . 65.420000000000002 111.008 173.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 94.8 mmm -81.05 -35.64 31.55 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.932 0.396 . . . . 74.319999999999993 111.103 174.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.582 ' HB3' ' HB2' ' A' ' 23' ' ' ALA . 18.6 t70 -142.98 138.75 30.29 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.457 -0.338 . . . . 65.299999999999997 110.913 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -61.79 -11.3 11.77 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.435 0.902 . . . . 73.519999999999996 113.435 -175.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.472 ' O ' ' HD3' ' A' ' 24' ' ' PRO . . . -150.08 51.59 0.53 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.973 -0.632 . . . . 72.420000000000002 112.954 177.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.582 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . . . -83.8 109.49 18.87 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.567 0.58 . . . . 23.239999999999998 112.567 -177.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.569 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 88.9 Cg_endo -79.95 108.05 2.17 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.987 1.791 . . . . 63.420000000000002 111.083 171.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 13' ' ' VAL . 14.6 t -79.02 144.3 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.414 0.626 . . . . 60.439999999999998 111.528 -172.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.612 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -95.36 138.82 32.52 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.106 -0.497 . . . . 73.010000000000005 111.479 -171.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.53 HG21 ' HD2' ' A' ' 42' ' ' ARG . 86.9 m -52.68 -38.81 61.15 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.049 0.452 . . . . 63.009999999999998 111.163 175.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -60.54 -58.52 8.14 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.054 -0.521 . . . . 71.030000000000001 111.016 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -51.17 -46.31 62.04 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.128 0.489 . . . . 64.400000000000006 111.312 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.5 mt -60.48 -44.48 96.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.117 -0.492 . . . . 74.310000000000002 111.505 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.59 -48.01 83.33 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.789 0.328 . . . . 61.32 111.615 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.67 -52.75 63.06 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.39 -0.368 . . . . 64.25 111.881 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.37 -37.7 87.8 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.366 0.506 . . . . 74.049999999999997 112.366 -178.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.24 -35.85 58.79 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 111.841 0.312 . . . . 52.32 111.841 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.26 33.14 8.27 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.284 -0.484 . . . . 51.109999999999999 112.706 -176.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.8 mt -120.11 171.77 8.23 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.2 0.524 . . . . 74.329999999999998 111.708 -177.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.494 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.7 m -81.84 147.28 29.43 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.985 -0.552 . . . . 62.030000000000001 111.08 178.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.497 ' O ' ' HD3' ' A' ' 42' ' ' ARG . 47.5 mm -51.17 -58.59 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 112.904 0.705 . . . . 75.319999999999993 112.904 -175.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -62.42 -32.1 72.89 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.994 0.426 . . . . 75.319999999999993 111.336 -178.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -61.32 -45.26 95.17 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.378 0.609 . . . . 74.219999999999999 110.378 175.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 37' ' ' SER . 71.3 t -62.45 -36.8 76.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 115.842 -0.617 . . . . 73.319999999999993 111.658 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.53 ' HD2' HG21 ' A' ' 27' ' ' THR . 0.3 OUTLIER -47.29 -53.07 14.46 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 121.128 0.489 . . . . 73.420000000000002 111.179 173.348 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.401 ' O ' ' HG3' ' A' ' 47' ' ' GLN . 74.1 mt -60.06 -48.67 80.74 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.617 -0.72 . . . . 73.439999999999998 111.516 -177.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -57.42 -50.04 74.29 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.373 -0.376 . . . . 74.420000000000002 111.782 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 67.8 mt -62.96 -46.61 86.89 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.872 0.368 . . . . 60.329999999999998 111.862 -176.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -61.11 -41.77 97.3 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.544 -0.298 . . . . 74.239999999999995 111.732 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 87.3 mt-30 -65.48 -40.02 92.62 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.755 0.312 . . . . 74.450000000000003 111.325 176.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.0 -30.48 70.98 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.882 0.373 . . . . 74.310000000000002 111.127 175.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -65.09 -44.81 87.63 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.889 0.376 . . . . 73.519999999999996 110.946 173.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -62.21 -48.03 81.81 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.314 0.487 . . . . 75.209999999999994 112.314 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.546 HG23 HG23 ' A' ' 53' ' ' VAL . 33.2 m -74.29 2.8 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 112.802 0.668 . . . . 74.109999999999999 112.802 -177.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.72 34.99 10.61 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.747 -0.739 . . . . 51.030000000000001 114.255 174.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.546 HG23 HG23 ' A' ' 51' ' ' VAL . 63.7 t -107.65 -60.69 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 122.383 -0.481 . . . . 64.109999999999999 111.101 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 69' ' ' LEU . 79.3 mt -100.95 163.99 12.03 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.955 0.724 . . . . 70.040000000000006 112.955 -175.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -136.51 145.02 44.61 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.532 -0.758 . . . . 62.329999999999998 110.264 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -84.15 141.55 30.99 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.176 0.513 . . . . 74.129999999999995 112.292 -174.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 48.5 t . . . . . 0 C--O 1.241 0.635 0 CA-C-O 121.239 0.542 . . . . 61.020000000000003 109.831 172.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.569 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 87.7 mt . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 120.612 0.244 . . . . 74.340000000000003 110.507 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -129.83 122.67 29.18 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.035 0.445 . . . . 75.319999999999993 111.995 -175.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -104.16 -172.72 2.16 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.284 -0.416 . . . . 61.329999999999998 109.916 171.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 54' ' ' LEU . 3.0 pp -126.38 164.6 20.73 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.153 -0.342 . . . . 72.430000000000007 110.582 172.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.3 mt . . . . . 0 CA--C 1.536 0.404 0 CA-C-O 121.336 0.588 . . . . 74.430000000000007 110.779 178.852 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 5' ' ' ILE . 2.0 mp . . . . . 0 N--CA 1.474 0.764 0 CA-C-O 120.869 0.366 . . . . 74.340000000000003 111.034 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 51.4 t -60.09 -36.62 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 116.459 -0.337 . . . . 73.310000000000002 111.211 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 95.0 m -54.27 -41.21 68.58 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.445 -0.343 . . . . 72.140000000000001 111.436 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.537 ' O ' HG13 ' A' ' 12' ' ' ILE . 23.1 ttmm -60.89 -47.06 88.14 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.761 0.315 . . . . 70.439999999999998 110.59 177.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 13' ' ' VAL . 62.7 mt -57.26 -46.7 85.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 120.827 0.346 . . . . 64.420000000000002 111.039 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 72.1 mt -59.61 -42.96 89.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.912 0.386 . . . . 73.409999999999997 111.126 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.2 t -62.73 -39.1 93.01 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.894 0.378 . . . . 72.319999999999993 111.365 177.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 8' ' ' LYS . 94.1 mt -61.68 -51.03 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.806 0.336 . . . . 73.540000000000006 110.599 176.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.572 HG13 HG21 ' A' ' 25' ' ' VAL . 59.0 t -60.9 -45.13 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 116.392 -0.367 . . . . 74.530000000000001 111.479 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.477 ' HA ' HD21 ' A' ' 69' ' ' LEU . 57.7 tp60 -60.26 -46.21 90.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.867 0.365 . . . . 70.120000000000005 110.997 177.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -61.55 -39.18 90.16 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.956 0.408 . . . . 73.5 110.859 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 12' ' ' ILE . 16.6 mmm-85 -65.27 -41.31 94.32 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.802 0.334 . . . . 72.140000000000001 111.216 175.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -64.73 -31.12 72.2 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.511 0.672 . . . . 74.129999999999995 110.591 173.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -75.8 -20.32 58.3 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.336 -0.847 . . . . 73.310000000000002 110.681 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 94.5 mmm -102.79 -69.64 0.78 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.018 -0.537 . . . . 70.439999999999998 111.383 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.507 ' HB3' ' HB3' ' A' ' 23' ' ' ALA . 49.3 m-20 -66.66 -66.5 0.55 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.051 0.389 . . . . 62.450000000000003 112.051 -178.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.1 t70 69.3 -60.87 0.45 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.423 0.689 . . . . 71.450000000000003 111.544 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.66 -28.13 72.53 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.276 -0.487 . . . . 74.5 112.73 176.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 20' ' ' ASP . . . -103.25 134.01 20.01 Favored Pre-proline 0 CA--C 1.538 0.507 0 O-C-N 122.579 -0.366 . . . . 74.329999999999998 110.92 177.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.515 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 8.0 Cg_exo -71.88 167.0 27.84 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.533 2.155 . . . . 54.530000000000001 113.145 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.572 HG21 HG13 ' A' ' 13' ' ' VAL . 29.1 t -85.44 142.07 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 115.999 -0.546 . . . . 73.209999999999994 110.763 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.538 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -102.12 146.56 27.77 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.717 0.294 . . . . 70.299999999999997 110.628 -179.199 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.4 m -59.54 -29.72 68.11 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.26 0.552 . . . . 73.25 110.932 176.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -58.53 -61.62 2.46 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.617 -0.72 . . . . 74.209999999999994 111.761 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.502 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 3.2 m-20 -51.64 -42.95 62.44 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.185 -0.462 . . . . 75.540000000000006 111.792 -178.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.6 mt -64.54 -42.36 94.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 116.33 -0.396 . . . . 74.010000000000005 111.25 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.1 -47.85 81.08 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.976 0.417 . . . . 71.439999999999998 111.797 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -67.76 -42.29 82.0 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.156 0.428 . . . . 73.450000000000003 112.156 178.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.59 -49.51 53.4 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.33 0.492 . . . . 72.109999999999999 112.33 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.6 -28.18 51.47 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.243 0.46 . . . . 72.230000000000004 112.243 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.76 54.38 3.47 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.203 -0.522 . . . . 44.119999999999997 112.763 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.4 mt -132.83 159.0 41.08 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.02 0.438 . . . . 73.209999999999994 111.384 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.1 m -73.46 145.72 45.52 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.306 -0.246 . . . . 75.010000000000005 110.805 174.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.2 mm -50.23 -41.47 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 112.403 0.52 . . . . 72.519999999999996 112.403 -176.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.417 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 56.6 t80 -59.83 -55.39 34.8 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.9 0.381 . . . . 70.340000000000003 111.001 175.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -52.0 -45.72 64.63 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.024 -0.534 . . . . 64.129999999999995 111.392 177.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.56 -49.37 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.161 -0.472 . . . . 72.310000000000002 111.182 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 mtm105 -58.34 -36.89 74.12 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.662 -0.245 . . . . 75.040000000000006 111.587 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.517 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 88.7 mt -56.56 -52.39 64.97 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.183 0.516 . . . . 70.439999999999998 110.306 177.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -64.96 -43.59 92.15 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.197 -0.456 . . . . 74.209999999999994 112.052 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.7 mt -65.86 -50.0 66.13 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.9 0.381 . . . . 54.399999999999999 111.853 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -62.74 -34.12 76.54 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.532 -0.304 . . . . 63.009999999999998 111.631 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 11.7 mm-40 -68.12 -47.96 66.73 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.119 -0.363 . . . . 55.439999999999998 110.977 174.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.5 mt -58.17 -32.8 68.55 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.043 0.449 . . . . 71.209999999999994 110.977 175.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.432 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 5.2 t60 -68.19 -44.96 74.68 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.9 0.381 . . . . 71.400000000000006 111.143 173.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.5 -42.35 95.89 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.127 -0.488 . . . . 62.549999999999997 111.753 -177.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.516 HG23 HG23 ' A' ' 53' ' ' VAL . 25.3 m -74.44 -9.79 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 112.151 0.426 . . . . 74.430000000000007 112.151 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.49 10.91 37.19 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 115.033 0.773 . . . . 62.43 115.033 173.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.516 HG23 HG23 ' A' ' 51' ' ' VAL . 92.5 t -82.26 -52.87 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 117.626 0.713 . . . . 64.439999999999998 111.439 177.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 91.9 mt -106.09 160.99 14.88 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.323 0.583 . . . . 54.119999999999997 112.035 -177.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -129.39 139.3 51.73 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.847 -0.615 . . . . 71.540000000000006 110.088 174.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -88.91 103.25 15.84 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.062 0.458 . . . . 61.340000000000003 111.488 -176.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.553 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 44.8 t . . . . . 0 CA--C 1.54 0.569 0 CA-C-O 121.086 0.47 . . . . 72.25 110.56 175.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.553 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 85.4 mt . . . . . 0 CA--C 1.54 0.564 0 CA-C-O 120.672 0.272 . . . . 65.510000000000005 111.17 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -128.24 147.23 50.58 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.05 0.452 . . . . 75.129999999999995 112.142 -176.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -150.89 134.62 16.5 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.497 -0.32 . . . . 73.329999999999998 111.161 174.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.52 ' O ' HD12 ' A' ' 69' ' ' LEU . 2.4 pp -78.69 141.86 37.59 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.184 0.516 . . . . 65.310000000000002 111.745 177.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.497 ' H ' HD23 ' A' ' 70' ' ' LEU . 1.9 pt? . . . . . 0 N--CA 1.471 0.621 0 CA-C-N 116.284 -0.416 . . . . 71.450000000000003 111.674 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.1 mm . . . . . 0 CA--C 1.539 0.539 0 CA-C-O 120.947 0.403 . . . . 72.450000000000003 111.557 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.1 t -62.86 -52.78 55.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.844 0.354 . . . . 71.219999999999999 111.359 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.4 m -59.19 -35.37 73.47 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.499 -0.319 . . . . 52.240000000000002 111.405 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -57.36 -50.71 72.1 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 110.134 -0.321 . . . . 70.340000000000003 110.134 176.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.48 HG23 HG21 ' A' ' 30' ' ' ILE . 67.2 mt -57.95 -51.79 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 116.212 -0.449 . . . . 72.120000000000005 111.546 175.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 79.3 mt -55.55 -47.26 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 112.319 0.489 . . . . 73.010000000000005 112.319 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.1 p -60.46 -42.46 96.24 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.882 0.372 . . . . 72.549999999999997 111.277 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.434 HG21 ' HA ' ' A' ' 30' ' ' ILE . 93.8 mt -63.08 -46.97 94.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 116.208 -0.451 . . . . 53.549999999999997 111.304 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.614 HG13 HG21 ' A' ' 25' ' ' VAL . 80.9 t -54.03 -55.27 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.987 0.422 . . . . 61.100000000000001 111.189 176.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -57.93 -40.01 79.42 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.239 -0.437 . . . . 71.040000000000006 111.664 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -66.18 -42.97 88.15 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.915 0.388 . . . . 64.150000000000006 110.936 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.496 ' HB2' HG22 ' A' ' 25' ' ' VAL . 5.0 mmp_? -57.58 -39.95 77.91 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.866 0.365 . . . . 74.400000000000006 110.564 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.679 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 14.6 mm100 -61.97 -40.63 96.25 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.066 0.46 . . . . 71.329999999999998 110.935 174.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -60.88 -28.79 69.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.247 -0.433 . . . . 73.239999999999995 111.766 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 28.1 mmt -60.54 -53.38 58.26 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.665 0.617 . . . . 74.019999999999996 112.665 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.695 ' HB3' ' HB2' ' A' ' 23' ' ' ALA . 13.4 t70 -117.9 142.35 47.43 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.77 0.319 . . . . 72.430000000000007 111.156 -176.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -63.01 94.08 0.07 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.307 0.575 . . . . 63.140000000000001 111.027 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.55 43.45 7.34 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 115.886 -0.597 . . . . 72.340000000000003 112.04 -174.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.695 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . . . -67.53 147.15 98.79 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 113.208 0.818 . . . . 62.549999999999997 113.208 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.441 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 90.4 Cg_endo -100.71 131.04 0.15 Allowed 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 123.21 2.607 . . . . 71.530000000000001 111.463 159.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.614 HG21 HG13 ' A' ' 13' ' ' VAL . 48.8 t -79.31 138.38 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.165 0.507 . . . . 72.450000000000003 112.012 -176.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.422 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -89.8 134.11 34.36 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.227 -0.442 . . . . 71.430000000000007 110.437 177.1 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 56.2 m -55.75 -27.99 53.59 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.09 0.471 . . . . 71.230000000000004 111.615 177.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -65.22 -54.59 27.16 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.216 -0.447 . . . . 70.409999999999997 112.098 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.25 -50.42 38.84 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 122.856 0.463 . . . . 72.409999999999997 112.119 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.48 HG21 HG23 ' A' ' 9' ' ' ILE . 53.1 mt -58.17 -57.78 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.151 -0.477 . . . . 71.420000000000002 111.787 -177.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.11 -45.49 87.16 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.947 0.403 . . . . 61.219999999999999 111.524 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -61.6 -42.4 98.82 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.806 -0.634 . . . . 75.310000000000002 111.896 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.03 -41.41 28.93 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.519 0.563 . . . . 73.239999999999995 112.519 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.33 -19.87 60.31 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.513 0.56 . . . . 75.540000000000006 112.513 -176.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.32 17.0 56.46 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.042 -0.599 . . . . 73.319999999999993 112.817 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.4 mt -106.44 170.93 7.63 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.993 0.425 . . . . 74.200000000000003 111.306 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.5 t -94.68 161.98 13.97 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.323 -0.399 . . . . 63.119999999999997 111.157 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -57.15 -48.9 81.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 112.566 0.58 . . . . 63.119999999999997 112.566 -174.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.518 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 29.4 p90 -60.13 -44.07 95.18 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.998 0.427 . . . . 71.420000000000002 111.042 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -57.62 -52.3 65.97 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.62 0.724 . . . . 74.329999999999998 110.832 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.459 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 92.0 t -59.55 -46.27 93.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.542 -0.754 . . . . 64.540000000000006 111.414 178.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.5 mtm105 -58.5 -28.95 65.88 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.116 0.413 . . . . 72.519999999999996 112.116 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 87.6 mt -65.82 -52.34 51.39 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.983 0.42 . . . . 72.109999999999999 110.836 174.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -63.29 -41.02 98.94 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.438 -0.346 . . . . 74.430000000000007 111.569 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 88.2 mt -62.68 -37.93 88.39 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.0 0.428 . . . . 64.450000000000003 111.091 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -60.87 -42.66 98.32 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.304 -0.407 . . . . 74.019999999999996 110.741 176.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -62.49 -51.68 66.49 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.255 -0.43 . . . . 71.329999999999998 110.928 176.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.2 mt -57.92 -31.77 67.12 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.148 0.499 . . . . 74.409999999999997 111.407 176.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -70.88 -34.38 71.54 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.068 0.461 . . . . 64.239999999999995 110.836 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -73.46 -41.08 63.62 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.085 -0.507 . . . . 73.310000000000002 111.456 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.549 HG23 HG23 ' A' ' 53' ' ' VAL . 36.0 m -84.13 7.76 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 N-CA-C 112.886 0.699 . . . . 74.239999999999995 112.886 -177.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.51 44.7 10.51 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 120.942 -0.647 . . . . 71.239999999999995 114.46 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.549 HG23 HG23 ' A' ' 51' ' ' VAL . 91.2 t -114.31 -42.89 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.002 0.43 . . . . 54.219999999999999 111.331 175.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.4 mt -116.85 151.92 35.53 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.841 0.682 . . . . 52.420000000000002 112.841 -176.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.502 ' HB2' HD22 ' A' ' 70' ' ' LEU . 1.4 tm-20 -122.98 128.16 49.83 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.112 -0.949 . . . . 73.219999999999999 108.683 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.504 ' NZ ' ' HB3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -87.49 93.67 9.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.147 0.498 . . . . 62.25 111.311 -172.641 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 82.1 t . . . . . 0 CA--C 1.538 0.515 0 CA-C-N 115.91 -0.587 . . . . 73.239999999999995 111.963 -178.395 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 82.6 mt . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 120.927 0.394 . . . . 72.549999999999997 110.977 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -123.14 121.81 36.9 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.999 0.428 . . . . 74.439999999999998 111.687 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -118.67 127.45 53.58 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.345 -0.389 . . . . 70.120000000000005 110.755 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 69' ' ' LEU . 3.3 pp -79.16 150.35 31.74 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.077 0.465 . . . . 71.150000000000006 111.534 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 55' ' ' GLU . 2.1 pt? . . . . . 0 CA--C 1.537 0.476 0 CA-C-N 116.175 -0.466 . . . . 51.420000000000002 110.887 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.8 tt . . . . . 0 CA--C 1.543 0.674 0 CA-C-O 121.123 0.487 . . . . 71.109999999999999 111.449 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.472 HG11 HD21 ' A' ' 48' ' ' LEU . 49.8 t -56.69 -29.92 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 112.599 0.592 . . . . 72.219999999999999 112.599 -176.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.2 m -51.91 -41.07 61.69 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.893 0.378 . . . . 75.120000000000005 111.527 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.481 ' O ' HG13 ' A' ' 12' ' ' ILE . 4.4 ttmp? -54.41 -52.09 62.82 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.07 0.462 . . . . 73.109999999999999 110.722 174.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.535 HG23 HG21 ' A' ' 30' ' ' ILE . 67.4 mt -59.1 -45.27 92.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.8 -0.637 . . . . 54.549999999999997 111.572 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.6 mt -58.41 -43.35 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.082 0.468 . . . . 52.25 111.053 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.2 t -64.0 -40.15 95.72 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.198 -0.455 . . . . 70.310000000000002 111.205 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 8' ' ' LYS . 84.9 mt -63.18 -44.53 99.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 120.705 0.288 . . . . 75.219999999999999 111.375 177.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.536 HG13 HG21 ' A' ' 25' ' ' VAL . 91.7 t -54.1 -53.62 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 121.409 0.623 . . . . 74.239999999999995 110.663 174.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -56.52 -44.65 80.97 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.439 -0.8 . . . . 54.530000000000001 111.442 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 19' ' ' MET . 6.7 tp10 -58.34 -52.23 66.49 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.011 0.434 . . . . 70.349999999999994 111.258 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.48 ' HD2' ' HB3' ' A' ' 29' ' ' ASP . 1.9 mmp_? -49.93 -36.96 29.74 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.99 -0.55 . . . . 72.099999999999994 111.326 177.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.745 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 78.3 mt-30 -74.85 -42.53 57.79 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.227 -0.442 . . . . 70.430000000000007 112.019 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -56.86 -28.74 62.15 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.081 0.467 . . . . 71.340000000000003 111.424 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.41 ' HG2' ' O ' ' A' ' 15' ' ' GLU . 26.4 mmt -72.58 -39.25 67.54 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.455 0.539 . . . . 65.129999999999995 112.455 -178.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.677 ' HB2' ' HB2' ' A' ' 23' ' ' ALA . 4.1 m-20 -127.58 20.11 6.69 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.304 0.483 . . . . 73.430000000000007 112.304 -175.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.8 t70 59.22 -88.19 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.028 0.531 . . . . 72.120000000000005 112.429 176.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -85.94 56.38 4.83 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.682 -0.567 . . . . 54.240000000000002 111.682 177.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.745 ' HB3' ' HA ' ' A' ' 17' ' ' GLN . . . -96.0 118.17 65.9 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 113.327 0.862 . . . . 74.310000000000002 113.327 -171.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.459 ' HB3' HG11 ' A' ' 57' ' ' VAL . 91.3 Cg_endo -78.08 118.97 4.51 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.217 1.944 . . . . 71.530000000000001 110.72 168.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.536 HG21 HG13 ' A' ' 13' ' ' VAL . 61.7 t -78.34 132.53 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 121.075 0.464 . . . . 73.319999999999993 112.084 -171.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.491 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -89.6 132.67 34.99 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.856 -0.611 . . . . 65.329999999999998 110.297 -179.408 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.435 HG23 HD12 ' A' ' 45' ' ' LEU . 56.4 m -49.48 -38.53 30.32 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.566 0.58 . . . . 73.209999999999994 112.566 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -72.38 -29.1 63.45 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.612 0.597 . . . . 60.43 112.612 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.48 ' HB3' ' HD2' ' A' ' 16' ' ' ARG . 76.4 m-20 -54.04 -49.29 69.29 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.424 0.631 . . . . 73.329999999999998 111.06 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.535 HG21 HG23 ' A' ' 9' ' ' ILE . 59.0 mt -64.64 -37.08 79.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.653 -0.703 . . . . 74.420000000000002 111.388 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.27 -47.87 80.53 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.446 -0.343 . . . . 61.409999999999997 111.439 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -65.15 -48.74 72.46 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.8 0.333 . . . . 70.230000000000004 111.459 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.56 -52.6 63.79 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.452 0.538 . . . . 44.219999999999999 112.452 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.6 -19.9 44.45 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.418 0.525 . . . . 74.329999999999998 112.418 -177.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.79 47.22 20.86 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.828 -0.701 . . . . 53.109999999999999 112.594 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt -118.14 179.0 4.23 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.96 0.409 . . . . 74.329999999999998 111.404 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.8 t -86.57 143.72 27.55 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 111.734 0.272 . . . . 74.010000000000005 111.734 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.1 mm -55.18 -52.21 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 112.052 0.389 . . . . 74.540000000000006 112.052 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.407 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 60.6 t80 -60.41 -42.93 97.02 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.032 0.444 . . . . 74.519999999999996 110.99 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -57.32 -56.13 25.79 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.75 -0.659 . . . . 70.319999999999993 111.461 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 82.7 t -56.84 -41.42 75.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.193 -0.458 . . . . 72.329999999999998 111.204 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -54.87 -46.02 74.69 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.351 -0.386 . . . . 72.310000000000002 111.437 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 84.4 mt -61.84 -45.1 95.28 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.255 -0.429 . . . . 62.240000000000002 112.061 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.409 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 63.5 m-85 -68.68 -37.92 79.96 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.796 0.295 . . . . 64.420000000000002 111.796 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.52 HD13 ' NE1' ' A' ' 67' ' ' TRP . 93.7 mt -66.32 -37.33 85.14 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.072 0.463 . . . . 74.510000000000005 111.001 174.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.47 -55.99 27.61 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.974 -0.557 . . . . 73.109999999999999 111.094 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 3.8 pt20 -60.65 -37.88 82.98 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.526 -0.306 . . . . 75.219999999999999 111.576 -177.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.472 HD21 HG11 ' A' ' 6' ' ' VAL . 83.7 mt -61.01 -44.84 96.83 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.982 0.42 . . . . 73.439999999999998 111.11 176.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -68.01 -30.88 70.23 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.952 0.406 . . . . 74.239999999999995 111.177 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -78.58 -31.94 47.47 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.219 0.452 . . . . 75.239999999999995 112.219 -177.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.506 HG23 HG23 ' A' ' 53' ' ' VAL . 33.5 m -83.35 -25.6 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 121.966 -0.459 . . . . 62.530000000000001 111.468 176.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 118.54 8.81 9.76 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 120.973 -0.632 . . . . 61.530000000000001 114.334 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.506 HG23 HG23 ' A' ' 51' ' ' VAL . 91.5 t -77.88 -42.14 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 117.483 0.642 . . . . 74.120000000000005 111.572 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.7 mt -110.89 133.87 53.02 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.147 0.499 . . . . 71.299999999999997 112.038 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.506 ' HG2' ' NH2' ' A' ' 68' ' ' ARG . 8.1 tp10 -91.8 154.77 18.7 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.923 -0.581 . . . . 73.299999999999997 111.05 176.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -80.22 136.35 36.45 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.202 0.525 . . . . 64.109999999999999 112.015 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.459 HG11 ' HB3' ' A' ' 24' ' ' PRO . 44.3 t . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 121.054 0.454 . . . . 72.219999999999999 110.232 170.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 86.3 mt . . . . . 0 CA--C 1.536 0.423 0 N-CA-C 109.79 -0.448 . . . . 65.439999999999998 109.79 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.52 ' NE1' HD13 ' A' ' 45' ' ' LEU . 42.6 m95 -107.17 127.82 53.85 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.863 0.69 . . . . 74.519999999999996 112.863 -169.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.506 ' NH2' ' HG2' ' A' ' 55' ' ' GLU . 47.6 ttp180 -120.44 165.01 15.52 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.264 -0.643 . . . . 75.409999999999997 109.264 175.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.7 pp -123.41 151.64 42.4 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.331 -0.856 . . . . 53.130000000000003 111.988 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.441 HD23 ' N ' ' A' ' 70' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.469 0.523 0 CA-C-N 115.923 -0.581 . . . . 72.530000000000001 111.357 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.446 ' N ' HD12 ' A' ' 5' ' ' ILE . 2.7 mp . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 112.242 0.46 . . . . 72.430000000000007 112.242 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.2 t -61.93 -54.83 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.121 0.486 . . . . 73.540000000000006 111.377 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 m -59.62 -31.42 69.49 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.019 -0.537 . . . . 72.409999999999997 111.46 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.514 ' O ' HG13 ' A' ' 12' ' ' ILE . 60.5 tptt -57.49 -57.0 14.59 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.2 -0.455 . . . . 73.219999999999999 110.679 176.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.486 ' HA ' HD12 ' A' ' 12' ' ' ILE . 67.1 mt -58.2 -43.56 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 116.141 -0.481 . . . . 75.239999999999995 111.63 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.0 mt -60.63 -42.74 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.12 0.486 . . . . 73.010000000000005 111.101 176.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.0 t -65.4 -33.34 75.73 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.215 -0.448 . . . . 61.509999999999998 111.271 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 8' ' ' LYS . 96.9 mt -63.44 -48.41 87.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.365 -0.38 . . . . 72.239999999999995 110.934 175.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.8 t -58.15 -47.35 87.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 120.735 0.302 . . . . 71.540000000000006 111.229 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -59.47 -45.43 91.67 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.15 0.5 . . . . 74.409999999999997 111.041 177.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -53.64 -46.9 70.69 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.963 -0.562 . . . . 73.140000000000001 111.52 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 12' ' ' ILE . 7.6 mmm180 -67.87 -37.43 81.79 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.216 -0.447 . . . . 64.519999999999996 111.473 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -62.9 -32.87 74.23 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.081 0.4 . . . . 73.25 112.081 176.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -92.21 -29.23 16.56 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.975 0.731 . . . . 75.219999999999999 112.975 -175.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.488 ' SD ' ' HD2' ' A' ' 16' ' ' ARG . 27.2 ptm -70.35 -26.67 63.85 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.119 -0.363 . . . . 74.340000000000003 111.598 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -127.13 179.25 5.52 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 116.475 -0.329 . . . . 63.229999999999997 110.337 -177.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -104.21 -12.58 16.59 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 122.156 -0.34 . . . . 73.329999999999998 111.91 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.3 44.09 0.23 Allowed Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.878 -0.677 . . . . 44.409999999999997 113.409 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.78 107.22 38.78 Favored Pre-proline 0 CA--C 1.537 0.444 0 O-C-N 122.562 -0.375 . . . . 62.539999999999999 111.62 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.55 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 46.6 Cg_endo -68.52 138.85 43.2 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.22 1.947 . . . . 44.409999999999997 111.696 176.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.421 HG22 ' HB2' ' A' ' 16' ' ' ARG . 7.9 t -79.96 120.61 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 120.899 0.38 . . . . 74.109999999999999 111.13 -175.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.501 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -80.63 132.49 35.61 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.607 -0.269 . . . . 70.310000000000002 110.996 -176.821 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.3 m -51.97 -44.46 64.02 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.903 0.383 . . . . 71.230000000000004 111.665 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.503 ' NH1' HG13 ' A' ' 38' ' ' ILE . 36.1 mmt180 -61.21 -45.92 92.6 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.207 0.527 . . . . 75.400000000000006 110.682 176.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -58.52 -40.77 83.84 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.792 -0.64 . . . . 62.530000000000001 111.455 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 26' ' ' LYS . 66.0 mt -61.92 -39.69 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.793 0.33 . . . . 73.019999999999996 111.157 176.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.521 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -57.93 -48.74 79.02 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.268 -0.424 . . . . 72.420000000000002 111.892 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.13 -43.55 94.92 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 111.995 0.368 . . . . 72.010000000000005 111.995 176.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.12 -41.72 94.6 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.332 0.493 . . . . 75.310000000000002 112.332 -178.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.63 -23.91 27.33 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.218 0.451 . . . . 64.329999999999998 112.218 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.17 40.46 24.4 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.227 -0.511 . . . . 72.439999999999998 113.231 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.9 mt -128.63 161.06 30.53 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.613 -0.345 . . . . 72.25 111.37 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 41' ' ' VAL . 66.9 m -68.1 150.97 47.72 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.515 -0.311 . . . . 71.409999999999997 111.096 176.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.503 HG13 ' NH1' ' A' ' 28' ' ' ARG . 49.7 mm -52.21 -48.83 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 112.31 0.485 . . . . 62.32 112.31 -176.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.497 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 78.2 t80 -59.2 -49.05 79.35 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.529 -0.305 . . . . 75.310000000000002 111.242 178.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -54.98 -50.81 68.04 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.244 0.545 . . . . 72.299999999999997 110.899 176.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.521 HG21 ' HA ' ' A' ' 31' ' ' ALA . 88.8 t -56.18 -49.64 75.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.078 -0.51 . . . . 51.119999999999997 111.345 178.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.573 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 31.6 mtp180 -60.98 -34.3 74.56 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 111.752 0.278 . . . . 63.210000000000001 111.752 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 79.2 mt -55.78 -47.42 77.08 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.15 0.5 . . . . 74.239999999999995 110.407 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.409 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 87.0 m-85 -65.51 -43.43 90.12 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.058 -0.519 . . . . 73.329999999999998 111.522 175.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.486 HD13 ' NE1' ' A' ' 67' ' ' TRP . 89.5 mt -64.15 -50.15 69.33 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 111.85 0.315 . . . . 72.239999999999995 111.85 -177.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 42' ' ' ARG . 62.1 mm-40 -56.83 -45.82 82.1 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.32 -0.4 . . . . 54.009999999999998 111.061 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 88.3 mt-30 -62.92 -49.81 73.33 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.536 0.208 . . . . 60.409999999999997 110.973 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.427 ' HA ' HG22 ' A' ' 51' ' ' VAL . 94.5 mt -57.85 -28.95 64.58 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.019 0.437 . . . . 70.120000000000005 111.127 176.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.465 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 31.4 t-80 -67.07 -56.69 8.97 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.06 0.457 . . . . 73.25 111.077 174.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.13 -23.79 64.02 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.252 0.834 . . . . 74.219999999999999 113.252 -175.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.525 HG23 HG23 ' A' ' 53' ' ' VAL . 25.1 m -84.78 -4.58 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 121.887 -0.508 . . . . 73.239999999999995 111.947 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.3 17.9 38.17 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 114.617 0.607 . . . . 65.349999999999994 114.617 173.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.525 HG23 HG23 ' A' ' 51' ' ' VAL . 97.3 t -90.91 -50.01 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 117.294 0.547 . . . . 52.299999999999997 111.327 177.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.7 mt -106.69 131.03 54.29 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.178 0.513 . . . . 71.430000000000007 111.893 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -101.34 143.65 31.12 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.907 -0.588 . . . . 74.510000000000005 111.003 177.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.447 ' HD3' ' N ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -66.11 141.47 58.1 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.802 0.667 . . . . 70.129999999999995 112.802 -175.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 51.0 t . . . . . 0 N--CA 1.471 0.624 0 CA-C-N 116.285 -0.416 . . . . 73.510000000000005 110.959 171.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 66.8 mt . . . . . 0 CA--C 1.539 0.537 0 N-CA-C 109.969 -0.382 . . . . 65.420000000000002 109.969 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.486 ' NE1' HD13 ' A' ' 45' ' ' LEU . 75.7 m95 -121.16 147.86 45.02 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.328 0.585 . . . . 72.129999999999995 112.389 -174.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -148.78 133.68 18.04 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.934 -0.576 . . . . 71.140000000000001 110.397 173.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 pp -72.74 163.31 28.3 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.733 -0.604 . . . . 74.120000000000005 110.856 174.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.8 mt . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 112.191 0.441 . . . . 73.329999999999998 112.191 -175.566 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 70.2 mt . . . . . 0 N--CA 1.475 0.79 0 CA-C-O 120.875 0.369 . . . . 72.049999999999997 111.925 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.6 t -71.73 -46.04 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.093 0.473 . . . . 73.129999999999995 111.22 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.9 m -55.24 -39.52 69.83 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.8 -0.636 . . . . 54.229999999999997 112.227 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.517 ' O ' HG13 ' A' ' 12' ' ' ILE . 55.6 tptt -61.96 -50.86 70.42 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.739 0.304 . . . . 72.099999999999994 110.732 177.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 72.7 mt -55.79 -46.36 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.886 0.374 . . . . 73.430000000000007 111.486 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.2 mt -58.88 -45.22 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 121.192 0.52 . . . . 73.319999999999993 110.93 176.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.2 t -62.39 -35.17 78.36 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.003 -0.544 . . . . 71.420000000000002 111.821 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.565 HG21 ' HA ' ' A' ' 30' ' ' ILE . 96.8 mt -64.73 -49.7 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.871 0.367 . . . . 74.349999999999994 111.2 177.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 64.2 t -54.2 -49.17 64.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.062 0.458 . . . . 64.150000000000006 110.969 177.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -62.46 -44.09 97.25 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.012 -0.54 . . . . 70.109999999999999 111.487 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.416 ' HA ' ' ND2' ' A' ' 18' ' ' ASN . 10.1 tp10 -61.62 -37.46 84.06 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.153 0.501 . . . . 74.299999999999997 111.04 -178.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.481 ' HG3' HG13 ' A' ' 25' ' ' VAL . 8.3 mmm180 -64.29 -40.06 95.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 73.530000000000001 110.79 174.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' A' ' 21' ' ' ASP . 74.1 mt-30 -72.69 -4.57 32.0 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.871 0.367 . . . . 72.239999999999995 111.58 175.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.416 ' ND2' ' HA ' ' A' ' 15' ' ' GLU . 81.2 m-20 -87.38 -42.56 12.76 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.029 0.442 . . . . 62.509999999999998 109.85 167.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 89.8 mmm -76.84 -66.91 0.76 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.938 -0.574 . . . . 74.230000000000004 111.319 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -71.5 -14.3 62.07 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.998 0.428 . . . . 75.019999999999996 111.087 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 17' ' ' GLN . 17.0 t70 74.54 -68.27 0.22 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.992 0.917 . . . . 72.120000000000005 112.673 177.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -136.1 36.81 1.97 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.553 -0.832 . . . . 65.540000000000006 113.885 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -102.85 152.72 38.52 Favored Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 122.51 -0.406 . . . . 71.519999999999996 111.499 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.554 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 49.9 Cg_endo -68.21 129.19 18.81 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.29 1.993 . . . . 75.430000000000007 111.999 174.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.481 HG13 ' HG3' ' A' ' 16' ' ' ARG . 38.5 t -79.44 135.83 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.155 0.502 . . . . 60.310000000000002 111.68 -174.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.542 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -88.28 135.72 33.32 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.139 -0.482 . . . . 72.049999999999997 111.29 -177.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.2 m -55.07 -31.27 61.03 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.907 0.384 . . . . 52.32 111.963 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -60.54 -54.15 48.89 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 111.798 0.295 . . . . 75.200000000000003 111.798 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.42 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 2.3 m-20 -57.82 -37.48 73.88 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.885 0.374 . . . . 73.120000000000005 111.619 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.565 ' HA ' HG21 ' A' ' 12' ' ' ILE . 59.0 mt -66.91 -49.23 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.428 -0.351 . . . . 73.310000000000002 111.293 178.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.06 -34.85 73.98 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.992 0.425 . . . . 61.210000000000001 111.455 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -66.08 -51.92 53.6 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.042 -0.526 . . . . 73.530000000000001 111.35 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.02 -35.84 72.17 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.506 0.558 . . . . 74.040000000000006 112.506 -177.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.18 -33.69 38.1 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.391 0.515 . . . . 54.43 112.391 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.37 -0.11 83.01 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.001 -0.618 . . . . 73.099999999999994 112.989 -177.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 71.6 mt -85.1 160.0 20.06 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 122.602 -0.352 . . . . 75.450000000000003 110.897 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 41' ' ' VAL . 47.6 t -79.74 157.44 27.13 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 120.788 0.328 . . . . 73.540000000000006 111.8 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.0 mm -51.95 -52.37 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 112.808 0.67 . . . . 72.349999999999994 112.808 -174.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.532 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 32.9 p90 -58.29 -44.43 88.49 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.985 0.421 . . . . 71.030000000000001 111.083 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -62.13 -47.09 86.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.241 0.543 . . . . 64.030000000000001 110.993 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 37' ' ' SER . 95.0 t -60.04 -51.47 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 115.972 -0.558 . . . . 73.010000000000005 111.877 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -62.94 -26.05 68.63 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 111.893 0.331 . . . . 71.209999999999994 111.893 -177.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 79.5 mt -65.99 -51.47 58.1 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.617 0.246 . . . . 63.039999999999999 111.011 175.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -65.56 -39.61 91.87 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.757 0.313 . . . . 72.319999999999993 111.695 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.504 HD13 ' CD1' ' A' ' 67' ' ' TRP . 96.5 mt -58.2 -41.69 84.53 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.344 0.592 . . . . 73.420000000000002 110.651 174.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -60.6 -43.97 96.79 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.629 -0.714 . . . . 75.319999999999993 111.054 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 74.9 mt-30 -60.38 -38.03 82.62 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.208 -0.451 . . . . 71.329999999999998 111.249 176.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 93.0 mt -63.83 -32.76 74.38 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.711 0.291 . . . . 64.099999999999994 111.309 175.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -70.56 -41.39 72.5 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 122.06 -0.4 . . . . 75.230000000000004 110.555 171.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -56.12 -42.68 77.23 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.785 -0.643 . . . . 73.129999999999995 111.848 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.559 HG23 HG23 ' A' ' 53' ' ' VAL . 35.0 m -82.13 -15.13 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 112.492 0.553 . . . . 63.130000000000003 112.492 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.92 8.06 32.43 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 114.658 0.623 . . . . 72.540000000000006 114.658 175.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.559 HG23 HG23 ' A' ' 51' ' ' VAL . 95.1 t -77.12 -52.61 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 117.409 0.605 . . . . 64.349999999999994 111.975 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.0 mt -106.41 149.94 26.52 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.72 0.637 . . . . 74.530000000000001 112.72 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 68' ' ' ARG . 12.6 pt-20 -111.1 146.08 37.44 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.992 -0.549 . . . . 74.540000000000006 110.068 172.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.429 ' HB2' ' HE3' ' A' ' 56' ' ' LYS . 46.1 mtmt -80.86 104.38 11.33 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.851 0.358 . . . . 52.049999999999997 111.475 -177.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.582 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 53.3 t . . . . . 0 C--O 1.241 0.644 0 CA-C-O 121.724 0.773 . . . . 70.420000000000002 110.948 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.582 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 72.8 mt . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 110.091 -0.337 . . . . 61.32 110.091 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.504 ' CD1' HD13 ' A' ' 45' ' ' LEU . 74.5 m95 -121.52 139.11 53.92 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.133 0.492 . . . . 74.25 112.005 -175.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.536 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 46.3 ttt180 -136.42 128.11 28.94 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.342 -0.39 . . . . 75.510000000000005 110.548 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 69' ' ' LEU . 4.6 pp -79.35 138.99 37.89 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.519 -0.738 . . . . 63.509999999999998 111.269 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.478 HD23 ' H ' ' A' ' 70' ' ' LEU . 2.1 pt? . . . . . 0 N--CA 1.469 0.486 0 CA-C-N 116.215 -0.448 . . . . 73.319999999999993 110.944 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.42 HG23 HD11 ' A' ' 36' ' ' LEU . 48.0 mm . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 112.819 0.674 . . . . 74.150000000000006 112.819 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.9 t -62.52 -57.77 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 120.949 0.404 . . . . 71.140000000000001 111.682 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.5 m -63.39 -34.44 77.74 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.981 0.42 . . . . 75.420000000000002 111.276 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.408 ' O ' HG13 ' A' ' 12' ' ' ILE . 57.0 tptt -56.19 -53.14 60.74 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.202 -0.453 . . . . 74.510000000000005 110.837 177.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.416 HG23 HG21 ' A' ' 30' ' ' ILE . 62.7 mt -59.1 -47.32 90.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.107 -0.497 . . . . 61.530000000000001 111.965 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 61.4 mt -60.42 -43.19 93.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 112.093 0.405 . . . . 54.210000000000001 112.093 -178.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 85.4 p -60.65 -36.87 79.73 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 120.781 0.324 . . . . 60.229999999999997 111.176 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.593 HG21 ' HA ' ' A' ' 30' ' ' ILE . 79.8 mt -64.29 -40.73 90.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.078 0.466 . . . . 71.140000000000001 111.504 176.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.58 -52.06 65.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 120.885 0.374 . . . . 53.310000000000002 110.914 177.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -59.35 -40.76 87.44 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.949 0.404 . . . . 74.310000000000002 110.864 176.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 12' ' ' ILE . 16.9 tp10 -47.75 -56.04 8.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.246 0.618 . . . . 65.409999999999997 111.841 177.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.504 ' HG3' HG13 ' A' ' 25' ' ' VAL . 1.2 mmp_? -63.09 -37.56 87.69 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.393 -0.367 . . . . 73.209999999999994 111.555 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -79.61 -13.99 59.12 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 111.955 0.354 . . . . 75.420000000000002 111.955 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -73.11 -35.95 66.66 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.028 0.442 . . . . 62.32 109.862 170.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.1 mmt -67.17 -58.79 4.21 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.814 -0.63 . . . . 63.149999999999999 110.885 172.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -124.61 104.12 8.52 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.435 -0.348 . . . . 71.239999999999995 110.836 176.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -61.38 -14.38 27.32 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.317 0.858 . . . . 64.209999999999994 113.317 -175.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -117.35 15.13 13.21 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 120.92 -0.657 . . . . 44.340000000000003 113.908 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.53 128.46 26.89 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 117.272 0.536 . . . . 42.409999999999997 112.082 -177.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.575 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 58.7 Cg_endo -71.42 135.45 26.61 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.364 2.043 . . . . 75.109999999999999 112.865 176.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.504 HG13 ' HG3' ' A' ' 16' ' ' ARG . 24.5 t -80.41 139.87 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 120.846 0.355 . . . . 62.439999999999998 111.449 -177.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.514 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 12.0 mptt -91.63 130.03 37.51 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.406 -0.361 . . . . 73.040000000000006 110.946 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.3 m -47.05 -34.5 5.84 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 120.919 0.39 . . . . 74.540000000000006 111.935 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -60.09 -49.26 78.33 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.386 -0.37 . . . . 72.140000000000001 111.795 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -56.22 -49.55 73.77 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.095 0.474 . . . . 74.540000000000006 110.788 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.593 ' HA ' HG21 ' A' ' 12' ' ' ILE . 64.3 mt -59.06 -48.36 86.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.907 -0.588 . . . . 64.519999999999996 111.555 178.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.483 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -57.73 -52.25 66.21 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.274 -0.421 . . . . 75.450000000000003 111.813 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -65.3 -41.97 93.54 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.285 -0.416 . . . . 74.439999999999998 111.711 -177.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.93 -39.69 87.41 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.214 0.45 . . . . 73.340000000000003 112.214 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.03 -20.79 40.95 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.001 0.371 . . . . 72.129999999999995 112.001 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.55 32.75 24.04 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.212 -0.518 . . . . 73.219999999999999 112.617 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.42 HD11 HG23 ' A' ' 5' ' ' ILE . 74.2 mt -122.21 161.71 22.72 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.873 0.368 . . . . 64.010000000000005 111.161 -177.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 41' ' ' VAL . 69.0 m -82.78 152.13 25.83 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.703 0.287 . . . . 73.450000000000003 111.528 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.8 mm -50.56 -46.04 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 112.28 0.474 . . . . 70.219999999999999 112.28 -176.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -57.87 -52.07 66.99 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.809 0.338 . . . . 64.420000000000002 111.8 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -58.54 -46.49 86.73 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.209 0.528 . . . . 72.209999999999994 111.277 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.483 HG21 ' HA ' ' A' ' 31' ' ' ALA . 57.9 t -61.54 -42.23 93.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.802 -0.636 . . . . 73.420000000000002 111.52 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -55.03 -39.64 69.36 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.784 0.326 . . . . 72.209999999999994 111.615 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.56 -52.48 60.88 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.274 -0.421 . . . . 74.510000000000005 111.042 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -59.57 -50.21 74.76 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 111.932 0.345 . . . . 70.239999999999995 111.932 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.424 HD13 ' CD1' ' A' ' 67' ' ' TRP . 92.2 mt -57.51 -43.99 84.69 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.863 0.363 . . . . 71.099999999999994 111.69 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -59.1 -50.38 74.26 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.017 0.437 . . . . 74.150000000000006 110.796 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -54.87 -44.55 74.13 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.038 -0.528 . . . . 71.219999999999999 110.807 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.471 ' HA ' HG22 ' A' ' 51' ' ' VAL . 89.1 mt -59.46 -29.68 67.98 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.3 -0.409 . . . . 70.409999999999997 111.782 178.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -72.53 -46.46 54.44 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.955 -0.466 . . . . 75.019999999999996 110.89 174.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -70.39 -16.89 63.01 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.835 0.68 . . . . 61.140000000000001 112.835 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.592 HG23 HG23 ' A' ' 53' ' ' VAL . 30.1 m -98.96 4.64 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 O-C-N 122.106 -0.372 . . . . 70.409999999999997 111.749 176.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.44 31.42 27.7 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 114.7 0.64 . . . . 65.140000000000001 114.7 174.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.592 HG23 HG23 ' A' ' 51' ' ' VAL . 95.3 t -105.81 -54.59 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 117.213 0.506 . . . . 71.329999999999998 111.749 176.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.1 mt -99.18 162.91 12.79 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.889 0.7 . . . . 51.020000000000003 112.889 -176.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 68' ' ' ARG . 17.0 tp10 -124.95 149.56 47.52 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.381 -0.827 . . . . 53.530000000000001 110.709 -175.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -78.96 129.28 34.31 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.048 0.758 . . . . 70.409999999999997 113.048 -172.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.9 t . . . . . 0 CA--C 1.541 0.619 0 CA-C-O 120.757 0.313 . . . . 72.329999999999998 111.188 170.471 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 58.2 mt . . . . . 0 CA--C 1.538 0.484 0 CA-C-O 120.883 0.373 . . . . 71.430000000000007 110.159 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.424 ' CD1' HD13 ' A' ' 45' ' ' LEU . 57.7 m95 -126.37 135.86 51.97 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.191 0.811 . . . . 70.340000000000003 113.191 -171.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.533 ' HB2' ' HB3' ' A' ' 55' ' ' GLU . 63.0 mtp180 -113.24 176.21 5.12 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.521 -0.763 . . . . 62.299999999999997 109.333 169.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.444 ' O ' HD12 ' A' ' 69' ' ' LEU . 3.5 pp -127.1 149.66 49.84 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.715 -0.616 . . . . 63.539999999999999 112.343 175.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.438 ' H ' HD23 ' A' ' 70' ' ' LEU . 1.4 pt? . . . . . 0 N--CA 1.469 0.513 0 CA-C-N 116.204 -0.453 . . . . 74.450000000000003 110.866 173.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 120.852 0.358 . . . . 70.200000000000003 110.947 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.4 m -155.68 -22.71 0.11 Allowed 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 120.803 0.335 . . . . 61.329999999999998 111.507 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.539 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -46.74 -45.78 19.91 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.132 0.79 . . . . 52.340000000000003 113.132 179.423 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.2 t 47.15 -79.71 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.42 0.896 . . . . 72.409999999999997 113.42 176.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.48 ' N ' ' O ' ' A' ' 3' ' ' GLU . 8.1 tp -54.45 -35.83 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.902 0.382 . . . . 73.25 111.374 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' A' ' 3' ' ' GLU . 59.5 t -63.65 -42.04 94.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 120.756 0.312 . . . . 73.109999999999999 111.018 176.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.2 m -61.13 -41.12 96.14 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.004 0.43 . . . . 73.230000000000004 110.706 175.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.421 ' O ' HG13 ' A' ' 12' ' ' ILE . 62.0 tttp -57.27 -46.39 83.13 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.201 -0.454 . . . . 53.399999999999999 110.293 173.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.483 ' O ' HG23 ' A' ' 13' ' ' VAL . 70.3 mt -55.99 -48.83 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.205 -0.452 . . . . 64.310000000000002 111.494 176.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.5 mt -57.14 -45.24 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.012 0.434 . . . . 72.409999999999997 111.112 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.6 t -57.23 -45.94 83.42 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.171 -0.468 . . . . 71.109999999999999 111.064 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 8' ' ' LYS . 94.1 mt -59.37 -45.11 93.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.223 -0.444 . . . . 41.100000000000001 111.058 176.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 9' ' ' ILE . 96.2 t -57.98 -49.61 80.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.486 -0.324 . . . . 72.519999999999996 111.543 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -61.99 -52.66 63.11 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.938 0.399 . . . . 74.25 111.436 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -65.2 -32.58 74.33 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.101 -0.499 . . . . 51.32 111.936 -175.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.1 mmm180 -65.69 -62.72 1.35 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 122.17 -0.331 . . . . 73.439999999999998 111.737 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -56.56 -24.33 46.41 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.263 0.554 . . . . 64.239999999999995 110.901 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -64.52 -41.02 96.64 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.76 -0.655 . . . . 71.120000000000005 110.577 172.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 65.5 mtt -82.24 -28.15 32.07 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.347 -0.388 . . . . 74.010000000000005 111.792 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -77.65 -10.49 59.54 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.676 0.274 . . . . 72.310000000000002 111.252 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 64.1 -74.75 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.431 0.692 . . . . 75.219999999999999 112.835 174.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -106.44 -11.8 26.42 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.917 -0.659 . . . . 41.210000000000001 113.395 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -103.28 141.36 22.34 Favored Pre-proline 0 CA--C 1.538 0.511 0 O-C-N 122.541 -0.387 . . . . 63.43 112.022 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.528 ' HG2' ' HB3' ' A' ' 66' ' ' LEU . 53.5 Cg_endo -71.35 -176.56 1.98 Allowed 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.483 2.122 . . . . 65.310000000000002 113.216 175.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.406 HG21 ' HA ' ' A' ' 13' ' ' VAL . 13.4 t -88.75 152.13 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.248 -0.433 . . . . 74.430000000000007 111.755 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.568 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 10.8 mptt -98.86 132.44 44.21 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.399 -0.364 . . . . 75.430000000000007 111.188 -176.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.8 m -47.42 -47.16 26.86 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.012 0.375 . . . . 65.150000000000006 112.012 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -59.22 -55.77 30.7 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.505 -0.316 . . . . 74.510000000000005 111.653 175.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -51.53 -39.59 58.0 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.188 -0.46 . . . . 74.530000000000001 112.077 -174.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.5 mt -59.69 -41.42 85.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.067 0.46 . . . . 63.520000000000003 110.919 175.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.9 -39.41 83.61 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.226 -0.443 . . . . 74.420000000000002 111.282 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -60.75 -56.63 18.95 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.957 0.408 . . . . 75.219999999999999 111.31 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.26 -45.85 90.09 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.257 -0.428 . . . . 61.229999999999997 112.04 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.98 -23.61 58.3 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.214 0.45 . . . . 74.319999999999993 112.214 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.86 44.67 23.96 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.247 -0.501 . . . . 61.219999999999999 112.558 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.3 mt -126.88 178.67 5.81 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.135 0.493 . . . . 60.409999999999997 111.623 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.406 ' O ' HG23 ' A' ' 41' ' ' VAL . 31.1 t -87.02 147.93 25.51 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.93 -0.577 . . . . 64.129999999999995 111.339 176.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.8 mm -55.65 -44.41 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 116.308 -0.405 . . . . 64.129999999999995 112.001 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.556 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 72.1 t80 -61.49 -53.93 49.93 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 111.566 0.21 . . . . 73.120000000000005 111.566 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -51.77 -49.1 63.3 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.508 0.67 . . . . 74.239999999999995 111.383 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 37' ' ' SER . 94.3 t -60.37 -51.6 71.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.717 -0.674 . . . . 74.109999999999999 112.204 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -60.76 -27.07 67.69 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 122.387 -0.196 . . . . 72.230000000000004 111.356 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 87.5 mt -62.46 -54.64 37.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.742 0.306 . . . . 55.240000000000002 110.375 175.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -57.82 -47.49 82.47 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.043 0.449 . . . . 74.140000000000001 111.08 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.2 mt -58.74 -43.83 90.32 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.034 -0.53 . . . . 44.439999999999998 111.983 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 49' ' ' HIS . 34.8 tt0 -67.06 -40.38 87.09 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.73 0.3 . . . . 74.349999999999994 111.553 -178.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -63.41 -50.23 70.65 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.938 0.399 . . . . 62.409999999999997 110.836 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.6 mt -58.46 -31.66 68.0 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.179 0.514 . . . . 72.239999999999995 110.927 174.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.537 ' HD2' ' HA ' ' A' ' 55' ' ' GLU . 28.3 t-80 -64.61 -54.58 29.8 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.246 -0.434 . . . . 72.530000000000001 111.768 176.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -66.42 -26.27 67.15 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.011 0.375 . . . . 63.219999999999999 112.011 -173.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.536 HG23 HG23 ' A' ' 53' ' ' VAL . 26.1 m -85.34 -1.5 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 112.21 0.448 . . . . 54.409999999999997 112.21 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.33 -14.81 47.26 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 115.053 0.781 . . . . 73.439999999999998 115.053 172.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.536 HG23 HG23 ' A' ' 51' ' ' VAL . 59.8 t -62.39 -51.02 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 117.833 0.816 . . . . 73.109999999999999 111.808 -176.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 94.2 mt -114.8 154.2 29.0 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.861 0.362 . . . . 64.409999999999997 111.618 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.537 ' HA ' ' HD2' ' A' ' 49' ' ' HIS . 9.0 tp10 -121.69 147.3 46.06 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.229 0.537 . . . . 43.219999999999999 110.998 176.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.427 ' HG2' ' OE1' ' A' ' 55' ' ' GLU . 23.2 pttm -81.7 95.39 7.22 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.593 -0.73 . . . . 71.409999999999997 111.855 -178.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.514 HG11 ' HG3' ' A' ' 24' ' ' PRO . 44.0 t -85.64 83.97 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 121.505 0.669 . . . . 75.510000000000005 110.118 174.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.49 ' HB2' HG21 ' A' ' 63' ' ' VAL . 28.7 p-10 -154.63 152.48 30.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.059 -0.519 . . . . 74.030000000000001 111.746 -177.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.87 -33.09 74.84 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.182 -0.463 . . . . 70.420000000000002 111.318 175.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 151.61 -112.11 0.52 Allowed Glycine 0 CA--C 1.527 0.791 0 CA-C-N 116.33 -0.395 . . . . 65.510000000000005 112.899 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.457 ' N ' ' HD2' ' A' ' 61' ' ' LYS . 12.2 mptt -97.35 153.37 18.12 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.003 0.43 . . . . 43.32 110.998 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.38 4.9 85.64 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.284 -0.484 . . . . 51.130000000000003 113.407 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.49 HG21 ' HB2' ' A' ' 58' ' ' ASN . 27.2 m -119.21 145.65 38.87 Favored Pre-proline 0 CA--C 1.54 0.587 0 O-C-N 122.499 -0.412 . . . . 63.229999999999997 111.626 -179.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.94 -24.48 76.46 Favored 'Trans proline' 0 N--CA 1.482 0.837 0 C-N-CA 122.868 2.378 . . . . 32.039999999999999 113.26 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.63 124.71 1.48 Allowed Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.205 -0.522 . . . . 60.5 113.3 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.528 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 83.7 mt -111.78 136.25 51.3 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.907 0.384 . . . . 51.299999999999997 110.665 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -111.45 132.79 54.21 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.378 0.608 . . . . 64.25 112.182 -175.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -136.76 138.13 40.6 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.744 -0.662 . . . . 73.150000000000006 110.885 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.418 ' O ' HD12 ' A' ' 69' ' ' LEU . 2.4 pp -83.23 153.23 24.82 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.806 0.336 . . . . 74.540000000000006 111.697 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.582 ' HG ' ' HG2' ' A' ' 71' ' ' GLU . 1.9 pt? -143.4 -49.82 0.32 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.005 0.372 . . . . 50.32 112.005 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.582 ' HG2' ' HG ' ' A' ' 70' ' ' LEU . 28.0 mm-40 . . . . . 0 C--O 1.255 1.351 0 CA-C-O 118.48 -0.771 . . . . 73.230000000000004 111.867 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 120.912 0.387 . . . . 75.239999999999995 111.646 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.8 m -102.06 21.62 14.49 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.801 0.334 . . . . 75.140000000000001 111.759 -176.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -101.09 21.36 13.99 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.638 0.607 . . . . 73.299999999999997 112.638 -169.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.8 p -66.5 -6.24 14.15 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 112.698 0.629 . . . . 75.450000000000003 112.698 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.534 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.8 mp -56.36 -37.1 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 120.804 0.335 . . . . 72.430000000000007 111.493 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.5 t -60.71 -53.02 54.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.806 0.336 . . . . 70.109999999999999 111.274 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.0 m -60.41 -36.16 77.49 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.022 0.439 . . . . 71.340000000000003 111.079 177.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.517 ' O ' HG13 ' A' ' 12' ' ' ILE . 62.4 tttp -60.05 -49.05 79.2 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.213 -0.449 . . . . 73.439999999999998 111.135 176.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.445 ' HA ' HD12 ' A' ' 12' ' ' ILE . 72.9 mt -59.6 -42.97 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.7 0.286 . . . . 70.439999999999998 111.502 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.1 mt -57.43 -43.61 82.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 121.328 0.585 . . . . 73.200000000000003 110.574 174.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.7 m -66.15 -30.73 71.27 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.881 -0.599 . . . . 73.239999999999995 111.604 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 8' ' ' LYS . 94.5 mt -67.07 -47.72 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.638 0.256 . . . . 73.209999999999994 111.279 177.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.491 HG11 HD22 ' A' ' 54' ' ' LEU . 56.1 t -60.12 -45.36 95.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.841 0.353 . . . . 74.230000000000004 110.45 175.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -54.77 -48.25 72.91 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.038 -0.528 . . . . 65.549999999999997 110.629 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.552 ' O ' ' HG2' ' A' ' 19' ' ' MET . 29.2 tt0 -57.24 -65.54 0.61 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.775 -0.648 . . . . 75.129999999999995 111.452 178.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -51.51 -51.86 51.69 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.844 0.354 . . . . 72.340000000000003 111.917 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -57.42 -35.27 69.86 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.117 -0.492 . . . . 73.140000000000001 111.56 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -81.39 -26.53 35.38 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.042 0.386 . . . . 74.019999999999996 112.042 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.552 ' HG2' ' O ' ' A' ' 15' ' ' GLU . 24.3 mmt -71.22 -58.94 3.06 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.839 0.352 . . . . 72.120000000000005 111.047 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -74.29 -29.52 61.69 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.602 -0.272 . . . . 75.239999999999995 111.235 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.1 t70 69.14 -72.57 0.1 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.539 0.57 . . . . 72.150000000000006 112.539 173.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.65 41.42 3.09 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.188 -0.53 . . . . 54.020000000000003 113.161 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.19 140.26 8.49 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 112.187 0.44 . . . . 73.540000000000006 112.187 -177.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.545 ' HG2' HD13 ' A' ' 66' ' ' LEU . 54.5 Cg_endo -71.66 151.9 58.59 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.516 2.144 . . . . 71.209999999999994 112.512 172.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.1 t -80.88 150.36 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 120.906 0.384 . . . . 65.040000000000006 111.447 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.457 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -112.24 150.25 31.17 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.697 0.284 . . . . 74.340000000000003 110.819 -179.532 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.0 m -55.65 -31.85 62.68 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.02 0.438 . . . . 64.219999999999999 111.508 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -64.17 -59.21 4.71 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.182 -0.463 . . . . 72.019999999999996 112.175 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.417 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -67.49 -20.25 65.43 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.629 0.603 . . . . 74.209999999999994 112.629 -178.439 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 26' ' ' LYS . 77.3 mt -67.93 -51.22 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.048 0.451 . . . . 73.140000000000001 110.358 170.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.512 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -58.07 -39.42 78.47 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.124 -0.489 . . . . 75.409999999999997 111.189 175.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -51.81 -52.48 48.87 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.693 -0.685 . . . . 70.030000000000001 111.543 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.23 -24.94 60.55 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.956 0.408 . . . . 63.140000000000001 111.923 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.65 -24.33 36.38 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.062 0.393 . . . . 73.030000000000001 112.062 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.87 23.29 78.11 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.077 -0.582 . . . . 34.409999999999997 112.24 -174.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.7 mt -118.13 178.21 4.51 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.401 0.62 . . . . 53.439999999999998 111.783 -175.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.8 m -82.51 149.17 27.69 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.896 -0.593 . . . . 72.140000000000001 111.554 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.6 mm -52.89 -41.96 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 120.929 0.395 . . . . 43.119999999999997 111.966 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.467 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 47.4 t80 -60.65 -59.78 4.85 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.149 -0.478 . . . . 74.120000000000005 111.644 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -48.44 -58.04 5.22 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.92 0.391 . . . . 72.439999999999998 111.376 176.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.569 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 94.9 t -53.3 -45.95 56.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.01 -0.541 . . . . 72.040000000000006 111.535 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.496 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 7.7 tpt180 -60.86 -41.67 96.37 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.65 -0.25 . . . . 74.129999999999995 111.38 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 89.1 mt -55.51 -44.62 76.81 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.329 0.585 . . . . 70.5 110.738 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -66.25 -41.74 89.54 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.884 -0.598 . . . . 74.230000000000004 111.553 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 89.5 mt -59.43 -45.44 91.54 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.829 0.347 . . . . 54.210000000000001 111.103 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 42' ' ' ARG . 58.1 mm-40 -52.65 -52.74 54.35 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.293 0.568 . . . . 74.420000000000002 110.749 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -65.87 -33.53 76.05 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.842 -0.617 . . . . 62.229999999999997 111.848 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.401 ' HA ' HG22 ' A' ' 51' ' ' VAL . 76.8 mt -64.89 -27.79 69.1 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.846 0.355 . . . . 75.319999999999993 111.333 176.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -75.39 -37.6 60.42 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.131 0.491 . . . . 71.109999999999999 110.142 172.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -63.57 -43.64 96.4 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.773 -0.649 . . . . 65.140000000000001 112.388 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.539 HG23 HG23 ' A' ' 53' ' ' VAL . 25.5 m -80.07 -12.74 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.741 0.645 . . . . 73.430000000000007 112.741 -177.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.2 52.97 1.66 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.027 -0.606 . . . . 70.540000000000006 113.645 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.539 HG23 HG23 ' A' ' 51' ' ' VAL . 94.4 t -124.77 -56.88 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.021 0.438 . . . . 61.100000000000001 111.113 176.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 69' ' ' LEU . 70.1 mt -100.03 138.83 36.57 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.337 -0.392 . . . . 73.310000000000002 111.91 -177.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -109.46 160.5 16.16 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.263 -0.426 . . . . 74.549999999999997 110.295 174.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -100.07 136.25 40.26 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.19 0.519 . . . . 63.43 111.958 -176.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.9 t -121.08 127.44 75.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 116.118 -0.492 . . . . 70.120000000000005 110.484 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.417 ' HB2' HG21 ' A' ' 63' ' ' VAL . 31.5 p30 -173.0 -176.93 1.49 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.125 0.488 . . . . 64.450000000000003 112.212 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.573 ' HB3' HG11 ' A' ' 63' ' ' VAL . . . -91.95 -36.2 13.57 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.099 -0.5 . . . . 73.400000000000006 111.554 173.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.576 ' H ' HG21 ' A' ' 63' ' ' VAL . . . 136.91 -77.07 0.35 Allowed Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.377 -0.439 . . . . 75.209999999999994 113.517 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -95.62 128.14 42.24 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.236 0.458 . . . . 73.450000000000003 112.236 -175.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.67 43.21 99.31 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.274 -0.421 . . . . 62.020000000000003 113.767 175.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.576 HG21 ' H ' ' A' ' 60' ' ' GLY . 31.5 m -134.21 154.13 79.86 Favored Pre-proline 0 N--CA 1.47 0.532 0 O-C-N 122.492 -0.417 . . . . 71.299999999999997 111.421 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -78.59 119.32 4.43 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.299 1.999 . . . . 75.099999999999994 112.859 176.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.59 105.54 0.76 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.218 -0.515 . . . . 63.219999999999999 113.228 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.545 HD13 ' HG2' ' A' ' 24' ' ' PRO . 77.0 mt -85.48 153.77 22.24 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.853 0.358 . . . . 73.409999999999997 111.041 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -109.23 137.09 47.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.424 0.63 . . . . 72.150000000000006 112.279 -175.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -154.22 116.88 4.39 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.0 -0.545 . . . . 61.329999999999998 110.187 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 54' ' ' LEU . 2.3 pp -66.05 174.44 2.52 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.027 0.751 . . . . 72.230000000000004 113.027 -172.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 78.2 mt -59.92 90.67 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.938 -0.574 . . . . 74.010000000000005 111.35 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 C--O 1.251 1.146 0 CA-C-N 115.629 -0.714 . . . . 65.200000000000003 111.149 -178.728 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.436 ' C ' ' SD ' ' A' ' 1' ' ' MET . 3.1 ppp? . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 112.311 0.486 . . . . 72.129999999999995 112.311 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.7 m -80.68 87.09 5.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.184 0.516 . . . . 72.140000000000001 111.92 -175.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -106.49 149.03 27.5 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.964 -0.562 . . . . 55.130000000000003 110.319 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.2 t -51.86 -34.39 40.54 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 112.602 0.593 . . . . 72.239999999999995 112.602 -174.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.589 HG12 HD11 ' A' ' 36' ' ' LEU . 10.8 tp -69.91 -30.81 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 112.191 0.441 . . . . 71.409999999999997 112.191 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.6 t -57.57 -37.25 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 120.911 0.386 . . . . 52.43 111.507 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.2 m -54.26 -47.87 71.81 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.0 0.429 . . . . 71.420000000000002 111.083 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.453 ' O ' HG13 ' A' ' 12' ' ' ILE . 87.5 tttt -66.28 -40.4 90.06 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.562 -0.29 . . . . 74.329999999999998 110.767 177.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.458 ' O ' HG23 ' A' ' 13' ' ' VAL . 67.4 mt -53.35 -47.33 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 120.81 0.338 . . . . 64.540000000000006 111.316 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.7 mt -59.12 -43.86 90.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.933 0.397 . . . . 75.040000000000006 110.926 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.8 t -61.16 -40.06 92.47 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.421 -0.354 . . . . 75.109999999999999 111.763 176.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.462 HD13 ' HB3' ' A' ' 33' ' ' ALA . 82.4 mt -61.69 -43.41 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.82 0.343 . . . . 72.540000000000006 110.736 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.527 ' HA ' HG21 ' A' ' 25' ' ' VAL . 91.5 t -59.04 -47.56 89.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.965 0.412 . . . . 71.420000000000002 111.018 176.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -60.54 -47.17 87.36 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.086 0.47 . . . . 74.129999999999995 111.264 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.01 -52.37 65.82 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.275 0.56 . . . . 73.030000000000001 111.039 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.612 ' HA ' ' HG2' ' A' ' 19' ' ' MET . 1.0 OUTLIER -62.1 -35.53 78.97 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.358 -0.383 . . . . 72.140000000000001 111.706 178.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -62.88 -25.18 68.18 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 122.315 -0.241 . . . . 74.310000000000002 111.261 173.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -84.47 -20.94 30.9 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.563 0.579 . . . . 74.140000000000001 112.563 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.612 ' HG2' ' HA ' ' A' ' 16' ' ' ARG . 20.4 ptm -89.25 -38.82 13.94 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.944 -0.473 . . . . 74.209999999999994 112.171 173.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -89.94 -41.47 11.75 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 111.88 0.326 . . . . 61.32 111.88 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 63.26 -74.58 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.807 0.669 . . . . 64.310000000000002 112.807 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.42 -28.57 73.65 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.094 -0.574 . . . . 63.32 113.495 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.36 147.0 33.84 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 120.765 0.317 . . . . 74.140000000000001 111.76 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.573 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 6.0 Cg_exo -72.86 172.19 15.87 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.447 2.098 . . . . 64.329999999999998 112.522 176.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.527 HG21 ' HA ' ' A' ' 13' ' ' VAL . 40.3 t -80.15 150.02 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.167 -0.47 . . . . 71.109999999999999 111.719 -175.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.611 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -100.05 145.94 27.34 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.347 -0.388 . . . . 53.409999999999997 110.624 -177.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.0 m -54.43 -34.7 61.9 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.567 0.58 . . . . 54.039999999999999 112.567 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -62.4 -42.65 99.59 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.447 0.536 . . . . 72.299999999999997 112.447 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -53.89 -42.95 69.23 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.152 0.427 . . . . 72.5 112.152 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.457 ' N ' HD12 ' A' ' 30' ' ' ILE . 2.9 mp -65.56 -50.1 73.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.979 0.419 . . . . 75.239999999999995 111.035 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.32 -58.57 7.89 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.01 0.433 . . . . 74.439999999999998 112.058 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.87 -42.4 93.61 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.804 0.668 . . . . 45.140000000000001 112.804 -178.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.462 ' HB3' HD13 ' A' ' 12' ' ' ILE . . . -75.25 -34.31 61.38 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.343 0.497 . . . . 71.299999999999997 112.343 -178.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.432 ' HB1' HD11 ' A' ' 5' ' ' ILE . . . -85.42 -21.19 28.89 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.133 0.42 . . . . 64.239999999999995 112.133 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.81 22.16 53.87 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.242 -0.504 . . . . 74.439999999999998 112.821 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.589 HD11 HG12 ' A' ' 5' ' ' ILE . 73.3 mt -101.42 173.83 6.26 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.959 0.409 . . . . 74.319999999999993 111.591 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.417 ' O ' HG23 ' A' ' 41' ' ' VAL . 47.4 t -98.01 148.29 23.65 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.354 -0.384 . . . . 75.129999999999995 111.051 177.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.3 mm -50.61 -49.32 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 112.836 0.68 . . . . 74.209999999999994 112.836 -175.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.534 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 47.6 t80 -51.37 -50.62 59.18 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.892 0.33 . . . . 71.230000000000004 111.892 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.46 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 27.6 tt0 -69.04 -40.3 78.67 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.844 0.354 . . . . 74.209999999999994 111.371 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 37' ' ' SER . 69.9 t -60.54 -51.71 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.418 -0.356 . . . . 74.120000000000005 111.875 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 8.7 ptm180 -57.41 -36.06 70.84 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.629 -0.259 . . . . 75.040000000000006 111.287 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 94.0 mt -60.16 -48.44 81.71 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.729 0.299 . . . . 74.430000000000007 110.932 177.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.46 ' CE2' ' HG2' ' A' ' 40' ' ' GLN . 25.5 m-85 -57.34 -48.05 80.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.04 0.447 . . . . 73.540000000000006 110.919 176.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.455 HD13 ' NE1' ' A' ' 67' ' ' TRP . 78.9 mt -60.97 -43.8 98.27 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.871 -0.604 . . . . 74.430000000000007 111.727 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 42' ' ' ARG . 46.9 mt-10 -57.98 -52.2 66.52 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.044 0.45 . . . . 62.109999999999999 111.089 175.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 83.9 mm-40 -59.25 -40.33 85.63 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.098 -0.501 . . . . 63.240000000000002 111.343 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.6 mt -59.9 -40.12 87.71 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.723 0.297 . . . . 71.120000000000005 111.468 176.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 65.3 t60 -67.12 -40.24 86.8 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.037 -0.415 . . . . 63.130000000000003 111.104 174.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -65.81 -43.42 88.67 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.068 -0.514 . . . . 54.539999999999999 112.156 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.517 HG23 HG23 ' A' ' 53' ' ' VAL . 34.0 m -78.27 -12.03 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 112.448 0.536 . . . . 65.329999999999998 112.448 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.93 52.51 1.5 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.085 -0.579 . . . . 53.329999999999998 113.713 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.517 HG23 HG23 ' A' ' 51' ' ' VAL . 91.3 t -124.17 -44.49 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 120.973 0.416 . . . . 54.200000000000003 111.323 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.7 mt -110.12 142.57 41.43 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.431 0.634 . . . . 72.310000000000002 112.517 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -91.44 119.63 31.58 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.373 -0.83 . . . . 61.210000000000001 109.038 172.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -85.18 94.86 8.98 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.163 0.506 . . . . 73.109999999999999 110.845 -173.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.451 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 51.4 t -93.31 148.59 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.877 -0.602 . . . . 63.229999999999997 112.183 -176.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -134.56 100.12 4.55 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.358 -0.383 . . . . 70.540000000000006 110.568 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.16 96.8 0.85 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.15 0.5 . . . . 60.520000000000003 111.463 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.63 -92.17 1.51 Allowed Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.357 -0.449 . . . . 55.119999999999997 112.754 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -175.33 -36.58 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.776 0.322 . . . . 75.120000000000005 111.421 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.44 -29.59 72.05 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.438 -0.411 . . . . 65.129999999999995 113.714 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.9 m -76.05 140.45 70.03 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-O 120.93 0.395 . . . . 73.420000000000002 111.69 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.05 -36.09 39.44 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.607 2.205 . . . . 73.030000000000001 113.219 -178.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 167.0 155.85 9.32 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 120.895 -0.669 . . . . 52.450000000000003 113.318 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 92.0 mt -133.45 139.01 46.46 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 122.915 0.486 . . . . 72.219999999999999 110.198 177.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.455 ' NE1' HD13 ' A' ' 45' ' ' LEU . 59.9 m95 -115.99 123.38 47.87 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.547 0.689 . . . . 75.329999999999998 112.452 -171.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 -128.46 113.33 15.39 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.768 -0.651 . . . . 73.430000000000007 110.788 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.455 ' O ' HD12 ' A' ' 69' ' ' LEU . 3.7 pp -63.48 149.95 44.92 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.904 -0.498 . . . . 74.310000000000002 111.866 -178.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 87.8 mt -84.25 160.18 20.82 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.225 -0.443 . . . . 73.340000000000003 111.522 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 C--O 1.252 1.23 0 CA-C-O 118.42 -0.8 . . . . 70.439999999999998 112.467 -179.105 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 mmt . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.591 0.234 . . . . 72.140000000000001 110.775 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.1 m -71.46 -45.86 61.48 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.135 0.42 . . . . 74.340000000000003 112.135 -178.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -79.77 157.71 27.03 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.942 0.401 . . . . 51.43 111.439 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.3 t -115.8 111.36 20.39 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.051 0.389 . . . . 71.319999999999993 112.051 -175.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.483 HG21 HD11 ' A' ' 36' ' ' LEU . 61.3 mt -65.94 -33.73 65.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 121.063 0.459 . . . . 73.239999999999995 110.145 173.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.9 t -58.49 -54.89 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.084 -0.507 . . . . 71.120000000000005 111.321 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.5 m -61.04 -33.82 73.9 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.981 0.42 . . . . 54.109999999999999 111.066 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.427 ' O ' HG13 ' A' ' 12' ' ' ILE . 61.9 tttp -59.28 -49.42 77.9 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.976 0.417 . . . . 72.530000000000001 110.692 176.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.513 ' O ' HG23 ' A' ' 13' ' ' VAL . 73.2 mt -56.91 -49.72 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.184 -0.462 . . . . 64.209999999999994 111.175 176.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.9 mt -53.74 -42.65 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 121.156 0.503 . . . . 75.150000000000006 111.457 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.0 m -62.77 -43.33 99.09 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.168 -0.469 . . . . 35.109999999999999 111.244 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 8' ' ' LYS . 74.8 mt -61.06 -43.31 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.043 0.449 . . . . 60.119999999999997 111.255 177.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.575 HG12 ' NE2' ' A' ' 17' ' ' GLN . 81.1 t -57.96 -52.15 61.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 116.064 -0.517 . . . . 71.239999999999995 111.391 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -63.71 -41.32 98.1 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.703 0.287 . . . . 72.25 111.524 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -51.58 -53.09 41.87 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.768 0.318 . . . . 75.310000000000002 111.158 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.529 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 3.1 mmp_? -57.05 -46.76 82.2 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 111.911 0.337 . . . . 73.340000000000003 111.911 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.575 ' NE2' HG12 ' A' ' 13' ' ' VAL . 66.0 mt-30 -64.69 -38.07 89.74 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.99 0.424 . . . . 64.329999999999998 112.14 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -77.76 -41.23 38.29 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.271 0.471 . . . . 72.510000000000005 112.271 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.5 mmt -75.71 -45.46 36.59 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.177 0.436 . . . . 70.510000000000005 112.177 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -82.28 -25.84 33.66 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.923 0.392 . . . . 61.310000000000002 110.538 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.8 t70 67.26 104.96 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.438 0.695 . . . . 74.109999999999999 112.01 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.7 -31.03 5.74 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 115.922 -0.581 . . . . 52.240000000000002 113.906 177.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.79 140.13 95.44 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 113.04 0.756 . . . . 74.200000000000003 113.04 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.19 146.4 17.81 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.899 2.399 . . . . 71.310000000000002 112.371 173.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.474 HG22 ' HB2' ' A' ' 16' ' ' ARG . 22.1 t -85.66 138.46 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.028 0.442 . . . . 72.109999999999999 112.061 -175.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.445 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -98.92 144.7 27.81 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.995 -0.548 . . . . 45.310000000000002 110.693 178.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 57.8 m -57.16 -32.73 66.72 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.843 0.354 . . . . 64.409999999999997 111.07 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -56.99 -57.54 12.1 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.243 -0.435 . . . . 74.129999999999995 112.147 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -54.59 -42.55 71.24 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.748 0.309 . . . . 64.400000000000006 111.712 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.401 ' HA ' HG21 ' A' ' 12' ' ' ILE . 58.7 mt -63.49 -43.71 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.404 -0.362 . . . . 71.209999999999994 111.337 177.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.1 -49.6 77.0 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.06 0.393 . . . . 74.430000000000007 112.06 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -65.48 -42.87 91.74 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.042 0.386 . . . . 51.520000000000003 112.042 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.89 -35.46 74.66 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.373 0.509 . . . . 72.030000000000001 112.373 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.64 -24.14 24.03 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.985 0.365 . . . . 62.329999999999998 111.985 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.29 37.4 24.6 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.365 -0.445 . . . . 65.150000000000006 112.96 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.483 HD11 HG21 ' A' ' 5' ' ' ILE . 84.1 mt -123.05 174.65 7.07 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.964 0.411 . . . . 71.349999999999994 111.743 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 41' ' ' VAL . 49.3 m -86.8 144.71 26.92 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.477 -0.329 . . . . 70.219999999999999 111.277 177.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.2 mm -47.15 -51.13 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 112.396 0.517 . . . . 75.310000000000002 112.396 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.497 ' CE2' HD11 ' A' ' 43' ' ' LEU . 82.8 t80 -54.44 -56.38 19.3 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.251 -0.431 . . . . 73.129999999999995 111.36 177.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -54.88 -49.0 72.26 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.073 -0.512 . . . . 75.310000000000002 111.69 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 37' ' ' SER . 89.4 t -54.68 -53.03 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.983 -0.553 . . . . 71.299999999999997 111.625 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -65.85 -26.85 67.84 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.949 -0.3 . . . . 73.340000000000003 111.61 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.497 HD11 ' CE2' ' A' ' 39' ' ' TYR . 80.7 mt -58.31 -48.77 79.46 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.948 0.404 . . . . 54.409999999999997 110.287 174.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -66.04 -34.12 77.37 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.234 -0.439 . . . . 64.109999999999999 111.192 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 88.5 mt -63.21 -46.08 88.66 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.66 0.267 . . . . 52.310000000000002 111.062 176.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 49' ' ' HIS . 1.1 mp0 -55.68 -48.09 75.66 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.717 0.294 . . . . 65.099999999999994 110.789 174.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 94.7 mt-30 -56.8 -50.7 71.55 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.813 0.34 . . . . 73.129999999999995 111.055 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.522 ' HA ' HG22 ' A' ' 51' ' ' VAL . 95.1 mt -58.52 -30.57 67.17 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.118 0.485 . . . . 71.230000000000004 111.439 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.475 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 7.3 t-80 -65.9 -45.95 80.09 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.901 0.382 . . . . 72.409999999999997 111.446 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -79.84 -23.73 41.8 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.222 0.823 . . . . 74.340000000000003 113.222 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 48' ' ' LEU . 23.9 m -89.77 6.49 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 121.838 -0.539 . . . . 75.209999999999994 111.78 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.1 57.78 3.36 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 116.325 -0.398 . . . . 63.130000000000003 113.934 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.469 HG23 HG23 ' A' ' 51' ' ' VAL . 90.2 t -131.77 -51.94 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 122.431 -0.452 . . . . 52.25 111.816 177.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.9 mt -97.01 143.97 27.35 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.933 0.716 . . . . 70.230000000000004 112.933 -175.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -102.03 153.24 20.09 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.215 -0.902 . . . . 72.129999999999995 110.89 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.547 ' HD3' ' N ' ' A' ' 56' ' ' LYS . 1.8 mppt? -97.21 119.85 36.48 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.767 0.318 . . . . 65.420000000000002 110.902 -176.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 49.2 t -108.83 106.96 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-O 121.132 0.491 . . . . 72.099999999999994 112.186 -178.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -88.82 101.69 14.28 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.986 0.422 . . . . 64.150000000000006 110.511 175.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.435 ' H ' HG21 ' A' ' 63' ' ' VAL . . . -76.47 -11.42 59.88 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.598 0.592 . . . . 71.319999999999993 112.598 -177.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.406 ' O ' HG22 ' A' ' 63' ' ' VAL . . . 165.8 178.48 38.77 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.714 -0.755 . . . . 62.439999999999998 113.256 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -77.1 96.0 4.36 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.777 0.322 . . . . 72.230000000000004 111.248 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 142.55 -23.06 2.35 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.865 -0.683 . . . . 31.23 113.145 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.435 HG21 ' H ' ' A' ' 59' ' ' ALA . 32.9 m -80.53 137.73 51.52 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 116.912 0.356 . . . . 73.140000000000001 111.437 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.72 -47.33 4.03 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.284 1.989 . . . . 70.019999999999996 112.341 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 159.1 117.68 0.49 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.097 -0.573 . . . . 53.329999999999998 112.875 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 94.4 mt -88.46 159.88 17.78 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.632 0.253 . . . . 75.140000000000001 110.643 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -106.16 132.8 51.79 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.611 0.967 . . . . 72.150000000000006 113.611 -169.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 68' ' ' ARG . 12.4 mtp180 -139.21 -168.64 2.49 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.505 -0.771 . . . . 71.540000000000006 109.755 169.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 pp -114.21 169.16 9.23 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 122.026 -0.421 . . . . 71.0 111.225 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.12 92.9 0.41 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.059 0.456 . . . . 74.420000000000002 111.054 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 . . . . . 0 C--O 1.252 1.232 0 CA-C-O 118.748 -0.644 . . . . 71.349999999999994 111.593 -176.713 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.597 0.237 . . . . 74.230000000000004 111.501 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 t 67.24 31.38 6.65 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.851 0.686 . . . . 74.409999999999997 112.851 174.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -93.55 12.56 24.79 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.596 0.591 . . . . 71.230000000000004 112.596 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.0 m -60.39 -40.12 89.74 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.826 -0.546 . . . . 63.450000000000003 110.909 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 36' ' ' LEU . 14.6 tt -63.13 -31.56 53.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.248 0.547 . . . . 71.120000000000005 110.877 174.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.5 t -69.07 -35.56 69.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.266 -0.425 . . . . 75.430000000000007 110.815 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.1 m -52.96 -43.47 66.39 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.101 0.477 . . . . 73.530000000000001 110.318 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.557 ' O ' HG13 ' A' ' 12' ' ' ILE . 40.5 ttmt -60.45 -48.51 81.45 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.993 -0.549 . . . . 75.299999999999997 110.776 175.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.4 mt -52.57 -47.17 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.892 0.377 . . . . 73.319999999999993 111.512 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.6 mt -61.8 -45.58 98.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.049 0.452 . . . . 42.109999999999999 111.202 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 84.7 p -67.96 -18.35 64.71 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.906 0.336 . . . . 61.439999999999998 111.906 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 8' ' ' LYS . 99.3 mt -75.01 -44.83 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.081 0.467 . . . . 70.219999999999999 110.417 172.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.8 t -59.96 -41.51 86.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.195 0.521 . . . . 63.219999999999999 110.34 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -65.36 -45.33 84.57 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.884 -0.598 . . . . 75.430000000000007 110.526 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -51.09 -52.2 45.94 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.14 -0.482 . . . . 50.219999999999999 111.734 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.9 mmt-85 -61.97 -37.68 85.68 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 111.952 0.353 . . . . 75.510000000000005 111.952 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -74.88 -12.97 60.49 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 122.148 -0.345 . . . . 64.510000000000005 111.86 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -82.6 -45.55 14.44 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.906 0.384 . . . . 70.319999999999993 110.459 171.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 93.6 mmm -70.11 -65.22 0.75 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.176 -0.466 . . . . 71.310000000000002 110.632 176.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -81.68 102.86 10.98 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.989 0.423 . . . . 74.040000000000006 110.004 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -51.11 95.57 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.115 0.783 . . . . 62.340000000000003 113.115 -172.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.91 33.05 84.57 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 115.721 -0.672 . . . . 74.5 113.657 175.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.96 145.97 30.69 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 120.879 0.371 . . . . 44.439999999999998 111.962 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.586 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 38.4 Cg_endo -65.28 131.56 28.73 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.513 2.142 . . . . 64.200000000000003 112.838 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.3 t -82.62 147.88 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.084 -0.507 . . . . 53.229999999999997 111.866 -176.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.448 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -100.61 146.72 26.79 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.297 -0.41 . . . . 64.019999999999996 111.035 -178.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.4 m -57.17 -32.53 66.52 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 111.909 0.337 . . . . 72.150000000000006 111.909 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 28' ' ' ARG . 3.9 mpt_? -60.75 -53.82 52.74 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.096 0.406 . . . . 71.150000000000006 112.096 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.421 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 9.5 m-20 -53.11 -47.61 68.49 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.969 0.414 . . . . 74.319999999999993 111.339 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.532 ' HA ' HG21 ' A' ' 12' ' ' ILE . 61.5 mt -59.49 -43.83 91.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.96 -0.564 . . . . 75.120000000000005 111.389 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.557 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -62.5 -54.34 41.47 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.167 0.432 . . . . 71.230000000000004 112.167 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.35 -43.87 96.46 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.95 0.352 . . . . 63.520000000000003 111.95 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.422 ' HB3' HD13 ' A' ' 12' ' ' ILE . . . -62.91 -37.81 88.46 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.79 0.329 . . . . 62.119999999999997 111.709 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.92 -18.58 36.9 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.99 0.424 . . . . 65.420000000000002 111.63 176.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.86 20.69 70.12 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.327 -0.397 . . . . 74.129999999999995 113.569 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.505 HD11 HD11 ' A' ' 5' ' ' ILE . 84.4 mt -111.61 176.39 5.04 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.14 0.495 . . . . 75.299999999999997 112.04 -175.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.6 m -83.29 147.45 27.96 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.026 -0.534 . . . . 75.530000000000001 111.711 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 39.6 mm -50.6 -51.29 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 112.796 0.665 . . . . 44.210000000000001 112.796 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.404 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 77.8 t80 -60.81 -49.6 76.82 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.742 0.306 . . . . 54.210000000000001 111.635 -178.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -58.11 -50.41 73.59 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.176 0.513 . . . . 71.239999999999995 111.144 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.557 HG21 ' HA ' ' A' ' 31' ' ' ALA . 73.1 t -55.38 -46.56 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.139 -0.482 . . . . 74.0 111.131 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.508 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 16.5 ttt180 -53.11 -44.22 67.47 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.256 -0.429 . . . . 74.129999999999995 111.4 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 97.6 mt -54.69 -47.07 74.12 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.051 0.453 . . . . 71.239999999999995 110.781 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -62.41 -46.29 89.27 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.101 -0.499 . . . . 72.239999999999995 111.282 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 85.0 mt -61.42 -40.94 96.26 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.349 -0.387 . . . . 62.219999999999999 111.712 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' A' ' 42' ' ' ARG . 55.5 mt-10 -59.31 -42.25 90.94 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.971 0.415 . . . . 72.430000000000007 111.107 177.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -71.88 -33.12 68.1 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.813 0.339 . . . . 65.450000000000003 111.159 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.73 -29.11 69.58 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.017 0.437 . . . . 72.129999999999995 111.207 174.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.44 ' HD2' ' HA ' ' A' ' 55' ' ' GLU . 54.4 t-80 -73.37 -28.96 62.32 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.083 0.468 . . . . 74.510000000000005 110.603 172.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -73.96 -52.25 13.42 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.927 -0.578 . . . . 74.209999999999994 111.584 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.518 HG23 HG23 ' A' ' 53' ' ' VAL . 34.1 m -73.5 -10.96 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 113.144 0.794 . . . . 75.209999999999994 113.144 -176.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.53 49.08 2.05 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.005 -0.617 . . . . 54.520000000000003 114.042 176.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.518 HG23 HG23 ' A' ' 51' ' ' VAL . 91.7 t -118.65 -52.5 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.968 0.413 . . . . 55.0 111.427 176.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 86.4 mt -114.91 148.57 38.48 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.018 0.437 . . . . 74.0 111.979 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.44 ' HA ' ' HD2' ' A' ' 49' ' ' HIS . 10.1 tp10 -111.97 133.7 53.99 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.216 -0.447 . . . . 73.230000000000004 111.092 174.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -85.65 97.89 10.37 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.987 -0.551 . . . . 73.540000000000006 110.734 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 46.7 t -68.97 112.26 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 115.987 -0.551 . . . . 34.130000000000003 111.552 -178.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -136.13 116.67 13.81 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.026 -0.534 . . . . 74.120000000000005 110.717 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.407 ' H ' HG21 ' A' ' 63' ' ' VAL . . . -106.13 22.78 15.11 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.662 0.615 . . . . 65.120000000000005 112.662 -177.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.3 175.37 27.2 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.904 -0.665 . . . . 31.449999999999999 113.104 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -75.36 120.74 21.24 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.952 0.406 . . . . 74.140000000000001 111.686 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.44 49.61 19.05 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.188 -0.53 . . . . 63.020000000000003 113.582 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.407 HG21 ' H ' ' A' ' 59' ' ' ALA . 33.6 m -117.07 159.74 39.92 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 122.464 -0.433 . . . . 74.319999999999993 111.367 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -51.43 119.63 5.77 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.671 2.247 . . . . 70.439999999999998 113.391 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.2 105.63 2.02 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 121.196 -0.526 . . . . 44.140000000000001 113.224 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.586 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 87.3 mt -107.0 162.06 14.18 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.832 0.349 . . . . 63.530000000000001 111.329 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -124.38 133.54 53.39 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.307 0.575 . . . . 74.439999999999998 112.313 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -127.46 121.33 30.49 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.283 -0.417 . . . . 72.319999999999993 110.705 172.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.461 ' O ' HD12 ' A' ' 69' ' ' LEU . 2.9 pp -69.99 147.6 49.92 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.947 0.403 . . . . 72.109999999999999 111.659 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 72.5 mt -81.04 85.95 6.21 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.437 -0.347 . . . . 73.420000000000002 111.662 -177.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 C--O 1.255 1.371 0 CA-C-O 118.459 -0.782 . . . . 73.319999999999993 112.972 177.21 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 120.658 0.266 . . . . 62.039999999999999 111.552 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t 61.57 15.76 7.07 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.023 0.44 . . . . 53.340000000000003 111.545 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -81.52 93.94 6.77 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.136 0.493 . . . . 73.140000000000001 110.679 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 63.8 p -102.02 116.22 32.23 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.935 -0.575 . . . . 74.25 111.909 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.0 tp -59.35 -40.67 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 116.195 -0.457 . . . . 71.140000000000001 112.003 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.8 t -61.78 -51.32 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 111.696 0.258 . . . . 73.140000000000001 111.696 -177.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.1 m -56.63 -37.53 70.85 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.905 0.383 . . . . 63.420000000000002 111.423 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.504 ' O ' HG13 ' A' ' 12' ' ' ILE . 37.3 ttpt -65.28 -43.61 90.64 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.471 -0.331 . . . . 65.129999999999995 110.721 176.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.489 HG23 HG21 ' A' ' 30' ' ' ILE . 69.2 mt -59.41 -44.83 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.737 0.303 . . . . 72.420000000000002 111.503 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 69.0 mt -56.68 -45.65 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.27 0.557 . . . . 64.040000000000006 110.771 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.6 m -66.98 -29.32 69.13 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.933 -0.576 . . . . 73.230000000000004 111.905 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 8' ' ' LYS . 94.0 mt -63.94 -44.02 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.056 0.455 . . . . 61.009999999999998 110.91 174.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.425 ' HA ' HG21 ' A' ' 25' ' ' VAL . 59.3 t -57.31 -47.15 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.116 0.484 . . . . 73.310000000000002 110.729 175.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -61.27 -46.59 89.7 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.08 -0.509 . . . . 62.420000000000002 110.992 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -56.3 -46.75 79.67 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.1 -0.5 . . . . 70.540000000000006 111.421 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.42 ' HD3' ' SD ' ' A' ' 19' ' ' MET . 11.1 mmt180 -61.33 -36.67 80.79 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.5 -0.318 . . . . 72.530000000000001 111.729 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.428 ' NE2' ' HG ' ' A' ' 69' ' ' LEU . 73.6 mt-30 -75.79 -21.6 57.2 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.782 0.325 . . . . 70.129999999999995 111.814 176.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -70.53 -36.12 73.54 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.366 0.603 . . . . 74.049999999999997 110.04 170.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.42 ' SD ' ' HD3' ' A' ' 16' ' ' ARG . 74.3 mtp -67.69 -50.39 57.83 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.548 -0.751 . . . . 61.119999999999997 111.062 176.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -122.5 116.74 24.45 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.132 -0.486 . . . . 73.209999999999994 110.494 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -40.33 -53.28 2.6 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.213 0.82 . . . . 61.200000000000003 113.213 -173.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.94 53.98 0.7 Allowed Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.19 -0.529 . . . . 53.539999999999999 113.046 -176.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.414 ' HA ' ' HD2' ' A' ' 24' ' ' PRO . . . -101.83 110.27 61.7 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.361 0.504 . . . . 62.049999999999997 112.361 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.587 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 56.4 Cg_endo -69.88 122.29 8.94 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.093 1.862 . . . . 72.409999999999997 110.767 170.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.425 HG21 ' HA ' ' A' ' 13' ' ' VAL . 22.0 t -79.38 141.47 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 112.37 0.508 . . . . 71.340000000000003 112.37 -167.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -97.58 151.07 20.43 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.134 -0.484 . . . . 71.219999999999999 110.867 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.4 m -53.05 -37.33 61.5 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.201 -0.454 . . . . 62.399999999999999 111.526 175.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -64.22 -44.36 92.13 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.295 -0.411 . . . . 74.140000000000001 112.009 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.04 -41.34 98.0 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.994 0.426 . . . . 74.409999999999997 111.548 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.489 HG21 HG23 ' A' ' 9' ' ' ILE . 60.2 mt -65.78 -43.37 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 116.515 -0.311 . . . . 61.399999999999999 111.045 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.59 -37.51 81.6 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.202 0.525 . . . . 32.32 110.893 174.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.36 -48.33 81.77 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.662 -0.699 . . . . 73.010000000000005 111.697 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.16 -50.29 49.04 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.018 0.377 . . . . 62.399999999999999 112.018 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.0 -19.65 61.16 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.584 0.587 . . . . 74.109999999999999 112.584 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.17 40.0 51.36 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.159 -0.543 . . . . 63.420000000000002 112.673 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.4 175.26 6.53 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.805 0.336 . . . . 65.450000000000003 111.241 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.2 t -85.07 153.76 22.5 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.747 0.308 . . . . 70.120000000000005 111.192 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.59 -50.13 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 112.954 0.724 . . . . 65.200000000000003 112.954 -175.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -66.62 -44.72 81.29 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 122.197 -0.315 . . . . 63.509999999999998 111.763 -175.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -51.07 -55.44 17.56 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.203 0.525 . . . . 75.109999999999999 111.054 175.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.445 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 82.7 t -61.1 -39.86 83.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.064 -0.516 . . . . 71.299999999999997 110.942 176.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -53.52 -41.44 66.34 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.243 -0.435 . . . . 54.039999999999999 110.684 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.3 mt -62.92 -52.86 61.41 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.001 -0.545 . . . . 71.420000000000002 111.285 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -56.05 -36.85 68.5 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.011 0.434 . . . . 64.019999999999996 111.357 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.552 HD13 ' NE1' ' A' ' 67' ' ' TRP . 99.1 mt -69.78 -40.11 76.23 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.408 -0.36 . . . . 75.219999999999999 111.756 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -60.73 -37.94 83.45 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.025 0.44 . . . . 75.209999999999994 110.685 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -61.4 -54.02 49.06 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.385 -0.371 . . . . 52.520000000000003 110.712 174.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.5 mt -57.11 -31.53 65.39 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.15 0.5 . . . . 73.030000000000001 111.608 176.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -63.71 -50.82 67.65 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.921 -0.581 . . . . 71.129999999999995 111.803 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -76.79 -40.65 47.43 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.944 0.72 . . . . 73.319999999999993 112.944 -176.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.505 HG23 HG23 ' A' ' 53' ' ' VAL . 23.5 m -67.58 -16.14 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 112.253 0.464 . . . . 73.040000000000006 112.253 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.61 48.29 2.36 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.185 -0.531 . . . . 75.109999999999999 113.935 177.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.505 HG23 HG23 ' A' ' 51' ' ' VAL . 97.9 t -118.71 -40.94 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 121.075 0.464 . . . . 71.120000000000005 111.28 176.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.418 HD13 ' HB3' ' A' ' 67' ' ' TRP . 83.5 mt -112.85 136.45 52.46 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.401 0.619 . . . . 63.409999999999997 112.296 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -91.65 143.15 26.85 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.586 -0.734 . . . . 55.030000000000001 109.971 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -93.94 105.08 17.11 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.889 0.852 . . . . 75.129999999999995 111.662 -174.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 28.6 t -82.75 75.7 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.358 0.599 . . . . 74.0 110.588 177.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 63.9 t30 177.5 -80.16 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.08 -0.964 . . . . 71.140000000000001 110.629 177.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -174.08 126.36 0.36 Allowed 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.619 0.6 . . . . 55.149999999999999 112.619 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.55 -106.2 0.47 Allowed Glycine 0 CA--C 1.533 1.211 0 N-CA-C 115.227 0.851 . . . . 65.010000000000005 115.227 170.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.439 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -161.69 163.74 29.59 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.456 0.302 . . . . 54.439999999999998 111.463 -174.418 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.79 -55.62 3.02 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 121.403 -0.427 . . . . 74.010000000000005 113.729 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.5 m -55.97 150.85 27.22 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 112.243 0.461 . . . . 72.530000000000001 112.243 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.26 99.77 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.847 2.365 . . . . 72.329999999999998 112.918 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -125.83 151.13 17.67 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 121.079 -0.581 . . . . 65.109999999999999 112.934 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.587 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 67.0 mt -83.26 140.54 32.45 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.973 0.416 . . . . 74.030000000000001 110.191 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.552 ' NE1' HD13 ' A' ' 45' ' ' LEU . 67.1 m95 -93.88 116.43 28.89 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.335 0.588 . . . . 63.130000000000003 112.179 -172.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -114.69 111.49 21.37 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.843 -0.617 . . . . 72.310000000000002 110.534 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.428 ' HG ' ' NE2' ' A' ' 17' ' ' GLN . 3.5 pp -59.3 156.02 13.4 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 122.008 -0.433 . . . . 75.239999999999995 111.504 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.7 mt -67.92 101.84 1.17 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.166 0.507 . . . . 73.299999999999997 111.231 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--O 1.254 1.293 0 CA-C-O 118.43 -0.795 . . . . 73.140000000000001 111.792 178.285 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.621 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 120.929 0.395 . . . . 72.439999999999998 111.328 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.3 m -76.37 79.87 3.11 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.426 0.631 . . . . 44.310000000000002 111.699 -177.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -86.69 44.31 1.15 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.762 -0.654 . . . . 72.219999999999999 111.586 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 94.7 p 49.58 31.59 4.29 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.234 0.827 . . . . 74.409999999999997 113.234 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.685 HD12 ' H ' ' A' ' 5' ' ' ILE . 4.5 mp -58.64 -47.86 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 121.098 0.475 . . . . 71.239999999999995 110.87 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.17 -47.11 91.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-N 116.116 -0.493 . . . . 74.310000000000002 111.145 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.1 m -52.22 -46.08 65.54 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.166 0.508 . . . . 72.329999999999998 111.354 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -55.36 -55.14 35.0 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.95 -0.568 . . . . 73.030000000000001 111.298 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.464 ' O ' HG23 ' A' ' 13' ' ' VAL . 62.8 mt -60.44 -46.04 95.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 112.038 0.384 . . . . 73.230000000000004 112.038 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.8 mt -58.51 -50.93 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 111.892 0.33 . . . . 74.430000000000007 111.892 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.6 p -55.92 -43.65 77.54 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.792 0.33 . . . . 40.420000000000002 111.771 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 82.5 mt -61.68 -55.91 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.927 0.394 . . . . 43.329999999999998 111.589 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 9' ' ' ILE . 80.1 t -55.07 -41.84 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.063 0.459 . . . . 72.420000000000002 111.523 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -65.5 -53.23 45.43 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.128 -0.487 . . . . 73.319999999999993 111.17 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -51.64 -49.5 62.16 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.104 0.478 . . . . 74.549999999999997 111.328 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -54.3 -51.12 65.65 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.733 -0.667 . . . . 74.239999999999995 111.943 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.487 ' NE2' ' HA ' ' A' ' 68' ' ' ARG . 78.3 mt-30 -66.32 -16.45 64.06 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.306 0.484 . . . . 74.400000000000006 112.306 -178.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -78.8 -29.63 45.01 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 122.045 -0.409 . . . . 53.130000000000003 110.791 170.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 23.2 mmt -91.5 -74.19 0.51 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.825 0.345 . . . . 71.340000000000003 111.54 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.27 77.79 8.91 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.91 0.862 . . . . 74.129999999999995 111.157 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -85.92 -28.06 24.57 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.116 -0.947 . . . . 74.430000000000007 111.06 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.36 -3.38 82.25 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 116.056 -0.52 . . . . 71.109999999999999 113.641 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -150.92 119.87 3.54 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 122.436 -0.45 . . . . 54.130000000000003 111.315 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.551 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 10.8 Cg_endo -52.59 152.87 15.4 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.99 2.46 . . . . 74.109999999999999 113.435 -178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.6 t -79.99 150.36 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 112.141 0.423 . . . . 64.120000000000005 112.141 -172.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.511 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 9.9 mptt -96.69 151.42 19.64 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.868 0.366 . . . . 72.140000000000001 111.262 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.8 m -56.0 -36.58 68.08 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 116.286 -0.415 . . . . 73.439999999999998 111.957 177.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.2 mtm-85 -57.07 -58.33 8.66 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.975 0.417 . . . . 75.219999999999999 111.501 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.91 -44.19 70.34 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.651 -0.704 . . . . 73.140000000000001 112.27 -177.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.6 mt -63.68 -46.29 95.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.065 0.459 . . . . 64.439999999999998 111.115 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.548 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -62.74 -43.88 97.64 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.933 0.396 . . . . 64.549999999999997 111.578 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.35 -47.28 84.9 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.062 -0.517 . . . . 61.030000000000001 111.2 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.67 -29.56 68.88 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 111.895 0.332 . . . . 63.340000000000003 111.895 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.14 -15.44 36.11 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.103 0.409 . . . . 52.43 112.103 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.14 27.4 71.98 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.425 -0.417 . . . . 44.530000000000001 112.832 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.6 mt -117.87 175.29 5.73 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.126 0.488 . . . . 73.140000000000001 111.753 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.5 t -80.23 149.31 30.47 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.399 0.518 . . . . 72.25 112.399 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.7 mm -51.92 -40.52 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.962 -0.563 . . . . 73.200000000000003 111.001 174.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.454 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 85.8 t80 -64.83 -56.61 12.4 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.939 -0.573 . . . . 74.420000000000002 111.855 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -57.96 -51.06 71.2 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.178 0.513 . . . . 71.349999999999994 111.633 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.548 HG21 ' HA ' ' A' ' 31' ' ' ALA . 78.2 t -55.87 -47.94 79.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.146 -0.479 . . . . 74.540000000000006 111.602 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -57.35 -38.33 73.97 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.572 -0.286 . . . . 65.010000000000005 111.52 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 92.2 mt -58.38 -46.45 86.32 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.809 0.338 . . . . 54.420000000000002 111.079 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -65.99 -44.17 85.64 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.787 0.327 . . . . 71.319999999999993 111.517 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.74 -48.43 81.83 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.116 0.484 . . . . 75.540000000000006 111.634 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.25 -41.34 90.11 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.318 -0.401 . . . . 73.299999999999997 111.79 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -61.72 -41.55 97.77 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.217 -0.302 . . . . 73.200000000000003 111.386 176.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.9 mt -60.01 -33.39 71.93 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.763 0.316 . . . . 64.430000000000007 111.166 176.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -66.22 -49.76 66.17 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 122.166 -0.334 . . . . 72.439999999999998 110.959 172.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.63 -32.07 71.24 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 112.085 0.402 . . . . 75.230000000000004 112.085 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.453 HG23 HG23 ' A' ' 53' ' ' VAL . 30.9 m -90.96 2.66 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 112.717 0.636 . . . . 62.340000000000003 112.717 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.03 51.93 3.43 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.222 -0.513 . . . . 52.240000000000002 114.202 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.453 HG23 HG23 ' A' ' 51' ' ' VAL . 60.9 t -129.71 -58.51 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 122.394 -0.474 . . . . 75.040000000000006 110.91 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.5 mt -104.37 178.43 4.56 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.211 0.529 . . . . 74.019999999999996 111.872 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.548 ' HB3' ' HG3' ' A' ' 68' ' ' ARG . 11.7 tp10 -138.03 144.78 41.2 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 120.843 0.354 . . . . 72.5 111.254 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -89.81 129.18 36.23 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.128 0.788 . . . . 74.239999999999995 113.128 -174.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.545 ' O ' ' HB2' ' A' ' 58' ' ' ASN . 45.4 t -120.36 116.31 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 108.679 -0.859 . . . . 64.140000000000001 108.679 165.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.545 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 4.4 m-20 77.05 131.28 0.05 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.234 0.614 . . . . 72.0 110.825 -169.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.22 -80.96 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.247 0.832 . . . . 72.329999999999998 113.247 -173.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 175.47 -18.64 0.05 OUTLIER Glycine 0 CA--C 1.531 1.034 0 C-N-CA 121.075 -0.583 . . . . 72.430000000000007 113.717 -176.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -74.52 100.08 3.78 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 122.146 -0.62 . . . . 75.099999999999994 111.388 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.37 -42.0 1.89 Allowed Glycine 0 CA--C 1.533 1.175 0 C-N-CA 121.235 -0.507 . . . . 72.150000000000006 113.612 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.425 ' HB ' HD22 ' A' ' 58' ' ' ASN . 29.0 m -60.46 136.91 92.23 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 122.636 0.374 . . . . 75.329999999999998 111.955 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.48 -31.46 51.19 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.775 2.317 . . . . 75.530000000000001 113.325 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.63 113.99 3.88 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.066 -0.588 . . . . 50.100000000000001 113.414 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 96.4 mt -109.39 137.1 47.76 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.108 0.48 . . . . 63.210000000000001 110.227 175.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 28.8 m95 -123.4 143.24 50.25 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.636 0.606 . . . . 75.209999999999994 112.636 -169.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.548 ' HG3' ' HB3' ' A' ' 55' ' ' GLU . 9.1 ptm180 -147.69 174.43 11.79 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.668 -0.696 . . . . 72.409999999999997 110.862 174.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.459 ' HG ' ' OE1' ' A' ' 17' ' ' GLN . 3.3 pp -125.22 177.57 6.05 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.872 0.368 . . . . 52.210000000000001 111.426 175.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.526 ' N ' HD23 ' A' ' 70' ' ' LEU . 1.3 pt? -142.2 79.16 1.65 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.416 0.627 . . . . 71.129999999999995 110.751 176.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 . . . . . 0 C--O 1.256 1.417 0 CA-C-O 118.782 -0.627 . . . . 42.530000000000001 111.104 -179.731 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.422 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.1 mpp? . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.963 0.411 . . . . 75.200000000000003 110.744 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.8 m -99.79 -68.31 0.81 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 111.894 0.331 . . . . 45.409999999999997 111.894 -175.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -88.99 138.58 31.28 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 116.371 -0.377 . . . . 74.299999999999997 110.748 -174.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.8 m -117.55 -36.01 3.82 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.148 0.795 . . . . 75.209999999999994 113.148 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.465 ' N ' HD12 ' A' ' 5' ' ' ILE . 2.1 mp -70.86 -58.17 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 112.154 0.427 . . . . 72.340000000000003 112.154 -173.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.92 -35.07 72.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.189 0.518 . . . . 65.109999999999999 110.48 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.0 m -61.28 -38.14 85.7 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.042 -0.526 . . . . 74.040000000000006 110.603 173.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.43 ' O ' HG13 ' A' ' 12' ' ' ILE . 86.8 tttt -63.35 -42.53 98.92 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.308 -0.406 . . . . 64.239999999999995 110.613 174.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.433 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.5 mt -52.19 -45.13 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.027 0.441 . . . . 70.109999999999999 110.796 174.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.4 mt -58.45 -44.38 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 116.224 -0.444 . . . . 75.099999999999994 111.203 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.9 m -59.64 -42.2 92.24 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.393 -0.367 . . . . 72.329999999999998 111.266 176.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 8' ' ' LYS . 82.9 mt -59.59 -46.05 93.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.055 0.455 . . . . 75.239999999999995 111.054 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.558 ' HA ' HG21 ' A' ' 25' ' ' VAL . 63.7 t -60.5 -49.63 83.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.082 0.468 . . . . 62.149999999999999 111.096 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.521 ' NE2' HD21 ' A' ' 18' ' ' ASN . 24.7 tm0? -58.65 -41.59 86.42 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.239 0.542 . . . . 52.210000000000001 110.677 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -60.05 -51.04 71.33 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.779 -0.646 . . . . 73.209999999999994 112.156 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.482 ' HB2' HG22 ' A' ' 25' ' ' VAL . 27.4 mmt180 -59.09 -35.4 73.35 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.664 0.269 . . . . 75.439999999999998 111.202 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.507 ' NE2' HG12 ' A' ' 13' ' ' VAL . 44.1 mt-30 -67.02 -27.33 67.32 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.976 0.417 . . . . 74.030000000000001 111.642 175.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.532 HD22 ' N ' ' A' ' 18' ' ' ASN . 0.8 OUTLIER -76.17 -23.12 54.73 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.963 0.411 . . . . 71.439999999999998 110.898 174.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.7 mmt -75.19 -54.99 6.19 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.06 -0.518 . . . . 71.25 110.345 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -119.99 98.97 6.34 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.166 -0.47 . . . . 74.049999999999997 110.592 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -61.76 -15.89 44.88 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.844 0.683 . . . . 63.310000000000002 112.844 -174.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -117.29 31.88 5.64 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.34 -0.457 . . . . 51.530000000000001 113.297 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -140.36 136.97 17.2 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 112.45 0.537 . . . . 73.010000000000005 112.45 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.556 ' HG2' HD13 ' A' ' 66' ' ' LEU . 82.7 Cg_endo -83.29 159.61 15.1 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.63 2.22 . . . . 62.409999999999997 112.312 172.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.558 HG21 ' HA ' ' A' ' 13' ' ' VAL . 11.2 t -85.91 156.2 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.055 0.455 . . . . 71.530000000000001 111.986 -175.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.46 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -99.95 140.17 34.55 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.263 -0.426 . . . . 70.109999999999999 110.783 -175.14 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.2 m -55.61 -41.1 73.0 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.874 0.369 . . . . 73.329999999999998 111.791 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -61.43 -52.72 63.4 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.892 0.377 . . . . 72.409999999999997 111.353 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.09 -35.66 75.7 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.238 -0.437 . . . . 74.439999999999998 111.772 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.529 HG21 HD21 ' A' ' 45' ' ' LEU . 77.8 mt -66.95 -56.28 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.801 0.334 . . . . 51.530000000000001 111.464 176.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.412 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -56.45 -43.42 79.49 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.087 0.403 . . . . 71.140000000000001 112.087 -178.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.51 -53.03 58.4 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.041 -0.527 . . . . 51.539999999999999 110.958 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.11 -29.47 70.59 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 111.933 0.346 . . . . 60.200000000000003 111.933 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.75 -27.13 44.66 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.905 0.383 . . . . 62.009999999999998 111.914 177.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.99 45.99 9.85 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.089 -0.577 . . . . 41.100000000000001 112.965 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.2 mt -135.5 178.16 7.26 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.732 -0.275 . . . . 74.129999999999995 111.045 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.422 ' O ' HG23 ' A' ' 41' ' ' VAL . 66.5 m -82.18 142.9 31.8 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 122.395 -0.191 . . . . 74.310000000000002 111.306 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.443 ' O ' ' HG3' ' A' ' 42' ' ' ARG . 48.2 mm -51.72 -55.68 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 122.53 0.332 . . . . 61.140000000000001 111.752 -176.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -54.17 -48.19 71.19 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.036 0.446 . . . . 72.129999999999995 111.474 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -58.12 -45.94 86.45 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.865 -0.607 . . . . 73.439999999999998 111.795 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 37' ' ' SER . 99.1 t -66.71 -39.27 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.319 -0.4 . . . . 74.409999999999997 111.637 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 38' ' ' ILE . 79.4 mtp180 -53.4 -44.45 68.73 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.809 0.337 . . . . 72.129999999999995 110.856 176.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.44 ' O ' ' HG3' ' A' ' 47' ' ' GLN . 98.2 mt -59.61 -49.51 77.48 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.23 -0.441 . . . . 71.219999999999999 111.054 176.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 21.4 m-30 -58.85 -43.87 90.88 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.888 0.375 . . . . 53.299999999999997 111.717 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.529 HD21 HG21 ' A' ' 30' ' ' ILE . 96.7 mt -63.45 -45.54 90.4 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.373 -0.376 . . . . 74.340000000000003 111.588 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -61.33 -39.7 91.5 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 121.214 -0.194 . . . . 53.119999999999997 110.788 175.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 80.9 mt-30 -58.45 -44.16 89.1 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.965 0.412 . . . . 63.329999999999998 110.976 172.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.86 -31.22 71.46 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.345 -0.389 . . . . 75.519999999999996 111.946 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -73.98 -36.67 64.57 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.082 0.468 . . . . 75.450000000000003 110.918 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -64.26 -50.46 67.86 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.159 -0.473 . . . . 71.140000000000001 111.291 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.549 HG23 HG23 ' A' ' 53' ' ' VAL . 33.7 m -75.56 4.13 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 N-CA-C 112.641 0.608 . . . . 73.430000000000007 112.641 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.71 29.53 38.84 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 114.952 0.741 . . . . 74.319999999999993 114.952 171.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.549 HG23 HG23 ' A' ' 51' ' ' VAL . 82.2 t -96.46 -60.15 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 117.413 0.607 . . . . 75.519999999999996 111.269 174.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.462 HD22 HG11 ' A' ' 13' ' ' VAL . 71.5 mt -99.26 145.48 27.24 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.226 0.536 . . . . 71.239999999999995 112.206 -176.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.525 ' HB2' HD23 ' A' ' 70' ' ' LEU . 9.3 tp10 -92.39 142.59 27.28 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.983 -0.553 . . . . 74.150000000000006 111.085 174.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -87.84 107.06 18.49 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.838 -0.619 . . . . 71.329999999999998 110.666 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.6 t -108.99 104.9 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 121.012 0.434 . . . . 65.150000000000006 112.002 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -119.04 114.16 22.08 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.882 0.373 . . . . 74.340000000000003 110.709 176.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.99 -0.68 49.91 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.35 0.5 . . . . 75.230000000000004 112.35 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.98 -158.46 25.21 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 121.198 -0.525 . . . . 74.109999999999999 112.892 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -81.83 159.91 23.64 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.971 0.415 . . . . 74.450000000000003 111.31 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.11 -54.82 4.98 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.032 -0.604 . . . . 53.539999999999999 112.319 -177.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.0 m -79.44 133.7 59.5 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 122.737 -0.273 . . . . 62.509999999999998 110.742 174.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -74.86 -174.08 1.78 Allowed 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.416 2.078 . . . . 73.019999999999996 113.274 -177.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.08 99.02 1.51 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.131 -0.557 . . . . 63.340000000000003 112.456 177.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.556 HD13 ' HG2' ' A' ' 24' ' ' PRO . 96.4 mt -73.81 141.86 46.19 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.036 0.446 . . . . 64.019999999999996 111.319 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.452 ' CD1' HD13 ' A' ' 45' ' ' LEU . 67.1 m95 -108.04 117.54 34.39 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.809 0.67 . . . . 64.25 112.809 -170.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.475 ' HG3' ' OE1' ' A' ' 17' ' ' GLN . 55.8 ttt180 -120.63 178.7 4.58 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.402 -0.962 . . . . 73.340000000000003 108.402 171.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 54' ' ' LEU . 2.3 pp -101.52 160.97 13.98 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.526 1.057 . . . . 61.520000000000003 111.557 174.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.525 HD23 ' HB2' ' A' ' 55' ' ' GLU . 84.3 mt -69.12 93.15 0.58 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.891 0.377 . . . . 72.150000000000006 110.337 176.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 C--O 1.253 1.243 0 CA-C-O 118.37 -0.824 . . . . 73.439999999999998 111.897 -174.341 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.746 0.308 . . . . 53.130000000000003 111.373 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.9 t -68.17 101.41 1.16 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.751 0.31 . . . . 71.519999999999996 111.116 178.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -134.11 130.94 38.13 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.969 0.414 . . . . 73.549999999999997 111.276 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.9 m -63.07 -35.42 80.2 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.199 -0.455 . . . . 61.240000000000002 111.525 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.7 mm -59.47 -48.07 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.05 0.452 . . . . 53.409999999999997 111.139 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.3 t -61.46 -48.11 90.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.341 -0.391 . . . . 73.0 110.923 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 99.5 m -58.13 -39.61 79.17 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.246 -0.434 . . . . 74.409999999999997 111.613 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.467 ' O ' HG13 ' A' ' 12' ' ' ILE . 60.1 tptt -57.57 -53.99 51.93 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.116 0.484 . . . . 71.510000000000005 110.485 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.527 HG23 HG21 ' A' ' 30' ' ' ILE . 67.8 mt -57.78 -48.65 83.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 115.784 -0.644 . . . . 74.549999999999997 111.931 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.7 mt -59.32 -44.31 92.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-O 120.966 0.412 . . . . 74.430000000000007 111.608 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.2 t -63.05 -32.49 73.87 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.336 -0.393 . . . . 70.239999999999995 111.556 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 8' ' ' LYS . 99.0 mt -71.35 -49.0 50.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.898 0.38 . . . . 72.340000000000003 111.336 176.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 9' ' ' ILE . 89.6 t -56.48 -44.09 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.135 0.493 . . . . 60.350000000000001 110.776 176.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -65.6 -39.96 92.13 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.945 -0.57 . . . . 74.200000000000003 110.898 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -55.57 -47.85 75.73 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.167 0.508 . . . . 52.399999999999999 110.87 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.572 ' HA ' ' HG2' ' A' ' 19' ' ' MET . 0.3 OUTLIER -64.46 -34.35 77.99 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.088 -0.506 . . . . 65.299999999999997 111.398 178.281 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.417 ' NE2' ' HG3' ' A' ' 68' ' ' ARG . 12.3 mm-40 -65.07 -40.03 94.1 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.038 0.447 . . . . 71.340000000000003 111.651 174.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -75.99 -21.94 56.38 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.281 0.474 . . . . 74.349999999999994 112.281 -177.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.572 ' HG2' ' HA ' ' A' ' 16' ' ' ARG . 24.8 ptm -83.77 -32.29 25.48 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.956 -0.465 . . . . 65.319999999999993 111.379 176.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -152.17 115.29 4.69 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.091 0.472 . . . . 71.0 110.805 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -69.4 -13.44 62.36 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.998 0.74 . . . . 74.129999999999995 112.998 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.03 15.15 12.34 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.052 -0.594 . . . . 72.239999999999995 113.487 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -107.71 113.58 61.25 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 112.174 0.435 . . . . 61.049999999999997 112.174 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.83 140.78 32.57 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.36 2.04 . . . . 71.319999999999993 112.067 172.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.411 HG13 ' HG3' ' A' ' 16' ' ' ARG . 5.4 t -79.12 154.64 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 120.923 0.392 . . . . 74.340000000000003 111.199 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.567 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 2.3 mptp? -107.58 139.0 42.79 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.65 -0.25 . . . . 74.120000000000005 110.737 -177.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.2 m -53.49 -51.13 63.75 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.066 0.46 . . . . 65.540000000000006 111.8 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -64.85 -31.26 72.4 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.114 0.412 . . . . 65.219999999999999 112.114 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -63.54 -52.69 60.01 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.945 0.403 . . . . 63.299999999999997 111.046 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.527 HG21 HG23 ' A' ' 9' ' ' ILE . 64.2 mt -55.89 -43.13 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.045 0.45 . . . . 73.129999999999995 110.892 176.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.78 -35.68 73.21 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.102 -0.499 . . . . 73.420000000000002 111.876 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -74.1 -48.46 29.52 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.763 0.316 . . . . 71.349999999999994 110.992 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.11 -28.66 69.92 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.114 0.413 . . . . 70.219999999999999 112.114 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.22 -26.45 16.64 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.297 0.48 . . . . 53.439999999999998 112.297 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.21 31.47 38.25 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.267 -0.492 . . . . 73.099999999999994 112.713 -176.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.5 mt -115.35 169.26 9.28 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.845 0.355 . . . . 63.119999999999997 111.432 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.412 ' O ' HG23 ' A' ' 41' ' ' VAL . 46.1 t -87.7 151.49 22.89 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.029 0.443 . . . . 62.32 111.772 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.1 mm -58.09 -48.85 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 112.985 0.735 . . . . 60.200000000000003 112.985 -172.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.552 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 41.8 p90 -56.68 -38.67 72.57 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 111.853 0.316 . . . . 74.530000000000001 111.853 -176.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -75.84 -47.18 26.64 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.079 0.466 . . . . 65.329999999999998 111.091 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 37' ' ' SER . 90.9 t -55.23 -48.28 76.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 116.17 -0.468 . . . . 72.329999999999998 111.614 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -65.61 -29.72 70.34 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 111.887 0.329 . . . . 71.239999999999995 111.887 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 65.6 mt -59.03 -49.28 78.49 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.167 -0.333 . . . . 61.329999999999998 110.577 176.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -61.28 -53.27 58.96 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.352 -0.385 . . . . 74.019999999999996 111.191 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.426 HD13 ' CD1' ' A' ' 67' ' ' TRP . 89.0 mt -55.37 -49.73 71.53 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.226 0.536 . . . . 74.310000000000002 112.393 -178.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.79 -41.73 95.6 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.937 -0.574 . . . . 62.340000000000003 112.095 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -68.83 -41.13 78.95 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.741 0.305 . . . . 75.25 110.942 176.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.0 mt -59.68 -31.63 69.74 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.746 0.307 . . . . 61.439999999999998 111.102 175.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.512 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 42.0 t-80 -66.43 -48.6 69.49 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.987 0.423 . . . . 73.129999999999995 111.031 173.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -59.96 -33.56 72.09 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 116.123 -0.489 . . . . 71.420000000000002 111.933 -176.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.523 HG23 HG23 ' A' ' 53' ' ' VAL . 33.9 m -89.44 1.53 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 112.841 0.682 . . . . 73.329999999999998 112.841 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.44 19.52 51.98 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 114.82 0.688 . . . . 53.210000000000001 114.82 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.523 HG23 HG23 ' A' ' 51' ' ' VAL . 81.6 t -88.53 -48.24 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 122.16 -0.612 . . . . 75.219999999999999 111.027 175.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 85.9 mt -114.79 152.39 32.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.285 -0.416 . . . . 61.200000000000003 111.503 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.459 ' HA ' ' HD2' ' A' ' 49' ' ' HIS . 10.5 tp10 -109.28 149.99 28.63 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.488 -0.323 . . . . 73.549999999999997 110.299 173.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -98.86 137.78 36.94 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.165 0.507 . . . . 74.430000000000007 111.215 -178.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.513 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 88.7 t -121.25 132.81 69.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 120.995 0.426 . . . . 71.540000000000006 111.57 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -153.15 101.04 2.52 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.308 -0.405 . . . . 51.240000000000002 110.113 177.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.69 -28.91 66.23 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.247 0.832 . . . . 43.310000000000002 113.247 -174.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.488 ' O ' HG22 ' A' ' 63' ' ' VAL . . . 179.93 165.12 33.31 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.755 -0.736 . . . . 73.230000000000004 113.438 -178.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -61.38 97.29 0.07 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.181 0.515 . . . . 64.400000000000006 111.015 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 144.1 -31.2 1.86 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-N 115.848 -0.614 . . . . 62.530000000000001 112.716 -177.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 60' ' ' GLY . 18.2 m -80.66 156.39 73.0 Favored Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 122.466 -0.432 . . . . 55.229999999999997 111.154 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 63' ' ' VAL . 50.4 Cg_endo -67.41 167.02 21.68 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.651 2.234 . . . . 73.120000000000005 113.722 -178.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.87 97.31 1.62 Allowed Glycine 0 CA--C 1.525 0.717 0 CA-C-N 115.979 -0.555 . . . . 52.210000000000001 112.605 176.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.513 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 70.5 mt -88.58 164.18 15.51 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.934 0.397 . . . . 71.150000000000006 111.597 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.426 ' CD1' HD13 ' A' ' 45' ' ' LEU . 72.8 m95 -131.45 154.04 49.11 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.856 0.36 . . . . 74.349999999999994 111.351 -178.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.417 ' HG3' ' NE2' ' A' ' 17' ' ' GLN . 50.7 ttt85 -165.3 117.55 1.16 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.551 -0.295 . . . . 74.310000000000002 110.992 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 54' ' ' LEU . 4.2 pp -64.21 155.29 32.29 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.953 0.406 . . . . 71.450000000000003 111.661 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.518 HD23 ' H ' ' A' ' 70' ' ' LEU . 1.8 pt? -123.06 13.64 9.76 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.035 0.445 . . . . 74.230000000000004 111.184 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.746 -0.645 . . . . 74.239999999999995 110.782 179.895 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.427 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 120.85 0.357 . . . . 75.319999999999993 111.563 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 84.3 p -161.33 167.12 26.43 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.336 -0.393 . . . . 53.229999999999997 110.913 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -68.53 101.09 1.2 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.201 0.524 . . . . 73.540000000000006 111.309 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.6 t -81.0 24.83 0.49 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.131 0.419 . . . . 75.450000000000003 112.131 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.64 HG12 HD11 ' A' ' 36' ' ' LEU . 9.5 tp -55.79 -36.19 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.314 0.487 . . . . 73.349999999999994 112.314 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.7 t -58.46 -50.26 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.853 0.359 . . . . 63.43 111.509 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.9 m -60.88 -40.02 91.43 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.937 0.398 . . . . 74.409999999999997 111.041 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.484 ' O ' HG13 ' A' ' 12' ' ' ILE . 4.4 ttmp? -58.93 -48.77 80.3 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.34 -0.391 . . . . 74.230000000000004 111.095 177.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.9 mt -56.47 -48.11 80.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.421 -0.354 . . . . 75.299999999999997 111.586 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.5 mt -59.14 -43.27 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.079 0.466 . . . . 73.329999999999998 111.018 176.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.4 t -60.52 -40.02 89.92 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.948 -0.569 . . . . 71.209999999999994 111.628 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 8' ' ' LYS . 86.8 mt -61.08 -51.06 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.093 0.473 . . . . 53.25 111.185 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.6 t -57.97 -51.01 76.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.105 0.478 . . . . 54.210000000000001 111.008 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -54.07 -47.38 71.73 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.998 -0.546 . . . . 72.239999999999995 111.349 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -57.52 -53.49 57.56 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.145 -0.479 . . . . 54.530000000000001 111.785 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -62.69 -27.17 69.06 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.568 -0.287 . . . . 75.310000000000002 111.71 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -80.22 -26.79 38.94 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 122.16 -0.337 . . . . 75.010000000000005 111.705 175.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -64.59 -26.11 68.26 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.225 0.536 . . . . 62.119999999999997 109.856 170.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.0 mmm -78.43 -60.18 2.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.708 -0.678 . . . . 74.230000000000004 111.548 173.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 23' ' ' ALA . 24.6 m-20 -94.13 -55.86 3.05 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.771 0.656 . . . . 54.219999999999999 112.771 -176.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.3 t70 68.47 -69.08 0.16 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.455 0.702 . . . . 74.030000000000001 111.834 -176.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.44 -35.34 84.86 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.983 -0.627 . . . . 75.310000000000002 112.812 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 20' ' ' ASP . . . -96.38 129.37 33.58 Favored Pre-proline 0 CA--C 1.541 0.63 0 O-C-N 122.618 -0.343 . . . . 74.439999999999998 111.069 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.04 164.14 33.1 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.421 2.08 . . . . 72.230000000000004 113.251 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.4 t -84.85 145.64 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.285 -0.416 . . . . 71.420000000000002 110.742 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.449 ' HD2' ' H ' ' A' ' 26' ' ' LYS . 6.5 mptt -90.06 141.16 28.94 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.706 0.289 . . . . 54.509999999999998 110.788 -176.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.1 m -52.01 -38.31 56.39 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.851 0.357 . . . . 60.350000000000001 111.873 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 28' ' ' ARG . 5.2 mpt_? -63.35 -47.56 81.64 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 122.37 -0.206 . . . . 73.349999999999994 111.552 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.22 -52.5 51.95 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.002 0.429 . . . . 70.340000000000003 111.196 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.56 HG21 HD21 ' A' ' 45' ' ' LEU . 58.3 mt -58.44 -53.89 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 115.764 -0.653 . . . . 74.129999999999995 111.742 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.468 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -60.85 -45.43 94.55 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.096 0.406 . . . . 72.120000000000005 112.096 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.16 -40.4 96.05 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.088 -0.506 . . . . 70.200000000000003 111.595 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.402 ' HB3' HD13 ' A' ' 12' ' ' ILE . . . -71.97 -38.29 69.76 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.877 0.37 . . . . 33.399999999999999 111.324 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.82 -35.27 72.41 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.287 -0.415 . . . . 62.539999999999999 111.659 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.97 23.2 42.4 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.394 -0.432 . . . . 65.219999999999999 113.509 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.64 HD11 HG12 ' A' ' 5' ' ' ILE . 85.7 mt -113.24 171.67 7.41 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.964 0.412 . . . . 72.0 111.705 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.5 m -71.65 144.36 49.42 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.261 -0.427 . . . . 71.019999999999996 111.404 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.1 mm -50.85 -58.22 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.35 0.5 . . . . 63.310000000000002 112.35 -174.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.471 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 47.8 p90 -54.02 -40.69 67.26 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.158 0.429 . . . . 62.200000000000003 112.158 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -65.43 -47.3 76.7 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.169 0.509 . . . . 65.140000000000001 111.016 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' A' ' 31' ' ' ALA . 60.9 t -58.7 -44.29 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.147 -0.479 . . . . 72.5 111.024 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -58.52 -33.69 70.14 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.616 -0.265 . . . . 64.049999999999997 111.686 178.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.533 ' O ' ' HG3' ' A' ' 47' ' ' GLN . 95.1 mt -60.07 -52.58 64.74 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 110.167 -0.309 . . . . 65.230000000000004 110.167 175.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -56.83 -46.0 81.96 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.115 0.484 . . . . 75.109999999999999 111.256 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.56 HD21 HG21 ' A' ' 30' ' ' ILE . 92.9 mt -59.92 -46.6 88.84 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.089 -0.505 . . . . 73.430000000000007 111.918 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -67.29 -37.18 83.0 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.509 0.195 . . . . 73.409999999999997 111.34 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 96.2 mt-30 -59.66 -45.19 92.8 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.064 0.459 . . . . 63.350000000000001 110.602 174.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 94.3 mt -61.42 -34.13 74.87 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.379 -0.373 . . . . 74.510000000000005 111.416 176.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.532 ' HD2' ' HA ' ' A' ' 55' ' ' GLU . 46.5 t-80 -70.56 -28.71 65.11 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.149 0.499 . . . . 73.200000000000003 111.015 174.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -79.65 -41.66 26.48 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.143 -0.481 . . . . 73.430000000000007 111.765 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.6 m -77.79 -24.71 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 111.914 0.339 . . . . 63.119999999999997 111.914 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.6 69.02 0.61 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.098 -0.572 . . . . 62.539999999999999 113.12 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 99.4 t -141.36 -60.92 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.111 0.481 . . . . 73.129999999999995 110.787 177.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.665 HD23 ' HB3' ' A' ' 69' ' ' LEU . 80.9 mt -103.98 145.75 29.7 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.148 -0.478 . . . . 74.230000000000004 111.962 -177.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.549 ' HB2' HD22 ' A' ' 70' ' ' LEU . 12.0 tp10 -108.53 141.11 40.91 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.029 0.442 . . . . 73.329999999999998 110.838 172.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? -89.96 94.87 9.97 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.144 0.497 . . . . 73.230000000000004 111.495 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.577 ' O ' ' HB2' ' A' ' 58' ' ' ASN . 42.2 t -77.68 85.89 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 120.967 0.413 . . . . 75.030000000000001 110.835 177.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.577 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 66.1 t30 162.4 -177.86 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.221 1.008 . . . . 73.0 108.994 -178.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.43 ' HB3' HG21 ' A' ' 63' ' ' VAL . . . -67.83 -172.04 0.25 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 110.204 -0.295 . . . . 22.420000000000002 110.204 166.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -147.09 -158.47 7.84 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.159 -1.02 . . . . 52.409999999999997 114.009 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm 72.0 7.96 5.89 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.327 0.651 . . . . 61.299999999999997 112.377 176.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.57 -43.96 0.55 Allowed Glycine 0 CA--C 1.53 0.975 0 C-N-CA 120.55 -0.833 . . . . 71.209999999999994 113.933 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.43 HG21 ' HB3' ' A' ' 59' ' ' ALA . 33.7 m -54.3 151.58 13.28 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 122.331 0.252 . . . . 44.25 111.536 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -52.83 -69.34 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.089 2.526 . . . . 74.25 113.819 -172.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.431 ' HA2' ' CB ' ' A' ' 58' ' ' ASN . . . 84.94 151.58 14.74 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.699 -0.762 . . . . 75.420000000000002 114.164 177.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 66' ' ' LEU . 5.9 mp -110.06 133.55 53.09 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 110.025 -0.361 . . . . 61.539999999999999 110.025 174.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.443 ' CD1' HD13 ' A' ' 45' ' ' LEU . 58.2 m95 -102.23 133.93 46.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.469 0.652 . . . . 73.200000000000003 111.906 -172.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -141.31 114.47 8.66 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.778 -0.646 . . . . 73.120000000000005 111.088 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.665 ' HB3' HD23 ' A' ' 54' ' ' LEU . 4.2 pp -67.76 151.58 46.99 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.426 0.631 . . . . 71.430000000000007 111.9 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.549 HD22 ' HB2' ' A' ' 55' ' ' GLU . 1.7 pt? -139.56 159.66 41.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.39 -0.823 . . . . 72.099999999999994 110.648 -177.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.875 -0.583 . . . . 70.439999999999998 110.311 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtp . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 120.929 0.395 . . . . 53.240000000000002 111.594 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.0 m -81.18 -47.78 12.98 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.159 0.504 . . . . 73.420000000000002 109.829 172.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 59.92 20.92 9.91 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.147 0.795 . . . . 62.450000000000003 113.147 167.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.5 m 64.5 21.19 12.39 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.187 0.44 . . . . 73.420000000000002 112.187 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.9 tp -55.03 -27.08 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 112.054 0.39 . . . . 72.519999999999996 112.054 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.467 HG13 HD21 ' A' ' 48' ' ' LEU . 61.6 t -53.27 -49.53 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.402 -0.363 . . . . 72.450000000000003 111.955 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.0 m -55.45 -46.2 76.81 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.898 0.38 . . . . 74.329999999999998 111.408 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.499 ' O ' HG13 ' A' ' 12' ' ' ILE . 53.8 tptt -55.99 -50.61 70.37 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.366 -0.379 . . . . 64.450000000000003 111.49 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.3 mt -57.19 -42.33 79.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.312 -0.404 . . . . 64.219999999999999 111.562 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.2 mt -61.56 -46.06 97.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 121.003 0.43 . . . . 71.439999999999998 110.903 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.8 m -60.75 -32.67 71.96 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.348 -0.387 . . . . 55.409999999999997 111.506 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.536 HG21 ' HA ' ' A' ' 30' ' ' ILE . 96.4 mt -67.21 -41.32 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.788 0.328 . . . . 74.400000000000006 111.55 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.437 ' HA ' HG21 ' A' ' 25' ' ' VAL . 59.5 t -59.95 -41.23 85.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 121.207 0.527 . . . . 62.219999999999999 110.714 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -64.56 -48.15 76.09 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.058 0.456 . . . . 61.32 110.514 173.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -53.06 -56.3 17.21 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.624 -0.716 . . . . 74.040000000000006 112.25 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -67.48 -39.14 85.23 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.511 0.559 . . . . 61.350000000000001 112.511 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -74.21 -20.33 60.22 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.406 -0.518 . . . . 72.420000000000002 110.71 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -71.51 -24.53 61.98 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.497 0.665 . . . . 74.129999999999995 109.514 172.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.1 mmt -79.64 -47.89 14.65 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.871 -0.604 . . . . 75.120000000000005 111.504 169.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -98.56 84.69 3.21 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.052 0.453 . . . . 75.299999999999997 110.969 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -57.05 -37.34 71.66 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.397 0.518 . . . . 63.0 112.397 -177.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -108.11 20.14 31.33 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.244 -0.503 . . . . 74.109999999999999 113.868 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.436 ' HA ' ' HD2' ' A' ' 24' ' ' PRO . . . -158.39 108.33 1.68 Allowed Pre-proline 0 N--CA 1.468 0.459 0 CA-C-N 117.053 0.427 . . . . 62.219999999999999 111.785 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.53 ' HB3' ' HB2' ' A' ' 68' ' ' ARG . 1.5 Cg_endo -48.34 177.39 0.02 OUTLIER 'Trans proline' 0 CA--C 1.552 1.414 0 C-N-CA 122.954 2.436 . . . . 54.439999999999998 114.501 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.437 HG21 ' HA ' ' A' ' 13' ' ' VAL . 44.1 t -79.57 152.93 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 112.824 0.675 . . . . 72.040000000000006 112.824 -169.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.639 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 8.2 mptt -105.86 146.09 30.38 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.715 -0.675 . . . . 54.439999999999998 110.082 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.4 m -53.71 -44.34 69.77 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.652 0.612 . . . . 55.299999999999997 112.652 -176.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -59.47 -43.58 93.2 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 111.7 0.259 . . . . 72.129999999999995 111.7 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.465 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 2.8 m-20 -56.46 -39.62 73.47 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.039 0.447 . . . . 72.340000000000003 112.043 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.615 HG21 HD21 ' A' ' 45' ' ' LEU . 61.5 mt -68.94 -44.51 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.954 0.406 . . . . 71.239999999999995 111.289 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.473 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -61.82 -35.28 77.76 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.104 0.478 . . . . 53.299999999999997 111.162 175.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -65.58 -55.59 16.88 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.658 -0.701 . . . . 73.409999999999997 111.737 178.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.39 -37.99 87.9 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.762 0.653 . . . . 42.240000000000002 112.762 -176.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.48 -28.91 30.89 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 111.974 0.361 . . . . 73.049999999999997 111.974 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.64 39.05 22.6 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.066 -0.587 . . . . 53.439999999999998 112.586 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.5 mt -117.43 172.71 7.15 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 122.658 -0.319 . . . . 65.439999999999998 111.236 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.401 ' O ' HG23 ' A' ' 41' ' ' VAL . 50.6 m -78.99 148.14 32.67 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.663 -0.244 . . . . 74.310000000000002 111.439 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.6 mm -52.66 -58.56 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 112.407 0.521 . . . . 75.219999999999999 112.407 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -57.05 -41.83 79.4 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.959 0.409 . . . . 74.120000000000005 111.567 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -56.42 -49.64 73.97 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.462 0.649 . . . . 61.329999999999998 111.068 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.473 HG21 ' HA ' ' A' ' 31' ' ' ALA . 64.2 t -65.11 -39.47 85.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.838 -0.619 . . . . 72.310000000000002 111.352 178.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.4 mmm-85 -50.94 -48.17 60.95 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.889 0.376 . . . . 71.310000000000002 111.315 175.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.5 mt -59.01 -51.59 69.39 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.183 -0.462 . . . . 75.219999999999999 111.091 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -60.2 -45.15 94.15 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.4 0.519 . . . . 75.140000000000001 112.4 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.615 HD21 HG21 ' A' ' 30' ' ' ILE . 91.0 mt -64.6 -52.77 55.79 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.175 0.512 . . . . 73.420000000000002 111.515 -177.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.405 ' HG2' ' HH2' ' A' ' 67' ' ' TRP . 34.4 mt-10 -66.34 -29.22 69.37 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.101 -0.5 . . . . 74.450000000000003 111.993 -177.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -74.56 -37.84 62.86 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 122.104 -0.373 . . . . 71.030000000000001 111.052 172.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.467 HD21 HG13 ' A' ' 6' ' ' VAL . 62.1 mt -64.37 -26.54 68.51 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.883 0.373 . . . . 71.019999999999996 110.843 173.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -72.86 -40.35 65.75 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.887 0.375 . . . . 74.099999999999994 110.69 171.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.19 -38.2 88.21 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 116.216 -0.447 . . . . 72.430000000000007 111.744 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.6 HG23 HG23 ' A' ' 53' ' ' VAL . 35.4 m -81.25 -12.09 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 112.218 0.451 . . . . 72.5 112.218 177.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.18 24.93 13.43 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 120.986 -0.626 . . . . 73.400000000000006 114.62 174.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.6 HG23 HG23 ' A' ' 51' ' ' VAL . 64.4 t -91.71 -56.59 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 117.493 0.647 . . . . 65.25 111.332 175.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 61.5 mt -105.13 125.88 51.46 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.079 -0.509 . . . . 73.230000000000004 111.498 -176.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -93.87 140.19 29.98 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.887 0.375 . . . . 74.5 111.703 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . 97.2 mttt -88.62 94.01 9.75 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.97 0.414 . . . . 72.319999999999993 110.58 175.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.403 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 59.6 t -71.62 132.53 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.666 -0.243 . . . . 74.450000000000003 110.461 175.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.403 ' HB3' ' O ' ' A' ' 57' ' ' VAL . 63.6 t30 73.39 24.4 2.35 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.316 0.579 . . . . 73.129999999999995 111.144 -177.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' A' ' 56' ' ' LYS . . . -74.37 -17.63 60.79 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.204 0.446 . . . . 53.530000000000001 112.204 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.35 -94.21 0.01 OUTLIER Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.589 -0.339 . . . . 71.420000000000002 113.427 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -127.46 38.91 3.98 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.945 0.402 . . . . 71.040000000000006 111.009 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.11 42.5 1.28 Allowed Glycine 0 CA--C 1.53 1.03 0 N-CA-C 114.561 0.585 . . . . 73.010000000000005 114.561 173.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.7 m -111.67 146.87 35.59 Favored Pre-proline 0 N--CA 1.472 0.664 0 CA-C-N 117.491 0.646 . . . . 74.040000000000006 111.225 175.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.75 95.25 0.4 Allowed 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.391 2.061 . . . . 72.319999999999993 112.168 174.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -99.27 -134.94 8.69 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.19 -0.528 . . . . 75.409999999999997 113.341 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 91.4 mt -97.27 132.57 42.89 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.043 0.449 . . . . 70.409999999999997 111.764 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.405 ' HH2' ' HG2' ' A' ' 46' ' ' GLU . 85.3 m95 -84.4 125.42 32.32 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.563 0.697 . . . . 73.200000000000003 112.614 -175.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.53 ' HB2' ' HB3' ' A' ' 24' ' ' PRO . 74.0 ttt180 -139.97 117.78 11.68 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.897 -0.592 . . . . 72.5 110.768 176.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 69' ' ' LEU . 2.6 pt? -66.35 152.9 44.05 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.865 0.364 . . . . 75.340000000000003 111.12 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.6 mt -80.69 124.76 29.29 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.91 0.386 . . . . 74.010000000000005 111.826 -176.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.396 -0.811 . . . . 72.140000000000001 111.324 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 120.514 0.197 . . . . 73.25 110.847 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.7 p -57.59 99.61 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.16 0.505 . . . . 74.340000000000003 111.485 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.76 -33.48 71.73 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.77 -0.65 . . . . 51.210000000000001 111.166 177.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.8 t -75.35 87.89 2.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.978 -0.556 . . . . 74.209999999999994 112.007 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.598 HD11 HD11 ' A' ' 36' ' ' LEU . 14.3 tt -59.63 -24.84 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.728 0.775 . . . . 72.209999999999994 109.917 171.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.556 HG13 HD11 ' A' ' 48' ' ' LEU . 92.8 t -56.83 -49.35 79.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.085 -0.962 . . . . 71.319999999999993 111.25 173.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.4 m -58.62 -33.3 69.88 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.133 0.492 . . . . 63.299999999999997 111.443 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.441 ' O ' HG13 ' A' ' 12' ' ' ILE . 58.8 tttp -62.58 -49.82 73.73 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.056 0.455 . . . . 61.310000000000002 110.297 174.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.497 ' HA ' HD12 ' A' ' 12' ' ' ILE . 72.1 mt -58.34 -43.53 86.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.98 -0.554 . . . . 52.420000000000002 111.332 178.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 73.6 mt -57.5 -42.08 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.911 0.386 . . . . 64.450000000000003 111.068 176.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.9 m -64.0 -34.16 77.37 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.252 -0.431 . . . . 64.120000000000005 111.28 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 9' ' ' ILE . 83.6 mt -66.39 -46.01 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.918 0.39 . . . . 61.310000000000002 110.98 176.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.54 -45.58 96.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.054 0.454 . . . . 74.019999999999996 110.768 175.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -55.91 -49.6 73.01 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.009 -0.541 . . . . 64.109999999999999 111.165 175.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -54.63 -56.34 20.02 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.682 -0.69 . . . . 64.030000000000001 111.522 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 35.9 mmt-85 -57.53 -40.11 78.08 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.27 -0.423 . . . . 70.109999999999999 111.907 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.49 ' O ' ' N ' ' A' ' 21' ' ' ASP . 59.9 mt-30 -61.35 -47.36 86.25 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.245 -0.284 . . . . 72.519999999999996 110.989 175.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -57.93 -27.02 62.99 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.293 0.479 . . . . 70.239999999999995 112.293 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 47.9 mtt -55.78 -41.71 74.47 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.164 0.431 . . . . 71.439999999999998 112.164 174.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 23' ' ' ALA . 30.7 t70 -128.63 8.58 5.86 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.021 0.439 . . . . 60.200000000000003 111.667 -176.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' A' ' 17' ' ' GLN . 31.9 t70 54.73 97.24 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.398 0.679 . . . . 71.230000000000004 112.418 -176.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.17 -13.6 66.64 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 114.465 0.546 . . . . 44.310000000000002 114.465 176.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . . . -56.42 120.58 36.86 Favored Pre-proline 0 N--CA 1.473 0.691 0 N-CA-C 112.493 0.553 . . . . 52.119999999999997 112.493 -177.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.546 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 72.6 Cg_endo -75.1 152.91 40.88 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.62 2.213 . . . . 71.409999999999997 112.813 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.1 t -117.13 150.86 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 O-C-N 122.301 -0.249 . . . . 71.200000000000003 111.566 -175.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.455 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 9.6 mptt -87.91 158.14 18.77 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.894 0.378 . . . . 71.510000000000005 110.803 176.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.509 HG21 ' HB2' ' A' ' 42' ' ' ARG . 56.0 m -56.38 -47.29 79.22 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.903 0.382 . . . . 72.219999999999999 111.814 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.48 -37.78 87.28 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.759 0.314 . . . . 64.5 111.264 -177.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 3.5 m-20 -64.23 -44.75 90.88 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.81 0.338 . . . . 74.349999999999994 111.413 178.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.65 -47.41 91.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 116.193 -0.458 . . . . 73.299999999999997 111.014 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.497 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -57.81 -41.98 83.29 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.04 0.448 . . . . 23.41 111.331 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -62.95 -47.54 82.78 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.043 -0.526 . . . . 73.439999999999998 111.53 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.43 -26.64 66.51 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.914 0.388 . . . . 71.150000000000006 111.994 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.73 -22.04 22.39 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.052 0.39 . . . . 73.329999999999998 112.052 178.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.36 34.21 54.97 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.213 -0.518 . . . . 75.299999999999997 112.507 -174.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.598 HD11 HD11 ' A' ' 5' ' ' ILE . 95.7 mt -115.34 -178.85 3.48 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.118 0.485 . . . . 65.129999999999995 111.624 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.4 m -84.85 141.86 30.15 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.853 -0.612 . . . . 74.0 111.077 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.3 mm -55.61 -58.51 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.578 0.584 . . . . 74.340000000000003 112.578 -173.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.469 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 41.5 t80 -60.44 -40.44 91.11 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.818 0.342 . . . . 62.100000000000001 111.453 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.473 ' HG3' ' HE2' ' A' ' 44' ' ' TYR . 5.8 tp-100 -57.45 -52.5 65.12 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.231 0.539 . . . . 71.439999999999998 111.149 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.497 HG21 ' HA ' ' A' ' 31' ' ' ALA . 71.6 t -58.54 -45.15 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.005 -0.543 . . . . 73.329999999999998 111.345 176.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.509 ' HB2' HG21 ' A' ' 27' ' ' THR . 76.5 ttt180 -51.23 -39.32 56.36 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.116 -0.493 . . . . 61.409999999999997 111.524 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 93.4 mt -65.49 -44.72 86.2 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.365 -0.38 . . . . 64.140000000000001 111.547 177.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.473 ' HE2' ' HG3' ' A' ' 40' ' ' GLN . 69.3 m-85 -62.37 -40.35 96.15 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.246 0.546 . . . . 74.209999999999994 111.126 177.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.498 HD13 ' CD1' ' A' ' 67' ' ' TRP . 81.9 mt -65.39 -45.14 85.18 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.247 -0.433 . . . . 73.209999999999994 111.452 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -66.1 -38.86 89.3 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.578 0.584 . . . . 72.120000000000005 112.578 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 20.9 pt20 -66.67 -36.63 83.0 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 120.779 -0.369 . . . . 74.319999999999993 110.659 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.556 HD11 HG13 ' A' ' 6' ' ' VAL . 85.2 mt -68.12 -38.86 82.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.18 0.514 . . . . 75.010000000000005 110.842 173.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.401 ' CE1' ' HD3' ' A' ' 56' ' ' LYS . 12.9 t-80 -68.28 -21.56 64.78 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.994 -0.548 . . . . 72.409999999999997 111.029 175.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -83.4 -50.9 7.87 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.22 -0.445 . . . . 72.230000000000004 111.603 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.2 m -70.72 -31.11 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 112.776 0.658 . . . . 51.210000000000001 112.776 -177.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 116.89 43.89 0.6 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 120.836 -0.697 . . . . 74.230000000000004 114.093 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.29 -38.06 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.081 0.467 . . . . 75.230000000000004 111.293 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.8 mt -111.28 136.98 49.6 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.938 0.399 . . . . 50.32 111.629 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -103.32 136.14 43.64 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.116 -0.493 . . . . 54.009999999999998 109.804 172.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.401 ' HD3' ' CE1' ' A' ' 49' ' ' HIS . 19.0 pttm -94.0 144.13 25.74 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.137 0.494 . . . . 64.540000000000006 110.99 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 16.2 t -103.77 142.9 16.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.36 -0.608 . . . . 60.439999999999998 109.36 173.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 71.2 m-20 76.44 163.34 0.24 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.149 0.58 . . . . 62.140000000000001 111.367 -174.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.27 -17.57 64.83 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.041 0.756 . . . . 65.109999999999999 113.041 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.07 -37.86 2.38 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 120.844 -0.693 . . . . 64.439999999999998 113.205 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -75.97 119.83 20.48 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 122.514 -0.404 . . . . 72.109999999999999 110.673 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.62 -60.71 3.29 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.163 -0.541 . . . . 74.519999999999996 113.041 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.418 ' CG2' ' HB3' ' A' ' 58' ' ' ASN . 33.4 m -75.86 152.44 84.75 Favored Pre-proline 0 CA--C 1.544 0.742 0 O-C-N 122.627 -0.337 . . . . 65.519999999999996 111.42 178.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -66.77 119.15 6.15 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.514 2.143 . . . . 62.310000000000002 113.207 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.21 108.46 2.52 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.021 -0.609 . . . . 74.5 112.659 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.599 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 49.5 mt -91.05 143.55 26.58 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.944 0.402 . . . . 55.310000000000002 111.042 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.498 ' CD1' HD13 ' A' ' 45' ' ' LEU . 49.8 m95 -106.3 127.68 53.43 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.887 0.375 . . . . 73.239999999999995 111.869 -176.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -140.58 121.67 14.71 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.215 0.531 . . . . 74.239999999999995 110.945 173.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 pp -69.23 161.23 29.63 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.949 0.404 . . . . 75.129999999999995 111.6 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.5 HD23 ' N ' ' A' ' 70' ' ' LEU . 1.5 pt? -138.9 34.48 2.17 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.313 -0.403 . . . . 51.32 111.451 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 . . . . . 0 C--O 1.254 1.329 0 CA-C-O 118.767 -0.635 . . . . 53.310000000000002 111.865 177.236 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtt . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 120.871 0.367 . . . . 71.310000000000002 111.872 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 91.2 p -92.91 -20.1 20.98 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.012 0.434 . . . . 63.43 110.729 174.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -63.69 137.06 57.93 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.884 -0.598 . . . . 72.209999999999994 112.077 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.8 m -75.05 65.0 1.42 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.06 0.457 . . . . 73.109999999999999 111.005 176.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.456 HG12 HD11 ' A' ' 36' ' ' LEU . 8.6 tp -60.7 -38.53 78.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.206 -0.452 . . . . 65.099999999999994 111.924 -177.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.7 t -58.81 -47.13 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.274 0.559 . . . . 70.310000000000002 110.932 178.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 m -61.49 -40.2 93.71 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.93 -0.577 . . . . 70.219999999999999 110.95 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.527 ' O ' HG13 ' A' ' 12' ' ' ILE . 88.5 tttt -61.14 -46.47 90.42 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.139 -0.482 . . . . 74.319999999999993 110.893 177.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 13' ' ' VAL . 78.2 mt -55.21 -49.28 73.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.88 0.372 . . . . 75.5 111.229 176.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 69.8 mt -59.09 -40.63 81.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.106 0.479 . . . . 74.430000000000007 111.02 176.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.3 t -63.38 -35.7 81.27 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.304 -0.407 . . . . 73.530000000000001 111.194 176.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 8' ' ' LYS . 86.0 mt -65.51 -44.14 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-O 121.245 0.545 . . . . 73.310000000000002 110.449 175.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 9' ' ' ILE . 95.5 t -56.92 -46.92 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 115.898 -0.592 . . . . 73.420000000000002 111.063 176.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -61.33 -49.15 78.16 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.208 -0.451 . . . . 72.400000000000006 110.96 176.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -54.47 -53.36 55.27 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.902 -0.59 . . . . 65.140000000000001 111.633 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.52 ' HG3' HG13 ' A' ' 25' ' ' VAL . 5.7 mmp_? -56.12 -42.22 76.51 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.239 -0.437 . . . . 71.400000000000006 112.128 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.41 ' NE2' ' HA ' ' A' ' 68' ' ' ARG . 77.8 mt-30 -70.25 -31.09 68.32 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.728 0.299 . . . . 71.299999999999997 111.692 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -60.68 -33.42 72.82 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.119 0.485 . . . . 71.010000000000005 110.825 173.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 95.7 mmm -61.59 -34.87 76.36 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.004 -0.544 . . . . 74.200000000000003 111.955 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -159.52 110.17 1.97 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.887 0.375 . . . . 63.549999999999997 110.68 177.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -59.85 -17.7 38.5 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.56 0.578 . . . . 73.140000000000001 112.56 -178.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.9 12.74 59.2 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 120.985 -0.626 . . . . 73.209999999999994 113.329 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . . . -122.98 139.8 32.17 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 117.06 0.43 . . . . 64.409999999999997 112.144 -177.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.418 ' HG2' HD13 ' A' ' 66' ' ' LEU . 9.8 Cg_endo -87.95 174.3 4.7 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.041 2.494 . . . . 71.430000000000007 112.495 175.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.52 HG13 ' HG3' ' A' ' 16' ' ' ARG . 21.2 t -101.93 135.86 36.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.372 -0.376 . . . . 51.240000000000002 111.212 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.42 143.05 27.12 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.621 0.248 . . . . 64.120000000000005 111.025 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 67.9 m -55.97 -37.26 68.82 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.168 0.509 . . . . 54.039999999999999 110.79 173.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.1 mmm-85 -60.55 -55.8 28.98 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.016 -0.538 . . . . 65.340000000000003 111.196 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -51.62 -44.92 63.07 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.99 -0.55 . . . . 71.540000000000006 111.643 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.0 mt -61.83 -45.39 98.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.385 -0.37 . . . . 73.209999999999994 111.306 177.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.55 -31.92 71.01 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.896 0.379 . . . . 62.43 111.647 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -67.46 -51.08 55.71 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.231 -0.441 . . . . 74.0 111.362 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.48 -26.97 60.36 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.231 0.456 . . . . 74.120000000000005 112.231 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.67 -28.49 23.12 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.082 0.401 . . . . 63.140000000000001 112.082 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.02 32.58 60.49 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.043 -0.598 . . . . 42.450000000000003 113.317 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.456 HD11 HG12 ' A' ' 5' ' ' ILE . 88.7 mt -115.59 166.57 11.77 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.916 0.388 . . . . 74.329999999999998 111.042 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.404 ' O ' HG23 ' A' ' 41' ' ' VAL . 97.6 p -70.08 143.72 52.35 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.768 0.318 . . . . 72.310000000000002 111.277 178.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.5 mm -49.15 -50.08 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 112.366 0.506 . . . . 75.409999999999997 112.366 -177.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -62.67 -42.82 99.82 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.719 0.295 . . . . 73.329999999999998 111.405 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -63.97 -43.85 94.49 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.901 0.382 . . . . 74.5 111.077 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 37' ' ' SER . 81.9 t -57.84 -42.93 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.975 0.417 . . . . 63.329999999999998 110.539 175.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -55.84 -40.44 72.85 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.025 -0.534 . . . . 73.430000000000007 111.429 175.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.1 mt -59.34 -44.52 92.64 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.805 0.336 . . . . 71.409999999999997 111.17 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -65.37 -53.95 35.96 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.364 -0.38 . . . . 62.520000000000003 111.797 177.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.478 HD13 ' CD1' ' A' ' 67' ' ' TRP . 89.5 mt -56.84 -38.3 72.46 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.101 0.477 . . . . 63.25 111.705 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -61.64 -53.66 53.24 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.956 -0.566 . . . . 73.439999999999998 110.985 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -67.79 -39.03 84.08 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 111.804 0.298 . . . . 73.319999999999993 111.804 -178.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.9 mt -61.01 -35.26 76.4 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.214 0.531 . . . . 74.200000000000003 110.782 173.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -67.07 -46.23 74.93 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.254 -0.43 . . . . 71.439999999999998 111.517 174.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -66.09 -41.61 90.44 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.271 0.471 . . . . 73.340000000000003 112.271 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.504 HG23 HG23 ' A' ' 53' ' ' VAL . 34.4 m -71.15 -17.86 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 112.14 0.422 . . . . 55.409999999999997 112.14 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.65 29.19 5.1 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 120.836 -0.697 . . . . 74.319999999999993 114.274 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.504 HG23 HG23 ' A' ' 51' ' ' VAL . 97.3 t -94.87 -49.74 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 117.369 0.584 . . . . 75.310000000000002 110.895 174.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.8 mt -112.54 138.76 48.84 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.09 0.472 . . . . 75.310000000000002 111.866 -178.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.511 ' HB3' ' HG3' ' A' ' 68' ' ' ARG . 33.7 tt0 -91.76 146.3 23.87 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.382 -0.372 . . . . 64.129999999999995 110.171 175.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -87.68 138.62 31.31 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.17 0.433 . . . . 74.409999999999997 112.17 -174.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 62.1 t -132.49 108.75 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.922 0.392 . . . . 72.430000000000007 110.486 172.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.5 t30 60.74 93.79 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.211 0.529 . . . . 74.120000000000005 112.167 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.823 ' HA ' HG21 ' A' ' 63' ' ' VAL . . . -135.03 163.51 29.71 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.79 0.329 . . . . 75.430000000000007 111.82 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 137.37 -124.16 2.97 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 120.828 -0.701 . . . . 62.43 113.926 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -78.71 103.27 8.54 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.501 0.556 . . . . 74.409999999999997 112.501 -173.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 50.94 57.22 11.38 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 113.974 0.35 . . . . 72.439999999999998 113.974 176.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.823 HG21 ' HA ' ' A' ' 59' ' ' ALA . 32.6 m -100.93 158.81 31.11 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.625 -0.338 . . . . 74.519999999999996 111.618 -178.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.41 -17.11 39.34 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.157 1.905 . . . . 64.439999999999998 112.189 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.57 96.25 0.03 OUTLIER Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.849 -0.614 . . . . 61.439999999999998 113.64 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 94.3 mt -98.29 130.86 44.98 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.976 0.417 . . . . 65.439999999999998 110.304 174.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.478 ' CD1' HD13 ' A' ' 45' ' ' LEU . 57.9 m95 -128.39 146.77 50.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.249 0.547 . . . . 74.099999999999994 111.844 -175.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.511 ' HG3' ' HB3' ' A' ' 55' ' ' GLU . 5.8 ptm180 -138.74 172.3 13.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.929 -0.578 . . . . 73.299999999999997 110.029 174.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pp -108.7 168.92 8.99 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.132 -0.355 . . . . 74.239999999999995 110.867 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.5 mt -69.71 78.53 0.44 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.083 0.468 . . . . 63.409999999999997 111.707 -177.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 . . . . . 0 C--O 1.257 1.45 0 CA-C-O 118.843 -0.598 . . . . 75.439999999999998 111.076 -179.953 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.747 0.308 . . . . 65.510000000000005 110.563 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.1 p -72.55 106.56 4.66 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.261 0.553 . . . . 50.200000000000003 112.422 -174.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -104.84 108.43 19.91 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.986 -0.552 . . . . 74.209999999999994 111.235 175.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.3 t -176.56 111.56 0.09 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.012 0.435 . . . . 72.030000000000001 112.028 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.4 mm -76.15 -35.68 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 121.058 0.456 . . . . 71.420000000000002 110.386 176.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.1 t -57.73 -48.11 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.018 0.437 . . . . 54.539999999999999 110.91 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 78.0 m -61.33 -35.47 77.49 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.412 -0.358 . . . . 53.420000000000002 110.982 176.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.51 ' O ' HG13 ' A' ' 12' ' ' ILE . 86.9 tttt -60.28 -47.91 83.99 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.433 -0.349 . . . . 72.219999999999999 110.612 176.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 68.1 mt -57.32 -48.47 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.308 -0.405 . . . . 61.43 111.371 176.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.4 mt -57.21 -40.47 73.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.136 0.493 . . . . 64.030000000000001 110.993 176.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.6 m -61.34 -45.33 94.87 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.087 -0.506 . . . . 70.340000000000003 111.022 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.544 ' O ' ' HG2' ' A' ' 16' ' ' ARG . 83.1 mt -57.94 -56.03 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.17 -0.468 . . . . 72.120000000000005 111.563 179.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.548 HG12 HD23 ' A' ' 69' ' ' LEU . 49.0 t -56.82 -50.81 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.847 0.356 . . . . 63.130000000000003 111.602 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -57.11 -45.67 83.24 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.089 0.471 . . . . 61.210000000000001 111.219 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -60.02 -40.48 89.45 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.291 -0.413 . . . . 72.010000000000005 111.419 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 12' ' ' ILE . 23.4 mmm-85 -62.23 -39.48 92.95 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 122.178 -0.326 . . . . 65.010000000000005 110.503 175.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -65.69 -26.09 67.61 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.057 0.456 . . . . 50.229999999999997 111.556 175.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -78.05 -18.98 55.15 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.846 0.355 . . . . 65.420000000000002 111.008 173.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 94.8 mmm -81.05 -35.64 31.55 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.932 0.396 . . . . 74.319999999999993 111.103 174.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.582 ' HB3' ' HB2' ' A' ' 23' ' ' ALA . 18.6 t70 -142.98 138.75 30.29 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.457 -0.338 . . . . 65.299999999999997 110.913 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -61.79 -11.3 11.77 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.435 0.902 . . . . 73.519999999999996 113.435 -175.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.472 ' O ' ' HD3' ' A' ' 24' ' ' PRO . . . -150.08 51.59 0.53 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.973 -0.632 . . . . 72.420000000000002 112.954 177.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.582 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . . . -83.8 109.49 18.87 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.567 0.58 . . . . 23.239999999999998 112.567 -177.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.569 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 88.9 Cg_endo -79.95 108.05 2.17 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.987 1.791 . . . . 63.420000000000002 111.083 171.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 13' ' ' VAL . 14.6 t -79.02 144.3 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.414 0.626 . . . . 60.439999999999998 111.528 -172.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.612 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -95.36 138.82 32.52 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.106 -0.497 . . . . 73.010000000000005 111.479 -171.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.53 HG21 ' HD2' ' A' ' 42' ' ' ARG . 86.9 m -52.68 -38.81 61.15 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.049 0.452 . . . . 63.009999999999998 111.163 175.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -60.54 -58.52 8.14 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.054 -0.521 . . . . 71.030000000000001 111.016 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -51.17 -46.31 62.04 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.128 0.489 . . . . 64.400000000000006 111.312 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.5 mt -60.48 -44.48 96.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.117 -0.492 . . . . 74.310000000000002 111.505 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.59 -48.01 83.33 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.789 0.328 . . . . 61.32 111.615 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.67 -52.75 63.06 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.39 -0.368 . . . . 64.25 111.881 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.37 -37.7 87.8 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.366 0.506 . . . . 74.049999999999997 112.366 -178.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.24 -35.85 58.79 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 111.841 0.312 . . . . 52.32 111.841 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.26 33.14 8.27 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.284 -0.484 . . . . 51.109999999999999 112.706 -176.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.8 mt -120.11 171.77 8.23 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.2 0.524 . . . . 74.329999999999998 111.708 -177.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.494 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.7 m -81.84 147.28 29.43 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.985 -0.552 . . . . 62.030000000000001 111.08 178.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.497 ' O ' ' HD3' ' A' ' 42' ' ' ARG . 47.5 mm -51.17 -58.59 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 112.904 0.705 . . . . 75.319999999999993 112.904 -175.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -62.42 -32.1 72.89 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.994 0.426 . . . . 75.319999999999993 111.336 -178.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -61.32 -45.26 95.17 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.378 0.609 . . . . 74.219999999999999 110.378 175.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 37' ' ' SER . 71.3 t -62.45 -36.8 76.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 115.842 -0.617 . . . . 73.319999999999993 111.658 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.53 ' HD2' HG21 ' A' ' 27' ' ' THR . 0.3 OUTLIER -47.29 -53.07 14.46 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 121.128 0.489 . . . . 73.420000000000002 111.179 173.348 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.401 ' O ' ' HG3' ' A' ' 47' ' ' GLN . 74.1 mt -60.06 -48.67 80.74 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.617 -0.72 . . . . 73.439999999999998 111.516 -177.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -57.42 -50.04 74.29 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.373 -0.376 . . . . 74.420000000000002 111.782 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 67.8 mt -62.96 -46.61 86.89 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.872 0.368 . . . . 60.329999999999998 111.862 -176.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -61.11 -41.77 97.3 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.544 -0.298 . . . . 74.239999999999995 111.732 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 87.3 mt-30 -65.48 -40.02 92.62 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.755 0.312 . . . . 74.450000000000003 111.325 176.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.0 -30.48 70.98 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.882 0.373 . . . . 74.310000000000002 111.127 175.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -65.09 -44.81 87.63 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.889 0.376 . . . . 73.519999999999996 110.946 173.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -62.21 -48.03 81.81 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.314 0.487 . . . . 75.209999999999994 112.314 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.546 HG23 HG23 ' A' ' 53' ' ' VAL . 33.2 m -74.29 2.8 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 112.802 0.668 . . . . 74.109999999999999 112.802 -177.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.72 34.99 10.61 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.747 -0.739 . . . . 51.030000000000001 114.255 174.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.546 HG23 HG23 ' A' ' 51' ' ' VAL . 63.7 t -107.65 -60.69 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 122.383 -0.481 . . . . 64.109999999999999 111.101 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 69' ' ' LEU . 79.3 mt -100.95 163.99 12.03 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.955 0.724 . . . . 70.040000000000006 112.955 -175.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -136.51 145.02 44.61 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.532 -0.758 . . . . 62.329999999999998 110.264 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -84.15 141.55 30.99 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.176 0.513 . . . . 74.129999999999995 112.292 -174.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 48.5 t -120.23 88.54 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.635 0 CA-C-O 121.239 0.542 . . . . 61.020000000000003 109.831 172.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -161.93 -167.38 1.65 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.642 -0.708 . . . . 74.230000000000004 111.365 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.92 -57.62 3.13 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.179 0.437 . . . . 71.319999999999993 112.179 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.96 -132.64 7.06 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.123 -0.56 . . . . 44.329999999999998 113.709 -176.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -124.24 146.78 48.52 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 122.389 -0.477 . . . . 74.340000000000003 110.867 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.14 -37.94 1.55 Allowed Glycine 0 CA--C 1.533 1.16 0 N-CA-C 114.393 0.517 . . . . 60.329999999999998 114.393 176.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.1 m -55.33 133.13 69.9 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 112.16 0.429 . . . . 74.530000000000001 112.16 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.87 146.98 61.17 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.609 2.206 . . . . 73.420000000000002 113.596 -176.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.64 -119.19 0.54 Allowed Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.971 -0.559 . . . . 51.229999999999997 112.02 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.569 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 87.7 mt -107.64 154.17 21.84 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.946 0.373 . . . . 74.340000000000003 110.507 176.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -129.83 122.67 29.18 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.035 0.445 . . . . 75.319999999999993 111.995 -175.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.425 HH21 ' CD ' ' A' ' 71' ' ' GLU . 75.5 mtp180 -104.16 -172.72 2.16 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.284 -0.416 . . . . 61.329999999999998 109.916 171.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 54' ' ' LEU . 3.0 pp -126.38 164.6 20.73 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.153 -0.342 . . . . 72.430000000000007 110.582 172.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.3 mt -67.32 92.25 0.28 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.336 0.588 . . . . 74.430000000000007 110.779 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.425 ' CD ' HH21 ' A' ' 68' ' ' ARG . 41.9 mt-10 . . . . . 0 C--O 1.252 1.2 0 CA-C-N 115.103 -0.953 . . . . 74.109999999999999 111.887 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 120.756 0.312 . . . . 75.030000000000001 111.641 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.3 t -138.37 130.86 29.07 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.763 0.316 . . . . 75.340000000000003 110.727 175.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -133.41 22.95 4.04 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.24 0.543 . . . . 53.539999999999999 111.179 -178.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.1 t -78.92 68.09 4.78 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.114 0.483 . . . . 62.149999999999999 111.674 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 5' ' ' ILE . 2.0 mp -91.12 -39.4 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 120.869 0.366 . . . . 74.340000000000003 111.034 177.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 51.4 t -60.09 -36.62 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 116.459 -0.337 . . . . 73.310000000000002 111.211 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 95.0 m -54.27 -41.21 68.58 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.445 -0.343 . . . . 72.140000000000001 111.436 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.537 ' O ' HG13 ' A' ' 12' ' ' ILE . 23.1 ttmm -60.89 -47.06 88.14 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.761 0.315 . . . . 70.439999999999998 110.59 177.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 13' ' ' VAL . 62.7 mt -57.26 -46.7 85.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 120.827 0.346 . . . . 64.420000000000002 111.039 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 72.1 mt -59.61 -42.96 89.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.912 0.386 . . . . 73.409999999999997 111.126 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.2 t -62.73 -39.1 93.01 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.894 0.378 . . . . 72.319999999999993 111.365 177.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 8' ' ' LYS . 94.1 mt -61.68 -51.03 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.806 0.336 . . . . 73.540000000000006 110.599 176.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.572 HG13 HG21 ' A' ' 25' ' ' VAL . 59.0 t -60.9 -45.13 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 116.392 -0.367 . . . . 74.530000000000001 111.479 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.477 ' HA ' HD21 ' A' ' 69' ' ' LEU . 57.7 tp60 -60.26 -46.21 90.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.867 0.365 . . . . 70.120000000000005 110.997 177.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -61.55 -39.18 90.16 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.956 0.408 . . . . 73.5 110.859 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 12' ' ' ILE . 16.6 mmm-85 -65.27 -41.31 94.32 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.802 0.334 . . . . 72.140000000000001 111.216 175.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -64.73 -31.12 72.2 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.511 0.672 . . . . 74.129999999999995 110.591 173.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -75.8 -20.32 58.3 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.336 -0.847 . . . . 73.310000000000002 110.681 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 94.5 mmm -102.79 -69.64 0.78 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.018 -0.537 . . . . 70.439999999999998 111.383 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.507 ' HB3' ' HB3' ' A' ' 23' ' ' ALA . 49.3 m-20 -66.66 -66.5 0.55 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.051 0.389 . . . . 62.450000000000003 112.051 -178.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.1 t70 69.3 -60.87 0.45 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.423 0.689 . . . . 71.450000000000003 111.544 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.66 -28.13 72.53 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.276 -0.487 . . . . 74.5 112.73 176.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 20' ' ' ASP . . . -103.25 134.01 20.01 Favored Pre-proline 0 CA--C 1.538 0.507 0 O-C-N 122.579 -0.366 . . . . 74.329999999999998 110.92 177.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.515 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 8.0 Cg_exo -71.88 167.0 27.84 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.533 2.155 . . . . 54.530000000000001 113.145 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.572 HG21 HG13 ' A' ' 13' ' ' VAL . 29.1 t -85.44 142.07 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 115.999 -0.546 . . . . 73.209999999999994 110.763 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.538 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -102.12 146.56 27.77 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.717 0.294 . . . . 70.299999999999997 110.628 -179.199 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.4 m -59.54 -29.72 68.11 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.26 0.552 . . . . 73.25 110.932 176.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -58.53 -61.62 2.46 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.617 -0.72 . . . . 74.209999999999994 111.761 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.502 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 3.2 m-20 -51.64 -42.95 62.44 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.185 -0.462 . . . . 75.540000000000006 111.792 -178.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.6 mt -64.54 -42.36 94.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 116.33 -0.396 . . . . 74.010000000000005 111.25 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.1 -47.85 81.08 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.976 0.417 . . . . 71.439999999999998 111.797 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -67.76 -42.29 82.0 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.156 0.428 . . . . 73.450000000000003 112.156 178.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.59 -49.51 53.4 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.33 0.492 . . . . 72.109999999999999 112.33 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.6 -28.18 51.47 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.243 0.46 . . . . 72.230000000000004 112.243 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.76 54.38 3.47 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.203 -0.522 . . . . 44.119999999999997 112.763 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.4 mt -132.83 159.0 41.08 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.02 0.438 . . . . 73.209999999999994 111.384 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.1 m -73.46 145.72 45.52 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.306 -0.246 . . . . 75.010000000000005 110.805 174.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.2 mm -50.23 -41.47 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 112.403 0.52 . . . . 72.519999999999996 112.403 -176.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.417 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 56.6 t80 -59.83 -55.39 34.8 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.9 0.381 . . . . 70.340000000000003 111.001 175.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -52.0 -45.72 64.63 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.024 -0.534 . . . . 64.129999999999995 111.392 177.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.56 -49.37 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.161 -0.472 . . . . 72.310000000000002 111.182 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 mtm105 -58.34 -36.89 74.12 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.662 -0.245 . . . . 75.040000000000006 111.587 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.517 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 88.7 mt -56.56 -52.39 64.97 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.183 0.516 . . . . 70.439999999999998 110.306 177.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -64.96 -43.59 92.15 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.197 -0.456 . . . . 74.209999999999994 112.052 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.7 mt -65.86 -50.0 66.13 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.9 0.381 . . . . 54.399999999999999 111.853 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -62.74 -34.12 76.54 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.532 -0.304 . . . . 63.009999999999998 111.631 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 11.7 mm-40 -68.12 -47.96 66.73 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.119 -0.363 . . . . 55.439999999999998 110.977 174.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.5 mt -58.17 -32.8 68.55 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.043 0.449 . . . . 71.209999999999994 110.977 175.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.432 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 5.2 t60 -68.19 -44.96 74.68 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.9 0.381 . . . . 71.400000000000006 111.143 173.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.5 -42.35 95.89 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.127 -0.488 . . . . 62.549999999999997 111.753 -177.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.516 HG23 HG23 ' A' ' 53' ' ' VAL . 25.3 m -74.44 -9.79 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 112.151 0.426 . . . . 74.430000000000007 112.151 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.49 10.91 37.19 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 115.033 0.773 . . . . 62.43 115.033 173.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.516 HG23 HG23 ' A' ' 51' ' ' VAL . 92.5 t -82.26 -52.87 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 117.626 0.713 . . . . 64.439999999999998 111.439 177.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 49' ' ' HIS . 91.9 mt -106.09 160.99 14.88 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.323 0.583 . . . . 54.119999999999997 112.035 -177.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -129.39 139.3 51.73 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.847 -0.615 . . . . 71.540000000000006 110.088 174.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -88.91 103.25 15.84 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.062 0.458 . . . . 61.340000000000003 111.488 -176.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.553 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 44.8 t -79.15 93.13 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.086 0.47 . . . . 72.25 110.56 175.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.432 ' ND2' HG23 ' A' ' 63' ' ' VAL . 28.1 t-20 -143.2 122.83 13.28 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.935 0.398 . . . . 73.430000000000007 111.364 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.23 -21.99 62.05 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.625 0.602 . . . . 74.430000000000007 112.625 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 145.64 -164.88 28.06 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.088 -0.577 . . . . 34.210000000000001 113.489 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -59.07 116.82 4.09 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 122.769 0.428 . . . . 71.25 111.692 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 126.86 -59.74 0.67 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.401 -0.428 . . . . 72.200000000000003 112.872 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.432 HG23 ' ND2' ' A' ' 58' ' ' ASN . 31.7 m -70.11 153.8 95.05 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 112.058 0.392 . . . . 74.209999999999994 112.058 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.76 155.75 68.72 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.484 2.122 . . . . 63.299999999999997 113.399 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.91 104.44 2.56 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.089 -0.577 . . . . 52.340000000000003 112.644 176.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.553 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 85.4 mt -94.48 156.16 16.59 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.806 0.303 . . . . 65.510000000000005 111.17 178.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -128.24 147.23 50.58 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.05 0.452 . . . . 75.129999999999995 112.142 -176.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -150.89 134.62 16.5 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.497 -0.32 . . . . 73.329999999999998 111.161 174.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.52 ' O ' HD12 ' A' ' 69' ' ' LEU . 2.4 pp -78.69 141.86 37.59 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.184 0.516 . . . . 65.310000000000002 111.745 177.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.497 HD23 ' H ' ' A' ' 70' ' ' LEU . 1.9 pt? -124.86 -26.65 3.72 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.284 -0.416 . . . . 71.450000000000003 111.674 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 . . . . . 0 C--O 1.252 1.219 0 CA-C-O 118.815 -0.612 . . . . 61.439999999999998 111.294 179.549 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.8 mtp . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 120.743 0.306 . . . . 44.109999999999999 111.558 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.9 t 57.59 72.7 0.5 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.991 0.737 . . . . 73.530000000000001 112.991 175.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -104.98 100.5 10.1 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.089 0.471 . . . . 64.030000000000001 110.328 174.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.3 m -91.78 102.51 15.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.039 -0.528 . . . . 50.25 111.221 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.1 mm -61.65 -49.91 82.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.947 0.403 . . . . 72.450000000000003 111.557 -177.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.1 t -62.86 -52.78 55.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.844 0.354 . . . . 71.219999999999999 111.359 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.4 m -59.19 -35.37 73.47 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.499 -0.319 . . . . 52.240000000000002 111.405 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -57.36 -50.71 72.1 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 110.134 -0.321 . . . . 70.340000000000003 110.134 176.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.48 HG23 HG21 ' A' ' 30' ' ' ILE . 67.2 mt -57.95 -51.79 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 116.212 -0.449 . . . . 72.120000000000005 111.546 175.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 79.3 mt -55.55 -47.26 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 112.319 0.489 . . . . 73.010000000000005 112.319 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.1 p -60.46 -42.46 96.24 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.882 0.372 . . . . 72.549999999999997 111.277 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.434 HG21 ' HA ' ' A' ' 30' ' ' ILE . 93.8 mt -63.08 -46.97 94.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 116.208 -0.451 . . . . 53.549999999999997 111.304 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.614 HG13 HG21 ' A' ' 25' ' ' VAL . 80.9 t -54.03 -55.27 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.987 0.422 . . . . 61.100000000000001 111.189 176.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -57.93 -40.01 79.42 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.239 -0.437 . . . . 71.040000000000006 111.664 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -66.18 -42.97 88.15 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.915 0.388 . . . . 64.150000000000006 110.936 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.496 ' HB2' HG22 ' A' ' 25' ' ' VAL . 5.0 mmp_? -57.58 -39.95 77.91 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.866 0.365 . . . . 74.400000000000006 110.564 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.679 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 14.6 mm100 -61.97 -40.63 96.25 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.066 0.46 . . . . 71.329999999999998 110.935 174.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -60.88 -28.79 69.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.247 -0.433 . . . . 73.239999999999995 111.766 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 28.1 mmt -60.54 -53.38 58.26 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.665 0.617 . . . . 74.019999999999996 112.665 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.695 ' HB3' ' HB2' ' A' ' 23' ' ' ALA . 13.4 t70 -117.9 142.35 47.43 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.77 0.319 . . . . 72.430000000000007 111.156 -176.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -63.01 94.08 0.07 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.307 0.575 . . . . 63.140000000000001 111.027 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.55 43.45 7.34 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 115.886 -0.597 . . . . 72.340000000000003 112.04 -174.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.695 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . . . -67.53 147.15 98.79 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 113.208 0.818 . . . . 62.549999999999997 113.208 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.441 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 90.4 Cg_endo -100.71 131.04 0.15 Allowed 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 123.21 2.607 . . . . 71.530000000000001 111.463 159.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.614 HG21 HG13 ' A' ' 13' ' ' VAL . 48.8 t -79.31 138.38 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.165 0.507 . . . . 72.450000000000003 112.012 -176.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.422 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -89.8 134.11 34.36 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.227 -0.442 . . . . 71.430000000000007 110.437 177.1 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 56.2 m -55.75 -27.99 53.59 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.09 0.471 . . . . 71.230000000000004 111.615 177.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -65.22 -54.59 27.16 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.216 -0.447 . . . . 70.409999999999997 112.098 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.25 -50.42 38.84 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 122.856 0.463 . . . . 72.409999999999997 112.119 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.48 HG21 HG23 ' A' ' 9' ' ' ILE . 53.1 mt -58.17 -57.78 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.151 -0.477 . . . . 71.420000000000002 111.787 -177.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.11 -45.49 87.16 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.947 0.403 . . . . 61.219999999999999 111.524 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -61.6 -42.4 98.82 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.806 -0.634 . . . . 75.310000000000002 111.896 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.03 -41.41 28.93 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.519 0.563 . . . . 73.239999999999995 112.519 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.33 -19.87 60.31 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.513 0.56 . . . . 75.540000000000006 112.513 -176.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.32 17.0 56.46 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.042 -0.599 . . . . 73.319999999999993 112.817 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.4 mt -106.44 170.93 7.63 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.993 0.425 . . . . 74.200000000000003 111.306 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.5 t -94.68 161.98 13.97 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.323 -0.399 . . . . 63.119999999999997 111.157 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -57.15 -48.9 81.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 112.566 0.58 . . . . 63.119999999999997 112.566 -174.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.518 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 29.4 p90 -60.13 -44.07 95.18 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.998 0.427 . . . . 71.420000000000002 111.042 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -57.62 -52.3 65.97 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.62 0.724 . . . . 74.329999999999998 110.832 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.459 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 92.0 t -59.55 -46.27 93.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.542 -0.754 . . . . 64.540000000000006 111.414 178.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.5 mtm105 -58.5 -28.95 65.88 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.116 0.413 . . . . 72.519999999999996 112.116 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 87.6 mt -65.82 -52.34 51.39 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.983 0.42 . . . . 72.109999999999999 110.836 174.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -63.29 -41.02 98.94 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.438 -0.346 . . . . 74.430000000000007 111.569 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 88.2 mt -62.68 -37.93 88.39 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.0 0.428 . . . . 64.450000000000003 111.091 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -60.87 -42.66 98.32 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.304 -0.407 . . . . 74.019999999999996 110.741 176.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -62.49 -51.68 66.49 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.255 -0.43 . . . . 71.329999999999998 110.928 176.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.2 mt -57.92 -31.77 67.12 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.148 0.499 . . . . 74.409999999999997 111.407 176.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -70.88 -34.38 71.54 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.068 0.461 . . . . 64.239999999999995 110.836 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -73.46 -41.08 63.62 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.085 -0.507 . . . . 73.310000000000002 111.456 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.549 HG23 HG23 ' A' ' 53' ' ' VAL . 36.0 m -84.13 7.76 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 N-CA-C 112.886 0.699 . . . . 74.239999999999995 112.886 -177.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.51 44.7 10.51 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 120.942 -0.647 . . . . 71.239999999999995 114.46 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.549 HG23 HG23 ' A' ' 51' ' ' VAL . 91.2 t -114.31 -42.89 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.002 0.43 . . . . 54.219999999999999 111.331 175.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.4 mt -116.85 151.92 35.53 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.841 0.682 . . . . 52.420000000000002 112.841 -176.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.502 ' HB2' HD22 ' A' ' 70' ' ' LEU . 1.4 tm-20 -122.98 128.16 49.83 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.112 -0.949 . . . . 73.219999999999999 108.683 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.617 ' HB3' ' HZ3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -87.49 93.67 9.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.147 0.498 . . . . 62.25 111.311 -172.641 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 82.1 t -75.08 121.0 25.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 115.91 -0.587 . . . . 73.239999999999995 111.963 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -141.98 125.2 16.42 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.939 0.399 . . . . 45.439999999999998 110.869 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.465 ' N ' HG21 ' A' ' 63' ' ' VAL . . . -76.37 66.17 2.38 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.318 0.488 . . . . 74.430000000000007 112.318 -178.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.59 -147.58 19.51 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 114.146 0.418 . . . . 71.319999999999993 114.146 177.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -89.06 136.94 32.74 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.742 0.645 . . . . 74.099999999999994 112.742 -177.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.23 44.36 93.9 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 115.954 -0.567 . . . . 44.039999999999999 114.267 174.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.465 HG21 ' N ' ' A' ' 59' ' ' ALA . 26.4 m -127.29 154.22 77.04 Favored Pre-proline 0 CA--C 1.542 0.655 0 O-C-N 122.575 -0.368 . . . . 74.239999999999995 111.731 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.61 130.43 33.48 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.938 2.426 . . . . 64.049999999999997 113.497 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.04 107.72 2.57 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 116.186 -0.461 . . . . 63.229999999999997 113.295 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 82.6 mt -99.34 157.78 16.17 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.927 0.394 . . . . 72.549999999999997 110.977 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -123.14 121.81 36.9 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.999 0.428 . . . . 74.439999999999998 111.687 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -118.67 127.45 53.58 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.345 -0.389 . . . . 70.120000000000005 110.755 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 69' ' ' LEU . 3.3 pp -79.16 150.35 31.74 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.077 0.465 . . . . 71.150000000000006 111.534 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 55' ' ' GLU . 2.1 pt? -143.34 131.61 22.04 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.175 -0.466 . . . . 51.420000000000002 110.887 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.276 0 CA-C-O 118.192 -0.908 . . . . 63.439999999999998 112.058 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.603 ' SD ' HG23 ' A' ' 6' ' ' VAL . 24.5 ptt? . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.875 0.369 . . . . 72.439999999999998 111.703 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.0 m -104.49 -40.07 6.19 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.237 -0.438 . . . . 74.310000000000002 110.039 169.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -99.81 165.09 11.74 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.254 -0.43 . . . . 61.219999999999999 110.84 173.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.3 m -73.07 90.45 1.53 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.051 0.453 . . . . 55.310000000000002 111.541 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.8 tt -102.28 -22.67 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 121.123 0.487 . . . . 71.109999999999999 111.449 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.603 HG23 ' SD ' ' A' ' 1' ' ' MET . 49.8 t -56.69 -29.92 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 112.599 0.592 . . . . 72.219999999999999 112.599 -176.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.2 m -51.91 -41.07 61.69 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.893 0.378 . . . . 75.120000000000005 111.527 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.481 ' O ' HG13 ' A' ' 12' ' ' ILE . 4.4 ttmp? -54.41 -52.09 62.82 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.07 0.462 . . . . 73.109999999999999 110.722 174.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.535 HG23 HG21 ' A' ' 30' ' ' ILE . 67.4 mt -59.1 -45.27 92.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.8 -0.637 . . . . 54.549999999999997 111.572 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.6 mt -58.41 -43.35 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.082 0.468 . . . . 52.25 111.053 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.2 t -64.0 -40.15 95.72 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.198 -0.455 . . . . 70.310000000000002 111.205 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 8' ' ' LYS . 84.9 mt -63.18 -44.53 99.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 120.705 0.288 . . . . 75.219999999999999 111.375 177.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.536 HG13 HG21 ' A' ' 25' ' ' VAL . 91.7 t -54.1 -53.62 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 121.409 0.623 . . . . 74.239999999999995 110.663 174.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -56.52 -44.65 80.97 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.439 -0.8 . . . . 54.530000000000001 111.442 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 19' ' ' MET . 6.7 tp10 -58.34 -52.23 66.49 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.011 0.434 . . . . 70.349999999999994 111.258 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.48 ' HD2' ' HB3' ' A' ' 29' ' ' ASP . 1.9 mmp_? -49.93 -36.96 29.74 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.99 -0.55 . . . . 72.099999999999994 111.326 177.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.745 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 78.3 mt-30 -74.85 -42.53 57.79 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.227 -0.442 . . . . 70.430000000000007 112.019 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -56.86 -28.74 62.15 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.081 0.467 . . . . 71.340000000000003 111.424 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.41 ' HG2' ' O ' ' A' ' 15' ' ' GLU . 26.4 mmt -72.58 -39.25 67.54 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.455 0.539 . . . . 65.129999999999995 112.455 -178.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.677 ' HB2' ' HB2' ' A' ' 23' ' ' ALA . 4.1 m-20 -127.58 20.11 6.69 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.304 0.483 . . . . 73.430000000000007 112.304 -175.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.8 t70 59.22 -88.19 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.028 0.531 . . . . 72.120000000000005 112.429 176.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -85.94 56.38 4.83 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.682 -0.567 . . . . 54.240000000000002 111.682 177.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.745 ' HB3' ' HA ' ' A' ' 17' ' ' GLN . . . -96.0 118.17 65.9 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 113.327 0.862 . . . . 74.310000000000002 113.327 -171.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.459 ' HB3' HG11 ' A' ' 57' ' ' VAL . 91.3 Cg_endo -78.08 118.97 4.51 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.217 1.944 . . . . 71.530000000000001 110.72 168.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.536 HG21 HG13 ' A' ' 13' ' ' VAL . 61.7 t -78.34 132.53 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 121.075 0.464 . . . . 73.319999999999993 112.084 -171.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.491 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -89.6 132.67 34.99 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.856 -0.611 . . . . 65.329999999999998 110.297 -179.408 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.435 HG23 HD12 ' A' ' 45' ' ' LEU . 56.4 m -49.48 -38.53 30.32 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.566 0.58 . . . . 73.209999999999994 112.566 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -72.38 -29.1 63.45 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.612 0.597 . . . . 60.43 112.612 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.48 ' HB3' ' HD2' ' A' ' 16' ' ' ARG . 76.4 m-20 -54.04 -49.29 69.29 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.424 0.631 . . . . 73.329999999999998 111.06 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.535 HG21 HG23 ' A' ' 9' ' ' ILE . 59.0 mt -64.64 -37.08 79.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.653 -0.703 . . . . 74.420000000000002 111.388 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.27 -47.87 80.53 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.446 -0.343 . . . . 61.409999999999997 111.439 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -65.15 -48.74 72.46 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.8 0.333 . . . . 70.230000000000004 111.459 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.56 -52.6 63.79 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.452 0.538 . . . . 44.219999999999999 112.452 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.6 -19.9 44.45 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.418 0.525 . . . . 74.329999999999998 112.418 -177.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.79 47.22 20.86 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.828 -0.701 . . . . 53.109999999999999 112.594 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt -118.14 179.0 4.23 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.96 0.409 . . . . 74.329999999999998 111.404 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.8 t -86.57 143.72 27.55 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 111.734 0.272 . . . . 74.010000000000005 111.734 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.1 mm -55.18 -52.21 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 112.052 0.389 . . . . 74.540000000000006 112.052 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.407 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 60.6 t80 -60.41 -42.93 97.02 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.032 0.444 . . . . 74.519999999999996 110.99 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -57.32 -56.13 25.79 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.75 -0.659 . . . . 70.319999999999993 111.461 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 82.7 t -56.84 -41.42 75.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.193 -0.458 . . . . 72.329999999999998 111.204 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -54.87 -46.02 74.69 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.351 -0.386 . . . . 72.310000000000002 111.437 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 84.4 mt -61.84 -45.1 95.28 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.255 -0.429 . . . . 62.240000000000002 112.061 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.409 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 63.5 m-85 -68.68 -37.92 79.96 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.796 0.295 . . . . 64.420000000000002 111.796 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.52 HD13 ' NE1' ' A' ' 67' ' ' TRP . 93.7 mt -66.32 -37.33 85.14 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.072 0.463 . . . . 74.510000000000005 111.001 174.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.47 -55.99 27.61 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.974 -0.557 . . . . 73.109999999999999 111.094 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 3.8 pt20 -60.65 -37.88 82.98 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.526 -0.306 . . . . 75.219999999999999 111.576 -177.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.472 HD21 HG11 ' A' ' 6' ' ' VAL . 83.7 mt -61.01 -44.84 96.83 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.982 0.42 . . . . 73.439999999999998 111.11 176.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -68.01 -30.88 70.23 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.952 0.406 . . . . 74.239999999999995 111.177 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -78.58 -31.94 47.47 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.219 0.452 . . . . 75.239999999999995 112.219 -177.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.506 HG23 HG23 ' A' ' 53' ' ' VAL . 33.5 m -83.35 -25.6 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 121.966 -0.459 . . . . 62.530000000000001 111.468 176.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 118.54 8.81 9.76 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 120.973 -0.632 . . . . 61.530000000000001 114.334 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.506 HG23 HG23 ' A' ' 51' ' ' VAL . 91.5 t -77.88 -42.14 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 117.483 0.642 . . . . 74.120000000000005 111.572 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.7 mt -110.89 133.87 53.02 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.147 0.499 . . . . 71.299999999999997 112.038 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.506 ' HG2' ' NH2' ' A' ' 68' ' ' ARG . 8.1 tp10 -91.8 154.77 18.7 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.923 -0.581 . . . . 73.299999999999997 111.05 176.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -80.22 136.35 36.45 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.202 0.525 . . . . 64.109999999999999 112.015 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.459 HG11 ' HB3' ' A' ' 24' ' ' PRO . 44.3 t -131.96 92.72 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.054 0.454 . . . . 72.219999999999999 110.232 170.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.556 ' HB3' ' HA2' ' A' ' 65' ' ' GLY . 27.3 p-10 -158.41 149.38 20.62 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.023 0.439 . . . . 62.310000000000002 112.151 -177.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.92 10.76 10.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.928 0.394 . . . . 61.240000000000002 111.961 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.99 -62.01 4.6 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.39 -0.433 . . . . 34.210000000000001 113.784 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -71.52 125.76 27.9 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.255 0.465 . . . . 71.239999999999995 112.255 -176.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.87 -67.05 1.72 Allowed Glycine 0 CA--C 1.529 0.919 0 N-CA-C 114.587 0.595 . . . . 60.140000000000001 114.587 173.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.4 m -52.22 130.83 42.04 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 112.987 0.736 . . . . 71.319999999999993 112.987 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.6 -40.64 17.22 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.603 2.202 . . . . 73.209999999999994 112.624 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.556 ' HA2' ' HB3' ' A' ' 58' ' ' ASN . . . 141.13 133.16 2.89 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.026 -0.607 . . . . 71.549999999999997 113.313 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 86.3 mt -101.63 150.9 22.63 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 109.79 -0.448 . . . . 65.439999999999998 109.79 173.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.52 ' NE1' HD13 ' A' ' 45' ' ' LEU . 42.6 m95 -107.17 127.82 53.85 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.863 0.69 . . . . 74.519999999999996 112.863 -169.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.506 ' NH2' ' HG2' ' A' ' 55' ' ' GLU . 47.6 ttp180 -120.44 165.01 15.52 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.264 -0.643 . . . . 75.409999999999997 109.264 175.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.7 pp -123.41 151.64 42.4 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.331 -0.856 . . . . 53.130000000000003 111.988 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.441 HD23 ' N ' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -123.18 23.33 9.2 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.923 -0.581 . . . . 72.530000000000001 111.357 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 . . . . . 0 C--O 1.253 1.24 0 CA-C-O 119.097 -0.477 . . . . 61.409999999999997 110.938 179.687 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 120.736 0.303 . . . . 74.439999999999998 111.482 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.6 t -153.6 91.86 1.52 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.877 0.37 . . . . 51.039999999999999 111.189 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -176.25 -171.89 0.45 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.198 -0.455 . . . . 74.140000000000001 111.099 -177.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.1 p 53.2 37.67 25.66 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.393 0.677 . . . . 72.120000000000005 112.401 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.498 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.7 mp -53.86 -47.87 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 112.242 0.46 . . . . 72.430000000000007 112.242 -175.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.2 t -61.93 -54.83 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.121 0.486 . . . . 73.540000000000006 111.377 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 m -59.62 -31.42 69.49 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.019 -0.537 . . . . 72.409999999999997 111.46 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.514 ' O ' HG13 ' A' ' 12' ' ' ILE . 60.5 tptt -57.49 -57.0 14.59 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.2 -0.455 . . . . 73.219999999999999 110.679 176.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.486 ' HA ' HD12 ' A' ' 12' ' ' ILE . 67.1 mt -58.2 -43.56 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 116.141 -0.481 . . . . 75.239999999999995 111.63 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.0 mt -60.63 -42.74 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.12 0.486 . . . . 73.010000000000005 111.101 176.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.0 t -65.4 -33.34 75.73 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.215 -0.448 . . . . 61.509999999999998 111.271 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 8' ' ' LYS . 96.9 mt -63.44 -48.41 87.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.365 -0.38 . . . . 72.239999999999995 110.934 175.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.8 t -58.15 -47.35 87.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 120.735 0.302 . . . . 71.540000000000006 111.229 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -59.47 -45.43 91.67 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.15 0.5 . . . . 74.409999999999997 111.041 177.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -53.64 -46.9 70.69 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.963 -0.562 . . . . 73.140000000000001 111.52 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 12' ' ' ILE . 7.6 mmm180 -67.87 -37.43 81.79 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.216 -0.447 . . . . 64.519999999999996 111.473 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -62.9 -32.87 74.23 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.081 0.4 . . . . 73.25 112.081 176.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -92.21 -29.23 16.56 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.975 0.731 . . . . 75.219999999999999 112.975 -175.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.488 ' SD ' ' HD2' ' A' ' 16' ' ' ARG . 27.2 ptm -70.35 -26.67 63.85 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.119 -0.363 . . . . 74.340000000000003 111.598 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -127.13 179.25 5.52 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 116.475 -0.329 . . . . 63.229999999999997 110.337 -177.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -104.21 -12.58 16.59 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 122.156 -0.34 . . . . 73.329999999999998 111.91 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.3 44.09 0.23 Allowed Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.878 -0.677 . . . . 44.409999999999997 113.409 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.78 107.22 38.78 Favored Pre-proline 0 CA--C 1.537 0.444 0 O-C-N 122.562 -0.375 . . . . 62.539999999999999 111.62 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.55 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 46.6 Cg_endo -68.52 138.85 43.2 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.22 1.947 . . . . 44.409999999999997 111.696 176.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.421 HG22 ' HB2' ' A' ' 16' ' ' ARG . 7.9 t -79.96 120.61 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 120.899 0.38 . . . . 74.109999999999999 111.13 -175.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.501 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -80.63 132.49 35.61 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.607 -0.269 . . . . 70.310000000000002 110.996 -176.821 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.3 m -51.97 -44.46 64.02 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.903 0.383 . . . . 71.230000000000004 111.665 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.503 ' NH1' HG13 ' A' ' 38' ' ' ILE . 36.1 mmt180 -61.21 -45.92 92.6 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.207 0.527 . . . . 75.400000000000006 110.682 176.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -58.52 -40.77 83.84 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.792 -0.64 . . . . 62.530000000000001 111.455 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 26' ' ' LYS . 66.0 mt -61.92 -39.69 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.793 0.33 . . . . 73.019999999999996 111.157 176.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.521 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -57.93 -48.74 79.02 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.268 -0.424 . . . . 72.420000000000002 111.892 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.13 -43.55 94.92 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 111.995 0.368 . . . . 72.010000000000005 111.995 176.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.12 -41.72 94.6 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.332 0.493 . . . . 75.310000000000002 112.332 -178.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.63 -23.91 27.33 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.218 0.451 . . . . 64.329999999999998 112.218 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.17 40.46 24.4 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.227 -0.511 . . . . 72.439999999999998 113.231 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.9 mt -128.63 161.06 30.53 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.613 -0.345 . . . . 72.25 111.37 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 41' ' ' VAL . 66.9 m -68.1 150.97 47.72 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.515 -0.311 . . . . 71.409999999999997 111.096 176.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.503 HG13 ' NH1' ' A' ' 28' ' ' ARG . 49.7 mm -52.21 -48.83 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 112.31 0.485 . . . . 62.32 112.31 -176.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.497 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 78.2 t80 -59.2 -49.05 79.35 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.529 -0.305 . . . . 75.310000000000002 111.242 178.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -54.98 -50.81 68.04 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.244 0.545 . . . . 72.299999999999997 110.899 176.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.521 HG21 ' HA ' ' A' ' 31' ' ' ALA . 88.8 t -56.18 -49.64 75.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.078 -0.51 . . . . 51.119999999999997 111.345 178.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.573 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 31.6 mtp180 -60.98 -34.3 74.56 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 111.752 0.278 . . . . 63.210000000000001 111.752 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 79.2 mt -55.78 -47.42 77.08 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.15 0.5 . . . . 74.239999999999995 110.407 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.409 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 87.0 m-85 -65.51 -43.43 90.12 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.058 -0.519 . . . . 73.329999999999998 111.522 175.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.486 HD13 ' NE1' ' A' ' 67' ' ' TRP . 89.5 mt -64.15 -50.15 69.33 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 111.85 0.315 . . . . 72.239999999999995 111.85 -177.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 42' ' ' ARG . 62.1 mm-40 -56.83 -45.82 82.1 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.32 -0.4 . . . . 54.009999999999998 111.061 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 88.3 mt-30 -62.92 -49.81 73.33 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.536 0.208 . . . . 60.409999999999997 110.973 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.427 ' HA ' HG22 ' A' ' 51' ' ' VAL . 94.5 mt -57.85 -28.95 64.58 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.019 0.437 . . . . 70.120000000000005 111.127 176.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.465 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 31.4 t-80 -67.07 -56.69 8.97 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.06 0.457 . . . . 73.25 111.077 174.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.13 -23.79 64.02 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.252 0.834 . . . . 74.219999999999999 113.252 -175.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.525 HG23 HG23 ' A' ' 53' ' ' VAL . 25.1 m -84.78 -4.58 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 121.887 -0.508 . . . . 73.239999999999995 111.947 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.3 17.9 38.17 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 114.617 0.607 . . . . 65.349999999999994 114.617 173.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.525 HG23 HG23 ' A' ' 51' ' ' VAL . 97.3 t -90.91 -50.01 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 117.294 0.547 . . . . 52.299999999999997 111.327 177.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.7 mt -106.69 131.03 54.29 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.178 0.513 . . . . 71.430000000000007 111.893 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -101.34 143.65 31.12 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.907 -0.588 . . . . 74.510000000000005 111.003 177.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.447 ' HD3' ' N ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -66.11 141.47 58.1 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.802 0.667 . . . . 70.129999999999995 112.802 -175.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 51.0 t -134.41 102.15 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 116.285 -0.416 . . . . 73.510000000000005 110.959 171.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.1 t30 49.37 87.09 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.901 0.48 . . . . 61.229999999999997 112.108 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.566 ' HB2' ' HA2' ' A' ' 65' ' ' GLY . . . -156.71 175.77 13.61 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.989 0.737 . . . . 62.119999999999997 112.989 -175.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 143.05 -106.95 0.45 Allowed Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.508 -0.769 . . . . 74.329999999999998 111.93 -177.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.9 mtmm -128.34 136.53 51.07 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.969 0.414 . . . . 75.219999999999999 111.003 174.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.1 8.48 87.4 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.159 -0.543 . . . . 52.049999999999997 112.301 -175.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.71 122.15 11.07 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 122.973 0.509 . . . . 74.209999999999994 111.391 -176.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.77 111.88 1.65 Allowed 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.732 2.288 . . . . 73.510000000000005 112.397 175.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.566 ' HA2' ' HB2' ' A' ' 59' ' ' ALA . . . -56.38 123.66 32.23 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.32 -0.467 . . . . 73.200000000000003 114.175 -177.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 66.8 mt -102.08 143.86 31.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.969 -0.382 . . . . 65.420000000000002 109.969 174.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.486 ' NE1' HD13 ' A' ' 45' ' ' LEU . 75.7 m95 -121.16 147.86 45.02 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.328 0.585 . . . . 72.129999999999995 112.389 -174.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -148.78 133.68 18.04 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.934 -0.576 . . . . 71.140000000000001 110.397 173.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 pp -72.74 163.31 28.3 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.733 -0.604 . . . . 74.120000000000005 110.856 174.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.8 mt -68.18 86.14 0.26 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.191 0.441 . . . . 73.329999999999998 112.191 -175.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 C--O 1.254 1.296 0 CA-C-O 118.416 -0.802 . . . . 52.109999999999999 112.891 179.411 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 mmt . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.89 0.376 . . . . 74.329999999999998 110.624 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.1 m -91.63 148.99 21.87 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.74 0.305 . . . . 52.109999999999999 111.259 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -61.72 -21.8 64.82 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.189 0.519 . . . . 73.319999999999993 110.903 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.4 m -56.79 -27.87 60.47 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.717 -0.674 . . . . 51.200000000000003 112.564 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 70.2 mt -52.34 -56.2 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 120.875 0.369 . . . . 72.049999999999997 111.925 -178.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.6 t -71.73 -46.04 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.093 0.473 . . . . 73.129999999999995 111.22 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.9 m -55.24 -39.52 69.83 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.8 -0.636 . . . . 54.229999999999997 112.227 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.517 ' O ' HG13 ' A' ' 12' ' ' ILE . 55.6 tptt -61.96 -50.86 70.42 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.739 0.304 . . . . 72.099999999999994 110.732 177.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 72.7 mt -55.79 -46.36 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.886 0.374 . . . . 73.430000000000007 111.486 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.2 mt -58.88 -45.22 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 121.192 0.52 . . . . 73.319999999999993 110.93 176.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.2 t -62.39 -35.17 78.36 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.003 -0.544 . . . . 71.420000000000002 111.821 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.565 HG21 ' HA ' ' A' ' 30' ' ' ILE . 96.8 mt -64.73 -49.7 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.871 0.367 . . . . 74.349999999999994 111.2 177.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 64.2 t -54.2 -49.17 64.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.062 0.458 . . . . 64.150000000000006 110.969 177.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -62.46 -44.09 97.25 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.012 -0.54 . . . . 70.109999999999999 111.487 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.416 ' HA ' ' ND2' ' A' ' 18' ' ' ASN . 10.1 tp10 -61.62 -37.46 84.06 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.153 0.501 . . . . 74.299999999999997 111.04 -178.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.481 ' HG3' HG13 ' A' ' 25' ' ' VAL . 8.3 mmm180 -64.29 -40.06 95.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 73.530000000000001 110.79 174.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' A' ' 21' ' ' ASP . 74.1 mt-30 -72.69 -4.57 32.0 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.871 0.367 . . . . 72.239999999999995 111.58 175.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.416 ' ND2' ' HA ' ' A' ' 15' ' ' GLU . 81.2 m-20 -87.38 -42.56 12.76 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.029 0.442 . . . . 62.509999999999998 109.85 167.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 89.8 mmm -76.84 -66.91 0.76 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.938 -0.574 . . . . 74.230000000000004 111.319 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -71.5 -14.3 62.07 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.998 0.428 . . . . 75.019999999999996 111.087 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 17' ' ' GLN . 17.0 t70 74.54 -68.27 0.22 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.992 0.917 . . . . 72.120000000000005 112.673 177.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -136.1 36.81 1.97 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.553 -0.832 . . . . 65.540000000000006 113.885 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -102.85 152.72 38.52 Favored Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 122.51 -0.406 . . . . 71.519999999999996 111.499 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.554 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 49.9 Cg_endo -68.21 129.19 18.81 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.29 1.993 . . . . 75.430000000000007 111.999 174.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.481 HG13 ' HG3' ' A' ' 16' ' ' ARG . 38.5 t -79.44 135.83 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.155 0.502 . . . . 60.310000000000002 111.68 -174.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.542 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -88.28 135.72 33.32 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.139 -0.482 . . . . 72.049999999999997 111.29 -177.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.2 m -55.07 -31.27 61.03 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.907 0.384 . . . . 52.32 111.963 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -60.54 -54.15 48.89 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 111.798 0.295 . . . . 75.200000000000003 111.798 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.42 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 2.3 m-20 -57.82 -37.48 73.88 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.885 0.374 . . . . 73.120000000000005 111.619 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.565 ' HA ' HG21 ' A' ' 12' ' ' ILE . 59.0 mt -66.91 -49.23 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.428 -0.351 . . . . 73.310000000000002 111.293 178.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.06 -34.85 73.98 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.992 0.425 . . . . 61.210000000000001 111.455 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -66.08 -51.92 53.6 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.042 -0.526 . . . . 73.530000000000001 111.35 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.02 -35.84 72.17 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.506 0.558 . . . . 74.040000000000006 112.506 -177.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.18 -33.69 38.1 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.391 0.515 . . . . 54.43 112.391 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.37 -0.11 83.01 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.001 -0.618 . . . . 73.099999999999994 112.989 -177.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 71.6 mt -85.1 160.0 20.06 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 122.602 -0.352 . . . . 75.450000000000003 110.897 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 41' ' ' VAL . 47.6 t -79.74 157.44 27.13 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 120.788 0.328 . . . . 73.540000000000006 111.8 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.0 mm -51.95 -52.37 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 112.808 0.67 . . . . 72.349999999999994 112.808 -174.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.532 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 32.9 p90 -58.29 -44.43 88.49 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.985 0.421 . . . . 71.030000000000001 111.083 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -62.13 -47.09 86.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.241 0.543 . . . . 64.030000000000001 110.993 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 37' ' ' SER . 95.0 t -60.04 -51.47 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 115.972 -0.558 . . . . 73.010000000000005 111.877 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -62.94 -26.05 68.63 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 111.893 0.331 . . . . 71.209999999999994 111.893 -177.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 39' ' ' TYR . 79.5 mt -65.99 -51.47 58.1 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.617 0.246 . . . . 63.039999999999999 111.011 175.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -65.56 -39.61 91.87 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.757 0.313 . . . . 72.319999999999993 111.695 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.504 HD13 ' CD1' ' A' ' 67' ' ' TRP . 96.5 mt -58.2 -41.69 84.53 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.344 0.592 . . . . 73.420000000000002 110.651 174.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -60.6 -43.97 96.79 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.629 -0.714 . . . . 75.319999999999993 111.054 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 43' ' ' LEU . 74.9 mt-30 -60.38 -38.03 82.62 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.208 -0.451 . . . . 71.329999999999998 111.249 176.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 93.0 mt -63.83 -32.76 74.38 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.711 0.291 . . . . 64.099999999999994 111.309 175.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -70.56 -41.39 72.5 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 122.06 -0.4 . . . . 75.230000000000004 110.555 171.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -56.12 -42.68 77.23 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.785 -0.643 . . . . 73.129999999999995 111.848 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.559 HG23 HG23 ' A' ' 53' ' ' VAL . 35.0 m -82.13 -15.13 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 112.492 0.553 . . . . 63.130000000000003 112.492 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.92 8.06 32.43 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 114.658 0.623 . . . . 72.540000000000006 114.658 175.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.559 HG23 HG23 ' A' ' 51' ' ' VAL . 95.1 t -77.12 -52.61 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 117.409 0.605 . . . . 64.349999999999994 111.975 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.0 mt -106.41 149.94 26.52 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.72 0.637 . . . . 74.530000000000001 112.72 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 68' ' ' ARG . 12.6 pt-20 -111.1 146.08 37.44 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.992 -0.549 . . . . 74.540000000000006 110.068 172.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.429 ' HB2' ' HE3' ' A' ' 56' ' ' LYS . 46.1 mtmt -80.86 104.38 11.33 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.851 0.358 . . . . 52.049999999999997 111.475 -177.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.582 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 53.3 t -88.0 90.5 3.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-O 121.724 0.773 . . . . 70.420000000000002 110.948 176.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.767 HD21 ' HA2' ' A' ' 65' ' ' GLY . 15.5 m120 -138.93 89.4 2.36 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.974 -1.012 . . . . 41.399999999999999 109.681 174.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.42 -58.55 3.19 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.759 0.651 . . . . 73.5 112.759 -173.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -100.3 -168.58 29.12 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.1 -0.571 . . . . 63.119999999999997 113.89 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -98.12 135.32 39.95 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 122.52 -0.4 . . . . 61.109999999999999 111.343 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.16 27.35 33.89 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 121.152 -0.547 . . . . 63.530000000000001 112.808 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 32.6 m -106.56 153.21 40.73 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 120.78 0.324 . . . . 74.129999999999995 111.857 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -76.67 162.15 33.11 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.558 2.172 . . . . 74.310000000000002 112.85 176.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.767 ' HA2' HD21 ' A' ' 58' ' ' ASN . . . -74.72 103.46 1.54 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.0 -0.619 . . . . 72.400000000000006 113.22 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.582 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 72.8 mt -99.96 139.12 36.09 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.966 0.383 . . . . 61.32 110.091 175.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.504 ' CD1' HD13 ' A' ' 45' ' ' LEU . 74.5 m95 -121.52 139.11 53.92 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.133 0.492 . . . . 74.25 112.005 -175.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.536 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 46.3 ttt180 -136.42 128.11 28.94 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.342 -0.39 . . . . 75.510000000000005 110.548 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 69' ' ' LEU . 4.6 pp -79.35 138.99 37.89 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.519 -0.738 . . . . 63.509999999999998 111.269 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.478 HD23 ' H ' ' A' ' 70' ' ' LEU . 2.1 pt? -124.6 11.47 8.54 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.215 -0.448 . . . . 73.319999999999993 110.944 179.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 . . . . . 0 C--O 1.254 1.332 0 CA-C-O 118.546 -0.74 . . . . 62.409999999999997 110.945 -178.741 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.8 mtp . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.809 0.338 . . . . 52.439999999999998 111.333 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.9 m 56.56 18.95 3.87 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.208 0.818 . . . . 53.219999999999999 113.208 176.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 58.72 26.98 15.31 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-O 121.498 0.666 . . . . 54.119999999999997 111.31 178.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.7 p -50.22 -57.64 7.36 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.257 0.836 . . . . 64.409999999999997 113.257 -174.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.42 HG23 HD11 ' A' ' 36' ' ' LEU . 48.0 mm -49.58 -41.3 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 112.819 0.674 . . . . 74.150000000000006 112.819 -175.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.9 t -62.52 -57.77 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 120.949 0.404 . . . . 71.140000000000001 111.682 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.5 m -63.39 -34.44 77.74 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.981 0.42 . . . . 75.420000000000002 111.276 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.408 ' O ' HG13 ' A' ' 12' ' ' ILE . 57.0 tptt -56.19 -53.14 60.74 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.202 -0.453 . . . . 74.510000000000005 110.837 177.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.416 HG23 HG21 ' A' ' 30' ' ' ILE . 62.7 mt -59.1 -47.32 90.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.107 -0.497 . . . . 61.530000000000001 111.965 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 61.4 mt -60.42 -43.19 93.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 112.093 0.405 . . . . 54.210000000000001 112.093 -178.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 85.4 p -60.65 -36.87 79.73 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 120.781 0.324 . . . . 60.229999999999997 111.176 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.593 HG21 ' HA ' ' A' ' 30' ' ' ILE . 79.8 mt -64.29 -40.73 90.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.078 0.466 . . . . 71.140000000000001 111.504 176.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.58 -52.06 65.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 120.885 0.374 . . . . 53.310000000000002 110.914 177.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -59.35 -40.76 87.44 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.949 0.404 . . . . 74.310000000000002 110.864 176.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 12' ' ' ILE . 16.9 tp10 -47.75 -56.04 8.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.246 0.618 . . . . 65.409999999999997 111.841 177.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.504 ' HG3' HG13 ' A' ' 25' ' ' VAL . 1.2 mmp_? -63.09 -37.56 87.69 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.393 -0.367 . . . . 73.209999999999994 111.555 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -79.61 -13.99 59.12 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 111.955 0.354 . . . . 75.420000000000002 111.955 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -73.11 -35.95 66.66 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.028 0.442 . . . . 62.32 109.862 170.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.1 mmt -67.17 -58.79 4.21 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.814 -0.63 . . . . 63.149999999999999 110.885 172.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -124.61 104.12 8.52 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.435 -0.348 . . . . 71.239999999999995 110.836 176.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -61.38 -14.38 27.32 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.317 0.858 . . . . 64.209999999999994 113.317 -175.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -117.35 15.13 13.21 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 120.92 -0.657 . . . . 44.340000000000003 113.908 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.53 128.46 26.89 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 117.272 0.536 . . . . 42.409999999999997 112.082 -177.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.575 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 58.7 Cg_endo -71.42 135.45 26.61 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.364 2.043 . . . . 75.109999999999999 112.865 176.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.504 HG13 ' HG3' ' A' ' 16' ' ' ARG . 24.5 t -80.41 139.87 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 120.846 0.355 . . . . 62.439999999999998 111.449 -177.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.514 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 12.0 mptt -91.63 130.03 37.51 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.406 -0.361 . . . . 73.040000000000006 110.946 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.3 m -47.05 -34.5 5.84 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 120.919 0.39 . . . . 74.540000000000006 111.935 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -60.09 -49.26 78.33 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.386 -0.37 . . . . 72.140000000000001 111.795 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -56.22 -49.55 73.77 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.095 0.474 . . . . 74.540000000000006 110.788 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.593 ' HA ' HG21 ' A' ' 12' ' ' ILE . 64.3 mt -59.06 -48.36 86.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.907 -0.588 . . . . 64.519999999999996 111.555 178.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.483 ' HA ' HG21 ' A' ' 41' ' ' VAL . . . -57.73 -52.25 66.21 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.274 -0.421 . . . . 75.450000000000003 111.813 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -65.3 -41.97 93.54 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.285 -0.416 . . . . 74.439999999999998 111.711 -177.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.93 -39.69 87.41 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.214 0.45 . . . . 73.340000000000003 112.214 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.03 -20.79 40.95 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.001 0.371 . . . . 72.129999999999995 112.001 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.55 32.75 24.04 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.212 -0.518 . . . . 73.219999999999999 112.617 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.42 HD11 HG23 ' A' ' 5' ' ' ILE . 74.2 mt -122.21 161.71 22.72 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.873 0.368 . . . . 64.010000000000005 111.161 -177.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 41' ' ' VAL . 69.0 m -82.78 152.13 25.83 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.703 0.287 . . . . 73.450000000000003 111.528 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.8 mm -50.56 -46.04 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 112.28 0.474 . . . . 70.219999999999999 112.28 -176.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -57.87 -52.07 66.99 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.809 0.338 . . . . 64.420000000000002 111.8 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -58.54 -46.49 86.73 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.209 0.528 . . . . 72.209999999999994 111.277 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.483 HG21 ' HA ' ' A' ' 31' ' ' ALA . 57.9 t -61.54 -42.23 93.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.802 -0.636 . . . . 73.420000000000002 111.52 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -55.03 -39.64 69.36 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.784 0.326 . . . . 72.209999999999994 111.615 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.56 -52.48 60.88 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.274 -0.421 . . . . 74.510000000000005 111.042 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -59.57 -50.21 74.76 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 111.932 0.345 . . . . 70.239999999999995 111.932 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.424 HD13 ' CD1' ' A' ' 67' ' ' TRP . 92.2 mt -57.51 -43.99 84.69 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.863 0.363 . . . . 71.099999999999994 111.69 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -59.1 -50.38 74.26 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.017 0.437 . . . . 74.150000000000006 110.796 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -54.87 -44.55 74.13 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.038 -0.528 . . . . 71.219999999999999 110.807 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.471 ' HA ' HG22 ' A' ' 51' ' ' VAL . 89.1 mt -59.46 -29.68 67.98 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.3 -0.409 . . . . 70.409999999999997 111.782 178.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -72.53 -46.46 54.44 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.955 -0.466 . . . . 75.019999999999996 110.89 174.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -70.39 -16.89 63.01 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.835 0.68 . . . . 61.140000000000001 112.835 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.592 HG23 HG23 ' A' ' 53' ' ' VAL . 30.1 m -98.96 4.64 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 O-C-N 122.106 -0.372 . . . . 70.409999999999997 111.749 176.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.44 31.42 27.7 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 114.7 0.64 . . . . 65.140000000000001 114.7 174.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.592 HG23 HG23 ' A' ' 51' ' ' VAL . 95.3 t -105.81 -54.59 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 117.213 0.506 . . . . 71.329999999999998 111.749 176.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.1 mt -99.18 162.91 12.79 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.889 0.7 . . . . 51.020000000000003 112.889 -176.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 68' ' ' ARG . 17.0 tp10 -124.95 149.56 47.52 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.381 -0.827 . . . . 53.530000000000001 110.709 -175.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -78.96 129.28 34.31 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.048 0.758 . . . . 70.409999999999997 113.048 -172.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.9 t -140.09 115.83 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.757 0.313 . . . . 72.329999999999998 111.188 170.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.8 t30 56.5 88.78 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.559 0.577 . . . . 54.439999999999998 112.559 175.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.501 ' HA ' HG21 ' A' ' 63' ' ' VAL . . . -136.53 152.77 50.87 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.063 -0.517 . . . . 62.049999999999997 111.646 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.28 -103.16 0.47 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.18 -0.533 . . . . 72.120000000000005 113.381 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.784 ' HD2' ' H ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -104.8 126.73 52.17 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.935 0.397 . . . . 72.409999999999997 111.742 -174.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.47 49.04 62.2 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.199 -0.455 . . . . 61.310000000000002 113.597 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.501 HG21 ' HA ' ' A' ' 59' ' ' ALA . 35.5 m -116.96 140.14 26.62 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 112.042 0.386 . . . . 72.540000000000006 112.042 -175.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -83.63 -3.45 10.64 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.947 2.431 . . . . 60.219999999999999 112.908 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.92 102.96 0.08 OUTLIER Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.181 -0.533 . . . . 54.240000000000002 113.024 -177.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 24' ' ' PRO . 58.2 mt -107.64 133.11 52.55 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.883 0.373 . . . . 71.430000000000007 110.159 177.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.424 ' CD1' HD13 ' A' ' 45' ' ' LEU . 57.7 m95 -126.37 135.86 51.97 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.191 0.811 . . . . 70.340000000000003 113.191 -171.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.533 ' HB2' ' HB3' ' A' ' 55' ' ' GLU . 63.0 mtp180 -113.24 176.21 5.12 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.521 -0.763 . . . . 62.299999999999997 109.333 169.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.444 ' O ' HD12 ' A' ' 69' ' ' LEU . 3.5 pp -127.1 149.66 49.84 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.715 -0.616 . . . . 63.539999999999999 112.343 175.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.438 ' H ' HD23 ' A' ' 70' ' ' LEU . 1.4 pt? -121.57 -5.97 9.22 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.204 -0.453 . . . . 74.450000000000003 110.866 173.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.251 1.137 0 N-CA-C 112.975 0.731 . . . . 73.430000000000007 112.975 176.275 . . . . . . . . 0 0 . 1 stop_ save_